| Symbol | LLY |
|---|---|
| Name | ELI LILLY & CO |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Pharmaceutical Preparations |
| Address | LILLY CORPORATE CTR, INDIANAPOLIS, IN 46285 |
| Telephone | 3172762000 |
| Fax | — |
| — | |
| Website | https://www.lilly.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000059478 |
| Description | Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lillys key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. Additional info from NASDAQ: |
2026-05-19 20:19
Director Sulzberger Gabrielle 🟢 acquired 5 shares of ELI LILLY & Co (LLY) at $988.09 Transaction Date: May 18, 2026 | Filing ID: 000010
Read more
2026-05-19 20:18
Director LUCIANO JUAN R 🟢 acquired 16 shares of ELI LILLY & Co (LLY) at $988.09 Transaction Date: May 18, 2026 | Filing ID: 000055
Read more
2026-05-19 20:17
Director Fyrwald J Erik 🟢 acquired 10 shares of ELI LILLY & Co (LLY) at $988.09 Transaction Date: May 18, 2026 | Filing ID: 000053
Read more
2026-05-19 20:16
Director Alvarez Ralph 🟢 acquired 13 shares of ELI LILLY & Co (LLY) at $988.09 Transaction Date: May 18, 2026 | Filing ID: 000008
Read more
2026-05-18 14:00
Lilly to participate in Bernsteins 42nd Annual Strategic Decisions Conference
Read more
2026-05-11 17:31
New Form SD - ELI LILLY & Co <b>Filed:</b> 2026-05-11 <b>AccNo:</b> 0000059478-26-000051 <b>Size:</b> 28 KB
Read more
2026-05-08 07:09
New Form 424B2 - ELI LILLY & Co <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001193125-26-213175 <b>Size:</b> 897 KB
Read more
2026-05-07 20:00
LILLY ENDOWMENT INC 🔴 sold 15.8K shares of ELI LILLY & Co (LLY) at $996.18 ($15.8M) Transaction Date: May 06, 2026 | Filing ID: 000015
Read more
2026-05-06 20:35
📋 LILLY ENDOWMENT, INC. (Shareholder) plans to sell 300K shares of ELI LILLY AND COMPANY (at $988.87 each, total $296.7M) Filed: May 06, 2026 | ID: 000013
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT00065312 | An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes | Phase2 | Diabetes Mellitus, Non-Insulin-Dependent | Completed | — | — | ClinicalTrials.gov |
| NCT00089869 | A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schiz… | Phase1 | Schizophrenia | Completed | — | — | ClinicalTrials.gov |
| NCT02307812 | Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal J… | — | Gastric Cancer | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT05225259 | Expanded Access for LOXO-260 in Participants With Cancer Caused by an Abnormal … | — | Carcinoma, Non-Small-Cell Lung | No_Longer_Available | — | — | ClinicalTrials.gov |
| NCT05172700 | Expanded Access Program for Pirtobrutinib for Participants With B-Cell Cancer | — | Leukemia, Lymphocytic, Chronic, B-Cell | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT02632994 | Master Rollover Protocol for Continued Safety Assessment of Study Drug | — | Cancer | Available | — | — | ClinicalTrials.gov |
| NCT00089869 | A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schiz… | Phase1 | Schizophrenia | Completed | — | — | ClinicalTrials.gov |
| NCT02792725 | Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of… | — | Metastatic Breast Cancer | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT04603651 | Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment o… | — | COVID-19 | No_Longer_Available | — | — | ClinicalTrials.gov |
| NCT00034463 | ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer | Phase1 | Metastases | Completed | — | — | ClinicalTrials.gov |
| NCT03994627 | Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma | — | Soft Tissue Sarcoma | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT00071708 | Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neurosci… | — | Major Depressive Disorder | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT02632994 | Master Rollover Protocol for Continued Safety Assessment of Study Drug | — | Cancer | Available | — | — | ClinicalTrials.gov |
| NCT00097383 | Study of Alimta and Epirubicin Administered in Patients With Locally Advanced o… | Phase1 | Breast Cancer | Completed | — | — | ClinicalTrials.gov |
| NCT05225259 | Expanded Access for LOXO-260 in Participants With Cancer Caused by an Abnormal … | — | Carcinoma, Non-Small-Cell Lung | No_Longer_Available | — | — | ClinicalTrials.gov |
| NCT02792725 | Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of… | — | Metastatic Breast Cancer | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT03906331 | Expanded Access for the Treatment of Cancers With Rearranged During Transfectio… | — | Non Small Cell Lung Cancer | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT00178451 | Stroke Prevention With Abciximab in Carotid Endarterectomy | Phase1 | Carotid Stenosis | Withdrawn | — | — | ClinicalTrials.gov |
| NCT03763604 | Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment … | — | Metastatic Breast Cancer | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT00136929 | Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardi… | Na | Myocardial Infarction | Unknown | — | — | ClinicalTrials.gov |
| NCT00097383 | Study of Alimta and Epirubicin Administered in Patients With Locally Advanced o… | Phase1 | Breast Cancer | Completed | — | — | ClinicalTrials.gov |
| NCT00034125 | Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metast… | Phase3 | Breast Neoplasms | Completed | — | — | ClinicalTrials.gov |
| NCT00094640 | Pharmacokinetic Characterization of Intramuscular Olanzapine Depot | Phase1 | Schizophrenia | Completed | — | — | ClinicalTrials.gov |
| NCT03554434 | An Expanded Access Program for AM0010 (Pegilodecakin) | — | Melanoma | No_Longer_Available | — | — | ClinicalTrials.gov |
| NCT00071708 | Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neurosci… | — | Major Depressive Disorder | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT00065312 | An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes | Phase2 | Diabetes Mellitus, Non-Insulin-Dependent | Completed | — | — | ClinicalTrials.gov |
| NCT01674738 | TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell L… | Phase2 | Carcinoma, Non-Small-Cell Lung | Withdrawn | — | — | ClinicalTrials.gov |
| NCT03763604 | Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment … | — | Metastatic Breast Cancer | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT00055432 | Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With … | Phase2 | Ovarian Cancer | Terminated | — | — | ClinicalTrials.gov |
| NCT00051506 | ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive St… | Phase2 | Lung Neoplasms | Completed | — | — | ClinicalTrials.gov |
| NCT00046137 | Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteop… | Phase3 | Osteoporosis, Postmenopausal | Completed | — | — | ClinicalTrials.gov |
| NCT03906331 | Expanded Access for the Treatment of Cancers With Rearranged During Transfectio… | — | Non Small Cell Lung Cancer | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT00040625 | ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Ma… | — | Mesothelioma | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT00035971 | EVA: Evista Alendronate Comparison | Phase4 | Osteoporosis | Completed | — | — | ClinicalTrials.gov |
| NCT01724580 | Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes | — | Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE) | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT05172700 | Expanded Access Program for Pirtobrutinib for Participants With B-Cell Cancer | — | Leukemia, Lymphocytic, Chronic, B-Cell | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT00035061 | A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurr… | Phase2 | Urologic Neoplasms | Completed | — | — | ClinicalTrials.gov |
| NCT00035971 | EVA: Evista Alendronate Comparison | Phase4 | Osteoporosis | Completed | — | — | ClinicalTrials.gov |
| NCT00035061 | A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurr… | Phase2 | Urologic Neoplasms | Completed | — | — | ClinicalTrials.gov |
| NCT00035035 | A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in P… | Phase3 | Pancreatic Neoplasms | Completed | — | — | ClinicalTrials.gov |
| NCT00035035 | A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in P… | Phase3 | Pancreatic Neoplasms | Completed | — | — | ClinicalTrials.gov |
| NCT00034619 | A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered … | Phase2 | Colorectal Cancer | Completed | — | — | ClinicalTrials.gov |
| NCT00034606 | Comparing 3 Schedules of Alimta Plus Gemzar | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | — | — | ClinicalTrials.gov |
| NCT00034593 | A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or … | Phase2 | Urologic Neoplasms | Completed | — | — | ClinicalTrials.gov |
| NCT00034502 | A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previo… | Phase1 | Colorectal Cancer | Completed | — | — | ClinicalTrials.gov |
| NCT00136929 | Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardi… | Na | Myocardial Infarction | Unknown | — | — | ClinicalTrials.gov |
| NCT00034619 | A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered … | Phase2 | Colorectal Cancer | Completed | — | — | ClinicalTrials.gov |
| NCT00497484 | Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidis… | Na | Pseudohypoparathyroidism | Unknown | — | — | ClinicalTrials.gov |
| NCT00040625 | ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Ma… | — | Mesothelioma | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT03994627 | Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma | — | Soft Tissue Sarcoma | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT01674738 | TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell L… | Phase2 | Carcinoma, Non-Small-Cell Lung | Withdrawn | — | — | ClinicalTrials.gov |
| NCT00034489 | A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients… | Phase2 | Breast Neoplasms | Completed | — | — | ClinicalTrials.gov |
| NCT04603651 | Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment o… | — | COVID-19 | No_Longer_Available | — | — | ClinicalTrials.gov |
| NCT00178451 | Stroke Prevention With Abciximab in Carotid Endarterectomy | Phase1 | Carotid Stenosis | Withdrawn | — | — | ClinicalTrials.gov |
| NCT03554434 | An Expanded Access Program for AM0010 (Pegilodecakin) | — | Melanoma | No_Longer_Available | — | — | ClinicalTrials.gov |
| NCT00046137 | Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteop… | Phase3 | Osteoporosis, Postmenopausal | Completed | — | — | ClinicalTrials.gov |
| NCT00094640 | Pharmacokinetic Characterization of Intramuscular Olanzapine Depot | Phase1 | Schizophrenia | Completed | — | — | ClinicalTrials.gov |
| NCT06033001 | Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostat… | — | Castration-Resistant Prostatic Cancer | Temporarily_Not_Available | — | — | ClinicalTrials.gov |
| NCT02065765 | International Expanded Access Program to Provide Ramucirumab for the Treatment … | — | Metastatic Gastric Cancer | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT02307812 | Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal J… | — | Gastric Cancer | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT00051506 | ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive St… | Phase2 | Lung Neoplasms | Completed | — | — | ClinicalTrials.gov |
| NCT00034606 | Comparing 3 Schedules of Alimta Plus Gemzar | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | — | — | ClinicalTrials.gov |
| NCT00034125 | Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metast… | Phase3 | Breast Neoplasms | Completed | — | — | ClinicalTrials.gov |
| NCT00055432 | Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With … | Phase2 | Ovarian Cancer | Terminated | — | — | ClinicalTrials.gov |
| NCT00034463 | ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic Cancer | Phase1 | Metastases | Completed | — | — | ClinicalTrials.gov |
| NCT00034489 | A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients… | Phase2 | Breast Neoplasms | Completed | — | — | ClinicalTrials.gov |
| NCT01724580 | Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes | — | Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE) | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT00034593 | A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or … | Phase2 | Urologic Neoplasms | Completed | — | — | ClinicalTrials.gov |
| NCT00034502 | A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previo… | Phase1 | Colorectal Cancer | Completed | — | — | ClinicalTrials.gov |
| NCT00497484 | Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidis… | Na | Pseudohypoparathyroidism | Unknown | — | — | ClinicalTrials.gov |
| NCT02065765 | International Expanded Access Program to Provide Ramucirumab for the Treatment … | — | Metastatic Gastric Cancer | Approved_For_Marketing | — | — | ClinicalTrials.gov |
| NCT06033001 | Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostat… | — | Castration-Resistant Prostatic Cancer | Temporarily_Not_Available | — | — | ClinicalTrials.gov |
| NCT06911944 | Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation | Phase4 | Down Syndrome (DS) | Not_Yet_Recruiting | 2026-08-01 | 2028-12-31 | ClinicalTrials.gov |
| NCT06911944 | Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation | Phase4 | Down Syndrome (DS) | Not_Yet_Recruiting | 2026-08-01 | 2028-12-31 | ClinicalTrials.gov |
| NCT07209267 | Baricitinib Curative Repression of HIV-1 | Phase2 | HIV Infection | Not_Yet_Recruiting | 2026-07-01 | 2028-01-01 | ClinicalTrials.gov |
| NCT07209267 | Baricitinib Curative Repression of HIV-1 | Phase2 | HIV Infection | Not_Yet_Recruiting | 2026-07-01 | 2028-01-01 | ClinicalTrials.gov |
| NCT07101328 | A Study of LY4152199 in Participants With Previously Treated B-cell Malignancie… | Phase1 | Lymphoma, Non-Hodgkin | Not_Yet_Recruiting | 2026-06-01 | 2029-09-01 | ClinicalTrials.gov |
| NCT07572773 | CHAMP Lung Cancer Screening Program | Na | Lung Cancer | Not_Yet_Recruiting | 2026-06-01 | 2028-05-01 | ClinicalTrials.gov |
| NCT07472608 | Obesity Medicine Bank of the Quebec Heart and Lung Institute - Laval University… | — | Obesity | Not_Yet_Recruiting | 2026-06-01 | 2051-06-01 | ClinicalTrials.gov |
| NCT07548450 | Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Re… | Phase2 | Waldenstrom Macroglobulinemia | Not_Yet_Recruiting | 2026-06-01 | 2035-06-01 | ClinicalTrials.gov |
| NCT07547540 | A Study of LY3971297 in Participants With Heart Failure | Phase1 | Heart Failure | Not_Yet_Recruiting | 2026-06-01 | 2027-08-01 | ClinicalTrials.gov |
| NCT07101328 | A Study of LY4152199 in Participants With Previously Treated B-cell Malignancie… | Phase1 | Lymphoma, Non-Hodgkin | Not_Yet_Recruiting | 2026-06-01 | 2029-09-01 | ClinicalTrials.gov |
| NCT07572773 | CHAMP Lung Cancer Screening Program | Na | Lung Cancer | Not_Yet_Recruiting | 2026-06-01 | 2028-05-01 | ClinicalTrials.gov |
| NCT07589608 | A Study to Investigate Weight Management With Macupatide and Eloralintide, Alon… | Phase2 | Overweight | Not_Yet_Recruiting | 2026-06-01 | 2028-02-01 | ClinicalTrials.gov |
| NCT07548450 | Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Re… | Phase2 | Waldenstrom Macroglobulinemia | Not_Yet_Recruiting | 2026-06-01 | 2035-06-01 | ClinicalTrials.gov |
| NCT07472608 | Obesity Medicine Bank of the Quebec Heart and Lung Institute - Laval University… | — | Obesity | Not_Yet_Recruiting | 2026-06-01 | 2051-06-01 | ClinicalTrials.gov |
| NCT07589608 | A Study to Investigate Weight Management With Macupatide and Eloralintide, Alon… | Phase2 | Overweight | Not_Yet_Recruiting | 2026-06-01 | 2028-02-01 | ClinicalTrials.gov |
| NCT07547540 | A Study of LY3971297 in Participants With Heart Failure | Phase1 | Heart Failure | Not_Yet_Recruiting | 2026-06-01 | 2027-08-01 | ClinicalTrials.gov |
| NCT07545759 | A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrom… | Phase2 | Irritable Bowel Syndrome | Recruiting | 2026-05-06 | 2027-11-01 | ClinicalTrials.gov |
| NCT07545759 | A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrom… | Phase2 | Irritable Bowel Syndrome | Recruiting | 2026-05-06 | 2027-11-01 | ClinicalTrials.gov |
| NCT07483073 | A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative C… | Phase2 | Colitis, Ulcerative | Recruiting | 2026-05-04 | 2028-03-01 | ClinicalTrials.gov |
| NCT07483099 | A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab… | Phase2 | Crohn Disease | Recruiting | 2026-05-04 | 2028-03-01 | ClinicalTrials.gov |
| NCT07483073 | A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative C… | Phase2 | Colitis, Ulcerative | Recruiting | 2026-05-04 | 2028-03-01 | ClinicalTrials.gov |
| NCT07483099 | A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab… | Phase2 | Crohn Disease | Recruiting | 2026-05-04 | 2028-03-01 | ClinicalTrials.gov |
| NCT07566338 | A Study of LY4302814 in Healthy Participants | Phase1 | Healthy | Not_Yet_Recruiting | 2026-05-01 | 2027-08-01 | ClinicalTrials.gov |
| NCT07592572 | A Study of the Effects of Itraconazole on LY4395089 in Healthy Participants | Phase1 | Healthy | Not_Yet_Recruiting | 2026-05-01 | 2026-07-01 | ClinicalTrials.gov |
| NCT07589595 | A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (… | Phase2 | Cognitive Dysfunction | Not_Yet_Recruiting | 2026-05-01 | 2028-08-01 | ClinicalTrials.gov |
| NCT07571174 | A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Scler… | Phase1 | Amyotrophic Lateral Sclerosis | Not_Yet_Recruiting | 2026-05-01 | 2029-06-01 | ClinicalTrials.gov |
| NCT07571200 | A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic… | Phase1 | Amyotrophic Lateral Sclerosis | Not_Yet_Recruiting | 2026-05-01 | 2029-06-01 | ClinicalTrials.gov |
| NCT07287098 | A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Recept… | Phase2 | Breast Neoplasms | Not_Yet_Recruiting | 2026-05-01 | 2029-12-01 | ClinicalTrials.gov |
| NCT07287098 | A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Recept… | Phase2 | Breast Neoplasms | Not_Yet_Recruiting | 2026-05-01 | 2029-12-01 | ClinicalTrials.gov |
| NCT07566338 | A Study of LY4302814 in Healthy Participants | Phase1 | Healthy | Not_Yet_Recruiting | 2026-05-01 | 2027-08-01 | ClinicalTrials.gov |
| NCT07571200 | A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic… | Phase1 | Amyotrophic Lateral Sclerosis | Not_Yet_Recruiting | 2026-05-01 | 2029-06-01 | ClinicalTrials.gov |
| NCT07571174 | A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Scler… | Phase1 | Amyotrophic Lateral Sclerosis | Not_Yet_Recruiting | 2026-05-01 | 2029-06-01 | ClinicalTrials.gov |
| NCT07589595 | A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (… | Phase2 | Cognitive Dysfunction | Not_Yet_Recruiting | 2026-05-01 | 2028-08-01 | ClinicalTrials.gov |
| NCT07592572 | A Study of the Effects of Itraconazole on LY4395089 in Healthy Participants | Phase1 | Healthy | Not_Yet_Recruiting | 2026-05-01 | 2026-07-01 | ClinicalTrials.gov |
| NCT07545772 | A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrom… | Phase2 | Irritable Bowel Syndrome | Recruiting | 2026-04-29 | 2027-09-01 | ClinicalTrials.gov |
| NCT07545772 | A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrom… | Phase2 | Irritable Bowel Syndrome | Recruiting | 2026-04-29 | 2027-09-01 | ClinicalTrials.gov |
| NCT07226843 | A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers | Phase1 | Lymphoma, Non-Hodgkin's | Recruiting | 2026-04-17 | 2030-02-01 | ClinicalTrials.gov |
| NCT07226843 | A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers | Phase1 | Lymphoma, Non-Hodgkin's | Recruiting | 2026-04-17 | 2030-02-01 | ClinicalTrials.gov |
| NCT07533006 | A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Lo… | Phase2 | Alopecia Areata | Recruiting | 2026-04-14 | 2027-10-01 | ClinicalTrials.gov |
| NCT07533019 | A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo | Phase2 | Vitiligo | Recruiting | 2026-04-14 | 2027-09-01 | ClinicalTrials.gov |
| NCT07533019 | A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo | Phase2 | Vitiligo | Recruiting | 2026-04-14 | 2027-09-01 | ClinicalTrials.gov |
| NCT07533006 | A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Lo… | Phase2 | Alopecia Areata | Recruiting | 2026-04-14 | 2027-10-01 | ClinicalTrials.gov |
| NCT07571161 | Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired… | Phase3 | Alzheimer Disease | Not_Yet_Recruiting | 2026-04-01 | 2030-04-01 | ClinicalTrials.gov |
| NCT07511816 | A Study of LY4515100 in Participants With Pain Following Third Molar Removal | Phase2 | Acute Pain | Recruiting | 2026-04-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT07545590 | A Study of Eltrekibart (LY3041658) in Healthy Participants | Phase1 | Healthy | Not_Yet_Recruiting | 2026-04-01 | 2026-08-01 | ClinicalTrials.gov |
| NCT06868381 | A Trial of Baricitinib in Patients With Cardiac Sarcoidosis | Phase2 | Cardiac Sarcoidosis | Not_Yet_Recruiting | 2026-04-01 | 2028-12-01 | ClinicalTrials.gov |
| NCT07571161 | Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired… | Phase3 | Alzheimer Disease | Not_Yet_Recruiting | 2026-04-01 | 2030-04-01 | ClinicalTrials.gov |
| NCT07511816 | A Study of LY4515100 in Participants With Pain Following Third Molar Removal | Phase2 | Acute Pain | Recruiting | 2026-04-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT07545590 | A Study of Eltrekibart (LY3041658) in Healthy Participants | Phase1 | Healthy | Not_Yet_Recruiting | 2026-04-01 | 2026-08-01 | ClinicalTrials.gov |
| NCT06868381 | A Trial of Baricitinib in Patients With Cardiac Sarcoidosis | Phase2 | Cardiac Sarcoidosis | Not_Yet_Recruiting | 2026-04-01 | 2028-12-01 | ClinicalTrials.gov |
| NCT07519525 | A Study of [14C]-LY4064809 in Healthy Participants | Phase1 | Healthy | Recruiting | 2026-03-27 | 2026-05-01 | ClinicalTrials.gov |
| NCT07519525 | A Study of [14C]-LY4064809 in Healthy Participants | Phase1 | Healthy | Recruiting | 2026-03-27 | 2026-05-01 | ClinicalTrials.gov |
| NCT07415044 | LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis | Phase2 | Ulcerative Colitis (UC) | Recruiting | 2026-03-26 | 2031-07-01 | ClinicalTrials.gov |
| NCT07415044 | LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis | Phase2 | Ulcerative Colitis (UC) | Recruiting | 2026-03-26 | 2031-07-01 | ClinicalTrials.gov |
| NCT07446101 | A Study of Mirikizumab Solution (LY3074828) in Healthy Participants | Phase1 | Healthy | Recruiting | 2026-03-24 | 2027-02-01 | ClinicalTrials.gov |
| NCT07446101 | A Study of Mirikizumab Solution (LY3074828) in Healthy Participants | Phase1 | Healthy | Recruiting | 2026-03-24 | 2027-02-01 | ClinicalTrials.gov |
| NCT07476118 | A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or O… | Phase1 | Obesity | Recruiting | 2026-03-18 | 2027-02-01 | ClinicalTrials.gov |
| NCT07476118 | A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or O… | Phase1 | Obesity | Recruiting | 2026-03-18 | 2027-02-01 | ClinicalTrials.gov |
| NCT07218341 | A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic L… | Phase4 | Chronic Lymphocytic Leukemia | Recruiting | 2026-03-09 | 2032-12-01 | ClinicalTrials.gov |
| NCT07218341 | A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic L… | Phase4 | Chronic Lymphocytic Leukemia | Recruiting | 2026-03-09 | 2032-12-01 | ClinicalTrials.gov |
| NCT07443956 | Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis | Na | Psoriatic Arthritis (PsA) | Recruiting | 2026-03-09 | 2030-05-01 | ClinicalTrials.gov |
| NCT07443956 | Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis | Na | Psoriatic Arthritis (PsA) | Recruiting | 2026-03-09 | 2030-05-01 | ClinicalTrials.gov |
| NCT07503613 | Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy | — | Vestibular Schwannoma | Enrolling_By_Invitation | 2026-03-02 | 2040-04-01 | ClinicalTrials.gov |
| NCT07439250 | A Study of Olomorasib (LY3537982) in Healthy Participants | Phase1 | Healthy | Completed | 2026-03-02 | 2026-04-17 | ClinicalTrials.gov |
| NCT07503613 | Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy | — | Vestibular Schwannoma | Enrolling_By_Invitation | 2026-03-02 | 2040-04-01 | ClinicalTrials.gov |
| NCT07439250 | A Study of Olomorasib (LY3537982) in Healthy Participants | Phase1 | Healthy | Completed | 2026-03-02 | 2026-04-17 | ClinicalTrials.gov |
| NCT07485153 | A Study to Compare Two Different Sleep Tests in Participants With No Symptoms o… | — | Alzheimer's Disease | Not_Yet_Recruiting | 2026-03-01 | 2026-09-01 | ClinicalTrials.gov |
| NCT07485153 | A Study to Compare Two Different Sleep Tests in Participants With No Symptoms o… | — | Alzheimer's Disease | Not_Yet_Recruiting | 2026-03-01 | 2026-09-01 | ClinicalTrials.gov |
| NCT07438444 | A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either T… | Phase4 | Diabetes Mellitus, Type 2 | Recruiting | 2026-02-27 | 2027-10-01 | ClinicalTrials.gov |
| NCT07438444 | A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either T… | Phase4 | Diabetes Mellitus, Type 2 | Recruiting | 2026-02-27 | 2027-10-01 | ClinicalTrials.gov |
| NCT07426380 | A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and i… | Phase1 | Kidney Disease | Recruiting | 2026-02-24 | 2026-10-01 | ClinicalTrials.gov |
| NCT07426380 | A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and i… | Phase1 | Kidney Disease | Recruiting | 2026-02-24 | 2026-10-01 | ClinicalTrials.gov |
| NCT07285018 | A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants Wit… | Phase2 | Diabetic Peripheral Neuropathic Pain | Recruiting | 2026-02-16 | 2027-07-01 | ClinicalTrials.gov |
| NCT07285018 | A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants Wit… | Phase2 | Diabetic Peripheral Neuropathic Pain | Recruiting | 2026-02-16 | 2027-07-01 | ClinicalTrials.gov |
| NCT07420283 | A Study of Brenipatide in Participants With Opioid Use Disorder | Phase2 | Opioid Use Disorder | Recruiting | 2026-02-13 | 2028-03-01 | ClinicalTrials.gov |
| NCT07420283 | A Study of Brenipatide in Participants With Opioid Use Disorder | Phase2 | Opioid Use Disorder | Recruiting | 2026-02-13 | 2028-03-01 | ClinicalTrials.gov |
| NCT07410507 | A Study of Brenipatide in Adult Participants With Schizophrenia | Phase2 | Schizophrenia | Recruiting | 2026-02-10 | 2027-11-01 | ClinicalTrials.gov |
| NCT07369011 | A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apne… | Phase3 | Sleep Apnea, Obstructive | Recruiting | 2026-02-10 | 2028-04-01 | ClinicalTrials.gov |
| NCT07401862 | A Study of Eloralintide (LY3841136) in Participants With Different Levels of Li… | Phase1 | Hepatic Insufficiency | Recruiting | 2026-02-10 | 2027-03-01 | ClinicalTrials.gov |
| NCT07392190 | A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who… | Phase3 | Overweight | Recruiting | 2026-02-10 | 2028-07-01 | ClinicalTrials.gov |
| NCT07410507 | A Study of Brenipatide in Adult Participants With Schizophrenia | Phase2 | Schizophrenia | Recruiting | 2026-02-10 | 2027-11-01 | ClinicalTrials.gov |
| NCT07392190 | A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who… | Phase3 | Overweight | Recruiting | 2026-02-10 | 2028-07-01 | ClinicalTrials.gov |
| NCT07401862 | A Study of Eloralintide (LY3841136) in Participants With Different Levels of Li… | Phase1 | Hepatic Insufficiency | Recruiting | 2026-02-10 | 2027-03-01 | ClinicalTrials.gov |
| NCT07369011 | A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apne… | Phase3 | Sleep Apnea, Obstructive | Recruiting | 2026-02-10 | 2028-04-01 | ClinicalTrials.gov |
| NCT07412756 | A Study of Brenipatide in Adult Participants With Major Depressive Disorder | Phase3 | Depressive Disorder, Major | Recruiting | 2026-02-09 | 2028-02-01 | ClinicalTrials.gov |
| NCT07353931 | Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthr… | Phase3 | Osteoarthritis | Recruiting | 2026-02-09 | 2028-05-01 | ClinicalTrials.gov |
| NCT07412756 | A Study of Brenipatide in Adult Participants With Major Depressive Disorder | Phase3 | Depressive Disorder, Major | Recruiting | 2026-02-09 | 2028-02-01 | ClinicalTrials.gov |
| NCT07353931 | Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthr… | Phase3 | Osteoarthritis | Recruiting | 2026-02-09 | 2028-05-01 | ClinicalTrials.gov |
| NCT07321886 | A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight… | Phase3 | Obesity | Recruiting | 2026-02-06 | 2030-07-01 | ClinicalTrials.gov |
| NCT07321886 | A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight… | Phase3 | Obesity | Recruiting | 2026-02-06 | 2030-07-01 | ClinicalTrials.gov |
| NCT07222332 | A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children a… | Phase3 | Diabetes Mellitus, Type 1 | Recruiting | 2026-02-05 | 2028-07-01 | ClinicalTrials.gov |
| NCT07222332 | A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children a… | Phase3 | Diabetes Mellitus, Type 1 | Recruiting | 2026-02-05 | 2028-07-01 | ClinicalTrials.gov |
| NCT07276958 | A Study of LY4298445 in Healthy Participants and Participants With Systemic Lup… | Phase1 | Healthy | Recruiting | 2026-02-04 | 2028-03-01 | ClinicalTrials.gov |
| NCT07276958 | A Study of LY4298445 in Healthy Participants and Participants With Systemic Lup… | Phase1 | Healthy | Recruiting | 2026-02-04 | 2028-03-01 | ClinicalTrials.gov |
| NCT07191873 | Tirzepatide in Idiopathic Intracranial Hypertension Trial | Phase4 | Idiopathic Intracranial Hypertension (IIH) | Not_Yet_Recruiting | 2026-02-01 | 2028-02-01 | ClinicalTrials.gov |
| NCT07191873 | Tirzepatide in Idiopathic Intracranial Hypertension Trial | Phase4 | Idiopathic Intracranial Hypertension (IIH) | Not_Yet_Recruiting | 2026-02-01 | 2028-02-01 | ClinicalTrials.gov |
| NCT07346495 | A Study of Remternetug (LY3372993) in Healthy Chinese Participants | Phase1 | Healthy | Active_Not_Recruiting | 2026-01-31 | 2027-01-01 | ClinicalTrials.gov |
| NCT07346495 | A Study of Remternetug (LY3372993) in Healthy Chinese Participants | Phase1 | Healthy | Active_Not_Recruiting | 2026-01-31 | 2027-01-01 | ClinicalTrials.gov |
| NCT07357415 | A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who … | Phase3 | Obesity | Recruiting | 2026-01-24 | 2028-11-01 | ClinicalTrials.gov |
| NCT07357415 | A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who … | Phase3 | Obesity | Recruiting | 2026-01-24 | 2028-11-01 | ClinicalTrials.gov |
| NCT07339722 | A Study of LY4515100 in Healthy Participants | Phase1 | Healthy | Recruiting | 2026-01-15 | 2026-07-01 | ClinicalTrials.gov |
| NCT07339722 | A Study of LY4515100 in Healthy Participants | Phase1 | Healthy | Recruiting | 2026-01-15 | 2026-07-01 | ClinicalTrials.gov |
| NCT07299084 | A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding … | Phase1 | Diabetes Mellitus, Type 2 | Active_Not_Recruiting | 2026-01-14 | 2026-11-01 | ClinicalTrials.gov |
| NCT07299084 | A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding … | Phase1 | Diabetes Mellitus, Type 2 | Active_Not_Recruiting | 2026-01-14 | 2026-11-01 | ClinicalTrials.gov |
| NCT07339735 | A Study of LY4064809 in Healthy Adult Participants | Phase1 | Healthy Participants | Completed | 2026-01-12 | 2026-03-19 | ClinicalTrials.gov |
| NCT07339735 | A Study of LY4064809 in Healthy Adult Participants | Phase1 | Healthy Participants | Completed | 2026-01-12 | 2026-03-19 | ClinicalTrials.gov |
| NCT07222137 | A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in … | Phase3 | Diabetes Mellitus, Type 1 | Recruiting | 2026-01-12 | 2031-07-01 | ClinicalTrials.gov |
| NCT07222137 | A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in … | Phase3 | Diabetes Mellitus, Type 1 | Recruiting | 2026-01-12 | 2031-07-01 | ClinicalTrials.gov |
| NCT07313813 | A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) … | Phase1 | Type 2 Diabetes Mellitus (T2DM) | Active_Not_Recruiting | 2025-12-29 | 2026-08-01 | ClinicalTrials.gov |
| NCT07313813 | A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) … | Phase1 | Type 2 Diabetes Mellitus (T2DM) | Active_Not_Recruiting | 2025-12-29 | 2026-08-01 | ClinicalTrials.gov |
| NCT07174336 | A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in … | Phase3 | Breast Neoplasms | Recruiting | 2025-12-22 | 2033-05-01 | ClinicalTrials.gov |
| NCT07174336 | A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in … | Phase3 | Breast Neoplasms | Recruiting | 2025-12-22 | 2033-05-01 | ClinicalTrials.gov |
| NCT07258836 | A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer | Phase1 | Neoplasms | Recruiting | 2025-12-22 | 2027-01-01 | ClinicalTrials.gov |
| NCT07258836 | A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer | Phase1 | Neoplasms | Recruiting | 2025-12-22 | 2027-01-01 | ClinicalTrials.gov |
| NCT07282600 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight,… | Phase3 | Overweight | Recruiting | 2025-12-15 | 2028-02-01 | ClinicalTrials.gov |
| NCT07282600 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight,… | Phase3 | Overweight | Recruiting | 2025-12-15 | 2028-02-01 | ClinicalTrials.gov |
| NCT07279688 | Justification And Evaluation of Baricitinib Plus Corticosteroids Versus cortico… | Phase3 | Polymyalgia Rheumatica (PMR) | Not_Yet_Recruiting | 2025-12-12 | 2029-06-12 | ClinicalTrials.gov |
| NCT07279688 | Justification And Evaluation of Baricitinib Plus Corticosteroids Versus cortico… | Phase3 | Polymyalgia Rheumatica (PMR) | Not_Yet_Recruiting | 2025-12-12 | 2029-06-12 | ClinicalTrials.gov |
| NCT07218380 | A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary … | Phase3 | Carcinoma, Transitional Cell | Recruiting | 2025-12-12 | 2033-05-01 | ClinicalTrials.gov |
| NCT07218380 | A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary … | Phase3 | Carcinoma, Transitional Cell | Recruiting | 2025-12-12 | 2033-05-01 | ClinicalTrials.gov |
| NCT07269210 | A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglycerid… | Phase2 | Severe Hypertriglyceridemia | Recruiting | 2025-12-08 | 2027-08-01 | ClinicalTrials.gov |
| NCT07269210 | A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglycerid… | Phase2 | Severe Hypertriglyceridemia | Recruiting | 2025-12-08 | 2027-08-01 | ClinicalTrials.gov |
| NCT07258849 | A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid A… | Phase1 | Rheumatoid Arthritis (RA) | Recruiting | 2025-12-02 | 2028-03-01 | ClinicalTrials.gov |
| NCT07258849 | A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid A… | Phase1 | Rheumatoid Arthritis (RA) | Recruiting | 2025-12-02 | 2028-03-01 | ClinicalTrials.gov |
| NCT07241390 | A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With A… | Phase3 | Atherosclerosis Cardiovascular Disease | Recruiting | 2025-12-01 | 2031-08-01 | ClinicalTrials.gov |
| NCT07241390 | A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With A… | Phase3 | Atherosclerosis Cardiovascular Disease | Recruiting | 2025-12-01 | 2031-08-01 | ClinicalTrials.gov |
| NCT07254234 | A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With … | — | Cognitive Dysfunction | Not_Yet_Recruiting | 2025-12-01 | 2026-08-01 | ClinicalTrials.gov |
| NCT07254234 | A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With … | — | Cognitive Dysfunction | Not_Yet_Recruiting | 2025-12-01 | 2026-08-01 | ClinicalTrials.gov |
| NCT07169851 | A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused b… | Phase2 | Nausea | Recruiting | 2025-11-28 | 2027-02-01 | ClinicalTrials.gov |
| NCT07169851 | A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused b… | Phase2 | Nausea | Recruiting | 2025-11-28 | 2027-02-01 | ClinicalTrials.gov |
| NCT07286175 | A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipol… | Phase2 | Bipolar Disorder | Recruiting | 2025-11-24 | 2027-11-01 | ClinicalTrials.gov |
| NCT07247084 | A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Part… | Phase4 | Obesity | Recruiting | 2025-11-24 | 2032-07-01 | ClinicalTrials.gov |
| NCT07286175 | A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipol… | Phase2 | Bipolar Disorder | Recruiting | 2025-11-24 | 2027-11-01 | ClinicalTrials.gov |
| NCT07247084 | A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Part… | Phase4 | Obesity | Recruiting | 2025-11-24 | 2032-07-01 | ClinicalTrials.gov |
| NCT07225556 | A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwi… | Phase1 | Overweight | Recruiting | 2025-11-18 | 2026-12-01 | ClinicalTrials.gov |
| NCT07225556 | A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwi… | Phase1 | Overweight | Recruiting | 2025-11-18 | 2026-12-01 | ClinicalTrials.gov |
| NCT06948786 | Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades… | Phase2 | Grade 1 Follicular Lymphoma | Recruiting | 2025-11-17 | 2031-07-31 | ClinicalTrials.gov |
| NCT06948786 | Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades… | Phase2 | Grade 1 Follicular Lymphoma | Recruiting | 2025-11-17 | 2031-07-31 | ClinicalTrials.gov |
| NCT07232719 | A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight | Phase3 | Obesity | Active_Not_Recruiting | 2025-11-17 | 2027-07-01 | ClinicalTrials.gov |
| NCT07232719 | A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight | Phase3 | Obesity | Active_Not_Recruiting | 2025-11-17 | 2027-07-01 | ClinicalTrials.gov |
| NCT07231952 | A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström'… | Phase2 | Waldenstrom Macroglobulinemia | Recruiting | 2025-11-11 | 2028-04-11 | ClinicalTrials.gov |
| NCT07231952 | A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström'… | Phase2 | Waldenstrom Macroglobulinemia | Recruiting | 2025-11-11 | 2028-04-11 | ClinicalTrials.gov |
| NCT07186101 | LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately… | Phase2 | Ulcerative Colitis | Recruiting | 2025-11-10 | 2029-03-01 | ClinicalTrials.gov |
| NCT07186101 | LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately… | Phase2 | Ulcerative Colitis | Recruiting | 2025-11-10 | 2029-03-01 | ClinicalTrials.gov |
| NCT07202871 | A Study of How the Body Absorbs LY3537031 | Phase1 | Healthy | Active_Not_Recruiting | 2025-11-03 | 2026-09-01 | ClinicalTrials.gov |
| NCT07223840 | A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid … | Phase2 | Smoking | Recruiting | 2025-11-03 | 2027-02-01 | ClinicalTrials.gov |
| NCT07202871 | A Study of How the Body Absorbs LY3537031 | Phase1 | Healthy | Active_Not_Recruiting | 2025-11-03 | 2026-09-01 | ClinicalTrials.gov |
| NCT07223840 | A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid … | Phase2 | Smoking | Recruiting | 2025-11-03 | 2027-02-01 | ClinicalTrials.gov |
| NCT07223593 | Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Dise… | Phase3 | Peripheral Arterial Disease | Recruiting | 2025-10-31 | 2028-06-01 | ClinicalTrials.gov |
| NCT07223593 | Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Dise… | Phase3 | Peripheral Arterial Disease | Recruiting | 2025-10-31 | 2028-06-01 | ClinicalTrials.gov |
| NCT06906640 | Implementation pRogram to Improve Screening and Management for CKD in Diabetes … | Na | Chronic Kidney Disease(CKD) | Recruiting | 2025-10-28 | 2027-04-01 | ClinicalTrials.gov |
| NCT06906627 | Implementation pRogram to Improve Screening and Management for CKD in Diabetes … | Na | Chronic Kidney Disease(CKD) | Recruiting | 2025-10-28 | 2027-04-01 | ClinicalTrials.gov |
| NCT06906627 | Implementation pRogram to Improve Screening and Management for CKD in Diabetes … | Na | Chronic Kidney Disease(CKD) | Recruiting | 2025-10-28 | 2027-04-01 | ClinicalTrials.gov |
| NCT06906640 | Implementation pRogram to Improve Screening and Management for CKD in Diabetes … | Na | Chronic Kidney Disease(CKD) | Recruiting | 2025-10-28 | 2027-04-01 | ClinicalTrials.gov |
| NCT07232732 | A Study of LY3549492 in Healthy Participants and Participants With Overweight o… | Phase1 | Healthy | Recruiting | 2025-10-27 | 2026-07-01 | ClinicalTrials.gov |
| NCT07232732 | A Study of LY3549492 in Healthy Participants and Participants With Overweight o… | Phase1 | Healthy | Recruiting | 2025-10-27 | 2026-07-01 | ClinicalTrials.gov |
| NCT07247357 | A Study of LY4064809 in Healthy Adult Chinese Participants | Phase1 | Healthy | Completed | 2025-10-24 | 2025-12-16 | ClinicalTrials.gov |
| NCT07247357 | A Study of LY4064809 in Healthy Adult Chinese Participants | Phase1 | Healthy | Completed | 2025-10-24 | 2025-12-16 | ClinicalTrials.gov |
| NCT07213791 | A Study of LY4337713 in Participants With FAP-Positive Solid Tumors | Phase1 | Ovarian Neoplasms | Recruiting | 2025-10-22 | 2033-03-01 | ClinicalTrials.gov |
| NCT07219173 | A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants Wit… | Phase2 | Asthma | Recruiting | 2025-10-22 | 2028-06-01 | ClinicalTrials.gov |
| NCT07213804 | A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants Wi… | Phase3 | Ovarian Neoplasms | Recruiting | 2025-10-22 | 2031-08-01 | ClinicalTrials.gov |
| NCT07213791 | A Study of LY4337713 in Participants With FAP-Positive Solid Tumors | Phase1 | Ovarian Neoplasms | Recruiting | 2025-10-22 | 2033-03-01 | ClinicalTrials.gov |
| NCT07219173 | A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants Wit… | Phase2 | Asthma | Recruiting | 2025-10-22 | 2028-06-01 | ClinicalTrials.gov |
| NCT07213804 | A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants Wi… | Phase3 | Ovarian Neoplasms | Recruiting | 2025-10-22 | 2031-08-01 | ClinicalTrials.gov |
| NCT07165002 | A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With No… | Phase1 | Healthy | Recruiting | 2025-10-20 | 2026-08-01 | ClinicalTrials.gov |
| NCT07165002 | A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With No… | Phase1 | Healthy | Recruiting | 2025-10-20 | 2026-08-01 | ClinicalTrials.gov |
| NCT07219953 | A Study of Brenipatide in Participants With Alcohol Use Disorder | Phase3 | Alcohol Use Disorder | Recruiting | 2025-10-16 | 2028-04-01 | ClinicalTrials.gov |
| NCT07215559 | A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Com… | Phase2 | Obesity | Recruiting | 2025-10-16 | 2027-05-01 | ClinicalTrials.gov |
| NCT07219953 | A Study of Brenipatide in Participants With Alcohol Use Disorder | Phase3 | Alcohol Use Disorder | Recruiting | 2025-10-16 | 2028-04-01 | ClinicalTrials.gov |
| NCT07215559 | A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Com… | Phase2 | Obesity | Recruiting | 2025-10-16 | 2027-05-01 | ClinicalTrials.gov |
| NCT07165028 | A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Assoc… | Phase3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | Recruiting | 2025-10-15 | 2032-08-01 | ClinicalTrials.gov |
| NCT07219966 | A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Diso… | Phase3 | Alcohol Use Disorder | Recruiting | 2025-10-15 | 2028-04-01 | ClinicalTrials.gov |
| NCT07219966 | A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Diso… | Phase3 | Alcohol Use Disorder | Recruiting | 2025-10-15 | 2028-04-01 | ClinicalTrials.gov |
| NCT07165028 | A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Assoc… | Phase3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | Recruiting | 2025-10-15 | 2032-08-01 | ClinicalTrials.gov |
| NCT07215312 | A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated Wi… | Phase2 | Diabetes Mellitus, Type 2 | Recruiting | 2025-10-13 | 2026-12-01 | ClinicalTrials.gov |
| NCT07215312 | A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated Wi… | Phase2 | Diabetes Mellitus, Type 2 | Recruiting | 2025-10-13 | 2026-12-01 | ClinicalTrials.gov |
| NCT07202884 | A Study of Orforglipron in Female Participants With Stress Urinary Incontinence… | Phase3 | Urinary Incontinence,Stress | Recruiting | 2025-09-30 | 2028-03-01 | ClinicalTrials.gov |
| NCT07285590 | Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituxi… | Phase2 | Mantle Cell Lymphoma (MCL) | Recruiting | 2025-09-30 | 2032-12-01 | ClinicalTrials.gov |
| NCT07202884 | A Study of Orforglipron in Female Participants With Stress Urinary Incontinence… | Phase3 | Urinary Incontinence,Stress | Recruiting | 2025-09-30 | 2028-03-01 | ClinicalTrials.gov |
| NCT07285590 | Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituxi… | Phase2 | Mantle Cell Lymphoma (MCL) | Recruiting | 2025-09-30 | 2032-12-01 | ClinicalTrials.gov |
| NCT07165015 | A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal… | Phase1 | Renal Impairment | Completed | 2025-09-18 | 2026-04-16 | ClinicalTrials.gov |
| NCT07165015 | A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal… | Phase1 | Renal Impairment | Completed | 2025-09-18 | 2026-04-16 | ClinicalTrials.gov |
| NCT06847399 | Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylat… | Phase2 | Obesity and Overweight | Recruiting | 2025-09-17 | 2027-12-01 | ClinicalTrials.gov |
| NCT06847399 | Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylat… | Phase2 | Obesity and Overweight | Recruiting | 2025-09-17 | 2027-12-01 | ClinicalTrials.gov |
| NCT07124013 | A Study of Olomorasib (LY3537982) in Healthy Japanese Participants | Phase1 | Healthy | Completed | 2025-09-16 | 2026-01-05 | ClinicalTrials.gov |
| NCT07124013 | A Study of Olomorasib (LY3537982) in Healthy Japanese Participants | Phase1 | Healthy | Completed | 2025-09-16 | 2026-01-05 | ClinicalTrials.gov |
| NCT07153471 | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight … | Phase3 | Osteoarthritis | Recruiting | 2025-09-15 | 2028-05-01 | ClinicalTrials.gov |
| NCT07153471 | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight … | Phase3 | Osteoarthritis | Recruiting | 2025-09-15 | 2028-05-01 | ClinicalTrials.gov |
| NCT07157774 | Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults Wit… | Phase3 | Elevated Lp(a) | Recruiting | 2025-09-02 | 2031-03-01 | ClinicalTrials.gov |
| NCT07157774 | Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults Wit… | Phase3 | Elevated Lp(a) | Recruiting | 2025-09-02 | 2031-03-01 | ClinicalTrials.gov |
| NCT07152002 | A Study of LY4064912 in Healthy Participants and With Overweight or Obesity | Phase1 | Overweight or Obesity | Recruiting | 2025-08-28 | 2026-11-01 | ClinicalTrials.gov |
| NCT07152002 | A Study of LY4064912 in Healthy Participants and With Overweight or Obesity | Phase1 | Overweight or Obesity | Recruiting | 2025-08-28 | 2026-11-01 | ClinicalTrials.gov |
| NCT07142954 | Epidemiology and Biomarker Study in Alzheimer's Disease | Phase3 | Alzheimer Disease | Recruiting | 2025-08-25 | 2033-07-01 | ClinicalTrials.gov |
| NCT07142954 | Epidemiology and Biomarker Study in Alzheimer's Disease | Phase3 | Alzheimer Disease | Recruiting | 2025-08-25 | 2033-07-01 | ClinicalTrials.gov |
| NCT07140744 | A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Eval… | Na | Subjective Cognitive Impairment | Recruiting | 2025-08-22 | 2027-10-01 | ClinicalTrials.gov |
| NCT07140744 | A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Eval… | Na | Subjective Cognitive Impairment | Recruiting | 2025-08-22 | 2027-10-01 | ClinicalTrials.gov |
| NCT07137689 | A Study of LY3537982 in Participants With Kidney Problems Compared With Partici… | Phase1 | Renal Insufficiency | Completed | 2025-08-18 | 2026-04-10 | ClinicalTrials.gov |
| NCT07137689 | A Study of LY3537982 in Participants With Kidney Problems Compared With Partici… | Phase1 | Renal Insufficiency | Completed | 2025-08-18 | 2026-04-10 | ClinicalTrials.gov |
| NCT06864403 | Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch | Phase4 | Pouchitis | Recruiting | 2025-08-12 | 2027-04-01 | ClinicalTrials.gov |
| NCT06864403 | Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch | Phase4 | Pouchitis | Recruiting | 2025-08-12 | 2027-04-01 | ClinicalTrials.gov |
| NCT07030127 | A Study of LY3985863 in Healthy Participants | Phase1 | Healthy | Completed | 2025-08-11 | 2026-02-24 | ClinicalTrials.gov |
| NCT07030127 | A Study of LY3985863 in Healthy Participants | Phase1 | Healthy | Completed | 2025-08-11 | 2026-02-24 | ClinicalTrials.gov |
| NCT07162181 | Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types… | Phase2 | Lymphoma, Non-Hodgkin | Active_Not_Recruiting | 2025-08-07 | 2030-05-01 | ClinicalTrials.gov |
| NCT07162181 | Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types… | Phase2 | Lymphoma, Non-Hodgkin | Active_Not_Recruiting | 2025-08-07 | 2030-05-01 | ClinicalTrials.gov |
| NCT07114601 | A Study of LY4257496 in Participants With Cancer (OMNIRAY) | Phase1 | Breast Neoplasms | Recruiting | 2025-08-06 | 2035-04-01 | ClinicalTrials.gov |
| NCT07114601 | A Study of LY4257496 in Participants With Cancer (OMNIRAY) | Phase1 | Breast Neoplasms | Recruiting | 2025-08-06 | 2035-04-01 | ClinicalTrials.gov |
| NCT07100119 | A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis | Phase1 | ALS (Amyotrophic Lateral Sclerosis) | Recruiting | 2025-08-05 | 2027-09-01 | ClinicalTrials.gov |
| NCT07100119 | A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis | Phase1 | ALS (Amyotrophic Lateral Sclerosis) | Recruiting | 2025-08-05 | 2027-09-01 | ClinicalTrials.gov |
| NCT06721013 | A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia | Phase1 | Immune Thrombocytopenia (ITP) | Recruiting | 2025-07-30 | 2027-02-01 | ClinicalTrials.gov |
| NCT06721013 | A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia | Phase1 | Immune Thrombocytopenia (ITP) | Recruiting | 2025-07-30 | 2027-02-01 | ClinicalTrials.gov |
| NCT07046923 | A Study of LY4175408 in Participants With Advanced Cancer | Phase1 | Carcinoma, Non-Small-Cell Lung | Recruiting | 2025-07-28 | 2030-07-01 | ClinicalTrials.gov |
| NCT07046923 | A Study of LY4175408 in Participants With Advanced Cancer | Phase1 | Carcinoma, Non-Small-Cell Lung | Recruiting | 2025-07-28 | 2030-07-01 | ClinicalTrials.gov |
| NCT07073170 | A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus | Phase1 | Type 2 Diabetes | Completed | 2025-07-25 | 2026-01-27 | ClinicalTrials.gov |
| NCT07073170 | A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus | Phase1 | Type 2 Diabetes | Completed | 2025-07-25 | 2026-01-27 | ClinicalTrials.gov |
| NCT07090785 | A Study of LY4088044 in Healthy Participants | Phase1 | Healthy | Recruiting | 2025-07-24 | 2027-07-01 | ClinicalTrials.gov |
| NCT07090785 | A Study of LY4088044 in Healthy Participants | Phase1 | Healthy | Recruiting | 2025-07-24 | 2027-07-01 | ClinicalTrials.gov |
| NCT07063316 | SGLT2 Inhibitors and Renal Anemia in Japan: RWD | — | Chronic Kidney Disease | Active_Not_Recruiting | 2025-07-23 | 2026-12-25 | ClinicalTrials.gov |
| NCT07063316 | SGLT2 Inhibitors and Renal Anemia in Japan: RWD | — | Chronic Kidney Disease | Active_Not_Recruiting | 2025-07-23 | 2026-12-25 | ClinicalTrials.gov |
| NCT07085468 | A Study of LY3549492 in Healthy Weight Adult Participants | Phase2 | Healthy | Terminated | 2025-07-21 | 2025-08-14 | ClinicalTrials.gov |
| NCT07085468 | A Study of LY3549492 in Healthy Weight Adult Participants | Phase2 | Healthy | Terminated | 2025-07-21 | 2025-08-14 | ClinicalTrials.gov |
| NCT07059130 | Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Modera… | Phase4 | Crohn Disease (CD) | Not_Yet_Recruiting | 2025-07-16 | 2026-02-28 | ClinicalTrials.gov |
| NCT07059130 | Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Modera… | Phase4 | Crohn Disease (CD) | Not_Yet_Recruiting | 2025-07-16 | 2026-02-28 | ClinicalTrials.gov |
| NCT06967610 | Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Tim… | Phase2 | Chronic Lymphocytic Leukemia | Recruiting | 2025-07-15 | 2033-06-01 | ClinicalTrials.gov |
| NCT06967610 | Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Tim… | Phase2 | Chronic Lymphocytic Leukemia | Recruiting | 2025-07-15 | 2033-06-01 | ClinicalTrials.gov |
| NCT07044271 | A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants | Phase1 | Healthy | Recruiting | 2025-07-11 | 2025-11-01 | ClinicalTrials.gov |
| NCT07044271 | A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants | Phase1 | Healthy | Recruiting | 2025-07-11 | 2025-11-01 | ClinicalTrials.gov |
| NCT06839872 | A Study to Investigate the Sequencing Strategy of Pirtobrutinib After Disease P… | Phase2 | Chronic Lymphocytic Leukemia | Withdrawn | 2025-06-30 | 2030-07-29 | ClinicalTrials.gov |
| NCT06839872 | A Study to Investigate the Sequencing Strategy of Pirtobrutinib After Disease P… | Phase2 | Chronic Lymphocytic Leukemia | Withdrawn | 2025-06-30 | 2030-07-29 | ClinicalTrials.gov |
| NCT06896162 | PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Sele… | Na | Solid Tumor Malignancies | Recruiting | 2025-06-27 | 2028-06-01 | ClinicalTrials.gov |
| NCT06896162 | PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Sele… | Na | Solid Tumor Malignancies | Recruiting | 2025-06-27 | 2028-06-01 | ClinicalTrials.gov |
| NCT06937099 | Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately … | Phase3 | Crohn's Disease | Recruiting | 2025-06-26 | 2028-05-01 | ClinicalTrials.gov |
| NCT06937086 | Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants … | Phase3 | Ulcerative Colitis | Recruiting | 2025-06-26 | 2028-04-01 | ClinicalTrials.gov |
| NCT06937099 | Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately … | Phase3 | Crohn's Disease | Recruiting | 2025-06-26 | 2028-05-01 | ClinicalTrials.gov |
| NCT06937086 | Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants … | Phase3 | Ulcerative Colitis | Recruiting | 2025-06-26 | 2028-04-01 | ClinicalTrials.gov |
| NCT06630325 | A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With A… | Phase2 | Advanced Breast Carcinoma | Terminated | 2025-06-24 | 2026-03-11 | ClinicalTrials.gov |
| NCT07056309 | A Study of Remternetug (LY3372993) in Healthy Participants | Phase1 | Healthy | Completed | 2025-06-24 | 2025-12-15 | ClinicalTrials.gov |
| NCT07056309 | A Study of Remternetug (LY3372993) in Healthy Participants | Phase1 | Healthy | Completed | 2025-06-24 | 2025-12-15 | ClinicalTrials.gov |
| NCT06630325 | A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With A… | Phase2 | Advanced Breast Carcinoma | Terminated | 2025-06-24 | 2026-03-11 | ClinicalTrials.gov |
| NCT07039045 | A Study of [14C]-LY4065967 in Healthy Participants | Phase1 | Healthy | Completed | 2025-06-23 | 2025-08-16 | ClinicalTrials.gov |
| NCT07039045 | A Study of [14C]-LY4065967 in Healthy Participants | Phase1 | Healthy | Completed | 2025-06-23 | 2025-08-16 | ClinicalTrials.gov |
| NCT07030868 | A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes | Phase2 | Obesity | Terminated | 2025-06-19 | 2025-07-29 | ClinicalTrials.gov |
| NCT07030868 | A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes | Phase2 | Obesity | Terminated | 2025-06-19 | 2025-07-29 | ClinicalTrials.gov |
| NCT07006792 | A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moder… | Phase4 | Atopic Dermatitis | Recruiting | 2025-06-16 | 2026-09-01 | ClinicalTrials.gov |
| NCT07006792 | A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moder… | Phase4 | Atopic Dermatitis | Recruiting | 2025-06-16 | 2026-09-01 | ClinicalTrials.gov |
| NCT07005284 | A Study of LY3981314 in Healthy Participants | Phase1 | Healthy | Active_Not_Recruiting | 2025-06-09 | 2027-02-01 | ClinicalTrials.gov |
| NCT07005284 | A Study of LY3981314 in Healthy Participants | Phase1 | Healthy | Active_Not_Recruiting | 2025-06-09 | 2027-02-01 | ClinicalTrials.gov |
| NCT06982846 | A Study to Investigate the Response of Participants With Type 2 Diabetes Mellit… | Phase1 | Type 2 Diabetes Mellitus | Active_Not_Recruiting | 2025-06-06 | 2026-05-01 | ClinicalTrials.gov |
| NCT06982846 | A Study to Investigate the Response of Participants With Type 2 Diabetes Mellit… | Phase1 | Type 2 Diabetes Mellitus | Active_Not_Recruiting | 2025-06-06 | 2026-05-01 | ClinicalTrials.gov |
| NCT06982859 | A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin … | Phase1 | Diabetes Mellitus | Recruiting | 2025-06-02 | 2026-11-01 | ClinicalTrials.gov |
| NCT06982859 | A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin … | Phase1 | Diabetes Mellitus | Recruiting | 2025-06-02 | 2026-11-01 | ClinicalTrials.gov |
| NCT07035093 | A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweig… | Phase3 | Obesity | Recruiting | 2025-05-29 | 2027-09-01 | ClinicalTrials.gov |
| NCT07035093 | A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweig… | Phase3 | Obesity | Recruiting | 2025-05-29 | 2027-09-01 | ClinicalTrials.gov |
| NCT07021547 | A Study of LY3867070 in Healthy Participants | Phase1 | Healthy | Recruiting | 2025-05-27 | 2026-08-01 | ClinicalTrials.gov |
| NCT07021547 | A Study of LY3867070 in Healthy Participants | Phase1 | Healthy | Recruiting | 2025-05-27 | 2026-08-01 | ClinicalTrials.gov |
| NCT06901349 | A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Comb… | Phase2 | Obesity | Withdrawn | 2025-05-23 | 2025-06-10 | ClinicalTrials.gov |
| NCT06901349 | A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Comb… | Phase2 | Obesity | Withdrawn | 2025-05-23 | 2025-06-10 | ClinicalTrials.gov |
| NCT06876662 | A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Ch… | Phase4 | Chronic Lymphocytic Leukemia | Recruiting | 2025-05-20 | 2032-12-01 | ClinicalTrials.gov |
| NCT06876649 | A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib | Phase4 | Chronic Lymphocytic Leukemia | Recruiting | 2025-05-20 | 2032-12-01 | ClinicalTrials.gov |
| NCT06876649 | A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib | Phase4 | Chronic Lymphocytic Leukemia | Recruiting | 2025-05-20 | 2032-12-01 | ClinicalTrials.gov |
| NCT06991946 | Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatmen… | — | Metastatic Breast Cancer | Recruiting | 2025-05-20 | 2030-05-20 | ClinicalTrials.gov |
| NCT06991946 | Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatmen… | — | Metastatic Breast Cancer | Recruiting | 2025-05-20 | 2030-05-20 | ClinicalTrials.gov |
| NCT06876662 | A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Ch… | Phase4 | Chronic Lymphocytic Leukemia | Recruiting | 2025-05-20 | 2032-12-01 | ClinicalTrials.gov |
| NCT06972472 | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight … | Phase3 | Obesity | Active_Not_Recruiting | 2025-05-19 | 2027-08-01 | ClinicalTrials.gov |
| NCT06972472 | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight … | Phase3 | Obesity | Active_Not_Recruiting | 2025-05-19 | 2027-08-01 | ClinicalTrials.gov |
| NCT06945406 | A Study of LY4057996 in Healthy Participants and Participants With Type 1 and T… | Phase1 | Diabetes Mellitus, Type 1 | Recruiting | 2025-05-16 | 2026-12-01 | ClinicalTrials.gov |
| NCT06945406 | A Study of LY4057996 in Healthy Participants and Participants With Type 1 and T… | Phase1 | Diabetes Mellitus, Type 1 | Recruiting | 2025-05-16 | 2026-12-01 | ClinicalTrials.gov |
| NCT06993792 | A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or … | Phase3 | Obesity | Active_Not_Recruiting | 2025-05-15 | 2027-08-01 | ClinicalTrials.gov |
| NCT06993792 | A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or … | Phase3 | Obesity | Active_Not_Recruiting | 2025-05-15 | 2027-08-01 | ClinicalTrials.gov |
| NCT06972459 | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight … | Phase3 | Obesity | Active_Not_Recruiting | 2025-05-15 | 2027-08-01 | ClinicalTrials.gov |
| NCT06972459 | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight … | Phase3 | Obesity | Active_Not_Recruiting | 2025-05-15 | 2027-08-01 | ClinicalTrials.gov |
| NCT07046559 | A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerabilit… | Phase1 | Healthy | Recruiting | 2025-05-13 | 2027-09-01 | ClinicalTrials.gov |
| NCT07046559 | A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerabilit… | Phase1 | Healthy | Recruiting | 2025-05-13 | 2027-09-01 | ClinicalTrials.gov |
| NCT06962280 | A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and… | Phase3 | Type 1 Diabetes | Active_Not_Recruiting | 2025-05-12 | 2027-07-01 | ClinicalTrials.gov |
| NCT06962280 | A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and… | Phase3 | Type 1 Diabetes | Active_Not_Recruiting | 2025-05-12 | 2027-07-01 | ClinicalTrials.gov |
| NCT06696014 | Mirikizumab Real World Protocol | — | Ulcerative Colitis | Recruiting | 2025-05-08 | 2030-01-01 | ClinicalTrials.gov |
| NCT06696014 | Mirikizumab Real World Protocol | — | Ulcerative Colitis | Recruiting | 2025-05-08 | 2030-01-01 | ClinicalTrials.gov |
| NCT06869018 | A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2… | Phase1 | Healthy | Completed | 2025-05-07 | 2026-03-02 | ClinicalTrials.gov |
| NCT06869018 | A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2… | Phase1 | Healthy | Completed | 2025-05-07 | 2026-03-02 | ClinicalTrials.gov |
| NCT06812715 | Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib Aft… | Phase2 | Chronic Lymphocytic Leukemia | Recruiting | 2025-05-05 | 2031-05-01 | ClinicalTrials.gov |
| NCT06812715 | Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib Aft… | Phase2 | Chronic Lymphocytic Leukemia | Recruiting | 2025-05-05 | 2031-05-01 | ClinicalTrials.gov |
| NCT06964776 | A Study of LY4268989 (MORF-057) in Healthy Participants | Phase1 | Healthy | Completed | 2025-05-01 | 2026-02-17 | ClinicalTrials.gov |
| NCT06964776 | A Study of LY4268989 (MORF-057) in Healthy Participants | Phase1 | Healthy | Completed | 2025-05-01 | 2026-02-17 | ClinicalTrials.gov |
| NCT06952530 | A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypert… | Phase3 | Hypertension | Recruiting | 2025-04-30 | 2027-09-01 | ClinicalTrials.gov |
| NCT06948435 | A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypert… | Phase3 | Hypertension | Recruiting | 2025-04-30 | 2027-09-01 | ClinicalTrials.gov |
| NCT06948422 | A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertensio… | Phase3 | Hypertension | Recruiting | 2025-04-30 | 2027-09-01 | ClinicalTrials.gov |
| NCT06952530 | A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypert… | Phase3 | Hypertension | Recruiting | 2025-04-30 | 2027-09-01 | ClinicalTrials.gov |
| NCT06948435 | A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypert… | Phase3 | Hypertension | Recruiting | 2025-04-30 | 2027-09-01 | ClinicalTrials.gov |
| NCT06948422 | A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertensio… | Phase3 | Hypertension | Recruiting | 2025-04-30 | 2027-09-01 | ClinicalTrials.gov |
| NCT06914895 | A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 … | Phase3 | Type 1 Diabetes | Active_Not_Recruiting | 2025-04-25 | 2026-12-01 | ClinicalTrials.gov |
| NCT06914895 | A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 … | Phase3 | Type 1 Diabetes | Active_Not_Recruiting | 2025-04-25 | 2026-12-01 | ClinicalTrials.gov |
| NCT06945419 | A Study of LY4086940 in Healthy Participants and Participants With Overweight o… | Phase1 | Healthy | Recruiting | 2025-04-23 | 2026-07-01 | ClinicalTrials.gov |
| NCT06945419 | A Study of LY4086940 in Healthy Participants and Participants With Overweight o… | Phase1 | Healthy | Recruiting | 2025-04-23 | 2026-07-01 | ClinicalTrials.gov |
| NCT06916078 | A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate,… | Phase1 | Liver Dysfunction | Recruiting | 2025-04-23 | 2026-08-01 | ClinicalTrials.gov |
| NCT06916078 | A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate,… | Phase1 | Liver Dysfunction | Recruiting | 2025-04-23 | 2026-08-01 | ClinicalTrials.gov |
| NCT06908707 | A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in P… | Phase1 | Postmenopausal | Completed | 2025-04-22 | 2025-10-23 | ClinicalTrials.gov |
| NCT06908707 | A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in P… | Phase1 | Postmenopausal | Completed | 2025-04-22 | 2025-10-23 | ClinicalTrials.gov |
| NCT06916091 | A Study of Eloralintide (LY3841136) in Chinese Participants With Obesity or Ove… | Phase1 | Obesity | Completed | 2025-04-21 | 2025-09-09 | ClinicalTrials.gov |
| NCT06921759 | A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants … | Phase3 | Atopic Hand and Foot Dermatitis | Active_Not_Recruiting | 2025-04-21 | 2026-07-01 | ClinicalTrials.gov |
| NCT06916091 | A Study of Eloralintide (LY3841136) in Chinese Participants With Obesity or Ove… | Phase1 | Obesity | Completed | 2025-04-21 | 2025-09-09 | ClinicalTrials.gov |
| NCT06921759 | A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants … | Phase3 | Atopic Hand and Foot Dermatitis | Active_Not_Recruiting | 2025-04-21 | 2026-07-01 | ClinicalTrials.gov |
| NCT06916065 | A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Partic… | Phase1 | Overweight | Completed | 2025-04-09 | 2026-01-19 | ClinicalTrials.gov |
| NCT06916065 | A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Partic… | Phase1 | Overweight | Completed | 2025-04-09 | 2026-01-19 | ClinicalTrials.gov |
| NCT06916143 | Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853… | Phase1 | Healthy Participants | Active_Not_Recruiting | 2025-04-08 | 2026-07-01 | ClinicalTrials.gov |
| NCT06916143 | Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853… | Phase1 | Healthy Participants | Active_Not_Recruiting | 2025-04-08 | 2026-07-01 | ClinicalTrials.gov |
| NCT06897475 | A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes… | Phase2 | Type 2 Diabetes | Recruiting | 2025-03-28 | 2027-01-01 | ClinicalTrials.gov |
| NCT06897475 | A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes… | Phase2 | Type 2 Diabetes | Recruiting | 2025-03-28 | 2027-01-01 | ClinicalTrials.gov |
| NCT06890598 | Study of Olomorasib (LY3537982) in Combination With Standard of Care in Partici… | Phase3 | Carcinoma, Non-Small-Cell Lung | Recruiting | 2025-03-27 | 2032-02-01 | ClinicalTrials.gov |
| NCT06890598 | Study of Olomorasib (LY3537982) in Combination With Standard of Care in Partici… | Phase3 | Carcinoma, Non-Small-Cell Lung | Recruiting | 2025-03-27 | 2032-02-01 | ClinicalTrials.gov |
| NCT06890611 | A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY9000… | Phase1 | Healthy | Completed | 2025-03-25 | 2025-09-26 | ClinicalTrials.gov |
| NCT06890611 | A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY9000… | Phase1 | Healthy | Completed | 2025-03-25 | 2025-09-26 | ClinicalTrials.gov |
| NCT06810544 | Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in … | Phase1 | Non Small Cell Lung Cancer | Recruiting | 2025-03-24 | 2027-09-30 | ClinicalTrials.gov |
| NCT05940493 | Abemaciclib in Newly Diagnosed Meningioma Patients | Phase2 | Meningioma | Recruiting | 2025-03-24 | 2030-09-01 | ClinicalTrials.gov |
| NCT06810544 | Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in … | Phase1 | Non Small Cell Lung Cancer | Recruiting | 2025-03-24 | 2027-09-30 | ClinicalTrials.gov |
| NCT05940493 | Abemaciclib in Newly Diagnosed Meningioma Patients | Phase2 | Meningioma | Recruiting | 2025-03-24 | 2030-09-01 | ClinicalTrials.gov |
| NCT06857942 | A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following I… | Phase4 | Psoriasis | Recruiting | 2025-03-19 | 2028-05-01 | ClinicalTrials.gov |
| NCT06857942 | A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following I… | Phase4 | Psoriasis | Recruiting | 2025-03-19 | 2028-05-01 | ClinicalTrials.gov |
| NCT06859294 | A Study of LY3541860 in Adult Participants With Moderately to Severely Active R… | Phase2 | Rheumatoid Arthritis | Active_Not_Recruiting | 2025-03-19 | 2026-05-01 | ClinicalTrials.gov |
| NCT06025747 | Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatmen… | Phase1 | Retroperitoneal Sarcoma | Recruiting | 2025-03-19 | 2029-03-03 | ClinicalTrials.gov |
| NCT06859294 | A Study of LY3541860 in Adult Participants With Moderately to Severely Active R… | Phase2 | Rheumatoid Arthritis | Active_Not_Recruiting | 2025-03-19 | 2026-05-01 | ClinicalTrials.gov |
| NCT06025747 | Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatmen… | Phase1 | Retroperitoneal Sarcoma | Recruiting | 2025-03-19 | 2029-03-03 | ClinicalTrials.gov |
| NCT06864026 | A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixe… | Phase4 | Psoriatic Arthritis | Recruiting | 2025-03-06 | 2027-11-01 | ClinicalTrials.gov |
| NCT06864026 | A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixe… | Phase4 | Psoriatic Arthritis | Recruiting | 2025-03-06 | 2027-11-01 | ClinicalTrials.gov |
| NCT06859268 | A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in In… | Phase3 | Obesity | Active_Not_Recruiting | 2025-03-05 | 2028-04-01 | ClinicalTrials.gov |
| NCT06859268 | A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in In… | Phase3 | Obesity | Active_Not_Recruiting | 2025-03-05 | 2028-04-01 | ClinicalTrials.gov |
| NCT06855212 | Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing S… | Phase2 | Head and Neck Squamous Cell Carcinoma | Recruiting | 2025-02-26 | 2028-03-01 | ClinicalTrials.gov |
| NCT06855212 | Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing S… | Phase2 | Head and Neck Squamous Cell Carcinoma | Recruiting | 2025-02-26 | 2028-03-01 | ClinicalTrials.gov |
| NCT06390956 | Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Z… | Phase2 | Marginal Zone Lymphoma | Recruiting | 2025-02-20 | 2032-12-01 | ClinicalTrials.gov |
| NCT06390956 | Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Z… | Phase2 | Marginal Zone Lymphoma | Recruiting | 2025-02-20 | 2032-12-01 | ClinicalTrials.gov |
| NCT06809400 | A Study of LY4006896 in Healthy Participants and Participants With Parkinson's … | Phase1 | Parkinson Disease | Recruiting | 2025-02-18 | 2028-01-01 | ClinicalTrials.gov |
| NCT06809400 | A Study of LY4006896 in Healthy Participants and Participants With Parkinson's … | Phase1 | Parkinson Disease | Recruiting | 2025-02-18 | 2028-01-01 | ClinicalTrials.gov |
| NCT06824051 | A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overw… | Phase1 | Obesity | Completed | 2025-02-17 | 2026-01-26 | ClinicalTrials.gov |
| NCT06824051 | A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overw… | Phase1 | Obesity | Completed | 2025-02-17 | 2026-01-26 | ClinicalTrials.gov |
| NCT06835972 | A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Ca… | Phase1 | Metastatic Renal Cell Carcinoma | Recruiting | 2025-02-14 | 2027-02-01 | ClinicalTrials.gov |
| NCT06835972 | A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Ca… | Phase1 | Metastatic Renal Cell Carcinoma | Recruiting | 2025-02-14 | 2027-02-01 | ClinicalTrials.gov |
| NCT06817356 | A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcoho… | Phase2 | Alcohol Use Disorder | Active_Not_Recruiting | 2025-02-06 | 2026-08-01 | ClinicalTrials.gov |
| NCT06817356 | A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcoho… | Phase2 | Alcohol Use Disorder | Active_Not_Recruiting | 2025-02-06 | 2026-08-01 | ClinicalTrials.gov |
| NCT06808802 | To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokine… | Phase1 | Healthy | Completed | 2025-02-03 | 2025-04-15 | ClinicalTrials.gov |
| NCT06808802 | To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokine… | Phase1 | Healthy | Completed | 2025-02-03 | 2025-04-15 | ClinicalTrials.gov |
| NCT06522386 | GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax … | Phase2 | Mantle Cell Lymphoma | Active_Not_Recruiting | 2025-01-30 | 2029-02-28 | ClinicalTrials.gov |
| NCT06522386 | GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax … | Phase2 | Mantle Cell Lymphoma | Active_Not_Recruiting | 2025-01-30 | 2029-02-28 | ClinicalTrials.gov |
| NCT06797310 | Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of A… | Phase2 | Alopecia Areata | Not_Yet_Recruiting | 2025-01-23 | 2026-12-31 | ClinicalTrials.gov |
| NCT06797310 | Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of A… | Phase2 | Alopecia Areata | Not_Yet_Recruiting | 2025-01-23 | 2026-12-31 | ClinicalTrials.gov |
| NCT06517888 | Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma | Phase1 | Vestibular Schwannoma | Recruiting | 2025-01-17 | 2029-08-01 | ClinicalTrials.gov |
| NCT06517888 | Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma | Phase1 | Vestibular Schwannoma | Recruiting | 2025-01-17 | 2029-08-01 | ClinicalTrials.gov |
| NCT06739122 | A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants … | Phase3 | Type 2 Diabetes | Recruiting | 2025-01-10 | 2027-12-01 | ClinicalTrials.gov |
| NCT06739122 | A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants … | Phase3 | Type 2 Diabetes | Recruiting | 2025-01-10 | 2027-12-01 | ClinicalTrials.gov |
| NCT06588478 | A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants Wit… | Phase2 | Chronic Lymphocytic Leukemia | Recruiting | 2025-01-03 | 2028-12-01 | ClinicalTrials.gov |
| NCT06588478 | A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants Wit… | Phase2 | Chronic Lymphocytic Leukemia | Recruiting | 2025-01-03 | 2028-12-01 | ClinicalTrials.gov |
| NCT06692348 | A Study of Orforglipron (LY3502970) to Compare a Single Capsule and Multiple Ca… | Phase1 | Healthy | Completed | 2024-12-13 | 2025-06-09 | ClinicalTrials.gov |
| NCT06692348 | A Study of Orforglipron (LY3502970) to Compare a Single Capsule and Multiple Ca… | Phase1 | Healthy | Completed | 2024-12-13 | 2025-06-09 | ClinicalTrials.gov |
| NCT06704763 | A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Hea… | Phase1 | Healthy | Completed | 2024-12-06 | 2025-02-05 | ClinicalTrials.gov |
| NCT06704763 | A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Hea… | Phase1 | Healthy | Completed | 2024-12-06 | 2025-02-05 | ClinicalTrials.gov |
| NCT06719128 | A Study of Olomorasib (LY3537982) in Participants With Hepatic Impairment and H… | Phase1 | Hepatic Insufficiency | Completed | 2024-12-06 | 2025-08-25 | ClinicalTrials.gov |
| NCT06719128 | A Study of Olomorasib (LY3537982) in Participants With Hepatic Impairment and H… | Phase1 | Hepatic Insufficiency | Completed | 2024-12-06 | 2025-08-25 | ClinicalTrials.gov |
| NCT06709820 | A Study of LY4060874 in Healthy Participants | Phase1 | Healthy Participants | Completed | 2024-12-02 | 2026-02-20 | ClinicalTrials.gov |
| NCT06709820 | A Study of LY4060874 in Healthy Participants | Phase1 | Healthy Participants | Completed | 2024-12-02 | 2026-02-20 | ClinicalTrials.gov |
| NCT05552157 | A Study of Potential Disease Modifying Treatments in Individuals at Risk for or… | Phase2 | Alzheimers Disease | Recruiting | 2024-11-22 | 2034-08-30 | ClinicalTrials.gov |
| NCT06647498 | A Study of a Potential Disease Modifying Treatment in Individuals at Risk for o… | Phase2 | Alzheimers Disease | Recruiting | 2024-11-22 | 2034-08-01 | ClinicalTrials.gov |
| NCT05552157 | A Study of Potential Disease Modifying Treatments in Individuals at Risk for or… | Phase2 | Alzheimers Disease | Recruiting | 2024-11-22 | 2034-08-30 | ClinicalTrials.gov |
| NCT06647498 | A Study of a Potential Disease Modifying Treatment in Individuals at Risk for o… | Phase2 | Alzheimers Disease | Recruiting | 2024-11-22 | 2034-08-01 | ClinicalTrials.gov |
| NCT06191848 | Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoart… | Phase4 | Obesity | Recruiting | 2024-11-19 | 2037-05-01 | ClinicalTrials.gov |
| NCT06191848 | Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoart… | Phase4 | Obesity | Recruiting | 2024-11-19 | 2037-05-01 | ClinicalTrials.gov |
| NCT06672939 | A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or… | Phase3 | Obesity | Recruiting | 2024-11-18 | 2027-03-01 | ClinicalTrials.gov |
| NCT06672549 | A Platform Trial for Pediatric Participants With Obesity or Overweight (LY90004… | Phase3 | Obesity | Recruiting | 2024-11-18 | 2027-03-01 | ClinicalTrials.gov |
| NCT06672549 | A Platform Trial for Pediatric Participants With Obesity or Overweight (LY90004… | Phase3 | Obesity | Recruiting | 2024-11-18 | 2027-03-01 | ClinicalTrials.gov |
| NCT06672939 | A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or… | Phase3 | Obesity | Recruiting | 2024-11-18 | 2027-03-01 | ClinicalTrials.gov |
| NCT06678269 | A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast C… | Phase1 | Metastatic Breast Cancer | Recruiting | 2024-11-15 | 2028-11-30 | ClinicalTrials.gov |
| NCT06678269 | A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast C… | Phase1 | Metastatic Breast Cancer | Recruiting | 2024-11-15 | 2028-11-30 | ClinicalTrials.gov |
| NCT06683508 | A Study to Investigate Weight Management With LY3549492 Compared With Placebo i… | Phase2 | Obesity | Completed | 2024-11-13 | 2026-05-04 | ClinicalTrials.gov |
| NCT06683508 | A Study to Investigate Weight Management With LY3549492 Compared With Placebo i… | Phase2 | Obesity | Completed | 2024-11-13 | 2026-05-04 | ClinicalTrials.gov |
| NCT06696456 | Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy | — | Otoferlin Gene-mediated Hearing Loss | Enrolling_By_Invitation | 2024-11-11 | 2033-04-01 | ClinicalTrials.gov |
| NCT06696456 | Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy | — | Otoferlin Gene-mediated Hearing Loss | Enrolling_By_Invitation | 2024-11-11 | 2033-04-01 | ClinicalTrials.gov |
| NCT06690996 | A Study of LY4005130 in Healthy Participants | Phase1 | Healthy | Active_Not_Recruiting | 2024-11-08 | 2026-04-01 | ClinicalTrials.gov |
| NCT06690996 | A Study of LY4005130 in Healthy Participants | Phase1 | Healthy | Active_Not_Recruiting | 2024-11-08 | 2026-04-01 | ClinicalTrials.gov |
| NCT06662383 | A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adult… | Phase3 | Obesity | Active_Not_Recruiting | 2024-11-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT06662383 | A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adult… | Phase3 | Obesity | Active_Not_Recruiting | 2024-11-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT06657768 | A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's… | Phase1 | Alzheimer Disease | Recruiting | 2024-10-29 | 2027-07-01 | ClinicalTrials.gov |
| NCT06657768 | A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's… | Phase1 | Alzheimer Disease | Recruiting | 2024-10-29 | 2027-07-01 | ClinicalTrials.gov |
| NCT06644378 | A Study of [14C]-LY3866288 in Healthy Participants | Phase1 | Healthy | Completed | 2024-10-28 | 2025-01-03 | ClinicalTrials.gov |
| NCT06644378 | A Study of [14C]-LY3866288 in Healthy Participants | Phase1 | Healthy | Completed | 2024-10-28 | 2025-01-03 | ClinicalTrials.gov |
| NCT06413706 | A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in … | Phase2 | Glioma | Active_Not_Recruiting | 2024-10-25 | 2028-02-01 | ClinicalTrials.gov |
| NCT06413706 | A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in … | Phase2 | Glioma | Active_Not_Recruiting | 2024-10-25 | 2028-02-01 | ClinicalTrials.gov |
| NCT06653153 | A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-AL… | Phase3 | Alzheimer's Disease | Active_Not_Recruiting | 2024-10-24 | 2030-10-01 | ClinicalTrials.gov |
| NCT06653153 | A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-AL… | Phase3 | Alzheimer's Disease | Active_Not_Recruiting | 2024-10-24 | 2030-10-01 | ClinicalTrials.gov |
| NCT06649045 | A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea… | Phase3 | OSA | Active_Not_Recruiting | 2024-10-22 | 2027-01-01 | ClinicalTrials.gov |
| NCT06594159 | A Study of LY4065967 in Healthy Japanese Participants | Phase1 | Healthy | Completed | 2024-10-22 | 2025-03-11 | ClinicalTrials.gov |
| NCT06649045 | A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea… | Phase3 | OSA | Active_Not_Recruiting | 2024-10-22 | 2027-01-01 | ClinicalTrials.gov |
| NCT06594159 | A Study of LY4065967 in Healthy Japanese Participants | Phase1 | Healthy | Completed | 2024-10-22 | 2025-03-11 | ClinicalTrials.gov |
| NCT06643728 | A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzep… | Phase2 | Obesity | Active_Not_Recruiting | 2024-10-21 | 2027-01-01 | ClinicalTrials.gov |
| NCT06643728 | A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzep… | Phase2 | Obesity | Active_Not_Recruiting | 2024-10-21 | 2027-01-01 | ClinicalTrials.gov |
| NCT06607185 | A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant So… | Phase1 | Pancreatic Ductal Adenocarcinoma | Active_Not_Recruiting | 2024-10-21 | 2030-01-01 | ClinicalTrials.gov |
| NCT06607185 | A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant So… | Phase1 | Pancreatic Ductal Adenocarcinoma | Active_Not_Recruiting | 2024-10-21 | 2030-01-01 | ClinicalTrials.gov |
| NCT06641037 | A Study of LY3866288 in Healthy Participants | Phase1 | Healthy | Completed | 2024-10-17 | 2024-12-02 | ClinicalTrials.gov |
| NCT06641037 | A Study of LY3866288 in Healthy Participants | Phase1 | Healthy | Completed | 2024-10-17 | 2024-12-02 | ClinicalTrials.gov |
| NCT06635057 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During … | Phase4 | Type 2 Diabetes | Active_Not_Recruiting | 2024-10-11 | 2026-04-01 | ClinicalTrials.gov |
| NCT06635057 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During … | Phase4 | Type 2 Diabetes | Active_Not_Recruiting | 2024-10-11 | 2026-04-01 | ClinicalTrials.gov |
| NCT06598943 | A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Sev… | Phase2 | Ulcerative Colitis | Recruiting | 2024-10-10 | 2028-09-01 | ClinicalTrials.gov |
| NCT06362265 | A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants Wit… | Phase1 | Type 2 Diabetes Mellitus | Completed | 2024-10-10 | 2026-01-02 | ClinicalTrials.gov |
| NCT06598943 | A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Sev… | Phase2 | Ulcerative Colitis | Recruiting | 2024-10-10 | 2028-09-01 | ClinicalTrials.gov |
| NCT06362265 | A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants Wit… | Phase1 | Type 2 Diabetes Mellitus | Completed | 2024-10-10 | 2026-01-02 | ClinicalTrials.gov |
| NCT06598631 | Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease | Phase2 | Chronic Kidney Disease | Withdrawn | 2024-10-09 | 2024-12-30 | ClinicalTrials.gov |
| NCT06598631 | Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease | Phase2 | Chronic Kidney Disease | Withdrawn | 2024-10-09 | 2024-12-30 | ClinicalTrials.gov |
| NCT06566170 | A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus … | — | Alzheimer Disease | Recruiting | 2024-10-07 | 2033-02-01 | ClinicalTrials.gov |
| NCT06566170 | A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus … | — | Alzheimer Disease | Recruiting | 2024-10-07 | 2033-02-01 | ClinicalTrials.gov |
| NCT06588283 | Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-… | Phase3 | Psoriasis | Active_Not_Recruiting | 2024-09-30 | 2026-05-01 | ClinicalTrials.gov |
| NCT06588283 | Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-… | Phase3 | Psoriasis | Active_Not_Recruiting | 2024-09-30 | 2026-05-01 | ClinicalTrials.gov |
| NCT06594679 | A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of… | Phase1 | Ovarian Cancer | Recruiting | 2024-09-26 | 2027-09-18 | ClinicalTrials.gov |
| NCT06594679 | A Study of Niraparib in Combination With Abemaciclib for Late Line Treatment of… | Phase1 | Ovarian Cancer | Recruiting | 2024-09-26 | 2027-09-18 | ClinicalTrials.gov |
| NCT06366347 | ALPINE: Maintenance Letrozole/Abemaciclib | Phase2 | Endometrial Cancer | Recruiting | 2024-09-25 | 2029-03-01 | ClinicalTrials.gov |
| NCT06366347 | ALPINE: Maintenance Letrozole/Abemaciclib | Phase2 | Endometrial Cancer | Recruiting | 2024-09-25 | 2029-03-01 | ClinicalTrials.gov |
| NCT06588296 | Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic… | Phase3 | Psoriatic Arthritis | Completed | 2024-09-24 | 2026-04-23 | ClinicalTrials.gov |
| NCT06588296 | Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic… | Phase3 | Psoriatic Arthritis | Completed | 2024-09-24 | 2026-04-23 | ClinicalTrials.gov |
| NCT06603571 | A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298… | Phase2 | Obesity | Active_Not_Recruiting | 2024-09-20 | 2026-08-01 | ClinicalTrials.gov |
| NCT06603571 | A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298… | Phase2 | Obesity | Active_Not_Recruiting | 2024-09-20 | 2026-08-01 | ClinicalTrials.gov |
| NCT06561685 | A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors | Phase1 | Metastatic Solid Tumor | Recruiting | 2024-09-19 | 2027-10-01 | ClinicalTrials.gov |
| NCT06561685 | A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors | Phase1 | Metastatic Solid Tumor | Recruiting | 2024-09-19 | 2027-10-01 | ClinicalTrials.gov |
| NCT06584916 | A Study of Orforglipron for the Maintenance of Body Weight Reduction in Partici… | Phase3 | Obesity | Completed | 2024-09-13 | 2025-11-21 | ClinicalTrials.gov |
| NCT06584916 | A Study of Orforglipron for the Maintenance of Body Weight Reduction in Partici… | Phase3 | Obesity | Completed | 2024-09-13 | 2025-11-21 | ClinicalTrials.gov |
| NCT06586515 | MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tu… | Phase1 | Pancreatic Ductal Adenocarcinoma | Recruiting | 2024-09-12 | 2029-03-01 | ClinicalTrials.gov |
| NCT06586515 | MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tu… | Phase1 | Pancreatic Ductal Adenocarcinoma | Recruiting | 2024-09-12 | 2029-03-01 | ClinicalTrials.gov |
| NCT06606106 | A Study of LY3537031 in Overweight, Obese, and Healthy Participants | Phase1 | Overweight | Active_Not_Recruiting | 2024-09-05 | 2026-07-01 | ClinicalTrials.gov |
| NCT06606106 | A Study of LY3537031 in Overweight, Obese, and Healthy Participants | Phase1 | Overweight | Active_Not_Recruiting | 2024-09-05 | 2026-07-01 | ClinicalTrials.gov |
| NCT06538116 | A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease | Phase2 | Alzheimer Disease | Active_Not_Recruiting | 2024-08-26 | 2026-05-01 | ClinicalTrials.gov |
| NCT06538116 | A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease | Phase2 | Alzheimer Disease | Active_Not_Recruiting | 2024-08-26 | 2026-05-01 | ClinicalTrials.gov |
| NCT06553872 | Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleu… | Phase2 | Mantle Cell Lymphoma | Recruiting | 2024-08-23 | 2029-08-01 | ClinicalTrials.gov |
| NCT06553872 | Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleu… | Phase2 | Mantle Cell Lymphoma | Recruiting | 2024-08-23 | 2029-08-01 | ClinicalTrials.gov |
| NCT06568042 | Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory… | Phase2 | Neuropathic Pain | Active_Not_Recruiting | 2024-08-22 | 2026-09-01 | ClinicalTrials.gov |
| NCT06568042 | Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory… | Phase2 | Neuropathic Pain | Active_Not_Recruiting | 2024-08-22 | 2026-09-01 | ClinicalTrials.gov |
| NCT06557356 | A Study of LY3532226 in Participants With Obesity | Phase1 | Obesity | Completed | 2024-08-16 | 2025-12-12 | ClinicalTrials.gov |
| NCT06557356 | A Study of LY3532226 in Participants With Obesity | Phase1 | Obesity | Completed | 2024-08-16 | 2025-12-12 | ClinicalTrials.gov |
| NCT06297590 | A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzh… | Phase1 | Alzheimer Disease | Recruiting | 2024-08-15 | 2027-02-01 | ClinicalTrials.gov |
| NCT06297590 | A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzh… | Phase1 | Alzheimer Disease | Recruiting | 2024-08-15 | 2027-02-01 | ClinicalTrials.gov |
| NCT06458036 | Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE) | Phase2 | Differentiated Thyroid Cancer | Recruiting | 2024-07-29 | 2031-11-01 | ClinicalTrials.gov |
| NCT06458036 | Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE) | Phase2 | Differentiated Thyroid Cancer | Recruiting | 2024-07-29 | 2031-11-01 | ClinicalTrials.gov |
| NCT06516913 | A Study of Subcutaneous Injection in Healthy Participants | Na | Healthy | Completed | 2024-07-22 | 2024-09-07 | ClinicalTrials.gov |
| NCT06516913 | A Study of Subcutaneous Injection in Healthy Participants | Na | Healthy | Completed | 2024-07-22 | 2024-09-07 | ClinicalTrials.gov |
| NCT06226883 | A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Acti… | Phase2 | Inflammatory Bowel Diseases | Recruiting | 2024-07-18 | 2030-06-01 | ClinicalTrials.gov |
| NCT06226883 | A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Acti… | Phase2 | Inflammatory Bowel Diseases | Recruiting | 2024-07-18 | 2030-06-01 | ClinicalTrials.gov |
| NCT06465069 | A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Can… | Phase1 | Metastatic Solid Tumor | Recruiting | 2024-07-01 | 2027-05-01 | ClinicalTrials.gov |
| NCT06465069 | A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Can… | Phase1 | Metastatic Solid Tumor | Recruiting | 2024-07-01 | 2027-05-01 | ClinicalTrials.gov |
| NCT06515418 | Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared wit… | Phase2 | Obesity | Terminated | 2024-06-27 | 2025-02-12 | ClinicalTrials.gov |
| NCT06515418 | Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared wit… | Phase2 | Obesity | Terminated | 2024-06-27 | 2025-02-12 | ClinicalTrials.gov |
| NCT06440980 | A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy … | Phase1 | Healthy | Completed | 2024-06-24 | 2025-06-02 | ClinicalTrials.gov |
| NCT06475729 | A Bioequivalence Study of Citrate Free Mirikizumab (LY3074828) in Healthy Parti… | Phase1 | Healthy | Completed | 2024-06-24 | 2024-12-27 | ClinicalTrials.gov |
| NCT06475729 | A Bioequivalence Study of Citrate Free Mirikizumab (LY3074828) in Healthy Parti… | Phase1 | Healthy | Completed | 2024-06-24 | 2024-12-27 | ClinicalTrials.gov |
| NCT06440980 | A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy … | Phase1 | Healthy | Completed | 2024-06-24 | 2025-06-02 | ClinicalTrials.gov |
| NCT06252675 | Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma | Phase2 | Mantle Cell Lymphoma | Recruiting | 2024-06-11 | 2028-07-31 | ClinicalTrials.gov |
| NCT06252675 | Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma | Phase2 | Mantle Cell Lymphoma | Recruiting | 2024-06-11 | 2028-07-31 | ClinicalTrials.gov |
| NCT06395012 | A First-In-Human Study of LY3985297 in Healthy Participants | Phase1 | Healthy | Completed | 2024-06-07 | 2025-08-06 | ClinicalTrials.gov |
| NCT06395012 | A First-In-Human Study of LY3985297 in Healthy Participants | Phase1 | Healthy | Completed | 2024-06-07 | 2025-08-06 | ClinicalTrials.gov |
| NCT06444165 | Lebrikizumab Pen Ease of Use in Participants With Atopic Dermatitis | Phase3 | Atopic Dermatitis | Completed | 2024-06-04 | 2024-06-10 | ClinicalTrials.gov |
| NCT06444165 | Lebrikizumab Pen Ease of Use in Participants With Atopic Dermatitis | Phase3 | Atopic Dermatitis | Completed | 2024-06-04 | 2024-06-10 | ClinicalTrials.gov |
| NCT06439277 | A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidi… | Phase3 | Obesity | Recruiting | 2024-06-03 | 2030-12-01 | ClinicalTrials.gov |
| NCT06439277 | A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidi… | Phase3 | Obesity | Recruiting | 2024-06-03 | 2030-12-01 | ClinicalTrials.gov |
| NCT06400472 | A Study of LY4170156 in Participants With Selected Advanced Solid Tumors | Phase1 | Ovarian Neoplasms | Recruiting | 2024-05-20 | 2027-04-01 | ClinicalTrials.gov |
| NCT06400472 | A Study of LY4170156 in Participants With Selected Advanced Solid Tumors | Phase1 | Ovarian Neoplasms | Recruiting | 2024-05-20 | 2027-04-01 | ClinicalTrials.gov |
| NCT06280703 | A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabe… | Phase1 | Healthy | Recruiting | 2024-05-15 | 2026-09-01 | ClinicalTrials.gov |
| NCT06280703 | A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabe… | Phase1 | Healthy | Recruiting | 2024-05-15 | 2026-09-01 | ClinicalTrials.gov |
| NCT06370728 | A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healt… | Phase1 | Healthy | Completed | 2024-05-06 | 2024-07-23 | ClinicalTrials.gov |
| NCT06370728 | A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healt… | Phase1 | Healthy | Completed | 2024-05-06 | 2024-07-23 | ClinicalTrials.gov |
| NCT06104683 | A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants … | Phase2 | Relapsing Multiple Sclerosis | Withdrawn | 2024-05-01 | 2026-02-13 | ClinicalTrials.gov |
| NCT06104683 | A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants … | Phase2 | Relapsing Multiple Sclerosis | Withdrawn | 2024-05-01 | 2026-02-13 | ClinicalTrials.gov |
| NCT06383390 | The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Out… | Phase3 | Atherosclerotic Cardiovascular Disease (ASCVD) | Active_Not_Recruiting | 2024-04-30 | 2029-02-01 | ClinicalTrials.gov |
| NCT06383390 | The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Out… | Phase3 | Atherosclerotic Cardiovascular Disease (ASCVD) | Active_Not_Recruiting | 2024-04-30 | 2029-02-01 | ClinicalTrials.gov |
| NCT06338995 | A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis… | Phase3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | Recruiting | 2024-04-29 | 2028-03-01 | ClinicalTrials.gov |
| NCT06338995 | A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis… | Phase3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | Recruiting | 2024-04-29 | 2028-03-01 | ClinicalTrials.gov |
| NCT06339008 | A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis … | Phase3 | Perennial Allergic Rhinitis (PAR) | Recruiting | 2024-04-26 | 2028-10-01 | ClinicalTrials.gov |
| NCT06339008 | A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis … | Phase3 | Perennial Allergic Rhinitis (PAR) | Recruiting | 2024-04-26 | 2028-10-01 | ClinicalTrials.gov |
| NCT06280716 | A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatme… | Phase3 | Atopic Dermatitis | Active_Not_Recruiting | 2024-04-24 | 2026-08-01 | ClinicalTrials.gov |
| NCT06373146 | A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide A… | Phase2 | Obesity | Completed | 2024-04-24 | 2026-04-02 | ClinicalTrials.gov |
| NCT06280716 | A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatme… | Phase3 | Atopic Dermatitis | Active_Not_Recruiting | 2024-04-24 | 2026-08-01 | ClinicalTrials.gov |
| NCT06373146 | A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide A… | Phase2 | Obesity | Completed | 2024-04-24 | 2026-04-02 | ClinicalTrials.gov |
| NCT06240351 | A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of … | Phase4 | Frontal Fibrosing Alopecia | Active_Not_Recruiting | 2024-04-22 | 2027-07-31 | ClinicalTrials.gov |
| NCT06333262 | Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia | Phase2 | Chronic Lymphocytic Leukemia | Recruiting | 2024-04-22 | 2032-07-01 | ClinicalTrials.gov |
| NCT06333262 | Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia | Phase2 | Chronic Lymphocytic Leukemia | Recruiting | 2024-04-22 | 2032-07-01 | ClinicalTrials.gov |
| NCT06240351 | A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of … | Phase4 | Frontal Fibrosing Alopecia | Active_Not_Recruiting | 2024-04-22 | 2027-07-31 | ClinicalTrials.gov |
| NCT06370715 | A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2024-04-18 | 2025-09-02 | ClinicalTrials.gov |
| NCT06370715 | A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2024-04-18 | 2025-09-02 | ClinicalTrials.gov |
| NCT06297616 | A Study of LY3841136 in Japanese Participants With Obesity or Overweight | Phase1 | Obesity | Completed | 2024-04-15 | 2025-11-21 | ClinicalTrials.gov |
| NCT06297616 | A Study of LY3841136 in Japanese Participants With Obesity or Overweight | Phase1 | Obesity | Completed | 2024-04-15 | 2025-11-21 | ClinicalTrials.gov |
| NCT06354660 | Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 D… | Phase3 | Diabetes Type 2 | Completed | 2024-04-10 | 2026-02-20 | ClinicalTrials.gov |
| NCT06354660 | Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 D… | Phase3 | Diabetes Type 2 | Completed | 2024-04-10 | 2026-02-20 | ClinicalTrials.gov |
| NCT06365788 | Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-posi… | Phase2 | Triple Negative Breast Neoplasms | Recruiting | 2024-04-08 | 2028-12-01 | ClinicalTrials.gov |
| NCT06365788 | Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-posi… | Phase2 | Triple Negative Breast Neoplasms | Recruiting | 2024-04-08 | 2028-12-01 | ClinicalTrials.gov |
| NCT06345794 | A Study to Assess LY4100511 (DC-853) in Healthy Adult Participants | Phase1 | Healthy | Completed | 2024-04-03 | 2024-06-18 | ClinicalTrials.gov |
| NCT06229366 | [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Cast… | Phase1 | Prostate Cancer | Active_Not_Recruiting | 2024-04-03 | 2032-12-01 | ClinicalTrials.gov |
| NCT06229366 | [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Cast… | Phase1 | Prostate Cancer | Active_Not_Recruiting | 2024-04-03 | 2032-12-01 | ClinicalTrials.gov |
| NCT06345066 | A Study of LY3841136 in Overweight and Obese Participants | Phase1 | Obesity | Completed | 2024-04-03 | 2025-09-29 | ClinicalTrials.gov |
| NCT06345794 | A Study to Assess LY4100511 (DC-853) in Healthy Adult Participants | Phase1 | Healthy | Completed | 2024-04-03 | 2024-06-18 | ClinicalTrials.gov |
| NCT06345066 | A Study of LY3841136 in Overweight and Obese Participants | Phase1 | Obesity | Completed | 2024-04-03 | 2025-09-29 | ClinicalTrials.gov |
| NCT06243198 | A Study to Investigate the Safety and Pharmacokinetics of Lebrikizumab in Healt… | Phase1 | Healthy | Completed | 2024-03-28 | 2024-09-03 | ClinicalTrials.gov |
| NCT06243198 | A Study to Investigate the Safety and Pharmacokinetics of Lebrikizumab in Healt… | Phase1 | Healthy | Completed | 2024-03-28 | 2024-09-03 | ClinicalTrials.gov |
| NCT06313528 | A Study to Measure Calorie Consumption and Usage in Participants With Obesity U… | Phase1 | Obesity | Completed | 2024-03-20 | 2025-08-26 | ClinicalTrials.gov |
| NCT06313528 | A Study to Measure Calorie Consumption and Usage in Participants With Obesity U… | Phase1 | Obesity | Completed | 2024-03-20 | 2025-08-26 | ClinicalTrials.gov |
| NCT06220669 | A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis | Phase2 | Multiple Sclerosis | Active_Not_Recruiting | 2024-03-19 | 2026-07-01 | ClinicalTrials.gov |
| NCT06220669 | A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis | Phase2 | Multiple Sclerosis | Active_Not_Recruiting | 2024-03-19 | 2026-07-01 | ClinicalTrials.gov |
| NCT06297603 | Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabete… | Phase3 | Type 2 Diabetes | Active_Not_Recruiting | 2024-03-15 | 2026-11-01 | ClinicalTrials.gov |
| NCT06297603 | Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabete… | Phase3 | Type 2 Diabetes | Active_Not_Recruiting | 2024-03-15 | 2026-11-01 | ClinicalTrials.gov |
| NCT05509777 | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disea… | Phase3 | Crohn's Disease | Recruiting | 2024-03-13 | 2028-04-01 | ClinicalTrials.gov |
| NCT06158113 | Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept St… | Phase2 | Lichen Planus, Oral | Active_Not_Recruiting | 2024-03-13 | 2026-09-01 | ClinicalTrials.gov |
| NCT06158113 | Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept St… | Phase2 | Lichen Planus, Oral | Active_Not_Recruiting | 2024-03-13 | 2026-09-01 | ClinicalTrials.gov |
| NCT05509777 | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disea… | Phase3 | Crohn's Disease | Recruiting | 2024-03-13 | 2028-04-01 | ClinicalTrials.gov |
| NCT06342596 | A Study of Carbon-14-Labelled [14C] LY3473329 in Healthy Male Participants | Phase1 | Healthy | Completed | 2024-03-05 | 2024-05-01 | ClinicalTrials.gov |
| NCT06342596 | A Study of Carbon-14-Labelled [14C] LY3473329 in Healthy Male Participants | Phase1 | Healthy | Completed | 2024-03-05 | 2024-05-01 | ClinicalTrials.gov |
| NCT06292013 | A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adve… | Phase3 | Atherosclerotic Cardiovascular Disease (ASCVD) | Active_Not_Recruiting | 2024-03-05 | 2029-03-01 | ClinicalTrials.gov |
| NCT06238479 | A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Sol… | Phase1 | Metastatic Solid Tumor | Active_Not_Recruiting | 2024-03-05 | 2027-03-01 | ClinicalTrials.gov |
| NCT06292013 | A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adve… | Phase3 | Atherosclerotic Cardiovascular Disease (ASCVD) | Active_Not_Recruiting | 2024-03-05 | 2029-03-01 | ClinicalTrials.gov |
| NCT06238479 | A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Sol… | Phase1 | Metastatic Solid Tumor | Active_Not_Recruiting | 2024-03-05 | 2027-03-01 | ClinicalTrials.gov |
| NCT06235983 | A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors | Phase1 | Advanced Solid Tumors | Active_Not_Recruiting | 2024-02-29 | 2027-04-01 | ClinicalTrials.gov |
| NCT06235983 | A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors | Phase1 | Advanced Solid Tumors | Active_Not_Recruiting | 2024-02-29 | 2027-04-01 | ClinicalTrials.gov |
| NCT06085144 | Emgality for Migraine in Breastmilk | — | Migraine | Recruiting | 2024-02-26 | 2026-04-01 | ClinicalTrials.gov |
| NCT06085144 | Emgality for Migraine in Breastmilk | — | Migraine | Recruiting | 2024-02-26 | 2026-04-01 | ClinicalTrials.gov |
| NCT06260722 | Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type… | Phase3 | Diabetes Mellitus, Type 2 | Active_Not_Recruiting | 2024-02-21 | 2027-01-01 | ClinicalTrials.gov |
| NCT06260722 | Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type… | Phase3 | Diabetes Mellitus, Type 2 | Active_Not_Recruiting | 2024-02-21 | 2027-01-01 | ClinicalTrials.gov |
| NCT06230523 | A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity o… | Phase2 | Obesity | Completed | 2024-02-05 | 2025-08-14 | ClinicalTrials.gov |
| NCT06230523 | A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity o… | Phase2 | Obesity | Completed | 2024-02-05 | 2025-08-14 | ClinicalTrials.gov |
| NCT06043674 | Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutin… | Phase2 | Chronic Lymphocytic Leukemia | Recruiting | 2024-01-22 | 2033-01-15 | ClinicalTrials.gov |
| NCT06043674 | Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutin… | Phase2 | Chronic Lymphocytic Leukemia | Recruiting | 2024-01-22 | 2033-01-15 | ClinicalTrials.gov |
| NCT05985954 | Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combin… | Phase1 | Metastatic Colorectal Cancer | Recruiting | 2024-01-18 | 2028-03-28 | ClinicalTrials.gov |
| NCT05985954 | Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combin… | Phase1 | Metastatic Colorectal Cancer | Recruiting | 2024-01-18 | 2028-03-28 | ClinicalTrials.gov |
| NCT06173895 | A Relative Bioavailability Study of LY3454738 in Healthy Participants | Phase1 | Healthy | Completed | 2024-01-12 | 2024-05-02 | ClinicalTrials.gov |
| NCT06173895 | A Relative Bioavailability Study of LY3454738 in Healthy Participants | Phase1 | Healthy | Completed | 2024-01-12 | 2024-05-02 | ClinicalTrials.gov |
| NCT05999968 | Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial … | Phase1 | Prostatic Neoplasms | Completed | 2024-01-12 | 2026-01-21 | ClinicalTrials.gov |
| NCT05999968 | Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial … | Phase1 | Prostatic Neoplasms | Completed | 2024-01-12 | 2026-01-21 | ClinicalTrials.gov |
| NCT06192108 | A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Partic… | Phase3 | Type 2 Diabetes | Completed | 2024-01-10 | 2025-09-26 | ClinicalTrials.gov |
| NCT06192108 | A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Partic… | Phase3 | Type 2 Diabetes | Completed | 2024-01-10 | 2025-09-26 | ClinicalTrials.gov |
| NCT06194500 | A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants | Phase1 | Healthy Male | Completed | 2024-01-03 | 2024-02-15 | ClinicalTrials.gov |
| NCT06194500 | A Study of Carbon-14-Labeled [14C]-LY3549492 in Healthy Participants | Phase1 | Healthy Male | Completed | 2024-01-03 | 2024-02-15 | ClinicalTrials.gov |
| NCT05708859 | Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT | Phase4 | Type II Diabetes | Recruiting | 2024-01-02 | 2026-05-01 | ClinicalTrials.gov |
| NCT05708859 | Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT | Phase4 | Type II Diabetes | Recruiting | 2024-01-02 | 2026-05-01 | ClinicalTrials.gov |
| NCT06186622 | A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight… | Phase1 | Healthy | Completed | 2024-01-02 | 2024-07-10 | ClinicalTrials.gov |
| NCT06186622 | A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight… | Phase1 | Healthy | Completed | 2024-01-02 | 2024-07-10 | ClinicalTrials.gov |
| NCT06119581 | A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without … | Phase3 | Carcinoma, Non-Small-Cell Lung | Recruiting | 2023-12-21 | 2031-01-01 | ClinicalTrials.gov |
| NCT06119581 | A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without … | Phase3 | Carcinoma, Non-Small-Cell Lung | Recruiting | 2023-12-21 | 2031-01-01 | ClinicalTrials.gov |
| NCT06169982 | A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2023-12-07 | 2024-07-18 | ClinicalTrials.gov |
| NCT06148272 | A Study of LY3971297 in Healthy Participants | Phase1 | Healthy | Recruiting | 2023-12-07 | 2026-09-01 | ClinicalTrials.gov |
| NCT06169982 | A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2023-12-07 | 2024-07-18 | ClinicalTrials.gov |
| NCT06148272 | A Study of LY3971297 in Healthy Participants | Phase1 | Healthy | Recruiting | 2023-12-07 | 2026-09-01 | ClinicalTrials.gov |
| NCT06176768 | A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psori… | Phase2 | Plaque Psoriasis | Completed | 2023-12-06 | 2025-05-06 | ClinicalTrials.gov |
| NCT06176768 | A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psori… | Phase2 | Plaque Psoriasis | Completed | 2023-12-06 | 2025-05-06 | ClinicalTrials.gov |
| NCT06153355 | A First-In-Human Study of LY3839840 in Healthy Participants | Phase1 | Healthy | Completed | 2023-12-04 | 2025-05-22 | ClinicalTrials.gov |
| NCT06153355 | A First-In-Human Study of LY3839840 in Healthy Participants | Phase1 | Healthy | Completed | 2023-12-04 | 2025-05-22 | ClinicalTrials.gov |
| NCT05872204 | Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovar… | Phase2 | Low Grade Serous Ovarian Carcinoma | Recruiting | 2023-11-30 | 2028-01-01 | ClinicalTrials.gov |
| NCT05872204 | Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovar… | Phase2 | Low Grade Serous Ovarian Carcinoma | Recruiting | 2023-11-30 | 2028-01-01 | ClinicalTrials.gov |
| NCT05974579 | Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated W… | Phase1 | Amyotrophic Lateral Sclerosis | Active_Not_Recruiting | 2023-11-23 | 2025-03-31 | ClinicalTrials.gov |
| NCT05974579 | Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated W… | Phase1 | Amyotrophic Lateral Sclerosis | Active_Not_Recruiting | 2023-11-23 | 2025-03-31 | ClinicalTrials.gov |
| NCT05784246 | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to… | Phase3 | Ulcerative Colitis | Recruiting | 2023-11-22 | 2026-08-01 | ClinicalTrials.gov |
| NCT05784246 | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to… | Phase3 | Ulcerative Colitis | Recruiting | 2023-11-22 | 2026-08-01 | ClinicalTrials.gov |
| NCT06124807 | A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity o… | Phase2 | Obesity | Completed | 2023-11-17 | 2025-07-09 | ClinicalTrials.gov |
| NCT06132126 | A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Part… | Phase1 | Healthy | Completed | 2023-11-17 | 2024-06-28 | ClinicalTrials.gov |
| NCT06132126 | A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Part… | Phase1 | Healthy | Completed | 2023-11-17 | 2024-06-28 | ClinicalTrials.gov |
| NCT06124807 | A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity o… | Phase2 | Obesity | Completed | 2023-11-17 | 2025-07-09 | ClinicalTrials.gov |
| NCT06143956 | A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices… | Phase2 | Obesity | Recruiting | 2023-11-17 | 2028-02-01 | ClinicalTrials.gov |
| NCT06143956 | A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices… | Phase2 | Obesity | Recruiting | 2023-11-17 | 2028-02-01 | ClinicalTrials.gov |
| NCT06109311 | A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and In… | Phase3 | Type 2 Diabetes | Completed | 2023-11-10 | 2025-09-15 | ClinicalTrials.gov |
| NCT06109311 | A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and In… | Phase3 | Type 2 Diabetes | Completed | 2023-11-10 | 2025-09-15 | ClinicalTrials.gov |
| NCT05912621 | Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans … | Phase2 | Obesity | Recruiting | 2023-11-09 | 2029-12-01 | ClinicalTrials.gov |
| NCT05912621 | Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans … | Phase2 | Obesity | Recruiting | 2023-11-09 | 2029-12-01 | ClinicalTrials.gov |
| NCT06119529 | A Study of LY3872386 in Healthy Participants and Participants With Atopic Derma… | Phase1 | Healthy | Terminated | 2023-11-01 | 2024-04-08 | ClinicalTrials.gov |
| NCT06119529 | A Study of LY3872386 in Healthy Participants and Participants With Atopic Derma… | Phase1 | Healthy | Terminated | 2023-11-01 | 2024-04-08 | ClinicalTrials.gov |
| NCT05980000 | Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive He… | Phase2 | Recurrent Head and Neck Cancer | Active_Not_Recruiting | 2023-10-27 | 2030-06-30 | ClinicalTrials.gov |
| NCT06111521 | A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvasta… | Phase1 | Healthy | Completed | 2023-10-27 | 2024-04-01 | ClinicalTrials.gov |
| NCT06111521 | A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvasta… | Phase1 | Healthy | Completed | 2023-10-27 | 2024-04-01 | ClinicalTrials.gov |
| NCT05980000 | Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive He… | Phase2 | Recurrent Head and Neck Cancer | Active_Not_Recruiting | 2023-10-27 | 2030-06-30 | ClinicalTrials.gov |
| NCT06102512 | A Study of [14C]-LOXO-783 in Healthy Adult Participants | Phase1 | Healthy | Completed | 2023-10-23 | 2024-01-17 | ClinicalTrials.gov |
| NCT06046729 | A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Sever… | Phase2 | Hidradenitis Suppurativa | Active_Not_Recruiting | 2023-10-23 | 2026-08-01 | ClinicalTrials.gov |
| NCT06102512 | A Study of [14C]-LOXO-783 in Healthy Adult Participants | Phase1 | Healthy | Completed | 2023-10-23 | 2024-01-17 | ClinicalTrials.gov |
| NCT06046729 | A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Sever… | Phase2 | Hidradenitis Suppurativa | Active_Not_Recruiting | 2023-10-23 | 2026-08-01 | ClinicalTrials.gov |
| NCT06085482 | A Phase I Study of LY3502970 in Healthy Participants | Phase1 | Healthy | Completed | 2023-10-19 | 2024-01-05 | ClinicalTrials.gov |
| NCT06085482 | A Phase I Study of LY3502970 in Healthy Participants | Phase1 | Healthy | Completed | 2023-10-19 | 2024-01-05 | ClinicalTrials.gov |
| NCT06075667 | A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who H… | Phase3 | Obesity | Active_Not_Recruiting | 2023-10-16 | 2029-07-01 | ClinicalTrials.gov |
| NCT06075667 | A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who H… | Phase3 | Obesity | Active_Not_Recruiting | 2023-10-16 | 2029-07-01 | ClinicalTrials.gov |
| NCT05501704 | ETHAN - ET for Male BC | Phase2 | Male Breast Cancer | Recruiting | 2023-10-11 | 2036-04-01 | ClinicalTrials.gov |
| NCT05501704 | ETHAN - ET for Male BC | Phase2 | Male Breast Cancer | Recruiting | 2023-10-11 | 2036-04-01 | ClinicalTrials.gov |
| NCT06074562 | A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic… | Phase2 | Diabetic Peripheral Neuropathy | Completed | 2023-10-05 | 2025-06-11 | ClinicalTrials.gov |
| NCT06001762 | TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Bre… | Phase2 | Breast Cancer | Active_Not_Recruiting | 2023-10-05 | 2027-01-01 | ClinicalTrials.gov |
| NCT06001762 | TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Bre… | Phase2 | Breast Cancer | Active_Not_Recruiting | 2023-10-05 | 2027-01-01 | ClinicalTrials.gov |
| NCT05893797 | A Study of LY8888AX in Participants Using a Connected Insulin Management Platfo… | Na | Type 1 Diabetes | Completed | 2023-10-05 | 2024-09-16 | ClinicalTrials.gov |
| NCT06074562 | A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic… | Phase2 | Diabetic Peripheral Neuropathy | Completed | 2023-10-05 | 2025-06-11 | ClinicalTrials.gov |
| NCT05893797 | A Study of LY8888AX in Participants Using a Connected Insulin Management Platfo… | Na | Type 1 Diabetes | Completed | 2023-10-05 | 2024-09-16 | ClinicalTrials.gov |
| NCT06010004 | A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type … | Phase3 | Type 2 Diabetes | Completed | 2023-09-28 | 2025-06-05 | ClinicalTrials.gov |
| NCT06010004 | A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type … | Phase3 | Type 2 Diabetes | Completed | 2023-09-28 | 2025-06-05 | ClinicalTrials.gov |
| NCT06045221 | A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants W… | Phase3 | Type 2 Diabetes | Completed | 2023-09-22 | 2025-08-22 | ClinicalTrials.gov |
| NCT06045221 | A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants W… | Phase3 | Type 2 Diabetes | Completed | 2023-09-22 | 2025-08-22 | ClinicalTrials.gov |
| NCT06023095 | A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight Wit… | Phase1 | Overweight | Completed | 2023-09-21 | 2024-07-29 | ClinicalTrials.gov |
| NCT06023095 | A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight Wit… | Phase1 | Overweight | Completed | 2023-09-21 | 2024-07-29 | ClinicalTrials.gov |
| NCT06037252 | A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With T… | Phase2 | Type 2 Diabetes | Active_Not_Recruiting | 2023-09-21 | 2026-10-01 | ClinicalTrials.gov |
| NCT06037252 | A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With T… | Phase2 | Type 2 Diabetes | Active_Not_Recruiting | 2023-09-21 | 2026-10-01 | ClinicalTrials.gov |
| NCT06052462 | A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male Participants | Phase1 | Healthy | Completed | 2023-09-20 | 2023-11-04 | ClinicalTrials.gov |
| NCT06047548 | A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction… | Phase3 | Overweight | Completed | 2023-09-20 | 2026-01-20 | ClinicalTrials.gov |
| NCT06052462 | A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male Participants | Phase1 | Healthy | Completed | 2023-09-20 | 2023-11-04 | ClinicalTrials.gov |
| NCT06047548 | A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction… | Phase3 | Overweight | Completed | 2023-09-20 | 2026-01-20 | ClinicalTrials.gov |
| NCT06049108 | A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants | Phase1 | Healthy | Completed | 2023-09-15 | 2023-11-03 | ClinicalTrials.gov |
| NCT05821959 | Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss | Phase1 | Sensorineural Hearing Loss, Bilateral | Recruiting | 2023-09-15 | 2028-10-01 | ClinicalTrials.gov |
| NCT06049108 | A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants | Phase1 | Healthy | Completed | 2023-09-15 | 2023-11-03 | ClinicalTrials.gov |
| NCT05821959 | Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss | Phase1 | Sensorineural Hearing Loss, Bilateral | Recruiting | 2023-09-15 | 2028-10-01 | ClinicalTrials.gov |
| NCT06009653 | Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Meta… | Phase4 | Obesity | Withdrawn | 2023-09-13 | 2024-05-29 | ClinicalTrials.gov |
| NCT06009653 | Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Meta… | Phase4 | Obesity | Withdrawn | 2023-09-13 | 2024-05-29 | ClinicalTrials.gov |
| NCT06039826 | A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight o… | Phase1 | Overweight | Completed | 2023-09-12 | 2024-07-11 | ClinicalTrials.gov |
| NCT06039826 | A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight o… | Phase1 | Overweight | Completed | 2023-09-12 | 2024-07-11 | ClinicalTrials.gov |
| NCT06028425 | A Study to Evaluate the Effect of Food on LOXO-783 in Healthy Participants | Phase1 | Healthy | Completed | 2023-09-01 | 2023-12-23 | ClinicalTrials.gov |
| NCT06028425 | A Study to Evaluate the Effect of Food on LOXO-783 in Healthy Participants | Phase1 | Healthy | Completed | 2023-09-01 | 2023-12-23 | ClinicalTrials.gov |
| NCT06003465 | A Research Study Looking at Similarity Between LY3437943 Versions for Different… | Phase1 | Healthy | Completed | 2023-08-29 | 2024-02-08 | ClinicalTrials.gov |
| NCT06003465 | A Research Study Looking at Similarity Between LY3437943 Versions for Different… | Phase1 | Healthy | Completed | 2023-08-29 | 2024-02-08 | ClinicalTrials.gov |
| NCT06007638 | A Single and Multiple Ascending Dose Study of LY3876602 in Healthy Participants | Phase1 | Healthy | Completed | 2023-08-23 | 2025-09-20 | ClinicalTrials.gov |
| NCT06007638 | A Single and Multiple Ascending Dose Study of LY3876602 in Healthy Participants | Phase1 | Healthy | Completed | 2023-08-23 | 2025-09-20 | ClinicalTrials.gov |
| NCT05963022 | A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes… | Phase3 | Type 2 Diabetes | Completed | 2023-08-21 | 2024-10-09 | ClinicalTrials.gov |
| NCT05963022 | A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes… | Phase3 | Type 2 Diabetes | Completed | 2023-08-21 | 2024-10-09 | ClinicalTrials.gov |
| NCT06007937 | A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer | Phase1 | Non Small Cell Lung Cancer | Recruiting | 2023-08-17 | 2028-08-17 | ClinicalTrials.gov |
| NCT06007937 | A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer | Phase1 | Non Small Cell Lung Cancer | Recruiting | 2023-08-17 | 2028-08-17 | ClinicalTrials.gov |
| NCT06007651 | A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty L… | Phase1 | Dyslipidemias | Terminated | 2023-08-10 | 2025-02-12 | ClinicalTrials.gov |
| NCT06007651 | A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty L… | Phase1 | Dyslipidemias | Terminated | 2023-08-10 | 2025-02-12 | ClinicalTrials.gov |
| NCT05980416 | Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 | Phase1 | Stomach Neoplasm | Terminated | 2023-08-10 | 2025-06-02 | ClinicalTrials.gov |
| NCT05980416 | Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2 | Phase1 | Stomach Neoplasm | Terminated | 2023-08-10 | 2025-06-02 | ClinicalTrials.gov |
| NCT05971940 | A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes … | Phase3 | Type 2 Diabetes | Completed | 2023-08-09 | 2025-04-03 | ClinicalTrials.gov |
| NCT05617885 | Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer | Phase1 | Metastatic Prostate Cancer | Active_Not_Recruiting | 2023-08-09 | 2026-06-01 | ClinicalTrials.gov |
| NCT05617885 | Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer | Phase1 | Metastatic Prostate Cancer | Active_Not_Recruiting | 2023-08-09 | 2026-06-01 | ClinicalTrials.gov |
| NCT05971940 | A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes … | Phase3 | Type 2 Diabetes | Completed | 2023-08-09 | 2025-04-03 | ClinicalTrials.gov |
| NCT05960851 | A Study of LY3871801 in Healthy Asian and Non-Asian Participants | Phase1 | Healthy | Completed | 2023-08-09 | 2023-10-25 | ClinicalTrials.gov |
| NCT05960851 | A Study of LY3871801 in Healthy Asian and Non-Asian Participants | Phase1 | Healthy | Completed | 2023-08-09 | 2023-10-25 | ClinicalTrials.gov |
| NCT05931367 | A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity… | Phase3 | Obesity | Completed | 2023-08-01 | 2025-11-14 | ClinicalTrials.gov |
| NCT05931367 | A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity… | Phase3 | Obesity | Completed | 2023-08-01 | 2025-11-14 | ClinicalTrials.gov |
| NCT05978713 | A Study of Tirzepatide (LY3298176) in Healthy Lactating Females | Phase1 | Healthy | Completed | 2023-07-31 | 2024-03-12 | ClinicalTrials.gov |
| NCT05931380 | A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participa… | Phase3 | Obesity | Completed | 2023-07-31 | 2025-06-19 | ClinicalTrials.gov |
| NCT05978713 | A Study of Tirzepatide (LY3298176) in Healthy Lactating Females | Phase1 | Healthy | Completed | 2023-07-31 | 2024-03-12 | ClinicalTrials.gov |
| NCT05931380 | A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participa… | Phase3 | Obesity | Completed | 2023-07-31 | 2025-06-19 | ClinicalTrials.gov |
| NCT05906836 | A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastat… | Phase1 | Healthy | Completed | 2023-07-27 | 2023-10-31 | ClinicalTrials.gov |
| NCT05906836 | A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastat… | Phase1 | Healthy | Completed | 2023-07-27 | 2023-10-31 | ClinicalTrials.gov |
| NCT05959109 | A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Hea… | Phase1 | Healthy | Completed | 2023-07-21 | 2024-01-11 | ClinicalTrials.gov |
| NCT05959109 | A Relative Bioavailability Study of Peresolimab (LY3462817) Formulations in Hea… | Phase1 | Healthy | Completed | 2023-07-21 | 2024-01-11 | ClinicalTrials.gov |
| NCT05936151 | A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overw… | Phase2 | Overweight or Obesity | Completed | 2023-07-20 | 2025-10-21 | ClinicalTrials.gov |
| NCT05936151 | A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overw… | Phase2 | Overweight or Obesity | Completed | 2023-07-20 | 2025-10-21 | ClinicalTrials.gov |
| NCT05959096 | A Study of LY3437943 in Healthy Participants With a High Body Mass Index | Phase1 | Healthy | Completed | 2023-07-18 | 2024-07-25 | ClinicalTrials.gov |
| NCT05959096 | A Study of LY3437943 in Healthy Participants With a High Body Mass Index | Phase1 | Healthy | Completed | 2023-07-18 | 2024-07-25 | ClinicalTrials.gov |
| NCT05936138 | A Study of LY3502970 in Participants With Normal and Impaired Renal Function | Phase1 | Renal Insufficiency | Completed | 2023-07-13 | 2024-04-11 | ClinicalTrials.gov |
| NCT05916560 | A Study of LY3437943 in Participants With Impaired and Normal Liver Function | Phase1 | Healthy | Completed | 2023-07-13 | 2025-03-02 | ClinicalTrials.gov |
| NCT05936138 | A Study of LY3502970 in Participants With Normal and Impaired Renal Function | Phase1 | Renal Insufficiency | Completed | 2023-07-13 | 2024-04-11 | ClinicalTrials.gov |
| NCT05916560 | A Study of LY3437943 in Participants With Impaired and Normal Liver Function | Phase1 | Healthy | Completed | 2023-07-13 | 2025-03-02 | ClinicalTrials.gov |
| NCT05929079 | A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitu… | Phase3 | Type 2 Diabetes | Active_Not_Recruiting | 2023-07-11 | 2026-05-01 | ClinicalTrials.gov |
| NCT05929079 | A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitu… | Phase3 | Type 2 Diabetes | Active_Not_Recruiting | 2023-07-11 | 2026-05-01 | ClinicalTrials.gov |
| NCT05929066 | A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweig… | Phase3 | Obesity | Active_Not_Recruiting | 2023-07-10 | 2026-05-01 | ClinicalTrials.gov |
| NCT05929066 | A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweig… | Phase3 | Obesity | Active_Not_Recruiting | 2023-07-10 | 2026-05-01 | ClinicalTrials.gov |
| NCT06354101 | The Purpose of This Registry Study is to Learn More About Metabolic Health: App… | — | Metabolic Health | Withdrawn | 2023-07-01 | 2023-07-01 | ClinicalTrials.gov |
| NCT06354101 | The Purpose of This Registry Study is to Learn More About Metabolic Health: App… | — | Metabolic Health | Withdrawn | 2023-07-01 | 2023-07-01 | ClinicalTrials.gov |
| NCT05932446 | A Study to Compare Two Formulations of LY3819469 in Healthy Participants | Phase1 | Healthy | Completed | 2023-06-30 | 2023-11-07 | ClinicalTrials.gov |
| NCT05932446 | A Study to Compare Two Formulations of LY3819469 in Healthy Participants | Phase1 | Healthy | Completed | 2023-06-30 | 2023-11-07 | ClinicalTrials.gov |
| NCT05855967 | A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-… | Phase4 | Plaque Psoriasis | Completed | 2023-06-27 | 2024-09-23 | ClinicalTrials.gov |
| NCT05855967 | A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-… | Phase4 | Plaque Psoriasis | Completed | 2023-06-27 | 2024-09-23 | ClinicalTrials.gov |
| NCT05914688 | A Study to Compare Two Formulations of LY3209590 in Healthy Participants | Phase1 | Healthy | Completed | 2023-06-26 | 2024-01-18 | ClinicalTrials.gov |
| NCT05914688 | A Study to Compare Two Formulations of LY3209590 in Healthy Participants | Phase1 | Healthy | Completed | 2023-06-26 | 2024-01-18 | ClinicalTrials.gov |
| NCT05911841 | A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Se… | Phase2 | Atopic Dermatitis | Terminated | 2023-06-21 | 2025-03-14 | ClinicalTrials.gov |
| NCT05911841 | A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Se… | Phase2 | Atopic Dermatitis | Terminated | 2023-06-21 | 2025-03-14 | ClinicalTrials.gov |
| NCT05853887 | Liquid Biopsy Based NGS in Newly Diagnosed NSCLC | Na | Non Small Cell Lung Cancer Metastatic | Active_Not_Recruiting | 2023-06-15 | 2026-12-31 | ClinicalTrials.gov |
| NCT05853887 | Liquid Biopsy Based NGS in Newly Diagnosed NSCLC | Na | Non Small Cell Lung Cancer Metastatic | Active_Not_Recruiting | 2023-06-15 | 2026-12-31 | ClinicalTrials.gov |
| NCT05457998 | BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers | — | Alzheimer Disease | Enrolling_By_Invitation | 2023-06-14 | 2028-06-01 | ClinicalTrials.gov |
| NCT05457998 | BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers | — | Alzheimer Disease | Enrolling_By_Invitation | 2023-06-14 | 2028-06-01 | ClinicalTrials.gov |
| NCT05882032 | A Study of LY3502970 in Participants With Impaired and Normal Liver Function | Phase1 | Healthy | Completed | 2023-06-13 | 2024-11-18 | ClinicalTrials.gov |
| NCT05882032 | A Study of LY3502970 in Participants With Impaired and Normal Liver Function | Phase1 | Healthy | Completed | 2023-06-13 | 2024-11-18 | ClinicalTrials.gov |
| NCT05887999 | A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2023-06-12 | 2024-02-21 | ClinicalTrials.gov |
| NCT05887999 | A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2023-06-12 | 2024-02-21 | ClinicalTrials.gov |
| NCT05894928 | A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Partici… | Phase1 | Healthy | Completed | 2023-06-07 | 2023-07-09 | ClinicalTrials.gov |
| NCT05894928 | A Study to Evaluate the Effect of Cholestyramine on LOXO-783 in Healthy Partici… | Phase1 | Healthy | Completed | 2023-06-07 | 2023-07-09 | ClinicalTrials.gov |
| NCT05901311 | A Study of [14C]-LY3537982 in Healthy Participants | Phase1 | Healthy | Completed | 2023-06-05 | 2023-08-10 | ClinicalTrials.gov |
| NCT05901311 | A Study of [14C]-LY3537982 in Healthy Participants | Phase1 | Healthy | Completed | 2023-06-05 | 2023-08-10 | ClinicalTrials.gov |
| NCT05872620 | A Study of Orforglipron in Adult Participants With Obesity or Overweight and Ty… | Phase3 | Obesity | Completed | 2023-06-05 | 2025-08-08 | ClinicalTrials.gov |
| NCT05869903 | A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overw… | Phase3 | Obesity | Active_Not_Recruiting | 2023-06-05 | 2027-10-01 | ClinicalTrials.gov |
| NCT05872620 | A Study of Orforglipron in Adult Participants With Obesity or Overweight and Ty… | Phase3 | Obesity | Completed | 2023-06-05 | 2025-08-08 | ClinicalTrials.gov |
| NCT05869903 | A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overw… | Phase3 | Obesity | Active_Not_Recruiting | 2023-06-05 | 2027-10-01 | ClinicalTrials.gov |
| NCT05882045 | A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascu… | Phase3 | Obesity | Active_Not_Recruiting | 2023-05-30 | 2026-05-01 | ClinicalTrials.gov |
| NCT05882045 | A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascu… | Phase3 | Obesity | Active_Not_Recruiting | 2023-05-30 | 2026-05-01 | ClinicalTrials.gov |
| NCT05848258 | An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoi… | Phase2 | Rheumatoid Arthritis | Active_Not_Recruiting | 2023-05-23 | 2026-04-01 | ClinicalTrials.gov |
| NCT05848258 | An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoi… | Phase2 | Rheumatoid Arthritis | Active_Not_Recruiting | 2023-05-23 | 2026-04-01 | ClinicalTrials.gov |
| NCT05767021 | A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely … | Phase3 | Ulcerative Colitis | Active_Not_Recruiting | 2023-05-17 | 2026-04-01 | ClinicalTrials.gov |
| NCT05767021 | A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely … | Phase3 | Ulcerative Colitis | Active_Not_Recruiting | 2023-05-17 | 2026-04-01 | ClinicalTrials.gov |
| NCT05860933 | A Study of the Effects of Itraconazole or Carbamazepine on LY3537982 in Healthy… | Phase1 | Healthy | Completed | 2023-05-08 | 2023-08-28 | ClinicalTrials.gov |
| NCT05860933 | A Study of the Effects of Itraconazole or Carbamazepine on LY3537982 in Healthy… | Phase1 | Healthy | Completed | 2023-05-08 | 2023-08-28 | ClinicalTrials.gov |
| NCT05734690 | COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart … | Phase4 | Heart Failure | Completed | 2023-05-05 | 2025-06-09 | ClinicalTrials.gov |
| NCT05734690 | COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart … | Phase4 | Heart Failure | Completed | 2023-05-05 | 2025-06-09 | ClinicalTrials.gov |
| NCT05734495 | Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia | Phase2 | Waldenstrom Macroglobulinemia | Recruiting | 2023-05-02 | 2033-01-25 | ClinicalTrials.gov |
| NCT05734495 | Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia | Phase2 | Waldenstrom Macroglobulinemia | Recruiting | 2023-05-02 | 2033-01-25 | ClinicalTrials.gov |
| NCT05841238 | A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants | Phase1 | Healthy | Completed | 2023-04-26 | 2023-11-13 | ClinicalTrials.gov |
| NCT05841238 | A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants | Phase1 | Healthy | Completed | 2023-04-26 | 2023-11-13 | ClinicalTrials.gov |
| NCT05841277 | A Study of LY3819469 in Participants With Impaired and Normal Renal Function | Phase1 | Renal Insufficiency | Completed | 2023-04-25 | 2024-01-09 | ClinicalTrials.gov |
| NCT05841277 | A Study of LY3819469 in Participants With Impaired and Normal Renal Function | Phase1 | Renal Insufficiency | Completed | 2023-04-25 | 2024-01-09 | ClinicalTrials.gov |
| NCT05822830 | A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight W… | Phase3 | Obesity | Completed | 2023-04-21 | 2024-11-13 | ClinicalTrials.gov |
| NCT05822830 | A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight W… | Phase3 | Obesity | Completed | 2023-04-21 | 2024-11-13 | ClinicalTrials.gov |
| NCT05237388 | Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease | Phase2 | Chronic Kidney Diseases | Completed | 2023-04-20 | 2026-04-03 | ClinicalTrials.gov |
| NCT05237388 | Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease | Phase2 | Chronic Kidney Diseases | Completed | 2023-04-20 | 2026-04-03 | ClinicalTrials.gov |
| NCT05768139 | First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination … | Phase1 | Breast Cancer | Recruiting | 2023-04-17 | 2030-07-01 | ClinicalTrials.gov |
| NCT05768139 | First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination … | Phase1 | Breast Cancer | Recruiting | 2023-04-17 | 2030-07-01 | ClinicalTrials.gov |
| NCT05824858 | A Study of the Effect of Food on LY3537982 in Healthy Participants | Phase1 | Healthy | Completed | 2023-04-12 | 2023-06-17 | ClinicalTrials.gov |
| NCT05824858 | A Study of the Effect of Food on LY3537982 in Healthy Participants | Phase1 | Healthy | Completed | 2023-04-12 | 2023-06-17 | ClinicalTrials.gov |
| NCT05803421 | A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine i… | Phase3 | Type 2 Diabetes | Completed | 2023-04-03 | 2026-03-16 | ClinicalTrials.gov |
| NCT05803421 | A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine i… | Phase3 | Type 2 Diabetes | Completed | 2023-04-03 | 2026-03-16 | ClinicalTrials.gov |
| NCT05810597 | A Research Study Looking at Similarity Between Tirzepatide Versions for Differe… | Phase1 | Healthy | Completed | 2023-04-03 | 2023-07-17 | ClinicalTrials.gov |
| NCT05810597 | A Research Study Looking at Similarity Between Tirzepatide Versions for Differe… | Phase1 | Healthy | Completed | 2023-04-03 | 2023-07-17 | ClinicalTrials.gov |
| NCT05794243 | A Multiple-Dose Study of LY3493269 in Healthy Participants | Phase1 | Healthy | Terminated | 2023-03-23 | 2023-06-20 | ClinicalTrials.gov |
| NCT05794243 | A Multiple-Dose Study of LY3493269 in Healthy Participants | Phase1 | Healthy | Terminated | 2023-03-23 | 2023-06-20 | ClinicalTrials.gov |
| NCT05757531 | A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male Participants | Phase1 | Healthy | Completed | 2023-03-17 | 2023-06-23 | ClinicalTrials.gov |
| NCT05757531 | A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male Participants | Phase1 | Healthy | Completed | 2023-03-17 | 2023-06-23 | ClinicalTrials.gov |
| NCT05778864 | A Study of LY3473329 in Participants With Impaired and Normal Renal Function | Phase1 | Renal Insufficiency | Completed | 2023-03-17 | 2024-09-06 | ClinicalTrials.gov |
| NCT05778864 | A Study of LY3473329 in Participants With Impaired and Normal Renal Function | Phase1 | Renal Insufficiency | Completed | 2023-03-17 | 2024-09-06 | ClinicalTrials.gov |
| NCT05633602 | Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recur… | Phase3 | Recurrent Lung Non-Small Cell Carcinoma | Active_Not_Recruiting | 2023-03-14 | 2028-03-15 | ClinicalTrials.gov |
| NCT05633602 | Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recur… | Phase3 | Recurrent Lung Non-Small Cell Carcinoma | Active_Not_Recruiting | 2023-03-14 | 2028-03-15 | ClinicalTrials.gov |
| NCT05735483 | A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150)… | Phase3 | Atopic Dermatitis | Enrolling_By_Invitation | 2023-03-09 | 2029-04-01 | ClinicalTrials.gov |
| NCT05735483 | A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150)… | Phase3 | Atopic Dermatitis | Enrolling_By_Invitation | 2023-03-09 | 2029-04-01 | ClinicalTrials.gov |
| NCT05706506 | A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching Fro… | Phase4 | Type 2 Diabetes | Completed | 2023-03-08 | 2023-10-31 | ClinicalTrials.gov |
| NCT05706506 | A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching Fro… | Phase4 | Type 2 Diabetes | Completed | 2023-03-08 | 2023-10-31 | ClinicalTrials.gov |
| NCT05668962 | Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC | Phase2 | Thyroid Cancer | Recruiting | 2023-03-01 | 2026-01-01 | ClinicalTrials.gov |
| NCT05668962 | Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC | Phase2 | Thyroid Cancer | Recruiting | 2023-03-01 | 2026-01-01 | ClinicalTrials.gov |
| NCT05738486 | A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early… | Phase3 | Alzheimer's Disease | Active_Not_Recruiting | 2023-02-28 | 2027-05-01 | ClinicalTrials.gov |
| NCT05738486 | A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early… | Phase3 | Alzheimer's Disease | Active_Not_Recruiting | 2023-02-28 | 2027-05-01 | ClinicalTrials.gov |
| NCT05723198 | A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Yea… | Phase3 | Areata Alopecia | Recruiting | 2023-02-27 | 2030-02-01 | ClinicalTrials.gov |
| NCT05723198 | A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Yea… | Phase3 | Areata Alopecia | Recruiting | 2023-02-27 | 2030-02-01 | ClinicalTrials.gov |
| NCT05749848 | A Study of Carbon-14-Labelled [14C] LY3372689 in Healthy Male Participants | Phase1 | Healthy | Completed | 2023-02-24 | 2023-04-18 | ClinicalTrials.gov |
| NCT05749848 | A Study of Carbon-14-Labelled [14C] LY3372689 in Healthy Male Participants | Phase1 | Healthy | Completed | 2023-02-24 | 2023-04-18 | ClinicalTrials.gov |
| NCT05608252 | VS-6766+Abema+Fulv in Met HR+/HER- BC | Phase1 | Breast Cancer | Recruiting | 2023-02-23 | 2028-12-31 | ClinicalTrials.gov |
| NCT05608252 | VS-6766+Abema+Fulv in Met HR+/HER- BC | Phase1 | Breast Cancer | Recruiting | 2023-02-23 | 2028-12-31 | ClinicalTrials.gov |
| NCT06937411 | A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of D… | Phase1 | Healthy | Completed | 2023-02-13 | 2023-10-30 | ClinicalTrials.gov |
| NCT06937411 | A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of D… | Phase1 | Healthy | Completed | 2023-02-13 | 2023-10-30 | ClinicalTrials.gov |
| NCT05727072 | A Study of LY3848575 in Healthy Participants | Phase1 | Healthy | Completed | 2023-02-10 | 2024-02-19 | ClinicalTrials.gov |
| NCT05727072 | A Study of LY3848575 in Healthy Participants | Phase1 | Healthy | Completed | 2023-02-10 | 2024-02-19 | ClinicalTrials.gov |
| NCT05536804 | A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity a… | Phase2 | Overweight | Active_Not_Recruiting | 2023-02-08 | 2026-10-01 | ClinicalTrials.gov |
| NCT05536804 | A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity a… | Phase2 | Overweight | Active_Not_Recruiting | 2023-02-08 | 2026-10-01 | ClinicalTrials.gov |
| NCT05696847 | A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity | Phase1 | Obesity | Completed | 2023-02-07 | 2025-01-16 | ClinicalTrials.gov |
| NCT05696847 | A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity | Phase1 | Obesity | Completed | 2023-02-07 | 2025-01-16 | ClinicalTrials.gov |
| NCT05691712 | A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes | Phase3 | Diabetes Type 2 | Completed | 2023-02-05 | 2024-07-01 | ClinicalTrials.gov |
| NCT05691712 | A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes | Phase3 | Diabetes Type 2 | Completed | 2023-02-05 | 2024-07-01 | ClinicalTrials.gov |
| NCT05592275 | A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With … | Phase2 | Heart Failure | Terminated | 2023-02-03 | 2025-01-22 | ClinicalTrials.gov |
| NCT05592275 | A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With … | Phase2 | Heart Failure | Terminated | 2023-02-03 | 2025-01-22 | ClinicalTrials.gov |
| NCT05692869 | A Study of Continuous Blood Pressure Monitoring in Healthy Participants | Na | Healthy | Completed | 2023-01-31 | 2023-04-04 | ClinicalTrials.gov |
| NCT05692869 | A Study of Continuous Blood Pressure Monitoring in Healthy Participants | Na | Healthy | Completed | 2023-01-31 | 2023-04-04 | ClinicalTrials.gov |
| NCT05529069 | Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Man… | Phase2 | Mantle Cell Lymphoma | Recruiting | 2023-01-25 | 2027-04-28 | ClinicalTrials.gov |
| NCT05714072 | A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Mye… | Phase1 | Myelofibrosis Due to and Following Polycythemia Vera | Recruiting | 2023-01-25 | 2027-01-01 | ClinicalTrials.gov |
| NCT05714072 | A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Mye… | Phase1 | Myelofibrosis Due to and Following Polycythemia Vera | Recruiting | 2023-01-25 | 2027-01-01 | ClinicalTrials.gov |
| NCT05529069 | Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Man… | Phase2 | Mantle Cell Lymphoma | Recruiting | 2023-01-25 | 2027-04-28 | ClinicalTrials.gov |
| NCT05662332 | A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Part… | Phase3 | Type 2 Diabetes | Completed | 2023-01-14 | 2024-07-19 | ClinicalTrials.gov |
| NCT05662332 | A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Part… | Phase3 | Type 2 Diabetes | Completed | 2023-01-14 | 2024-07-19 | ClinicalTrials.gov |
| NCT05614739 | FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a C… | Phase1 | Urinary Bladder Neoplasms | Recruiting | 2023-01-12 | 2027-06-01 | ClinicalTrials.gov |
| NCT05372419 | A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult … | Phase3 | Atopic Dermatitis | Completed | 2023-01-12 | 2025-02-17 | ClinicalTrials.gov |
| NCT05372419 | A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult … | Phase3 | Atopic Dermatitis | Completed | 2023-01-12 | 2025-02-17 | ClinicalTrials.gov |
| NCT05614739 | FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a C… | Phase1 | Urinary Bladder Neoplasms | Recruiting | 2023-01-12 | 2027-06-01 | ClinicalTrials.gov |
| NCT05659537 | A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitu… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2022-12-29 | 2024-01-16 | ClinicalTrials.gov |
| NCT05659537 | A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitu… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2022-12-29 | 2024-01-16 | ClinicalTrials.gov |
| NCT05487599 | A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestation… | Phase1 | Gaucher Disease | Recruiting | 2022-12-20 | 2031-11-30 | ClinicalTrials.gov |
| NCT05536349 | Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab… | Phase2 | Leukemia | Recruiting | 2022-12-20 | 2028-04-25 | ClinicalTrials.gov |
| NCT05487599 | A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestation… | Phase1 | Gaucher Disease | Recruiting | 2022-12-20 | 2031-11-30 | ClinicalTrials.gov |
| NCT05536349 | Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab… | Phase2 | Leukemia | Recruiting | 2022-12-20 | 2028-04-25 | ClinicalTrials.gov |
| NCT05369403 | A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With M… | Phase3 | Atopic Dermatitis | Completed | 2022-12-19 | 2025-02-05 | ClinicalTrials.gov |
| NCT05369403 | A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With M… | Phase3 | Atopic Dermatitis | Completed | 2022-12-19 | 2025-02-05 | ClinicalTrials.gov |
| NCT05630196 | A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants Wit… | Phase2 | Chronic Low-back Pain | Completed | 2022-12-08 | 2023-06-15 | ClinicalTrials.gov |
| NCT05630196 | A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants Wit… | Phase2 | Chronic Low-back Pain | Completed | 2022-12-08 | 2023-06-15 | ClinicalTrials.gov |
| NCT05644353 | A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participa… | Phase1 | Healthy | Completed | 2022-12-05 | 2023-05-25 | ClinicalTrials.gov |
| NCT05644353 | A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participa… | Phase1 | Healthy | Completed | 2022-12-05 | 2023-05-25 | ClinicalTrials.gov |
| NCT05596747 | A Study of LY3209590 in Chinese Participants With Type 2 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2022-11-30 | 2023-10-10 | ClinicalTrials.gov |
| NCT05564039 | A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes S… | Phase4 | Type 2 Diabetes | Completed | 2022-11-30 | 2024-08-12 | ClinicalTrials.gov |
| NCT05596747 | A Study of LY3209590 in Chinese Participants With Type 2 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2022-11-30 | 2023-10-10 | ClinicalTrials.gov |
| NCT05564039 | A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes S… | Phase4 | Type 2 Diabetes | Completed | 2022-11-30 | 2024-08-12 | ClinicalTrials.gov |
| NCT05563246 | A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High… | Phase2 | Lipoprotein Disorder | Completed | 2022-11-24 | 2024-03-14 | ClinicalTrials.gov |
| NCT05563246 | A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High… | Phase2 | Lipoprotein Disorder | Completed | 2022-11-24 | 2024-03-14 | ClinicalTrials.gov |
| NCT05580250 | A Study of LY3526318 in Healthy Male Japanese Participants | Phase1 | Healthy | Withdrawn | 2022-11-22 | 2022-12-08 | ClinicalTrials.gov |
| NCT05620563 | A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants Wit… | Phase2 | Osteoarthritis | Completed | 2022-11-22 | 2023-06-12 | ClinicalTrials.gov |
| NCT05620563 | A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants Wit… | Phase2 | Osteoarthritis | Completed | 2022-11-22 | 2023-06-12 | ClinicalTrials.gov |
| NCT05580250 | A Study of LY3526318 in Healthy Male Japanese Participants | Phase1 | Healthy | Withdrawn | 2022-11-22 | 2022-12-08 | ClinicalTrials.gov |
| NCT05611957 | A Study of LY3437943 in Healthy Participants and Participants With Impaired Ren… | Phase1 | Healthy | Completed | 2022-11-16 | 2023-09-05 | ClinicalTrials.gov |
| NCT05616013 | Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight … | Phase2 | Obesity | Completed | 2022-11-16 | 2025-06-14 | ClinicalTrials.gov |
| NCT05623839 | A Study of LY3305677 in Participants With Obesity Or Overweight | Phase1 | Overweight | Completed | 2022-11-16 | 2023-06-27 | ClinicalTrials.gov |
| NCT05623839 | A Study of LY3305677 in Participants With Obesity Or Overweight | Phase1 | Overweight | Completed | 2022-11-16 | 2023-06-27 | ClinicalTrials.gov |
| NCT05616013 | Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight … | Phase2 | Obesity | Completed | 2022-11-16 | 2025-06-14 | ClinicalTrials.gov |
| NCT05611957 | A Study of LY3437943 in Healthy Participants and Participants With Impaired Ren… | Phase1 | Healthy | Completed | 2022-11-16 | 2023-09-05 | ClinicalTrials.gov |
| NCT05615467 | A Study of Effect of LY3556050 on Metformin in Healthy Participants | Phase1 | Healthy | Completed | 2022-11-15 | 2022-12-27 | ClinicalTrials.gov |
| NCT05615467 | A Study of Effect of LY3556050 on Metformin in Healthy Participants | Phase1 | Healthy | Completed | 2022-11-15 | 2022-12-27 | ClinicalTrials.gov |
| NCT05620576 | A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants Wit… | Phase2 | Diabetic Peripheral Neuropathic Pain | Completed | 2022-11-14 | 2023-08-01 | ClinicalTrials.gov |
| NCT05609825 | A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyc… | Phase1 | Hypertriglyceridemia | Terminated | 2022-11-14 | 2024-01-10 | ClinicalTrials.gov |
| NCT05609825 | A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyc… | Phase1 | Hypertriglyceridemia | Terminated | 2022-11-14 | 2024-01-10 | ClinicalTrials.gov |
| NCT05620576 | A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants Wit… | Phase2 | Diabetic Peripheral Neuropathic Pain | Completed | 2022-11-14 | 2023-08-01 | ClinicalTrials.gov |
| NCT05582096 | A Study of LY3457263 in Obese Participants | Phase1 | Overweight | Completed | 2022-11-11 | 2023-06-08 | ClinicalTrials.gov |
| NCT05615532 | A Relative Bioavailability Study of LY3209590 in Healthy Participants | Phase1 | Healthy | Completed | 2022-11-11 | 2023-06-28 | ClinicalTrials.gov |
| NCT05582096 | A Study of LY3457263 in Obese Participants | Phase1 | Overweight | Completed | 2022-11-11 | 2023-06-08 | ClinicalTrials.gov |
| NCT05615532 | A Relative Bioavailability Study of LY3209590 in Healthy Participants | Phase1 | Healthy | Completed | 2022-11-11 | 2023-06-28 | ClinicalTrials.gov |
| NCT05602675 | A Drug Interaction Study of LY3871801 in Healthy Participants | Phase1 | Healthy | Completed | 2022-11-02 | 2023-03-29 | ClinicalTrials.gov |
| NCT05602675 | A Drug Interaction Study of LY3871801 in Healthy Participants | Phase1 | Healthy | Completed | 2022-11-02 | 2023-03-29 | ClinicalTrials.gov |
| NCT05548231 | A Study of LY3437943 in Chinese Participants With Obesity Or Overweight | Phase1 | Overweight | Completed | 2022-10-24 | 2023-07-27 | ClinicalTrials.gov |
| NCT05548231 | A Study of LY3437943 in Chinese Participants With Obesity Or Overweight | Phase1 | Overweight | Completed | 2022-10-24 | 2023-07-27 | ClinicalTrials.gov |
| NCT05565742 | A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)] | Phase2 | Lipoprotein Disorder | Completed | 2022-10-20 | 2024-10-17 | ClinicalTrials.gov |
| NCT05565742 | A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)] | Phase2 | Lipoprotein Disorder | Completed | 2022-10-20 | 2024-10-17 | ClinicalTrials.gov |
| NCT05559359 | A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Ag… | Phase3 | Atopic Dermatitis | Active_Not_Recruiting | 2022-10-18 | 2026-12-01 | ClinicalTrials.gov |
| NCT05559359 | A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Ag… | Phase3 | Atopic Dermatitis | Active_Not_Recruiting | 2022-10-18 | 2026-12-01 | ClinicalTrials.gov |
| NCT05573230 | A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants | Phase1 | Healthy | Completed | 2022-10-17 | 2023-01-17 | ClinicalTrials.gov |
| NCT05573230 | A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants | Phase1 | Healthy | Completed | 2022-10-17 | 2023-01-17 | ClinicalTrials.gov |
| NCT05556512 | A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality … | Phase3 | Obesity | Active_Not_Recruiting | 2022-10-11 | 2027-10-01 | ClinicalTrials.gov |
| NCT05556512 | A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality … | Phase3 | Obesity | Active_Not_Recruiting | 2022-10-11 | 2027-10-01 | ClinicalTrials.gov |
| NCT05508789 | A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheim… | Phase3 | Alzheimer Disease | Active_Not_Recruiting | 2022-10-10 | 2028-07-01 | ClinicalTrials.gov |
| NCT05508789 | A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheim… | Phase3 | Alzheimer Disease | Active_Not_Recruiting | 2022-10-10 | 2028-07-01 | ClinicalTrials.gov |
| NCT05509790 | A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer | Phase1 | Breast Neoplasms | Active_Not_Recruiting | 2022-10-09 | 2026-12-01 | ClinicalTrials.gov |
| NCT05509790 | A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer | Phase1 | Breast Neoplasms | Active_Not_Recruiting | 2022-10-09 | 2026-12-01 | ClinicalTrials.gov |
| NCT05565729 | A Phase I Study of LY3471851 in Healthy Participants | Phase1 | Healthy | Completed | 2022-10-05 | 2023-02-23 | ClinicalTrials.gov |
| NCT05565729 | A Phase I Study of LY3471851 in Healthy Participants | Phase1 | Healthy | Completed | 2022-10-05 | 2023-02-23 | ClinicalTrials.gov |
| NCT05567159 | A Study of Donanemab (LY3002813) in Healthy Participants | Phase1 | Healthy | Completed | 2022-10-04 | 2023-07-14 | ClinicalTrials.gov |
| NCT05514054 | A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With … | Phase3 | Breast Neoplasms | Active_Not_Recruiting | 2022-10-04 | 2032-03-01 | ClinicalTrials.gov |
| NCT05514054 | A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With … | Phase3 | Breast Neoplasms | Active_Not_Recruiting | 2022-10-04 | 2032-03-01 | ClinicalTrials.gov |
| NCT05567159 | A Study of Donanemab (LY3002813) in Healthy Participants | Phase1 | Healthy | Completed | 2022-10-04 | 2023-07-14 | ClinicalTrials.gov |
| NCT05440786 | CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarco… | Phase2 | Sarcoma, Ewing | Active_Not_Recruiting | 2022-09-20 | 2026-12-01 | ClinicalTrials.gov |
| NCT05440786 | CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarco… | Phase2 | Sarcoma, Ewing | Active_Not_Recruiting | 2022-09-20 | 2026-12-01 | ClinicalTrials.gov |
| NCT05533411 | A Study of Donanemab (LY3002813) in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2022-09-14 | 2023-01-05 | ClinicalTrials.gov |
| NCT05577169 | Incorporating Mind-body Skills With Diabetes Education in Adolescents With Type… | Na | Type 1 Diabetes | Completed | 2022-09-14 | 2024-12-31 | ClinicalTrials.gov |
| NCT05533411 | A Study of Donanemab (LY3002813) in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2022-09-14 | 2023-01-05 | ClinicalTrials.gov |
| NCT05577169 | Incorporating Mind-body Skills With Diabetes Education in Adolescents With Type… | Na | Type 1 Diabetes | Completed | 2022-09-14 | 2024-12-31 | ClinicalTrials.gov |
| NCT05509816 | A Study of Imlunestrant (LY3484356) in Healthy Women | Phase1 | Healthy | Completed | 2022-09-12 | 2022-11-30 | ClinicalTrials.gov |
| NCT05509816 | A Study of Imlunestrant (LY3484356) in Healthy Women | Phase1 | Healthy | Completed | 2022-09-12 | 2022-11-30 | ClinicalTrials.gov |
| NCT05588622 | Meru Health Program for Cancer Patients With Depression and Anxiety | Na | Depression | Completed | 2022-09-06 | 2023-07-01 | ClinicalTrials.gov |
| NCT05588622 | Meru Health Program for Cancer Patients With Depression and Anxiety | Na | Depression | Completed | 2022-09-06 | 2023-07-01 | ClinicalTrials.gov |
| NCT05496959 | 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Ol… | Phase2 | Oligometastatic Prostate Carcinoma | Active_Not_Recruiting | 2022-09-02 | 2033-09-01 | ClinicalTrials.gov |
| NCT05496959 | 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Ol… | Phase2 | Oligometastatic Prostate Carcinoma | Active_Not_Recruiting | 2022-09-02 | 2033-09-01 | ClinicalTrials.gov |
| NCT05516758 | A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely … | Phase2 | Rheumatoid Arthritis | Terminated | 2022-08-31 | 2025-01-17 | ClinicalTrials.gov |
| NCT05403502 | Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With t… | Na | Type 1 Diabetes | Completed | 2022-08-31 | 2023-08-02 | ClinicalTrials.gov |
| NCT05515601 | A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants | Phase1 | Healthy | Completed | 2022-08-31 | 2023-02-20 | ClinicalTrials.gov |
| NCT05403502 | Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With t… | Na | Type 1 Diabetes | Completed | 2022-08-31 | 2023-08-02 | ClinicalTrials.gov |
| NCT05516758 | A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely … | Phase2 | Rheumatoid Arthritis | Terminated | 2022-08-31 | 2025-01-17 | ClinicalTrials.gov |
| NCT05515601 | A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants | Phase1 | Healthy | Completed | 2022-08-31 | 2023-02-20 | ClinicalTrials.gov |
| NCT05463744 | A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in … | Phase3 | Type 1 Diabetes | Completed | 2022-08-12 | 2024-05-07 | ClinicalTrials.gov |
| NCT05463744 | A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in … | Phase3 | Type 1 Diabetes | Completed | 2022-08-12 | 2024-05-07 | ClinicalTrials.gov |
| NCT05462756 | A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared… | Phase3 | Type 2 Diabetes | Completed | 2022-08-11 | 2024-02-27 | ClinicalTrials.gov |
| NCT05492201 | A Study of LY3873862 in Healthy Participants | Phase1 | Healthy | Completed | 2022-08-11 | 2025-04-29 | ClinicalTrials.gov |
| NCT05486208 | A Study of LY3844583 in Healthy Participants and Participants With Atopic Derma… | Phase1 | Healthy | Terminated | 2022-08-11 | 2024-01-20 | ClinicalTrials.gov |
| NCT05462756 | A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared… | Phase3 | Type 2 Diabetes | Completed | 2022-08-11 | 2024-02-27 | ClinicalTrials.gov |
| NCT05492201 | A Study of LY3873862 in Healthy Participants | Phase1 | Healthy | Completed | 2022-08-11 | 2025-04-29 | ClinicalTrials.gov |
| NCT05486208 | A Study of LY3844583 in Healthy Participants and Participants With Atopic Derma… | Phase1 | Healthy | Terminated | 2022-08-11 | 2024-01-20 | ClinicalTrials.gov |
| NCT05444569 | A Study of LY3537021 in Healthy Participants | Phase1 | Healthy | Completed | 2022-08-08 | 2023-02-24 | ClinicalTrials.gov |
| NCT05444569 | A Study of LY3537021 in Healthy Participants | Phase1 | Healthy | Completed | 2022-08-08 | 2023-02-24 | ClinicalTrials.gov |
| NCT05463731 | A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TR… | Phase3 | Alzheimer's Disease | Active_Not_Recruiting | 2022-08-01 | 2026-03-01 | ClinicalTrials.gov |
| NCT05433584 | A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Par… | Phase4 | Type 2 Diabetes | Active_Not_Recruiting | 2022-08-01 | 2027-11-01 | ClinicalTrials.gov |
| NCT05469126 | A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants | Phase1 | Healthy | Completed | 2022-08-01 | 2022-11-03 | ClinicalTrials.gov |
| NCT05433584 | A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Par… | Phase4 | Type 2 Diabetes | Active_Not_Recruiting | 2022-08-01 | 2027-11-01 | ClinicalTrials.gov |
| NCT05463731 | A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TR… | Phase3 | Alzheimer's Disease | Active_Not_Recruiting | 2022-08-01 | 2026-03-01 | ClinicalTrials.gov |
| NCT05469126 | A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants | Phase1 | Healthy | Completed | 2022-08-01 | 2022-11-03 | ClinicalTrials.gov |
| NCT05167409 | A Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory … | Phase2 | Microsatellite Stable Metastatic Colorectal Cancer | Active_Not_Recruiting | 2022-07-28 | 2026-03-01 | ClinicalTrials.gov |
| NCT05167409 | A Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory … | Phase2 | Microsatellite Stable Metastatic Colorectal Cancer | Active_Not_Recruiting | 2022-07-28 | 2026-03-01 | ClinicalTrials.gov |
| NCT05254743 | A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chron… | Phase3 | Chronic Lymphocytic Leukemia | Recruiting | 2022-07-22 | 2028-01-01 | ClinicalTrials.gov |
| NCT05254743 | A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chron… | Phase3 | Chronic Lymphocytic Leukemia | Recruiting | 2022-07-22 | 2028-01-01 | ClinicalTrials.gov |
| NCT05256654 | A Study of LY3561774 in Participants With Mixed Dyslipidemia | Phase2 | Dyslipidemias | Completed | 2022-07-20 | 2024-05-23 | ClinicalTrials.gov |
| NCT05256654 | A Study of LY3561774 in Participants With Mixed Dyslipidemia | Phase2 | Dyslipidemias | Completed | 2022-07-20 | 2024-05-23 | ClinicalTrials.gov |
| NCT05572073 | Otoferlin Gene-mediated Hearing Loss Natural History Study | — | Sensorineural Hearing Loss, Bilateral | Recruiting | 2022-07-14 | 2029-02-01 | ClinicalTrials.gov |
| NCT05572073 | Otoferlin Gene-mediated Hearing Loss Natural History Study | — | Sensorineural Hearing Loss, Bilateral | Recruiting | 2022-07-14 | 2029-02-01 | ClinicalTrials.gov |
| NCT05016297 | Efficacy and Safety of Baricitinib in Sjogren's Syndrome | Phase2 | Sjogren's Syndrome | Completed | 2022-07-14 | 2024-11-22 | ClinicalTrials.gov |
| NCT05016297 | Efficacy and Safety of Baricitinib in Sjogren's Syndrome | Phase2 | Sjogren's Syndrome | Completed | 2022-07-14 | 2024-11-22 | ClinicalTrials.gov |
| NCT05217446 | A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compare… | Phase2 | Metastatic Colorectal Cancer | Active_Not_Recruiting | 2022-07-11 | 2027-01-26 | ClinicalTrials.gov |
| NCT05217446 | A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compare… | Phase2 | Metastatic Colorectal Cancer | Active_Not_Recruiting | 2022-07-11 | 2027-01-26 | ClinicalTrials.gov |
| NCT05445232 | A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants | Phase1 | Obesity | Completed | 2022-07-08 | 2023-02-24 | ClinicalTrials.gov |
| NCT05113537 | Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resi… | Phase1 | Castration-Resistant Prostate Carcinoma | Recruiting | 2022-07-08 | 2027-12-31 | ClinicalTrials.gov |
| NCT05113537 | Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resi… | Phase1 | Castration-Resistant Prostate Carcinoma | Recruiting | 2022-07-08 | 2027-12-31 | ClinicalTrials.gov |
| NCT05445232 | A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants | Phase1 | Obesity | Completed | 2022-07-08 | 2023-02-24 | ClinicalTrials.gov |
| NCT05444556 | A Study of Imlunestrant (LY3484356) in Female Healthy Participants | Phase1 | Healthy | Completed | 2022-07-07 | 2022-11-02 | ClinicalTrials.gov |
| NCT05444556 | A Study of Imlunestrant (LY3484356) in Female Healthy Participants | Phase1 | Healthy | Completed | 2022-07-07 | 2022-11-02 | ClinicalTrials.gov |
| NCT05440344 | A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver … | Phase1 | Hepatic Insufficiency | Completed | 2022-07-05 | 2024-02-28 | ClinicalTrials.gov |
| NCT05440344 | A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver … | Phase1 | Hepatic Insufficiency | Completed | 2022-07-05 | 2024-02-28 | ClinicalTrials.gov |
| NCT05440136 | A Safety Study of LY3462817 in Healthy Japanese and Non-Japanese Participants | Phase1 | Healthy | Completed | 2022-06-28 | 2023-03-08 | ClinicalTrials.gov |
| NCT05440136 | A Safety Study of LY3462817 in Healthy Japanese and Non-Japanese Participants | Phase1 | Healthy | Completed | 2022-06-28 | 2023-03-08 | ClinicalTrials.gov |
| NCT05412004 | Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176… | Phase3 | Obstructive Sleep Apnea | Completed | 2022-06-21 | 2024-03-29 | ClinicalTrials.gov |
| NCT05412004 | Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176… | Phase3 | Obstructive Sleep Apnea | Completed | 2022-06-21 | 2024-03-29 | ClinicalTrials.gov |
| NCT05395481 | A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Me… | Phase1 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Active_Not_Recruiting | 2022-06-08 | 2026-05-01 | ClinicalTrials.gov |
| NCT05395481 | A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Me… | Phase1 | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Active_Not_Recruiting | 2022-06-08 | 2026-05-01 | ClinicalTrials.gov |
| NCT05407961 | A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2022-06-07 | 2024-01-12 | ClinicalTrials.gov |
| NCT05407961 | A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2022-06-07 | 2024-01-12 | ClinicalTrials.gov |
| NCT05362058 | A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults Wit… | Phase3 | Diabetes | Completed | 2022-06-03 | 2024-04-10 | ClinicalTrials.gov |
| NCT05362058 | A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults Wit… | Phase3 | Diabetes | Completed | 2022-06-03 | 2024-04-10 | ClinicalTrials.gov |
| NCT05377333 | A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in P… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2022-06-02 | 2023-11-22 | ClinicalTrials.gov |
| NCT05377333 | A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in P… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2022-06-02 | 2023-11-22 | ClinicalTrials.gov |
| NCT06085079 | Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-… | Phase4 | Uveitis, Posterior | Unknown | 2022-06-01 | 2024-12-30 | ClinicalTrials.gov |
| NCT06085079 | Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-… | Phase4 | Uveitis, Posterior | Unknown | 2022-06-01 | 2024-12-30 | ClinicalTrials.gov |
| NCT05313802 | A Study of LY3502970 in Healthy Overweight and Obese Participants | Phase1 | Healthy | Completed | 2022-05-26 | 2022-09-09 | ClinicalTrials.gov |
| NCT05313802 | A Study of LY3502970 in Healthy Overweight and Obese Participants | Phase1 | Healthy | Completed | 2022-05-26 | 2022-09-09 | ClinicalTrials.gov |
| NCT05341089 | A Study of Two Different Formulations of LY3502970 in Healthy Participants | Phase1 | Healthy | Completed | 2022-05-17 | 2022-09-01 | ClinicalTrials.gov |
| NCT05341089 | A Study of Two Different Formulations of LY3502970 in Healthy Participants | Phase1 | Healthy | Completed | 2022-05-17 | 2022-09-01 | ClinicalTrials.gov |
| NCT05307705 | A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors | Phase1 | Breast Cancer | Active_Not_Recruiting | 2022-05-11 | 2026-12-01 | ClinicalTrials.gov |
| NCT05307705 | A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors | Phase1 | Breast Cancer | Active_Not_Recruiting | 2022-05-11 | 2026-12-01 | ClinicalTrials.gov |
| NCT05380323 | A Study of LY3541105 in Healthy and Overweight Participants | Phase1 | Overweight | Completed | 2022-05-10 | 2024-08-27 | ClinicalTrials.gov |
| NCT05380323 | A Study of LY3541105 in Healthy and Overweight Participants | Phase1 | Overweight | Completed | 2022-05-10 | 2024-08-27 | ClinicalTrials.gov |
| NCT05327595 | A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM) | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2022-05-09 | 2024-04-22 | ClinicalTrials.gov |
| NCT05327595 | A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM) | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2022-05-09 | 2024-04-22 | ClinicalTrials.gov |
| NCT05325294 | Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults an… | Na | Type 1 Diabetes | Completed | 2022-05-05 | 2024-01-03 | ClinicalTrials.gov |
| NCT05325294 | Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults an… | Na | Type 1 Diabetes | Completed | 2022-05-05 | 2024-01-03 | ClinicalTrials.gov |
| NCT05362760 | Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive H… | Phase4 | Hormone Receptor-positive Metastatic Breast Cancer | Recruiting | 2022-04-27 | 2029-04-01 | ClinicalTrials.gov |
| NCT05362760 | Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive H… | Phase4 | Hormone Receptor-positive Metastatic Breast Cancer | Recruiting | 2022-04-27 | 2029-04-01 | ClinicalTrials.gov |
| NCT05324124 | A Study of the Effect of Food on Selpercatinib (LY3527723) in Healthy Participa… | Phase1 | Healthy | Completed | 2022-04-19 | 2022-06-22 | ClinicalTrials.gov |
| NCT05324124 | A Study of the Effect of Food on Selpercatinib (LY3527723) in Healthy Participa… | Phase1 | Healthy | Completed | 2022-04-19 | 2022-06-22 | ClinicalTrials.gov |
| NCT05262764 | Post Marketing Surveillance (PMS) of JARDIANCE in Chronic Heart Failure (CHF) | — | Heart Failure | Completed | 2022-04-15 | 2024-06-28 | ClinicalTrials.gov |
| NCT05262764 | Post Marketing Surveillance (PMS) of JARDIANCE in Chronic Heart Failure (CHF) | — | Heart Failure | Completed | 2022-04-15 | 2024-06-28 | ClinicalTrials.gov |
| NCT05288166 | A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer… | Phase3 | Prostatic Neoplasms | Active_Not_Recruiting | 2022-04-14 | 2027-10-01 | ClinicalTrials.gov |
| NCT05288166 | A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer… | Phase3 | Prostatic Neoplasms | Active_Not_Recruiting | 2022-04-14 | 2027-10-01 | ClinicalTrials.gov |
| NCT05254795 | Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board As… | Na | Non-Small Cell Lung Cancer | Active_Not_Recruiting | 2022-04-13 | 2026-12-22 | ClinicalTrials.gov |
| NCT05254795 | Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board As… | Na | Non-Small Cell Lung Cancer | Active_Not_Recruiting | 2022-04-13 | 2026-12-22 | ClinicalTrials.gov |
| NCT05260021 | A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Partici… | Phase3 | Type2 Diabetes | Completed | 2022-04-13 | 2025-01-28 | ClinicalTrials.gov |
| NCT05260021 | A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Partici… | Phase3 | Type2 Diabetes | Completed | 2022-04-13 | 2025-01-28 | ClinicalTrials.gov |
| NCT05295940 | A Study of LY3841136 in Healthy and Overweight Participants | Phase1 | Obesity | Completed | 2022-03-30 | 2024-01-25 | ClinicalTrials.gov |
| NCT05295940 | A Study of LY3841136 in Healthy and Overweight Participants | Phase1 | Obesity | Completed | 2022-03-30 | 2024-01-25 | ClinicalTrials.gov |
| NCT04992312 | A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diab… | Phase1 | Type 1 Diabetes | Completed | 2022-03-24 | 2023-11-05 | ClinicalTrials.gov |
| NCT04992312 | A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diab… | Phase1 | Type 1 Diabetes | Completed | 2022-03-24 | 2023-11-05 | ClinicalTrials.gov |
| NCT05241834 | A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET)… | Phase1 | Carcinoma, Non-Small-Cell Lung | Active_Not_Recruiting | 2022-03-23 | 2026-06-01 | ClinicalTrials.gov |
| NCT05241834 | A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET)… | Phase1 | Carcinoma, Non-Small-Cell Lung | Active_Not_Recruiting | 2022-03-23 | 2026-06-01 | ClinicalTrials.gov |
| NCT05292040 | A Study of LY3857210 in Healthy Participants | Phase1 | Healthy | Completed | 2022-03-17 | 2022-12-14 | ClinicalTrials.gov |
| NCT05292040 | A Study of LY3857210 in Healthy Participants | Phase1 | Healthy | Completed | 2022-03-17 | 2022-12-14 | ClinicalTrials.gov |
| NCT05169567 | Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant i… | Phase3 | Breast Neoplasm | Active_Not_Recruiting | 2022-03-11 | 2027-12-01 | ClinicalTrials.gov |
| NCT05169567 | Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant i… | Phase3 | Breast Neoplasm | Active_Not_Recruiting | 2022-03-11 | 2027-12-01 | ClinicalTrials.gov |
| NCT05300932 | A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis | Phase4 | Systemic Sclerosis | Active_Not_Recruiting | 2022-03-08 | 2026-11-12 | ClinicalTrials.gov |
| NCT05275400 | A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in … | Phase3 | Type 2 Diabetes | Completed | 2022-03-08 | 2024-05-15 | ClinicalTrials.gov |
| NCT05275400 | A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in … | Phase3 | Type 2 Diabetes | Completed | 2022-03-08 | 2024-05-15 | ClinicalTrials.gov |
| NCT05300932 | A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis | Phase4 | Systemic Sclerosis | Active_Not_Recruiting | 2022-03-08 | 2026-11-12 | ClinicalTrials.gov |
| NCT05123586 | A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Mode… | Phase2 | Systemic Lupus Erythematosus | Terminated | 2022-03-07 | 2023-12-29 | ClinicalTrials.gov |
| NCT05123586 | A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Mode… | Phase2 | Systemic Lupus Erythematosus | Terminated | 2022-03-07 | 2023-12-29 | ClinicalTrials.gov |
| NCT05267327 | A Prospective Post-Marketing Observational Safety Study of Verzenios® (Abemacic… | — | The Incidence of AEs and SAEs Receiving Verzenios® Over a Period of Approximately 24 Weeks | Not_Yet_Recruiting | 2022-03-01 | 2026-05-01 | ClinicalTrials.gov |
| NCT05267327 | A Prospective Post-Marketing Observational Safety Study of Verzenios® (Abemacic… | — | The Incidence of AEs and SAEs Receiving Verzenios® Over a Period of Approximately 24 Weeks | Not_Yet_Recruiting | 2022-03-01 | 2026-05-01 | ClinicalTrials.gov |
| NCT05263505 | Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid | Phase2 | Mucous Membrane Pemphigoid | Terminated | 2022-02-21 | 2023-09-11 | ClinicalTrials.gov |
| NCT05263505 | Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid | Phase2 | Mucous Membrane Pemphigoid | Terminated | 2022-02-21 | 2023-09-11 | ClinicalTrials.gov |
| NCT05262387 | A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants W… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2022-02-14 | 2023-03-07 | ClinicalTrials.gov |
| NCT05262387 | A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants W… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2022-02-14 | 2023-03-07 | ClinicalTrials.gov |
| NCT05222399 | A Study of LY3871801 in Healthy Participants | Phase1 | Healthy | Completed | 2022-02-04 | 2022-03-11 | ClinicalTrials.gov |
| NCT05222399 | A Study of LY3871801 in Healthy Participants | Phase1 | Healthy | Completed | 2022-02-04 | 2022-03-11 | ClinicalTrials.gov |
| NCT05177094 | Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With … | Phase2 | Diabetic Peripheral Neuropathic Pain | Completed | 2022-01-26 | 2022-10-13 | ClinicalTrials.gov |
| NCT05177094 | Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With … | Phase2 | Diabetic Peripheral Neuropathic Pain | Completed | 2022-01-26 | 2022-10-13 | ClinicalTrials.gov |
| NCT05002127 | A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (… | Phase2 | Gastric Cancer | Active_Not_Recruiting | 2022-01-15 | 2026-06-01 | ClinicalTrials.gov |
| NCT05002127 | A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (… | Phase2 | Gastric Cancer | Active_Not_Recruiting | 2022-01-15 | 2026-06-01 | ClinicalTrials.gov |
| NCT05176314 | A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LY3527727) and Rosuvastat… | Phase1 | Healthy | Completed | 2022-01-11 | 2022-04-20 | ClinicalTrials.gov |
| NCT05176314 | A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LY3527727) and Rosuvastat… | Phase1 | Healthy | Completed | 2022-01-11 | 2022-04-20 | ClinicalTrials.gov |
| NCT05205447 | Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy … | Phase1 | Healthy | Terminated | 2022-01-05 | 2022-04-12 | ClinicalTrials.gov |
| NCT05205447 | Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy … | Phase1 | Healthy | Terminated | 2022-01-05 | 2022-04-12 | ClinicalTrials.gov |
| NCT05074420 | A Study of Baricitinib (LY3009104) in Children With COVID-19 | Phase3 | Covid19 | Terminated | 2021-12-21 | 2024-11-04 | ClinicalTrials.gov |
| NCT05074420 | A Study of Baricitinib (LY3009104) in Children With COVID-19 | Phase3 | Covid19 | Terminated | 2021-12-21 | 2024-11-04 | ClinicalTrials.gov |
| NCT04819100 | A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Sm… | Phase3 | Carcinoma, Non-Small-Cell Lung | Active_Not_Recruiting | 2021-12-20 | 2028-05-01 | ClinicalTrials.gov |
| NCT04819100 | A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Sm… | Phase3 | Carcinoma, Non-Small-Cell Lung | Active_Not_Recruiting | 2021-12-20 | 2028-05-01 | ClinicalTrials.gov |
| NCT05127486 | A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine | Phase4 | Migraine | Completed | 2021-12-06 | 2023-05-23 | ClinicalTrials.gov |
| NCT05127486 | A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine | Phase4 | Migraine | Completed | 2021-12-06 | 2023-05-23 | ClinicalTrials.gov |
| NCT05136404 | A Relative Bioavailability Study of Selpercatinib (LY3527723) in Healthy Partic… | Phase1 | Healthy | Completed | 2021-12-03 | 2022-03-14 | ClinicalTrials.gov |
| NCT05136404 | A Relative Bioavailability Study of Selpercatinib (LY3527723) in Healthy Partic… | Phase1 | Healthy | Completed | 2021-12-03 | 2022-03-14 | ClinicalTrials.gov |
| NCT04923542 | Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Canc… | Phase1 | Brain Metastases | Recruiting | 2021-11-30 | 2026-12-01 | ClinicalTrials.gov |
| NCT04923542 | Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Canc… | Phase1 | Brain Metastases | Recruiting | 2021-11-30 | 2026-12-01 | ClinicalTrials.gov |
| NCT05154968 | A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an A… | Phase1 | Healthy Participants | Completed | 2021-11-24 | 2021-12-14 | ClinicalTrials.gov |
| NCT05154968 | A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an A… | Phase1 | Healthy Participants | Completed | 2021-11-24 | 2021-12-14 | ClinicalTrials.gov |
| NCT05108922 | A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With … | Phase3 | Mild Cognitive Impairment (MCI) | Completed | 2021-11-16 | 2023-09-19 | ClinicalTrials.gov |
| NCT05108922 | A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With … | Phase3 | Mild Cognitive Impairment (MCI) | Completed | 2021-11-16 | 2023-09-19 | ClinicalTrials.gov |
| NCT05080218 | COVID-19 VaccinE Response in Rheumatology Patients | Phase4 | Rheumatoid Arthritis | Completed | 2021-11-15 | 2024-05-28 | ClinicalTrials.gov |
| NCT05080218 | COVID-19 VaccinE Response in Rheumatology Patients | Phase4 | Rheumatoid Arthritis | Completed | 2021-11-15 | 2024-05-28 | ClinicalTrials.gov |
| NCT05086445 | A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2021-11-12 | 2022-09-05 | ClinicalTrials.gov |
| NCT05086445 | A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2021-11-12 | 2022-09-05 | ClinicalTrials.gov |
| NCT05042310 | A Study of LY3541860 in Healthy Japanese and Non-Japanese Participants | Phase1 | Healthy | Completed | 2021-11-11 | 2023-12-27 | ClinicalTrials.gov |
| NCT05042310 | A Study of LY3541860 in Healthy Japanese and Non-Japanese Participants | Phase1 | Healthy | Completed | 2021-11-11 | 2023-12-27 | ClinicalTrials.gov |
| NCT04967521 | SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dediffer… | Phase3 | Advanced Dedifferentiated Liposarcoma | Active_Not_Recruiting | 2021-11-11 | 2026-12-01 | ClinicalTrials.gov |
| NCT05038787 | A Study of LY3473329 in Healthy Japanese Participants | Phase1 | Healthy | Completed | 2021-11-11 | 2022-04-07 | ClinicalTrials.gov |
| NCT05038787 | A Study of LY3473329 in Healthy Japanese Participants | Phase1 | Healthy | Completed | 2021-11-11 | 2022-04-07 | ClinicalTrials.gov |
| NCT04967521 | SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dediffer… | Phase3 | Advanced Dedifferentiated Liposarcoma | Active_Not_Recruiting | 2021-11-11 | 2026-12-01 | ClinicalTrials.gov |
| NCT05110794 | A Multiple-Dose Study of LY3502970 in Healthy Participants | Phase1 | Healthy | Completed | 2021-11-05 | 2022-02-10 | ClinicalTrials.gov |
| NCT05110794 | A Multiple-Dose Study of LY3502970 in Healthy Participants | Phase1 | Healthy | Completed | 2021-11-05 | 2022-02-10 | ClinicalTrials.gov |
| NCT05007769 | Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint … | Phase2 | Non-small Cell Lung Cancer | Withdrawn | 2021-10-31 | 2026-04-30 | ClinicalTrials.gov |
| NCT05007769 | Ramucirumab, Atezolizumab and N-803 After Progression on Any Immune Checkpoint … | Phase2 | Non-small Cell Lung Cancer | Withdrawn | 2021-10-31 | 2026-04-30 | ClinicalTrials.gov |
| NCT05089019 | A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy Part… | Phase1 | Healthy | Completed | 2021-10-29 | 2022-07-19 | ClinicalTrials.gov |
| NCT05089019 | A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy Part… | Phase1 | Healthy | Completed | 2021-10-29 | 2022-07-19 | ClinicalTrials.gov |
| NCT05086289 | Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With … | Phase2 | Chronic Low-back Pain | Completed | 2021-10-25 | 2022-06-17 | ClinicalTrials.gov |
| NCT05086289 | Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With … | Phase2 | Chronic Low-back Pain | Completed | 2021-10-25 | 2022-06-17 | ClinicalTrials.gov |
| NCT05067270 | A Study of Infusion Site Pain After Infusion of Excipients in Participants With… | Phase1 | Type 1 Diabetes Mellitus | Completed | 2021-10-22 | 2021-12-06 | ClinicalTrials.gov |
| NCT05067270 | A Study of Infusion Site Pain After Infusion of Excipients in Participants With… | Phase1 | Type 1 Diabetes Mellitus | Completed | 2021-10-22 | 2021-12-06 | ClinicalTrials.gov |
| NCT04486352 | A Study of Targeted Agents for Patients With Recurrent or Persistent Endometria… | Phase1 | Endometrial Cancer | Recruiting | 2021-10-20 | 2027-10-01 | ClinicalTrials.gov |
| NCT04486352 | A Study of Targeted Agents for Patients With Recurrent or Persistent Endometria… | Phase1 | Endometrial Cancer | Recruiting | 2021-10-20 | 2027-10-01 | ClinicalTrials.gov |
| NCT05080660 | Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With … | Phase2 | Osteoarthritis | Completed | 2021-10-12 | 2022-06-06 | ClinicalTrials.gov |
| NCT05080660 | Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With … | Phase2 | Osteoarthritis | Completed | 2021-10-12 | 2022-06-06 | ClinicalTrials.gov |
| NCT06181084 | A Study Comparing Different Formulations of LY3410738 in Healthy Adult Particip… | Phase1 | Healthy | Completed | 2021-10-11 | 2022-04-28 | ClinicalTrials.gov |
| NCT06181084 | A Study Comparing Different Formulations of LY3410738 in Healthy Adult Particip… | Phase1 | Healthy | Completed | 2021-10-11 | 2022-04-28 | ClinicalTrials.gov |
| NCT04208464 | JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM | Phase2 | Idiopathic Inflammatory Myopathies | Completed | 2021-10-07 | 2023-09-25 | ClinicalTrials.gov |
| NCT04208464 | JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM | Phase2 | Idiopathic Inflammatory Myopathies | Completed | 2021-10-07 | 2023-09-25 | ClinicalTrials.gov |
| NCT05069896 | A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy Parti… | Phase1 | Healthy | Completed | 2021-10-05 | 2022-06-22 | ClinicalTrials.gov |
| NCT05069896 | A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy Parti… | Phase1 | Healthy | Completed | 2021-10-05 | 2022-06-22 | ClinicalTrials.gov |
| NCT04975308 | A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlune… | Phase3 | Breast Neoplasms | Active_Not_Recruiting | 2021-10-04 | 2027-08-01 | ClinicalTrials.gov |
| NCT04974333 | Development of an Information Board and Mobile Application for the Care of Type… | Na | Diabetes Mellitus, Type 2 | Unknown | 2021-10-04 | 2024-02-28 | ClinicalTrials.gov |
| NCT04974333 | Development of an Information Board and Mobile Application for the Care of Type… | Na | Diabetes Mellitus, Type 2 | Unknown | 2021-10-04 | 2024-02-28 | ClinicalTrials.gov |
| NCT04975308 | A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlune… | Phase3 | Breast Neoplasms | Active_Not_Recruiting | 2021-10-04 | 2027-08-01 | ClinicalTrials.gov |
| NCT05024045 | Study of Oral LOXO-338 in Patients With Advanced Blood Cancers | Phase1 | Leukemia, Lymphocytic, Chronic, B-Cell | Active_Not_Recruiting | 2021-09-30 | 2026-06-01 | ClinicalTrials.gov |
| NCT05024045 | Study of Oral LOXO-338 in Patients With Advanced Blood Cancers | Phase1 | Leukemia, Lymphocytic, Chronic, B-Cell | Active_Not_Recruiting | 2021-09-30 | 2026-06-01 | ClinicalTrials.gov |
| NCT05051579 | A Study of LY3502970 in Participants With Obesity or Overweight With Weight-rel… | Phase2 | Obesity | Completed | 2021-09-29 | 2022-11-22 | ClinicalTrials.gov |
| NCT05051579 | A Study of LY3502970 in Participants With Obesity or Overweight With Weight-rel… | Phase2 | Obesity | Completed | 2021-09-29 | 2022-11-22 | ClinicalTrials.gov |
| NCT06258174 | A Study of Two Different Formulations of Pirtobrutinib (LOXO-305) In Healthy Pa… | Phase1 | Healthy | Completed | 2021-09-28 | 2021-12-22 | ClinicalTrials.gov |
| NCT06258174 | A Study of Two Different Formulations of Pirtobrutinib (LOXO-305) In Healthy Pa… | Phase1 | Healthy | Completed | 2021-09-28 | 2021-12-22 | ClinicalTrials.gov |
| NCT04848402 | A Device Study in Healthy Participants | Phase1 | Healthy | Completed | 2021-09-27 | 2022-07-22 | ClinicalTrials.gov |
| NCT04848402 | A Device Study in Healthy Participants | Phase1 | Healthy | Completed | 2021-09-27 | 2022-07-22 | ClinicalTrials.gov |
| NCT04003896 | A Study to Evaluate Abemaciclib in Advanced Biliary Tract Carcinoma | Phase2 | Biliary Tract Carcinoma | Terminated | 2021-09-24 | 2023-08-15 | ClinicalTrials.gov |
| NCT04003896 | A Study to Evaluate Abemaciclib in Advanced Biliary Tract Carcinoma | Phase2 | Biliary Tract Carcinoma | Terminated | 2021-09-24 | 2023-08-15 | ClinicalTrials.gov |
| NCT05023980 | A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in … | Phase3 | Chronic Lymphocytic Leukemia | Active_Not_Recruiting | 2021-09-23 | 2027-10-01 | ClinicalTrials.gov |
| NCT05023980 | A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in … | Phase3 | Chronic Lymphocytic Leukemia | Active_Not_Recruiting | 2021-09-23 | 2027-10-01 | ClinicalTrials.gov |
| NCT04965493 | A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus … | Phase3 | Chronic Lymphocytic Leukemia | Active_Not_Recruiting | 2021-09-20 | 2027-10-01 | ClinicalTrials.gov |
| NCT04965493 | A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus … | Phase3 | Chronic Lymphocytic Leukemia | Active_Not_Recruiting | 2021-09-20 | 2027-10-01 | ClinicalTrials.gov |
| NCT05063539 | A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Partic… | Phase2 | Alzheimer Disease | Completed | 2021-09-16 | 2025-05-22 | ClinicalTrials.gov |
| NCT05051566 | A Multiple Dose Study of LY3502970 in Healthy Participants | Phase1 | Healthy | Completed | 2021-09-16 | 2022-04-04 | ClinicalTrials.gov |
| NCT05051566 | A Multiple Dose Study of LY3502970 in Healthy Participants | Phase1 | Healthy | Completed | 2021-09-16 | 2022-04-04 | ClinicalTrials.gov |
| NCT05063539 | A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Partic… | Phase2 | Alzheimer Disease | Completed | 2021-09-16 | 2025-05-22 | ClinicalTrials.gov |
| NCT05048719 | A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus | Phase2 | Type 2 Diabetes | Completed | 2021-09-15 | 2022-09-30 | ClinicalTrials.gov |
| NCT05048719 | A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus | Phase2 | Type 2 Diabetes | Completed | 2021-09-15 | 2022-09-30 | ClinicalTrials.gov |
| NCT05024032 | A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabe… | Phase3 | Obesity | Completed | 2021-09-01 | 2022-12-27 | ClinicalTrials.gov |
| NCT05024032 | A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabe… | Phase3 | Obesity | Completed | 2021-09-01 | 2022-12-27 | ClinicalTrials.gov |
| NCT05026866 | A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Dise… | Phase3 | Alzheimer Disease | Active_Not_Recruiting | 2021-08-27 | 2027-11-01 | ClinicalTrials.gov |
| NCT05026866 | A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Dise… | Phase3 | Alzheimer Disease | Active_Not_Recruiting | 2021-08-27 | 2027-11-01 | ClinicalTrials.gov |
| NCT04751929 | Abemaciclib With or Without Atezolizumab for mCRPC | Phase2 | Prostate Cancer | Active_Not_Recruiting | 2021-08-20 | 2026-04-30 | ClinicalTrials.gov |
| NCT04751929 | Abemaciclib With or Without Atezolizumab for mCRPC | Phase2 | Prostate Cancer | Active_Not_Recruiting | 2021-08-20 | 2026-04-30 | ClinicalTrials.gov |
| NCT04998487 | A Single-Dose Study of LY3471851 in Healthy Participants | Phase1 | Healthy | Completed | 2021-08-16 | 2022-07-06 | ClinicalTrials.gov |
| NCT04864977 | A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participant… | Phase4 | Type 2 Diabetes | Withdrawn | 2021-08-16 | 2022-06-06 | ClinicalTrials.gov |
| NCT04864977 | A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participant… | Phase4 | Type 2 Diabetes | Withdrawn | 2021-08-16 | 2022-06-06 | ClinicalTrials.gov |
| NCT04998487 | A Single-Dose Study of LY3471851 in Healthy Participants | Phase1 | Healthy | Completed | 2021-08-16 | 2022-07-06 | ClinicalTrials.gov |
| NCT04991766 | A Study of [¹⁴C]-LY3484356 in Healthy Female Participants | Phase1 | Healthy | Completed | 2021-08-13 | 2022-04-02 | ClinicalTrials.gov |
| NCT04991766 | A Study of [¹⁴C]-LY3484356 in Healthy Female Participants | Phase1 | Healthy | Completed | 2021-08-13 | 2022-04-02 | ClinicalTrials.gov |
| NCT04975295 | A Study of LY3361237 in Participants With Psoriasis | Phase1 | Psoriasis | Completed | 2021-07-27 | 2022-11-29 | ClinicalTrials.gov |
| NCT04975295 | A Study of LY3361237 in Participants With Psoriasis | Phase1 | Psoriasis | Completed | 2021-07-27 | 2022-11-29 | ClinicalTrials.gov |
| NCT04956640 | Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G1… | Phase1 | Carcinoma, Non-Small-Cell Lung | Recruiting | 2021-07-19 | 2027-04-01 | ClinicalTrials.gov |
| NCT04956640 | Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G1… | Phase1 | Carcinoma, Non-Small-Cell Lung | Recruiting | 2021-07-19 | 2027-04-01 | ClinicalTrials.gov |
| NCT04870203 | Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis | Phase3 | Rheumatoid Arthritis | Active_Not_Recruiting | 2021-07-15 | 2027-03-01 | ClinicalTrials.gov |
| NCT04870203 | Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis | Phase3 | Rheumatoid Arthritis | Active_Not_Recruiting | 2021-07-15 | 2027-03-01 | ClinicalTrials.gov |
| NCT04957914 | A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes Me… | Phase1 | Type 2 Diabetes Mellitus | Completed | 2021-07-14 | 2022-10-17 | ClinicalTrials.gov |
| NCT04957914 | A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes Me… | Phase1 | Type 2 Diabetes Mellitus | Completed | 2021-07-14 | 2022-10-17 | ClinicalTrials.gov |
| NCT04411654 | Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVI… | Phase1 | Gaucher Disease, Type 2 | Active_Not_Recruiting | 2021-06-29 | 2028-05-01 | ClinicalTrials.gov |
| NCT04411654 | Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVI… | Phase1 | Gaucher Disease, Type 2 | Active_Not_Recruiting | 2021-06-29 | 2028-05-01 | ClinicalTrials.gov |
| NCT04914546 | A Study of LY3819469 in Healthy Participants | Phase1 | Healthy | Completed | 2021-06-14 | 2022-11-09 | ClinicalTrials.gov |
| NCT04914546 | A Study of LY3819469 in Healthy Participants | Phase1 | Healthy | Completed | 2021-06-14 | 2022-11-09 | ClinicalTrials.gov |
| NCT04923269 | A Study of LY3532226 in Healthy Participants | Phase1 | Healthy | Completed | 2021-06-10 | 2021-10-28 | ClinicalTrials.gov |
| NCT04923269 | A Study of LY3532226 in Healthy Participants | Phase1 | Healthy | Completed | 2021-06-10 | 2021-10-28 | ClinicalTrials.gov |
| NCT04481113 | Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor … | Phase1 | Anatomic Stage I Breast Cancer AJCC v8 | Completed | 2021-06-07 | 2025-06-20 | ClinicalTrials.gov |
| NCT04481113 | Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor … | Phase1 | Anatomic Stage I Breast Cancer AJCC v8 | Completed | 2021-06-07 | 2025-06-20 | ClinicalTrials.gov |
| NCT04840901 | A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in He… | Phase1 | Healthy | Completed | 2021-06-02 | 2022-02-11 | ClinicalTrials.gov |
| NCT04603183 | ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL | Phase2 | Breast Cancer Metastatic | Completed | 2021-06-02 | 2025-06-30 | ClinicalTrials.gov |
| NCT04840901 | A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in He… | Phase1 | Healthy | Completed | 2021-06-02 | 2022-02-11 | ClinicalTrials.gov |
| NCT04603183 | ABemaciclib, ET ± paclItaxel in aGgressive HR+/HER2- MBC trIaL | Phase2 | Breast Cancer Metastatic | Completed | 2021-06-02 | 2025-06-30 | ClinicalTrials.gov |
| NCT04840914 | A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ej… | Phase1 | Chronic Heart Failure With Reduced Ejection Fraction | Completed | 2021-06-01 | 2024-05-09 | ClinicalTrials.gov |
| NCT04840914 | A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ej… | Phase1 | Chronic Heart Failure With Reduced Ejection Fraction | Completed | 2021-06-01 | 2024-05-09 | ClinicalTrials.gov |
| NCT04844606 | A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Parti… | Phase3 | Ulcerative Colitis | Recruiting | 2021-05-26 | 2030-12-01 | ClinicalTrials.gov |
| NCT04844606 | A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Parti… | Phase3 | Ulcerative Colitis | Recruiting | 2021-05-26 | 2030-12-01 | ClinicalTrials.gov |
| NCT04823208 | A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2021-05-24 | 2022-06-23 | ClinicalTrials.gov |
| NCT04823208 | A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2021-05-24 | 2022-06-23 | ClinicalTrials.gov |
| NCT04881760 | A Study of LY3437943 in Participants Who Have Obesity or Are Overweight | Phase2 | Obesity | Completed | 2021-05-20 | 2022-11-22 | ClinicalTrials.gov |
| NCT04874636 | Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With … | Phase2 | Chronic Low-back Pain | Completed | 2021-05-20 | 2022-02-09 | ClinicalTrials.gov |
| NCT04881760 | A Study of LY3437943 in Participants Who Have Obesity or Are Overweight | Phase2 | Obesity | Completed | 2021-05-20 | 2022-11-22 | ClinicalTrials.gov |
| NCT04874636 | Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With … | Phase2 | Chronic Low-back Pain | Completed | 2021-05-20 | 2022-02-09 | ClinicalTrials.gov |
| NCT04849416 | A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lympho… | Phase2 | Leukemia, Lymphoid | Completed | 2021-05-14 | 2025-12-29 | ClinicalTrials.gov |
| NCT04849416 | A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lympho… | Phase2 | Leukemia, Lymphoid | Completed | 2021-05-14 | 2025-12-29 | ClinicalTrials.gov |
| NCT04881747 | A Study to Compare Two Different Formulations of Lasmiditan in Healthy Particip… | Phase1 | Healthy | Completed | 2021-05-14 | 2021-07-24 | ClinicalTrials.gov |
| NCT04881747 | A Study to Compare Two Different Formulations of Lasmiditan in Healthy Particip… | Phase1 | Healthy | Completed | 2021-05-14 | 2021-07-24 | ClinicalTrials.gov |
| NCT04867785 | A Study of LY3437943 in Participants With Type 2 Diabetes | Phase2 | Type 2 Diabetes | Completed | 2021-05-13 | 2022-10-27 | ClinicalTrials.gov |
| NCT04867785 | A Study of LY3437943 in Participants With Type 2 Diabetes | Phase2 | Type 2 Diabetes | Completed | 2021-05-13 | 2022-10-27 | ClinicalTrials.gov |
| NCT04844918 | A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease | Phase3 | Obesity | Completed | 2021-05-10 | 2023-06-24 | ClinicalTrials.gov |
| NCT04752332 | A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Ea… | Phase3 | Breast Neoplasms | Terminated | 2021-05-10 | 2024-06-26 | ClinicalTrials.gov |
| NCT04844918 | A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease | Phase3 | Obesity | Completed | 2021-05-10 | 2023-06-24 | ClinicalTrials.gov |
| NCT04752332 | A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Ea… | Phase3 | Breast Neoplasms | Terminated | 2021-05-10 | 2024-06-26 | ClinicalTrials.gov |
| NCT04707157 | Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With … | Phase2 | Diabetic Peripheral Neuropathic Pain | Terminated | 2021-05-06 | 2022-06-13 | ClinicalTrials.gov |
| NCT04707157 | Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With … | Phase2 | Diabetic Peripheral Neuropathic Pain | Terminated | 2021-05-06 | 2022-06-13 | ClinicalTrials.gov |
| NCT04682106 | A Study of LY3493269 in Healthy Participants | Phase1 | Healthy | Completed | 2021-05-03 | 2021-11-11 | ClinicalTrials.gov |
| NCT04682106 | A Study of LY3493269 in Healthy Participants | Phase1 | Healthy | Completed | 2021-05-03 | 2021-11-11 | ClinicalTrials.gov |
| NCT04840888 | A Study of LY3484356 in Healthy Female Participants | Phase1 | Healthy | Completed | 2021-04-26 | 2022-04-12 | ClinicalTrials.gov |
| NCT04840888 | A Study of LY3484356 in Healthy Female Participants | Phase1 | Healthy | Completed | 2021-04-26 | 2022-04-12 | ClinicalTrials.gov |
| NCT04647487 | A Study of LY3484356 in Women With Breast Cancer Before Having Surgery | Phase1 | Breast Cancer | Completed | 2021-04-21 | 2022-11-11 | ClinicalTrials.gov |
| NCT04647487 | A Study of LY3484356 in Women With Breast Cancer Before Having Surgery | Phase1 | Breast Cancer | Completed | 2021-04-21 | 2022-11-11 | ClinicalTrials.gov |
| NCT04847557 | A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Pres… | Phase3 | Obesity | Completed | 2021-04-20 | 2024-07-02 | ClinicalTrials.gov |
| NCT04469062 | A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis | Phase3 | Ulcerative Colitis | Withdrawn | 2021-04-20 | 2024-06-05 | ClinicalTrials.gov |
| NCT04469062 | A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis | Phase3 | Ulcerative Colitis | Withdrawn | 2021-04-20 | 2024-06-05 | ClinicalTrials.gov |
| NCT04847557 | A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Pres… | Phase3 | Obesity | Completed | 2021-04-20 | 2024-07-02 | ClinicalTrials.gov |
| NCT04151563 | A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Ad… | Phase1 | Carcinoma, Non-small Cell Lung Cancer | Withdrawn | 2021-04-15 | 2026-05-13 | ClinicalTrials.gov |
| NCT04151563 | A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Ad… | Phase1 | Carcinoma, Non-small Cell Lung Cancer | Withdrawn | 2021-04-15 | 2026-05-13 | ClinicalTrials.gov |
| NCT04614194 | Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaci… | Phase2 | Breast Cancer | Recruiting | 2021-04-15 | 2028-04-15 | ClinicalTrials.gov |
| NCT04614194 | Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaci… | Phase2 | Breast Cancer | Recruiting | 2021-04-15 | 2028-04-15 | ClinicalTrials.gov |
| NCT04527380 | A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthriti… | Phase3 | Juvenile Psoriatic Arthritis | Active_Not_Recruiting | 2021-04-13 | 2028-04-01 | ClinicalTrials.gov |
| NCT04809220 | A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type … | Phase3 | Diabetes Mellitus | Completed | 2021-04-13 | 2023-04-26 | ClinicalTrials.gov |
| NCT04527380 | A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthriti… | Phase3 | Juvenile Psoriatic Arthritis | Active_Not_Recruiting | 2021-04-13 | 2028-04-01 | ClinicalTrials.gov |
| NCT04809220 | A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type … | Phase3 | Diabetes Mellitus | Completed | 2021-04-13 | 2023-04-26 | ClinicalTrials.gov |
| NCT04662255 | Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients… | Phase3 | Lymphoma, Mantle-Cell | Active_Not_Recruiting | 2021-04-08 | 2028-04-01 | ClinicalTrials.gov |
| NCT04662255 | Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients… | Phase3 | Lymphoma, Mantle-Cell | Active_Not_Recruiting | 2021-04-08 | 2028-04-01 | ClinicalTrials.gov |
| NCT04680767 | A Study of LY3502970 in Healthy Male Participants | Phase1 | Healthy | Completed | 2021-03-29 | 2021-07-03 | ClinicalTrials.gov |
| NCT04660643 | A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight f… | Phase3 | Obesity | Completed | 2021-03-29 | 2023-05-18 | ClinicalTrials.gov |
| NCT04657016 | A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Los… | Phase3 | Obesity | Completed | 2021-03-29 | 2023-05-12 | ClinicalTrials.gov |
| NCT04657003 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Hav… | Phase3 | Type 2 Diabetes | Completed | 2021-03-29 | 2023-04-10 | ClinicalTrials.gov |
| NCT04680767 | A Study of LY3502970 in Healthy Male Participants | Phase1 | Healthy | Completed | 2021-03-29 | 2021-07-03 | ClinicalTrials.gov |
| NCT04660643 | A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight f… | Phase3 | Obesity | Completed | 2021-03-29 | 2023-05-18 | ClinicalTrials.gov |
| NCT04657016 | A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Los… | Phase3 | Obesity | Completed | 2021-03-29 | 2023-05-12 | ClinicalTrials.gov |
| NCT04657003 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Hav… | Phase3 | Type 2 Diabetes | Completed | 2021-03-29 | 2023-04-10 | ClinicalTrials.gov |
| NCT04677179 | A Study of LY3471851 in Adult Participants With Moderately to Severely Active U… | Phase2 | Colitis, Ulcerative | Terminated | 2021-03-22 | 2022-08-09 | ClinicalTrials.gov |
| NCT04677179 | A Study of LY3471851 in Adult Participants With Moderately to Severely Active U… | Phase2 | Colitis, Ulcerative | Terminated | 2021-03-22 | 2022-08-09 | ClinicalTrials.gov |
| NCT04768855 | A Study of LY3540378 in Healthy Participants | Phase1 | Healthy | Completed | 2021-03-17 | 2022-05-30 | ClinicalTrials.gov |
| NCT04768855 | A Study of LY3540378 in Healthy Participants | Phase1 | Healthy | Completed | 2021-03-17 | 2022-05-30 | ClinicalTrials.gov |
| NCT06194214 | A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-… | Phase1 | Healthy | Completed | 2021-03-11 | 2021-06-09 | ClinicalTrials.gov |
| NCT06194214 | A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Digoxin (P-… | Phase1 | Healthy | Completed | 2021-03-11 | 2021-06-09 | ClinicalTrials.gov |
| NCT04760314 | A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids… | Phase3 | Dermatitis, Atopic | Completed | 2021-03-10 | 2023-02-01 | ClinicalTrials.gov |
| NCT04760314 | A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids… | Phase3 | Dermatitis, Atopic | Completed | 2021-03-10 | 2023-02-01 | ClinicalTrials.gov |
| NCT04666038 | Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus… | Phase3 | Chronic Lymphocytic Leukemia | Active_Not_Recruiting | 2021-03-09 | 2027-05-01 | ClinicalTrials.gov |
| NCT04666038 | Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus… | Phase3 | Chronic Lymphocytic Leukemia | Active_Not_Recruiting | 2021-03-09 | 2027-05-01 | ClinicalTrials.gov |
| NCT04782076 | A Drug Drug Interaction (DDI) Study of Selpercatinib and Dabigatran in Healthy … | Phase1 | Healthy | Completed | 2021-03-05 | 2021-05-17 | ClinicalTrials.gov |
| NCT04782076 | A Drug Drug Interaction (DDI) Study of Selpercatinib and Dabigatran in Healthy … | Phase1 | Healthy | Completed | 2021-03-05 | 2021-05-17 | ClinicalTrials.gov |
| NCT04768842 | A Study of Two Different Formulations of LY3209590 in Healthy Participants | Phase1 | Healthy | Completed | 2021-03-03 | 2021-09-03 | ClinicalTrials.gov |
| NCT04768842 | A Study of Two Different Formulations of LY3209590 in Healthy Participants | Phase1 | Healthy | Completed | 2021-03-03 | 2021-09-03 | ClinicalTrials.gov |
| NCT04298983 | Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanc… | Phase2 | Prostate Cancer | Terminated | 2021-02-25 | 2024-09-04 | ClinicalTrials.gov |
| NCT04298983 | Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanc… | Phase2 | Prostate Cancer | Terminated | 2021-02-25 | 2024-09-04 | ClinicalTrials.gov |
| NCT05305924 | Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negativ… | Phase2 | ER-Positive Breast Cancer | Recruiting | 2021-02-25 | 2027-12-01 | ClinicalTrials.gov |
| NCT05305924 | Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negativ… | Phase2 | ER-Positive Breast Cancer | Recruiting | 2021-02-25 | 2027-12-01 | ClinicalTrials.gov |
| NCT06181045 | A Study of LY3410738 in Healthy Adult Participants | Phase1 | Healthy | Completed | 2021-02-24 | 2021-08-04 | ClinicalTrials.gov |
| NCT06181045 | A Study of LY3410738 in Healthy Adult Participants | Phase1 | Healthy | Completed | 2021-02-24 | 2021-08-04 | ClinicalTrials.gov |
| NCT04557384 | A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Partici… | Phase1 | Advanced Solid Tumor | Terminated | 2021-02-23 | 2021-05-25 | ClinicalTrials.gov |
| NCT04557384 | A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Partici… | Phase1 | Advanced Solid Tumor | Terminated | 2021-02-23 | 2021-05-25 | ClinicalTrials.gov |
| NCT04758234 | A Study of LY3549492 in Healthy Participants | Phase1 | Healthy | Completed | 2021-02-22 | 2022-01-10 | ClinicalTrials.gov |
| NCT04758234 | A Study of LY3549492 in Healthy Participants | Phase1 | Healthy | Completed | 2021-02-22 | 2022-01-10 | ClinicalTrials.gov |
| NCT04707196 | A Study of Abemaciclib in Indian Women With Advanced Breast Cancer | Phase4 | Breast Neoplasms | Completed | 2021-02-22 | 2023-01-09 | ClinicalTrials.gov |
| NCT04707196 | A Study of Abemaciclib in Indian Women With Advanced Breast Cancer | Phase4 | Breast Neoplasms | Completed | 2021-02-22 | 2023-01-09 | ClinicalTrials.gov |
| NCT04749914 | A Study of Lasmiditan in Healthy Volunteers | Phase1 | Healthy | Completed | 2021-02-15 | 2021-07-06 | ClinicalTrials.gov |
| NCT04749914 | A Study of Lasmiditan in Healthy Volunteers | Phase1 | Healthy | Completed | 2021-02-15 | 2021-07-06 | ClinicalTrials.gov |
| NCT06190678 | Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function… | Phase1 | Healthy | Completed | 2021-02-01 | 2021-06-04 | ClinicalTrials.gov |
| NCT04701658 | A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Corona… | Phase2 | COVID-19 | Completed | 2021-02-01 | 2021-06-22 | ClinicalTrials.gov |
| NCT04701658 | A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Corona… | Phase2 | COVID-19 | Completed | 2021-02-01 | 2021-06-22 | ClinicalTrials.gov |
| NCT06190678 | Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function… | Phase1 | Healthy | Completed | 2021-02-01 | 2021-06-04 | ClinicalTrials.gov |
| NCT04285671 | Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment o… | Phase1 | Metastatic Lung Non-Small Cell Carcinoma | Active_Not_Recruiting | 2021-01-29 | 2027-12-02 | ClinicalTrials.gov |
| NCT04285671 | Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment o… | Phase1 | Metastatic Lung Non-Small Cell Carcinoma | Active_Not_Recruiting | 2021-01-29 | 2027-12-02 | ClinicalTrials.gov |
| NCT04682184 | A Study of Continuous Heart Rate Monitoring in Healthy Participants | Na | Healthy | Completed | 2021-01-27 | 2021-03-25 | ClinicalTrials.gov |
| NCT04682184 | A Study of Continuous Heart Rate Monitoring in Healthy Participants | Na | Healthy | Completed | 2021-01-27 | 2021-03-25 | ClinicalTrials.gov |
| NCT04667182 | A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes | — | Type 1 Diabetes | Withdrawn | 2021-01-25 | 2021-12-06 | ClinicalTrials.gov |
| NCT04667182 | A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes | — | Type 1 Diabetes | Withdrawn | 2021-01-25 | 2021-12-06 | ClinicalTrials.gov |
| NCT03986502 | Financial Navigation Intervention in Improving Financial and Clinical Outcomes … | Na | Gastric Adenocarcinoma | Completed | 2021-01-22 | 2022-10-01 | ClinicalTrials.gov |
| NCT03986502 | Financial Navigation Intervention in Improving Financial and Clinical Outcomes … | Na | Gastric Adenocarcinoma | Completed | 2021-01-22 | 2022-10-01 | ClinicalTrials.gov |
| NCT04408924 | Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resis… | Phase2 | Metastatic Castration-Resistant Prostate Cancer | Completed | 2021-01-20 | 2023-06-02 | ClinicalTrials.gov |
| NCT04408924 | Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resis… | Phase2 | Metastatic Castration-Resistant Prostate Cancer | Completed | 2021-01-20 | 2023-06-02 | ClinicalTrials.gov |
| NCT04258826 | A Study to Evaluate LY3154207 on the Brain of Healthy Participants | Phase1 | Healthy | Completed | 2021-01-15 | 2022-01-28 | ClinicalTrials.gov |
| NCT04258826 | A Study to Evaluate LY3154207 on the Brain of Healthy Participants | Phase1 | Healthy | Completed | 2021-01-15 | 2022-01-28 | ClinicalTrials.gov |
| NCT06215430 | A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Sing… | Phase1 | Healthy | Completed | 2021-01-11 | 2021-04-15 | ClinicalTrials.gov |
| NCT06215430 | A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Sing… | Phase1 | Healthy | Completed | 2021-01-11 | 2021-04-15 | ClinicalTrials.gov |
| NCT04634253 | A Study of LY3462817 in Participants With Rheumatoid Arthritis | Phase2 | Rheumatoid Arthritis | Completed | 2021-01-04 | 2022-06-29 | ClinicalTrials.gov |
| NCT06180980 | A Study of the Effect of Food on Pirtobrutinib (LOXO-305) in Healthy Participan… | Phase1 | Healthy | Completed | 2021-01-04 | 2021-03-08 | ClinicalTrials.gov |
| NCT06180980 | A Study of the Effect of Food on Pirtobrutinib (LOXO-305) in Healthy Participan… | Phase1 | Healthy | Completed | 2021-01-04 | 2021-03-08 | ClinicalTrials.gov |
| NCT04656691 | At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID… | Phase4 | Covid19 | Terminated | 2021-01-04 | 2021-04-18 | ClinicalTrials.gov |
| NCT04656691 | At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID… | Phase4 | Covid19 | Terminated | 2021-01-04 | 2021-04-18 | ClinicalTrials.gov |
| NCT04634253 | A Study of LY3462817 in Participants With Rheumatoid Arthritis | Phase2 | Rheumatoid Arthritis | Completed | 2021-01-04 | 2022-06-29 | ClinicalTrials.gov |
| NCT04627064 | ABEMA Alone or in COMBO With MK-6482 | Phase1 | Clear Cell Renal Cell Carcinoma | Completed | 2020-12-31 | 2024-08-04 | ClinicalTrials.gov |
| NCT04627064 | ABEMA Alone or in COMBO With MK-6482 | Phase1 | Clear Cell Renal Cell Carcinoma | Completed | 2020-12-31 | 2024-08-04 | ClinicalTrials.gov |
| NCT04682119 | A Safety Study of LY3526318 in Healthy Participants | Phase1 | Healthy | Completed | 2020-12-29 | 2021-04-21 | ClinicalTrials.gov |
| NCT04682119 | A Safety Study of LY3526318 in Healthy Participants | Phase1 | Healthy | Completed | 2020-12-29 | 2021-04-21 | ClinicalTrials.gov |
| NCT04681768 | Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Meta… | — | Breast Cancer/ Metastatic Breast Cancer | Completed | 2020-12-22 | 2025-04-01 | ClinicalTrials.gov |
| NCT04681768 | Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Meta… | — | Breast Cancer/ Metastatic Breast Cancer | Completed | 2020-12-22 | 2025-04-01 | ClinicalTrials.gov |
| NCT04607421 | A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People Wi… | Phase3 | Neoplasms | Active_Not_Recruiting | 2020-12-21 | 2027-12-28 | ClinicalTrials.gov |
| NCT04607421 | A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People Wi… | Phase3 | Neoplasms | Active_Not_Recruiting | 2020-12-21 | 2027-12-28 | ClinicalTrials.gov |
| NCT06190691 | Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Liver Function … | Phase1 | Healthy | Completed | 2020-12-18 | 2021-12-30 | ClinicalTrials.gov |
| NCT06190691 | Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Liver Function … | Phase1 | Healthy | Completed | 2020-12-18 | 2021-12-30 | ClinicalTrials.gov |
| NCT04509674 | EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Fa… | Phase3 | Myocardial Infarction | Completed | 2020-12-16 | 2023-11-05 | ClinicalTrials.gov |
| NCT04509674 | EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Fa… | Phase3 | Myocardial Infarction | Completed | 2020-12-16 | 2023-11-05 | ClinicalTrials.gov |
| NCT06215521 | A Study to Evaluate the Effect of Pirtobrutinib (LOXO-305) on QTc Interval in H… | Phase1 | Healthy | Completed | 2020-12-15 | 2021-03-31 | ClinicalTrials.gov |
| NCT06215521 | A Study to Evaluate the Effect of Pirtobrutinib (LOXO-305) on QTc Interval in H… | Phase1 | Healthy | Completed | 2020-12-15 | 2021-03-31 | ClinicalTrials.gov |
| NCT04648865 | A Study of LY3537031 in Healthy Participants | Phase1 | Healthy | Completed | 2020-12-09 | 2021-06-04 | ClinicalTrials.gov |
| NCT04648865 | A Study of LY3537031 in Healthy Participants | Phase1 | Healthy | Completed | 2020-12-09 | 2021-06-04 | ClinicalTrials.gov |
| NCT04591626 | A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes | Phase3 | Type 2 Diabetes Mellitus | Completed | 2020-12-07 | 2022-04-28 | ClinicalTrials.gov |
| NCT04653168 | A Study of LY3041658 in Healthy Participants | Phase1 | Healthy | Completed | 2020-12-07 | 2021-05-28 | ClinicalTrials.gov |
| NCT04653168 | A Study of LY3041658 in Healthy Participants | Phase1 | Healthy | Completed | 2020-12-07 | 2021-05-28 | ClinicalTrials.gov |
| NCT04591626 | A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes | Phase3 | Type 2 Diabetes Mellitus | Completed | 2020-12-07 | 2022-04-28 | ClinicalTrials.gov |
| NCT04027101 | BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica | Phase2 | Polymyalgia Rheumatic (PMR) | Completed | 2020-12-01 | 2023-08-30 | ClinicalTrials.gov |
| NCT04027101 | BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica | Phase2 | Polymyalgia Rheumatic (PMR) | Completed | 2020-12-01 | 2023-08-30 | ClinicalTrials.gov |
| NCT04644809 | A Study of LY3561774 in Participants With Dyslipidemia | Phase1 | Dyslipidemias | Completed | 2020-11-30 | 2022-05-17 | ClinicalTrials.gov |
| NCT04644809 | A Study of LY3561774 in Participants With Dyslipidemia | Phase1 | Dyslipidemias | Completed | 2020-11-30 | 2022-05-17 | ClinicalTrials.gov |
| NCT04623541 | Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory C… | Phase1 | Relapsed/Refractory Chronic Lymphocytic Leukemia | Active_Not_Recruiting | 2020-11-25 | 2028-02-01 | ClinicalTrials.gov |
| NCT04616326 | A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With … | Phase3 | Chronic Migraine | Active_Not_Recruiting | 2020-11-25 | 2027-03-01 | ClinicalTrials.gov |
| NCT04641312 | A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabe… | Phase1 | Healthy | Completed | 2020-11-25 | 2021-12-21 | ClinicalTrials.gov |
| NCT04623541 | Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory C… | Phase1 | Relapsed/Refractory Chronic Lymphocytic Leukemia | Active_Not_Recruiting | 2020-11-25 | 2028-02-01 | ClinicalTrials.gov |
| NCT04641312 | A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabe… | Phase1 | Healthy | Completed | 2020-11-25 | 2021-12-21 | ClinicalTrials.gov |
| NCT04616326 | A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With … | Phase3 | Chronic Migraine | Active_Not_Recruiting | 2020-11-25 | 2027-03-01 | ClinicalTrials.gov |
| NCT04586907 | A Study of LY3537021 in Healthy Participants and Participants With Type 2 Diabe… | Phase1 | Healthy | Completed | 2020-11-23 | 2021-11-30 | ClinicalTrials.gov |
| NCT04640077 | A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participan… | Phase2 | Alzheimer Disease | Completed | 2020-11-23 | 2024-02-27 | ClinicalTrials.gov |
| NCT04586907 | A Study of LY3537021 in Healthy Participants and Participants With Type 2 Diabe… | Phase1 | Healthy | Completed | 2020-11-23 | 2021-11-30 | ClinicalTrials.gov |
| NCT04640077 | A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participan… | Phase2 | Alzheimer Disease | Completed | 2020-11-23 | 2024-02-27 | ClinicalTrials.gov |
| NCT04545710 | Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osi… | Phase2 | Lung Cancer | Active_Not_Recruiting | 2020-11-21 | 2026-12-01 | ClinicalTrials.gov |
| NCT04545710 | Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osi… | Phase2 | Lung Cancer | Active_Not_Recruiting | 2020-11-21 | 2026-12-01 | ClinicalTrials.gov |
| NCT04603001 | Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With… | Phase1 | Acute Myeloid Leukemia (AML) | Active_Not_Recruiting | 2020-11-19 | 2026-05-01 | ClinicalTrials.gov |
| NCT04603001 | Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With… | Phase1 | Acute Myeloid Leukemia (AML) | Active_Not_Recruiting | 2020-11-19 | 2026-05-01 | ClinicalTrials.gov |
| NCT04626297 | A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic D… | Phase3 | Atopic Dermatitis | Completed | 2020-11-17 | 2022-09-30 | ClinicalTrials.gov |
| NCT04626297 | A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic D… | Phase3 | Atopic Dermatitis | Completed | 2020-11-17 | 2022-09-30 | ClinicalTrials.gov |
| NCT04498910 | A Study of LY3451838 in Participants With Migraine | Phase2 | Migraine | Completed | 2020-11-16 | 2022-11-09 | ClinicalTrials.gov |
| NCT04498910 | A Study of LY3451838 in Participants With Migraine | Phase2 | Migraine | Completed | 2020-11-16 | 2022-11-09 | ClinicalTrials.gov |
| NCT04627038 | Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With … | Phase2 | Osteoarthritis | Completed | 2020-11-12 | 2021-10-21 | ClinicalTrials.gov |
| NCT04627038 | Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With … | Phase2 | Osteoarthritis | Completed | 2020-11-12 | 2021-10-21 | ClinicalTrials.gov |
| NCT06165146 | A Study of the Effects of Pirtobrutinib (LOXO-305) on Repaglinide (CYP2C8 Subst… | Phase1 | Healthy | Completed | 2020-11-10 | 2020-12-30 | ClinicalTrials.gov |
| NCT06165146 | A Study of the Effects of Pirtobrutinib (LOXO-305) on Repaglinide (CYP2C8 Subst… | Phase1 | Healthy | Completed | 2020-11-10 | 2020-12-30 | ClinicalTrials.gov |
| NCT04238819 | A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatm… | Phase1 | Relapsed Solid Tumor | Completed | 2020-11-09 | 2025-08-19 | ClinicalTrials.gov |
| NCT04238819 | A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatm… | Phase1 | Relapsed Solid Tumor | Completed | 2020-11-09 | 2025-08-19 | ClinicalTrials.gov |
| NCT04408625 | Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia … | Phase1 | Frontotemporal Dementia | Active_Not_Recruiting | 2020-11-09 | 2029-11-30 | ClinicalTrials.gov |
| NCT04408625 | Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia … | Phase1 | Frontotemporal Dementia | Active_Not_Recruiting | 2020-11-09 | 2029-11-30 | ClinicalTrials.gov |
| NCT04605991 | A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using… | Phase3 | Type 2 Diabetes | Completed | 2020-11-04 | 2022-02-04 | ClinicalTrials.gov |
| NCT04605991 | A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using… | Phase3 | Type 2 Diabetes | Completed | 2020-11-04 | 2022-02-04 | ClinicalTrials.gov |
| NCT04623138 | A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections | — | Covid19 | Completed | 2020-11-04 | 2021-06-01 | ClinicalTrials.gov |
| NCT04623138 | A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections | — | Covid19 | Completed | 2020-11-04 | 2021-06-01 | ClinicalTrials.gov |
| NCT04611789 | A Study of LY3832479 (LY-CoV016) in Healthy Participants 1 | Phase1 | Healthy | Completed | 2020-11-02 | 2021-02-10 | ClinicalTrials.gov |
| NCT04607733 | A Study of Mirikizumab in Healthy Participants | Phase1 | Healthy | Completed | 2020-11-02 | 2021-05-17 | ClinicalTrials.gov |
| NCT04611789 | A Study of LY3832479 (LY-CoV016) in Healthy Participants 1 | Phase1 | Healthy | Completed | 2020-11-02 | 2021-02-10 | ClinicalTrials.gov |
| NCT04607733 | A Study of Mirikizumab in Healthy Participants | Phase1 | Healthy | Completed | 2020-11-02 | 2021-05-17 | ClinicalTrials.gov |
| NCT04585776 | A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes | Phase2 | Type 1 Diabetes | Completed | 2020-10-30 | 2021-05-27 | ClinicalTrials.gov |
| NCT04585776 | A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes | Phase2 | Type 1 Diabetes | Completed | 2020-10-30 | 2021-05-27 | ClinicalTrials.gov |
| NCT04634409 | A Study of Immune System Proteins in Participants With Mild to Moderate COVID-1… | Phase2 | COVID-19 | Completed | 2020-10-29 | 2021-10-18 | ClinicalTrials.gov |
| NCT04634409 | A Study of Immune System Proteins in Participants With Mild to Moderate COVID-1… | Phase2 | COVID-19 | Completed | 2020-10-29 | 2021-10-18 | ClinicalTrials.gov |
| NCT04517253 | A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants… | Phase2 | Nakajo-Nishimura Syndrome | Terminated | 2020-10-27 | 2024-11-28 | ClinicalTrials.gov |
| NCT04517253 | A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants… | Phase2 | Nakajo-Nishimura Syndrome | Terminated | 2020-10-27 | 2024-11-28 | ClinicalTrials.gov |
| NCT04235959 | A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-10-21 | 2021-08-17 | ClinicalTrials.gov |
| NCT04235959 | A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-10-21 | 2021-08-17 | ClinicalTrials.gov |
| NCT04586920 | A Study of LY3509754 in Healthy Non-Japanese and Japanese Participants | Phase1 | Healthy | Terminated | 2020-10-20 | 2022-10-14 | ClinicalTrials.gov |
| NCT04586920 | A Study of LY3509754 in Healthy Non-Japanese and Japanese Participants | Phase1 | Healthy | Terminated | 2020-10-20 | 2022-10-14 | ClinicalTrials.gov |
| NCT04537923 | A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants… | Phase3 | Type 2 Diabetes | Completed | 2020-10-19 | 2022-11-01 | ClinicalTrials.gov |
| NCT04537923 | A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants… | Phase3 | Type 2 Diabetes | Completed | 2020-10-19 | 2022-11-01 | ClinicalTrials.gov |
| NCT04469764 | Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer | Phase2 | Recurrent Endometrial Carcinoma | Recruiting | 2020-10-16 | 2027-07-01 | ClinicalTrials.gov |
| NCT04469764 | Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer | Phase2 | Recurrent Endometrial Carcinoma | Recruiting | 2020-10-16 | 2027-07-01 | ClinicalTrials.gov |
| NCT04559568 | A Study of LY3522348 in Healthy Participants | Phase1 | Healthy | Completed | 2020-10-15 | 2021-08-17 | ClinicalTrials.gov |
| NCT04559568 | A Study of LY3522348 in Healthy Participants | Phase1 | Healthy | Completed | 2020-10-15 | 2021-08-17 | ClinicalTrials.gov |
| NCT04393285 | Abemaciclib and Letrozole to Treat Endometrial Cancer | Phase2 | Endometrial Cancer | Active_Not_Recruiting | 2020-10-10 | 2026-12-31 | ClinicalTrials.gov |
| NCT04393285 | Abemaciclib and Letrozole to Treat Endometrial Cancer | Phase2 | Endometrial Cancer | Active_Not_Recruiting | 2020-10-10 | 2026-12-31 | ClinicalTrials.gov |
| NCT03527108 | Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSC… | Phase2 | Non Small Cell Lung Cancer | Active_Not_Recruiting | 2020-10-08 | 2027-04-01 | ClinicalTrials.gov |
| NCT04426474 | A Study of LY3502970 in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-10-08 | 2021-07-12 | ClinicalTrials.gov |
| NCT03527108 | Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSC… | Phase2 | Non Small Cell Lung Cancer | Active_Not_Recruiting | 2020-10-08 | 2027-04-01 | ClinicalTrials.gov |
| NCT04426474 | A Study of LY3502970 in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-10-08 | 2021-07-12 | ClinicalTrials.gov |
| NCT04294147 | A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine B… | Phase4 | Migraine | Completed | 2020-10-06 | 2021-03-05 | ClinicalTrials.gov |
| NCT04294147 | A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine B… | Phase4 | Migraine | Completed | 2020-10-06 | 2021-03-05 | ClinicalTrials.gov |
| NCT04534283 | A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemacicl… | Phase2 | Cancer | Terminated | 2020-10-05 | 2023-08-07 | ClinicalTrials.gov |
| NCT04534283 | A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemacicl… | Phase2 | Cancer | Terminated | 2020-10-05 | 2023-08-07 | ClinicalTrials.gov |
| NCT04293393 | Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Int… | Phase2 | Early Breast Cancer | Active_Not_Recruiting | 2020-10-02 | 2033-02-28 | ClinicalTrials.gov |
| NCT04293393 | Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Int… | Phase2 | Early Breast Cancer | Active_Not_Recruiting | 2020-10-02 | 2033-02-28 | ClinicalTrials.gov |
| NCT04521686 | Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH… | Phase1 | Cholangiocarcinoma | Active_Not_Recruiting | 2020-10-01 | 2026-05-01 | ClinicalTrials.gov |
| NCT04521686 | Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH… | Phase1 | Cholangiocarcinoma | Active_Not_Recruiting | 2020-10-01 | 2026-05-01 | ClinicalTrials.gov |
| NCT04541628 | Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A | Phase1 | Hemophilia A | Terminated | 2020-09-28 | 2023-01-09 | ClinicalTrials.gov |
| NCT04541628 | Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A | Phase1 | Hemophilia A | Terminated | 2020-09-28 | 2023-01-09 | ClinicalTrials.gov |
| NCT06180954 | A Study of Carbon-14-Labelled [14C] LOXO-305 (Pirtobrutinib) in Healthy Male Pa… | Phase1 | Healthy | Completed | 2020-09-23 | 2020-11-06 | ClinicalTrials.gov |
| NCT06180954 | A Study of Carbon-14-Labelled [14C] LOXO-305 (Pirtobrutinib) in Healthy Male Pa… | Phase1 | Healthy | Completed | 2020-09-23 | 2020-11-06 | ClinicalTrials.gov |
| NCT04618809 | Improving the Approach to and Management of the Older Patient With Metastatic G… | Na | Metastatic Gastric Cancer | Unknown | 2020-09-22 | 2023-12-31 | ClinicalTrials.gov |
| NCT04618809 | Improving the Approach to and Management of the Older Patient With Metastatic G… | Na | Metastatic Gastric Cancer | Unknown | 2020-09-22 | 2023-12-31 | ClinicalTrials.gov |
| NCT04417361 | Galcanezumab for Vestibular Migraine | Phase2 | Vestibular Migraine | Completed | 2020-09-18 | 2023-09-29 | ClinicalTrials.gov |
| NCT04417361 | Galcanezumab for Vestibular Migraine | Phase2 | Vestibular Migraine | Completed | 2020-09-18 | 2023-09-29 | ClinicalTrials.gov |
| NCT04407234 | A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Par… | Phase1 | Overweight | Completed | 2020-09-15 | 2021-01-07 | ClinicalTrials.gov |
| NCT04407234 | A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Par… | Phase1 | Overweight | Completed | 2020-09-15 | 2021-01-07 | ClinicalTrials.gov |
| NCT04548219 | A Study to Compare Two Different Formulations of Mirikizumab in Healthy Partici… | Phase1 | Healthy | Completed | 2020-09-11 | 2021-01-11 | ClinicalTrials.gov |
| NCT04548219 | A Study to Compare Two Different Formulations of Mirikizumab in Healthy Partici… | Phase1 | Healthy | Completed | 2020-09-11 | 2021-01-11 | ClinicalTrials.gov |
| NCT04498390 | A Safety Study of LY3493269 in Healthy Participants | Phase1 | Healthy | Completed | 2020-09-03 | 2020-12-28 | ClinicalTrials.gov |
| NCT06180967 | A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Different F… | Phase1 | Healthy | Completed | 2020-09-03 | 2020-10-20 | ClinicalTrials.gov |
| NCT04498390 | A Safety Study of LY3493269 in Healthy Participants | Phase1 | Healthy | Completed | 2020-09-03 | 2020-12-28 | ClinicalTrials.gov |
| NCT06180967 | A Drug Drug Interaction (DDI) Study of Pirtobrutinib (LOXO-305) and Different F… | Phase1 | Healthy | Completed | 2020-09-03 | 2020-10-20 | ClinicalTrials.gov |
| NCT04565054 | Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic Hi… | Phase3 | Breast Cancer Female | Active_Not_Recruiting | 2020-09-02 | 2029-07-01 | ClinicalTrials.gov |
| NCT04537910 | A Study of LY3819253 (LY-CoV555) in Healthy Participants | Phase1 | Healthy | Completed | 2020-09-02 | 2020-12-28 | ClinicalTrials.gov |
| NCT04537910 | A Study of LY3819253 (LY-CoV555) in Healthy Participants | Phase1 | Healthy | Completed | 2020-09-02 | 2020-12-28 | ClinicalTrials.gov |
| NCT04565054 | Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic Hi… | Phase3 | Breast Cancer Female | Active_Not_Recruiting | 2020-09-02 | 2029-07-01 | ClinicalTrials.gov |
| NCT04493502 | A Study of LY3041658 in Adults With Hidradenitis Suppurativa | Phase2 | Hidradenitis Suppurativa | Completed | 2020-08-26 | 2022-10-13 | ClinicalTrials.gov |
| NCT04493502 | A Study of LY3041658 in Adults With Hidradenitis Suppurativa | Phase2 | Hidradenitis Suppurativa | Completed | 2020-08-26 | 2022-10-13 | ClinicalTrials.gov |
| NCT04515576 | A Study of LY3493269 in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-08-25 | 2021-03-09 | ClinicalTrials.gov |
| NCT04529096 | Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With … | Phase2 | Chronic Low-back Pain | Completed | 2020-08-25 | 2021-10-04 | ClinicalTrials.gov |
| NCT04515576 | A Study of LY3493269 in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-08-25 | 2021-03-09 | ClinicalTrials.gov |
| NCT04529096 | Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With … | Phase2 | Chronic Low-back Pain | Completed | 2020-08-25 | 2021-10-04 | ClinicalTrials.gov |
| NCT04311411 | A Study of Tirzepatide in Overweight and Very Overweight Participants | Phase1 | Obesity | Completed | 2020-08-24 | 2022-12-16 | ClinicalTrials.gov |
| NCT04311411 | A Study of Tirzepatide in Overweight and Very Overweight Participants | Phase1 | Obesity | Completed | 2020-08-24 | 2022-12-16 | ClinicalTrials.gov |
| NCT04518410 | ACTIV-2: A Study for Outpatients With COVID-19 | Phase2 | Coronavirus | Completed | 2020-08-19 | 2023-06-20 | ClinicalTrials.gov |
| NCT04433585 | A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) | Phase2 | Systemic Lupus Erythematosus | Completed | 2020-08-19 | 2023-02-16 | ClinicalTrials.gov |
| NCT04518410 | ACTIV-2: A Study for Outpatients With COVID-19 | Phase2 | Coronavirus | Completed | 2020-08-19 | 2023-06-20 | ClinicalTrials.gov |
| NCT04433585 | A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) | Phase2 | Systemic Lupus Erythematosus | Completed | 2020-08-19 | 2023-02-16 | ClinicalTrials.gov |
| NCT04472676 | A Study of LY3473329 in Healthy Participants | Phase1 | Healthy | Completed | 2020-08-18 | 2021-11-09 | ClinicalTrials.gov |
| NCT04472676 | A Study of LY3473329 in Healthy Participants | Phase1 | Healthy | Completed | 2020-08-18 | 2021-11-09 | ClinicalTrials.gov |
| NCT05826756 | Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-Worl… | — | Lung Cancer Patients | Unknown | 2020-08-15 | 2025-12-01 | ClinicalTrials.gov |
| NCT05826756 | Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-Worl… | — | Lung Cancer Patients | Unknown | 2020-08-15 | 2025-12-01 | ClinicalTrials.gov |
| NCT06181006 | A Study to Evaluate Pirtobrutinib (LOXO-305) in Healthy Adult Participants | Phase1 | Healthy | Completed | 2020-08-14 | 2020-12-01 | ClinicalTrials.gov |
| NCT06181006 | A Study to Evaluate Pirtobrutinib (LOXO-305) in Healthy Adult Participants | Phase1 | Healthy | Completed | 2020-08-14 | 2020-12-01 | ClinicalTrials.gov |
| NCT06901518 | The Effect of Galcanezumab-gnlm on Post-Traumatic, Migrainous Headaches | Phase4 | Post-Traumatic Headache | Completed | 2020-08-10 | 2024-11-30 | ClinicalTrials.gov |
| NCT06901518 | The Effect of Galcanezumab-gnlm on Post-Traumatic, Migrainous Headaches | Phase4 | Post-Traumatic Headache | Completed | 2020-08-10 | 2024-11-30 | ClinicalTrials.gov |
| NCT04392271 | A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy P… | Phase1 | Healthy | Completed | 2020-08-06 | 2020-10-14 | ClinicalTrials.gov |
| NCT04392271 | A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy P… | Phase1 | Healthy | Completed | 2020-08-06 | 2020-10-14 | ClinicalTrials.gov |
| NCT05780268 | LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment T… | Phase3 | COVID-19 | Completed | 2020-08-05 | 2021-02-01 | ClinicalTrials.gov |
| NCT05780268 | LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment T… | Phase3 | COVID-19 | Completed | 2020-08-05 | 2021-02-01 | ClinicalTrials.gov |
| NCT04501978 | ACTIV-3: Therapeutics for Inpatients With COVID-19 | Phase3 | Covid19 | Completed | 2020-08-04 | 2023-07-14 | ClinicalTrials.gov |
| NCT04501978 | ACTIV-3: Therapeutics for Inpatients With COVID-19 | Phase3 | Covid19 | Completed | 2020-08-04 | 2023-07-14 | ClinicalTrials.gov |
| NCT04497987 | A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-C… | Phase3 | COVID-19 | Completed | 2020-08-02 | 2021-05-20 | ClinicalTrials.gov |
| NCT04497987 | A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-C… | Phase3 | COVID-19 | Completed | 2020-08-02 | 2021-05-20 | ClinicalTrials.gov |
| NCT04495478 | A Study of Ramucirumab (LY3009806) in Healthy Participants | Phase1 | Healthy | Completed | 2020-07-30 | 2021-05-09 | ClinicalTrials.gov |
| NCT04495478 | A Study of Ramucirumab (LY3009806) in Healthy Participants | Phase1 | Healthy | Completed | 2020-07-30 | 2021-05-09 | ClinicalTrials.gov |
| NCT04271202 | Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action | Phase4 | Chronic Migraine | Completed | 2020-07-29 | 2023-11-22 | ClinicalTrials.gov |
| NCT04271202 | Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action | Phase4 | Chronic Migraine | Completed | 2020-07-29 | 2023-11-22 | ClinicalTrials.gov |
| NCT04311424 | Study of Tirzepatide in Healthy Participants | Phase1 | Healthy | Completed | 2020-07-28 | 2020-10-02 | ClinicalTrials.gov |
| NCT04311424 | Study of Tirzepatide in Healthy Participants | Phase1 | Healthy | Completed | 2020-07-28 | 2020-10-02 | ClinicalTrials.gov |
| NCT04158752 | Anti-CGRP for Inflammation and Pain Modulation in Small Fiber Neuropathy/Fibrom… | Phase4 | Trigeminal Neuralgia | Completed | 2020-07-24 | 2023-01-04 | ClinicalTrials.gov |
| NCT04158752 | Anti-CGRP for Inflammation and Pain Modulation in Small Fiber Neuropathy/Fibrom… | Phase4 | Trigeminal Neuralgia | Completed | 2020-07-24 | 2023-01-04 | ClinicalTrials.gov |
| NCT04305236 | Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative … | Phase2 | Breast Neoplasm | Terminated | 2020-07-23 | 2022-02-16 | ClinicalTrials.gov |
| NCT04305236 | Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative … | Phase2 | Breast Neoplasm | Terminated | 2020-07-23 | 2022-02-16 | ClinicalTrials.gov |
| NCT04081259 | LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy | Phase1 | Acute Myeloid Leukemia | Completed | 2020-07-15 | 2023-08-26 | ClinicalTrials.gov |
| NCT04476108 | Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With … | Phase2 | Diabetic Peripheral Neuropathic Pain | Completed | 2020-07-15 | 2021-11-11 | ClinicalTrials.gov |
| NCT04081259 | LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy | Phase1 | Acute Myeloid Leukemia | Completed | 2020-07-15 | 2023-08-26 | ClinicalTrials.gov |
| NCT04476108 | Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With … | Phase2 | Diabetic Peripheral Neuropathic Pain | Completed | 2020-07-15 | 2021-11-11 | ClinicalTrials.gov |
| NCT04484779 | A Study of an Insulin Management System in Participants With Type 1 or Type 2 D… | Na | Type 1 Diabetes | Completed | 2020-07-14 | 2020-12-22 | ClinicalTrials.gov |
| NCT04484779 | A Study of an Insulin Management System in Participants With Type 1 or Type 2 D… | Na | Type 1 Diabetes | Completed | 2020-07-14 | 2020-12-22 | ClinicalTrials.gov |
| NCT04391595 | LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients | Early_Phase1 | Glioblastoma | Completed | 2020-07-11 | 2025-09-03 | ClinicalTrials.gov |
| NCT04391595 | LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients | Early_Phase1 | Glioblastoma | Completed | 2020-07-11 | 2025-09-03 | ClinicalTrials.gov |
| NCT04081337 | A Study to Measure Energy Expenditure and Food Intake in Participants With Obes… | Phase1 | Obesity | Completed | 2020-07-09 | 2022-05-26 | ClinicalTrials.gov |
| NCT04081337 | A Study to Measure Energy Expenditure and Food Intake in Participants With Obes… | Phase1 | Obesity | Completed | 2020-07-09 | 2022-05-26 | ClinicalTrials.gov |
| NCT04220892 | Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High G… | Early_Phase1 | High Grade Glioma | Withdrawn | 2020-07-08 | 2020-07-08 | ClinicalTrials.gov |
| NCT04220892 | Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High G… | Early_Phase1 | High Grade Glioma | Withdrawn | 2020-07-08 | 2020-07-08 | ClinicalTrials.gov |
| NCT04451408 | A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy … | Phase1 | Alzheimer Disease | Completed | 2020-07-07 | 2024-11-18 | ClinicalTrials.gov |
| NCT04451408 | A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy … | Phase1 | Alzheimer Disease | Completed | 2020-07-07 | 2024-11-18 | ClinicalTrials.gov |
| NCT04450407 | A Study of LY3209590 in Participants With Type 1 Diabetes | Phase2 | Type 1 Diabetes Mellitus | Completed | 2020-07-06 | 2021-10-01 | ClinicalTrials.gov |
| NCT04450407 | A Study of LY3209590 in Participants With Type 1 Diabetes | Phase2 | Type 1 Diabetes Mellitus | Completed | 2020-07-06 | 2021-10-01 | ClinicalTrials.gov |
| NCT04456686 | Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With … | Phase2 | Osteoarthritis | Completed | 2020-07-01 | 2021-08-26 | ClinicalTrials.gov |
| NCT04450394 | A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus | Phase2 | Type 2 Diabetes Mellitus | Completed | 2020-07-01 | 2021-10-08 | ClinicalTrials.gov |
| NCT04456686 | Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With … | Phase2 | Osteoarthritis | Completed | 2020-07-01 | 2021-08-26 | ClinicalTrials.gov |
| NCT04450394 | A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus | Phase2 | Type 2 Diabetes Mellitus | Completed | 2020-07-01 | 2021-10-08 | ClinicalTrials.gov |
| NCT04396574 | A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 Wi… | Phase3 | Migraine | Terminated | 2020-06-30 | 2025-12-04 | ClinicalTrials.gov |
| NCT04396574 | A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 Wi… | Phase3 | Migraine | Terminated | 2020-06-30 | 2025-12-04 | ClinicalTrials.gov |
| NCT03846583 | Tucatinib + Abemaciclib + Herceptin for HER2+ MBC | Phase1 | Breast Cancer | Withdrawn | 2020-06-28 | 2020-09-22 | ClinicalTrials.gov |
| NCT03846583 | Tucatinib + Abemaciclib + Herceptin for HER2+ MBC | Phase1 | Breast Cancer | Withdrawn | 2020-06-28 | 2020-09-22 | ClinicalTrials.gov |
| NCT04232553 | A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Cro… | Phase3 | Crohn's Disease | Active_Not_Recruiting | 2020-06-22 | 2027-04-01 | ClinicalTrials.gov |
| NCT04232553 | A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Cro… | Phase3 | Crohn's Disease | Active_Not_Recruiting | 2020-06-22 | 2027-04-01 | ClinicalTrials.gov |
| NCT04441931 | A Study of LY3832479 (LY-CoV016) in Healthy Participants | Phase1 | Healthy | Completed | 2020-06-19 | 2020-10-02 | ClinicalTrials.gov |
| NCT04437511 | A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease… | Phase3 | Alzheimer Disease | Active_Not_Recruiting | 2020-06-19 | 2028-11-01 | ClinicalTrials.gov |
| NCT04437511 | A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease… | Phase3 | Alzheimer Disease | Active_Not_Recruiting | 2020-06-19 | 2028-11-01 | ClinicalTrials.gov |
| NCT04441931 | A Study of LY3832479 (LY-CoV016) in Healthy Participants | Phase1 | Healthy | Completed | 2020-06-19 | 2020-10-02 | ClinicalTrials.gov |
| NCT04427501 | A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With… | Phase2 | COVID-19 | Completed | 2020-06-17 | 2023-02-21 | ClinicalTrials.gov |
| NCT04427501 | A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With… | Phase2 | COVID-19 | Completed | 2020-06-17 | 2023-02-21 | ClinicalTrials.gov |
| NCT04396236 | A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migrai… | Phase3 | Migraine | Terminated | 2020-06-15 | 2025-11-12 | ClinicalTrials.gov |
| NCT04352114 | A Study of LY3461767 in Healthy Participants | Phase1 | Healthy | Completed | 2020-06-15 | 2021-01-13 | ClinicalTrials.gov |
| NCT04396236 | A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migrai… | Phase3 | Migraine | Terminated | 2020-06-15 | 2025-11-12 | ClinicalTrials.gov |
| NCT04352114 | A Study of LY3461767 in Healthy Participants | Phase1 | Healthy | Completed | 2020-06-15 | 2021-01-13 | ClinicalTrials.gov |
| NCT04392154 | Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants… | Phase3 | Atopic Dermatitis | Completed | 2020-06-15 | 2025-04-22 | ClinicalTrials.gov |
| NCT04392154 | Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants… | Phase3 | Atopic Dermatitis | Completed | 2020-06-15 | 2025-04-22 | ClinicalTrials.gov |
| NCT04421027 | A Study of Baricitinib (LY3009104) in Participants With COVID-19 | Phase3 | COVID-19 | Completed | 2020-06-12 | 2021-06-10 | ClinicalTrials.gov |
| NCT04421027 | A Study of Baricitinib (LY3009104) in Participants With COVID-19 | Phase3 | COVID-19 | Completed | 2020-06-12 | 2021-06-10 | ClinicalTrials.gov |
| NCT04106219 | A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neurobla… | Phase1 | Neuroblastoma | Active_Not_Recruiting | 2020-06-11 | 2026-08-01 | ClinicalTrials.gov |
| NCT04106219 | A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neurobla… | Phase1 | Neuroblastoma | Active_Not_Recruiting | 2020-06-11 | 2026-08-01 | ClinicalTrials.gov |
| NCT04657783 | French National Cohort of People With Type 1 Diabetes | — | Diabetes Mellitus, Type 1 | Recruiting | 2020-06-10 | 2035-06-10 | ClinicalTrials.gov |
| NCT04657783 | French National Cohort of People With Type 1 Diabetes | — | Diabetes Mellitus, Type 1 | Recruiting | 2020-06-10 | 2035-06-10 | ClinicalTrials.gov |
| NCT04255433 | A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovas… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2020-05-29 | 2025-06-12 | ClinicalTrials.gov |
| NCT04255433 | A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovas… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2020-05-29 | 2025-06-12 | ClinicalTrials.gov |
| NCT04411628 | A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 | Phase1 | COVID-19 | Completed | 2020-05-28 | 2020-08-26 | ClinicalTrials.gov |
| NCT04411628 | A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 | Phase1 | COVID-19 | Completed | 2020-05-28 | 2020-08-26 | ClinicalTrials.gov |
| NCT04386057 | LY3214996 +/- HCQ in Pancreatic Cancer | Phase2 | Pancreatic Cancer | Completed | 2020-05-27 | 2024-02-05 | ClinicalTrials.gov |
| NCT04386057 | LY3214996 +/- HCQ in Pancreatic Cancer | Phase2 | Pancreatic Cancer | Completed | 2020-05-27 | 2024-02-05 | ClinicalTrials.gov |
| NCT04157751 | A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for… | Phase3 | Heart Failure | Completed | 2020-05-18 | 2021-06-02 | ClinicalTrials.gov |
| NCT04004611 | A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Co… | Phase2 | Ulcerative Colitis | Completed | 2020-05-18 | 2023-03-15 | ClinicalTrials.gov |
| NCT04157751 | A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for… | Phase3 | Heart Failure | Completed | 2020-05-18 | 2021-06-02 | ClinicalTrials.gov |
| NCT04004611 | A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Co… | Phase2 | Ulcerative Colitis | Completed | 2020-05-18 | 2023-03-15 | ClinicalTrials.gov |
| NCT04372277 | Taltz in Combination With Enstilar for Psoriasis | Phase4 | Psoriasis | Recruiting | 2020-04-28 | 2021-03-30 | ClinicalTrials.gov |
| NCT04372277 | Taltz in Combination With Enstilar for Psoriasis | Phase4 | Psoriasis | Recruiting | 2020-04-28 | 2021-03-30 | ClinicalTrials.gov |
| NCT04342897 | A Study of LY3127804 in Participants With COVID-19 | Phase2 | COVID-19 | Terminated | 2020-04-20 | 2020-10-12 | ClinicalTrials.gov |
| NCT04342897 | A Study of LY3127804 in Participants With COVID-19 | Phase2 | COVID-19 | Terminated | 2020-04-20 | 2020-10-12 | ClinicalTrials.gov |
| NCT04285229 | A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axi… | Phase3 | Spondyloarthritis | Completed | 2020-04-10 | 2022-03-17 | ClinicalTrials.gov |
| NCT04285229 | A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axi… | Phase3 | Spondyloarthritis | Completed | 2020-04-10 | 2022-03-17 | ClinicalTrials.gov |
| NCT04270370 | A Study of LY3478045 in Healthy Participants | Phase1 | Healthy | Completed | 2020-03-16 | 2021-06-23 | ClinicalTrials.gov |
| NCT04270370 | A Study of LY3478045 in Healthy Participants | Phase1 | Healthy | Completed | 2020-03-16 | 2021-06-23 | ClinicalTrials.gov |
| NCT04280081 | A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors… | Phase2 | Solid Tumor | Active_Not_Recruiting | 2020-03-16 | 2027-11-01 | ClinicalTrials.gov |
| NCT04280081 | A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors… | Phase2 | Solid Tumor | Active_Not_Recruiting | 2020-03-16 | 2027-11-01 | ClinicalTrials.gov |
| NCT04145700 | CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With … | Phase1 | Synovial Sarcoma | Terminated | 2020-03-04 | 2023-02-23 | ClinicalTrials.gov |
| NCT04145700 | CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With … | Phase1 | Synovial Sarcoma | Terminated | 2020-03-04 | 2023-02-23 | ClinicalTrials.gov |
| NCT04030728 | Implementing Patients´ Competence in Oral Breast Cancer Therapy | — | Metastatic Breast Cancer | Unknown | 2020-03-01 | 2021-12-01 | ClinicalTrials.gov |
| NCT04030728 | Implementing Patients´ Competence in Oral Breast Cancer Therapy | — | Metastatic Breast Cancer | Unknown | 2020-03-01 | 2021-12-01 | ClinicalTrials.gov |
| NCT04276428 | A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-02-28 | 2020-11-28 | ClinicalTrials.gov |
| NCT04276428 | A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-02-28 | 2020-11-28 | ClinicalTrials.gov |
| NCT04172987 | A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pill… | Phase1 | Healthy | Completed | 2020-02-26 | 2021-02-09 | ClinicalTrials.gov |
| NCT04172987 | A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pill… | Phase1 | Healthy | Completed | 2020-02-26 | 2021-02-09 | ClinicalTrials.gov |
| NCT04276207 | A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Part… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2020-02-25 | 2020-08-10 | ClinicalTrials.gov |
| NCT04276207 | A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Part… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2020-02-25 | 2020-08-10 | ClinicalTrials.gov |
| NCT04050553 | A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-02-24 | 2022-01-25 | ClinicalTrials.gov |
| NCT04050553 | A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2020-02-24 | 2022-01-25 | ClinicalTrials.gov |
| NCT04230122 | A Study of LY3478006 in Healthy Participants | Phase1 | Healthy | Terminated | 2020-02-17 | 2020-06-04 | ClinicalTrials.gov |
| NCT04194944 | A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastati… | Phase3 | Non-Small Cell Lung Cancer | Active_Not_Recruiting | 2020-02-17 | 2030-06-01 | ClinicalTrials.gov |
| NCT04230122 | A Study of LY3478006 in Healthy Participants | Phase1 | Healthy | Terminated | 2020-02-17 | 2020-06-04 | ClinicalTrials.gov |
| NCT04194944 | A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastati… | Phase3 | Non-Small Cell Lung Cancer | Active_Not_Recruiting | 2020-02-17 | 2030-06-01 | ClinicalTrials.gov |
| NCT04086745 | A Study of Baricitinib in Participants With Rheumatoid Arthritis | Phase4 | Rheumatoid Arthritis | Completed | 2020-02-14 | 2025-05-19 | ClinicalTrials.gov |
| NCT04086745 | A Study of Baricitinib in Participants With Rheumatoid Arthritis | Phase4 | Rheumatoid Arthritis | Completed | 2020-02-14 | 2025-05-19 | ClinicalTrials.gov |
| NCT04088396 | A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 … | Phase3 | Systemic Juvenile Idiopathic Arthritis | Recruiting | 2020-02-12 | 2026-09-01 | ClinicalTrials.gov |
| NCT04088396 | A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 … | Phase3 | Systemic Juvenile Idiopathic Arthritis | Recruiting | 2020-02-12 | 2026-09-01 | ClinicalTrials.gov |
| NCT05134337 | Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Partic… | Phase1 | Healthy Volunteers | Completed | 2020-02-12 | 2020-10-30 | ClinicalTrials.gov |
| NCT05134337 | Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Partic… | Phase1 | Healthy Volunteers | Completed | 2020-02-12 | 2020-10-30 | ClinicalTrials.gov |
| NCT04211337 | A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary … | Phase3 | Medullary Thyroid Cancer | Active_Not_Recruiting | 2020-02-11 | 2027-11-01 | ClinicalTrials.gov |
| NCT04211337 | A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary … | Phase3 | Medullary Thyroid Cancer | Active_Not_Recruiting | 2020-02-11 | 2027-11-01 | ClinicalTrials.gov |
| NCT04250350 | Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolesce… | Phase3 | Atopic Dermatitis | Completed | 2020-02-11 | 2022-06-22 | ClinicalTrials.gov |
| NCT04250350 | Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolesce… | Phase3 | Atopic Dermatitis | Completed | 2020-02-11 | 2022-06-22 | ClinicalTrials.gov |
| NCT05134350 | Study of the Effect of Food and a Proton Pump Inhibitor (PPI; Omeprazole) on LO… | Phase1 | Healthy Volunteers | Completed | 2020-02-06 | 2020-03-23 | ClinicalTrials.gov |
| NCT05134350 | Study of the Effect of Food and a Proton Pump Inhibitor (PPI; Omeprazole) on LO… | Phase1 | Healthy Volunteers | Completed | 2020-02-06 | 2020-03-23 | ClinicalTrials.gov |
| NCT04259346 | A Study of Two Formulations of Ixekizumab in Healthy Participants | Phase1 | Healthy | Completed | 2020-02-05 | 2021-02-19 | ClinicalTrials.gov |
| NCT04259346 | A Study of Two Formulations of Ixekizumab in Healthy Participants | Phase1 | Healthy | Completed | 2020-02-05 | 2021-02-19 | ClinicalTrials.gov |
| NCT04043845 | ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies | Phase1 | Chronic Lymphocytic Leukemia | Withdrawn | 2020-02-03 | 2020-02-03 | ClinicalTrials.gov |
| NCT04250337 | Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Cor… | Phase3 | Atopic Dermatitis | Completed | 2020-02-03 | 2021-09-16 | ClinicalTrials.gov |
| NCT04250337 | Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Cor… | Phase3 | Atopic Dermatitis | Completed | 2020-02-03 | 2021-09-16 | ClinicalTrials.gov |
| NCT04043845 | ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies | Phase1 | Chronic Lymphocytic Leukemia | Withdrawn | 2020-02-03 | 2020-02-03 | ClinicalTrials.gov |
| NCT05986292 | A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices… | Phase2 | Osteoarthritis, Knee | Recruiting | 2020-01-30 | 2027-04-01 | ClinicalTrials.gov |
| NCT05986292 | A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices… | Phase2 | Osteoarthritis, Knee | Recruiting | 2020-01-30 | 2027-04-01 | ClinicalTrials.gov |
| NCT05999994 | A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for… | Phase2 | Neoplasms | Recruiting | 2020-01-22 | 2027-05-01 | ClinicalTrials.gov |
| NCT04145349 | CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With … | Phase1 | Desmoplastic Small Round Cell Tumor | Completed | 2020-01-22 | 2026-01-23 | ClinicalTrials.gov |
| NCT04145349 | CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With … | Phase1 | Desmoplastic Small Round Cell Tumor | Completed | 2020-01-22 | 2026-01-23 | ClinicalTrials.gov |
| NCT05999994 | A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for… | Phase2 | Neoplasms | Recruiting | 2020-01-22 | 2027-05-01 | ClinicalTrials.gov |
| NCT04243096 | Wearable Sensors in Knee OA | Na | Knee Osteoarthritis | Completed | 2020-01-21 | 2022-11-04 | ClinicalTrials.gov |
| NCT04243096 | Wearable Sensors in Knee OA | Na | Knee Osteoarthritis | Completed | 2020-01-21 | 2022-11-04 | ClinicalTrials.gov |
| NCT04148937 | A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizu… | Phase1 | Advanced Cancer | Completed | 2020-01-16 | 2022-06-20 | ClinicalTrials.gov |
| NCT04148937 | A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizu… | Phase1 | Advanced Cancer | Completed | 2020-01-16 | 2022-06-20 | ClinicalTrials.gov |
| NCT04106362 | Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients … | Phase2 | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Terminated | 2020-01-14 | 2023-05-23 | ClinicalTrials.gov |
| NCT04106362 | Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients … | Phase2 | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Terminated | 2020-01-14 | 2023-05-23 | ClinicalTrials.gov |
| NCT04178733 | A Safety Study of LY3493269 Given as a Single Injection in Healthy Participants | Phase1 | Healthy | Completed | 2020-01-10 | 2020-05-11 | ClinicalTrials.gov |
| NCT04178733 | A Safety Study of LY3493269 Given as a Single Injection in Healthy Participants | Phase1 | Healthy | Completed | 2020-01-10 | 2020-05-11 | ClinicalTrials.gov |
| NCT04127578 | Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Dis… | Phase1 | Parkinson Disease | Active_Not_Recruiting | 2020-01-03 | 2030-12-31 | ClinicalTrials.gov |
| NCT04127578 | Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Dis… | Phase1 | Parkinson Disease | Active_Not_Recruiting | 2020-01-03 | 2030-12-31 | ClinicalTrials.gov |
| NCT04031872 | LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal … | Phase1 | Colorectal Cancer Metastatic | Withdrawn | 2020-01-01 | 2020-01-01 | ClinicalTrials.gov |
| NCT04031872 | LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal … | Phase1 | Colorectal Cancer Metastatic | Withdrawn | 2020-01-01 | 2020-01-01 | ClinicalTrials.gov |
| NCT04161976 | A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes … | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2019-12-27 | 2020-07-14 | ClinicalTrials.gov |
| NCT04161976 | A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes … | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2019-12-27 | 2020-07-14 | ClinicalTrials.gov |
| NCT04071262 | A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therap… | Phase1 | Advanced Cancer | Completed | 2019-12-20 | 2021-08-30 | ClinicalTrials.gov |
| NCT04071262 | A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therap… | Phase1 | Advanced Cancer | Completed | 2019-12-20 | 2021-08-30 | ClinicalTrials.gov |
| NCT04143802 | A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM) | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2019-12-18 | 2020-12-28 | ClinicalTrials.gov |
| NCT04143802 | A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM) | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2019-12-18 | 2020-12-28 | ClinicalTrials.gov |
| NCT04153981 | A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabe… | Phase4 | Type 2 Diabetes Mellitus | Completed | 2019-12-16 | 2021-07-30 | ClinicalTrials.gov |
| NCT04153981 | A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabe… | Phase4 | Type 2 Diabetes Mellitus | Completed | 2019-12-16 | 2021-07-30 | ClinicalTrials.gov |
| NCT04183283 | A Study of LY3526318 in Healthy Women | Phase1 | Healthy | Completed | 2019-12-12 | 2020-03-06 | ClinicalTrials.gov |
| NCT04183283 | A Study of LY3526318 in Healthy Women | Phase1 | Healthy | Completed | 2019-12-12 | 2020-03-06 | ClinicalTrials.gov |
| NCT04188548 | A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer … | Phase1 | Breast Cancer | Active_Not_Recruiting | 2019-12-10 | 2027-12-01 | ClinicalTrials.gov |
| NCT04188548 | A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer … | Phase1 | Breast Cancer | Active_Not_Recruiting | 2019-12-10 | 2027-12-01 | ClinicalTrials.gov |
| NCT04093752 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metf… | Phase3 | Type 2 Diabetes | Completed | 2019-12-09 | 2021-11-24 | ClinicalTrials.gov |
| NCT04093752 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metf… | Phase3 | Type 2 Diabetes | Completed | 2019-12-09 | 2021-11-24 | ClinicalTrials.gov |
| NCT04158700 | A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Withdrawn | 2019-12-05 | 2023-05-11 | ClinicalTrials.gov |
| NCT04158700 | A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Withdrawn | 2019-12-05 | 2023-05-11 | ClinicalTrials.gov |
| NCT04137380 | A Study of Mirikizumab in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2019-12-04 | 2020-12-11 | ClinicalTrials.gov |
| NCT03993847 | CLassification of Axial SpondyloarthritiS Inception Cohort | — | Spondyloarthritis | Completed | 2019-12-04 | 2022-08-22 | ClinicalTrials.gov |
| NCT04184622 | A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight | Phase3 | Overweight | Completed | 2019-12-04 | 2024-07-06 | ClinicalTrials.gov |
| NCT04081350 | A Study of LY3471851 in Participants With Eczema | Phase1 | Dermatitis, Atopic | Completed | 2019-12-04 | 2022-06-24 | ClinicalTrials.gov |
| NCT04137380 | A Study of Mirikizumab in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2019-12-04 | 2020-12-11 | ClinicalTrials.gov |
| NCT04184622 | A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight | Phase3 | Overweight | Completed | 2019-12-04 | 2024-07-06 | ClinicalTrials.gov |
| NCT04081350 | A Study of LY3471851 in Participants With Eczema | Phase1 | Dermatitis, Atopic | Completed | 2019-12-04 | 2022-06-24 | ClinicalTrials.gov |
| NCT03993847 | CLassification of Axial SpondyloarthritiS Inception Cohort | — | Spondyloarthritis | Completed | 2019-12-04 | 2022-08-22 | ClinicalTrials.gov |
| NCT04040361 | Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-… | Phase2 | Non-small Cell Lung Cancer Stage IB | Unknown | 2019-11-30 | 2025-11-30 | ClinicalTrials.gov |
| NCT04040361 | Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-… | Phase2 | Non-small Cell Lung Cancer Stage IB | Unknown | 2019-11-30 | 2025-11-30 | ClinicalTrials.gov |
| NCT04047940 | A Study of LY900020 in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2019-11-29 | 2020-02-18 | ClinicalTrials.gov |
| NCT04047940 | A Study of LY900020 in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2019-11-29 | 2020-02-18 | ClinicalTrials.gov |
| NCT04165031 | A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C … | Phase1 | Advanced Solid Tumor | Terminated | 2019-11-28 | 2020-10-30 | ClinicalTrials.gov |
| NCT04165031 | A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C … | Phase1 | Advanced Solid Tumor | Terminated | 2019-11-28 | 2020-10-30 | ClinicalTrials.gov |
| NCT04119557 | A Study of LY3471851 in Participants With Psoriasis | Phase1 | Psoriasis | Completed | 2019-11-26 | 2021-07-21 | ClinicalTrials.gov |
| NCT04119557 | A Study of LY3471851 in Participants With Psoriasis | Phase1 | Psoriasis | Completed | 2019-11-26 | 2021-07-21 | ClinicalTrials.gov |
| NCT04152382 | A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis | Phase1 | Psoriasis | Terminated | 2019-11-20 | 2022-02-09 | ClinicalTrials.gov |
| NCT04156750 | A Study of LY3556050 in Healthy Participants | Phase1 | Healthy | Completed | 2019-11-20 | 2020-08-03 | ClinicalTrials.gov |
| NCT04085289 | A Study of Galcanezumab (LY2951742) in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2019-11-20 | 2020-05-21 | ClinicalTrials.gov |
| NCT04085289 | A Study of Galcanezumab (LY2951742) in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2019-11-20 | 2020-05-21 | ClinicalTrials.gov |
| NCT04152382 | A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis | Phase1 | Psoriasis | Terminated | 2019-11-20 | 2022-02-09 | ClinicalTrials.gov |
| NCT04156750 | A Study of LY3556050 in Healthy Participants | Phase1 | Healthy | Completed | 2019-11-20 | 2020-08-03 | ClinicalTrials.gov |
| NCT04166773 | A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepa… | Phase2 | Nonalcoholic Steatohepatitis | Completed | 2019-11-19 | 2024-01-10 | ClinicalTrials.gov |
| NCT04166773 | A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepa… | Phase2 | Nonalcoholic Steatohepatitis | Completed | 2019-11-19 | 2024-01-10 | ClinicalTrials.gov |
| NCT04049123 | A Study of LY900014 in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2019-11-18 | 2020-10-23 | ClinicalTrials.gov |
| NCT04049123 | A Study of LY900014 in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2019-11-18 | 2020-10-23 | ClinicalTrials.gov |
| NCT04159701 | A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria | Phase2 | Chronic Spontaneous Urticaria | Terminated | 2019-11-15 | 2021-02-24 | ClinicalTrials.gov |
| NCT04159701 | A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria | Phase2 | Chronic Spontaneous Urticaria | Terminated | 2019-11-15 | 2021-02-24 | ClinicalTrials.gov |
| NCT04081324 | A Study of Lasmiditan in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2019-11-13 | 2020-06-15 | ClinicalTrials.gov |
| NCT04081324 | A Study of Lasmiditan in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2019-11-13 | 2020-06-15 | ClinicalTrials.gov |
| NCT03891784 | Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Di… | Phase2 | Advanced Digestive System Neuroendocrine Neoplasm | Active_Not_Recruiting | 2019-10-31 | 2026-07-01 | ClinicalTrials.gov |
| NCT03891784 | Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Di… | Phase2 | Advanced Digestive System Neuroendocrine Neoplasm | Active_Not_Recruiting | 2019-10-31 | 2026-07-01 | ClinicalTrials.gov |
| NCT04133116 | A Study of LY3471851 in Healthy Participants | Phase1 | Healthy | Completed | 2019-10-29 | 2020-03-06 | ClinicalTrials.gov |
| NCT04178967 | Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate t… | Phase3 | Atopic Dermatitis | Completed | 2019-10-29 | 2022-04-28 | ClinicalTrials.gov |
| NCT04133116 | A Study of LY3471851 in Healthy Participants | Phase1 | Healthy | Completed | 2019-10-29 | 2020-03-06 | ClinicalTrials.gov |
| NCT04178967 | Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate t… | Phase3 | Atopic Dermatitis | Completed | 2019-10-29 | 2022-04-28 | ClinicalTrials.gov |
| NCT04099277 | A Study of LY3435151 in Participants With Solid Tumors | Phase1 | Solid Tumor | Terminated | 2019-10-28 | 2020-03-05 | ClinicalTrials.gov |
| NCT04099277 | A Study of LY3435151 in Participants With Solid Tumors | Phase1 | Solid Tumor | Terminated | 2019-10-28 | 2020-03-05 | ClinicalTrials.gov |
| NCT03928379 | A Study of LY3305677 in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2019-10-27 | 2021-07-08 | ClinicalTrials.gov |
| NCT03928379 | A Study of LY3305677 in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2019-10-27 | 2021-07-08 | ClinicalTrials.gov |
| NCT04106206 | A Safety Study of LY3372689 in Healthy Participants | Phase1 | Healthy | Completed | 2019-10-23 | 2020-02-12 | ClinicalTrials.gov |
| NCT04106206 | A Safety Study of LY3372689 in Healthy Participants | Phase1 | Healthy | Completed | 2019-10-23 | 2020-02-12 | ClinicalTrials.gov |
| NCT03994796 | Genetic Testing in Guiding Treatment for Patients With Brain Metastases | Phase2 | CDK Gene Mutation | Active_Not_Recruiting | 2019-10-17 | 2028-06-01 | ClinicalTrials.gov |
| NCT03994796 | Genetic Testing in Guiding Treatment for Patients With Brain Metastases | Phase2 | CDK Gene Mutation | Active_Not_Recruiting | 2019-10-17 | 2028-06-01 | ClinicalTrials.gov |
| NCT04088409 | A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18… | Phase3 | Uveitis | Active_Not_Recruiting | 2019-10-16 | 2028-07-01 | ClinicalTrials.gov |
| NCT04088409 | A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18… | Phase3 | Uveitis | Active_Not_Recruiting | 2019-10-16 | 2028-07-01 | ClinicalTrials.gov |
| NCT04088032 | Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early … | Early_Phase1 | Breast Cancer Female | Withdrawn | 2019-10-01 | 2020-12-31 | ClinicalTrials.gov |
| NCT04088032 | Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early … | Early_Phase1 | Breast Cancer Female | Withdrawn | 2019-10-01 | 2020-12-31 | ClinicalTrials.gov |
| NCT04146363 | Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate t… | Phase3 | Atopic Dermatitis | Completed | 2019-09-24 | 2022-05-03 | ClinicalTrials.gov |
| NCT04146363 | Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate t… | Phase3 | Atopic Dermatitis | Completed | 2019-09-24 | 2022-05-03 | ClinicalTrials.gov |
| NCT03988114 | A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Bre… | Phase4 | Metastatic Breast Cancer | Withdrawn | 2019-09-16 | 2023-03-23 | ClinicalTrials.gov |
| NCT03988114 | A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Bre… | Phase4 | Metastatic Breast Cancer | Withdrawn | 2019-09-16 | 2023-03-23 | ClinicalTrials.gov |
| NCT04050670 | A Study of Tirzepatide at Different Injection Sites in Participants With Differ… | Phase1 | Healthy | Completed | 2019-09-13 | 2020-04-03 | ClinicalTrials.gov |
| NCT04050670 | A Study of Tirzepatide at Different Injection Sites in Participants With Differ… | Phase1 | Healthy | Completed | 2019-09-13 | 2020-04-03 | ClinicalTrials.gov |
| NCT03843125 | A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) | Phase3 | Systemic Lupus Erythematosus | Terminated | 2019-09-09 | 2022-04-01 | ClinicalTrials.gov |
| NCT03843125 | A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) | Phase3 | Systemic Lupus Erythematosus | Terminated | 2019-09-09 | 2022-04-01 | ClinicalTrials.gov |
| NCT03955042 | Pemetrexed for the Treatment of Chordoma | Phase1 | Chordoma | Completed | 2019-09-06 | 2023-01-18 | ClinicalTrials.gov |
| NCT03955042 | Pemetrexed for the Treatment of Chordoma | Phase1 | Chordoma | Completed | 2019-09-06 | 2023-01-18 | ClinicalTrials.gov |
| NCT04032080 | LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer | Phase2 | Triple Negative Breast Cancer | Completed | 2019-09-05 | 2022-11-26 | ClinicalTrials.gov |
| NCT04032080 | LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer | Phase2 | Triple Negative Breast Cancer | Completed | 2019-09-05 | 2022-11-26 | ClinicalTrials.gov |
| NCT04052594 | A Study of LY3475766 in Healthy Participants | Phase1 | Dyslipidemias | Completed | 2019-09-03 | 2021-03-31 | ClinicalTrials.gov |
| NCT04052594 | A Study of LY3475766 in Healthy Participants | Phase1 | Dyslipidemias | Completed | 2019-09-03 | 2021-03-31 | ClinicalTrials.gov |
| NCT03648554 | Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST) | Phase4 | Diabetes Mellitus, Type 2 | Unknown | 2019-09-01 | 2024-03-30 | ClinicalTrials.gov |
| NCT03648554 | Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST) | Phase4 | Diabetes Mellitus, Type 2 | Unknown | 2019-09-01 | 2024-03-30 | ClinicalTrials.gov |
| NCT04039503 | A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 D… | Phase3 | Type 2 Diabetes | Completed | 2019-08-30 | 2021-01-13 | ClinicalTrials.gov |
| NCT04039503 | A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 D… | Phase3 | Type 2 Diabetes | Completed | 2019-08-30 | 2021-01-13 | ClinicalTrials.gov |
| NCT03997448 | Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Ga… | Phase2 | Gastroesophageal Cancer | Terminated | 2019-08-26 | 2020-01-30 | ClinicalTrials.gov |
| NCT03997448 | Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Ga… | Phase2 | Gastroesophageal Cancer | Terminated | 2019-08-26 | 2020-01-30 | ClinicalTrials.gov |
| NCT04004988 | A Study of Tirzepatide Administered by Two Different Devices in Healthy Partici… | Phase1 | Healthy | Completed | 2019-08-19 | 2019-12-16 | ClinicalTrials.gov |
| NCT04004988 | A Study of Tirzepatide Administered by Two Different Devices in Healthy Partici… | Phase1 | Healthy | Completed | 2019-08-19 | 2019-12-16 | ClinicalTrials.gov |
| NCT04031885 | A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to … | Phase4 | Metastatic Breast Cancer | Terminated | 2019-08-14 | 2020-08-11 | ClinicalTrials.gov |
| NCT04031885 | A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to … | Phase4 | Metastatic Breast Cancer | Terminated | 2019-08-14 | 2020-08-11 | ClinicalTrials.gov |
| NCT03531645 | Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma | Phase2 | Malignant Neoplasms of Female Genital Organs | Active_Not_Recruiting | 2019-08-13 | 2027-09-30 | ClinicalTrials.gov |
| NCT03531645 | Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma | Phase2 | Malignant Neoplasms of Female Genital Organs | Active_Not_Recruiting | 2019-08-13 | 2027-09-30 | ClinicalTrials.gov |
| NCT04014361 | A Study of LY3154885 in Healthy Participants | Phase1 | Healthy | Terminated | 2019-08-09 | 2020-02-09 | ClinicalTrials.gov |
| NCT04014361 | A Study of LY3154885 in Healthy Participants | Phase1 | Healthy | Terminated | 2019-08-09 | 2020-02-09 | ClinicalTrials.gov |
| NCT04023669 | Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcita… | Phase1 | Brain Tumor | Completed | 2019-08-08 | 2025-01-13 | ClinicalTrials.gov |
| NCT04023669 | Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcita… | Phase1 | Brain Tumor | Completed | 2019-08-08 | 2025-01-13 | ClinicalTrials.gov |
| NCT03955939 | A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Sprea… | Phase1 | Metastatic Breast Cancer | Completed | 2019-08-02 | 2020-05-14 | ClinicalTrials.gov |
| NCT03955939 | A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Sprea… | Phase1 | Metastatic Breast Cancer | Completed | 2019-08-02 | 2020-05-14 | ClinicalTrials.gov |
| NCT04033341 | A Study of LY3214996 in Healthy Participants | Phase1 | Healthy | Completed | 2019-08-01 | 2019-09-09 | ClinicalTrials.gov |
| NCT04033341 | A Study of LY3214996 in Healthy Participants | Phase1 | Healthy | Completed | 2019-08-01 | 2019-09-09 | ClinicalTrials.gov |
| NCT03963232 | A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine | Phase3 | Episodic Migraine | Completed | 2019-07-30 | 2022-03-11 | ClinicalTrials.gov |
| NCT03987919 | A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on The… | Phase3 | Type 2 Diabetes | Completed | 2019-07-30 | 2021-02-15 | ClinicalTrials.gov |
| NCT03963232 | A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine | Phase3 | Episodic Migraine | Completed | 2019-07-30 | 2022-03-11 | ClinicalTrials.gov |
| NCT03987919 | A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on The… | Phase3 | Type 2 Diabetes | Completed | 2019-07-30 | 2021-02-15 | ClinicalTrials.gov |
| NCT03936660 | A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and Hi… | Na | Diabetes Mellitus, Type 2 | Completed | 2019-07-25 | 2022-12-30 | ClinicalTrials.gov |
| NCT03909334 | Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metast… | Phase2 | Non Small Cell Lung Cancer | Active_Not_Recruiting | 2019-07-25 | 2027-01-01 | ClinicalTrials.gov |
| NCT03936660 | A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and Hi… | Na | Diabetes Mellitus, Type 2 | Completed | 2019-07-25 | 2022-12-30 | ClinicalTrials.gov |
| NCT03909334 | Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metast… | Phase2 | Non Small Cell Lung Cancer | Active_Not_Recruiting | 2019-07-25 | 2027-01-01 | ClinicalTrials.gov |
| NCT03926130 | A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease | Phase3 | Crohn's Disease | Completed | 2019-07-23 | 2023-10-02 | ClinicalTrials.gov |
| NCT03926130 | A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease | Phase3 | Crohn's Disease | Completed | 2019-07-23 | 2023-10-02 | ClinicalTrials.gov |
| NCT03940742 | A Study of Tirzepatide in Participants With Impaired Liver Function | Phase1 | Hepatic Insufficiency | Completed | 2019-07-22 | 2020-09-22 | ClinicalTrials.gov |
| NCT03988088 | A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine | Phase1 | Migraine | Completed | 2019-07-22 | 2020-02-24 | ClinicalTrials.gov |
| NCT03940742 | A Study of Tirzepatide in Participants With Impaired Liver Function | Phase1 | Hepatic Insufficiency | Completed | 2019-07-22 | 2020-09-22 | ClinicalTrials.gov |
| NCT03988088 | A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine | Phase1 | Migraine | Completed | 2019-07-22 | 2020-02-24 | ClinicalTrials.gov |
| NCT03898791 | A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell L… | Phase1 | Small Cell Lung Cancer | Completed | 2019-07-16 | 2021-03-30 | ClinicalTrials.gov |
| NCT03898791 | A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell L… | Phase1 | Small Cell Lung Cancer | Completed | 2019-07-16 | 2021-03-30 | ClinicalTrials.gov |
| NCT03899259 | A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopeci… | Phase3 | Alopecia Areata | Completed | 2019-07-08 | 2024-11-19 | ClinicalTrials.gov |
| NCT03899259 | A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopeci… | Phase3 | Alopecia Areata | Completed | 2019-07-08 | 2024-11-19 | ClinicalTrials.gov |
| NCT05338502 | Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy … | Phase1 | Healthy | Completed | 2019-07-08 | 2019-09-03 | ClinicalTrials.gov |
| NCT05338502 | Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy … | Phase1 | Healthy | Completed | 2019-07-08 | 2019-09-03 | ClinicalTrials.gov |
| NCT03942042 | A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pus… | Phase4 | Generalized Pustular Psoriasis | Completed | 2019-07-05 | 2020-07-22 | ClinicalTrials.gov |
| NCT03942042 | A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pus… | Phase4 | Generalized Pustular Psoriasis | Completed | 2019-07-05 | 2020-07-22 | ClinicalTrials.gov |
| NCT03997981 | Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY) | — | Chemotherapy-induced Peripheral Neuropathy | Unknown | 2019-07-03 | 2024-04-09 | ClinicalTrials.gov |
| NCT03997981 | Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY) | — | Chemotherapy-induced Peripheral Neuropathy | Unknown | 2019-07-03 | 2024-04-09 | ClinicalTrials.gov |
| NCT03951753 | A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM) | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2019-06-28 | 2021-04-08 | ClinicalTrials.gov |
| NCT03951753 | A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM) | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2019-06-28 | 2021-04-08 | ClinicalTrials.gov |
| NCT03670810 | A Study of Lasmiditan (LY573144) Over Four Migraine Attacks | Phase3 | Migraine | Completed | 2019-06-24 | 2021-07-08 | ClinicalTrials.gov |
| NCT03670810 | A Study of Lasmiditan (LY573144) Over Four Migraine Attacks | Phase3 | Migraine | Completed | 2019-06-24 | 2021-07-08 | ClinicalTrials.gov |
| NCT03977974 | A Study of LY3526318 in Healthy Participants | Phase1 | Healthy | Terminated | 2019-06-21 | 2020-03-05 | ClinicalTrials.gov |
| NCT03942029 | A Drug Interaction Study of LY3154207 in Healthy Participants | Phase1 | Healthy | Completed | 2019-06-21 | 2019-12-28 | ClinicalTrials.gov |
| NCT03977974 | A Study of LY3526318 in Healthy Participants | Phase1 | Healthy | Terminated | 2019-06-21 | 2020-03-05 | ClinicalTrials.gov |
| NCT03942029 | A Drug Interaction Study of LY3154207 in Healthy Participants | Phase1 | Healthy | Completed | 2019-06-21 | 2019-12-28 | ClinicalTrials.gov |
| NCT04612257 | Assessing Closed-loop Insulin Delivery in Children With Type 1 Diabetes. | Na | Diabetes Mellitus, Type 1 | Terminated | 2019-06-18 | 2022-06-13 | ClinicalTrials.gov |
| NCT04612257 | Assessing Closed-loop Insulin Delivery in Children With Type 1 Diabetes. | Na | Diabetes Mellitus, Type 1 | Terminated | 2019-06-18 | 2022-06-13 | ClinicalTrials.gov |
| NCT03899792 | A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advance… | Phase1 | Medullary Thyroid Cancer | Active_Not_Recruiting | 2019-06-13 | 2029-05-01 | ClinicalTrials.gov |
| NCT03899792 | A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advance… | Phase1 | Medullary Thyroid Cancer | Active_Not_Recruiting | 2019-06-13 | 2029-05-01 | ClinicalTrials.gov |
| NCT03929744 | A Study of LY3502970 in Healthy Participants | Phase1 | Healthy | Completed | 2019-06-12 | 2020-11-02 | ClinicalTrials.gov |
| NCT03929744 | A Study of LY3502970 in Healthy Participants | Phase1 | Healthy | Completed | 2019-06-12 | 2020-11-02 | ClinicalTrials.gov |
| NCT03905889 | A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell C… | Phase1 | Renal Cell Carcinoma Metastatic | Terminated | 2019-06-05 | 2022-03-08 | ClinicalTrials.gov |
| NCT03689855 | Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker… | Phase2 | Non-small Cell Lung Cancer | Completed | 2019-06-05 | 2024-04-22 | ClinicalTrials.gov |
| NCT03689855 | Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker… | Phase2 | Non-small Cell Lung Cancer | Completed | 2019-06-05 | 2024-04-22 | ClinicalTrials.gov |
| NCT03905889 | A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell C… | Phase1 | Renal Cell Carcinoma Metastatic | Terminated | 2019-06-05 | 2022-03-08 | ClinicalTrials.gov |
| NCT03921554 | JAK Inhibitor Treatment in AGS | Phase2 | Aicardi Goutieres Syndrome | Completed | 2019-06-03 | 2024-03-25 | ClinicalTrials.gov |
| NCT03954834 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Con… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2019-06-03 | 2020-10-28 | ClinicalTrials.gov |
| NCT03954834 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Con… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2019-06-03 | 2020-10-28 | ClinicalTrials.gov |
| NCT03921554 | JAK Inhibitor Treatment in AGS | Phase2 | Aicardi Goutieres Syndrome | Completed | 2019-06-03 | 2024-03-25 | ClinicalTrials.gov |
| NCT03962738 | A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participa… | Phase2 | Migraine | Completed | 2019-05-31 | 2020-06-08 | ClinicalTrials.gov |
| NCT03962738 | A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participa… | Phase2 | Migraine | Completed | 2019-05-31 | 2020-06-08 | ClinicalTrials.gov |
| NCT03655444 | Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squ… | Phase1 | Head and Neck Squamous Cell Carcinoma | Terminated | 2019-05-29 | 2020-08-24 | ClinicalTrials.gov |
| NCT03650764 | Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck… | Phase1 | Head and Neck Squamous Cell Carcinoma | Completed | 2019-05-29 | 2026-05-11 | ClinicalTrials.gov |
| NCT03655444 | Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squ… | Phase1 | Head and Neck Squamous Cell Carcinoma | Terminated | 2019-05-29 | 2020-08-24 | ClinicalTrials.gov |
| NCT03952130 | A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 … | Phase3 | Type 1 Diabetes Mellitus | Completed | 2019-05-29 | 2022-01-10 | ClinicalTrials.gov |
| NCT03952130 | A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 … | Phase3 | Type 1 Diabetes Mellitus | Completed | 2019-05-29 | 2022-01-10 | ClinicalTrials.gov |
| NCT03650764 | Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck… | Phase1 | Head and Neck Squamous Cell Carcinoma | Completed | 2019-05-29 | 2026-05-11 | ClinicalTrials.gov |
| NCT03952143 | A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 … | Phase3 | Type 2 Diabetes Mellitus | Completed | 2019-05-27 | 2021-01-20 | ClinicalTrials.gov |
| NCT03952143 | A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 … | Phase3 | Type 2 Diabetes Mellitus | Completed | 2019-05-27 | 2021-01-20 | ClinicalTrials.gov |
| NCT03936959 | A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer | Phase1 | Advanced Cancer | Terminated | 2019-05-24 | 2021-04-29 | ClinicalTrials.gov |
| NCT03952559 | A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Derm… | Phase3 | Atopic Dermatitis | Active_Not_Recruiting | 2019-05-24 | 2026-05-01 | ClinicalTrials.gov |
| NCT03936959 | A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer | Phase1 | Advanced Cancer | Terminated | 2019-05-24 | 2021-04-29 | ClinicalTrials.gov |
| NCT03952559 | A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Derm… | Phase3 | Atopic Dermatitis | Active_Not_Recruiting | 2019-05-24 | 2026-05-01 | ClinicalTrials.gov |
| NCT03933943 | A Study of LY3361237 in Participants With Systemic Lupus Erythematosus | Phase1 | Lupus Erythematosus, Systemic | Completed | 2019-05-21 | 2021-02-15 | ClinicalTrials.gov |
| NCT03933943 | A Study of LY3361237 in Participants With Systemic Lupus Erythematosus | Phase1 | Lupus Erythematosus, Systemic | Completed | 2019-05-21 | 2021-02-15 | ClinicalTrials.gov |
| NCT03626922 | Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Meta… | Phase1 | Metastatic Colorectal Cancer | Unknown | 2019-05-15 | 2022-11-01 | ClinicalTrials.gov |
| NCT03626922 | Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Meta… | Phase1 | Metastatic Colorectal Cancer | Unknown | 2019-05-15 | 2022-11-01 | ClinicalTrials.gov |
| NCT04016584 | Diabetes Pueblo Program - Application and Acceptability of Culturally Appropria… | Na | Type2 Diabetes | Completed | 2019-05-10 | 2020-02-25 | ClinicalTrials.gov |
| NCT04016584 | Diabetes Pueblo Program - Application and Acceptability of Culturally Appropria… | Na | Type2 Diabetes | Completed | 2019-05-10 | 2020-02-25 | ClinicalTrials.gov |
| NCT03944031 | A Study of the Effects of LY3372689 on the Brain in Healthy Participants | Phase1 | Healthy | Completed | 2019-05-08 | 2020-02-19 | ClinicalTrials.gov |
| NCT03944031 | A Study of the Effects of LY3372689 on the Brain in Healthy Participants | Phase1 | Healthy | Completed | 2019-05-08 | 2020-02-19 | ClinicalTrials.gov |
| NCT03861052 | A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With… | Phase3 | Type 2 Diabetes | Completed | 2019-05-07 | 2021-03-31 | ClinicalTrials.gov |
| NCT03861052 | A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With… | Phase3 | Type 2 Diabetes | Completed | 2019-05-07 | 2021-03-31 | ClinicalTrials.gov |
| NCT03913260 | A Study of Different Injectable Formulations of LY3375880 in Healthy Participan… | Phase1 | Healthy | Completed | 2019-05-01 | 2019-09-19 | ClinicalTrials.gov |
| NCT03913260 | A Study of Different Injectable Formulations of LY3375880 in Healthy Participan… | Phase1 | Healthy | Completed | 2019-05-01 | 2019-09-19 | ClinicalTrials.gov |
| NCT03915964 | A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis | Phase4 | Rheumatoid Arthritis | Completed | 2019-04-25 | 2025-05-28 | ClinicalTrials.gov |
| NCT03915964 | A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis | Phase4 | Rheumatoid Arthritis | Completed | 2019-04-25 | 2025-05-28 | ClinicalTrials.gov |
| NCT05630274 | A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval i… | Phase1 | Healthy | Completed | 2019-04-16 | 2019-06-21 | ClinicalTrials.gov |
| NCT05630274 | A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval i… | Phase1 | Healthy | Completed | 2019-04-16 | 2019-06-21 | ClinicalTrials.gov |
| NCT03740919 | A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolesce… | Phase3 | Type 1 Diabetes Mellitus | Completed | 2019-04-07 | 2021-07-02 | ClinicalTrials.gov |
| NCT03740919 | A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolesce… | Phase3 | Type 1 Diabetes Mellitus | Completed | 2019-04-07 | 2021-07-02 | ClinicalTrials.gov |
| NCT03773965 | A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old Wi… | Phase3 | Juvenile Idiopathic Arthritis | Recruiting | 2019-04-05 | 2031-07-01 | ClinicalTrials.gov |
| NCT03773965 | A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old Wi… | Phase3 | Juvenile Idiopathic Arthritis | Recruiting | 2019-04-05 | 2031-07-01 | ClinicalTrials.gov |
| NCT03882970 | A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2019-04-01 | 2021-01-04 | ClinicalTrials.gov |
| NCT03882970 | A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2019-04-01 | 2021-01-04 | ClinicalTrials.gov |
| NCT03732703 | Myeloma-Developing Regimens Using Genomics (MyDRUG) | Phase1 | Relapsed Refractory Multiple Myeloma | Completed | 2019-04-01 | 2024-12-31 | ClinicalTrials.gov |
| NCT03732703 | Myeloma-Developing Regimens Using Genomics (MyDRUG) | Phase1 | Relapsed Refractory Multiple Myeloma | Completed | 2019-04-01 | 2024-12-31 | ClinicalTrials.gov |
| NCT03861039 | A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2019-03-30 | 2021-02-16 | ClinicalTrials.gov |
| NCT03861039 | A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2019-03-30 | 2021-02-16 | ClinicalTrials.gov |
| NCT03742973 | A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholang… | Phase2 | Primary Biliary Cholangitis | Terminated | 2019-03-28 | 2019-09-26 | ClinicalTrials.gov |
| NCT03890003 | A Study of an Automated Insulin Delivery System in Adult Participants With Type… | Na | Type 1 Diabetes Mellitus | Completed | 2019-03-28 | 2019-05-06 | ClinicalTrials.gov |
| NCT03890003 | A Study of an Automated Insulin Delivery System in Adult Participants With Type… | Na | Type 1 Diabetes Mellitus | Completed | 2019-03-28 | 2019-05-06 | ClinicalTrials.gov |
| NCT03742973 | A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholang… | Phase2 | Primary Biliary Cholangitis | Terminated | 2019-03-28 | 2019-09-26 | ClinicalTrials.gov |
| NCT03886948 | A Study of Injections of LY3074828 in Healthy Participants | Phase1 | Healthy | Completed | 2019-03-27 | 2019-10-04 | ClinicalTrials.gov |
| NCT03886948 | A Study of Injections of LY3074828 in Healthy Participants | Phase1 | Healthy | Completed | 2019-03-27 | 2019-10-04 | ClinicalTrials.gov |
| NCT03740529 | A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL | Phase1 | Chronic Lymphocytic Leukemia | Completed | 2019-03-15 | 2025-12-23 | ClinicalTrials.gov |
| NCT03740529 | A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL | Phase1 | Chronic Lymphocytic Leukemia | Completed | 2019-03-15 | 2025-12-23 | ClinicalTrials.gov |
| NCT03841630 | A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants | Phase1 | Healthy | Completed | 2019-03-13 | 2019-07-25 | ClinicalTrials.gov |
| NCT03841630 | A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants | Phase1 | Healthy | Completed | 2019-03-13 | 2019-07-25 | ClinicalTrials.gov |
| NCT03762564 | Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma … | Phase2 | Squamous Cell Carcinoma of the Esophagus | Completed | 2019-03-08 | 2022-11-25 | ClinicalTrials.gov |
| NCT03762564 | Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma … | Phase2 | Squamous Cell Carcinoma of the Esophagus | Completed | 2019-03-08 | 2022-11-25 | ClinicalTrials.gov |
| NCT03849612 | A Study of an Automated Insulin Delivery System in Adult Participants With Type… | Na | Type 1 Diabetes Mellitus | Completed | 2019-02-21 | 2019-03-27 | ClinicalTrials.gov |
| NCT03849612 | A Study of an Automated Insulin Delivery System in Adult Participants With Type… | Na | Type 1 Diabetes Mellitus | Completed | 2019-02-21 | 2019-03-27 | ClinicalTrials.gov |
| NCT03848767 | A Study of an Automated Insulin Delivery System in Adult Participants With Type… | Na | Type 1 Diabetes Mellitus | Completed | 2019-02-20 | 2019-04-01 | ClinicalTrials.gov |
| NCT03848767 | A Study of an Automated Insulin Delivery System in Adult Participants With Type… | Na | Type 1 Diabetes Mellitus | Completed | 2019-02-20 | 2019-04-01 | ClinicalTrials.gov |
| NCT03760640 | A Study of LY900014 in a Medtronic Pump | Phase2 | Type1 Diabetes Mellitus | Completed | 2019-02-18 | 2019-10-07 | ClinicalTrials.gov |
| NCT03760640 | A Study of LY900014 in a Medtronic Pump | Phase2 | Type1 Diabetes Mellitus | Completed | 2019-02-18 | 2019-10-07 | ClinicalTrials.gov |
| NCT03830281 | A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Di… | Phase3 | Type 1 Diabetes Mellitus | Completed | 2019-02-14 | 2020-01-06 | ClinicalTrials.gov |
| NCT03830281 | A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Di… | Phase3 | Type 1 Diabetes Mellitus | Completed | 2019-02-14 | 2020-01-06 | ClinicalTrials.gov |
| NCT03831191 | A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis | Phase2 | Atopic Dermatitis | Terminated | 2019-02-12 | 2020-02-27 | ClinicalTrials.gov |
| NCT03831191 | A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis | Phase2 | Atopic Dermatitis | Terminated | 2019-02-12 | 2020-02-27 | ClinicalTrials.gov |
| NCT05338515 | A Study of Selpercatinib (LY3527723) in Healthy Participants | Phase1 | Healthy | Completed | 2019-02-12 | 2019-03-26 | ClinicalTrials.gov |
| NCT05338515 | A Study of Selpercatinib (LY3527723) in Healthy Participants | Phase1 | Healthy | Completed | 2019-02-12 | 2019-03-26 | ClinicalTrials.gov |
| NCT03652272 | Development and Evaluation of an Electronic Health Record-based Medication Comp… | Na | Medication Adherence | Completed | 2019-02-08 | 2021-09-27 | ClinicalTrials.gov |
| NCT03652272 | Development and Evaluation of an Electronic Health Record-based Medication Comp… | Na | Medication Adherence | Completed | 2019-02-08 | 2021-09-27 | ClinicalTrials.gov |
| NCT03758430 | A Study of Technology to Improve Glucose Control in Participants With Type 1 Di… | — | Diabetes Mellitus, Type 1 | Completed | 2019-02-06 | 2020-08-07 | ClinicalTrials.gov |
| NCT03758430 | A Study of Technology to Improve Glucose Control in Participants With Type 1 Di… | — | Diabetes Mellitus, Type 1 | Completed | 2019-02-06 | 2020-08-07 | ClinicalTrials.gov |
| NCT03837821 | (CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer | Early_Phase1 | Bladder Cancer | Active_Not_Recruiting | 2019-02-05 | 2026-12-01 | ClinicalTrials.gov |
| NCT03837821 | (CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer | Early_Phase1 | Bladder Cancer | Active_Not_Recruiting | 2019-02-05 | 2026-12-01 | ClinicalTrials.gov |
| NCT03819270 | A Safety Study of LY3372689 Given By Mouth to Healthy Participants | Phase1 | Healthy | Completed | 2019-02-05 | 2019-06-24 | ClinicalTrials.gov |
| NCT03819270 | A Safety Study of LY3372689 Given By Mouth to Healthy Participants | Phase1 | Healthy | Completed | 2019-02-05 | 2019-06-24 | ClinicalTrials.gov |
| NCT03830840 | Mil Familias Cohort Establishment: a Study to Understand Determinants of Diabet… | — | Type2 Diabetes Mellitus | Completed | 2019-02-01 | 2022-03-29 | ClinicalTrials.gov |
| NCT03830840 | Mil Familias Cohort Establishment: a Study to Understand Determinants of Diabet… | — | Type2 Diabetes Mellitus | Completed | 2019-02-01 | 2022-03-29 | ClinicalTrials.gov |
| NCT03594110 | EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) | Phase3 | Chronic Kidney Disease | Completed | 2019-01-31 | 2024-07-02 | ClinicalTrials.gov |
| NCT03770494 | A Study of LY3405105 in Participants With Advanced Cancer | Phase1 | Solid Tumor | Terminated | 2019-01-31 | 2021-02-04 | ClinicalTrials.gov |
| NCT03770494 | A Study of LY3405105 in Participants With Advanced Cancer | Phase1 | Solid Tumor | Terminated | 2019-01-31 | 2021-02-04 | ClinicalTrials.gov |
| NCT03594110 | EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) | Phase3 | Chronic Kidney Disease | Completed | 2019-01-31 | 2024-07-02 | ClinicalTrials.gov |
| NCT03745430 | RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line… | Phase1 | Pancreatic Adenocarcinoma | Completed | 2019-01-29 | 2023-04-23 | ClinicalTrials.gov |
| NCT03848416 | A Study of Ixekizumab in Healthy Participants | Phase1 | Healthy | Completed | 2019-01-29 | 2019-06-07 | ClinicalTrials.gov |
| NCT03848403 | Study of Ixekizumab in Healthy Participants | Phase1 | Healthy | Terminated | 2019-01-29 | 2019-07-18 | ClinicalTrials.gov |
| NCT03745430 | RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line… | Phase1 | Pancreatic Adenocarcinoma | Completed | 2019-01-29 | 2023-04-23 | ClinicalTrials.gov |
| NCT05469113 | A Study of Effects of Selpercatinib (LY3527723) on Repaglinide in Healthy Parti… | Phase1 | Healthy | Completed | 2019-01-29 | 2019-03-05 | ClinicalTrials.gov |
| NCT03848403 | Study of Ixekizumab in Healthy Participants | Phase1 | Healthy | Terminated | 2019-01-29 | 2019-07-18 | ClinicalTrials.gov |
| NCT03848416 | A Study of Ixekizumab in Healthy Participants | Phase1 | Healthy | Completed | 2019-01-29 | 2019-06-07 | ClinicalTrials.gov |
| NCT05469113 | A Study of Effects of Selpercatinib (LY3527723) on Repaglinide in Healthy Parti… | Phase1 | Healthy | Completed | 2019-01-29 | 2019-03-05 | ClinicalTrials.gov |
| NCT03654833 | Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Maligna… | Phase2 | Mesothelioma, Malignant | Unknown | 2019-01-28 | 2023-10-31 | ClinicalTrials.gov |
| NCT03654833 | Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Maligna… | Phase2 | Mesothelioma, Malignant | Unknown | 2019-01-28 | 2023-10-31 | ClinicalTrials.gov |
| NCT03520946 | RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refracto… | Phase3 | Colorectal Cancer | Completed | 2019-01-24 | 2024-07-30 | ClinicalTrials.gov |
| NCT03520946 | RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refracto… | Phase3 | Colorectal Cancer | Completed | 2019-01-24 | 2024-07-30 | ClinicalTrials.gov |
| NCT03735446 | Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MD… | Phase1 | Acute Myeloid Leukemia | Terminated | 2019-01-18 | 2019-03-29 | ClinicalTrials.gov |
| NCT03735446 | Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MD… | Phase1 | Acute Myeloid Leukemia | Terminated | 2019-01-18 | 2019-03-29 | ClinicalTrials.gov |
| NCT03761797 | A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Ty… | — | Diabetes Mellitus, Type 2 | Completed | 2019-01-15 | 2021-04-27 | ClinicalTrials.gov |
| NCT03761797 | A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Ty… | — | Diabetes Mellitus, Type 2 | Completed | 2019-01-15 | 2021-04-27 | ClinicalTrials.gov |
| NCT03792139 | An Interaction Study of LY3200882 in Healthy Participants | Phase1 | Healthy | Completed | 2019-01-08 | 2019-02-23 | ClinicalTrials.gov |
| NCT03792139 | An Interaction Study of LY3200882 in Healthy Participants | Phase1 | Healthy | Completed | 2019-01-08 | 2019-02-23 | ClinicalTrials.gov |
| NCT03958136 | Clinico-biological Data Collection Study of Metastatic Breast Cancer | Na | Breast Cancer | Active_Not_Recruiting | 2018-12-24 | 2036-12-30 | ClinicalTrials.gov |
| NCT03958136 | Clinico-biological Data Collection Study of Metastatic Breast Cancer | Na | Breast Cancer | Active_Not_Recruiting | 2018-12-24 | 2036-12-30 | ClinicalTrials.gov |
| NCT03675893 | RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in En… | Phase2 | Endometrial Cancer | Recruiting | 2018-12-24 | 2031-08-01 | ClinicalTrials.gov |
| NCT03675893 | RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in En… | Phase2 | Endometrial Cancer | Recruiting | 2018-12-24 | 2031-08-01 | ClinicalTrials.gov |
| NCT03339843 | Multiorgan Metabolic Imaging Response Assessment of Abemaciclib | Phase2 | Esophageal Adenocarcinoma | Completed | 2018-12-19 | 2023-12-20 | ClinicalTrials.gov |
| NCT05469100 | A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and … | Phase1 | Healthy | Completed | 2018-12-19 | 2019-08-07 | ClinicalTrials.gov |
| NCT05469100 | A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and … | Phase1 | Healthy | Completed | 2018-12-19 | 2019-08-07 | ClinicalTrials.gov |
| NCT03339843 | Multiorgan Metabolic Imaging Response Assessment of Abemaciclib | Phase2 | Esophageal Adenocarcinoma | Completed | 2018-12-19 | 2023-12-20 | ClinicalTrials.gov |
| NCT03773978 | A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old W… | Phase3 | Juvenile Idiopathic Arthritis | Completed | 2018-12-17 | 2022-01-26 | ClinicalTrials.gov |
| NCT03773978 | A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old W… | Phase3 | Juvenile Idiopathic Arthritis | Completed | 2018-12-17 | 2022-01-26 | ClinicalTrials.gov |
| NCT03715192 | A Safety Study of LY3462817 in Healthy Participants | Phase1 | Healthy | Completed | 2018-12-13 | 2019-12-11 | ClinicalTrials.gov |
| NCT03715192 | A Safety Study of LY3462817 in Healthy Participants | Phase1 | Healthy | Completed | 2018-12-13 | 2019-12-11 | ClinicalTrials.gov |
| NCT03692949 | A Study of LY3451838 in Healthy Participants | Phase1 | Healthy | Completed | 2018-12-11 | 2020-02-26 | ClinicalTrials.gov |
| NCT03692949 | A Study of LY3451838 in Healthy Participants | Phase1 | Healthy | Completed | 2018-12-11 | 2020-02-26 | ClinicalTrials.gov |
| NCT05436912 | A Study of Effects of Selpercatinib in Hepatically Impaired Participants and He… | Phase1 | Healthy | Completed | 2018-12-10 | 2019-10-30 | ClinicalTrials.gov |
| NCT05436912 | A Study of Effects of Selpercatinib in Hepatically Impaired Participants and He… | Phase1 | Healthy | Completed | 2018-12-10 | 2019-10-30 | ClinicalTrials.gov |
| NCT03764774 | A Study of LY3463251 in Healthy Participants | Phase1 | Healthy | Terminated | 2018-12-06 | 2020-12-07 | ClinicalTrials.gov |
| NCT03764774 | A Study of LY3463251 in Healthy Participants | Phase1 | Healthy | Terminated | 2018-12-06 | 2020-12-07 | ClinicalTrials.gov |
| NCT03750643 | A Study of LY3454738 in Healthy Participants and Participants With Atopic Derma… | Phase1 | Dermatitis, Atopic | Completed | 2018-11-29 | 2021-09-07 | ClinicalTrials.gov |
| NCT03750643 | A Study of LY3454738 in Healthy Participants and Participants With Atopic Derma… | Phase1 | Dermatitis, Atopic | Completed | 2018-11-29 | 2021-09-07 | ClinicalTrials.gov |
| NCT03703466 | A Study of Abemaciclib (LY2835219) With and Without Food in Participants With M… | Phase2 | Metastatic Breast Cancer | Completed | 2018-11-28 | 2023-03-09 | ClinicalTrials.gov |
| NCT03703466 | A Study of Abemaciclib (LY2835219) With and Without Food in Participants With M… | Phase2 | Metastatic Breast Cancer | Completed | 2018-11-28 | 2023-03-09 | ClinicalTrials.gov |
| NCT03706365 | A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2… | Phase2 | Prostate Cancer | Active_Not_Recruiting | 2018-11-26 | 2026-06-01 | ClinicalTrials.gov |
| NCT03706365 | A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2… | Phase2 | Prostate Cancer | Active_Not_Recruiting | 2018-11-26 | 2026-06-01 | ClinicalTrials.gov |
| NCT03752177 | A Study of LY3415244 in Participants With Advanced Solid Tumors | Phase1 | Solid Tumor | Terminated | 2018-11-22 | 2019-10-09 | ClinicalTrials.gov |
| NCT03752177 | A Study of LY3415244 in Participants With Advanced Solid Tumors | Phase1 | Solid Tumor | Terminated | 2018-11-22 | 2019-10-09 | ClinicalTrials.gov |
| NCT03726125 | A Study of LY3374849 in Healthy Participants | Phase1 | Healthy | Completed | 2018-11-20 | 2019-09-27 | ClinicalTrials.gov |
| NCT03730662 | A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a D… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2018-11-20 | 2021-04-22 | ClinicalTrials.gov |
| NCT03726125 | A Study of LY3374849 in Healthy Participants | Phase1 | Healthy | Completed | 2018-11-20 | 2019-09-27 | ClinicalTrials.gov |
| NCT03730662 | A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a D… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2018-11-20 | 2021-04-22 | ClinicalTrials.gov |
| NCT03765502 | A Study Comparing User Experience of Different Delivery Devices for Glucagon | Phase1 | Healthy | Completed | 2018-11-19 | 2019-01-03 | ClinicalTrials.gov |
| NCT03736772 | A Study of LY3090106 in Japanese and Caucasian Healthy Participants | Phase1 | Healthy | Completed | 2018-11-19 | 2019-03-13 | ClinicalTrials.gov |
| NCT03765502 | A Study Comparing User Experience of Different Delivery Devices for Glucagon | Phase1 | Healthy | Completed | 2018-11-19 | 2019-01-03 | ClinicalTrials.gov |
| NCT03736772 | A Study of LY3090106 in Japanese and Caucasian Healthy Participants | Phase1 | Healthy | Completed | 2018-11-19 | 2019-03-13 | ClinicalTrials.gov |
| NCT03760822 | Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Ga… | Phase2 | Stomach Cancer | Active_Not_Recruiting | 2018-11-16 | 2024-12-01 | ClinicalTrials.gov |
| NCT03733301 | A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids … | Phase3 | Atopic Dermatitis | Completed | 2018-11-16 | 2019-08-22 | ClinicalTrials.gov |
| NCT03760822 | Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Ga… | Phase2 | Stomach Cancer | Active_Not_Recruiting | 2018-11-16 | 2024-12-01 | ClinicalTrials.gov |
| NCT03733301 | A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids … | Phase3 | Atopic Dermatitis | Completed | 2018-11-16 | 2019-08-22 | ClinicalTrials.gov |
| NCT03736785 | A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus | Phase2 | Type 2 Diabetes Mellitus | Completed | 2018-11-15 | 2020-02-18 | ClinicalTrials.gov |
| NCT03736785 | A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus | Phase2 | Type 2 Diabetes Mellitus | Completed | 2018-11-15 | 2020-02-18 | ClinicalTrials.gov |
| NCT03743285 | A Study of an Automated Insulin Delivery System in Adult Participants With Type… | Na | Type 1 Diabetes Mellitus | Completed | 2018-11-14 | 2019-01-28 | ClinicalTrials.gov |
| NCT03743285 | A Study of an Automated Insulin Delivery System in Adult Participants With Type… | Na | Type 1 Diabetes Mellitus | Completed | 2018-11-14 | 2019-01-28 | ClinicalTrials.gov |
| NCT03573323 | A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With M… | Phase4 | Plaque Psoriasis | Completed | 2018-11-09 | 2020-01-08 | ClinicalTrials.gov |
| NCT03573323 | A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With M… | Phase4 | Plaque Psoriasis | Completed | 2018-11-09 | 2020-01-08 | ClinicalTrials.gov |
| NCT03720548 | A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's … | Phase1 | Alzheimer Disease | Completed | 2018-11-05 | 2019-05-14 | ClinicalTrials.gov |
| NCT03720548 | A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's … | Phase1 | Alzheimer Disease | Completed | 2018-11-05 | 2019-05-14 | ClinicalTrials.gov |
| NCT05918666 | National Register of Actionable Mutations | — | Solid Tumours in Advanced Stages | Active_Not_Recruiting | 2018-10-27 | 2026-10-27 | ClinicalTrials.gov |
| NCT05918666 | National Register of Actionable Mutations | — | Solid Tumours in Advanced Stages | Active_Not_Recruiting | 2018-10-27 | 2026-10-27 | ClinicalTrials.gov |
| NCT03695198 | A Study of LY3361237 in Healthy Participants | Phase1 | Healthy | Completed | 2018-10-26 | 2019-08-29 | ClinicalTrials.gov |
| NCT03695198 | A Study of LY3361237 in Healthy Participants | Phase1 | Healthy | Completed | 2018-10-26 | 2019-08-29 | ClinicalTrials.gov |
| NCT03718884 | A Study of Mirikizumab in Participants With Plaque Psoriasis | Phase1 | Psoriasis | Completed | 2018-10-23 | 2019-10-28 | ClinicalTrials.gov |
| NCT03718884 | A Study of Mirikizumab in Participants With Plaque Psoriasis | Phase1 | Psoriasis | Completed | 2018-10-23 | 2019-10-28 | ClinicalTrials.gov |
| NCT03524092 | A Maintenance Study of Mirikizumab in Participants With Moderately to Severely … | Phase3 | Ulcerative Colitis | Completed | 2018-10-19 | 2025-02-17 | ClinicalTrials.gov |
| NCT03524092 | A Maintenance Study of Mirikizumab in Participants With Moderately to Severely … | Phase3 | Ulcerative Colitis | Completed | 2018-10-19 | 2025-02-17 | ClinicalTrials.gov |
| NCT03724981 | A Study Comparing the Dulaglutide Pen and the Semaglutide Pen | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2018-10-18 | 2019-04-12 | ClinicalTrials.gov |
| NCT03724981 | A Study Comparing the Dulaglutide Pen and the Semaglutide Pen | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2018-10-18 | 2019-04-12 | ClinicalTrials.gov |
| NCT03748940 | Study of LY3074828 in Healthy Participants | Phase1 | Healthy | Completed | 2018-10-10 | 2019-06-18 | ClinicalTrials.gov |
| NCT03748940 | Study of LY3074828 in Healthy Participants | Phase1 | Healthy | Completed | 2018-10-10 | 2019-06-18 | ClinicalTrials.gov |
| NCT03153410 | Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients W… | Early_Phase1 | Pancreatic Cancer | Completed | 2018-09-27 | 2023-08-29 | ClinicalTrials.gov |
| NCT03153410 | Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients W… | Early_Phase1 | Pancreatic Cancer | Completed | 2018-09-27 | 2023-08-29 | ClinicalTrials.gov |
| NCT03555305 | A Study of Insulin Glargine (LY2963016) in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2018-09-26 | 2019-11-04 | ClinicalTrials.gov |
| NCT03555305 | A Study of Insulin Glargine (LY2963016) in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2018-09-26 | 2019-11-04 | ClinicalTrials.gov |
| NCT03570749 | A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe A… | Phase2 | Alopecia Areata | Completed | 2018-09-24 | 2025-01-29 | ClinicalTrials.gov |
| NCT03570749 | A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe A… | Phase2 | Alopecia Areata | Completed | 2018-09-24 | 2025-01-29 | ClinicalTrials.gov |
| NCT03662100 | A Study of Two Formulations of LY3074828 in Healthy Participants | Phase1 | Healthy | Completed | 2018-09-06 | 2019-01-25 | ClinicalTrials.gov |
| NCT03662100 | A Study of Two Formulations of LY3074828 in Healthy Participants | Phase1 | Healthy | Completed | 2018-09-06 | 2019-01-25 | ClinicalTrials.gov |
| NCT03556202 | A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3… | Phase3 | Psoriasis | Terminated | 2018-09-03 | 2022-02-07 | ClinicalTrials.gov |
| NCT03556202 | A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3… | Phase3 | Psoriasis | Terminated | 2018-09-03 | 2022-02-07 | ClinicalTrials.gov |
| NCT03611608 | A Study of LY3316531 in Healthy Participants | Phase1 | Healthy | Completed | 2018-08-30 | 2019-03-15 | ClinicalTrials.gov |
| NCT03611608 | A Study of LY3316531 in Healthy Participants | Phase1 | Healthy | Completed | 2018-08-30 | 2019-03-15 | ClinicalTrials.gov |
| NCT03629054 | This Study in Healthy People Tests Whether Taking a Low Strength of Empaglifloz… | Phase1 | Healthy | Completed | 2018-08-27 | 2018-11-05 | ClinicalTrials.gov |
| NCT03629054 | This Study in Healthy People Tests Whether Taking a Low Strength of Empaglifloz… | Phase1 | Healthy | Completed | 2018-08-27 | 2018-11-05 | ClinicalTrials.gov |
| NCT03470350 | Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorect… | Phase1 | Colorectal Cancer Metastatic | Withdrawn | 2018-08-24 | 2020-06-01 | ClinicalTrials.gov |
| NCT03470350 | Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorect… | Phase1 | Colorectal Cancer Metastatic | Withdrawn | 2018-08-24 | 2020-06-01 | ClinicalTrials.gov |
| NCT03643510 | Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Wom… | Phase2 | Adenocarcinoma of Endometrium | Completed | 2018-08-21 | 2026-03-12 | ClinicalTrials.gov |
| NCT03643510 | Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Wom… | Phase2 | Adenocarcinoma of Endometrium | Completed | 2018-08-21 | 2026-03-12 | ClinicalTrials.gov |
| NCT03603704 | A Study of LY3209590 in Japanese Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2018-08-17 | 2019-05-27 | ClinicalTrials.gov |
| NCT03603704 | A Study of LY3209590 in Japanese Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2018-08-17 | 2019-05-27 | ClinicalTrials.gov |
| NCT03616795 | Study of LY3154207 in Healthy Participants | Phase1 | Healthy | Completed | 2018-08-09 | 2018-11-05 | ClinicalTrials.gov |
| NCT03616795 | Study of LY3154207 in Healthy Participants | Phase1 | Healthy | Completed | 2018-08-09 | 2018-11-05 | ClinicalTrials.gov |
| NCT03616977 | Study to Compare 2 Formulations of LY900014 in Healthy Participants | Phase1 | Healthy | Completed | 2018-08-03 | 2018-10-19 | ClinicalTrials.gov |
| NCT03616977 | Study to Compare 2 Formulations of LY900014 in Healthy Participants | Phase1 | Healthy | Completed | 2018-08-03 | 2018-10-19 | ClinicalTrials.gov |
| NCT03616964 | A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-B… | Phase3 | Systemic Lupus Erythematosus | Completed | 2018-08-02 | 2021-10-20 | ClinicalTrials.gov |
| NCT03616912 | A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythema… | Phase3 | Systemic Lupus Erythematosus | Terminated | 2018-08-02 | 2022-03-09 | ClinicalTrials.gov |
| NCT03616912 | A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythema… | Phase3 | Systemic Lupus Erythematosus | Terminated | 2018-08-02 | 2022-03-09 | ClinicalTrials.gov |
| NCT03616964 | A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-B… | Phase3 | Systemic Lupus Erythematosus | Completed | 2018-08-02 | 2021-10-20 | ClinicalTrials.gov |
| NCT05630287 | A Study of Absorption, Metabolism, Excretion, and Absolute Bioavailability of C… | Phase1 | Healthy | Completed | 2018-08-01 | 2018-09-24 | ClinicalTrials.gov |
| NCT05630287 | A Study of Absorption, Metabolism, Excretion, and Absolute Bioavailability of C… | Phase1 | Healthy | Completed | 2018-08-01 | 2018-09-24 | ClinicalTrials.gov |
| NCT03559257 | A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine | Phase3 | Migraine | Completed | 2018-07-31 | 2019-09-19 | ClinicalTrials.gov |
| NCT03559257 | A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine | Phase3 | Migraine | Completed | 2018-07-31 | 2019-09-19 | ClinicalTrials.gov |
| NCT03519945 | A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Partici… | Phase3 | Ulcerative Colitis | Active_Not_Recruiting | 2018-07-18 | 2027-12-01 | ClinicalTrials.gov |
| NCT03519945 | A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Partici… | Phase3 | Ulcerative Colitis | Active_Not_Recruiting | 2018-07-18 | 2027-12-01 | ClinicalTrials.gov |
| NCT03590860 | A Study of LY3322207 in Healthy Participants and in Participants With Hypertens… | Phase1 | Hypertension | Terminated | 2018-07-13 | 2019-01-17 | ClinicalTrials.gov |
| NCT03590860 | A Study of LY3322207 in Healthy Participants and in Participants With Hypertens… | Phase1 | Hypertension | Terminated | 2018-07-13 | 2019-01-17 | ClinicalTrials.gov |
| NCT05338476 | A Study of Effects of Selpercatinib (LY3527723) on Midazolam in Healthy Partici… | Phase1 | Healthy | Completed | 2018-07-12 | 2018-09-18 | ClinicalTrials.gov |
| NCT05338476 | A Study of Effects of Selpercatinib (LY3527723) on Midazolam in Healthy Partici… | Phase1 | Healthy | Completed | 2018-07-12 | 2018-09-18 | ClinicalTrials.gov |
| NCT03559270 | A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atop… | Phase3 | Atopic Dermatitis | Terminated | 2018-06-27 | 2022-06-13 | ClinicalTrials.gov |
| NCT03579940 | A Study of Lasmiditan in Healthy Japanese and Caucasian Participants | Phase1 | Healthy | Completed | 2018-06-27 | 2018-08-09 | ClinicalTrials.gov |
| NCT03559270 | A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atop… | Phase3 | Atopic Dermatitis | Terminated | 2018-06-27 | 2022-06-13 | ClinicalTrials.gov |
| NCT03579940 | A Study of Lasmiditan in Healthy Japanese and Caucasian Participants | Phase1 | Healthy | Completed | 2018-06-27 | 2018-08-09 | ClinicalTrials.gov |
| NCT03502746 | Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothe… | Phase2 | Mesothelioma, Malignant | Terminated | 2018-06-26 | 2023-11-09 | ClinicalTrials.gov |
| NCT03502746 | Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothe… | Phase2 | Mesothelioma, Malignant | Terminated | 2018-06-26 | 2023-11-09 | ClinicalTrials.gov |
| NCT03535194 | A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab … | Phase3 | Psoriasis | Completed | 2018-06-26 | 2020-06-03 | ClinicalTrials.gov |
| NCT03535194 | A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab … | Phase3 | Psoriasis | Completed | 2018-06-26 | 2020-06-03 | ClinicalTrials.gov |
| NCT03518086 | An Induction Study of Mirikizumab in Participants With Moderately to Severely A… | Phase3 | Ulcerative Colitis | Completed | 2018-06-18 | 2024-05-15 | ClinicalTrials.gov |
| NCT03518086 | An Induction Study of Mirikizumab in Participants With Moderately to Severely A… | Phase3 | Ulcerative Colitis | Completed | 2018-06-18 | 2024-05-15 | ClinicalTrials.gov |
| NCT03559088 | A Study of the Effect of a Disease-Specific Migraine Smart Phone Application (A… | Na | Migraine | Completed | 2018-06-11 | 2019-04-26 | ClinicalTrials.gov |
| NCT03559088 | A Study of the Effect of a Disease-Specific Migraine Smart Phone Application (A… | Na | Migraine | Completed | 2018-06-11 | 2019-04-26 | ClinicalTrials.gov |
| NCT03545087 | A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared … | Phase1 | Renal Insufficiency | Withdrawn | 2018-06-01 | 2019-01-01 | ClinicalTrials.gov |
| NCT03545087 | A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared … | Phase1 | Renal Insufficiency | Withdrawn | 2018-06-01 | 2019-01-01 | ClinicalTrials.gov |
| NCT03499041 | A Study of LY3314814 in Participants With Liver Impairment | Phase1 | Hepatic Impairment | Withdrawn | 2018-06-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT03506399 | A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive | Phase1 | Healthy | Withdrawn | 2018-06-01 | 2018-10-01 | ClinicalTrials.gov |
| NCT03499041 | A Study of LY3314814 in Participants With Liver Impairment | Phase1 | Hepatic Impairment | Withdrawn | 2018-06-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT03506399 | A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive | Phase1 | Healthy | Withdrawn | 2018-06-01 | 2018-10-01 | ClinicalTrials.gov |
| NCT05468164 | A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY35277… | Phase1 | Healthy | Completed | 2018-05-31 | 2018-09-13 | ClinicalTrials.gov |
| NCT05468164 | A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY35277… | Phase1 | Healthy | Completed | 2018-05-31 | 2018-09-13 | ClinicalTrials.gov |
| NCT03574818 | Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectabl… | Phase2 | Squamous Cell Lung Cancer | Terminated | 2018-05-29 | 2019-09-26 | ClinicalTrials.gov |
| NCT03574818 | Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectabl… | Phase2 | Squamous Cell Lung Cancer | Terminated | 2018-05-29 | 2019-09-26 | ClinicalTrials.gov |
| NCT03485976 | Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP) | Phase2 | Pityriasis Rubra Pilaris | Completed | 2018-05-23 | 2020-01-13 | ClinicalTrials.gov |
| NCT03485976 | Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP) | Phase2 | Pityriasis Rubra Pilaris | Completed | 2018-05-23 | 2020-01-13 | ClinicalTrials.gov |
| NCT03485222 | Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Act… | Phase4 | Cardiovascular Diseases | Completed | 2018-05-21 | 2020-02-13 | ClinicalTrials.gov |
| NCT03485222 | Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Act… | Phase4 | Cardiovascular Diseases | Completed | 2018-05-21 | 2020-02-13 | ClinicalTrials.gov |
| NCT03495323 | A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibi… | Phase1 | Cancer | Completed | 2018-05-16 | 2021-02-01 | ClinicalTrials.gov |
| NCT03495323 | A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibi… | Phase1 | Cancer | Completed | 2018-05-16 | 2021-02-01 | ClinicalTrials.gov |
| NCT03428100 | A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Ad… | Phase3 | Atopic Dermatitis | Completed | 2018-05-15 | 2023-04-20 | ClinicalTrials.gov |
| NCT03428100 | A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Ad… | Phase3 | Atopic Dermatitis | Completed | 2018-05-15 | 2023-04-20 | ClinicalTrials.gov |
| NCT05338489 | A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in… | Phase1 | Healthy | Completed | 2018-05-11 | 2018-08-22 | ClinicalTrials.gov |
| NCT05338489 | A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in… | Phase1 | Healthy | Completed | 2018-05-11 | 2018-08-22 | ClinicalTrials.gov |
| NCT04260087 | New Daily Persistent Headache Biomarkers Study | — | New Daily Persistent Headache | Terminated | 2018-05-01 | 2021-11-18 | ClinicalTrials.gov |
| NCT04260087 | New Daily Persistent Headache Biomarkers Study | — | New Daily Persistent Headache | Terminated | 2018-05-01 | 2021-11-18 | ClinicalTrials.gov |
| NCT03518073 | A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease | Phase2 | Alzheimer Disease (AD) | Completed | 2018-04-30 | 2021-10-25 | ClinicalTrials.gov |
| NCT03518073 | A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease | Phase2 | Alzheimer Disease (AD) | Completed | 2018-04-30 | 2021-10-25 | ClinicalTrials.gov |
| NCT03364309 | A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Seve… | Phase3 | Plaque Psoriasis | Completed | 2018-04-26 | 2020-06-04 | ClinicalTrials.gov |
| NCT03364309 | A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Seve… | Phase3 | Plaque Psoriasis | Completed | 2018-04-26 | 2020-06-04 | ClinicalTrials.gov |
| NCT03482011 | A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Parti… | Phase3 | Psoriasis | Completed | 2018-04-24 | 2020-01-16 | ClinicalTrials.gov |
| NCT03482011 | A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Parti… | Phase3 | Psoriasis | Completed | 2018-04-24 | 2020-01-16 | ClinicalTrials.gov |
| NCT03556007 | A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematos… | Phase1 | Systemic Lupus Erythematosus | Completed | 2018-04-18 | 2019-08-29 | ClinicalTrials.gov |
| NCT03556007 | A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematos… | Phase1 | Systemic Lupus Erythematosus | Completed | 2018-04-18 | 2019-08-29 | ClinicalTrials.gov |
| NCT03907202 | A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of … | Phase1 | Type II Diabetes Mellitus | Terminated | 2018-04-17 | 2019-12-03 | ClinicalTrials.gov |
| NCT03907202 | A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of … | Phase1 | Type II Diabetes Mellitus | Terminated | 2018-04-17 | 2019-12-03 | ClinicalTrials.gov |
| NCT03414047 | A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurren… | Phase2 | Ovarian Cancer | Completed | 2018-04-10 | 2020-10-03 | ClinicalTrials.gov |
| NCT03414047 | A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurren… | Phase2 | Ovarian Cancer | Completed | 2018-04-10 | 2020-10-03 | ClinicalTrials.gov |
| NCT03495102 | A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants W… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2018-04-05 | 2019-10-10 | ClinicalTrials.gov |
| NCT03495102 | A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants W… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2018-04-05 | 2019-10-10 | ClinicalTrials.gov |
| NCT03482024 | A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function | Phase1 | Renal Insufficiency | Completed | 2018-03-30 | 2019-08-19 | ClinicalTrials.gov |
| NCT03482024 | A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function | Phase1 | Renal Insufficiency | Completed | 2018-03-30 | 2019-08-19 | ClinicalTrials.gov |
| NCT03334435 | A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis | Phase3 | Atopic Dermatitis | Completed | 2018-03-28 | 2023-07-12 | ClinicalTrials.gov |
| NCT03334435 | A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis | Phase3 | Atopic Dermatitis | Completed | 2018-03-28 | 2023-07-12 | ClinicalTrials.gov |
| NCT03465878 | A Study of LY900014 in Participants With Type 1 Diabetes Mellitus | Phase1 | Type 1 Diabetes Mellitus | Completed | 2018-03-26 | 2019-11-14 | ClinicalTrials.gov |
| NCT03459612 | A Study of Lasmiditan on Simulated Driving Performance in Healthy Participants | Phase1 | Healthy | Completed | 2018-03-26 | 2018-06-23 | ClinicalTrials.gov |
| NCT03465878 | A Study of LY900014 in Participants With Type 1 Diabetes Mellitus | Phase1 | Type 1 Diabetes Mellitus | Completed | 2018-03-26 | 2019-11-14 | ClinicalTrials.gov |
| NCT03459612 | A Study of Lasmiditan on Simulated Driving Performance in Healthy Participants | Phase1 | Healthy | Completed | 2018-03-26 | 2018-06-23 | ClinicalTrials.gov |
| NCT03338023 | A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Typ… | Phase3 | Type 1 Diabetes | Completed | 2018-03-23 | 2020-03-05 | ClinicalTrials.gov |
| NCT03338023 | A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Typ… | Phase3 | Type 1 Diabetes | Completed | 2018-03-23 | 2020-03-05 | ClinicalTrials.gov |
| NCT03338010 | A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Typ… | Phase3 | Type 2 Diabetes | Completed | 2018-03-22 | 2020-03-18 | ClinicalTrials.gov |
| NCT03382912 | Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone S… | Phase2 | Non Small Cell Lung Cancer | Terminated | 2018-03-22 | 2020-03-03 | ClinicalTrials.gov |
| NCT03382912 | Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone S… | Phase2 | Non Small Cell Lung Cancer | Terminated | 2018-03-22 | 2020-03-03 | ClinicalTrials.gov |
| NCT03338010 | A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Typ… | Phase3 | Type 2 Diabetes | Completed | 2018-03-22 | 2020-03-18 | ClinicalTrials.gov |
| NCT03448419 | This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Redu… | Phase3 | Heart Failure | Completed | 2018-03-20 | 2019-10-07 | ClinicalTrials.gov |
| NCT03448419 | This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Redu… | Phase3 | Heart Failure | Completed | 2018-03-20 | 2019-10-07 | ClinicalTrials.gov |
| NCT03448406 | This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Pres… | Phase3 | Heart Failure | Completed | 2018-03-20 | 2019-10-09 | ClinicalTrials.gov |
| NCT03448406 | This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Pres… | Phase3 | Heart Failure | Completed | 2018-03-20 | 2019-10-09 | ClinicalTrials.gov |
| NCT03382899 | Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab… | Phase2 | Non Small Cell Lung Cancer | Terminated | 2018-03-19 | 2020-03-05 | ClinicalTrials.gov |
| NCT03382899 | Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab… | Phase2 | Non Small Cell Lung Cancer | Terminated | 2018-03-19 | 2020-03-05 | ClinicalTrials.gov |
| NCT03449433 | A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2018-03-15 | 2018-08-14 | ClinicalTrials.gov |
| NCT03449433 | A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2018-03-15 | 2018-08-14 | ClinicalTrials.gov |
| NCT03432286 | A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With E… | Phase3 | Episodic Migraine | Active_Not_Recruiting | 2018-03-14 | 2026-11-01 | ClinicalTrials.gov |
| NCT03432286 | A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With E… | Phase3 | Episodic Migraine | Active_Not_Recruiting | 2018-03-14 | 2026-11-01 | ClinicalTrials.gov |
| NCT03456713 | A Study of LY3074828 in Healthy Participants | Phase1 | Healthy | Completed | 2018-03-06 | 2018-08-13 | ClinicalTrials.gov |
| NCT03456713 | A Study of LY3074828 in Healthy Participants | Phase1 | Healthy | Completed | 2018-03-06 | 2018-08-13 | ClinicalTrials.gov |
| NCT03482362 | Vinorelbine in Advanced BRAF-like Colon Cancer | Phase2 | Colon Cancer | Completed | 2018-03-01 | 2020-03-17 | ClinicalTrials.gov |
| NCT03332212 | A Study That Looks at the Function of the Heart in Patients With Heart Failure … | Phase3 | Heart Failure | Completed | 2018-03-01 | 2020-05-28 | ClinicalTrials.gov |
| NCT03332212 | A Study That Looks at the Function of the Heart in Patients With Heart Failure … | Phase3 | Heart Failure | Completed | 2018-03-01 | 2020-05-28 | ClinicalTrials.gov |
| NCT03482362 | Vinorelbine in Advanced BRAF-like Colon Cancer | Phase2 | Colon Cancer | Completed | 2018-03-01 | 2020-03-17 | ClinicalTrials.gov |
| NCT03433677 | A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous… | Phase3 | Diabetes Type 1 | Completed | 2018-02-21 | 2018-09-04 | ClinicalTrials.gov |
| NCT03421379 | A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mel… | Phase3 | Diabetes Mellitus | Completed | 2018-02-21 | 2018-08-20 | ClinicalTrials.gov |
| NCT03433677 | A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous… | Phase3 | Diabetes Type 1 | Completed | 2018-02-21 | 2018-09-04 | ClinicalTrials.gov |
| NCT03421379 | A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mel… | Phase3 | Diabetes Mellitus | Completed | 2018-02-21 | 2018-08-20 | ClinicalTrials.gov |
| NCT03435081 | A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Sever… | Phase3 | Atopic Dermatitis | Completed | 2018-02-20 | 2021-08-16 | ClinicalTrials.gov |
| NCT03435081 | A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Sever… | Phase3 | Atopic Dermatitis | Completed | 2018-02-20 | 2021-08-16 | ClinicalTrials.gov |
| NCT03407118 | A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2018-02-17 | 2018-07-12 | ClinicalTrials.gov |
| NCT03407118 | A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2018-02-17 | 2018-07-12 | ClinicalTrials.gov |
| NCT03443024 | A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Ato… | Phase2 | Atopic Dermatitis | Completed | 2018-01-30 | 2019-05-23 | ClinicalTrials.gov |
| NCT03443024 | A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Ato… | Phase2 | Atopic Dermatitis | Completed | 2018-01-30 | 2019-05-23 | ClinicalTrials.gov |
| NCT03418493 | A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis | Phase1 | Psoriasis | Completed | 2018-01-30 | 2019-07-29 | ClinicalTrials.gov |
| NCT03418493 | A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis | Phase1 | Psoriasis | Completed | 2018-01-30 | 2019-07-29 | ClinicalTrials.gov |
| NCT03395353 | A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adol… | Phase3 | Depressive Disorder | Terminated | 2018-01-29 | 2020-07-04 | ClinicalTrials.gov |
| NCT03395353 | A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adol… | Phase3 | Depressive Disorder | Terminated | 2018-01-29 | 2020-07-04 | ClinicalTrials.gov |
| NCT03406260 | A Study of Lasmiditan in Healthy Elderly Participants | Phase1 | Healthy | Completed | 2018-01-25 | 2018-04-13 | ClinicalTrials.gov |
| NCT03406260 | A Study of Lasmiditan in Healthy Elderly Participants | Phase1 | Healthy | Completed | 2018-01-25 | 2018-04-13 | ClinicalTrials.gov |
| NCT04194892 | A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants | Phase1 | Healthy | Completed | 2018-01-19 | 2018-03-14 | ClinicalTrials.gov |
| NCT04194892 | A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants | Phase1 | Healthy | Completed | 2018-01-19 | 2018-03-14 | ClinicalTrials.gov |
| NCT03222427 | A Study of LY3314814 in Healthy Participants | Phase1 | Healthy | Completed | 2018-01-15 | 2018-02-16 | ClinicalTrials.gov |
| NCT03222427 | A Study of LY3314814 in Healthy Participants | Phase1 | Healthy | Completed | 2018-01-15 | 2018-02-16 | ClinicalTrials.gov |
| NCT03292536 | Merestinib on Bone Metastases in Subjects With Breast Cancer | Phase1 | Bone Metastases | Terminated | 2018-01-11 | 2019-06-24 | ClinicalTrials.gov |
| NCT03292536 | Merestinib on Bone Metastases in Subjects With Breast Cancer | Phase1 | Bone Metastases | Terminated | 2018-01-11 | 2019-06-24 | ClinicalTrials.gov |
| NCT03367377 | A Study of LY3209590 in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2018-01-03 | 2018-10-03 | ClinicalTrials.gov |
| NCT03367377 | A Study of LY3209590 in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2018-01-03 | 2018-10-03 | ClinicalTrials.gov |
| NCT02623478 | A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabe… | Phase1 | Diabetes Mellitus, Type 1 | Withdrawn | 2018-01-01 | 2018-04-01 | ClinicalTrials.gov |
| NCT02623465 | A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insuli… | Phase1 | Diabetes Mellitus, Type 2 | Withdrawn | 2018-01-01 | 2018-04-01 | ClinicalTrials.gov |
| NCT02623478 | A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabe… | Phase1 | Diabetes Mellitus, Type 1 | Withdrawn | 2018-01-01 | 2018-04-01 | ClinicalTrials.gov |
| NCT03549416 | BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Op… | — | Atopic Dermatitis | Recruiting | 2018-01-01 | 2028-12-31 | ClinicalTrials.gov |
| NCT02623452 | A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insuli… | Phase1 | Diabetes Mellitus, Type 1 | Withdrawn | 2018-01-01 | 2018-04-01 | ClinicalTrials.gov |
| NCT02623465 | A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insuli… | Phase1 | Diabetes Mellitus, Type 2 | Withdrawn | 2018-01-01 | 2018-04-01 | ClinicalTrials.gov |
| NCT03549416 | BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Op… | — | Atopic Dermatitis | Recruiting | 2018-01-01 | 2028-12-31 | ClinicalTrials.gov |
| NCT02623452 | A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insuli… | Phase1 | Diabetes Mellitus, Type 1 | Withdrawn | 2018-01-01 | 2018-04-01 | ClinicalTrials.gov |
| NCT03370276 | Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamou… | Phase1 | Squamous Cell Carcinoma of the Oropharynx | Completed | 2017-12-20 | 2023-12-23 | ClinicalTrials.gov |
| NCT03370276 | Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamou… | Phase1 | Squamous Cell Carcinoma of the Oropharynx | Completed | 2017-12-20 | 2023-12-23 | ClinicalTrials.gov |
| NCT03375463 | A Study of Tirzepatide (LY3298176) in Healthy Participants | Phase1 | Healthy | Completed | 2017-12-19 | 2018-12-27 | ClinicalTrials.gov |
| NCT03375463 | A Study of Tirzepatide (LY3298176) in Healthy Participants | Phase1 | Healthy | Completed | 2017-12-19 | 2018-12-27 | ClinicalTrials.gov |
| NCT03381547 | A 3-Way Crossover Study to Evaluate the Pharmacokinetics in Participants After … | Phase1 | Healthy Adult Subjects | Completed | 2017-12-18 | 2018-02-11 | ClinicalTrials.gov |
| NCT03367403 | A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease… | Phase2 | Alzheimer Disease | Completed | 2017-12-18 | 2021-09-21 | ClinicalTrials.gov |
| NCT03367403 | A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease… | Phase2 | Alzheimer Disease | Completed | 2017-12-18 | 2021-09-21 | ClinicalTrials.gov |
| NCT03381547 | A 3-Way Crossover Study to Evaluate the Pharmacokinetics in Participants After … | Phase1 | Healthy Adult Subjects | Completed | 2017-12-18 | 2018-02-11 | ClinicalTrials.gov |
| NCT03368807 | Assessment of Mealtime Bolus Insulin Behavior | — | Diabetes Mellitus, Type 1 | Completed | 2017-12-11 | 2018-07-23 | ClinicalTrials.gov |
| NCT03368807 | Assessment of Mealtime Bolus Insulin Behavior | — | Diabetes Mellitus, Type 1 | Completed | 2017-12-11 | 2018-07-23 | ClinicalTrials.gov |
| NCT03363906 | A Study of Dulaglutide in Healthy Participants | Phase1 | Healthy | Completed | 2017-12-07 | 2018-06-06 | ClinicalTrials.gov |
| NCT03363906 | A Study of Dulaglutide in Healthy Participants | Phase1 | Healthy | Completed | 2017-12-07 | 2018-06-06 | ClinicalTrials.gov |
| NCT03334448 | A Study to Compare 2 Formulations of LY900014 in Healthy Participants | Phase1 | Healthy | Completed | 2017-12-04 | 2018-03-15 | ClinicalTrials.gov |
| NCT03315793 | A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depr… | Phase3 | Depressive Disorder | Completed | 2017-12-04 | 2019-11-08 | ClinicalTrials.gov |
| NCT03315793 | A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depr… | Phase3 | Depressive Disorder | Completed | 2017-12-04 | 2019-11-08 | ClinicalTrials.gov |
| NCT03334448 | A Study to Compare 2 Formulations of LY900014 in Healthy Participants | Phase1 | Healthy | Completed | 2017-12-04 | 2018-03-15 | ClinicalTrials.gov |
| NCT03334422 | Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Der… | Phase3 | Atopic Dermatitis | Completed | 2017-11-27 | 2018-12-12 | ClinicalTrials.gov |
| NCT03334422 | Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Der… | Phase3 | Atopic Dermatitis | Completed | 2017-11-27 | 2018-12-12 | ClinicalTrials.gov |
| NCT03334396 | A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic D… | Phase3 | Atopic Dermatitis | Completed | 2017-11-23 | 2019-08-16 | ClinicalTrials.gov |
| NCT03334396 | A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic D… | Phase3 | Atopic Dermatitis | Completed | 2017-11-23 | 2019-08-16 | ClinicalTrials.gov |
| NCT03310879 | Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alt… | Phase2 | Cancer | Recruiting | 2017-11-21 | 2027-09-30 | ClinicalTrials.gov |
| NCT03338803 | Real World Glycemic Effectiveness of Linagliptin | — | Diabetes Mellitus, Type 2 | Completed | 2017-11-21 | 2018-02-02 | ClinicalTrials.gov |
| NCT03310879 | Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alt… | Phase2 | Cancer | Recruiting | 2017-11-21 | 2027-09-30 | ClinicalTrials.gov |
| NCT03338803 | Real World Glycemic Effectiveness of Linagliptin | — | Diabetes Mellitus, Type 2 | Completed | 2017-11-21 | 2018-02-02 | ClinicalTrials.gov |
| NCT03343613 | A Study of LY3381916 Alone or in Combination With LY3300054 in Participants Wit… | Phase1 | Solid Tumor | Terminated | 2017-11-17 | 2020-05-04 | ClinicalTrials.gov |
| NCT03343587 | A Study of LY3375880 in Healthy Participants | Phase1 | Healthy | Completed | 2017-11-17 | 2018-11-16 | ClinicalTrials.gov |
| NCT03343587 | A Study of LY3375880 in Healthy Participants | Phase1 | Healthy | Completed | 2017-11-17 | 2018-11-16 | ClinicalTrials.gov |
| NCT03343613 | A Study of LY3381916 Alone or in Combination With LY3300054 in Participants Wit… | Phase1 | Solid Tumor | Terminated | 2017-11-17 | 2020-05-04 | ClinicalTrials.gov |
| NCT03322631 | A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes | Phase1 | Type 2 Diabetes Mellitus | Completed | 2017-11-15 | 2018-11-28 | ClinicalTrials.gov |
| NCT03322631 | A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes | Phase1 | Type 2 Diabetes Mellitus | Completed | 2017-11-15 | 2018-11-28 | ClinicalTrials.gov |
| NCT03341312 | A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants W… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2017-11-13 | 2018-03-31 | ClinicalTrials.gov |
| NCT03341299 | A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants W… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2017-11-13 | 2018-04-03 | ClinicalTrials.gov |
| NCT03341299 | A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants W… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2017-11-13 | 2018-04-03 | ClinicalTrials.gov |
| NCT03341312 | A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants W… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2017-11-13 | 2018-03-31 | ClinicalTrials.gov |
| NCT03339453 | A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus | Phase1 | Hypoglycemia | Completed | 2017-11-10 | 2018-01-13 | ClinicalTrials.gov |
| NCT03339453 | A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus | Phase1 | Hypoglycemia | Completed | 2017-11-10 | 2018-01-13 | ClinicalTrials.gov |
| NCT03305809 | A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (L… | Phase2 | Lewy Body Dementia | Completed | 2017-11-09 | 2020-07-10 | ClinicalTrials.gov |
| NCT03305809 | A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (L… | Phase2 | Lewy Body Dementia | Completed | 2017-11-09 | 2020-07-10 | ClinicalTrials.gov |
| NCT03367390 | A Study of an Automated Insulin Delivery System in Participants With Type 1 Dia… | Phase1 | Type1 Diabetes Mellitus | Completed | 2017-11-08 | 2018-02-09 | ClinicalTrials.gov |
| NCT03367390 | A Study of an Automated Insulin Delivery System in Participants With Type 1 Dia… | Phase1 | Type1 Diabetes Mellitus | Completed | 2017-11-08 | 2018-02-09 | ClinicalTrials.gov |
| NCT03031938 | Protocol to Monitor the Neurological Development of Infants With Exposure in Ut… | Phase3 | Osteoarthritis | Completed | 2017-11-03 | 2020-06-04 | ClinicalTrials.gov |
| NCT03031938 | Protocol to Monitor the Neurological Development of Infants With Exposure in Ut… | Phase3 | Osteoarthritis | Completed | 2017-11-03 | 2020-06-04 | ClinicalTrials.gov |
| NCT03141034 | Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-e… | Phase2 | Gastric Adenocarcinoma | Completed | 2017-11-01 | 2023-04-14 | ClinicalTrials.gov |
| NCT03141034 | Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-e… | Phase2 | Gastric Adenocarcinoma | Completed | 2017-11-01 | 2023-04-14 | ClinicalTrials.gov |
| NCT03315780 | A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Part… | Phase4 | Type 2 Diabetes | Completed | 2017-10-28 | 2018-02-28 | ClinicalTrials.gov |
| NCT03315780 | A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Part… | Phase4 | Type 2 Diabetes | Completed | 2017-10-28 | 2018-02-28 | ClinicalTrials.gov |
| NCT03325387 | A Study of Multiple Doses of LY3305677 in Healthy Participants | Phase1 | Healthy | Completed | 2017-10-27 | 2018-08-03 | ClinicalTrials.gov |
| NCT03325387 | A Study of Multiple Doses of LY3305677 in Healthy Participants | Phase1 | Healthy | Completed | 2017-10-27 | 2018-08-03 | ClinicalTrials.gov |
| NCT03311724 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes | Phase2 | Type 2 Diabetes | Completed | 2017-10-19 | 2018-04-24 | ClinicalTrials.gov |
| NCT03311724 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes | Phase2 | Type 2 Diabetes | Completed | 2017-10-19 | 2018-04-24 | ClinicalTrials.gov |
| NCT03283696 | A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants … | Phase1 | Soft Tissue Sarcoma | Completed | 2017-10-18 | 2019-08-25 | ClinicalTrials.gov |
| NCT03283696 | A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants … | Phase1 | Soft Tissue Sarcoma | Completed | 2017-10-18 | 2019-08-25 | ClinicalTrials.gov |
| NCT03310411 | A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants | Phase1 | Healthy | Completed | 2017-10-17 | 2017-12-23 | ClinicalTrials.gov |
| NCT03310411 | A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants | Phase1 | Healthy | Completed | 2017-10-17 | 2017-12-23 | ClinicalTrials.gov |
| NCT03363464 | Comparative Effectiveness of Empagliflozin in the US | — | Diabetes Mellitus, Type 2 | Active_Not_Recruiting | 2017-10-16 | 2026-05-31 | ClinicalTrials.gov |
| NCT03363464 | Comparative Effectiveness of Empagliflozin in the US | — | Diabetes Mellitus, Type 2 | Active_Not_Recruiting | 2017-10-16 | 2026-05-31 | ClinicalTrials.gov |
| NCT03308669 | A Study of Lasmiditan in Healthy Participants When Co-administered With Topiram… | Phase1 | Healthy | Completed | 2017-10-16 | 2017-12-02 | ClinicalTrials.gov |
| NCT03308669 | A Study of Lasmiditan in Healthy Participants When Co-administered With Topiram… | Phase1 | Healthy | Completed | 2017-10-16 | 2017-12-02 | ClinicalTrials.gov |
| NCT03286751 | A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Particip… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2017-10-13 | 2018-02-06 | ClinicalTrials.gov |
| NCT03286751 | A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Particip… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2017-10-13 | 2018-02-06 | ClinicalTrials.gov |
| NCT03305822 | A Study of LY900014 in Participants With Type 2 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2017-10-11 | 2017-12-14 | ClinicalTrials.gov |
| NCT03305822 | A Study of LY900014 in Participants With Type 2 Diabetes Mellitus | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2017-10-11 | 2017-12-14 | ClinicalTrials.gov |
| NCT03286218 | A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreation… | Phase1 | Recreational Drug Use | Completed | 2017-09-15 | 2017-11-20 | ClinicalTrials.gov |
| NCT03286218 | A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreation… | Phase1 | Recreational Drug Use | Completed | 2017-09-15 | 2017-11-20 | ClinicalTrials.gov |
| NCT03267732 | A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegi… | Phase1 | Healthy Adult Subjects | Completed | 2017-09-05 | 2017-10-30 | ClinicalTrials.gov |
| NCT03267732 | A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegi… | Phase1 | Healthy Adult Subjects | Completed | 2017-09-05 | 2017-10-30 | ClinicalTrials.gov |
| NCT03270644 | A Study of Lasmiditan and Propranolol in Healthy Participants | Phase1 | Healthy | Completed | 2017-08-31 | 2017-11-22 | ClinicalTrials.gov |
| NCT03259490 | This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and M… | Phase1 | Healthy | Completed | 2017-08-31 | 2017-11-13 | ClinicalTrials.gov |
| NCT03270644 | A Study of Lasmiditan and Propranolol in Healthy Participants | Phase1 | Healthy | Completed | 2017-08-31 | 2017-11-22 | ClinicalTrials.gov |
| NCT03259490 | This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and M… | Phase1 | Healthy | Completed | 2017-08-31 | 2017-11-13 | ClinicalTrials.gov |
| NCT03736486 | Mil Familias-Santa Barbara's Operational Pilot to Understand Diabetes in the La… | — | Type2 Diabetes Mellitus | Completed | 2017-08-24 | 2018-12-31 | ClinicalTrials.gov |
| NCT03736486 | Mil Familias-Santa Barbara's Operational Pilot to Understand Diabetes in the La… | — | Type2 Diabetes Mellitus | Completed | 2017-08-24 | 2018-12-31 | ClinicalTrials.gov |
| NCT03151551 | A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoria… | Phase4 | Psoriatic Arthritis | Completed | 2017-08-24 | 2019-09-04 | ClinicalTrials.gov |
| NCT03151551 | A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoria… | Phase4 | Psoriatic Arthritis | Completed | 2017-08-24 | 2019-09-04 | ClinicalTrials.gov |
| NCT03206177 | Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the U… | Phase1 | Carcinosarcoma, Ovarian | Completed | 2017-08-23 | 2024-02-13 | ClinicalTrials.gov |
| NCT03206177 | Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the U… | Phase1 | Carcinosarcoma, Ovarian | Completed | 2017-08-23 | 2024-02-13 | ClinicalTrials.gov |
| NCT03247790 | A Study of Lasmiditan in Participants With Migraine | Phase1 | Migraine Disorders | Completed | 2017-08-16 | 2018-01-15 | ClinicalTrials.gov |
| NCT03247790 | A Study of Lasmiditan in Participants With Migraine | Phase1 | Migraine Disorders | Completed | 2017-08-16 | 2018-01-15 | ClinicalTrials.gov |
| NCT03252015 | A Study of Multiple Doses of Lasmiditan in Healthy Participants | Phase1 | Healthy | Completed | 2017-08-15 | 2018-01-02 | ClinicalTrials.gov |
| NCT03252015 | A Study of Multiple Doses of Lasmiditan in Healthy Participants | Phase1 | Healthy | Completed | 2017-08-15 | 2018-01-02 | ClinicalTrials.gov |
| NCT03099538 | Ixekizumab in the Treatment of Bullous Pemphigoid | Phase2 | Bullous Pemphigoid | Completed | 2017-08-15 | 2019-06-06 | ClinicalTrials.gov |
| NCT03099538 | Ixekizumab in the Treatment of Bullous Pemphigoid | Phase2 | Bullous Pemphigoid | Completed | 2017-08-15 | 2019-06-06 | ClinicalTrials.gov |
| NCT03232983 | A Study of LY900014 Formulation at Different Injection Sites in Healthy Partici… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2017-08-14 | 2017-11-09 | ClinicalTrials.gov |
| NCT03232983 | A Study of LY900014 Formulation at Different Injection Sites in Healthy Partici… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2017-08-14 | 2017-11-09 | ClinicalTrials.gov |
| NCT03125239 | Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory A… | Phase1 | Relapsed Adult Acute Myeloid Leukemia | Completed | 2017-08-10 | 2020-06-01 | ClinicalTrials.gov |
| NCT03125239 | Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory A… | Phase1 | Relapsed Adult Acute Myeloid Leukemia | Completed | 2017-08-10 | 2020-06-01 | ClinicalTrials.gov |
| NCT02919696 | A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced… | Phase1 | Advanced Cancer | Completed | 2017-08-07 | 2019-09-03 | ClinicalTrials.gov |
| NCT02919696 | A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced… | Phase1 | Advanced Cancer | Completed | 2017-08-07 | 2019-09-03 | ClinicalTrials.gov |
| NCT03214367 | A Study of LY900014 in Participants With Type 1 Diabetes | Phase3 | Type 1 Diabetes Mellitus | Completed | 2017-07-17 | 2019-08-22 | ClinicalTrials.gov |
| NCT03220126 | A Study to Assess the Amount of LY3074828 That Gets Into the Body When Given Wi… | Phase1 | Healthy | Completed | 2017-07-17 | 2018-02-23 | ClinicalTrials.gov |
| NCT03214367 | A Study of LY900014 in Participants With Type 1 Diabetes | Phase3 | Type 1 Diabetes Mellitus | Completed | 2017-07-17 | 2019-08-22 | ClinicalTrials.gov |
| NCT03220126 | A Study to Assess the Amount of LY3074828 That Gets Into the Body When Given Wi… | Phase1 | Healthy | Completed | 2017-07-17 | 2018-02-23 | ClinicalTrials.gov |
| NCT03214380 | A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diab… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2017-07-14 | 2019-03-13 | ClinicalTrials.gov |
| NCT03214380 | A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diab… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2017-07-14 | 2019-03-13 | ClinicalTrials.gov |
| NCT03220646 | Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors | Phase2 | Brain Tumor | Active_Not_Recruiting | 2017-07-13 | 2026-07-01 | ClinicalTrials.gov |
| NCT03220646 | Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors | Phase2 | Brain Tumor | Active_Not_Recruiting | 2017-07-13 | 2026-07-01 | ClinicalTrials.gov |
| NCT03155997 | Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in … | Phase3 | Breast Cancer | Active_Not_Recruiting | 2017-07-12 | 2029-05-01 | ClinicalTrials.gov |
| NCT03155997 | Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in … | Phase3 | Breast Cancer | Active_Not_Recruiting | 2017-07-12 | 2029-05-01 | ClinicalTrials.gov |
| NCT03126591 | A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advan… | Phase1 | Soft Tissue Sarcoma | Completed | 2017-07-03 | 2023-02-21 | ClinicalTrials.gov |
| NCT03126591 | A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advan… | Phase1 | Soft Tissue Sarcoma | Completed | 2017-07-03 | 2023-02-21 | ClinicalTrials.gov |
| NCT03188510 | A Study of Two Different Formulations of LY3074828 in Healthy Participants | Phase1 | Healthy | Completed | 2017-06-30 | 2017-11-27 | ClinicalTrials.gov |
| NCT03188510 | A Study of Two Different Formulations of LY3074828 in Healthy Participants | Phase1 | Healthy | Completed | 2017-06-30 | 2017-11-27 | ClinicalTrials.gov |
| NCT03212638 | A Study of Baricitinib in Healthy Participants | Phase1 | Healthy | Completed | 2017-06-27 | 2017-11-01 | ClinicalTrials.gov |
| NCT03212638 | A Study of Baricitinib in Healthy Participants | Phase1 | Healthy | Completed | 2017-06-27 | 2017-11-01 | ClinicalTrials.gov |
| NCT03086369 | A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207… | Phase1 | Metastatic Pancreatic Cancer | Completed | 2017-06-22 | 2021-06-17 | ClinicalTrials.gov |
| NCT03086369 | A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207… | Phase1 | Metastatic Pancreatic Cancer | Completed | 2017-06-22 | 2021-06-17 | ClinicalTrials.gov |
| NCT03182920 | A Study of Lasmiditan in Healthy Participants | Phase1 | Healthy | Completed | 2017-06-16 | 2017-08-14 | ClinicalTrials.gov |
| NCT03182920 | A Study of Lasmiditan in Healthy Participants | Phase1 | Healthy | Completed | 2017-06-16 | 2017-08-14 | ClinicalTrials.gov |
| NCT03101254 | LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma | Phase1 | Melanoma | Completed | 2017-06-06 | 2020-11-11 | ClinicalTrials.gov |
| NCT03101254 | LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma | Phase1 | Melanoma | Completed | 2017-06-06 | 2020-11-11 | ClinicalTrials.gov |
| NCT03115099 | A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabe… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2017-05-31 | 2018-04-05 | ClinicalTrials.gov |
| NCT03115099 | A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabe… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2017-05-31 | 2018-04-05 | ClinicalTrials.gov |
| NCT03092934 | A Study of AK-01 (LY3295668) in Solid Tumors | Phase1 | Neoplasms | Completed | 2017-05-29 | 2020-04-20 | ClinicalTrials.gov |
| NCT03092934 | A Study of AK-01 (LY3295668) in Solid Tumors | Phase1 | Neoplasms | Completed | 2017-05-29 | 2020-04-20 | ClinicalTrials.gov |
| NCT03130439 | Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastat… | Phase2 | Breast Cancer | Terminated | 2017-05-26 | 2022-01-30 | ClinicalTrials.gov |
| NCT03130439 | Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastat… | Phase2 | Breast Cancer | Terminated | 2017-05-26 | 2022-01-30 | ClinicalTrials.gov |
| NCT03131687 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus | Phase2 | Type 2 Diabetes Mellitus | Completed | 2017-05-24 | 2018-08-01 | ClinicalTrials.gov |
| NCT03131687 | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus | Phase2 | Type 2 Diabetes Mellitus | Completed | 2017-05-24 | 2018-08-01 | ClinicalTrials.gov |
| NCT03148431 | A Study of LY3002815 in Healthy Participants | Phase1 | Healthy | Terminated | 2017-05-24 | 2018-09-26 | ClinicalTrials.gov |
| NCT03166124 | A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabe… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2017-05-24 | 2017-11-18 | ClinicalTrials.gov |
| NCT03148431 | A Study of LY3002815 in Healthy Participants | Phase1 | Healthy | Terminated | 2017-05-24 | 2018-09-26 | ClinicalTrials.gov |
| NCT03166124 | A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabe… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2017-05-24 | 2017-11-18 | ClinicalTrials.gov |
| NCT03129100 | A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axia… | Phase3 | Axial Spondyloarthritis | Completed | 2017-05-09 | 2021-05-27 | ClinicalTrials.gov |
| NCT03129100 | A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axia… | Phase3 | Axial Spondyloarthritis | Completed | 2017-05-09 | 2021-05-27 | ClinicalTrials.gov |
| NCT03137160 | An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderm… | Phase2 | Pyoderma Gangrenosum | Completed | 2017-05-04 | 2018-08-16 | ClinicalTrials.gov |
| NCT03137160 | An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderm… | Phase2 | Pyoderma Gangrenosum | Completed | 2017-05-04 | 2018-08-16 | ClinicalTrials.gov |
| NCT03157128 | A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors,… | Phase1 | Non-Small Cell Lung Cancer | Active_Not_Recruiting | 2017-05-02 | 2027-02-01 | ClinicalTrials.gov |
| NCT03157128 | A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors,… | Phase1 | Non-Small Cell Lung Cancer | Active_Not_Recruiting | 2017-05-02 | 2027-02-01 | ClinicalTrials.gov |
| NCT03072147 | Teriparatide as a Chondroregenerative Therapy in OA | Phase2 | Knee Osteoarthritis | Completed | 2017-05-01 | 2022-09-30 | ClinicalTrials.gov |
| NCT03072147 | Teriparatide as a Chondroregenerative Therapy in OA | Phase2 | Knee Osteoarthritis | Completed | 2017-05-01 | 2022-09-30 | ClinicalTrials.gov |
| NCT03053622 | A Study of Mirikizumab (LY3074828) Injection in Healthy Participants | Phase1 | Healthy | Completed | 2017-04-24 | 2018-04-03 | ClinicalTrials.gov |
| NCT03053622 | A Study of Mirikizumab (LY3074828) Injection in Healthy Participants | Phase1 | Healthy | Completed | 2017-04-24 | 2018-04-03 | ClinicalTrials.gov |
| NCT03040362 | Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Adm… | Phase1 | Healthy | Completed | 2017-04-20 | 2017-05-06 | ClinicalTrials.gov |
| NCT03040362 | Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Adm… | Phase1 | Healthy | Completed | 2017-04-20 | 2017-05-06 | ClinicalTrials.gov |
| NCT03073213 | A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris | Phase1 | Psoriasis | Completed | 2017-04-13 | 2019-05-14 | ClinicalTrials.gov |
| NCT03073213 | A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris | Phase1 | Psoriasis | Completed | 2017-04-13 | 2019-05-14 | ClinicalTrials.gov |
| NCT03099109 | A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Rela… | Phase1 | Solid Tumor | Completed | 2017-04-12 | 2023-08-30 | ClinicalTrials.gov |
| NCT03099109 | A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Rela… | Phase1 | Solid Tumor | Completed | 2017-04-12 | 2023-08-30 | ClinicalTrials.gov |
| NCT03099148 | A Study of LY3337641 in Healthy Participants | Phase1 | Healthy | Completed | 2017-04-04 | 2017-05-31 | ClinicalTrials.gov |
| NCT03099148 | A Study of LY3337641 in Healthy Participants | Phase1 | Healthy | Completed | 2017-04-04 | 2017-05-31 | ClinicalTrials.gov |
| NCT03009162 | Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function | Phase1 | Migraine | Completed | 2017-04-01 | 2017-06-02 | ClinicalTrials.gov |
| NCT03009162 | Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function | Phase1 | Migraine | Completed | 2017-04-01 | 2017-06-02 | ClinicalTrials.gov |
| NCT03073200 | Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Modera… | Phase3 | Plaque Psoriasis | Completed | 2017-03-28 | 2021-03-23 | ClinicalTrials.gov |
| NCT03073200 | Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Modera… | Phase3 | Plaque Psoriasis | Completed | 2017-03-28 | 2021-03-23 | ClinicalTrials.gov |
| NCT03076970 | Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral … | Phase1 | Migraine | Completed | 2017-03-21 | 2017-04-13 | ClinicalTrials.gov |
| NCT03076970 | Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral … | Phase1 | Migraine | Completed | 2017-03-21 | 2017-04-13 | ClinicalTrials.gov |
| NCT04380324 | A Study of NKTR-358 (LY3471851) in Healthy Participants | Phase1 | Healthy | Completed | 2017-03-19 | 2019-01-20 | ClinicalTrials.gov |
| NCT04380324 | A Study of NKTR-358 (LY3471851) in Healthy Participants | Phase1 | Healthy | Completed | 2017-03-19 | 2019-01-20 | ClinicalTrials.gov |
| NCT02972658 | A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia | Phase3 | Alzheimer's Disease | Terminated | 2017-03-15 | 2018-10-02 | ClinicalTrials.gov |
| NCT03083561 | A Study of LY3337641 in Japanese and Caucasian Healthy Participants | Phase1 | Healthy | Completed | 2017-03-15 | 2017-05-25 | ClinicalTrials.gov |
| NCT03083561 | A Study of LY3337641 in Japanese and Caucasian Healthy Participants | Phase1 | Healthy | Completed | 2017-03-15 | 2017-05-25 | ClinicalTrials.gov |
| NCT02972658 | A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia | Phase3 | Alzheimer's Disease | Terminated | 2017-03-15 | 2018-10-02 | ClinicalTrials.gov |
| NCT03040479 | Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Norma… | Phase1 | Migraine | Completed | 2017-03-14 | 2017-07-17 | ClinicalTrials.gov |
| NCT03040479 | Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Norma… | Phase1 | Migraine | Completed | 2017-03-14 | 2017-07-17 | ClinicalTrials.gov |
| NCT03057145 | Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid T… | Phase1 | Solid Tumor | Completed | 2017-03-10 | 2021-06-09 | ClinicalTrials.gov |
| NCT03057145 | Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid T… | Phase1 | Solid Tumor | Completed | 2017-03-10 | 2021-06-09 | ClinicalTrials.gov |
| NCT03026504 | Baricitinib in Relapsing Giant Cell Arteritis | Phase2 | Arteritis, Giant Cell | Completed | 2017-03-09 | 2021-04-12 | ClinicalTrials.gov |
| NCT03026504 | Baricitinib in Relapsing Giant Cell Arteritis | Phase2 | Arteritis, Giant Cell | Completed | 2017-03-09 | 2021-04-12 | ClinicalTrials.gov |
| NCT03057977 | EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced… | Phase3 | Heart Failure | Completed | 2017-03-06 | 2020-05-28 | ClinicalTrials.gov |
| NCT03025009 | A Study of LY3192767 in Healthy Participants | Phase1 | Healthy | Completed | 2017-03-06 | 2018-04-11 | ClinicalTrials.gov |
| NCT03057977 | EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced… | Phase3 | Heart Failure | Completed | 2017-03-06 | 2020-05-28 | ClinicalTrials.gov |
| NCT03025009 | A Study of LY3192767 in Healthy Participants | Phase1 | Healthy | Completed | 2017-03-06 | 2018-04-11 | ClinicalTrials.gov |
| NCT02898077 | A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants W… | Phase3 | Gastroesophageal Junction Adenocarcinoma | Completed | 2017-03-02 | 2021-04-12 | ClinicalTrials.gov |
| NCT03057951 | EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserv… | Phase3 | Heart Failure | Completed | 2017-03-02 | 2021-04-26 | ClinicalTrials.gov |
| NCT03057951 | EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserv… | Phase3 | Heart Failure | Completed | 2017-03-02 | 2021-04-26 | ClinicalTrials.gov |
| NCT02898077 | A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants W… | Phase3 | Gastroesophageal Junction Adenocarcinoma | Completed | 2017-03-02 | 2021-04-12 | ClinicalTrials.gov |
| NCT02923921 | Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-… | Phase3 | Pancreatic Cancer | Completed | 2017-03-01 | 2020-03-05 | ClinicalTrials.gov |
| NCT02923921 | Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-… | Phase3 | Pancreatic Cancer | Completed | 2017-03-01 | 2020-03-05 | ClinicalTrials.gov |
| NCT03056456 | A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an … | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2017-02-23 | 2017-06-19 | ClinicalTrials.gov |
| NCT03056456 | A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an … | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2017-02-23 | 2017-06-19 | ClinicalTrials.gov |
| NCT02981940 | A Study of Abemaciclib in Recurrent Glioblastoma | Phase2 | Glioblastoma | Active_Not_Recruiting | 2017-02-09 | 2026-06-30 | ClinicalTrials.gov |
| NCT02977780 | INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) | Phase2 | Glioblastoma | Recruiting | 2017-02-09 | 2028-04-30 | ClinicalTrials.gov |
| NCT02981940 | A Study of Abemaciclib in Recurrent Glioblastoma | Phase2 | Glioblastoma | Active_Not_Recruiting | 2017-02-09 | 2026-06-30 | ClinicalTrials.gov |
| NCT02977780 | INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) | Phase2 | Glioblastoma | Recruiting | 2017-02-09 | 2028-04-30 | ClinicalTrials.gov |
| NCT02959190 | A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine | Phase3 | Migraine | Completed | 2017-02-07 | 2019-08-10 | ClinicalTrials.gov |
| NCT02959190 | A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine | Phase3 | Migraine | Completed | 2017-02-07 | 2019-08-10 | ClinicalTrials.gov |
| NCT03018938 | A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Parti… | Phase4 | Type 2 Diabetes Mellitus | Completed | 2017-02-06 | 2019-07-12 | ClinicalTrials.gov |
| NCT03018938 | A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Parti… | Phase4 | Type 2 Diabetes Mellitus | Completed | 2017-02-06 | 2019-07-12 | ClinicalTrials.gov |
| NCT03027284 | A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Met… | Phase1 | Advanced Cancer | Completed | 2017-02-03 | 2020-03-17 | ClinicalTrials.gov |
| NCT03027284 | A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Met… | Phase1 | Advanced Cancer | Completed | 2017-02-03 | 2020-03-17 | ClinicalTrials.gov |
| NCT03019536 | A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheime… | Phase1 | Alzheimer Disease | Completed | 2017-01-31 | 2019-06-05 | ClinicalTrials.gov |
| NCT03019536 | A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheime… | Phase1 | Alzheimer Disease | Completed | 2017-01-31 | 2019-06-05 | ClinicalTrials.gov |
| NCT03012334 | The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participan… | Phase1 | Migraine | Completed | 2017-01-16 | 2017-06-08 | ClinicalTrials.gov |
| NCT03012334 | The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participan… | Phase1 | Migraine | Completed | 2017-01-16 | 2017-06-08 | ClinicalTrials.gov |
| NCT03023826 | A Study of LY3202626 in Healthy Participants | Phase1 | Healthy | Completed | 2017-01-15 | 2017-04-04 | ClinicalTrials.gov |
| NCT03023826 | A Study of LY3202626 in Healthy Participants | Phase1 | Healthy | Completed | 2017-01-15 | 2017-04-04 | ClinicalTrials.gov |
| NCT03019549 | A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Ros… | Phase1 | Healthy | Completed | 2017-01-12 | 2017-05-22 | ClinicalTrials.gov |
| NCT03019549 | A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Ros… | Phase1 | Healthy | Completed | 2017-01-12 | 2017-05-22 | ClinicalTrials.gov |
| NCT02981342 | A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in… | Phase2 | Pancreatic Ductal Adenocarcinoma | Completed | 2017-01-12 | 2018-11-09 | ClinicalTrials.gov |
| NCT02981342 | A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in… | Phase2 | Pancreatic Ductal Adenocarcinoma | Completed | 2017-01-12 | 2018-11-09 | ClinicalTrials.gov |
| NCT03050229 | SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hyperte… | Phase4 | Nocturnal Hypertension | Completed | 2017-01-01 | 2018-03-01 | ClinicalTrials.gov |
| NCT03050229 | SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hyperte… | Phase4 | Nocturnal Hypertension | Completed | 2017-01-01 | 2018-03-01 | ClinicalTrials.gov |
| NCT02963766 | A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diab… | Phase3 | Type 2 Diabetes | Completed | 2016-12-29 | 2022-01-12 | ClinicalTrials.gov |
| NCT02963766 | A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diab… | Phase3 | Type 2 Diabetes | Completed | 2016-12-29 | 2022-01-12 | ClinicalTrials.gov |
| NCT02993471 | A Study of Ixekizumab in Participants With Plaque Psoriasis | Phase1 | Psoriasis | Completed | 2016-12-22 | 2017-11-21 | ClinicalTrials.gov |
| NCT02993471 | A Study of Ixekizumab in Participants With Plaque Psoriasis | Phase1 | Psoriasis | Completed | 2016-12-22 | 2017-11-21 | ClinicalTrials.gov |
| NCT02942914 | A Study of LY3209590 in Healthy Participants and Participants With Type 2 Diabe… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2016-12-20 | 2017-10-18 | ClinicalTrials.gov |
| NCT02942914 | A Study of LY3209590 in Healthy Participants and Participants With Type 2 Diabe… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2016-12-20 | 2017-10-18 | ClinicalTrials.gov |
| NCT02891226 | A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease | Phase2 | Crohn's Disease | Completed | 2016-12-14 | 2021-02-05 | ClinicalTrials.gov |
| NCT02891226 | A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease | Phase2 | Crohn's Disease | Completed | 2016-12-14 | 2021-02-05 | ClinicalTrials.gov |
| NCT02989389 | A Study of LY3323795 in Healthy Participants | Phase1 | Healthy | Completed | 2016-12-12 | 2017-07-21 | ClinicalTrials.gov |
| NCT02989389 | A Study of LY3323795 in Healthy Participants | Phase1 | Healthy | Completed | 2016-12-12 | 2017-07-21 | ClinicalTrials.gov |
| NCT03047369 | The Myelin Disorders Biorepository Project | — | Leukodystrophy | Recruiting | 2016-12-08 | 2030-12-08 | ClinicalTrials.gov |
| NCT03047369 | The Myelin Disorders Biorepository Project | — | Leukodystrophy | Recruiting | 2016-12-08 | 2030-12-08 | ClinicalTrials.gov |
| NCT02972645 | A Study of LY3305677 in Healthy Participants | Phase1 | Healthy | Completed | 2016-12-05 | 2017-07-14 | ClinicalTrials.gov |
| NCT02763566 | A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer | Phase3 | Breast Cancer | Active_Not_Recruiting | 2016-12-05 | 2028-03-01 | ClinicalTrials.gov |
| NCT02763566 | A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer | Phase3 | Breast Cancer | Active_Not_Recruiting | 2016-12-05 | 2028-03-01 | ClinicalTrials.gov |
| NCT02972645 | A Study of LY3305677 in Healthy Participants | Phase1 | Healthy | Completed | 2016-12-05 | 2017-07-14 | ClinicalTrials.gov |
| NCT02963779 | A Study of LY2775240 in Healthy Participants | Phase1 | Healthy | Completed | 2016-12-01 | 2017-10-05 | ClinicalTrials.gov |
| NCT02973100 | A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabet… | Phase2 | Type 2 Diabetes | Completed | 2016-12-01 | 2017-08-14 | ClinicalTrials.gov |
| NCT02973100 | A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabet… | Phase2 | Type 2 Diabetes | Completed | 2016-12-01 | 2017-08-14 | ClinicalTrials.gov |
| NCT02963779 | A Study of LY2775240 in Healthy Participants | Phase1 | Healthy | Completed | 2016-12-01 | 2017-10-05 | ClinicalTrials.gov |
| NCT02937272 | A Study of LY3200882 in Participants With Solid Tumors | Phase1 | Solid Tumor | Active_Not_Recruiting | 2016-11-21 | 2027-08-01 | ClinicalTrials.gov |
| NCT02937272 | A Study of LY3200882 in Participants With Solid Tumors | Phase1 | Solid Tumor | Active_Not_Recruiting | 2016-11-21 | 2027-08-01 | ClinicalTrials.gov |
| NCT03464045 | Empa PASS on Urinary Tract Malignancies | — | Diabetes Mellitus, Type 2 | Completed | 2016-11-16 | 2024-03-11 | ClinicalTrials.gov |
| NCT03464045 | Empa PASS on Urinary Tract Malignancies | — | Diabetes Mellitus, Type 2 | Completed | 2016-11-16 | 2024-03-11 | ClinicalTrials.gov |
| NCT02779751 | A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Can… | Phase1 | Non Small Cell Lung Cancer | Active_Not_Recruiting | 2016-11-14 | 2026-12-01 | ClinicalTrials.gov |
| NCT02955953 | A Study Comparing Two Formulations of Insulin Glargine in Healthy Participants | Phase1 | Healthy | Completed | 2016-11-14 | 2017-01-04 | ClinicalTrials.gov |
| NCT02955953 | A Study Comparing Two Formulations of Insulin Glargine in Healthy Participants | Phase1 | Healthy | Completed | 2016-11-14 | 2017-01-04 | ClinicalTrials.gov |
| NCT02779751 | A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Can… | Phase1 | Non Small Cell Lung Cancer | Active_Not_Recruiting | 2016-11-14 | 2026-12-01 | ClinicalTrials.gov |
| NCT02920996 | Merestinib In Non-Small Cell Lung Cancer And Solid Tumors | Phase2 | Carcinoma, Non-Small-Cell Lung | Terminated | 2016-11-11 | 2023-10-01 | ClinicalTrials.gov |
| NCT02920996 | Merestinib In Non-Small Cell Lung Cancer And Solid Tumors | Phase2 | Carcinoma, Non-Small-Cell Lung | Terminated | 2016-11-11 | 2023-10-01 | ClinicalTrials.gov |
| NCT02959177 | A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migr… | Phase2 | Migraine | Completed | 2016-11-09 | 2019-01-18 | ClinicalTrials.gov |
| NCT02959177 | A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migr… | Phase2 | Migraine | Completed | 2016-11-09 | 2019-01-18 | ClinicalTrials.gov |
| NCT02896868 | A Study of LY3041658 in Participants With Skin Diseases | Phase1 | Skin Diseases | Completed | 2016-11-08 | 2019-03-19 | ClinicalTrials.gov |
| NCT02896868 | A Study of LY3041658 in Participants With Skin Diseases | Phase1 | Skin Diseases | Completed | 2016-11-08 | 2019-03-19 | ClinicalTrials.gov |
| NCT02784795 | A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors | Phase1 | Solid Tumor | Terminated | 2016-11-04 | 2020-02-13 | ClinicalTrials.gov |
| NCT02784795 | A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors | Phase1 | Solid Tumor | Terminated | 2016-11-04 | 2020-02-13 | ClinicalTrials.gov |
| NCT02941601 | A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy… | Phase2 | Locally Advanced Squamous Non-Small Cell Lung Cancer | Withdrawn | 2016-11-01 | 2019-02-01 | ClinicalTrials.gov |
| NCT02951780 | A Study of LY3185643 and rGlucagon in Healthy Participants | Phase1 | Healthy | Completed | 2016-11-01 | 2017-03-01 | ClinicalTrials.gov |
| NCT02942654 | A Study of LY900014 Formulation in Healthy Participants | Phase1 | Healthy | Completed | 2016-11-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02941601 | A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy… | Phase2 | Locally Advanced Squamous Non-Small Cell Lung Cancer | Withdrawn | 2016-11-01 | 2019-02-01 | ClinicalTrials.gov |
| NCT02942654 | A Study of LY900014 Formulation in Healthy Participants | Phase1 | Healthy | Completed | 2016-11-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02831491 | A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Part… | Phase2 | Stage IV Non-small Cell Lung Cancer | Withdrawn | 2016-11-01 | 2018-01-01 | ClinicalTrials.gov |
| NCT02951780 | A Study of LY3185643 and rGlucagon in Healthy Participants | Phase1 | Healthy | Completed | 2016-11-01 | 2017-03-01 | ClinicalTrials.gov |
| NCT02831491 | A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Part… | Phase2 | Stage IV Non-small Cell Lung Cancer | Withdrawn | 2016-11-01 | 2018-01-01 | ClinicalTrials.gov |
| NCT02951598 | A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer… | — | Alzheimer Disease | Active_Not_Recruiting | 2016-10-29 | 2026-04-28 | ClinicalTrials.gov |
| NCT02951598 | A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer… | — | Alzheimer Disease | Active_Not_Recruiting | 2016-10-29 | 2026-04-28 | ClinicalTrials.gov |
| NCT02789345 | A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib … | Phase1 | Non-small Cell Lung Cancer | Completed | 2016-10-24 | 2022-05-09 | ClinicalTrials.gov |
| NCT02789345 | A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib … | Phase1 | Non-small Cell Lung Cancer | Completed | 2016-10-24 | 2022-05-09 | ClinicalTrials.gov |
| NCT02745769 | A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Ag… | Phase1 | Advanced Cancer | Completed | 2016-10-21 | 2019-01-22 | ClinicalTrials.gov |
| NCT02745769 | A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Ag… | Phase1 | Advanced Cancer | Completed | 2016-10-21 | 2019-01-22 | ClinicalTrials.gov |
| NCT02783599 | A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma | Phase1 | Soft Tissue Sarcoma | Completed | 2016-10-11 | 2018-07-05 | ClinicalTrials.gov |
| NCT02783599 | A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma | Phase1 | Soft Tissue Sarcoma | Completed | 2016-10-11 | 2018-07-05 | ClinicalTrials.gov |
| NCT02906618 | Study of LY3039478 in Healthy Participants | Phase1 | Healthy | Completed | 2016-10-04 | 2016-11-11 | ClinicalTrials.gov |
| NCT02906618 | Study of LY3039478 in Healthy Participants | Phase1 | Healthy | Completed | 2016-10-04 | 2016-11-11 | ClinicalTrials.gov |
| NCT02918539 | Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Tri… | — | Alzheimer Disease | Completed | 2016-10-01 | 2017-10-18 | ClinicalTrials.gov |
| NCT02918539 | Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Tri… | — | Alzheimer Disease | Completed | 2016-10-01 | 2017-10-18 | ClinicalTrials.gov |
| NCT02897349 | Linagliptin Add-on to Insulin Background Therapy | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2016-09-30 | 2019-01-18 | ClinicalTrials.gov |
| NCT02897349 | Linagliptin Add-on to Insulin Background Therapy | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2016-09-30 | 2019-01-18 | ClinicalTrials.gov |
| NCT02857270 | A Study of LY3214996 Administered Alone or in Combination With Other Agents in … | Phase1 | Advanced Cancer | Completed | 2016-09-29 | 2022-10-24 | ClinicalTrials.gov |
| NCT02857270 | A Study of LY3214996 Administered Alone or in Combination With Other Agents in … | Phase1 | Advanced Cancer | Completed | 2016-09-29 | 2022-10-24 | ClinicalTrials.gov |
| NCT02766517 | Biomarker Study in Participants With Migraine | Early_Phase1 | Migraine Disorders | Completed | 2016-09-28 | 2017-01-01 | ClinicalTrials.gov |
| NCT02766517 | Biomarker Study in Participants With Migraine | Early_Phase1 | Migraine Disorders | Completed | 2016-09-28 | 2017-01-01 | ClinicalTrials.gov |
| NCT02778126 | A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2016-09-22 | 2017-07-27 | ClinicalTrials.gov |
| NCT02778126 | A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2016-09-22 | 2017-07-27 | ClinicalTrials.gov |
| NCT02899988 | A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaq… | Phase2 | Plaque Psoriasis | Completed | 2016-09-14 | 2019-05-08 | ClinicalTrials.gov |
| NCT05341102 | A Study of Single and Repeated Doses of LY3556050 in Healthy Participants | Phase1 | Healthy | Completed | 2016-09-14 | 2017-06-02 | ClinicalTrials.gov |
| NCT02747004 | A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women… | Phase2 | Metastatic Breast Cancer | Active_Not_Recruiting | 2016-09-14 | 2026-12-01 | ClinicalTrials.gov |
| NCT02747004 | A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women… | Phase2 | Metastatic Breast Cancer | Active_Not_Recruiting | 2016-09-14 | 2026-12-01 | ClinicalTrials.gov |
| NCT05341102 | A Study of Single and Repeated Doses of LY3556050 in Healthy Participants | Phase1 | Healthy | Completed | 2016-09-14 | 2017-06-02 | ClinicalTrials.gov |
| NCT02899988 | A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaq… | Phase2 | Plaque Psoriasis | Completed | 2016-09-14 | 2019-05-08 | ClinicalTrials.gov |
| NCT02581215 | Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic… | Phase2 | Pancreatic Cancer | Completed | 2016-09-11 | 2022-01-27 | ClinicalTrials.gov |
| NCT02581215 | Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic… | Phase2 | Pancreatic Cancer | Completed | 2016-09-11 | 2022-01-27 | ClinicalTrials.gov |
| NCT03050619 | Characteristics of Empagliflozin Initiators | — | Type 2 Diabetes | Completed | 2016-09-10 | 2016-10-14 | ClinicalTrials.gov |
| NCT03050619 | Characteristics of Empagliflozin Initiators | — | Type 2 Diabetes | Completed | 2016-09-10 | 2016-10-14 | ClinicalTrials.gov |
| NCT02836600 | A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors | Phase1 | Advanced Solid Tumor | Completed | 2016-09-09 | 2023-05-30 | ClinicalTrials.gov |
| NCT02836600 | A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors | Phase1 | Advanced Solid Tumor | Completed | 2016-09-09 | 2023-05-30 | ClinicalTrials.gov |
| NCT02737072 | A Study of LY2510924 and Durvalumab in Participants With Solid Tumors | Phase1 | Solid Tumor | Terminated | 2016-09-01 | 2017-09-25 | ClinicalTrials.gov |
| NCT02917733 | A Study of the Absorption, Distribution, Metabolism and Excretion of LY3039478 … | Phase1 | Healthy | Completed | 2016-09-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT02914379 | A Study of LY3337641 in Healthy Male Participants | Phase1 | Healthy | Completed | 2016-09-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT02737072 | A Study of LY2510924 and Durvalumab in Participants With Solid Tumors | Phase1 | Solid Tumor | Terminated | 2016-09-01 | 2017-09-25 | ClinicalTrials.gov |
| NCT02917733 | A Study of the Absorption, Distribution, Metabolism and Excretion of LY3039478 … | Phase1 | Healthy | Completed | 2016-09-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT02914379 | A Study of LY3337641 in Healthy Male Participants | Phase1 | Healthy | Completed | 2016-09-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT02677116 | A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in … | Phase1 | Neoplasm Metastasis | Completed | 2016-08-29 | 2019-04-03 | ClinicalTrials.gov |
| NCT02677116 | A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in … | Phase1 | Neoplasm Metastasis | Completed | 2016-08-29 | 2019-04-03 | ClinicalTrials.gov |
| NCT02674386 | Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a … | Phase3 | Osteoarthritis | Completed | 2016-08-23 | 2019-07-15 | ClinicalTrials.gov |
| NCT02674386 | Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a … | Phase3 | Osteoarthritis | Completed | 2016-08-23 | 2019-07-15 | ClinicalTrials.gov |
| NCT02628028 | A Study of LY3337641 in Rheumatoid Arthritis | Phase2 | Rheumatoid Arthritis | Terminated | 2016-08-22 | 2018-08-15 | ClinicalTrials.gov |
| NCT02628028 | A Study of LY3337641 in Rheumatoid Arthritis | Phase2 | Rheumatoid Arthritis | Terminated | 2016-08-22 | 2018-08-15 | ClinicalTrials.gov |
| NCT02860780 | A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participa… | Phase1 | Advanced Cancer | Completed | 2016-08-10 | 2017-05-15 | ClinicalTrials.gov |
| NCT02860780 | A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participa… | Phase1 | Advanced Cancer | Completed | 2016-08-10 | 2017-05-15 | ClinicalTrials.gov |
| NCT02757352 | A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Sp… | Phase3 | Axial Spondyloarthritis | Completed | 2016-08-02 | 2019-05-07 | ClinicalTrials.gov |
| NCT02757352 | A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Sp… | Phase3 | Axial Spondyloarthritis | Completed | 2016-08-02 | 2019-05-07 | ClinicalTrials.gov |
| NCT02750410 | A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes | Phase4 | Type 2 Diabetes | Completed | 2016-08-01 | 2018-06-18 | ClinicalTrials.gov |
| NCT02925234 | The Drug Rediscovery Protocol (DRUP Trial) | Phase2 | Cancer | Recruiting | 2016-08-01 | 2027-12-01 | ClinicalTrials.gov |
| NCT02925234 | The Drug Rediscovery Protocol (DRUP Trial) | Phase2 | Cancer | Recruiting | 2016-08-01 | 2027-12-01 | ClinicalTrials.gov |
| NCT02884089 | A Study of the Effect of Abemaciclib on Metformin and Iohexol in Healthy Partic… | Phase1 | Healthy | Completed | 2016-08-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02750410 | A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes | Phase4 | Type 2 Diabetes | Completed | 2016-08-01 | 2018-06-18 | ClinicalTrials.gov |
| NCT02884089 | A Study of the Effect of Abemaciclib on Metformin and Iohexol in Healthy Partic… | Phase1 | Healthy | Completed | 2016-08-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02821910 | Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Linaglip… | Phase1 | Healthy | Completed | 2016-07-20 | 2016-10-31 | ClinicalTrials.gov |
| NCT02821910 | Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Linaglip… | Phase1 | Healthy | Completed | 2016-07-20 | 2016-10-31 | ClinicalTrials.gov |
| NCT02797951 | A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache | Phase3 | Episodic Cluster Headache | Completed | 2016-07-13 | 2021-01-21 | ClinicalTrials.gov |
| NCT02797951 | A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache | Phase3 | Episodic Cluster Headache | Completed | 2016-07-13 | 2021-01-21 | ClinicalTrials.gov |
| NCT02836613 | A Study of Galcanezumab in Healthy Participants. | Phase1 | Healthy | Completed | 2016-07-01 | 2017-11-09 | ClinicalTrials.gov |
| NCT02846987 | Study of Abemaciclib in Dedifferentiated Liposarcoma | Phase2 | Sarcoma | Active_Not_Recruiting | 2016-07-01 | 2026-07-01 | ClinicalTrials.gov |
| NCT02783573 | A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disea… | Phase3 | Alzheimer's Disease | Terminated | 2016-07-01 | 2018-09-28 | ClinicalTrials.gov |
| NCT02846987 | Study of Abemaciclib in Dedifferentiated Liposarcoma | Phase2 | Sarcoma | Active_Not_Recruiting | 2016-07-01 | 2026-07-01 | ClinicalTrials.gov |
| NCT02818335 | A Study of LY3023414 Formulations and the Effect of Food | Phase1 | Healthy | Completed | 2016-07-01 | 2016-10-01 | ClinicalTrials.gov |
| NCT02783573 | A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disea… | Phase3 | Alzheimer's Disease | Terminated | 2016-07-01 | 2018-09-28 | ClinicalTrials.gov |
| NCT02818335 | A Study of LY3023414 Formulations and the Effect of Food | Phase1 | Healthy | Completed | 2016-07-01 | 2016-10-01 | ClinicalTrials.gov |
| NCT02836613 | A Study of Galcanezumab in Healthy Participants. | Phase1 | Healthy | Completed | 2016-07-01 | 2017-11-09 | ClinicalTrials.gov |
| NCT02791334 | A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination … | Phase1 | Solid Tumor | Completed | 2016-06-29 | 2024-06-27 | ClinicalTrials.gov |
| NCT02791334 | A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination … | Phase1 | Solid Tumor | Completed | 2016-06-29 | 2024-06-27 | ClinicalTrials.gov |
| NCT02791191 | A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer… | Phase2 | Alzheimer's Disease | Terminated | 2016-06-16 | 2018-07-02 | ClinicalTrials.gov |
| NCT02718911 | A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Particip… | Phase1 | Solid Tumor | Completed | 2016-06-16 | 2018-12-14 | ClinicalTrials.gov |
| NCT02718911 | A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Particip… | Phase1 | Solid Tumor | Completed | 2016-06-16 | 2018-12-14 | ClinicalTrials.gov |
| NCT02791191 | A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer… | Phase2 | Alzheimer's Disease | Terminated | 2016-06-16 | 2018-07-02 | ClinicalTrials.gov |
| NCT02734160 | A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants W… | Phase1 | Metastatic Pancreatic Cancer | Completed | 2016-06-15 | 2019-04-17 | ClinicalTrials.gov |
| NCT02734160 | A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants W… | Phase1 | Metastatic Pancreatic Cancer | Completed | 2016-06-15 | 2019-04-17 | ClinicalTrials.gov |
| NCT02795858 | A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients Wi… | Phase2 | Carcinoid Tumors | Completed | 2016-06-14 | 2023-12-31 | ClinicalTrials.gov |
| NCT02795858 | A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients Wi… | Phase2 | Carcinoid Tumors | Completed | 2016-06-14 | 2023-12-31 | ClinicalTrials.gov |
| NCT03402919 | Comprehensive Assessment of Neurodegeneration and Dementia | — | Dementia | Recruiting | 2016-06-01 | 2029-12-01 | ClinicalTrials.gov |
| NCT03402919 | Comprehensive Assessment of Neurodegeneration and Dementia | — | Dementia | Recruiting | 2016-06-01 | 2029-12-01 | ClinicalTrials.gov |
| NCT02760602 | A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's D… | Phase3 | Alzheimer's Disease | Terminated | 2016-06-01 | 2017-05-01 | ClinicalTrials.gov |
| NCT02760602 | A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's D… | Phase3 | Alzheimer's Disease | Terminated | 2016-06-01 | 2017-05-01 | ClinicalTrials.gov |
| NCT02675231 | A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or… | Phase2 | Hormone Receptor Positive Breast Cancer | Completed | 2016-05-23 | 2023-11-09 | ClinicalTrials.gov |
| NCT02675231 | A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or… | Phase2 | Hormone Receptor Positive Breast Cancer | Completed | 2016-05-23 | 2023-11-09 | ClinicalTrials.gov |
| NCT02711553 | A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Met… | Phase2 | Biliary Tract Cancer | Active_Not_Recruiting | 2016-05-19 | 2026-12-01 | ClinicalTrials.gov |
| NCT02711553 | A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Met… | Phase2 | Biliary Tract Cancer | Active_Not_Recruiting | 2016-05-19 | 2026-12-01 | ClinicalTrials.gov |
| NCT02758171 | Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin … | Phase1 | Healthy | Completed | 2016-05-17 | 2016-08-03 | ClinicalTrials.gov |
| NCT02758171 | Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin … | Phase1 | Healthy | Completed | 2016-05-17 | 2016-08-03 | ClinicalTrials.gov |
| NCT02735980 | A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease… | Phase2 | Small Cell Lung Cancer | Completed | 2016-05-11 | 2019-02-12 | ClinicalTrials.gov |
| NCT02735980 | A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease… | Phase2 | Small Cell Lung Cancer | Completed | 2016-05-11 | 2019-02-12 | ClinicalTrials.gov |
| NCT02759107 | A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants Wit… | Phase1 | Healthy | Completed | 2016-05-11 | 2017-06-26 | ClinicalTrials.gov |
| NCT02759107 | A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants Wit… | Phase1 | Healthy | Completed | 2016-05-11 | 2017-06-26 | ClinicalTrials.gov |
| NCT02632747 | Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2016-05-10 | 2019-07-02 | ClinicalTrials.gov |
| NCT02632747 | Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2016-05-10 | 2019-07-02 | ClinicalTrials.gov |
| NCT02652871 | LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Ac… | Phase1 | Leukemia | Completed | 2016-05-09 | 2019-07-16 | ClinicalTrials.gov |
| NCT02652871 | LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Ac… | Phase1 | Leukemia | Completed | 2016-05-09 | 2019-07-16 | ClinicalTrials.gov |
| NCT02452008 | Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in … | Phase2 | Prostate Cancer | Active_Not_Recruiting | 2016-05-03 | 2026-12-01 | ClinicalTrials.gov |
| NCT02452008 | Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in … | Phase2 | Prostate Cancer | Active_Not_Recruiting | 2016-05-03 | 2026-12-01 | ClinicalTrials.gov |
| NCT02696785 | A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographi… | Phase3 | Spondyloarthritis | Completed | 2016-05-02 | 2018-10-17 | ClinicalTrials.gov |
| NCT02696785 | A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographi… | Phase3 | Spondyloarthritis | Completed | 2016-05-02 | 2018-10-17 | ClinicalTrials.gov |
| NCT02770521 | A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese P… | Phase1 | Healthy | Completed | 2016-05-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02779738 | A Study of Merestinib (LY2801653) in Healthy Participants | Phase1 | Healthy | Completed | 2016-05-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02792400 | The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and So… | Na | Type 2 Diabetes | Completed | 2016-05-01 | 2018-07-01 | ClinicalTrials.gov |
| NCT02758613 | A Study of Baricitinib (LY3009104) in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2016-05-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02770521 | A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese P… | Phase1 | Healthy | Completed | 2016-05-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02758613 | A Study of Baricitinib (LY3009104) in Healthy Chinese Participants | Phase1 | Healthy | Completed | 2016-05-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02605174 | Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the… | Phase3 | Migraine With or Without Aura | Completed | 2016-05-01 | 2017-06-30 | ClinicalTrials.gov |
| NCT02792400 | The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and So… | Na | Type 2 Diabetes | Completed | 2016-05-01 | 2018-07-01 | ClinicalTrials.gov |
| NCT02605174 | Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the… | Phase3 | Migraine With or Without Aura | Completed | 2016-05-01 | 2017-06-30 | ClinicalTrials.gov |
| NCT02779738 | A Study of Merestinib (LY2801653) in Healthy Participants | Phase1 | Healthy | Completed | 2016-05-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02754830 | A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's … | Phase1 | Alzheimer's Disease | Completed | 2016-04-25 | 2018-07-10 | ClinicalTrials.gov |
| NCT02754830 | A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's … | Phase1 | Alzheimer's Disease | Completed | 2016-04-25 | 2018-07-10 | ClinicalTrials.gov |
| NCT02696798 | A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants Wit… | Phase3 | Spondyloarthritis | Completed | 2016-04-12 | 2019-05-03 | ClinicalTrials.gov |
| NCT02696798 | A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants Wit… | Phase3 | Spondyloarthritis | Completed | 2016-04-12 | 2019-05-03 | ClinicalTrials.gov |
| NCT02752087 | A Study to Compare the Effects of a Test and Reference Formulation of LY900014 … | Phase1 | Healthy | Completed | 2016-04-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02944110 | Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pan… | Na | Diabetes After Total Pancreatectomy | Unknown | 2016-04-01 | 2021-07-01 | ClinicalTrials.gov |
| NCT02752919 | Study of Galunisertib in Healthy Participants | Phase1 | Healthy | Completed | 2016-04-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02752087 | A Study to Compare the Effects of a Test and Reference Formulation of LY900014 … | Phase1 | Healthy | Completed | 2016-04-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02718898 | A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genit… | Phase3 | Genital Psoriasis | Completed | 2016-04-01 | 2018-02-21 | ClinicalTrials.gov |
| NCT02718898 | A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genit… | Phase3 | Genital Psoriasis | Completed | 2016-04-01 | 2018-02-21 | ClinicalTrials.gov |
| NCT02752919 | Study of Galunisertib in Healthy Participants | Phase1 | Healthy | Completed | 2016-04-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02944110 | Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pan… | Na | Diabetes After Total Pancreatectomy | Unknown | 2016-04-01 | 2021-07-01 | ClinicalTrials.gov |
| NCT02708095 | A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythema… | Phase2 | Systemic Lupus Erythematosus | Completed | 2016-03-24 | 2017-11-09 | ClinicalTrials.gov |
| NCT02688712 | ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer | Phase2 | Rectal Adenocarcinoma | Active_Not_Recruiting | 2016-03-24 | 2026-12-01 | ClinicalTrials.gov |
| NCT02688712 | ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer | Phase2 | Rectal Adenocarcinoma | Active_Not_Recruiting | 2016-03-24 | 2026-12-01 | ClinicalTrials.gov |
| NCT02708095 | A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythema… | Phase2 | Systemic Lupus Erythematosus | Completed | 2016-03-24 | 2017-11-09 | ClinicalTrials.gov |
| NCT02702011 | Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes Mellitus | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2016-03-20 | 2016-10-03 | ClinicalTrials.gov |
| NCT02702011 | Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes Mellitus | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2016-03-20 | 2016-10-03 | ClinicalTrials.gov |
| NCT02864914 | Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the … | — | Diabetes Mellitus, Type 2 | Completed | 2016-03-15 | 2022-07-29 | ClinicalTrials.gov |
| NCT02864914 | Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the … | — | Diabetes Mellitus, Type 2 | Completed | 2016-03-15 | 2022-07-29 | ClinicalTrials.gov |
| NCT02688088 | A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spre… | Phase1 | Neoplasm Metastasis | Completed | 2016-03-08 | 2021-01-06 | ClinicalTrials.gov |
| NCT02688088 | A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spre… | Phase1 | Neoplasm Metastasis | Completed | 2016-03-08 | 2021-01-06 | ClinicalTrials.gov |
| NCT02709486 | Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subject… | Phase3 | Osteoarthritis, Hip | Completed | 2016-03-02 | 2018-11-14 | ClinicalTrials.gov |
| NCT02709486 | Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subject… | Phase3 | Osteoarthritis, Hip | Completed | 2016-03-02 | 2018-11-14 | ClinicalTrials.gov |
| NCT02703337 | A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection T… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2016-03-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02703324 | A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus U… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2016-03-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02659020 | A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sar… | Phase1 | Soft Tissue Sarcoma | Completed | 2016-03-01 | 2021-04-27 | ClinicalTrials.gov |
| NCT02714569 | A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidem… | Phase1 | Dyslipidemias | Completed | 2016-03-01 | 2017-02-15 | ClinicalTrials.gov |
| NCT02703350 | A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection T… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2016-03-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02703350 | A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection T… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2016-03-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02703337 | A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection T… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2016-03-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02703324 | A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus U… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2016-03-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02659020 | A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sar… | Phase1 | Soft Tissue Sarcoma | Completed | 2016-03-01 | 2021-04-27 | ClinicalTrials.gov |
| NCT02714569 | A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidem… | Phase1 | Dyslipidemias | Completed | 2016-03-01 | 2017-02-15 | ClinicalTrials.gov |
| NCT02555644 | A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participa… | Phase1 | Head and Neck Neoplasms | Completed | 2016-02-24 | 2019-01-14 | ClinicalTrials.gov |
| NCT02555644 | A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participa… | Phase1 | Head and Neck Neoplasms | Completed | 2016-02-24 | 2019-01-14 | ClinicalTrials.gov |
| NCT02572687 | A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced … | Phase1 | Gastric Cancer | Completed | 2016-02-19 | 2021-01-13 | ClinicalTrials.gov |
| NCT02572687 | A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced … | Phase1 | Gastric Cancer | Completed | 2016-02-19 | 2021-01-13 | ClinicalTrials.gov |
| NCT02576938 | A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atop… | Phase2 | Atopic Dermatitis | Completed | 2016-02-01 | 2017-03-01 | ClinicalTrials.gov |
| NCT02677844 | A Study of Abemaciclib in Healthy Participants | Phase1 | Healthy | Completed | 2016-02-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02672423 | A Study of Abemaciclib in Healthy Participants | Phase1 | Healthy | Completed | 2016-02-01 | 2016-10-01 | ClinicalTrials.gov |
| NCT02677844 | A Study of Abemaciclib in Healthy Participants | Phase1 | Healthy | Completed | 2016-02-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02672423 | A Study of Abemaciclib in Healthy Participants | Phase1 | Healthy | Completed | 2016-02-01 | 2016-10-01 | ClinicalTrials.gov |
| NCT02576938 | A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atop… | Phase2 | Atopic Dermatitis | Completed | 2016-02-01 | 2017-03-01 | ClinicalTrials.gov |
| NCT02663128 | A Study of Lanabecestat (LY3314814) in Healthy Participants | Phase1 | Healthy | Completed | 2016-01-31 | 2016-03-31 | ClinicalTrials.gov |
| NCT02663128 | A Study of Lanabecestat (LY3314814) in Healthy Participants | Phase1 | Healthy | Completed | 2016-01-31 | 2016-03-31 | ClinicalTrials.gov |
| NCT02624700 | 2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Tr… | Phase2 | Breast Cancer | Terminated | 2016-01-28 | 2019-07-10 | ClinicalTrials.gov |
| NCT02624700 | 2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Tr… | Phase2 | Breast Cancer | Terminated | 2016-01-28 | 2019-07-10 | ClinicalTrials.gov |
| NCT02634801 | A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaqu… | Phase3 | Plaque Psoriasis | Completed | 2016-01-20 | 2017-11-14 | ClinicalTrials.gov |
| NCT02634801 | A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaqu… | Phase3 | Plaque Psoriasis | Completed | 2016-01-20 | 2017-11-14 | ClinicalTrials.gov |
| NCT02588950 | A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Terminated | 2016-01-12 | 2017-05-25 | ClinicalTrials.gov |
| NCT02588950 | A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Terminated | 2016-01-12 | 2017-05-25 | ClinicalTrials.gov |
| NCT02659865 | A Study of LY3039478 in Healthy Participants | Phase1 | Healthy | Completed | 2016-01-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02660502 | An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioCh… | Phase1 | Healthy | Completed | 2016-01-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02659865 | A Study of LY3039478 in Healthy Participants | Phase1 | Healthy | Completed | 2016-01-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02660502 | An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioCh… | Phase1 | Healthy | Completed | 2016-01-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT02580591 | Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T… | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2015-12-22 | 2017-09-20 | ClinicalTrials.gov |
| NCT02624778 | A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Dise… | Phase1 | Alzheimer Disease | Completed | 2015-12-22 | 2019-08-28 | ClinicalTrials.gov |
| NCT02580591 | Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T… | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2015-12-22 | 2017-09-20 | ClinicalTrials.gov |
| NCT02624778 | A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Dise… | Phase1 | Alzheimer Disease | Completed | 2015-12-22 | 2019-08-28 | ClinicalTrials.gov |
| NCT02564198 | A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors | Phase1 | Pediatric Solid Tumor | Completed | 2015-12-11 | 2019-07-16 | ClinicalTrials.gov |
| NCT02564198 | A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors | Phase1 | Pediatric Solid Tumor | Completed | 2015-12-11 | 2019-07-16 | ClinicalTrials.gov |
| NCT02614716 | A Study of LY3090106 in Participants With Sjögren's Syndrome (SS) | Phase1 | Sjögren's Syndrome | Completed | 2015-12-10 | 2018-09-05 | ClinicalTrials.gov |
| NCT02614716 | A Study of LY3090106 in Participants With Sjögren's Syndrome (SS) | Phase1 | Sjögren's Syndrome | Completed | 2015-12-10 | 2018-09-05 | ClinicalTrials.gov |
| NCT02589665 | A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulce… | Phase2 | Ulcerative Colitis | Completed | 2015-12-09 | 2019-05-07 | ClinicalTrials.gov |
| NCT02589665 | A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulce… | Phase2 | Ulcerative Colitis | Completed | 2015-12-09 | 2019-05-07 | ClinicalTrials.gov |
| NCT02614196 | Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Mi… | Phase3 | Migraine | Completed | 2015-12-04 | 2018-10-05 | ClinicalTrials.gov |
| NCT02614196 | Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Mi… | Phase3 | Migraine | Completed | 2015-12-04 | 2018-10-05 | ClinicalTrials.gov |
| NCT02568423 | A Study of Mirikizumab (LY3074828) in Healthy Participants | Phase1 | Healthy | Completed | 2015-12-02 | 2018-10-24 | ClinicalTrials.gov |
| NCT02568423 | A Study of Mirikizumab (LY3074828) in Healthy Participants | Phase1 | Healthy | Completed | 2015-12-02 | 2018-10-24 | ClinicalTrials.gov |
| NCT02622581 | Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (No… | — | Metastatic Non-small Cell Lung Cancer (NSCLC) | Recruiting | 2015-12-01 | 2027-12-01 | ClinicalTrials.gov |
| NCT02252367 | Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract S… | Phase4 | Prostatic Hyperplasia | Completed | 2015-12-01 | 2020-06-01 | ClinicalTrials.gov |
| NCT02614131 | A Study of LY2599666 in Healthy Participants and Participants With Mild Cogniti… | Phase1 | Healthy | Terminated | 2015-12-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02252367 | Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract S… | Phase4 | Prostatic Hyperplasia | Completed | 2015-12-01 | 2020-06-01 | ClinicalTrials.gov |
| NCT02622581 | Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (No… | — | Metastatic Non-small Cell Lung Cancer (NSCLC) | Recruiting | 2015-12-01 | 2027-12-01 | ClinicalTrials.gov |
| NCT02636361 | A Study of Various Formulations of LY900014 in Healthy Participants | Phase1 | Healthy | Completed | 2015-12-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT02614131 | A Study of LY2599666 in Healthy Participants and Participants With Mild Cogniti… | Phase1 | Healthy | Terminated | 2015-12-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02636361 | A Study of Various Formulations of LY900014 in Healthy Participants | Phase1 | Healthy | Completed | 2015-12-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT02614287 | A Safety Study of Galcanezumab in Participants With Migraine, With or Without A… | Phase3 | Migraine | Completed | 2015-11-30 | 2018-08-14 | ClinicalTrials.gov |
| NCT02614183 | Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1… | Phase3 | Migraine | Completed | 2015-11-30 | 2018-08-09 | ClinicalTrials.gov |
| NCT02614261 | Evaluation of Galcanezumab in the Prevention of Chronic Migraine | Phase3 | Chronic Migraine | Completed | 2015-11-30 | 2021-07-14 | ClinicalTrials.gov |
| NCT02614287 | A Safety Study of Galcanezumab in Participants With Migraine, With or Without A… | Phase3 | Migraine | Completed | 2015-11-30 | 2018-08-14 | ClinicalTrials.gov |
| NCT02614183 | Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1… | Phase3 | Migraine | Completed | 2015-11-30 | 2018-08-09 | ClinicalTrials.gov |
| NCT02614261 | Evaluation of Galcanezumab in the Prevention of Chronic Migraine | Phase3 | Chronic Migraine | Completed | 2015-11-30 | 2021-07-14 | ClinicalTrials.gov |
| NCT02604160 | A Study of LY3113593 in Participants With Chronic Kidney Disease | Phase1 | Chronic Kidney Disease | Completed | 2015-11-17 | 2016-06-22 | ClinicalTrials.gov |
| NCT02604160 | A Study of LY3113593 in Participants With Chronic Kidney Disease | Phase1 | Chronic Kidney Disease | Completed | 2015-11-17 | 2016-06-22 | ClinicalTrials.gov |
| NCT02597036 | A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors | Phase1 | Solid Tumors | Terminated | 2015-11-06 | 2020-05-24 | ClinicalTrials.gov |
| NCT02597036 | A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors | Phase1 | Solid Tumors | Terminated | 2015-11-06 | 2020-05-24 | ClinicalTrials.gov |
| NCT02597049 | A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus | Phase3 | Type 2 Diabetes Mellitus | Completed | 2015-11-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT02603861 | A Study of LY3154207 on Sleep in Healthy Male Participants | Phase1 | Healthy | Completed | 2015-11-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT02595736 | A Study of LY3200327 in Healthy Participants | Phase1 | Healthy | Completed | 2015-11-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02603861 | A Study of LY3154207 on Sleep in Healthy Male Participants | Phase1 | Healthy | Completed | 2015-11-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT02597049 | A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus | Phase3 | Type 2 Diabetes Mellitus | Completed | 2015-11-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT02595736 | A Study of LY3200327 in Healthy Participants | Phase1 | Healthy | Completed | 2015-11-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02568397 | A Drug-drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participan… | Phase1 | Healthy | Completed | 2015-10-31 | 2016-01-31 | ClinicalTrials.gov |
| NCT02568397 | A Drug-drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participan… | Phase1 | Healthy | Completed | 2015-10-31 | 2016-01-31 | ClinicalTrials.gov |
| NCT02609828 | Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer P… | Phase3 | Bone Metastasis | Completed | 2015-10-28 | 2021-06-25 | ClinicalTrials.gov |
| NCT02589639 | Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Pat… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2015-10-28 | 2018-01-05 | ClinicalTrials.gov |
| NCT02589639 | Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Pat… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2015-10-28 | 2018-01-05 | ClinicalTrials.gov |
| NCT02609828 | Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer P… | Phase3 | Bone Metastasis | Completed | 2015-10-28 | 2021-06-25 | ClinicalTrials.gov |
| NCT02561078 | An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Par… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2015-10-20 | 2017-05-09 | ClinicalTrials.gov |
| NCT02561078 | An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Par… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2015-10-20 | 2017-05-09 | ClinicalTrials.gov |
| NCT02576951 | A Study of Galcanezumab in Healthy Participants | Phase1 | Healthy | Completed | 2015-10-19 | 2018-01-08 | ClinicalTrials.gov |
| NCT02576951 | A Study of Galcanezumab in Healthy Participants | Phase1 | Healthy | Completed | 2015-10-19 | 2018-01-08 | ClinicalTrials.gov |
| NCT02392507 | A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Parti… | Phase2 | Carcinoma, Non-Small Cell Lung Cancer (NSCLC) | Completed | 2015-10-12 | 2019-11-06 | ClinicalTrials.gov |
| NCT02392507 | A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Parti… | Phase2 | Carcinoma, Non-Small Cell Lung Cancer (NSCLC) | Completed | 2015-10-12 | 2019-11-06 | ClinicalTrials.gov |
| NCT02514551 | A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participan… | Phase2 | Gastric Adenocarcinoma | Completed | 2015-10-12 | 2018-12-28 | ClinicalTrials.gov |
| NCT02514551 | A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participan… | Phase2 | Gastric Adenocarcinoma | Completed | 2015-10-12 | 2018-12-28 | ClinicalTrials.gov |
| NCT02565186 | An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of… | Phase3 | Migraine Disorders | Completed | 2015-10-07 | 2019-08-20 | ClinicalTrials.gov |
| NCT02565186 | An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of… | Phase3 | Migraine Disorders | Completed | 2015-10-07 | 2019-08-20 | ClinicalTrials.gov |
| NCT02539225 | A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junctio… | Phase2 | Metastatic Gastric Adenocarcinoma | Completed | 2015-10-05 | 2021-03-10 | ClinicalTrials.gov |
| NCT02539225 | A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junctio… | Phase2 | Metastatic Gastric Adenocarcinoma | Completed | 2015-10-05 | 2021-03-10 | ClinicalTrials.gov |
| NCT02518113 | A Study of LY3039478 in Combination With Dexamethasone in Participants With T-A… | Phase1 | T-cell Acute Lymphoblastic Leukemia | Completed | 2015-10-01 | 2018-01-15 | ClinicalTrials.gov |
| NCT02669524 | Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defec… | Na | Type 2 Diabetes | Completed | 2015-10-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02575703 | A Study of [¹⁴C]-LY3023414 in Healthy Participants | Phase1 | Healthy | Completed | 2015-10-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02669524 | Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defec… | Na | Type 2 Diabetes | Completed | 2015-10-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02518113 | A Study of LY3039478 in Combination With Dexamethasone in Participants With T-A… | Phase1 | T-cell Acute Lymphoblastic Leukemia | Completed | 2015-10-01 | 2018-01-15 | ClinicalTrials.gov |
| NCT02561806 | A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaqu… | Phase3 | Plaque Psoriasis | Completed | 2015-10-01 | 2017-10-01 | ClinicalTrials.gov |
| NCT02575703 | A Study of [¹⁴C]-LY3023414 in Healthy Participants | Phase1 | Healthy | Completed | 2015-10-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02514603 | A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cance… | Phase1 | Neoplasm | Completed | 2015-10-01 | 2017-04-10 | ClinicalTrials.gov |
| NCT02514603 | A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cance… | Phase1 | Neoplasm | Completed | 2015-10-01 | 2017-04-10 | ClinicalTrials.gov |
| NCT02561806 | A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaqu… | Phase3 | Plaque Psoriasis | Completed | 2015-10-01 | 2017-10-01 | ClinicalTrials.gov |
| NCT02540668 | A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy Pa… | Phase1 | Healthy | Completed | 2015-09-30 | 2016-01-31 | ClinicalTrials.gov |
| NCT02540668 | A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy Pa… | Phase1 | Healthy | Completed | 2015-09-30 | 2016-01-31 | ClinicalTrials.gov |
| NCT02562768 | A Study of LY3154207 in Healthy Participants and Participants With Parkinson's … | Phase1 | Parkinson's Disease | Completed | 2015-09-30 | 2017-03-03 | ClinicalTrials.gov |
| NCT02562768 | A Study of LY3154207 in Healthy Participants and Participants With Parkinson's … | Phase1 | Parkinson's Disease | Completed | 2015-09-30 | 2017-03-03 | ClinicalTrials.gov |
| NCT02584855 | A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants… | Phase3 | Psoriatic Arthritis | Completed | 2015-09-14 | 2018-10-30 | ClinicalTrials.gov |
| NCT02451943 | A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advance… | Phase3 | Soft Tissue Sarcoma | Completed | 2015-09-14 | 2024-06-27 | ClinicalTrials.gov |
| NCT02584855 | A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants… | Phase3 | Psoriatic Arthritis | Completed | 2015-09-14 | 2018-10-30 | ClinicalTrials.gov |
| NCT02451943 | A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advance… | Phase3 | Soft Tissue Sarcoma | Completed | 2015-09-14 | 2024-06-27 | ClinicalTrials.gov |
| NCT02451930 | A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475… | Phase1 | Stage IV Non-Small Cell Lung Cancer | Completed | 2015-09-04 | 2019-09-17 | ClinicalTrials.gov |
| NCT02451930 | A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475… | Phase1 | Stage IV Non-Small Cell Lung Cancer | Completed | 2015-09-04 | 2019-09-17 | ClinicalTrials.gov |
| NCT02555449 | A Study of [¹⁴C]-LY3202626 in Healthy Male Participants | Phase1 | Healthy | Completed | 2015-09-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02543918 | A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Health… | Phase1 | Healthy | Completed | 2015-09-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02549989 | Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Can… | Phase2 | Endometrial Cancer | Completed | 2015-09-01 | 2022-03-23 | ClinicalTrials.gov |
| NCT02536586 | A Study of LY3023414 in Japanese Participants With Advanced Cancer | Phase1 | Neoplasm | Completed | 2015-09-01 | 2017-02-09 | ClinicalTrials.gov |
| NCT02529553 | A Study of LY3076226 in Participants With Advanced or Metastatic Cancer | Phase1 | Advanced Cancer | Completed | 2015-09-01 | 2018-03-28 | ClinicalTrials.gov |
| NCT02543918 | A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Health… | Phase1 | Healthy | Completed | 2015-09-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02536586 | A Study of LY3023414 in Japanese Participants With Advanced Cancer | Phase1 | Neoplasm | Completed | 2015-09-01 | 2017-02-09 | ClinicalTrials.gov |
| NCT02562326 | A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability … | Phase1 | Type 2 Diabetes Mellitus | Completed | 2015-09-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT02562313 | A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid … | Phase1 | Type 1 Diabetes Mellitus | Completed | 2015-09-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT02555449 | A Study of [¹⁴C]-LY3202626 in Healthy Male Participants | Phase1 | Healthy | Completed | 2015-09-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02529553 | A Study of LY3076226 in Participants With Advanced or Metastatic Cancer | Phase1 | Advanced Cancer | Completed | 2015-09-01 | 2018-03-28 | ClinicalTrials.gov |
| NCT02562313 | A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid … | Phase1 | Type 1 Diabetes Mellitus | Completed | 2015-09-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT02562326 | A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability … | Phase1 | Type 2 Diabetes Mellitus | Completed | 2015-09-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT02549989 | Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Can… | Phase2 | Endometrial Cancer | Completed | 2015-09-01 | 2022-03-23 | ClinicalTrials.gov |
| NCT02528253 | A Phase 3 Study of Tanezumab for Chronic Low Back Pain | Phase3 | Low Back Pain | Completed | 2015-08-18 | 2018-12-20 | ClinicalTrials.gov |
| NCT02528253 | A Phase 3 Study of Tanezumab for Chronic Low Back Pain | Phase3 | Low Back Pain | Completed | 2015-08-18 | 2018-12-20 | ClinicalTrials.gov |
| NCT02450539 | A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-s… | Phase2 | Non-Small Cell Lung Cancer Stage IV | Completed | 2015-08-06 | 2020-07-29 | ClinicalTrials.gov |
| NCT02450539 | A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-s… | Phase2 | Non-Small Cell Lung Cancer Stage IV | Completed | 2015-08-06 | 2020-07-29 | ClinicalTrials.gov |
| NCT02441946 | A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hor… | Phase2 | Breast Cancer | Completed | 2015-08-01 | 2018-02-12 | ClinicalTrials.gov |
| NCT02525744 | A Study of a New LY900014 Formulation in Healthy Participants | Phase1 | Healthy | Completed | 2015-08-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT02528396 | To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone … | Phase1 | Type 1 Diabetes Mellitus | Completed | 2015-08-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02525744 | A Study of a New LY900014 Formulation in Healthy Participants | Phase1 | Healthy | Completed | 2015-08-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT02513550 | A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Partic… | Phase3 | Plaque Psoriasis | Completed | 2015-08-01 | 2017-08-03 | ClinicalTrials.gov |
| NCT02513550 | A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Partic… | Phase3 | Plaque Psoriasis | Completed | 2015-08-01 | 2017-08-03 | ClinicalTrials.gov |
| NCT02441946 | A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hor… | Phase2 | Breast Cancer | Completed | 2015-08-01 | 2018-02-12 | ClinicalTrials.gov |
| NCT02528396 | To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone … | Phase1 | Type 1 Diabetes Mellitus | Completed | 2015-08-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02443324 | A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ A… | Phase1 | Gastric Adenocarcinoma | Completed | 2015-07-29 | 2022-04-12 | ClinicalTrials.gov |
| NCT02443324 | A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ A… | Phase1 | Gastric Adenocarcinoma | Completed | 2015-07-29 | 2022-04-12 | ClinicalTrials.gov |
| NCT02435433 | A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatoce… | Phase3 | Hepatocellular Carcinoma | Completed | 2015-07-20 | 2021-11-19 | ClinicalTrials.gov |
| NCT02435433 | A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatoce… | Phase3 | Hepatocellular Carcinoma | Completed | 2015-07-20 | 2021-11-19 | ClinicalTrials.gov |
| NCT02426125 | A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urotheli… | Phase3 | Urothelial Carcinoma | Completed | 2015-07-13 | 2022-07-26 | ClinicalTrials.gov |
| NCT02426125 | A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urotheli… | Phase3 | Urothelial Carcinoma | Completed | 2015-07-13 | 2022-07-26 | ClinicalTrials.gov |
| NCT02443883 | A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gast… | Phase2 | Gastric Adenocarcinoma | Completed | 2015-07-07 | 2019-06-05 | ClinicalTrials.gov |
| NCT02443883 | A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gast… | Phase2 | Gastric Adenocarcinoma | Completed | 2015-07-07 | 2019-06-05 | ClinicalTrials.gov |
| NCT02490670 | A Study of Cephalexin Liquid in Healthy Participants | Phase1 | Healthy | Completed | 2015-07-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT02497391 | A Study of Different Particle Sizes of Evacetrapib in Healthy Participants | Phase1 | Healthy | Completed | 2015-07-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02490670 | A Study of Cephalexin Liquid in Healthy Participants | Phase1 | Healthy | Completed | 2015-07-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT02497391 | A Study of Different Particle Sizes of Evacetrapib in Healthy Participants | Phase1 | Healthy | Completed | 2015-07-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02443337 | A Study of LY3023414 and Necitumumab in Squamous Lung Cancer | Phase2 | Non-small Cell Lung Cancer Metastatic | Terminated | 2015-07-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT02443337 | A Study of LY3023414 and Necitumumab in Squamous Lung Cancer | Phase2 | Non-small Cell Lung Cancer Metastatic | Terminated | 2015-07-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT02148250 | PK/PD Study of U-500 Regular Insulin | Phase2 | Type 2 Diabetes | Completed | 2015-07-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT02148250 | PK/PD Study of U-500 Regular Insulin | Phase2 | Type 2 Diabetes | Completed | 2015-07-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT02414958 | Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With T… | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2015-06-30 | 2017-10-23 | ClinicalTrials.gov |
| NCT02414958 | Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With T… | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2015-06-30 | 2017-10-23 | ClinicalTrials.gov |
| NCT02438826 | A Study of Galcanezumab in Participants With Chronic Cluster Headache | Phase3 | Chronic Cluster Headache | Completed | 2015-06-18 | 2019-08-14 | ClinicalTrials.gov |
| NCT02438826 | A Study of Galcanezumab in Participants With Chronic Cluster Headache | Phase3 | Chronic Cluster Headache | Completed | 2015-06-18 | 2019-08-14 | ClinicalTrials.gov |
| NCT03870620 | Metastatic Breast Cancer in Austria | — | Breast Cancer | Recruiting | 2015-06-15 | 2025-06-01 | ClinicalTrials.gov |
| NCT03870620 | Metastatic Breast Cancer in Austria | — | Breast Cancer | Recruiting | 2015-06-15 | 2025-06-01 | ClinicalTrials.gov |
| NCT02489942 | Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diab… | — | Diabetes Mellitus, Type 2 | Completed | 2015-06-12 | 2020-12-04 | ClinicalTrials.gov |
| NCT02489942 | Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diab… | — | Diabetes Mellitus, Type 2 | Completed | 2015-06-12 | 2020-12-04 | ClinicalTrials.gov |
| NCT02411591 | A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung… | Phase1 | Carcinoma, Non-Small-Cell Lung | Completed | 2015-06-04 | 2019-05-28 | ClinicalTrials.gov |
| NCT02411591 | A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung… | Phase1 | Carcinoma, Non-Small-Cell Lung | Completed | 2015-06-04 | 2019-05-28 | ClinicalTrials.gov |
| NCT02683200 | MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver … | Early_Phase1 | Adult Hepatocellular Carcinoma | Completed | 2015-06-03 | 2022-01-01 | ClinicalTrials.gov |
| NCT02683200 | MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver … | Early_Phase1 | Adult Hepatocellular Carcinoma | Completed | 2015-06-03 | 2022-01-01 | ClinicalTrials.gov |
| NCT02482935 | A Study of Abemaciclib (LY2835219) in Healthy Participants With and Without Food | Phase1 | Healthy | Completed | 2015-06-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT02890134 | Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Au… | — | Systemic Autoimmune Diseases | Completed | 2015-06-01 | 2018-07-01 | ClinicalTrials.gov |
| NCT02890134 | Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Au… | — | Systemic Autoimmune Diseases | Completed | 2015-06-01 | 2018-07-01 | ClinicalTrials.gov |
| NCT02482935 | A Study of Abemaciclib (LY2835219) in Healthy Participants With and Without Food | Phase1 | Healthy | Completed | 2015-06-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT02443922 | Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glime… | Na | Type 2 Diabetes | Unknown | 2015-06-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02443922 | Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glime… | Na | Type 2 Diabetes | Unknown | 2015-06-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02397473 | A Study Of Galcanezumab In Participants With Episodic Cluster Headache | Phase3 | Episodic Cluster Headache | Completed | 2015-05-22 | 2018-06-04 | ClinicalTrials.gov |
| NCT02397473 | A Study Of Galcanezumab In Participants With Episodic Cluster Headache | Phase3 | Episodic Cluster Headache | Completed | 2015-05-22 | 2018-06-04 | ClinicalTrials.gov |
| NCT02453555 | Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabe… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2015-05-14 | 2017-03-27 | ClinicalTrials.gov |
| NCT02453555 | Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabe… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2015-05-14 | 2017-03-27 | ClinicalTrials.gov |
| NCT02489968 | Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Pat… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2015-05-12 | 2017-06-16 | ClinicalTrials.gov |
| NCT02489968 | Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Pat… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2015-05-12 | 2017-06-16 | ClinicalTrials.gov |
| NCT02411448 | A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously … | Phase3 | Metastatic Non-Small Cell Lung Cancer | Active_Not_Recruiting | 2015-05-06 | 2026-12-01 | ClinicalTrials.gov |
| NCT02411448 | A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously … | Phase3 | Metastatic Non-Small Cell Lung Cancer | Active_Not_Recruiting | 2015-05-06 | 2026-12-01 | ClinicalTrials.gov |
| NCT02304419 | A Study of Galunisertib on the Immune System in Participants With Cancer | Phase1 | Neoplasm | Completed | 2015-05-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02432976 | Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surger… | Phase2 | Quality of Life | Completed | 2015-05-01 | 2017-01-01 | ClinicalTrials.gov |
| NCT02304419 | A Study of Galunisertib on the Immune System in Participants With Cancer | Phase1 | Neoplasm | Completed | 2015-05-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02265536 | A Study of LY3022855 In Participants With Breast or Prostate Cancer | Phase1 | Neoplasms | Completed | 2015-05-01 | 2017-11-03 | ClinicalTrials.gov |
| NCT02265536 | A Study of LY3022855 In Participants With Breast or Prostate Cancer | Phase1 | Neoplasms | Completed | 2015-05-01 | 2017-11-03 | ClinicalTrials.gov |
| NCT02432976 | Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surger… | Phase2 | Quality of Life | Completed | 2015-05-01 | 2017-01-01 | ClinicalTrials.gov |
| NCT02406261 | A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participan… | Phase1 | Healthy | Completed | 2015-04-30 | 2015-08-31 | ClinicalTrials.gov |
| NCT02406261 | A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participan… | Phase1 | Healthy | Completed | 2015-04-30 | 2015-08-31 | ClinicalTrials.gov |
| NCT02407054 | A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer | Phase2 | Prostate Cancer Metastatic | Completed | 2015-04-29 | 2020-04-16 | ClinicalTrials.gov |
| NCT02407054 | A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer | Phase2 | Prostate Cancer Metastatic | Completed | 2015-04-29 | 2020-04-16 | ClinicalTrials.gov |
| NCT02308020 | A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-smal… | Phase2 | Breast Cancer | Completed | 2015-04-20 | 2019-11-08 | ClinicalTrials.gov |
| NCT02308020 | A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-smal… | Phase2 | Breast Cancer | Completed | 2015-04-20 | 2019-11-08 | ClinicalTrials.gov |
| NCT02417935 | A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuro… | Phase4 | Diabetic Peripheral Neuropathic Pain | Completed | 2015-04-01 | 2017-05-13 | ClinicalTrials.gov |
| NCT02387801 | A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe P… | Phase3 | Psoriasis | Completed | 2015-04-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02439320 | Lasmiditan Compared to Placebo in the Acute Treatment of Migraine: | Phase3 | Acute Migraine | Completed | 2015-04-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02439320 | Lasmiditan Compared to Placebo in the Acute Treatment of Migraine: | Phase3 | Acute Migraine | Completed | 2015-04-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02431754 | A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Sympto… | Phase4 | Benign Prostatic Hyperplasia | Completed | 2015-04-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT02417935 | A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuro… | Phase4 | Diabetic Peripheral Neuropathic Pain | Completed | 2015-04-01 | 2017-05-13 | ClinicalTrials.gov |
| NCT02387801 | A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe P… | Phase3 | Psoriasis | Completed | 2015-04-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT02431754 | A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Sympto… | Phase4 | Benign Prostatic Hyperplasia | Completed | 2015-04-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT02377752 | A Study of Olaratumab in Japanese Participants With Advanced Cancer | Phase1 | Neoplasm | Completed | 2015-03-23 | 2020-01-14 | ClinicalTrials.gov |
| NCT02377752 | A Study of Olaratumab in Japanese Participants With Advanced Cancer | Phase1 | Neoplasm | Completed | 2015-03-23 | 2020-01-14 | ClinicalTrials.gov |
| NCT02413203 | Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B | Na | Healthy | Completed | 2015-03-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02402933 | Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children a… | Phase3 | Hypoglycemia | Completed | 2015-03-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02387814 | A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment | Phase1 | Hepatic Insufficiency | Completed | 2015-03-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02385084 | A Study of LY2409021 Formulations in Healthy Participants | Phase1 | Healthy | Terminated | 2015-03-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02385084 | A Study of LY2409021 Formulations in Healthy Participants | Phase1 | Healthy | Terminated | 2015-03-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02387814 | A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment | Phase1 | Hepatic Insufficiency | Completed | 2015-03-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02402933 | Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children a… | Phase3 | Hypoglycemia | Completed | 2015-03-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02413203 | Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B | Na | Healthy | Completed | 2015-03-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02367131 | Daily Use of JARDIANCE® Tablets in Japanese Elderly Patients With Type 2 Diabet… | — | Diabetes Mellitus, Type 2 | Completed | 2015-02-24 | 2016-09-27 | ClinicalTrials.gov |
| NCT02367131 | Daily Use of JARDIANCE® Tablets in Japanese Elderly Patients With Type 2 Diabet… | — | Diabetes Mellitus, Type 2 | Completed | 2015-02-24 | 2016-09-27 | ClinicalTrials.gov |
| NCT02678182 | Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial | Phase2 | Adenocarcinoma of the Oesophagus | Active_Not_Recruiting | 2015-02-01 | 2027-06-01 | ClinicalTrials.gov |
| NCT02106364 | A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes M… | Phase3 | Diabetes Mellitus, Type 2 | Withdrawn | 2015-02-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02370485 | A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children | Phase1 | Healthy | Completed | 2015-02-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02359058 | A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Ad… | Phase1 | Stomach Neoplasms | Completed | 2015-02-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT02365571 | A Study of LY3154207 in Healthy Participants | Phase1 | Healthy Participants | Completed | 2015-02-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02365571 | A Study of LY3154207 in Healthy Participants | Phase1 | Healthy Participants | Completed | 2015-02-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02106364 | A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes M… | Phase3 | Diabetes Mellitus, Type 2 | Withdrawn | 2015-02-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02359058 | A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Ad… | Phase1 | Stomach Neoplasms | Completed | 2015-02-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT02678182 | Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial | Phase2 | Adenocarcinoma of the Oesophagus | Active_Not_Recruiting | 2015-02-01 | 2027-06-01 | ClinicalTrials.gov |
| NCT02370485 | A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children | Phase1 | Healthy | Completed | 2015-02-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT02326025 | A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue… | Phase1 | Sarcoma, Soft Tissue | Completed | 2015-01-22 | 2018-11-02 | ClinicalTrials.gov |
| NCT02326025 | A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue… | Phase1 | Sarcoma, Soft Tissue | Completed | 2015-01-22 | 2018-11-02 | ClinicalTrials.gov |
| NCT02314117 | A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplat… | Phase3 | Metastatic Gastric Adenocarcinoma | Completed | 2015-01-20 | 2020-08-14 | ClinicalTrials.gov |
| NCT02314117 | A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplat… | Phase3 | Metastatic Gastric Adenocarcinoma | Completed | 2015-01-20 | 2020-08-14 | ClinicalTrials.gov |
| NCT02340104 | A Study to Measure Baricitinib (LY3009104) Absorption in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2015-01-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT02260648 | A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese… | Phase3 | Hypercholesterolemia | Terminated | 2015-01-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02335346 | An Extension Study of Duloxetine in Osteoarthritis and Knee Pain (Extension of … | Phase3 | Osteoarthritis of the Knee | Completed | 2015-01-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT02342314 | A Study of LY3143753 and LY3185643 in Healthy Participants | Phase1 | Healthy | Completed | 2015-01-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT02317575 | A Study of LY900014 Formulations in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2015-01-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT02365558 | A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Health… | Phase1 | Healthy | Completed | 2015-01-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT02327143 | A Study of LY2835219 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2015-01-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT02327143 | A Study of LY2835219 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2015-01-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT02327286 | Randomized Clinical Trial of Lifestyle Interventions to Prevent Diabetes in Wom… | Na | Diabetes Mellitus | Completed | 2015-01-01 | 2022-03-31 | ClinicalTrials.gov |
| NCT02233296 | Food-Effect Study in Healthy Participants | Phase1 | Healthy | Completed | 2015-01-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02335346 | An Extension Study of Duloxetine in Osteoarthritis and Knee Pain (Extension of … | Phase3 | Osteoarthritis of the Knee | Completed | 2015-01-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT01969149 | Exenatide for Stress Hyperglycemia | Phase2 | Stress Hyperglycemia | Completed | 2015-01-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT02233296 | Food-Effect Study in Healthy Participants | Phase1 | Healthy | Completed | 2015-01-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02337387 | A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausa… | Phase1 | Osteoporosis, Postmenopausal | Terminated | 2015-01-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02340104 | A Study to Measure Baricitinib (LY3009104) Absorption in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2015-01-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT02342314 | A Study of LY3143753 and LY3185643 in Healthy Participants | Phase1 | Healthy | Completed | 2015-01-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT02260648 | A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese… | Phase3 | Hypercholesterolemia | Terminated | 2015-01-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02317575 | A Study of LY900014 Formulations in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2015-01-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT02423343 | A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced R… | Phase1 | Solid Tumor | Completed | 2015-01-01 | 2020-07-08 | ClinicalTrials.gov |
| NCT02365558 | A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Health… | Phase1 | Healthy | Completed | 2015-01-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT02423343 | A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced R… | Phase1 | Solid Tumor | Completed | 2015-01-01 | 2020-07-08 | ClinicalTrials.gov |
| NCT02806973 | A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2015-01-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT02806973 | A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2015-01-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01969149 | Exenatide for Stress Hyperglycemia | Phase2 | Stress Hyperglycemia | Completed | 2015-01-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT01984606 | Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2… | Phase3 | Diabetes Mellitus, Type 2 | Withdrawn | 2015-01-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT01984606 | Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2… | Phase3 | Diabetes Mellitus, Type 2 | Withdrawn | 2015-01-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT02337387 | A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausa… | Phase1 | Osteoporosis, Postmenopausal | Terminated | 2015-01-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02327286 | Randomized Clinical Trial of Lifestyle Interventions to Prevent Diabetes in Wom… | Na | Diabetes Mellitus | Completed | 2015-01-01 | 2022-03-31 | ClinicalTrials.gov |
| NCT02349295 | A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthrit… | Phase3 | Psoriatic Arthritis | Completed | 2014-12-31 | 2019-06-26 | ClinicalTrials.gov |
| NCT02349295 | A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthrit… | Phase3 | Psoriatic Arthritis | Completed | 2014-12-31 | 2019-06-26 | ClinicalTrials.gov |
| NCT02890121 | Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Au… | — | Systemic Autoimmune Diseases | Completed | 2014-12-01 | 2017-10-01 | ClinicalTrials.gov |
| NCT02323334 | A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's … | Phase1 | Healthy Volunteers | Completed | 2014-12-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT02293551 | A Study of Lispro Formulations in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-12-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT02302716 | A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diab… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2014-12-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02293551 | A Study of Lispro Formulations in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-12-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT02302716 | A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diab… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2014-12-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT02890147 | Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Au… | — | Healthy Subjects | Completed | 2014-12-01 | 2017-10-01 | ClinicalTrials.gov |
| NCT02890121 | Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Au… | — | Systemic Autoimmune Diseases | Completed | 2014-12-01 | 2017-10-01 | ClinicalTrials.gov |
| NCT02890147 | Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Au… | — | Healthy Subjects | Completed | 2014-12-01 | 2017-10-01 | ClinicalTrials.gov |
| NCT02323334 | A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's … | Phase1 | Healthy Volunteers | Completed | 2014-12-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT02240433 | A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (H… | Phase1 | Hepatocellular Carcinoma | Completed | 2014-11-12 | 2019-12-25 | ClinicalTrials.gov |
| NCT02240433 | A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (H… | Phase1 | Hepatocellular Carcinoma | Completed | 2014-11-12 | 2019-12-25 | ClinicalTrials.gov |
| NCT02246621 | A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Po… | Phase3 | Breast Cancer | Active_Not_Recruiting | 2014-11-06 | 2026-12-01 | ClinicalTrials.gov |
| NCT02246621 | A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Po… | Phase3 | Breast Cancer | Active_Not_Recruiting | 2014-11-06 | 2026-12-01 | ClinicalTrials.gov |
| NCT02263911 | A Study of Baricitinib in Healthy Japanese Participants | Phase1 | Healthy Participants | Completed | 2014-11-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02260635 | A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hyperc… | Phase3 | Hypercholesterolemia | Terminated | 2014-11-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02300259 | A Study of LY2623091 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-11-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT02300259 | A Study of LY2623091 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-11-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT02266472 | Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Ex… | Phase1 | Healthy | Completed | 2014-11-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02263911 | A Study of Baricitinib in Healthy Japanese Participants | Phase1 | Healthy Participants | Completed | 2014-11-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02260635 | A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hyperc… | Phase3 | Hypercholesterolemia | Terminated | 2014-11-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02266472 | Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Ex… | Phase1 | Healthy | Completed | 2014-11-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02152631 | A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS… | Phase3 | Non Small Cell Lung Cancer | Active_Not_Recruiting | 2014-10-03 | 2026-12-01 | ClinicalTrials.gov |
| NCT02152631 | A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS… | Phase3 | Non Small Cell Lung Cancer | Active_Not_Recruiting | 2014-10-03 | 2026-12-01 | ClinicalTrials.gov |
| NCT02256267 | A Study of LY2835219 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-10-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT02271425 | A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in He… | Phase1 | Healthy Volunteers | Completed | 2014-10-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT02265705 | A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (R… | Phase3 | Rheumatoid Arthritis | Completed | 2014-10-01 | 2017-05-01 | ClinicalTrials.gov |
| NCT02271425 | A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in He… | Phase1 | Healthy Volunteers | Completed | 2014-10-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT02265705 | A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (R… | Phase3 | Rheumatoid Arthritis | Completed | 2014-10-01 | 2017-05-01 | ClinicalTrials.gov |
| NCT02256267 | A Study of LY2835219 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-10-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT02248480 | A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis an… | Phase3 | Osteoarthritis of the Knee | Completed | 2014-10-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT02242903 | A Study of LY3079514 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-10-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT02242903 | A Study of LY3079514 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-10-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT02248480 | A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis an… | Phase3 | Osteoarthritis of the Knee | Completed | 2014-10-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT02227784 | A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol | Phase3 | Hyperlipidemia | Terminated | 2014-10-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02227784 | A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol | Phase3 | Hyperlipidemia | Terminated | 2014-10-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02224846 | A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction | Phase4 | Erectile Dysfunction | Completed | 2014-10-01 | 2017-05-01 | ClinicalTrials.gov |
| NCT02224846 | A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction | Phase4 | Erectile Dysfunction | Completed | 2014-10-01 | 2017-05-01 | ClinicalTrials.gov |
| NCT02245737 | An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's D… | Phase2 | Alzheimer´s Disease | Terminated | 2014-09-30 | 2018-10-04 | ClinicalTrials.gov |
| NCT02245737 | An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's D… | Phase2 | Alzheimer´s Disease | Terminated | 2014-09-30 | 2018-10-04 | ClinicalTrials.gov |
| NCT02240680 | Linagliptin as Add on to Basal Insulin in the Elderly | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2014-09-23 | 2017-04-25 | ClinicalTrials.gov |
| NCT02240680 | Linagliptin as Add on to Basal Insulin in the Elderly | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2014-09-23 | 2017-04-25 | ClinicalTrials.gov |
| NCT02226653 | A Study of Evacetrapib in Healthy Japanese Participants | Phase1 | Healthy Volunteers | Completed | 2014-09-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT02230995 | Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Ex… | Phase1 | Healthy | Completed | 2014-09-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT02226653 | A Study of Evacetrapib in Healthy Japanese Participants | Phase1 | Healthy Volunteers | Completed | 2014-09-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT02242981 | A Study of How the Body Breaks Down and Eliminates LY2623091 | Phase1 | Healthy Volunteers | Completed | 2014-09-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT02230995 | Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Ex… | Phase1 | Healthy | Completed | 2014-09-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT02242981 | A Study of How the Body Breaks Down and Eliminates LY2623091 | Phase1 | Healthy Volunteers | Completed | 2014-09-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT02178358 | A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma | Phase2 | Hepatocellular Carcinoma | Completed | 2014-08-08 | 2021-02-18 | ClinicalTrials.gov |
| NCT02178358 | A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma | Phase2 | Hepatocellular Carcinoma | Completed | 2014-08-08 | 2021-02-18 | ClinicalTrials.gov |
| NCT02221882 | A Study of LY3164530 in Participants With Cancer | Phase1 | Neoplasms | Completed | 2014-08-01 | 2017-03-07 | ClinicalTrials.gov |
| NCT02217618 | A Study of LY2409021 in Healthy Participants | Phase1 | Healthy Participants | Completed | 2014-08-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT02221882 | A Study of LY3164530 in Participants With Cancer | Phase1 | Neoplasms | Completed | 2014-08-01 | 2017-03-07 | ClinicalTrials.gov |
| NCT02194465 | A Study of LY2623091 in Participants With High Blood Pressure | Phase2 | Primary Hypertension | Completed | 2014-08-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02217618 | A Study of LY2409021 in Healthy Participants | Phase1 | Healthy Participants | Completed | 2014-08-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT02194465 | A Study of LY2623091 in Participants With High Blood Pressure | Phase2 | Primary Hypertension | Completed | 2014-08-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02197078 | Active Surveillance Research Program for the Assessment of the Safety and the E… | — | Diabetes Mellitus, Type 2 | Completed | 2014-07-30 | 2019-02-26 | ClinicalTrials.gov |
| NCT02197078 | Active Surveillance Research Program for the Assessment of the Safety and the E… | — | Diabetes Mellitus, Type 2 | Completed | 2014-07-30 | 2019-02-26 | ClinicalTrials.gov |
| NCT02182830 | 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive B… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2014-07-25 | 2017-05-18 | ClinicalTrials.gov |
| NCT02182830 | 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive B… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2014-07-25 | 2017-05-18 | ClinicalTrials.gov |
| NCT02107703 | A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Horm… | Phase3 | Breast Neoplasms | Active_Not_Recruiting | 2014-07-22 | 2027-12-01 | ClinicalTrials.gov |
| NCT02107703 | A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Horm… | Phase3 | Breast Neoplasms | Active_Not_Recruiting | 2014-07-22 | 2027-12-01 | ClinicalTrials.gov |
| NCT02163993 | A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache | Phase2 | Migraine Headache | Completed | 2014-07-07 | 2018-02-12 | ClinicalTrials.gov |
| NCT02163993 | A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache | Phase2 | Migraine Headache | Completed | 2014-07-07 | 2018-02-12 | ClinicalTrials.gov |
| NCT01970241 | Inpatient Diabetes on Corticosteroids | Phase4 | Diabetes Mellitus | Completed | 2014-07-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02197520 | A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sen… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2014-07-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT03275311 | Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 | — | Metastatic Breast Cancer | Recruiting | 2014-07-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT01870284 | Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS) | Phase3 | Spondylitis, Ankylosing | Withdrawn | 2014-07-01 | 2018-04-01 | ClinicalTrials.gov |
| NCT02188693 | Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With … | — | Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer | Unknown | 2014-07-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT01870284 | Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS) | Phase3 | Spondylitis, Ankylosing | Withdrawn | 2014-07-01 | 2018-04-01 | ClinicalTrials.gov |
| NCT02192190 | A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee … | Phase2 | Osteoarthritis, Knee | Terminated | 2014-07-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT02192190 | A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee … | Phase2 | Osteoarthritis, Knee | Terminated | 2014-07-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT02197520 | A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sen… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2014-07-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT03275311 | Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 | — | Metastatic Breast Cancer | Recruiting | 2014-07-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT01970241 | Inpatient Diabetes on Corticosteroids | Phase4 | Diabetes Mellitus | Completed | 2014-07-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT02188693 | Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With … | — | Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer | Unknown | 2014-07-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT02124148 | A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Part… | Phase1 | Neoplasm Metastasis | Completed | 2014-06-18 | 2020-02-13 | ClinicalTrials.gov |
| NCT02124148 | A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Part… | Phase1 | Neoplasm Metastasis | Completed | 2014-06-18 | 2020-02-13 | ClinicalTrials.gov |
| NCT02148627 | Safety Study of LY3041658 in Healthy Participants | Phase1 | Healthy | Completed | 2014-06-16 | 2017-02-11 | ClinicalTrials.gov |
| NCT02148627 | Safety Study of LY3041658 in Healthy Participants | Phase1 | Healthy | Completed | 2014-06-16 | 2017-02-11 | ClinicalTrials.gov |
| NCT02102490 | A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Brea… | Phase2 | Metastatic Breast Cancer | Completed | 2014-06-10 | 2018-10-22 | ClinicalTrials.gov |
| NCT02102490 | A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Brea… | Phase2 | Metastatic Breast Cancer | Completed | 2014-06-10 | 2018-10-22 | ClinicalTrials.gov |
| NCT02806960 | A Study of Single and Repeated Doses of Glucagon Administered to Participants W… | Phase1 | Diabetes Mellitus, Type 1 | Terminated | 2014-06-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02121834 | A Study of LY3050258 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-06-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02121834 | A Study of LY3050258 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-06-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02161731 | Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-06-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT02121483 | Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents … | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2014-06-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT02104765 | A Study of LY2951742 in Healthy Japanese and Caucasian Participants | Phase1 | Migraine Disorders | Completed | 2014-06-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT02144272 | Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis | Phase1 | Inflammatory Arthritis | Completed | 2014-06-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT02144272 | Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis | Phase1 | Inflammatory Arthritis | Completed | 2014-06-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT02144285 | A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidn… | Phase1 | Kidney Failure, Chronic | Completed | 2014-06-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02156492 | A Study of Evacetrapib With Selected Statins in Healthy Chinese Participants | Phase1 | Healthy Volunteers | Completed | 2014-06-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02121483 | Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents … | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2014-06-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT02152384 | A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2014-06-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02144285 | A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidn… | Phase1 | Kidney Failure, Chronic | Completed | 2014-06-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02104765 | A Study of LY2951742 in Healthy Japanese and Caucasian Participants | Phase1 | Migraine Disorders | Completed | 2014-06-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT02161731 | Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-06-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT02806960 | A Study of Single and Repeated Doses of Glucagon Administered to Participants W… | Phase1 | Diabetes Mellitus, Type 1 | Terminated | 2014-06-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02156492 | A Study of Evacetrapib With Selected Statins in Healthy Chinese Participants | Phase1 | Healthy Volunteers | Completed | 2014-06-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02152384 | A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2014-06-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02168803 | A Study of Evacetrapib in Participants With Abnormal Cholesterol | Phase1 | Dyslipidemia | Completed | 2014-05-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02123459 | A Study of Cephalexin Suspension in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-05-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT02123472 | A Study of Cephalexin Liquid for Pediatrics in Healthy Adults Participants | Phase1 | Healthy Volunteers | Completed | 2014-05-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT02171130 | Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia | Phase3 | Hypoglycemia | Completed | 2014-05-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02150707 | The Differential Effects of Diabetes Therapy on Inflammation | — | Diabetic Nephropathy | Completed | 2014-05-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02154646 | A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or… | Phase1 | Pancreatic Neoplasms | Completed | 2014-05-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT02138097 | Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns | — | Diabetes Mellitus, Type 2 | Completed | 2014-05-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02111083 | A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-05-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02102932 | Bioavailability of Empagliflozin/Metformin Fixed Dose Combinations (FDCs) in He… | Phase1 | Healthy | Completed | 2014-05-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02152371 | A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2014-05-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT02171130 | Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia | Phase3 | Hypoglycemia | Completed | 2014-05-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02123472 | A Study of Cephalexin Liquid for Pediatrics in Healthy Adults Participants | Phase1 | Healthy Volunteers | Completed | 2014-05-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT02140645 | Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral an… | — | Diabetes Mellitus, Type 2 | Completed | 2014-05-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02168803 | A Study of Evacetrapib in Participants With Abnormal Cholesterol | Phase1 | Dyslipidemia | Completed | 2014-05-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02132637 | A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Thera… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2014-05-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT02102932 | Bioavailability of Empagliflozin/Metformin Fixed Dose Combinations (FDCs) in He… | Phase1 | Healthy | Completed | 2014-05-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02132637 | A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Thera… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2014-05-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT02138097 | Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns | — | Diabetes Mellitus, Type 2 | Completed | 2014-05-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02140645 | Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral an… | — | Diabetes Mellitus, Type 2 | Completed | 2014-05-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02111083 | A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-05-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02121509 | Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended … | Phase1 | Healthy | Completed | 2014-05-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02121509 | Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended … | Phase1 | Healthy | Completed | 2014-05-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02154646 | A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or… | Phase1 | Pancreatic Neoplasms | Completed | 2014-05-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT02150707 | The Differential Effects of Diabetes Therapy on Inflammation | — | Diabetic Nephropathy | Completed | 2014-05-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02123459 | A Study of Cephalexin Suspension in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-05-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT02152371 | A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2014-05-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT02069041 | A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer | Phase1 | Carcinoma, Hepatocellular | Completed | 2014-04-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT02084082 | Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended R… | Phase1 | Healthy | Completed | 2014-04-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02084056 | Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/1000mg) Extended… | Phase1 | Healthy | Completed | 2014-04-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02069041 | A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer | Phase1 | Carcinoma, Hepatocellular | Completed | 2014-04-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT02123446 | A Study of Cephalexin Capsules in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-04-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT02117648 | A Study of LY2835219 in Participants With Cancer | Phase1 | Neoplasm | Completed | 2014-04-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02111096 | A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus | Phase2 | Diabetes Mellitus, Type 2 | Terminated | 2014-04-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT02109042 | A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants | Phase1 | Osteoporosis, Postmenopausal | Completed | 2014-04-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02109029 | A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fa… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2014-04-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02106923 | Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformi… | Phase1 | Healthy | Completed | 2014-04-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02346344 | Outpatient Characterization of the Variability of Insulin Secretory Parameters … | — | Type 2 Diabetes | Completed | 2014-04-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT02346344 | Outpatient Characterization of the Variability of Insulin Secretory Parameters … | — | Type 2 Diabetes | Completed | 2014-04-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT02123446 | A Study of Cephalexin Capsules in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-04-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT02117648 | A Study of LY2835219 in Participants With Cancer | Phase1 | Neoplasm | Completed | 2014-04-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT02111096 | A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus | Phase2 | Diabetes Mellitus, Type 2 | Terminated | 2014-04-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT02109042 | A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants | Phase1 | Osteoporosis, Postmenopausal | Completed | 2014-04-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02109029 | A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fa… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2014-04-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02106923 | Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformi… | Phase1 | Healthy | Completed | 2014-04-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02100826 | A Study of Cephalexin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-04-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT02084082 | Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended R… | Phase1 | Healthy | Completed | 2014-04-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02084056 | Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/1000mg) Extended… | Phase1 | Healthy | Completed | 2014-04-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02100826 | A Study of Cephalexin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-04-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT02079636 | A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug… | Phase1 | Carcinoma, Non-small Cell Lung | Completed | 2014-03-28 | 2019-08-29 | ClinicalTrials.gov |
| NCT02079636 | A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug… | Phase1 | Carcinoma, Non-small Cell Lung | Completed | 2014-03-28 | 2019-08-29 | ClinicalTrials.gov |
| NCT02057133 | A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Can… | Phase1 | Breast Neoplasms | Active_Not_Recruiting | 2014-03-10 | 2026-12-01 | ClinicalTrials.gov |
| NCT02057133 | A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Can… | Phase1 | Breast Neoplasms | Active_Not_Recruiting | 2014-03-10 | 2026-12-01 | ClinicalTrials.gov |
| NCT02082210 | A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Particip… | Phase1 | Advanced Cancer | Completed | 2014-03-07 | 2018-01-24 | ClinicalTrials.gov |
| NCT02082210 | A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Particip… | Phase1 | Advanced Cancer | Completed | 2014-03-07 | 2018-01-24 | ClinicalTrials.gov |
| NCT02091362 | A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type… | Phase2 | Type 2 Diabetes Mellitus | Completed | 2014-03-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT02008318 | A Study of Galunisertib in Participants With Myelodysplastic Syndromes | Phase2 | Myelodysplastic Syndromes | Completed | 2014-03-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT02091362 | A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type… | Phase2 | Type 2 Diabetes Mellitus | Completed | 2014-03-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT02008318 | A Study of Galunisertib in Participants With Myelodysplastic Syndromes | Phase2 | Myelodysplastic Syndromes | Completed | 2014-03-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT02008357 | Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memo… | Phase3 | Cognition Disorders | Completed | 2014-02-28 | 2023-06-08 | ClinicalTrials.gov |
| NCT02008357 | Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memo… | Phase3 | Cognition Disorders | Completed | 2014-02-28 | 2023-06-08 | ClinicalTrials.gov |
| NCT01824290 | A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hyperten… | Phase3 | Hypertension, Pulmonary | Completed | 2014-02-05 | 2021-03-10 | ClinicalTrials.gov |
| NCT01824290 | A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hyperten… | Phase3 | Hypertension, Pulmonary | Completed | 2014-02-05 | 2021-03-10 | ClinicalTrials.gov |
| NCT02059148 | A Study of LY2835219 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-02-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02072096 | A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diab… | Phase4 | Diabetes Mellitus, Type 2 | Terminated | 2014-02-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT02059148 | A Study of LY2835219 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2014-02-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT02072096 | A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diab… | Phase4 | Diabetes Mellitus, Type 2 | Terminated | 2014-02-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT02041091 | A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Parti… | Phase3 | Lupus Erythematosus, Systemic | Terminated | 2014-01-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02041091 | A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Parti… | Phase3 | Lupus Erythematosus, Systemic | Terminated | 2014-01-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT02014129 | A Study of LY2835219 in Japanese Participants With Advanced Cancer | Phase1 | Neoplasm Metastasis | Completed | 2013-12-18 | 2019-08-21 | ClinicalTrials.gov |
| NCT02014129 | A Study of LY2835219 in Japanese Participants With Advanced Cancer | Phase1 | Neoplasm Metastasis | Completed | 2013-12-18 | 2019-08-21 | ClinicalTrials.gov |
| NCT01983878 | A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastri… | Phase2 | Gastric Cancer | Completed | 2013-12-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT01995656 | A Study of LY3108743 in Healthy Participants and Participants With Type 2 Diabe… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2013-12-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01995656 | A Study of LY3108743 in Healthy Participants and Participants With Type 2 Diabe… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2013-12-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT02004132 | A Study of Axiron® in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-12-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT02004132 | A Study of Axiron® in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-12-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT02018887 | A Study of LY2969822 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-12-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT02020616 | A Study of the Safety and Effectiveness of LY3053102 in Participants With Type … | Phase1 | Type 2 Diabetes Mellitus | Terminated | 2013-12-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT01983878 | A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastri… | Phase2 | Gastric Cancer | Completed | 2013-12-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT01995526 | A Study of Insulin Peglispro in Healthy Male Japanese Participants | Phase1 | Healthy Volunteers | Completed | 2013-12-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01991483 | A Study of LY2928057 in Hemodialysis Participants | Phase1 | Renal Insufficiency, Chronic | Completed | 2013-12-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01995526 | A Study of Insulin Peglispro in Healthy Male Japanese Participants | Phase1 | Healthy Volunteers | Completed | 2013-12-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT02020616 | A Study of the Safety and Effectiveness of LY3053102 in Participants With Type … | Phase1 | Type 2 Diabetes Mellitus | Terminated | 2013-12-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT02018887 | A Study of LY2969822 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-12-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT01991483 | A Study of LY2928057 in Hemodialysis Participants | Phase1 | Renal Insufficiency, Chronic | Completed | 2013-12-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT02014116 | A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Sp… | Phase1 | Neoplasms | Terminated | 2013-11-26 | 2018-10-05 | ClinicalTrials.gov |
| NCT02014116 | A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Sp… | Phase1 | Neoplasms | Terminated | 2013-11-26 | 2018-10-05 | ClinicalTrials.gov |
| NCT02009449 | A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Soli… | Phase1 | Melanoma | Completed | 2013-11-15 | 2023-07-22 | ClinicalTrials.gov |
| NCT02009449 | A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Soli… | Phase1 | Melanoma | Completed | 2013-11-15 | 2023-07-22 | ClinicalTrials.gov |
| NCT01981408 | A Study of LY2801653 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-11-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01925989 | A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Br… | Phase1 | Type 1 Diabetes Mellitus | Completed | 2013-11-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01925989 | A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Br… | Phase1 | Type 1 Diabetes Mellitus | Completed | 2013-11-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01969747 | Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2013-11-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01981408 | A Study of LY2801653 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-11-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01991158 | GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma | Phase2 | Extranodal NK/T-cell Lymphoma, Nasal Type | Unknown | 2013-11-01 | 2020-11-01 | ClinicalTrials.gov |
| NCT01994746 | Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2013-11-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT01997411 | Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabe… | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2013-11-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT01969747 | Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2013-11-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT02095288 | Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - … | — | Healthy | Active_Not_Recruiting | 2013-11-01 | 2029-07-01 | ClinicalTrials.gov |
| NCT02095288 | Lipidomics Screening of Anti-inflammatory Drugs and Drug Candidates in Vitro - … | — | Healthy | Active_Not_Recruiting | 2013-11-01 | 2029-07-01 | ClinicalTrials.gov |
| NCT01997411 | Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabe… | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2013-11-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT01994746 | Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2013-11-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT01991158 | GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma | Phase2 | Extranodal NK/T-cell Lymphoma, Nasal Type | Unknown | 2013-11-01 | 2020-11-01 | ClinicalTrials.gov |
| NCT01975220 | Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformi… | Phase1 | Healthy | Completed | 2013-10-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01968057 | A Study of Baricitinib and Ciclosporin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-10-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01965808 | A Study of LY2157299 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-10-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01965782 | A Study of [14C]-LY3023703 in Healthy Participants | Phase1 | Healthy Volunteers | Terminated | 2013-10-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01960140 | A Study of Baricitinib and Simvastatin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-10-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01958489 | A Study of Evacetrapib in Japanese and Non-Japanese Participants | Phase1 | Healthy Volunteers | Completed | 2013-10-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01947933 | A Safety Study of Mirikizumab (LY3074828) | Phase1 | Psoriasis | Completed | 2013-10-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT01975220 | Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformi… | Phase1 | Healthy | Completed | 2013-10-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01965782 | A Study of [14C]-LY3023703 in Healthy Participants | Phase1 | Healthy Volunteers | Terminated | 2013-10-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01960140 | A Study of Baricitinib and Simvastatin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-10-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01925144 | A Study of Baricitinib and Omeprazole in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-10-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01958489 | A Study of Evacetrapib in Japanese and Non-Japanese Participants | Phase1 | Healthy Volunteers | Completed | 2013-10-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01771250 | A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 D… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2013-10-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01947933 | A Safety Study of Mirikizumab (LY3074828) | Phase1 | Psoriasis | Completed | 2013-10-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT01771250 | A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 D… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2013-10-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01925144 | A Study of Baricitinib and Omeprazole in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-10-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01968070 | A Study of LY3127760 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-10-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01968057 | A Study of Baricitinib and Ciclosporin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-10-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01965808 | A Study of LY2157299 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-10-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01968070 | A Study of LY3127760 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-10-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01804803 | DIgital Assisted MONitoring for DiabeteS - I | Na | Diabetes Mellitus | Completed | 2013-09-09 | 2017-11-30 | ClinicalTrials.gov |
| NCT01804803 | DIgital Assisted MONitoring for DiabeteS - I | Na | Diabetes Mellitus | Completed | 2013-09-09 | 2017-11-30 | ClinicalTrials.gov |
| NCT01959334 | Evaluate the Immunogenicity of a Novel Glucagon Formulation | Phase3 | Drug-specific Antibodies | Completed | 2013-09-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01947855 | Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Ty… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2013-09-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01947855 | Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Ty… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2013-09-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01937871 | A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectil… | Phase3 | Benign Prostate Hyperplasia | Completed | 2013-09-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01937026 | A Study of Baricitinib and Probenecid in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-09-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01914666 | An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chr… | Phase3 | Back Pain Lower Back Chronic | Completed | 2013-09-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01931475 | A Study of Duloxetine in Participants With Chronic Pain Due to Osteoarthritis i… | Phase3 | Osteoarthritis | Completed | 2013-09-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01937871 | A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectil… | Phase3 | Benign Prostate Hyperplasia | Completed | 2013-09-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01937026 | A Study of Baricitinib and Probenecid in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-09-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01959334 | Evaluate the Immunogenicity of a Novel Glucagon Formulation | Phase3 | Drug-specific Antibodies | Completed | 2013-09-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01865084 | A Study of Tadalafil for Duchenne Muscular Dystrophy | Phase3 | Muscular Dystrophy, Duchenne | Terminated | 2013-09-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT01931475 | A Study of Duloxetine in Participants With Chronic Pain Due to Osteoarthritis i… | Phase3 | Osteoarthritis | Completed | 2013-09-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01865084 | A Study of Tadalafil for Duchenne Muscular Dystrophy | Phase3 | Muscular Dystrophy, Duchenne | Terminated | 2013-09-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT01914666 | An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chr… | Phase3 | Back Pain Lower Back Chronic | Completed | 2013-09-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01897480 | A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activ… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2013-08-28 | 2026-01-08 | ClinicalTrials.gov |
| NCT01897480 | A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activ… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2013-08-28 | 2026-01-08 | ClinicalTrials.gov |
| NCT01874938 | A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer | Phase2 | Gastric Cancer | Completed | 2013-08-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01924299 | A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in He… | Phase1 | Healthy Volunteers | Completed | 2013-08-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01874938 | A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer | Phase2 | Gastric Cancer | Completed | 2013-08-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01900652 | A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2013-08-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT01900652 | A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2013-08-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT01929707 | A Study of LY3050258 in Healthy Participants | Phase1 | Healthy Participants | Completed | 2013-08-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01929109 | A Study of LY2409021 in Participants With Different Levels of Kidney Function | Phase1 | Kidney Failure, Chronic | Completed | 2013-08-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01925157 | A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid A… | Phase1 | Rheumatoid Arthritis | Completed | 2013-08-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01924299 | A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in He… | Phase1 | Healthy Volunteers | Completed | 2013-08-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01921790 | Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma | Phase2 | Extranodal NK/T-cell Lymphoma, Nasal Type | Unknown | 2013-08-01 | 2020-08-01 | ClinicalTrials.gov |
| NCT01919398 | A Study of LY2940680 in Japanese Participants With Advanced Cancers | Phase1 | Neoplasm Metastasis | Completed | 2013-08-01 | 2017-06-28 | ClinicalTrials.gov |
| NCT01913314 | A Study of Carbon-14-Labeled LY2835219 ([^14C]-LY2835219) in Healthy Participan… | Phase1 | Healthy Volunteers | Completed | 2013-08-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01910311 | A Study of Baricitinib and Rifampicin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-08-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01910311 | A Study of Baricitinib and Rifampicin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-08-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01913314 | A Study of Carbon-14-Labeled LY2835219 ([^14C]-LY2835219) in Healthy Participan… | Phase1 | Healthy Volunteers | Completed | 2013-08-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01929707 | A Study of LY3050258 in Healthy Participants | Phase1 | Healthy Participants | Completed | 2013-08-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01929109 | A Study of LY2409021 in Participants With Different Levels of Kidney Function | Phase1 | Kidney Failure, Chronic | Completed | 2013-08-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01919398 | A Study of LY2940680 in Japanese Participants With Advanced Cancers | Phase1 | Neoplasm Metastasis | Completed | 2013-08-01 | 2017-06-28 | ClinicalTrials.gov |
| NCT01925157 | A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid A… | Phase1 | Rheumatoid Arthritis | Completed | 2013-08-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01921790 | Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma | Phase2 | Extranodal NK/T-cell Lymphoma, Nasal Type | Unknown | 2013-08-01 | 2020-08-01 | ClinicalTrials.gov |
| NCT01903356 | A Regulatory Requirement Non Interventional Study to Monitor Safety and Effecti… | — | Diabetes Mellitus, Type 2 | Completed | 2013-07-11 | 2017-06-10 | ClinicalTrials.gov |
| NCT01903356 | A Regulatory Requirement Non Interventional Study to Monitor Safety and Effecti… | — | Diabetes Mellitus, Type 2 | Completed | 2013-07-11 | 2017-06-10 | ClinicalTrials.gov |
| NCT01897532 | Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patien… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2013-07-10 | 2018-01-18 | ClinicalTrials.gov |
| NCT01897532 | Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patien… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2013-07-10 | 2018-01-18 | ClinicalTrials.gov |
| NCT01903083 | Chemoimmunotherapy and Radiation in Pancreatic Cancer | Phase1 | Locally Advanced Malignant Neoplasm | Completed | 2013-07-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT01904383 | PMS of Trazenta on the Long-term Use as Add-on Therapy | — | Diabetes Mellitus, Type 2 | Completed | 2013-07-01 | 2018-10-04 | ClinicalTrials.gov |
| NCT01908582 | A Study of Evacetrapib and Rifampin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-07-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01908582 | A Study of Evacetrapib and Rifampin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-07-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01904383 | PMS of Trazenta on the Long-term Use as Add-on Therapy | — | Diabetes Mellitus, Type 2 | Completed | 2013-07-01 | 2018-10-04 | ClinicalTrials.gov |
| NCT01903434 | A Study of Evacetrapib (LY2484595) in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-07-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01697514 | A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma | Phase1 | Medulloblastoma, Childhood | Withdrawn | 2013-07-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT01903083 | Chemoimmunotherapy and Radiation in Pancreatic Cancer | Phase1 | Locally Advanced Malignant Neoplasm | Completed | 2013-07-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT01900665 | Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Plac… | Phase3 | Alzheimer's Disease | Terminated | 2013-07-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT01896011 | Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical… | Phase3 | Non Displaced Atypical Femoral Fractures | Completed | 2013-07-01 | 2022-12-01 | ClinicalTrials.gov |
| NCT01897493 | A Study of Evacetrapib and Digoxin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-07-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01897493 | A Study of Evacetrapib and Digoxin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-07-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01896726 | A Study of Baricitinib and Birth Control Pills in Healthy Females | Phase1 | Healthy Volunteers | Completed | 2013-07-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01900665 | Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Plac… | Phase3 | Alzheimer's Disease | Terminated | 2013-07-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT01894568 | A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Trea… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2013-07-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01893281 | The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With … | Phase4 | Hypogonadism | Completed | 2013-07-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01893281 | The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With … | Phase4 | Hypogonadism | Completed | 2013-07-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01894568 | A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Trea… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2013-07-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01896011 | Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical… | Phase3 | Non Displaced Atypical Femoral Fractures | Completed | 2013-07-01 | 2022-12-01 | ClinicalTrials.gov |
| NCT01896726 | A Study of Baricitinib and Birth Control Pills in Healthy Females | Phase1 | Healthy Volunteers | Completed | 2013-07-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01697514 | A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma | Phase1 | Medulloblastoma, Childhood | Withdrawn | 2013-07-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT01903434 | A Study of Evacetrapib (LY2484595) in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-07-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01885078 | An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis | Phase3 | Rheumatoid Arthritis | Completed | 2013-06-27 | 2020-11-12 | ClinicalTrials.gov |
| NCT01885078 | An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis | Phase3 | Rheumatoid Arthritis | Completed | 2013-06-27 | 2020-11-12 | ClinicalTrials.gov |
| NCT01877265 | A Study of LY2605541 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-06-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01890967 | A Study of LY3015014 in Participants With High Cholesterol | Phase2 | Hypercholesterolemia | Completed | 2013-06-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01877265 | A Study of LY2605541 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-06-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01874756 | The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307… | Phase2 | Schizophrenia | Terminated | 2013-06-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT01872910 | A Study of LY3023703 Testing Pain Relief After Wisdom Teeth Removal | Phase2 | Acute Pain | Completed | 2013-06-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01871493 | A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-06-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01870388 | A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease | Phase1 | Liver Diseases | Completed | 2013-06-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01870297 | A Study of LY3025876 in Participants With Diabetes | Phase1 | Type 2 Diabetes Mellitus | Completed | 2013-06-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01867307 | Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2013-06-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01867216 | A Study of Multiple Doses of LY2922470 in Participants With Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2013-06-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01890967 | A Study of LY3015014 in Participants With High Cholesterol | Phase2 | Hypercholesterolemia | Completed | 2013-06-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01874756 | The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307… | Phase2 | Schizophrenia | Terminated | 2013-06-01 | 2017-12-01 | ClinicalTrials.gov |
| NCT01872910 | A Study of LY3023703 Testing Pain Relief After Wisdom Teeth Removal | Phase2 | Acute Pain | Completed | 2013-06-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01871493 | A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-06-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01870388 | A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease | Phase1 | Liver Diseases | Completed | 2013-06-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01870297 | A Study of LY3025876 in Participants With Diabetes | Phase1 | Type 2 Diabetes Mellitus | Completed | 2013-06-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01867307 | Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2013-06-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01867216 | A Study of Multiple Doses of LY2922470 in Participants With Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2013-06-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01765400 | Platelet Inhibition in Patients With Systolic Heart Failure | Phase4 | Systolic Heart Failure | Completed | 2013-05-15 | 2015-12-28 | ClinicalTrials.gov |
| NCT01765400 | Platelet Inhibition in Patients With Systolic Heart Failure | Phase4 | Systolic Heart Failure | Completed | 2013-05-15 | 2015-12-28 | ClinicalTrials.gov |
| NCT01763788 | A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Sma… | Phase1 | Squamous Non-small Cell Lung Cancer | Completed | 2013-05-07 | 2018-10-17 | ClinicalTrials.gov |
| NCT01763788 | A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Sma… | Phase1 | Squamous Non-small Cell Lung Cancer | Completed | 2013-05-07 | 2018-10-17 | ClinicalTrials.gov |
| NCT01837641 | A Study of LY3002813 in Participants With Alzheimer's Disease | Phase1 | Alzheimer Disease | Completed | 2013-05-03 | 2016-08-24 | ClinicalTrials.gov |
| NCT01837641 | A Study of LY3002813 in Participants With Alzheimer's Disease | Phase1 | Alzheimer Disease | Completed | 2013-05-03 | 2016-08-24 | ClinicalTrials.gov |
| NCT01859078 | A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in H… | Phase1 | Healthy Volunteers | Completed | 2013-05-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01821703 | A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-05-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01816295 | A Study in Men With Low Testosterone to Measure the Effects of Testosterone Sol… | Phase3 | Hypogonadism | Completed | 2013-05-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01808651 | A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing | Phase3 | Major Depressive Disorder | Completed | 2013-05-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01836198 | The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2… | Phase1 | Healthy Volunteers | Completed | 2013-05-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01845077 | Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin … | Phase1 | Healthy | Completed | 2013-05-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01846702 | A Study of LY3084077 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-05-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01849055 | A Multiple Dose Study of LY3023703 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-05-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01855919 | A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain | Phase3 | Back Pain Lower Back Chronic | Completed | 2013-05-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01859078 | A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in H… | Phase1 | Healthy Volunteers | Completed | 2013-05-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01808651 | A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing | Phase3 | Major Depressive Disorder | Completed | 2013-05-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01816295 | A Study in Men With Low Testosterone to Measure the Effects of Testosterone Sol… | Phase3 | Hypogonadism | Completed | 2013-05-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01821703 | A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-05-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01836198 | The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2… | Phase1 | Healthy Volunteers | Completed | 2013-05-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01845077 | Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin … | Phase1 | Healthy | Completed | 2013-05-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01846702 | A Study of LY3084077 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-05-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01849055 | A Multiple Dose Study of LY3023703 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-05-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01855919 | A Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain | Phase3 | Back Pain Lower Back Chronic | Completed | 2013-05-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01836185 | A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairm… | Phase1 | Hepatic Insufficiency | Completed | 2013-04-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01825889 | A Study of Evacetrapib (LY2484595) in Participants With Severe Renal Impairment… | Phase1 | Cardiovascular Disease | Completed | 2013-04-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01825876 | A Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-04-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01825889 | A Study of Evacetrapib (LY2484595) in Participants With Severe Renal Impairment… | Phase1 | Cardiovascular Disease | Completed | 2013-04-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01794000 | A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD) | Phase3 | Sickle Cell Disease | Terminated | 2013-04-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01836185 | A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairm… | Phase1 | Hepatic Insufficiency | Completed | 2013-04-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01825876 | A Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-04-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01794000 | A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD) | Phase3 | Sickle Cell Disease | Terminated | 2013-04-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01739309 | Study of LY2835219 for Mantle Cell Lymphoma | Phase2 | Mantle Cell Lymphoma | Completed | 2013-03-20 | 2022-09-05 | ClinicalTrials.gov |
| NCT01739309 | Study of LY2835219 for Mantle Cell Lymphoma | Phase2 | Mantle Cell Lymphoma | Completed | 2013-03-20 | 2022-09-05 | ClinicalTrials.gov |
| NCT01810432 | Study of Food on Evacetrapib (LY2484595) in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-03-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01808612 | A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing | Phase3 | Major Depressive Disorder | Completed | 2013-03-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01807026 | A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Al… | Phase1 | Alzheimer Disease | Completed | 2013-03-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01790438 | A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2013-03-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01788566 | A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Lin… | Phase2 | Non-small Cell Lung Cancer | Completed | 2013-03-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01777191 | Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participan… | Phase3 | Plaque Psoriasis | Completed | 2013-03-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT01774981 | Study of LY3016859 in Participants With Diabetic Nephropathy | Phase1 | Diabetic Nephropathy | Completed | 2013-03-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT01818245 | A Study of LY2605541 in Healthy Participants and in the Elderly | Phase1 | Healthy Volunteers | Completed | 2013-03-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01632306 | A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreati… | Phase1 | Pancreatic Cancer | Terminated | 2013-03-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT02778100 | A Study of Nasal Glucagon in Participants With a Common Cold | Phase1 | Common Cold | Completed | 2013-03-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01777191 | Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participan… | Phase3 | Plaque Psoriasis | Completed | 2013-03-01 | 2015-05-01 | ClinicalTrials.gov |
| NCT01807026 | A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Al… | Phase1 | Alzheimer Disease | Completed | 2013-03-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01788566 | A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Lin… | Phase2 | Non-small Cell Lung Cancer | Completed | 2013-03-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01790438 | A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2013-03-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01774981 | Study of LY3016859 in Participants With Diabetic Nephropathy | Phase1 | Diabetic Nephropathy | Completed | 2013-03-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT01818245 | A Study of LY2605541 in Healthy Participants and in the Elderly | Phase1 | Healthy Volunteers | Completed | 2013-03-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01810432 | Study of Food on Evacetrapib (LY2484595) in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-03-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01808612 | A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing | Phase3 | Major Depressive Disorder | Completed | 2013-03-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT02778100 | A Study of Nasal Glucagon in Participants With a Common Cold | Phase1 | Common Cold | Completed | 2013-03-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01632306 | A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreati… | Phase1 | Pancreatic Cancer | Terminated | 2013-03-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01734785 | Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compare… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2013-02-08 | 2015-03-23 | ClinicalTrials.gov |
| NCT01734785 | Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compare… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2013-02-08 | 2015-03-23 | ClinicalTrials.gov |
| NCT01774968 | Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2013-02-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01769404 | A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2013-02-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01769404 | A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2013-02-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01774968 | Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2013-02-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01775904 | A Study of Two Dosage Forms of LY2886721 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-02-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01784211 | A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diab… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2013-02-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01787903 | The Effects of RT-CGM on Glycemia and QoL in Patients With T1DM and IHA | Na | Type 1 Diabetes Mellitus | Completed | 2013-02-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT01792284 | A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus | Phase3 | Type 1 Diabetes Mellitus | Completed | 2013-02-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01792518 | MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabet… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2013-02-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01792518 | MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabet… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2013-02-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01792284 | A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus | Phase3 | Type 1 Diabetes Mellitus | Completed | 2013-02-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01787903 | The Effects of RT-CGM on Glycemia and QoL in Patients With T1DM and IHA | Na | Type 1 Diabetes Mellitus | Completed | 2013-02-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT01784211 | A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diab… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2013-02-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01775904 | A Study of Two Dosage Forms of LY2886721 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-02-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01769391 | A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous … | Phase2 | Squamous Non Small Cell Lung Cancer | Completed | 2013-01-01 | 2017-07-01 | ClinicalTrials.gov |
| NCT01721044 | A Moderate to Severe Rheumatoid Arthritis Study | Phase3 | Rheumatoid Arthritis | Completed | 2013-01-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT01722292 | A Study of LY2940680 in Small Cell Lung Cancer | Phase1 | Small Cell Lung Carcinoma | Terminated | 2013-01-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT01778049 | Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background M… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2013-01-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01769378 | Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabet… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2013-01-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01753856 | Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteo… | Phase4 | Osteoporosis | Completed | 2013-01-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01750853 | A Study of LY3045697 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-01-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01773473 | Comparison of Insulin Mix25 Versus Mix50 | Phase4 | Type 2 Diabetes Mellitus | Completed | 2013-01-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01721044 | A Moderate to Severe Rheumatoid Arthritis Study | Phase3 | Rheumatoid Arthritis | Completed | 2013-01-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT01722292 | A Study of LY2940680 in Small Cell Lung Cancer | Phase1 | Small Cell Lung Carcinoma | Terminated | 2013-01-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT01778049 | Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background M… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2013-01-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01746745 | A Study of LY2940680 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-01-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01746004 | A Study of LY2157299 Monohydrate in Healthy Volunteers | Phase1 | Healthy Volunteers | Completed | 2013-01-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01773473 | Comparison of Insulin Mix25 Versus Mix50 | Phase4 | Type 2 Diabetes Mellitus | Completed | 2013-01-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01746004 | A Study of LY2157299 Monohydrate in Healthy Volunteers | Phase1 | Healthy Volunteers | Completed | 2013-01-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01746745 | A Study of LY2940680 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-01-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01750853 | A Study of LY3045697 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2013-01-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01753856 | Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteo… | Phase4 | Osteoporosis | Completed | 2013-01-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01769378 | Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabet… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2013-01-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01769391 | A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous … | Phase2 | Squamous Non Small Cell Lung Cancer | Completed | 2013-01-01 | 2017-07-01 | ClinicalTrials.gov |
| NCT01746017 | A Study of LY2922470 in Healthy Participants and Participants With Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2012-12-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01736254 | A Study of Evacetrapib in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2012-12-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01721057 | A Study in Moderate to Severe Rheumatoid Arthritis Participants | Phase3 | Rheumatoid Arthritis | Completed | 2012-12-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01746732 | A Study of Evacetrapib in Healthy Female Participants | Phase1 | Healthy Volunteers | Completed | 2012-12-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01760005 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementi… | Phase2 | Alzheimers Disease | Active_Not_Recruiting | 2012-12-01 | 2028-07-01 | ClinicalTrials.gov |
| NCT01705587 | Fracture (FX) Improvement With Teriparatide: FiX-IT Study | Phase4 | Osteoporosis | Completed | 2012-12-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT01748552 | A Study of LY2922083 in Healthy Participants and Participants With Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2012-12-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01721057 | A Study in Moderate to Severe Rheumatoid Arthritis Participants | Phase3 | Rheumatoid Arthritis | Completed | 2012-12-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01703091 | A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatm… | Phase2 | Non-small Cell Lung Cancer Metastatic | Completed | 2012-12-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT01748552 | A Study of LY2922083 in Healthy Participants and Participants With Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2012-12-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01695239 | A Study of Ixekizumab in Participants With Active Psoriatic Arthritis | Phase3 | Psoriasis, Arthritic | Completed | 2012-12-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT01695239 | A Study of Ixekizumab in Participants With Active Psoriatic Arthritis | Phase3 | Psoriasis, Arthritic | Completed | 2012-12-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT01705587 | Fracture (FX) Improvement With Teriparatide: FiX-IT Study | Phase4 | Osteoporosis | Completed | 2012-12-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT04623242 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementi… | Phase2 | Alzheimers Disease | Completed | 2012-12-01 | 2020-03-06 | ClinicalTrials.gov |
| NCT01736241 | A Study of LY3053102 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2012-12-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01736254 | A Study of Evacetrapib in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2012-12-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01760005 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementi… | Phase2 | Alzheimers Disease | Active_Not_Recruiting | 2012-12-01 | 2028-07-01 | ClinicalTrials.gov |
| NCT01746017 | A Study of LY2922470 in Healthy Participants and Participants With Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2012-12-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01751399 | A Single Dose Study of LY2605541 in Participants With Liver Impairment | Phase1 | Healthy Volunteers | Completed | 2012-12-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01736241 | A Study of LY3053102 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2012-12-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01703091 | A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatm… | Phase2 | Non-small Cell Lung Cancer Metastatic | Completed | 2012-12-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT01751399 | A Single Dose Study of LY2605541 in Participants With Liver Impairment | Phase1 | Healthy Volunteers | Completed | 2012-12-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT04623242 | Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementi… | Phase2 | Alzheimers Disease | Completed | 2012-12-01 | 2020-03-06 | ClinicalTrials.gov |
| NCT01746732 | A Study of Evacetrapib in Healthy Female Participants | Phase1 | Healthy Volunteers | Completed | 2012-12-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01707147 | A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta … | — | Diabetes Mellitus, Type 2 | Completed | 2012-11-16 | 2017-07-11 | ClinicalTrials.gov |
| NCT01707147 | A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta … | — | Diabetes Mellitus, Type 2 | Completed | 2012-11-16 | 2017-07-11 | ClinicalTrials.gov |
| NCT01742767 | Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC | Phase2 | NSCLC | Unknown | 2012-11-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01711359 | A Study in Participants With Moderate to Severe Rheumatoid Arthritis | Phase3 | Rheumatoid Arthritis | Completed | 2012-11-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT01725451 | A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in … | Phase1 | Healthy Participants | Completed | 2012-11-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01682135 | A Study in Participants With Advanced Solid Tumors | Phase1 | Solid Tumor | Completed | 2012-11-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01682135 | A Study in Participants With Advanced Solid Tumors | Phase1 | Solid Tumor | Completed | 2012-11-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01711359 | A Study in Participants With Moderate to Severe Rheumatoid Arthritis | Phase3 | Rheumatoid Arthritis | Completed | 2012-11-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT01722825 | Study of LY2157299 in Japanese Participants With Cancer | Phase1 | Neoplasms | Completed | 2012-11-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01725451 | A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in … | Phase1 | Healthy Participants | Completed | 2012-11-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01722825 | Study of LY2157299 in Japanese Participants With Cancer | Phase1 | Neoplasms | Completed | 2012-11-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01742767 | Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC | Phase2 | NSCLC | Unknown | 2012-11-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01687998 | A Study of Evacetrapib in High-Risk Vascular Disease | Phase3 | Cardiovascular Diseases | Terminated | 2012-10-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT01709110 | VERtebral Fracture Treatment Comparisons in Osteoporotic Women | Phase4 | Postmenopausal Osteoporosis | Completed | 2012-10-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT01703702 | Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management a… | Phase4 | Alzheimer's Disease | Completed | 2012-10-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01695005 | A Study of LY3039478 in Participants With Advanced Cancer | Phase1 | Neoplasms | Completed | 2012-10-01 | 2018-06-26 | ClinicalTrials.gov |
| NCT01719003 | Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatm… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2012-10-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01687998 | A Study of Evacetrapib in High-Risk Vascular Disease | Phase3 | Cardiovascular Diseases | Terminated | 2012-10-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT01703286 | Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compare… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2012-10-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01703702 | Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management a… | Phase4 | Alzheimer's Disease | Completed | 2012-10-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01719003 | Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatm… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2012-10-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01695005 | A Study of LY3039478 in Participants With Advanced Cancer | Phase1 | Neoplasms | Completed | 2012-10-01 | 2018-06-26 | ClinicalTrials.gov |
| NCT01710358 | A Study in Moderate to Severe Rheumatoid Arthritis | Phase3 | Rheumatoid Arthritis | Completed | 2012-10-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01709110 | VERtebral Fracture Treatment Comparisons in Osteoporotic Women | Phase4 | Postmenopausal Osteoporosis | Completed | 2012-10-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT01662882 | A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imagin… | Phase2 | Alzheimer's Disease | Completed | 2012-10-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01708902 | Study to Compare the Efficacy and Safety of Administration of the Fix Dose Comb… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2012-10-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01634555 | A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combinatio… | Phase2 | Solid Tumors | Completed | 2012-10-01 | 2018-02-01 | ClinicalTrials.gov |
| NCT01649297 | A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2012-10-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01662882 | A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imagin… | Phase2 | Alzheimer's Disease | Completed | 2012-10-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01710358 | A Study in Moderate to Severe Rheumatoid Arthritis | Phase3 | Rheumatoid Arthritis | Completed | 2012-10-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01708902 | Study to Compare the Efficacy and Safety of Administration of the Fix Dose Comb… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2012-10-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01634555 | A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combinatio… | Phase2 | Solid Tumors | Completed | 2012-10-01 | 2018-02-01 | ClinicalTrials.gov |
| NCT01703286 | Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compare… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2012-10-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01649297 | A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2012-10-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01687478 | A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression | Phase3 | Treatment Resistant Depression | Terminated | 2012-09-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT01676701 | Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participant… | Phase3 | Rheumatoid Arthritis | Terminated | 2012-09-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01681186 | A Study of LY2940680 in Healthy Participants | Phase1 | Healthy Participants | Completed | 2012-09-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01687478 | A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression | Phase3 | Treatment Resistant Depression | Terminated | 2012-09-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT01688635 | A Study to Compare LY2963016 and US-approved Lantus® After Single Dose Administ… | Phase1 | Healthy | Completed | 2012-09-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01936376 | A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In… | — | Head and Neck Cancer | Unknown | 2012-09-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01936376 | A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In… | — | Head and Neck Cancer | Unknown | 2012-09-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01688635 | A Study to Compare LY2963016 and US-approved Lantus® After Single Dose Administ… | Phase1 | Healthy | Completed | 2012-09-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01681186 | A Study of LY2940680 in Healthy Participants | Phase1 | Healthy Participants | Completed | 2012-09-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01676701 | Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participant… | Phase3 | Rheumatoid Arthritis | Terminated | 2012-09-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01660815 | A Study of Florbetapir (18F) in Japanese Healthy Volunteers | Phase1 | Alzheimer's Disease | Completed | 2012-08-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01624467 | A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Adva… | Phase2 | Solid Tumors | Completed | 2012-08-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01667900 | A Study of Dulaglutide in Chinese Participants | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2012-08-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01671085 | A Study of LY3015014 in Healthy Participants With High Cholesterol | Phase1 | Healthy Volunteers | Completed | 2012-08-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01660815 | A Study of Florbetapir (18F) in Japanese Healthy Volunteers | Phase1 | Alzheimer's Disease | Completed | 2012-08-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01524705 | FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) | Phase4 | Type 2 Diabetes | Completed | 2012-08-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01683409 | A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabeti… | Phase2 | Diabetic Kidney Disease | Completed | 2012-08-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT01667900 | A Study of Dulaglutide in Chinese Participants | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2012-08-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01606748 | A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitab… | Phase2 | Malignant Solid Tumor | Completed | 2012-08-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT01624467 | A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Adva… | Phase2 | Solid Tumors | Completed | 2012-08-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01524705 | FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) | Phase4 | Type 2 Diabetes | Completed | 2012-08-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01606748 | A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitab… | Phase2 | Malignant Solid Tumor | Completed | 2012-08-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT01683409 | A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabeti… | Phase2 | Diabetic Kidney Disease | Completed | 2012-08-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT01671085 | A Study of LY3015014 in Healthy Participants With High Cholesterol | Phase1 | Healthy Volunteers | Completed | 2012-08-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01655225 | A Study of LY3023414 in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2012-07-31 | 2022-02-02 | ClinicalTrials.gov |
| NCT01655225 | A Study of LY3023414 in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2012-07-31 | 2022-02-02 | ClinicalTrials.gov |
| NCT01646177 | A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3) | Phase3 | Psoriasis | Completed | 2012-07-28 | 2019-07-22 | ClinicalTrials.gov |
| NCT01646177 | A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3) | Phase3 | Psoriasis | Completed | 2012-07-28 | 2019-07-22 | ClinicalTrials.gov |
| NCT01640249 | A Study of LY3006072 in Healthy Participants | Phase1 | Healthy Volunteers | Terminated | 2012-07-24 | 2012-11-26 | ClinicalTrials.gov |
| NCT01640249 | A Study of LY3006072 in Healthy Participants | Phase1 | Healthy Volunteers | Terminated | 2012-07-24 | 2012-11-26 | ClinicalTrials.gov |
| NCT01650259 | Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Melli… | — | Diabetes Mellitus, Type 2 | Completed | 2012-07-23 | 2017-09-14 | ClinicalTrials.gov |
| NCT01650259 | Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Melli… | — | Diabetes Mellitus, Type 2 | Completed | 2012-07-23 | 2017-09-14 | ClinicalTrials.gov |
| NCT01515306 | A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tu… | Phase2 | Malignant Solid Tumor | Completed | 2012-07-19 | 2021-02-22 | ClinicalTrials.gov |
| NCT01515306 | A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tu… | Phase2 | Malignant Solid Tumor | Completed | 2012-07-19 | 2021-02-22 | ClinicalTrials.gov |
| NCT01484431 | A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hyp… | Phase1 | Pulmonary Arterial Hypertension | Completed | 2012-07-17 | 2019-04-03 | ClinicalTrials.gov |
| NCT01484431 | A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hyp… | Phase1 | Pulmonary Arterial Hypertension | Completed | 2012-07-17 | 2019-04-03 | ClinicalTrials.gov |
| NCT01634165 | A Study of LY2963016 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2012-07-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01654380 | A Study of LY2605541 Versus Insulin Glargine on Blood Sugar | Phase1 | Healthy Volunteers | Completed | 2012-07-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01654380 | A Study of LY2605541 Versus Insulin Glargine on Blood Sugar | Phase1 | Healthy Volunteers | Completed | 2012-07-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01648790 | A Study of Prasugrel in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2012-07-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01648582 | A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine i… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2012-07-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01646203 | A Study of IMC-TR1 in Participants With Advanced Solid Tumors | Phase1 | Neoplasms | Completed | 2012-07-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT01644500 | A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Typ… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2012-07-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01640834 | Study of LY2409021 in Participants With Type 1 Diabetes | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2012-07-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01638325 | A Study of Insulin Lispro With BioChaperone Excipient in Healthy Participants | Phase1 | Healthy Participants | Completed | 2012-07-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01621178 | A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Part… | Phase3 | Type 2 Diabetes | Completed | 2012-07-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT01602224 | A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multip… | Phase2 | Multiple Myeloma | Completed | 2012-07-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01621178 | A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Part… | Phase3 | Type 2 Diabetes | Completed | 2012-07-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT01567163 | A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors | Phase2 | Malignant Solid Tumor | Completed | 2012-07-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01556438 | Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refact… | Phase1 | Multiple Myeloma | Completed | 2012-07-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT01602224 | A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multip… | Phase2 | Multiple Myeloma | Completed | 2012-07-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01663857 | A Study LY2228820 for Recurrent Ovarian Cancer | Phase1 | Epithelial Ovarian Cancer | Completed | 2012-07-01 | 2018-05-11 | ClinicalTrials.gov |
| NCT01567163 | A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors | Phase2 | Malignant Solid Tumor | Completed | 2012-07-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01556438 | Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refact… | Phase1 | Multiple Myeloma | Completed | 2012-07-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT01634165 | A Study of LY2963016 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2012-07-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01638325 | A Study of Insulin Lispro With BioChaperone Excipient in Healthy Participants | Phase1 | Healthy Participants | Completed | 2012-07-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01640834 | Study of LY2409021 in Participants With Type 1 Diabetes | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2012-07-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01644500 | A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Typ… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2012-07-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01646203 | A Study of IMC-TR1 in Participants With Advanced Solid Tumors | Phase1 | Neoplasms | Completed | 2012-07-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT01648582 | A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine i… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2012-07-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01663857 | A Study LY2228820 for Recurrent Ovarian Cancer | Phase1 | Epithelial Ovarian Cancer | Completed | 2012-07-01 | 2018-05-11 | ClinicalTrials.gov |
| NCT01648790 | A Study of Prasugrel in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2012-07-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01625988 | A Study of LY2951742 in Participants With Migraine | Phase2 | Migraine Headache | Completed | 2012-06-28 | 2013-09-18 | ClinicalTrials.gov |
| NCT01625988 | A Study of LY2951742 in Participants With Migraine | Phase2 | Migraine Headache | Completed | 2012-06-28 | 2013-09-18 | ClinicalTrials.gov |
| NCT01520220 | Study of LY2784544 Testing Alternative Dosing in Participants With Myeloprolife… | Phase1 | Myeloproliferative Neoplasms of | Completed | 2012-06-11 | 2017-02-24 | ClinicalTrials.gov |
| NCT01520220 | Study of LY2784544 Testing Alternative Dosing in Participants With Myeloprolife… | Phase1 | Myeloproliferative Neoplasms of | Completed | 2012-06-11 | 2017-02-24 | ClinicalTrials.gov |
| NCT01621191 | An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT… | Phase3 | Fibromyalgia | Completed | 2012-06-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01624259 | A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes | Phase3 | Type 2 Diabetes | Completed | 2012-06-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01602289 | A Study of LY2875358 in Japanese Participants With Advanced Cancer | Phase1 | Solid Tumors | Completed | 2012-06-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01632566 | A Multiple-dose Study of LY3031207 in Healthy Participants | Phase1 | Healthy Volunteers | Terminated | 2012-06-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01632579 | A Single Dose Study of LY3023703 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2012-06-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01632579 | A Single Dose Study of LY3023703 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2012-06-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01602289 | A Study of LY2875358 in Japanese Participants With Advanced Cancer | Phase1 | Solid Tumors | Completed | 2012-06-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01618916 | A Study of LY3015014 in Otherwise Healthy Participants With High Low-density Li… | Phase1 | Healthy Volunteers | Completed | 2012-06-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01618916 | A Study of LY3015014 in Otherwise Healthy Participants With High Low-density Li… | Phase1 | Healthy Volunteers | Completed | 2012-06-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01624233 | A Study in Japanese Participants With Moderate-to-Severe Psoriasis | Phase3 | Psoriasis | Completed | 2012-06-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT01621191 | An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT… | Phase3 | Fibromyalgia | Completed | 2012-06-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01624233 | A Study in Japanese Participants With Moderate-to-Severe Psoriasis | Phase3 | Psoriasis | Completed | 2012-06-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT01624259 | A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes | Phase3 | Type 2 Diabetes | Completed | 2012-06-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01632566 | A Multiple-dose Study of LY3031207 in Healthy Participants | Phase1 | Healthy Volunteers | Terminated | 2012-06-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01594723 | A Study of LY2784544 in Participants With Myeloproliferative Neoplasms | Phase2 | Neoplasms, Hematologic | Active_Not_Recruiting | 2012-05-22 | 2026-12-01 | ClinicalTrials.gov |
| NCT01594723 | A Study of LY2784544 in Participants With Myeloproliferative Neoplasms | Phase2 | Neoplasms, Hematologic | Active_Not_Recruiting | 2012-05-22 | 2026-12-01 | ClinicalTrials.gov |
| NCT01597245 | A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2) | Phase3 | Psoriasis | Completed | 2012-05-18 | 2019-06-18 | ClinicalTrials.gov |
| NCT01597245 | A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2) | Phase3 | Psoriasis | Completed | 2012-05-18 | 2019-06-18 | ClinicalTrials.gov |
| NCT01663220 | Characterization of the Variability of Insulin Secretory Parameters in the Meal… | — | Type 2 Diabetes | Completed | 2012-05-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01582451 | A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2012-05-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01576549 | A Study of LY2127399 in Rheumatoid Arthritis | Phase2 | Rheumatoid Arthritis | Terminated | 2012-05-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01663207 | Characterization of the Variability Of Insulin Secretory Parameters in the Meal… | — | Type 2 Diabetes | Completed | 2012-05-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01604408 | A Study in Older Participants Who Have Fallen and Have Muscle Weakness | Phase2 | Muscle Weakness | Completed | 2012-05-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01600950 | A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2012-05-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01582451 | A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2012-05-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01576549 | A Study of LY2127399 in Rheumatoid Arthritis | Phase2 | Rheumatoid Arthritis | Terminated | 2012-05-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01663207 | Characterization of the Variability Of Insulin Secretory Parameters in the Meal… | — | Type 2 Diabetes | Completed | 2012-05-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01604408 | A Study in Older Participants Who Have Fallen and Have Muscle Weakness | Phase2 | Muscle Weakness | Completed | 2012-05-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01663220 | Characterization of the Variability of Insulin Secretory Parameters in the Meal… | — | Type 2 Diabetes | Completed | 2012-05-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01600950 | A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With… | Phase1 | Diabetes Mellitus, Type 1 | Completed | 2012-05-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01582269 | A Study in Recurrent Glioblastoma (GB) | Phase2 | Glioblastoma | Completed | 2012-04-26 | 2024-10-10 | ClinicalTrials.gov |
| NCT01582269 | A Study in Recurrent Glioblastoma (GB) | Phase2 | Glioblastoma | Completed | 2012-04-26 | 2024-10-10 | ClinicalTrials.gov |
| NCT01577355 | A Study of LY2784544 in Healthy Male Subjects | Phase1 | Healthy Male Volunteers | Completed | 2012-04-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01581658 | Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Typ… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2012-04-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01569126 | A Study of LY110140 in Healthy Japanese Male Participants | Phase1 | Healthy Volunteer | Completed | 2012-04-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01569126 | A Study of LY110140 in Healthy Japanese Male Participants | Phase1 | Healthy Volunteer | Completed | 2012-04-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01588366 | The Effects of LY2409021 on the Liver | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2012-04-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01545583 | A Study of LY3016859 in Healthy Volunteers | Phase1 | Healthy Volunteers | Completed | 2012-04-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01524237 | A Study of LY2979165 and LY2140023 in Healthy Volunteers | Phase1 | Healthy Volunteers | Completed | 2012-04-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01524237 | A Study of LY2979165 and LY2140023 in Healthy Volunteers | Phase1 | Healthy Volunteers | Completed | 2012-04-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01584232 | A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus | Phase3 | Type 2 Diabetes Mellitus | Completed | 2012-04-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01588366 | The Effects of LY2409021 on the Liver | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2012-04-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01577355 | A Study of LY2784544 in Healthy Male Subjects | Phase1 | Healthy Male Volunteers | Completed | 2012-04-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01545583 | A Study of LY3016859 in Healthy Volunteers | Phase1 | Healthy Volunteers | Completed | 2012-04-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01584232 | A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus | Phase3 | Type 2 Diabetes Mellitus | Completed | 2012-04-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01581658 | Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Typ… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2012-04-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01593293 | Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell … | Phase3 | Non-small Cell Lung Cancer | Unknown | 2012-03-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT01587651 | Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subject… | Phase4 | Coronary Artery Disease | Completed | 2012-03-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01538446 | Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel | Phase4 | Acute Coronary Syndrome | Completed | 2012-03-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT01561430 | Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or M… | Phase1 | Alzheimer's Disease | Terminated | 2012-03-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01558700 | Duloxetine in Osteoarthritis (OA) Pain | Phase4 | Osteoarthritis | Completed | 2012-03-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01593293 | Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell … | Phase3 | Non-small Cell Lung Cancer | Unknown | 2012-03-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT01552057 | A Study of Duloxetine in Fibromyalgia | Phase3 | Fibromyalgia | Completed | 2012-03-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01558271 | A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus | Phase3 | Type 2 Diabetes Mellitus | Completed | 2012-03-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01524770 | A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Vers… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2012-03-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01556594 | Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients… | Phase2 | Hypoglycemia | Completed | 2012-03-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01524770 | A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Vers… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2012-03-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01538446 | Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel | Phase4 | Acute Coronary Syndrome | Completed | 2012-03-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT01552057 | A Study of Duloxetine in Fibromyalgia | Phase3 | Fibromyalgia | Completed | 2012-03-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01556594 | Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients… | Phase2 | Hypoglycemia | Completed | 2012-03-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01558271 | A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus | Phase3 | Type 2 Diabetes Mellitus | Completed | 2012-03-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01558700 | Duloxetine in Osteoarthritis (OA) Pain | Phase4 | Osteoarthritis | Completed | 2012-03-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01561430 | Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or M… | Phase1 | Alzheimer's Disease | Terminated | 2012-03-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01587651 | Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subject… | Phase4 | Coronary Artery Disease | Completed | 2012-03-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01528124 | A Study of LY3025876 in Healthy Volunteers | Phase1 | Healthy Volunteers | Completed | 2012-02-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01469000 | A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Can… | Phase2 | Carcinoma, Non Small Cell Lung | Completed | 2012-02-01 | 2017-11-01 | ClinicalTrials.gov |
| NCT01473589 | Effect of Teriparatide on Hip Fracture Healing | Phase3 | Femur Neck Fracture | Completed | 2012-02-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01543620 | Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephro… | — | Cystic Fibrosis | Unknown | 2012-02-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01537887 | A Study of LY2484595 on the Electrical Activity of the Heart | Phase1 | Healthy Volunteers | Completed | 2012-02-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01536951 | A Study of LY3009104 in Healthy Participants | Phase1 | Healthy Participants | Completed | 2012-02-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01534273 | A Study of LY2886721 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2012-02-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01515358 | A Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy Partici… | Phase1 | Healthy Volunteers | Completed | 2012-02-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01515358 | A Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy Partici… | Phase1 | Healthy Volunteers | Completed | 2012-02-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01473589 | Effect of Teriparatide on Hip Fracture Healing | Phase3 | Femur Neck Fracture | Completed | 2012-02-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01469000 | A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Can… | Phase2 | Carcinoma, Non Small Cell Lung | Completed | 2012-02-01 | 2017-11-01 | ClinicalTrials.gov |
| NCT01528124 | A Study of LY3025876 in Healthy Volunteers | Phase1 | Healthy Volunteers | Completed | 2012-02-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01543620 | Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephro… | — | Cystic Fibrosis | Unknown | 2012-02-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01537887 | A Study of LY2484595 on the Electrical Activity of the Heart | Phase1 | Healthy Volunteers | Completed | 2012-02-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01536951 | A Study of LY3009104 in Healthy Participants | Phase1 | Healthy Participants | Completed | 2012-02-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01534273 | A Study of LY2886721 in Healthy Participants | Phase1 | Healthy Volunteers | Completed | 2012-02-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01512979 | Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2012-01-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01454284 | A Study in Participants With Type I Diabetes Mellitus | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2012-01-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01488708 | On Open-Label Study in Participants With Systemic Lupus Erythematosus | Phase3 | Systemic Lupus Erythematosus | Terminated | 2012-01-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01481779 | A Study in Participants With Type 1 Diabetes Mellitus | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2012-01-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01473602 | Second Study of the Effect of Teriparatide on Hip Fracture Healing | Phase3 | Femur Neck Fracture | Completed | 2012-01-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01511393 | An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) | — | Diabetes | Enrolling_By_Invitation | 2012-01-01 | 2039-12-01 | ClinicalTrials.gov |
| NCT01512979 | Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2012-01-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01660464 | Guided Self-Help for Parents of Adolescents With Attention-Deficit/Hyperactivit… | Na | Attention-Deficit/Hyperactivity Disorder | Completed | 2012-01-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01454284 | A Study in Participants With Type I Diabetes Mellitus | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2012-01-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01481779 | A Study in Participants With Type 1 Diabetes Mellitus | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2012-01-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01488708 | On Open-Label Study in Participants With Systemic Lupus Erythematosus | Phase3 | Systemic Lupus Erythematosus | Terminated | 2012-01-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01511393 | An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) | — | Diabetes | Enrolling_By_Invitation | 2012-01-01 | 2039-12-01 | ClinicalTrials.gov |
| NCT01660464 | Guided Self-Help for Parents of Adolescents With Attention-Deficit/Hyperactivit… | Na | Attention-Deficit/Hyperactivity Disorder | Completed | 2012-01-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01473602 | Second Study of the Effect of Teriparatide on Hip Fracture Healing | Phase3 | Femur Neck Fracture | Completed | 2012-01-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01459016 | A Non-drug Methods Study in Participants With Alzheimer's Disease | Phase1 | Alzheimer's Disease | Completed | 2011-12-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01468987 | A Study in Participants With Type 2 Diabetes Mellitus | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-12-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01473563 | A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advan… | Phase2 | Nonsquamous Non-Small Cell Neoplasm of Lung | Completed | 2011-12-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01474538 | Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participan… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2011-12-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01468987 | A Study in Participants With Type 2 Diabetes Mellitus | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-12-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01474538 | Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participan… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2011-12-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01473563 | A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advan… | Phase2 | Nonsquamous Non-Small Cell Neoplasm of Lung | Completed | 2011-12-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01460342 | Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperp… | Phase3 | Benign Prostatic Hyperplasia | Completed | 2011-12-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01660191 | A Study Comparing CoQ10 Levels While Taking 3 Different Statins | Phase4 | Hypercholesterolemia | Completed | 2011-12-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01660191 | A Study Comparing CoQ10 Levels While Taking 3 Different Statins | Phase4 | Hypercholesterolemia | Completed | 2011-12-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01505530 | A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer | Phase2 | Pancreatic Cancer | Completed | 2011-12-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT01505530 | A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer | Phase2 | Pancreatic Cancer | Completed | 2011-12-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT01490632 | A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psorias… | Phase2 | Psoriasis | Completed | 2011-12-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01487083 | A Long-Term Study in Schizophrenia | Phase3 | Schizophrenia | Terminated | 2011-12-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01490632 | A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psorias… | Phase2 | Psoriasis | Completed | 2011-12-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01459016 | A Non-drug Methods Study in Participants With Alzheimer's Disease | Phase1 | Alzheimer's Disease | Completed | 2011-12-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01487083 | A Long-Term Study in Schizophrenia | Phase3 | Schizophrenia | Terminated | 2011-12-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01463631 | A Study of LY3007113 in Participants With Advanced Cancer | Phase1 | Metastatic Cancer | Completed | 2011-12-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01463631 | A Study of LY3007113 in Participants With Advanced Cancer | Phase1 | Metastatic Cancer | Completed | 2011-12-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01460342 | Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperp… | Phase3 | Benign Prostatic Hyperplasia | Completed | 2011-12-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01474512 | A Phase 3 Study in Participants With Moderate to Severe Psoriasis | Phase3 | Psoriasis | Completed | 2011-11-16 | 2018-09-20 | ClinicalTrials.gov |
| NCT01474512 | A Phase 3 Study in Participants With Moderate to Severe Psoriasis | Phase3 | Psoriasis | Completed | 2011-11-16 | 2018-09-20 | ClinicalTrials.gov |
| NCT01477567 | A First-in-Human Study of LY3009385 in Healthy Participants | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-11-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01438814 | Linagliptin in Combination With Metformin in Treatment Naive Patients With Type… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2011-11-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01432951 | A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Soli… | Phase1 | Solid Tumor | Completed | 2011-11-01 | 2018-01-05 | ClinicalTrials.gov |
| NCT01427933 | A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin… | Phase2 | Breast Cancer | Completed | 2011-11-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01476345 | A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY2963016 to La… | Phase1 | Diabetes Mellitus | Completed | 2011-11-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01477567 | A First-in-Human Study of LY3009385 in Healthy Participants | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-11-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01435616 | A Study in Patients With Type 2 Diabetes Mellitus | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-11-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01469013 | Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheu… | Phase2 | Arthritis, Rheumatoid | Completed | 2011-11-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01468181 | A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus | Phase3 | Type 2 Diabetes Mellitus | Completed | 2011-11-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01432951 | A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Soli… | Phase1 | Solid Tumor | Completed | 2011-11-01 | 2018-01-05 | ClinicalTrials.gov |
| NCT01435616 | A Study in Patients With Type 2 Diabetes Mellitus | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-11-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01476696 | A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease | Phase2 | Sickle Cell Disease | Completed | 2011-11-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01438814 | Linagliptin in Combination With Metformin in Treatment Naive Patients With Type… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2011-11-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01469013 | Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheu… | Phase2 | Arthritis, Rheumatoid | Completed | 2011-11-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01468181 | A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus | Phase3 | Type 2 Diabetes Mellitus | Completed | 2011-11-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01427933 | A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin… | Phase2 | Breast Cancer | Completed | 2011-11-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01476345 | A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY2963016 to La… | Phase1 | Diabetes Mellitus | Completed | 2011-11-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01476696 | A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease | Phase2 | Sickle Cell Disease | Completed | 2011-11-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01449630 | A Study of LY3031207 in Healthy Subjects | Phase1 | Healthy Volunteers | Completed | 2011-10-24 | 2012-04-02 | ClinicalTrials.gov |
| NCT01449630 | A Study of LY3031207 in Healthy Subjects | Phase1 | Healthy Volunteers | Completed | 2011-10-24 | 2012-04-02 | ClinicalTrials.gov |
| NCT00957853 | Preoperative Treatment With Cetuximab and/or IMC-A12 | Phase2 | Head and Neck Squamous Cell Carcinoma | Completed | 2011-10-17 | 2018-08-15 | ClinicalTrials.gov |
| NCT00957853 | Preoperative Treatment With Cetuximab and/or IMC-A12 | Phase2 | Head and Neck Squamous Cell Carcinoma | Completed | 2011-10-17 | 2018-08-15 | ClinicalTrials.gov |
| NCT01443078 | Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-smal… | Phase2 | Lung Cancer | Completed | 2011-10-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01460381 | A Study to Evaluate the Effect of Genotype on LY2216684 | Phase1 | Depressive Disorder, Major | Completed | 2011-10-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01443078 | Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-smal… | Phase2 | Lung Cancer | Completed | 2011-10-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01448824 | A Study of LY2484595 on Pharmacokinetics in Healthy Participants | Phase1 | Healthy Participants | Completed | 2011-10-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT01460407 | A Study to Evaluate the Effect of Clarithromycin on LY2216684 | Phase1 | Depressive Disorder, Major | Completed | 2011-10-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01450098 | A Study of LY2484595 in Healthy Subjects | Phase1 | Healthy Volunteers | Completed | 2011-10-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01454973 | Characterization of the Variability of Insulin Secretory Parameters in the Meal… | — | Type 2 Diabetes | Completed | 2011-10-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01458210 | A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-10-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT02778113 | A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults | Phase1 | Healthy | Completed | 2011-10-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01460368 | A Study on the Effects of LY2409021 on the Electrical Impulses of the Heart | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-10-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01460381 | A Study to Evaluate the Effect of Genotype on LY2216684 | Phase1 | Depressive Disorder, Major | Completed | 2011-10-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01460407 | A Study to Evaluate the Effect of Clarithromycin on LY2216684 | Phase1 | Depressive Disorder, Major | Completed | 2011-10-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT02778113 | A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults | Phase1 | Healthy | Completed | 2011-10-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01448824 | A Study of LY2484595 on Pharmacokinetics in Healthy Participants | Phase1 | Healthy Participants | Completed | 2011-10-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT01450098 | A Study of LY2484595 in Healthy Subjects | Phase1 | Healthy Volunteers | Completed | 2011-10-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01454973 | Characterization of the Variability of Insulin Secretory Parameters in the Meal… | — | Type 2 Diabetes | Completed | 2011-10-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01458210 | A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-10-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT01460368 | A Study on the Effects of LY2409021 on the Electrical Impulses of the Heart | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-10-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT03465436 | A Study of Lasmiditan on the Heart in Healthy Participants | Phase1 | Healthy | Completed | 2011-09-16 | 2011-12-20 | ClinicalTrials.gov |
| NCT03465436 | A Study of Lasmiditan on the Heart in Healthy Participants | Phase1 | Healthy | Completed | 2011-09-16 | 2011-12-20 | ClinicalTrials.gov |
| NCT01427972 | A Study of LY2623091 in Male and Females With Chronic Kidney Disease | Phase2 | Chronic Kidney Disease | Completed | 2011-09-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01427972 | A Study of LY2623091 in Male and Females With Chronic Kidney Disease | Phase2 | Chronic Kidney Disease | Completed | 2011-09-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01426412 | A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprot… | Phase1 | Hyperlipidemia | Completed | 2011-09-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01421459 | A Study in Adults With Type 2 Diabetes | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-09-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01281228 | The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesit… | Na | Diabetes Mellitus | Completed | 2011-09-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01426412 | A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprot… | Phase1 | Hyperlipidemia | Completed | 2011-09-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01439568 | A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carci… | Phase2 | Extensive Stage Small Cell Lung Carcinoma | Completed | 2011-09-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT01408095 | A Study in Patients With Type 2 Diabetes | Phase2 | Diabetes Mellitus, Type 2 | Withdrawn | 2011-09-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01436201 | A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Par… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-09-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01281228 | The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesit… | Na | Diabetes Mellitus | Completed | 2011-09-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01408095 | A Study in Patients With Type 2 Diabetes | Phase2 | Diabetes Mellitus, Type 2 | Withdrawn | 2011-09-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01432938 | A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Parti… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-09-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01440478 | The Effects of Urinary pH Changes on an Investigational Compound in Healthy Sub… | Phase1 | Healthy Subjects | Completed | 2011-09-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01421459 | A Study in Adults With Type 2 Diabetes | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-09-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01439568 | A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carci… | Phase2 | Extensive Stage Small Cell Lung Carcinoma | Completed | 2011-09-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT01440478 | The Effects of Urinary pH Changes on an Investigational Compound in Healthy Sub… | Phase1 | Healthy Subjects | Completed | 2011-09-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01436201 | A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Par… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-09-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01432938 | A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Parti… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-09-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01430091 | A Relative Bioavailability Study of a Prasugrel Orally Disintegrating Tablet | Phase1 | Sickle Cell Disease | Completed | 2011-09-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01430091 | A Relative Bioavailability Study of a Prasugrel Orally Disintegrating Tablet | Phase1 | Sickle Cell Disease | Completed | 2011-09-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01419236 | A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels | Phase2 | Ejaculatory Dysfunction | Completed | 2011-08-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01430104 | A Study of Teriparatide in Japanese Osteoporosis Patients | Phase4 | Osteoporosis | Completed | 2011-08-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01422876 | Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed D… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-08-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01292252 | Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion | Phase4 | Lumbar Spondylosis | Completed | 2011-08-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT01316263 | A Study of Olaratumab (IMC-3G3) in Previously Treated Participants With Unresec… | Phase2 | Gastrointestinal Stromal Tumor (GIST) | Terminated | 2011-08-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01370499 | A Study of LY2216684 in Participants With Major Depression Disorder | Phase3 | Major Depressive Disorder | Completed | 2011-08-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01388335 | A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Path… | Phase1 | Solid Tumor | Completed | 2011-08-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01391130 | A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carci… | Phase2 | Metastatic Clear Cell Renal Cell Carcinoma | Terminated | 2011-08-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT01400516 | Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial | Phase4 | Rheumatoid Arthritis | Completed | 2011-08-01 | 2016-07-28 | ClinicalTrials.gov |
| NCT01370499 | A Study of LY2216684 in Participants With Major Depression Disorder | Phase3 | Major Depressive Disorder | Completed | 2011-08-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01408888 | A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-08-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01416389 | A Study of LY2523355 in Participants With Breast Cancer | Phase2 | Metastatic Breast Cancer | Completed | 2011-08-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01421147 | A Study in Adults With Type 1 Diabetes | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2011-08-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01419236 | A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels | Phase2 | Ejaculatory Dysfunction | Completed | 2011-08-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01421147 | A Study in Adults With Type 1 Diabetes | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2011-08-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01422876 | Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed D… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-08-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01416389 | A Study of LY2523355 in Participants With Breast Cancer | Phase2 | Metastatic Breast Cancer | Completed | 2011-08-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01430104 | A Study of Teriparatide in Japanese Osteoporosis Patients | Phase4 | Osteoporosis | Completed | 2011-08-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01388335 | A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Path… | Phase1 | Solid Tumor | Completed | 2011-08-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01408888 | A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-08-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01391130 | A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carci… | Phase2 | Metastatic Clear Cell Renal Cell Carcinoma | Terminated | 2011-08-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT01490372 | Gestational Diabetes Mellitus and Cardiometabolic Syndrome in Offspring | — | Gestational Diabetes Mellitus | Completed | 2011-08-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01400516 | Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial | Phase4 | Rheumatoid Arthritis | Completed | 2011-08-01 | 2016-07-28 | ClinicalTrials.gov |
| NCT01292252 | Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion | Phase4 | Lumbar Spondylosis | Completed | 2011-08-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT01316263 | A Study of Olaratumab (IMC-3G3) in Previously Treated Participants With Unresec… | Phase2 | Gastrointestinal Stromal Tumor (GIST) | Terminated | 2011-08-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01490372 | Gestational Diabetes Mellitus and Cardiometabolic Syndrome in Offspring | — | Gestational Diabetes Mellitus | Completed | 2011-08-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01394952 | Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) | Phase3 | Cardiovascular Disease | Completed | 2011-07-22 | 2018-08-21 | ClinicalTrials.gov |
| NCT01394952 | Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) | Phase3 | Cardiovascular Disease | Completed | 2011-07-22 | 2018-08-21 | ClinicalTrials.gov |
| NCT01451606 | Duloxetine for the Treatment of Chronic Pelvic Pain | Phase4 | Pelvis Pain Chronic | Terminated | 2011-07-11 | 2015-11-04 | ClinicalTrials.gov |
| NCT01451606 | Duloxetine for the Treatment of Chronic Pelvic Pain | Phase4 | Pelvis Pain Chronic | Terminated | 2011-07-11 | 2015-11-04 | ClinicalTrials.gov |
| NCT01389752 | A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY221… | Phase1 | Depressive Disorder, Major | Completed | 2011-07-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01369511 | A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replac… | Phase2 | Muscular Atrophy | Completed | 2011-07-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01398475 | A Relative Bioavailability and Food Effect Study of New Formulations | Phase1 | Chronic Inflammatory Disorder | Completed | 2011-07-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01389765 | A Study to Evaluate the Effect of Food on LY2216684 | Phase1 | Depressive Disorder, Major | Completed | 2011-07-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00816959 | Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Ly… | Phase3 | Hodgkin's Lymphoma | Unknown | 2011-07-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT00797472 | Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease | Phase2 | Hodgkin's Disease | Unknown | 2011-07-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01401543 | A Bioavailability Study of LY2452473 and Tadalafil | Phase1 | Erectile Dysfunction | Completed | 2011-07-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01400971 | An Observational Study to Understand Challenges Associated With Progression of … | — | Diabetes Mellitus, Type 2 | Completed | 2011-07-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01369511 | A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replac… | Phase2 | Muscular Atrophy | Completed | 2011-07-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT02903238 | Brain Morphometry in OA Patients Treated With Duloxetine | Na | Pain | Completed | 2011-07-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01391221 | Inflammatory Markers and Cognitive Function in Major Depression | Phase4 | Major Depression | Unknown | 2011-07-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT00816959 | Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Ly… | Phase3 | Hodgkin's Lymphoma | Unknown | 2011-07-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT00797472 | Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease | Phase2 | Hodgkin's Disease | Unknown | 2011-07-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01401543 | A Bioavailability Study of LY2452473 and Tadalafil | Phase1 | Erectile Dysfunction | Completed | 2011-07-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01400971 | An Observational Study to Understand Challenges Associated With Progression of … | — | Diabetes Mellitus, Type 2 | Completed | 2011-07-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01398475 | A Relative Bioavailability and Food Effect Study of New Formulations | Phase1 | Chronic Inflammatory Disorder | Completed | 2011-07-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01389765 | A Study to Evaluate the Effect of Food on LY2216684 | Phase1 | Depressive Disorder, Major | Completed | 2011-07-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01389752 | A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY221… | Phase1 | Depressive Disorder, Major | Completed | 2011-07-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01383967 | A Study of LY2979165 in Healthy Subjects | Phase1 | Bipolar Disorder | Completed | 2011-07-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01383967 | A Study of LY2979165 in Healthy Subjects | Phase1 | Bipolar Disorder | Completed | 2011-07-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT02903238 | Brain Morphometry in OA Patients Treated With Duloxetine | Na | Pain | Completed | 2011-07-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01391221 | Inflammatory Markers and Cognitive Function in Major Depression | Phase4 | Major Depression | Unknown | 2011-07-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01346358 | A Study of IMC-CS4 in Subjects With Advanced Solid Tumors | Phase1 | Neoplasms | Completed | 2011-06-15 | 2018-05-31 | ClinicalTrials.gov |
| NCT01346358 | A Study of IMC-CS4 in Subjects With Advanced Solid Tumors | Phase1 | Neoplasms | Completed | 2011-06-15 | 2018-05-31 | ClinicalTrials.gov |
| NCT01226511 | A Study in Pediatric Participants With Generalized Anxiety Disorder | Phase3 | Anxiety Neuroses | Completed | 2011-06-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01380691 | A Study of LY2216684 in Healthy Participants | Phase1 | Major Depressive Disorder | Completed | 2011-06-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01375075 | A Study of LY2484595 in Japanese Subjects | Phase2 | Dyslipidemias | Completed | 2011-06-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01374178 | A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy Sub… | Phase1 | Diabetes Mellitus | Completed | 2011-06-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01373931 | A Study of LY2216684 in Healthy Females | Phase1 | Depressive Disorder, Major | Completed | 2011-06-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01373216 | Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Card… | Phase3 | Coronary Artery Disease | Completed | 2011-06-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01373164 | A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic… | Phase1 | Neoplasms | Completed | 2011-06-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT01372085 | Single Dose Study in Healthy Participants to Investigate the Safety and Absorpt… | Phase1 | Healthy Participants | Completed | 2011-06-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01370005 | 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive P… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-06-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01367262 | Disposition of Carbon-14-Labeled LY2886721 ([^14C]-LY2886721) Following Oral Ad… | Phase1 | Healthy Volunteers | Completed | 2011-06-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01358968 | A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pat… | Phase1 | Cancer | Completed | 2011-06-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01352507 | A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China | Phase4 | Erectile Dysfunction | Completed | 2011-06-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01215942 | An Open Label Study for Participants With Rheumatoid Arthritis | Phase3 | Rheumatoid Arthritis | Terminated | 2011-06-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01380691 | A Study of LY2216684 in Healthy Participants | Phase1 | Major Depressive Disorder | Completed | 2011-06-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01375075 | A Study of LY2484595 in Japanese Subjects | Phase2 | Dyslipidemias | Completed | 2011-06-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01374178 | A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy Sub… | Phase1 | Diabetes Mellitus | Completed | 2011-06-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01373931 | A Study of LY2216684 in Healthy Females | Phase1 | Depressive Disorder, Major | Completed | 2011-06-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01373216 | Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Card… | Phase3 | Coronary Artery Disease | Completed | 2011-06-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01373164 | A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic… | Phase1 | Neoplasms | Completed | 2011-06-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT01372085 | Single Dose Study in Healthy Participants to Investigate the Safety and Absorpt… | Phase1 | Healthy Participants | Completed | 2011-06-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01370005 | 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive P… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-06-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01367262 | Disposition of Carbon-14-Labeled LY2886721 ([^14C]-LY2886721) Following Oral Ad… | Phase1 | Healthy Volunteers | Completed | 2011-06-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01358968 | A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pat… | Phase1 | Cancer | Completed | 2011-06-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01352507 | A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China | Phase4 | Erectile Dysfunction | Completed | 2011-06-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01226511 | A Study in Pediatric Participants With Generalized Anxiety Disorder | Phase3 | Anxiety Neuroses | Completed | 2011-06-01 | 2013-06-01 | ClinicalTrials.gov |
| NCT01215942 | An Open Label Study for Participants With Rheumatoid Arthritis | Phase3 | Rheumatoid Arthritis | Terminated | 2011-06-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01358981 | A Study of LY2881835 in Healthy People and People With Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-05-24 | 2011-08-17 | ClinicalTrials.gov |
| NCT01358981 | A Study of LY2881835 in Healthy People and People With Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-05-24 | 2011-08-17 | ClinicalTrials.gov |
| NCT01263782 | BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lu… | Phase2 | Lung Cancer | Completed | 2011-05-17 | 2017-08-15 | ClinicalTrials.gov |
| NCT01263782 | BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lu… | Phase2 | Lung Cancer | Completed | 2011-05-17 | 2017-08-15 | ClinicalTrials.gov |
| NCT01354015 | Diabetes Remote Care Management System | Na | Diabetes | Completed | 2011-05-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT01341470 | A Study of LY2495655 in Healthy Subjects | Phase1 | Healthy Volunteer | Completed | 2011-05-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01354015 | Diabetes Remote Care Management System | Na | Diabetes | Completed | 2011-05-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT01341470 | A Study of LY2495655 in Healthy Subjects | Phase1 | Healthy Volunteer | Completed | 2011-05-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01368081 | Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With T… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-05-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01368081 | Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With T… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-05-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01360424 | Teriparatide Treatment in Patients With Inherited Osteoporosis | Phase4 | Osteoporosis | Completed | 2011-05-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01341457 | A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid… | Phase1 | Solid Tumors | Completed | 2011-05-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT01341457 | A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid… | Phase1 | Solid Tumors | Completed | 2011-05-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT01360424 | Teriparatide Treatment in Patients With Inherited Osteoporosis | Phase4 | Osteoporosis | Completed | 2011-05-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01299272 | A Study in Prevention of Re-emergence of Depression Symptoms | Phase3 | Major Depressive Disorder | Completed | 2011-05-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01299272 | A Study in Prevention of Re-emergence of Depression Symptoms | Phase3 | Major Depressive Disorder | Completed | 2011-05-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01179672 | A Study in Participants With Diabetic Peripheral Neuropathic Pain in China | Phase3 | Diabetic Neuropathy, Painful | Completed | 2011-04-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01246960 | A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesop… | Phase2 | Stomach Cancer | Completed | 2011-04-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01200290 | A Study in Participants With End-Stage Renal Disease | Phase2 | Kidney Failure, Chronic | Completed | 2011-04-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01342484 | Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Typ… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2011-04-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT01326117 | Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis | Phase4 | Gastroparesis | Withdrawn | 2011-04-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01200290 | A Study in Participants With End-Stage Renal Disease | Phase2 | Kidney Failure, Chronic | Completed | 2011-04-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01282463 | Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone … | Phase2 | Carcinoma of Urinary Tract | Completed | 2011-04-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01175824 | Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2011-04-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01220271 | A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patien… | Phase1 | Glioma | Completed | 2011-04-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT01232452 | A Study in Non-Small Cell Lung Cancer | Phase2 | Non-Small-Cell Lung Carcinoma | Completed | 2011-04-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT01179672 | A Study in Participants With Diabetic Peripheral Neuropathic Pain in China | Phase3 | Diabetic Neuropathy, Painful | Completed | 2011-04-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01246960 | A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesop… | Phase2 | Stomach Cancer | Completed | 2011-04-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01354496 | A Study of LY2409021 Formulations and the Effect of Food | Phase1 | Healthy Volunteers | Completed | 2011-04-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01354496 | A Study of LY2409021 Formulations and the Effect of Food | Phase1 | Healthy Volunteers | Completed | 2011-04-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01059643 | A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal… | Phase2 | Ovarian Cancer | Completed | 2011-04-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01337596 | A Study of LY2951742 in Healthy Volunteers | Phase1 | Migraines | Completed | 2011-04-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01342484 | Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Typ… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2011-04-01 | 2016-02-01 | ClinicalTrials.gov |
| NCT01337596 | A Study of LY2951742 in Healthy Volunteers | Phase1 | Migraines | Completed | 2011-04-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01282463 | Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone … | Phase2 | Carcinoma of Urinary Tract | Completed | 2011-04-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01326117 | Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis | Phase4 | Gastroparesis | Withdrawn | 2011-04-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01232452 | A Study in Non-Small Cell Lung Cancer | Phase2 | Non-Small-Cell Lung Carcinoma | Completed | 2011-04-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT01220271 | A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patien… | Phase1 | Glioma | Completed | 2011-04-01 | 2016-11-01 | ClinicalTrials.gov |
| NCT01175824 | Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2011-04-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01059643 | A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal… | Phase2 | Ovarian Cancer | Completed | 2011-04-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01246986 | A Study of LY2157299 in Participants With Hepatocellular Carcinoma | Phase2 | Carcinoma, Hepatocellular | Completed | 2011-03-30 | 2019-12-24 | ClinicalTrials.gov |
| NCT01246986 | A Study of LY2157299 in Participants With Hepatocellular Carcinoma | Phase2 | Carcinoma, Hepatocellular | Completed | 2011-03-30 | 2019-12-24 | ClinicalTrials.gov |
| NCT01136746 | Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lis… | Phase3 | Hyperglycemia | Terminated | 2011-03-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01288989 | A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced S… | Phase1 | Neoplasms | Completed | 2011-03-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01136746 | Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lis… | Phase3 | Hyperglycemia | Terminated | 2011-03-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01185340 | A Study in Participants With Major Depressive Disorder Who Are Partial Responde… | Phase3 | Major Depressive Disorder | Completed | 2011-03-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01187407 | A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Partici… | Phase3 | Major Depressive Disorder (MDD) | Completed | 2011-03-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01330953 | A First Human Study of a Ferroportin Antibody | Phase1 | Healthy Volunteers | Completed | 2011-03-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01234402 | Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination W… | Phase2 | Breast Cancer | Completed | 2011-03-01 | 2017-07-01 | ClinicalTrials.gov |
| NCT01237587 | A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome | Phase3 | Fibromyalgia | Completed | 2011-03-01 | 2017-11-28 | ClinicalTrials.gov |
| NCT01185340 | A Study in Participants With Major Depressive Disorder Who Are Partial Responde… | Phase3 | Major Depressive Disorder | Completed | 2011-03-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01187407 | A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Partici… | Phase3 | Major Depressive Disorder (MDD) | Completed | 2011-03-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01288989 | A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced S… | Phase1 | Neoplasms | Completed | 2011-03-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01324999 | Tadalafil for Sarcoidosis Associated Pulmonary Hypertension | Phase2 | Pulmonary Hypertension | Completed | 2011-03-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01324388 | A Study of the Effect of LY2189265 on Two Blood Pressure Drugs | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-03-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01319929 | A Study of LY2828360 in Patients With Osteoarthritic Knee Pain | Phase2 | Osteoarthritis, Knee | Completed | 2011-03-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01313286 | A Study to Compare Two Forms of LY2608204 in Healthy People | Phase1 | Healthy Volunteers | Completed | 2011-03-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01319929 | A Study of LY2828360 in Patients With Osteoarthritic Knee Pain | Phase2 | Osteoarthritis, Knee | Completed | 2011-03-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01313286 | A Study to Compare Two Forms of LY2608204 in Healthy People | Phase1 | Healthy Volunteers | Completed | 2011-03-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01234402 | Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination W… | Phase2 | Breast Cancer | Completed | 2011-03-01 | 2017-07-01 | ClinicalTrials.gov |
| NCT01324388 | A Study of the Effect of LY2189265 on Two Blood Pressure Drugs | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-03-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01324999 | Tadalafil for Sarcoidosis Associated Pulmonary Hypertension | Phase2 | Pulmonary Hypertension | Completed | 2011-03-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01237587 | A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome | Phase3 | Fibromyalgia | Completed | 2011-03-01 | 2017-11-28 | ClinicalTrials.gov |
| NCT01330953 | A First Human Study of a Ferroportin Antibody | Phase1 | Healthy Volunteers | Completed | 2011-03-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01139775 | A Study in Non Small Cell Lung Cancer | Phase1 | Non Small Cell Lung Cancer | Completed | 2011-02-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01289990 | Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-02-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01301092 | A Study to Compare the Concentrations of LY2189265 After Different Methods of A… | Phase1 | Diabetes Mellitus, Type II | Completed | 2011-02-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01306214 | Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With T… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-02-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01306214 | Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With T… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-02-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01139775 | A Study in Non Small Cell Lung Cancer | Phase1 | Non Small Cell Lung Cancer | Completed | 2011-02-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01286818 | A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramuciru… | Phase1 | Colorectal Carcinoma | Completed | 2011-02-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01289990 | Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2011-02-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT01296568 | C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors | Phase1 | Advanced Cancer | Completed | 2011-02-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT01297062 | A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenat… | Phase1 | Healthy Subjects | Completed | 2011-02-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01299285 | Disposition of 14C-LY3009104 Following Oral Administration in Healthy Human Sub… | Phase1 | Healthy Volunteers | Completed | 2011-02-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01279187 | The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in… | Phase2 | Implant | Terminated | 2011-02-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT01175811 | A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Dia… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2011-02-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01286818 | A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramuciru… | Phase1 | Colorectal Carcinoma | Completed | 2011-02-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01300260 | Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-02-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01301092 | A Study to Compare the Concentrations of LY2189265 After Different Methods of A… | Phase1 | Diabetes Mellitus, Type II | Completed | 2011-02-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01296568 | C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors | Phase1 | Advanced Cancer | Completed | 2011-02-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT01297062 | A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenat… | Phase1 | Healthy Subjects | Completed | 2011-02-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01175811 | A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Dia… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2011-02-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01279187 | The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in… | Phase2 | Implant | Terminated | 2011-02-01 | 2015-11-01 | ClinicalTrials.gov |
| NCT01299285 | Disposition of 14C-LY3009104 Following Oral Administration in Healthy Human Sub… | Phase1 | Healthy Volunteers | Completed | 2011-02-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01300260 | Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2011-02-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01241448 | A Study of LY2409021 in Patients With Type 2 Diabetes | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2011-01-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01202760 | A Rheumatoid Arthritis Study in Participants | Phase3 | Rheumatoid Arthritis | Completed | 2011-01-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01202773 | A Study in Participants With Rheumatoid Arthritis | Phase3 | Rheumatoid Arthritis | Terminated | 2011-01-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01184508 | A Study in Migraine Prevention | Phase2 | Migraine Headache | Terminated | 2011-01-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01184508 | A Study in Migraine Prevention | Phase2 | Migraine Headache | Terminated | 2011-01-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01205438 | A Study of LY2127399 in Participants With Systemic Lupus Erythematosus | Phase3 | Systemic Lupus Erythematosus | Completed | 2011-01-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01205438 | A Study of LY2127399 in Participants With Systemic Lupus Erythematosus | Phase3 | Systemic Lupus Erythematosus | Completed | 2011-01-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01241448 | A Study of LY2409021 in Patients With Type 2 Diabetes | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2011-01-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01202773 | A Study in Participants With Rheumatoid Arthritis | Phase3 | Rheumatoid Arthritis | Terminated | 2011-01-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01275157 | Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human Sub… | Phase1 | Healthy Volunteers | Completed | 2011-01-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01275157 | Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human Sub… | Phase1 | Healthy Volunteers | Completed | 2011-01-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01202760 | A Rheumatoid Arthritis Study in Participants | Phase3 | Rheumatoid Arthritis | Completed | 2011-01-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01183780 | A Study in Second Line Metastatic Colorectal Cancer | Phase3 | Colorectal Cancer | Completed | 2010-12-02 | 2016-06-20 | ClinicalTrials.gov |
| NCT01183780 | A Study in Second Line Metastatic Colorectal Cancer | Phase3 | Colorectal Cancer | Completed | 2010-12-02 | 2016-06-20 | ClinicalTrials.gov |
| NCT01227252 | A Safety Study of LY2886721 Multiple Doses in Healthy Subjects | Phase1 | Alzheimer's Disease | Completed | 2010-12-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01127633 | Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease | Phase3 | Alzheimer's Disease | Terminated | 2010-12-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT01168973 | A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Lin… | Phase3 | Non-Small Cell Lung Cancer | Completed | 2010-12-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT01170663 | A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gas… | Phase3 | Gastric Cancer | Completed | 2010-12-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT01196091 | A Study of LY2127399 in Participants With Systemic Lupus Erythematosus | Phase3 | Systemic Lupus Erythematosus | Completed | 2010-12-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01198002 | A Rheumatoid Arthritis Study in Participants on a Background Treatment of Metho… | Phase3 | Rheumatoid Arthritis | Terminated | 2010-12-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01212107 | A Phase 1 Study of LY2874455 in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2010-12-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT01215955 | Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Dia… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2010-12-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01232439 | A Study of Brain Receptor Occupancy in Healthy Subjects | Phase1 | Alcohol Dependence | Completed | 2010-12-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01236118 | A Study of LY2439821 in Rheumatoid Arthritis | Phase1 | Rheumatoid Arthritis | Completed | 2010-12-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01301066 | A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infect… | Phase4 | Dyslipidemia | Completed | 2010-12-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01275144 | A Study of the Effect of LY2216684 on Lorazepam | Phase1 | Major Depressive Disorder | Completed | 2010-12-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01266590 | A Study of LY2216684 and Digoxin in Healthy Subjects | Phase1 | Major Depressive Disorder | Completed | 2010-12-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01263223 | A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective … | Phase1 | Major Depressive Disorder | Completed | 2010-12-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01263197 | A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol | Phase1 | Major Depressive Disorder | Completed | 2010-12-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01263119 | A Study of LY2216684 and Warfarin in Healthy Subjects | Phase1 | Major Depressive Disorder | Completed | 2010-12-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01263106 | A Study of LY2216684 and Theophylline in Healthy Subjects | Phase1 | Major Depressive Disorder | Completed | 2010-12-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01263093 | A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of … | Phase1 | Major Depressive Disorder | Completed | 2010-12-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01256567 | A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer | Phase1 | Breast Cancer | Completed | 2010-12-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01250834 | LY2189265 and Atorvastatin Interaction Study | Phase1 | Healthy Volunteers | Completed | 2010-12-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01236118 | A Study of LY2439821 in Rheumatoid Arthritis | Phase1 | Rheumatoid Arthritis | Completed | 2010-12-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01232439 | A Study of Brain Receptor Occupancy in Healthy Subjects | Phase1 | Alcohol Dependence | Completed | 2010-12-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01227252 | A Safety Study of LY2886721 Multiple Doses in Healthy Subjects | Phase1 | Alzheimer's Disease | Completed | 2010-12-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01250834 | LY2189265 and Atorvastatin Interaction Study | Phase1 | Healthy Volunteers | Completed | 2010-12-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01215955 | Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Dia… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2010-12-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01212107 | A Phase 1 Study of LY2874455 in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2010-12-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT01198002 | A Rheumatoid Arthritis Study in Participants on a Background Treatment of Metho… | Phase3 | Rheumatoid Arthritis | Terminated | 2010-12-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01196091 | A Study of LY2127399 in Participants With Systemic Lupus Erythematosus | Phase3 | Systemic Lupus Erythematosus | Completed | 2010-12-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT01170663 | A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gas… | Phase3 | Gastric Cancer | Completed | 2010-12-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT01168973 | A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Lin… | Phase3 | Non-Small Cell Lung Cancer | Completed | 2010-12-01 | 2016-08-01 | ClinicalTrials.gov |
| NCT01127633 | Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease | Phase3 | Alzheimer's Disease | Terminated | 2010-12-01 | 2017-02-01 | ClinicalTrials.gov |
| NCT01256567 | A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer | Phase1 | Breast Cancer | Completed | 2010-12-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01263093 | A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of … | Phase1 | Major Depressive Disorder | Completed | 2010-12-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01263106 | A Study of LY2216684 and Theophylline in Healthy Subjects | Phase1 | Major Depressive Disorder | Completed | 2010-12-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01263119 | A Study of LY2216684 and Warfarin in Healthy Subjects | Phase1 | Major Depressive Disorder | Completed | 2010-12-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01263197 | A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol | Phase1 | Major Depressive Disorder | Completed | 2010-12-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01263223 | A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective … | Phase1 | Major Depressive Disorder | Completed | 2010-12-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01266590 | A Study of LY2216684 and Digoxin in Healthy Subjects | Phase1 | Major Depressive Disorder | Completed | 2010-12-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01275144 | A Study of the Effect of LY2216684 on Lorazepam | Phase1 | Major Depressive Disorder | Completed | 2010-12-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01301066 | A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infect… | Phase4 | Dyslipidemia | Completed | 2010-12-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01243424 | CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Pat… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-11-11 | 2018-08-21 | ClinicalTrials.gov |
| NCT01243424 | CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Pat… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-11-11 | 2018-08-21 | ClinicalTrials.gov |
| NCT01241461 | A Study of LY2584702 in Solid Tumors | Phase1 | Cancer | Completed | 2010-11-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01173601 | A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults… | Phase3 | Major Depressive Disorder | Completed | 2010-11-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01248052 | A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in… | Phase1 | Bipolar Disorder | Completed | 2010-11-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01191268 | A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4) | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-11-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01214603 | A Study in Participants With Acute Leukemia | Phase2 | Leukemia | Completed | 2010-11-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01250873 | A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline | Phase1 | Major Depressive Disorder | Completed | 2010-11-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01250145 | A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teripara… | Phase1 | Osteoporosis, Postmenopausal | Completed | 2010-11-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01134107 | Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2010-11-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01140893 | Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous … | Phase2 | Type 2 Diabetes | Unknown | 2010-11-01 | — | ClinicalTrials.gov |
| NCT01247363 | A Study of LY2608204 in Patients With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2010-11-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01257178 | A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic … | Phase1 | Insomnia | Terminated | 2010-11-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01257178 | A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic … | Phase1 | Insomnia | Terminated | 2010-11-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01253525 | Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastr… | Phase1 | Adenocarcinoma | Completed | 2010-11-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01253525 | Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastr… | Phase1 | Adenocarcinoma | Completed | 2010-11-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01247350 | A Study of LY3009104(Baricitinib) for Healthy Subjects | Phase1 | Healthy Volunteer | Completed | 2010-11-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01253304 | A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (L… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2010-11-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01134107 | Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2010-11-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01250873 | A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline | Phase1 | Major Depressive Disorder | Completed | 2010-11-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01165021 | A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsq… | Phase2 | Non Small Cell Lung Cancer | Completed | 2010-11-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT01250145 | A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teripara… | Phase1 | Osteoporosis, Postmenopausal | Completed | 2010-11-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01248052 | A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in… | Phase1 | Bipolar Disorder | Completed | 2010-11-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01247363 | A Study of LY2608204 in Patients With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2010-11-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01247350 | A Study of LY3009104(Baricitinib) for Healthy Subjects | Phase1 | Healthy Volunteer | Completed | 2010-11-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01140893 | Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous … | Phase2 | Type 2 Diabetes | Unknown | 2010-11-01 | — | ClinicalTrials.gov |
| NCT01165021 | A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsq… | Phase2 | Non Small Cell Lung Cancer | Completed | 2010-11-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT01214603 | A Study in Participants With Acute Leukemia | Phase2 | Leukemia | Completed | 2010-11-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01241461 | A Study of LY2584702 in Solid Tumors | Phase1 | Cancer | Completed | 2010-11-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01173601 | A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults… | Phase3 | Major Depressive Disorder | Completed | 2010-11-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01253304 | A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (L… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2010-11-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01191268 | A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4) | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-11-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01241435 | A Study of LY2216684 in Participants With Impaired Hepatic Function | Phase1 | Depressive Disorder, Major | Completed | 2010-10-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01185964 | A Study of Olaratumab in Soft Tissue Sarcoma | Phase1 | Sarcoma, Soft Tissue | Completed | 2010-10-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT01185353 | A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Th… | Phase2 | Arthritis, Rheumatoid | Completed | 2010-10-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01118780 | A Study of Duloxetine in Elderly Generalized Anxiety Disorder | Phase4 | Generalized Anxiety Disorder | Completed | 2010-10-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01243957 | A Study to Measure if There is Any Difference in How the Body Breaks Down or In… | Phase1 | Major Depressive Disorder | Completed | 2010-10-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01241435 | A Study of LY2216684 in Participants With Impaired Hepatic Function | Phase1 | Depressive Disorder, Major | Completed | 2010-10-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01237899 | Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on… | Phase1 | Chronic Kidney Disease | Completed | 2010-10-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01237405 | A Study of FolateScan in Patients With Knee Osteoarthritis | — | Knee Osteoarthritis | Completed | 2010-10-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01236105 | Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624… | Phase1 | Insomnia | Completed | 2010-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01364584 | Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes | Na | Type 2 Diabetes | Completed | 2010-10-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01215097 | Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-10-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01214239 | Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-10-01 | — | ClinicalTrials.gov |
| NCT01204710 | A Study of Olaratumab (IMC-3G3) in Prostate Cancer | Phase2 | Prostate Cancer | Completed | 2010-10-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01155661 | A Safety Study in Participants With Major Depressive Disorder | Phase3 | Depressive Disorder, Major | Completed | 2010-10-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01185964 | A Study of Olaratumab in Soft Tissue Sarcoma | Phase1 | Sarcoma, Soft Tissue | Completed | 2010-10-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT01185353 | A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Th… | Phase2 | Arthritis, Rheumatoid | Completed | 2010-10-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01160289 | A Study of LY900010 in Erectile Dysfunction | Phase2 | Erectile Dysfunction | Completed | 2010-10-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01159938 | A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2010-10-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01155661 | A Safety Study in Participants With Major Depressive Disorder | Phase3 | Depressive Disorder, Major | Completed | 2010-10-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01140347 | A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (… | Phase3 | Hepatocellular Carcinoma | Completed | 2010-10-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01140347 | A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (… | Phase3 | Hepatocellular Carcinoma | Completed | 2010-10-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT01118780 | A Study of Duloxetine in Elderly Generalized Anxiety Disorder | Phase4 | Generalized Anxiety Disorder | Completed | 2010-10-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01160289 | A Study of LY900010 in Erectile Dysfunction | Phase2 | Erectile Dysfunction | Completed | 2010-10-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01159938 | A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2010-10-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01364584 | Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes | Na | Type 2 Diabetes | Completed | 2010-10-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01237899 | Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on… | Phase1 | Chronic Kidney Disease | Completed | 2010-10-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01237405 | A Study of FolateScan in Patients With Knee Osteoarthritis | — | Knee Osteoarthritis | Completed | 2010-10-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01236105 | Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624… | Phase1 | Insomnia | Completed | 2010-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01243957 | A Study to Measure if There is Any Difference in How the Body Breaks Down or In… | Phase1 | Major Depressive Disorder | Completed | 2010-10-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01215097 | Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-10-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01214239 | Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-10-01 | — | ClinicalTrials.gov |
| NCT01204710 | A Study of Olaratumab (IMC-3G3) in Prostate Cancer | Phase2 | Prostate Cancer | Completed | 2010-10-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01139762 | A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Ur… | Phase3 | Benign Prostatic Hyperplasia | Completed | 2010-09-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01152190 | A Study in Benign Prostatic Hyperplasia | Phase3 | Benign Prostatic Hyperplasia | Completed | 2010-09-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01152190 | A Study in Benign Prostatic Hyperplasia | Phase3 | Benign Prostatic Hyperplasia | Completed | 2010-09-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01215968 | A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drin… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2010-09-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01199822 | Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Pa… | Phase1 | Malignancy | Completed | 2010-09-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01226485 | A Study in Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2010-09-01 | 2017-10-01 | ClinicalTrials.gov |
| NCT01160744 | A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2010-09-01 | 2018-04-01 | ClinicalTrials.gov |
| NCT01209832 | A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients | Phase1 | Advanced Cancer | Terminated | 2010-09-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01210001 | Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-09-01 | — | ClinicalTrials.gov |
| NCT01204294 | Comprehensive Add on Study in Japan | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-09-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01194830 | Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Ty… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-09-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01215968 | A Study to Evaluate the Effect of LY2189265 on the Speed at Which Food and Drin… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2010-09-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01226485 | A Study in Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2010-09-01 | 2017-10-01 | ClinicalTrials.gov |
| NCT01209832 | A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients | Phase1 | Advanced Cancer | Terminated | 2010-09-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01210001 | Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-09-01 | — | ClinicalTrials.gov |
| NCT01194830 | Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Ty… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-09-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01193218 | Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Dia… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2010-09-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01160744 | A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2010-09-01 | 2018-04-01 | ClinicalTrials.gov |
| NCT01204294 | Comprehensive Add on Study in Japan | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-09-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01199822 | Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Pa… | Phase1 | Malignancy | Completed | 2010-09-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01139762 | A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Ur… | Phase3 | Benign Prostatic Hyperplasia | Completed | 2010-09-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01193218 | Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Dia… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2010-09-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01111604 | A Study of Ramucirumab or Icrucumab in Colorectal Cancer | Phase2 | Colon Cancer | Completed | 2010-08-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01183013 | 30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-08-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01189422 | Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes | Phase1 | Type 1 Diabetes Mellitus | Terminated | 2010-08-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01183013 | 30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-08-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01167881 | Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-08-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT01177943 | A Bioequivalence (BE) Study in Healthy Subjects | Phase1 | Attention Deficit Hyperactivity Disorder | Completed | 2010-08-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01167881 | Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-08-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT01148498 | A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's | Phase2 | Alzheimer's Disease | Completed | 2010-08-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01147627 | Effect of Different Interventions on Glycemic Control and β-cell Function in Ne… | Na | Diabetes Mellitus, Type 2 | Completed | 2010-08-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01144377 | A Study of LY2541546 in Women With Low Bone Mineral Density | Phase2 | Osteoporosis | Completed | 2010-08-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01130532 | A Study in Erectile Dysfunction | Phase4 | Erectile Dysfunction | Completed | 2010-08-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01148498 | A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's | Phase2 | Alzheimer's Disease | Completed | 2010-08-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01147627 | Effect of Different Interventions on Glycemic Control and β-cell Function in Ne… | Na | Diabetes Mellitus, Type 2 | Completed | 2010-08-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01144377 | A Study of LY2541546 in Women With Low Bone Mineral Density | Phase2 | Osteoporosis | Completed | 2010-08-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01087970 | A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Ne… | Phase2 | Head and Neck Neoplasms | Completed | 2010-08-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01111604 | A Study of Ramucirumab or Icrucumab in Colorectal Cancer | Phase2 | Colon Cancer | Completed | 2010-08-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT01189422 | Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes | Phase1 | Type 1 Diabetes Mellitus | Terminated | 2010-08-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01130532 | A Study in Erectile Dysfunction | Phase4 | Erectile Dysfunction | Completed | 2010-08-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01177943 | A Bioequivalence (BE) Study in Healthy Subjects | Phase1 | Attention Deficit Hyperactivity Disorder | Completed | 2010-08-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01087970 | A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Ne… | Phase2 | Head and Neck Neoplasms | Completed | 2010-08-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01173081 | The Use of Teriparatide as an Adjunctive Therapy for the Treatment of Jones Fra… | Phase4 | Fractures | Unknown | 2010-07-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01158404 | Notch Inhibitor in Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2010-07-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01158404 | Notch Inhibitor in Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2010-07-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01177813 | Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-07-01 | — | ClinicalTrials.gov |
| NCT01164501 | Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabete… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-07-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01131676 | BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-07-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01185548 | A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymph… | Phase1 | Lymphoma | Terminated | 2010-07-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01185548 | A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymph… | Phase1 | Lymphoma | Terminated | 2010-07-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01113801 | A Study in Participants With Diabetic Kidney Disease | Phase2 | Diabetic Kidney Disease | Terminated | 2010-07-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01159600 | Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on t… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-07-01 | — | ClinicalTrials.gov |
| NCT01177813 | Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-07-01 | — | ClinicalTrials.gov |
| NCT01178099 | An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults | Phase1 | Anemia, Sickle Cell | Completed | 2010-07-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01109524 | Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Trea… | Phase2 | Lung Neoplasms | Completed | 2010-07-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01178099 | An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults | Phase1 | Anemia, Sickle Cell | Completed | 2010-07-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01167023 | Prasugrel Versus Placebo in Adult Sickle Cell Disease | Phase2 | Sickle Cell Anemia | Completed | 2010-07-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01109524 | Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Trea… | Phase2 | Lung Neoplasms | Completed | 2010-07-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT01183650 | A Study of Tadalafil in Benign Prostatic Hyperplasia | Phase1 | Benign Prostatic Hyperplasia | Completed | 2010-07-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00895180 | Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patient… | Phase2 | Adult Glioblastoma Multiforme | Completed | 2010-07-01 | 2014-03-04 | ClinicalTrials.gov |
| NCT01167023 | Prasugrel Versus Placebo in Adult Sickle Cell Disease | Phase2 | Sickle Cell Anemia | Completed | 2010-07-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01164501 | Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabete… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-07-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01183650 | A Study of Tadalafil in Benign Prostatic Hyperplasia | Phase1 | Benign Prostatic Hyperplasia | Completed | 2010-07-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01159600 | Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on t… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-07-01 | — | ClinicalTrials.gov |
| NCT01131676 | BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-07-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT00895180 | Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patient… | Phase2 | Adult Glioblastoma Multiforme | Completed | 2010-07-01 | 2014-03-04 | ClinicalTrials.gov |
| NCT01173081 | The Use of Teriparatide as an Adjunctive Therapy for the Treatment of Jones Fra… | Phase4 | Fractures | Unknown | 2010-07-01 | 2014-04-01 | ClinicalTrials.gov |
| NCT01113801 | A Study in Participants With Diabetic Kidney Disease | Phase2 | Diabetic Kidney Disease | Terminated | 2010-07-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01139788 | A Study of LY2624587 in Patients With Advanced Cancer | Phase1 | Metastatic Cancer | Completed | 2010-06-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01127646 | A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents | Phase4 | Attention Deficit Hyperactivity Disorder | Terminated | 2010-06-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01127646 | A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents | Phase4 | Attention Deficit Hyperactivity Disorder | Terminated | 2010-06-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01363284 | Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients | Na | Diabetes | Completed | 2010-06-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01139788 | A Study of LY2624587 in Patients With Advanced Cancer | Phase1 | Metastatic Cancer | Completed | 2010-06-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01081041 | A Study in Head and Neck Cancer | Phase2 | Head and Neck Cancer | Completed | 2010-06-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01363284 | Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients | Na | Diabetes | Completed | 2010-06-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01129674 | A Long-Term, Open-Label, Study on Schizophrenia | Phase2 | Schizophrenia | Terminated | 2010-06-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01133405 | A Safety Study of LY2886721 Single Doses in Healthy Subjects | Phase1 | Alzheimer's Disease | Completed | 2010-06-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01081041 | A Study in Head and Neck Cancer | Phase2 | Head and Neck Cancer | Completed | 2010-06-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01149421 | A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 D… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2010-06-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01063075 | A Study in Advanced Solid Tumors | Phase2 | Solid Tumor | Completed | 2010-06-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01063075 | A Study in Advanced Solid Tumors | Phase2 | Solid Tumor | Completed | 2010-06-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT01133405 | A Safety Study of LY2886721 Single Doses in Healthy Subjects | Phase1 | Alzheimer's Disease | Completed | 2010-06-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01137006 | An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignan… | Phase1 | Malignant Melanoma | Completed | 2010-06-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01137006 | An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignan… | Phase1 | Malignant Melanoma | Completed | 2010-06-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01149421 | A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 D… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2010-06-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01129674 | A Long-Term, Open-Label, Study on Schizophrenia | Phase2 | Schizophrenia | Terminated | 2010-06-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01104701 | A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics … | Phase2 | Type 2 Diabetes | Completed | 2010-05-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01122264 | A Study in Patients With Erectile Dysfunction | Phase4 | Erectile Dysfunction | Completed | 2010-05-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01253265 | A Study in Rheumatoid Arthritis | Phase1 | Rheumatoid Arthritis | Completed | 2010-05-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01133392 | Bioequivalence of Two Lispro Formulations | Phase1 | Healthy Volunteers | Completed | 2010-05-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT01131104 | A Study to Determine if There is a Possible Association Between NAION and Phosp… | — | Nonarteritic Anterior Ischemic Optic Neuropathy | Completed | 2010-05-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01253291 | A Study of Japanese Rheumatoid Arthritis Participants | Phase1 | Rheumatoid Arthritis | Completed | 2010-05-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01126580 | A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3) | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-05-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01253291 | A Study of Japanese Rheumatoid Arthritis Participants | Phase1 | Rheumatoid Arthritis | Completed | 2010-05-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01119456 | A Study of IMC-RON8 in Advanced Solid Tumors | Phase1 | Cancer | Completed | 2010-05-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01122264 | A Study in Patients With Erectile Dysfunction | Phase4 | Erectile Dysfunction | Completed | 2010-05-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01119456 | A Study of IMC-RON8 in Advanced Solid Tumors | Phase1 | Cancer | Completed | 2010-05-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01115738 | Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients | Phase2 | Acute Coronary Syndrome | Completed | 2010-05-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01107444 | Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients W… | Phase2 | Non-small Cell Lung Cancer | Completed | 2010-05-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01107444 | Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients W… | Phase2 | Non-small Cell Lung Cancer | Completed | 2010-05-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01104701 | A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics … | Phase2 | Type 2 Diabetes | Completed | 2010-05-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01115738 | Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients | Phase2 | Acute Coronary Syndrome | Completed | 2010-05-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01351246 | Guided Self-Help for Parents of Children With Attention-Deficit/Hyperactivity D… | Na | Attention-Deficit/Hyperactivity Disorder | Completed | 2010-05-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01133392 | Bioequivalence of Two Lispro Formulations | Phase1 | Healthy Volunteers | Completed | 2010-05-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT01351246 | Guided Self-Help for Parents of Children With Attention-Deficit/Hyperactivity D… | Na | Attention-Deficit/Hyperactivity Disorder | Completed | 2010-05-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01126580 | A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3) | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-05-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01131104 | A Study to Determine if There is a Possible Association Between NAION and Phosp… | — | Nonarteritic Anterior Ischemic Optic Neuropathy | Completed | 2010-05-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01253265 | A Study in Rheumatoid Arthritis | Phase1 | Rheumatoid Arthritis | Completed | 2010-05-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01287546 | A Study of LY2875358 in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2010-04-13 | 2016-10-26 | ClinicalTrials.gov |
| NCT01287546 | A Study of LY2875358 in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2010-04-13 | 2016-10-26 | ClinicalTrials.gov |
| NCT01134120 | A Study in Myeloproliferative Disorders | Phase1 | Myeloproliferative Disorders | Completed | 2010-04-01 | 2018-02-22 | ClinicalTrials.gov |
| NCT01097707 | A Study in Men With Benign Prostatic Hyperplasia | Phase2 | Benign Prostatic Hyperplasia | Terminated | 2010-04-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01099358 | Study in Advanced Solid Tumors | Phase2 | Solid Tumor | Completed | 2010-04-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT01105975 | A Study of LY2484595 in Patients With High LDL-C or Low HDL-C | Phase2 | Dyslipidemia | Completed | 2010-04-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01107457 | A Study in Participants With Moderate to Severe Psoriasis | Phase2 | Psoriasis | Completed | 2010-04-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT01109316 | Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2010-04-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01109316 | Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2010-04-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01107457 | A Study in Participants With Moderate to Severe Psoriasis | Phase2 | Psoriasis | Completed | 2010-04-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT01097707 | A Study in Men With Benign Prostatic Hyperplasia | Phase2 | Benign Prostatic Hyperplasia | Terminated | 2010-04-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01060059 | Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in… | — | Type 2 Diabetes Mellitus | Completed | 2010-04-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01134120 | A Study in Myeloproliferative Disorders | Phase1 | Myeloproliferative Disorders | Completed | 2010-04-01 | 2018-02-22 | ClinicalTrials.gov |
| NCT01060059 | Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in… | — | Type 2 Diabetes Mellitus | Completed | 2010-04-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01099358 | Study in Advanced Solid Tumors | Phase2 | Solid Tumor | Completed | 2010-04-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT01105975 | A Study of LY2484595 in Patients With High LDL-C or Low HDL-C | Phase2 | Dyslipidemia | Completed | 2010-04-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01088386 | Zyprexa® Relprevv™ Patient Care Program | — | Schizophrenia | Enrolling_By_Invitation | 2010-03-03 | 2026-06-01 | ClinicalTrials.gov |
| NCT01088386 | Zyprexa® Relprevv™ Patient Care Program | — | Schizophrenia | Enrolling_By_Invitation | 2010-03-03 | 2026-06-01 | ClinicalTrials.gov |
| NCT01089556 | A Study in Painful Diabetic Neuropathy | Phase3 | Diabetic Neuropathy, Painful | Completed | 2010-03-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01253278 | A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2010-03-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01117831 | An Analysis of Diabetes Control in Puerto Rico | — | Diabetes Mellitus | Completed | 2010-03-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01115803 | A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tu… | Phase1 | Metastases, Neoplasm | Terminated | 2010-03-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01115751 | A Study in Patients With Advanced or Metastatic Cancer | Phase1 | Metastases, Neoplasm | Completed | 2010-03-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01107925 | Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body W… | Phase1 | Coronary Artery Disease | Completed | 2010-03-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01107912 | Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patient… | Phase1 | Coronary Artery Disease | Completed | 2010-03-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01089621 | A Study for Adolescents With Fibromyalgia Syndrome | Phase4 | Fibromyalgia | Withdrawn | 2010-03-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT01089556 | A Study in Painful Diabetic Neuropathy | Phase3 | Diabetic Neuropathy, Painful | Completed | 2010-03-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01088503 | Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal As… | — | Acute Coronary Syndrome | Completed | 2010-03-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01087502 | Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Mo… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-03-01 | — | ClinicalTrials.gov |
| NCT01086748 | A Study in Schizophrenia Patients | Phase2 | Schizophrenia | Completed | 2010-03-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01084005 | Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-03-01 | — | ClinicalTrials.gov |
| NCT01070329 | A Study in Depression and Associated Painful Physical Symptoms | Phase4 | Major Depressive Disorder | Completed | 2010-03-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01070329 | A Study in Depression and Associated Painful Physical Symptoms | Phase4 | Major Depressive Disorder | Completed | 2010-03-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01084005 | Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-03-01 | — | ClinicalTrials.gov |
| NCT01086748 | A Study in Schizophrenia Patients | Phase2 | Schizophrenia | Completed | 2010-03-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01087502 | Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Mo… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-03-01 | — | ClinicalTrials.gov |
| NCT01088503 | Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal As… | — | Acute Coronary Syndrome | Completed | 2010-03-01 | 2014-01-01 | ClinicalTrials.gov |
| NCT01089621 | A Study for Adolescents With Fibromyalgia Syndrome | Phase4 | Fibromyalgia | Withdrawn | 2010-03-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT01107912 | Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patient… | Phase1 | Coronary Artery Disease | Completed | 2010-03-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01107925 | Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body W… | Phase1 | Coronary Artery Disease | Completed | 2010-03-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT01115751 | A Study in Patients With Advanced or Metastatic Cancer | Phase1 | Metastases, Neoplasm | Completed | 2010-03-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01115803 | A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tu… | Phase1 | Metastases, Neoplasm | Terminated | 2010-03-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT01117831 | An Analysis of Diabetes Control in Puerto Rico | — | Diabetes Mellitus | Completed | 2010-03-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01253278 | A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2010-03-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01075282 | A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2) | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-02-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT00725400 | Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiati… | Phase2 | Colorectal Carcinoma | Withdrawn | 2010-02-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT01064687 | A Study in Participants With Type 2 Diabetes Mellitus | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-02-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01029795 | A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2… | Phase2 | Diabetes Mellitus, Type 2 | Terminated | 2010-02-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT01057589 | A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck C… | Phase2 | Head and Neck Neoplasms | Completed | 2010-02-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT00894504 | Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast C… | Phase2 | Metastatic Breast Cancer | Completed | 2010-02-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT00894504 | Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast C… | Phase2 | Metastatic Breast Cancer | Completed | 2010-02-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT01064687 | A Study in Participants With Type 2 Diabetes Mellitus | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-02-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT00747968 | The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart … | Phase2 | Type 2 Diabetes | Completed | 2010-02-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01115790 | A Phase 1 Study in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2010-02-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT01075282 | A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2) | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2010-02-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01115790 | A Phase 1 Study in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2010-02-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT01029795 | A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2… | Phase2 | Diabetes Mellitus, Type 2 | Terminated | 2010-02-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT01057589 | A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck C… | Phase2 | Head and Neck Neoplasms | Completed | 2010-02-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT00725400 | Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiati… | Phase2 | Colorectal Carcinoma | Withdrawn | 2010-02-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT00747968 | The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart … | Phase2 | Type 2 Diabetes | Completed | 2010-02-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00981058 | First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung… | Phase3 | Non Small Cell Lung Cancer | Completed | 2010-01-07 | 2024-05-30 | ClinicalTrials.gov |
| NCT00981058 | First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung… | Phase3 | Non Small Cell Lung Cancer | Completed | 2010-01-07 | 2024-05-30 | ClinicalTrials.gov |
| NCT01027871 | A Study for Patients With Type 2 Diabetes | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2010-01-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01088464 | Study of IMC-11F8 in Participants With Advanced Solid Tumors | Phase1 | Neoplasms | Completed | 2010-01-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT00918203 | A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previ… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2010-01-01 | 2017-11-17 | ClinicalTrials.gov |
| NCT01066845 | Post Marketing Observational Study in Patients With Pulmonary Arterial Hyperten… | — | Pulmonary Arterial Hypertension | Completed | 2010-01-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01029886 | Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects Wit… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2010-01-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01056549 | Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle … | Na | Hyperlipidemia | Completed | 2010-01-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT00918203 | A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previ… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2010-01-01 | 2017-11-17 | ClinicalTrials.gov |
| NCT01055808 | Observational Study in Japanese Type 2 Diabetes Patients | — | Diabetes Mellitus, Type 2 | Completed | 2010-01-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01159847 | Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-ons… | Phase1 | Type 1 Diabetes | Completed | 2010-01-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01051466 | A Study of the Neurobiology of Depression | Phase4 | Major Depressive Disorder | Completed | 2010-01-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01049412 | A Study for Patients With Type 1 Diabetes | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2010-01-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01042158 | A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertensio… | Phase4 | Pulmonary Arterial Hypertension | Completed | 2010-01-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT01042158 | A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertensio… | Phase4 | Pulmonary Arterial Hypertension | Completed | 2010-01-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT01029886 | Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects Wit… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2010-01-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01340976 | A Phase 1 Study of LY2787106 in Cancer and Anemia | Phase1 | Anemia | Completed | 2010-01-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01049412 | A Study for Patients With Type 1 Diabetes | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2010-01-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01159847 | Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-ons… | Phase1 | Type 1 Diabetes | Completed | 2010-01-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01027871 | A Study for Patients With Type 2 Diabetes | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2010-01-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01340976 | A Phase 1 Study of LY2787106 in Cancer and Anemia | Phase1 | Anemia | Completed | 2010-01-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01088464 | Study of IMC-11F8 in Participants With Advanced Solid Tumors | Phase1 | Neoplasms | Completed | 2010-01-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT01051466 | A Study of the Neurobiology of Depression | Phase4 | Major Depressive Disorder | Completed | 2010-01-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01055808 | Observational Study in Japanese Type 2 Diabetes Patients | — | Diabetes Mellitus, Type 2 | Completed | 2010-01-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01056549 | Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle … | Na | Hyperlipidemia | Completed | 2010-01-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01066845 | Post Marketing Observational Study in Patients With Pulmonary Arterial Hyperten… | — | Pulmonary Arterial Hypertension | Completed | 2010-01-01 | 2014-08-01 | ClinicalTrials.gov |
| NCT01394016 | A Phase 1 Study of LY2835219 In Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2009-12-07 | 2022-04-12 | ClinicalTrials.gov |
| NCT01394016 | A Phase 1 Study of LY2835219 In Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2009-12-07 | 2022-04-12 | ClinicalTrials.gov |
| NCT01025284 | A Study for Participants With Small-Cell Lung Cancer | Phase2 | Small Cell Lung Cancer | Completed | 2009-12-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01035138 | A Study of Semagacestat for Alzheimer's Patients | Phase3 | Alzheimer's Disease | Completed | 2009-12-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01025284 | A Study for Participants With Small-Cell Lung Cancer | Phase2 | Small Cell Lung Cancer | Completed | 2009-12-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01025089 | Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Loc… | Phase2 | Thymoma | Active_Not_Recruiting | 2009-12-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT01025089 | Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Loc… | Phase2 | Thymoma | Active_Not_Recruiting | 2009-12-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT01024244 | A Study of LY2599506 in Patients With Type 2 Diabetes | Phase2 | Diabetes Mellitus, Type 2 | Terminated | 2009-12-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT01018810 | A Study for Adults With Plaque Psoriasis | Phase2 | Psoriasis | Terminated | 2009-12-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT01015287 | A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myoca… | Phase3 | Acute Coronary Syndromes | Completed | 2009-12-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT00997503 | TAXUS Libertē Post Approval Study | — | Coronary Artery Disease | Completed | 2009-12-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT00954915 | Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Mo… | Phase1 | Psoriasis | Terminated | 2009-12-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT01018810 | A Study for Adults With Plaque Psoriasis | Phase2 | Psoriasis | Terminated | 2009-12-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT01035138 | A Study of Semagacestat for Alzheimer's Patients | Phase3 | Alzheimer's Disease | Completed | 2009-12-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01006252 | A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melan… | Phase3 | Melanoma | Terminated | 2009-12-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01015287 | A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myoca… | Phase3 | Acute Coronary Syndromes | Completed | 2009-12-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT00997503 | TAXUS Libertē Post Approval Study | — | Coronary Artery Disease | Completed | 2009-12-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT01006252 | A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melan… | Phase3 | Melanoma | Terminated | 2009-12-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00954915 | Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Mo… | Phase1 | Psoriasis | Terminated | 2009-12-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT01024244 | A Study of LY2599506 in Patients With Type 2 Diabetes | Phase2 | Diabetes Mellitus, Type 2 | Terminated | 2009-12-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00982111 | First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung … | Phase3 | Non Small Cell Lung Cancer | Completed | 2009-11-02 | 2020-12-23 | ClinicalTrials.gov |
| NCT00982111 | First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung … | Phase3 | Non Small Cell Lung Cancer | Completed | 2009-11-02 | 2020-12-23 | ClinicalTrials.gov |
| NCT01018680 | A Study Comparing Duloxetine Versus Placebo in Patients Taking a Nonsteroidal A… | Phase3 | Osteoarthritis Knee Pain | Completed | 2009-11-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00988858 | A Study of Advanced or Metastatic Non-small Cell Lung Cancer | Phase2 | Non Small Cell Lung Cancer | Completed | 2009-11-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT00969618 | A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyp… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2009-11-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00969618 | A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyp… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2009-11-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00988858 | A Study of Advanced or Metastatic Non-small Cell Lung Cancer | Phase2 | Non Small Cell Lung Cancer | Completed | 2009-11-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT01000805 | A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful… | Phase4 | Major Depressive Disorder | Completed | 2009-11-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01005680 | A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Adv… | Phase3 | Non Small Cell Lung Cancer | Completed | 2009-11-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01007032 | A Study of IMC-A12 in Advanced Solid Tumors | Phase1 | Tumors | Completed | 2009-11-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01011556 | A Study for the Transdermal Application of Teriparatide | Phase2 | Osteoporosis | Completed | 2009-11-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01011868 | Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Ty… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2009-11-01 | — | ClinicalTrials.gov |
| NCT01017731 | Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes | Phase2 | Cancer | Completed | 2009-11-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01017874 | A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With N… | Phase3 | Non Small Cell Lung Cancer | Completed | 2009-11-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT01018680 | A Study Comparing Duloxetine Versus Placebo in Patients Taking a Nonsteroidal A… | Phase3 | Osteoarthritis Knee Pain | Completed | 2009-11-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01020786 | A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients | Phase4 | Non Small Cell Lung Cancer | Completed | 2009-11-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01026818 | A Study of Tadalafil After Radical Prostatectomy | Phase4 | Erectile Dysfunction | Completed | 2009-11-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01026818 | A Study of Tadalafil After Radical Prostatectomy | Phase4 | Erectile Dysfunction | Completed | 2009-11-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01020786 | A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients | Phase4 | Non Small Cell Lung Cancer | Completed | 2009-11-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01017874 | A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With N… | Phase3 | Non Small Cell Lung Cancer | Completed | 2009-11-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT01017731 | Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes | Phase2 | Cancer | Completed | 2009-11-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01011868 | Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Ty… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2009-11-01 | — | ClinicalTrials.gov |
| NCT01011556 | A Study for the Transdermal Application of Teriparatide | Phase2 | Osteoporosis | Completed | 2009-11-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT01007032 | A Study of IMC-A12 in Advanced Solid Tumors | Phase1 | Tumors | Completed | 2009-11-01 | 2015-04-01 | ClinicalTrials.gov |
| NCT01005680 | A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Adv… | Phase3 | Non Small Cell Lung Cancer | Completed | 2009-11-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT01000805 | A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful… | Phase4 | Major Depressive Disorder | Completed | 2009-11-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT01000480 | A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer | Phase2 | Non Small Cell Lung Cancer | Completed | 2009-10-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01001104 | A Study of LY2189265 in Japanese Patients With Type 2 Diabetes | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2009-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01003184 | Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2009-10-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01004250 | A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small … | Phase2 | Non-Small Cell Lung Cancer | Completed | 2009-10-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00977938 | The Dual Antiplatelet Therapy Study (DAPT Study) | Phase4 | Coronary Artery Disease | Completed | 2009-10-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01000480 | A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer | Phase2 | Non Small Cell Lung Cancer | Completed | 2009-10-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT00993421 | A Weight Loss Study in Overweight Men and Women | Phase2 | Obesity | Terminated | 2009-10-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00970632 | A Study of Tadalafil in Men With Benign Prostatic Hyperplasia | Phase3 | Benign Prostatic Hyperplasia (BPH) | Completed | 2009-10-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT01003184 | Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2009-10-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01001104 | A Study of LY2189265 in Japanese Patients With Type 2 Diabetes | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2009-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00970632 | A Study of Tadalafil in Men With Benign Prostatic Hyperplasia | Phase3 | Benign Prostatic Hyperplasia (BPH) | Completed | 2009-10-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00985712 | A Study on the Effect of 2 Pen Devices on HbA1c | Phase4 | Diabetes Mellitus, Type 1 | Completed | 2009-10-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01004250 | A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small … | Phase2 | Non-Small Cell Lung Cancer | Completed | 2009-10-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00977938 | The Dual Antiplatelet Therapy Study (DAPT Study) | Phase4 | Coronary Artery Disease | Completed | 2009-10-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01107899 | Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-p… | Phase1 | Acute Coronary Syndromes | Terminated | 2009-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00985712 | A Study on the Effect of 2 Pen Devices on HbA1c | Phase4 | Diabetes Mellitus, Type 1 | Completed | 2009-10-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00801736 | ERCC1 Targeted Trial | Phase3 | Lung Cancer | Terminated | 2009-10-01 | — | ClinicalTrials.gov |
| NCT00996658 | Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemi… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2009-10-01 | — | ClinicalTrials.gov |
| NCT00801736 | ERCC1 Targeted Trial | Phase3 | Lung Cancer | Terminated | 2009-10-01 | — | ClinicalTrials.gov |
| NCT00993421 | A Weight Loss Study in Overweight Men and Women | Phase2 | Obesity | Terminated | 2009-10-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT01107899 | Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-p… | Phase1 | Acute Coronary Syndromes | Terminated | 2009-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00996658 | Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemi… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2009-10-01 | — | ClinicalTrials.gov |
| NCT01285037 | A Study of LY2801653 in Advanced Cancer | Phase1 | Cancer | Completed | 2009-09-09 | 2017-09-11 | ClinicalTrials.gov |
| NCT01285037 | A Study of LY2801653 in Advanced Cancer | Phase1 | Cancer | Completed | 2009-09-09 | 2017-09-11 | ClinicalTrials.gov |
| NCT00920582 | Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adu… | Phase3 | Type 1 Diabetes Mellitus | Terminated | 2009-09-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT00960661 | A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformi… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2009-09-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01662817 | Major Depressive Disorder (MDD) | — | Depression | Completed | 2009-09-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT01784614 | A Study of LY2624803 in Japanese Participants With Transient Insomnia | Phase1 | Sleep Initiation and Maintenance Disorders | Completed | 2009-09-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT01662817 | Major Depressive Disorder (MDD) | — | Depression | Completed | 2009-09-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT01742091 | A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women | Phase1 | Healthy | Completed | 2009-09-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT01742091 | A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women | Phase1 | Healthy | Completed | 2009-09-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00976456 | Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Pat… | Phase3 | Non-squamous Non-small Cell Lung Cancer | Completed | 2009-09-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT00948675 | Study of Participants With Advanced Non-Small Cell Lung Cancer | Phase3 | Advanced Non-Small Cell Lung Cancer | Completed | 2009-09-01 | 2020-11-06 | ClinicalTrials.gov |
| NCT01005355 | Study of IMC-1121B in Patients With Advanced Solid Tumors | Phase1 | Advanced Solid Tumors | Completed | 2009-09-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00992225 | A Study of LY573636-sodium in Patients With Metastatic Breast Cancer | Phase2 | Breast Cancer | Completed | 2009-09-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00989157 | Effects of Gastric Bypass on Blood Levels of Duloxetine | Phase3 | Bariatric Surgery | Completed | 2009-09-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT00985504 | A Study of Patients With Major Depressive Disorder and Residual Apathy | Phase4 | Major Depressive Disorder | Completed | 2009-09-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00982020 | Study in Adolescents With Schizophrenia or Bipolar Disorder | Phase4 | Bipolar I Disorder | Completed | 2009-09-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT00920582 | Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adu… | Phase3 | Type 1 Diabetes Mellitus | Terminated | 2009-09-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT00965081 | A Study for Adult Patients With Fibromyalgia | Phase4 | Fibromyalgia, Primary | Completed | 2009-09-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT01784614 | A Study of LY2624803 in Japanese Participants With Transient Insomnia | Phase1 | Sleep Initiation and Maintenance Disorders | Completed | 2009-09-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT01253226 | A Study for Japanese Participants With Rheumatoid Arthritis (RA) | Phase1 | Rheumatoid Arthritis | Completed | 2009-09-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00970281 | A Study of Olanzapine in Patients With Schizophrenia | Phase3 | Schizophrenia | Completed | 2009-09-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01253226 | A Study for Japanese Participants With Rheumatoid Arthritis (RA) | Phase1 | Rheumatoid Arthritis | Completed | 2009-09-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00965419 | A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder | Phase2 | Attention Deficit Hyperactivity Disorder | Terminated | 2009-09-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT00948675 | Study of Participants With Advanced Non-Small Cell Lung Cancer | Phase3 | Advanced Non-Small Cell Lung Cancer | Completed | 2009-09-01 | 2020-11-06 | ClinicalTrials.gov |
| NCT00970281 | A Study of Olanzapine in Patients With Schizophrenia | Phase3 | Schizophrenia | Completed | 2009-09-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00971997 | A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2009-09-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00976456 | Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Pat… | Phase3 | Non-squamous Non-small Cell Lung Cancer | Completed | 2009-09-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT00965081 | A Study for Adult Patients With Fibromyalgia | Phase4 | Fibromyalgia, Primary | Completed | 2009-09-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT00982020 | Study in Adolescents With Schizophrenia or Bipolar Disorder | Phase4 | Bipolar I Disorder | Completed | 2009-09-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT00965419 | A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder | Phase2 | Attention Deficit Hyperactivity Disorder | Terminated | 2009-09-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT00985504 | A Study of Patients With Major Depressive Disorder and Residual Apathy | Phase4 | Major Depressive Disorder | Completed | 2009-09-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00989157 | Effects of Gastric Bypass on Blood Levels of Duloxetine | Phase3 | Bariatric Surgery | Completed | 2009-09-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT00992225 | A Study of LY573636-sodium in Patients With Metastatic Breast Cancer | Phase2 | Breast Cancer | Completed | 2009-09-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00960661 | A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformi… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2009-09-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01005355 | Study of IMC-1121B in Patients With Advanced Solid Tumors | Phase1 | Advanced Solid Tumors | Completed | 2009-09-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00971997 | A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2009-09-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00954447 | Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2009-08-01 | — | ClinicalTrials.gov |
| NCT00954447 | Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2009-08-01 | — | ClinicalTrials.gov |
| NCT00954876 | Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Meta… | Phase2 | Metastatic Colorectal Cancer | Withdrawn | 2009-08-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00958568 | A Study in Relapse Prevention of Treatment-Resistant Depression | Phase3 | Treatment Resistant Depression | Completed | 2009-08-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT00960986 | A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Dis… | Phase4 | Major Depressive Disorder (MDD) | Completed | 2009-08-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00962104 | Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity … | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2009-08-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00966875 | A Study in Patients With Rheumatoid Arthritis | Phase2 | Rheumatoid Arthritis | Completed | 2009-08-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT00962104 | Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity … | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2009-08-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00960986 | A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Dis… | Phase4 | Major Depressive Disorder (MDD) | Completed | 2009-08-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00958568 | A Study in Relapse Prevention of Treatment-Resistant Depression | Phase3 | Treatment Resistant Depression | Completed | 2009-08-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01106534 | XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort | Phase4 | Chronic Total Occlusion of Coronary Artery | Completed | 2009-08-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT01106534 | XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort | Phase4 | Chronic Total Occlusion of Coronary Artery | Completed | 2009-08-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT00954876 | Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Meta… | Phase2 | Metastatic Colorectal Cancer | Withdrawn | 2009-08-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00917384 | Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With… | Phase3 | Gastric Cancer | Completed | 2009-08-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT00966875 | A Study in Patients With Rheumatoid Arthritis | Phase2 | Rheumatoid Arthritis | Completed | 2009-08-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT00917384 | Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With… | Phase3 | Gastric Cancer | Completed | 2009-08-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT00917267 | A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Co… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2009-07-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00883051 | Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment | Phase2 | Migraine Disorders | Completed | 2009-07-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00927186 | Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal … | Phase4 | Osteoporosis, Post-menopausal | Completed | 2009-07-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT00883051 | Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment | Phase2 | Migraine Disorders | Completed | 2009-07-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT01074151 | The Cymbalta Pregnancy Registry | — | Pregnancy | Completed | 2009-07-01 | 2021-07-26 | ClinicalTrials.gov |
| NCT00935532 | Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Co… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2009-07-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00945945 | A Study of Duloxetine in Patients With Osteoarthritis Knee Pain | Phase3 | Osteoarthritis Knee Pain | Completed | 2009-07-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00910299 | Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on … | Phase2 | Coronary Artery Disease (CAD) | Terminated | 2009-07-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00917267 | A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Co… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2009-07-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00927186 | Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal … | Phase4 | Osteoporosis, Post-menopausal | Completed | 2009-07-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT00910299 | Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on … | Phase2 | Coronary Artery Disease (CAD) | Terminated | 2009-07-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00945945 | A Study of Duloxetine in Patients With Osteoarthritis Knee Pain | Phase3 | Osteoarthritis Knee Pain | Completed | 2009-07-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00935532 | Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Co… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2009-07-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01074151 | The Cymbalta Pregnancy Registry | — | Pregnancy | Completed | 2009-07-01 | 2021-07-26 | ClinicalTrials.gov |
| NCT00887926 | Study of IMC-EB10 in Participant With Leukemia | Phase1 | Myeloid Leukemia | Terminated | 2009-06-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00887926 | Study of IMC-EB10 in Participant With Leukemia | Phase1 | Myeloid Leukemia | Terminated | 2009-06-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00922636 | A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder | Phase2 | Attention Deficit Hyperactivity Disorder | Completed | 2009-06-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00826228 | Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord I… | Phase4 | Osteoporosis | Completed | 2009-06-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00922636 | A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder | Phase2 | Attention Deficit Hyperactivity Disorder | Completed | 2009-06-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00906282 | Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Sq… | Phase2 | Non Small Cell Lung Cancer | Completed | 2009-06-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT00913835 | A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platin… | Phase2 | Ovarian Neoplasms | Completed | 2009-06-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT00906282 | Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Sq… | Phase2 | Non Small Cell Lung Cancer | Completed | 2009-06-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT00942188 | A Study of LY2189102 in Patients With Type 2 Diabetes | Phase2 | Type 2 Diabetes | Completed | 2009-06-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT00826228 | Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord I… | Phase4 | Osteoporosis | Completed | 2009-06-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00913835 | A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platin… | Phase2 | Ovarian Neoplasms | Completed | 2009-06-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT00942188 | A Study of LY2189102 in Patients With Type 2 Diabetes | Phase2 | Type 2 Diabetes | Completed | 2009-06-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT00906373 | A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced … | Phase2 | Hepatocellular Carcinoma | Completed | 2009-05-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT00905372 | Effect of LY2062430 on the Progression of Alzheimer's Disease | Phase3 | Alzheimer's Disease | Completed | 2009-05-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT00904683 | Effect of LY2062430 on the Progression of Alzheimer's Disease | Phase3 | Alzheimer's Disease | Completed | 2009-05-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT00845039 | A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Pa… | Phase2 | Colon Cancer | Terminated | 2009-05-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00889369 | Duloxetine for Major Depression in Peri-/Postmenopausal Women | Phase4 | Major Depressive Disorder | Unknown | 2009-05-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT00845039 | A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Pa… | Phase2 | Colon Cancer | Terminated | 2009-05-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00904683 | Effect of LY2062430 on the Progression of Alzheimer's Disease | Phase3 | Alzheimer's Disease | Completed | 2009-05-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT00905372 | Effect of LY2062430 on the Progression of Alzheimer's Disease | Phase3 | Alzheimer's Disease | Completed | 2009-05-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT00906373 | A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced … | Phase2 | Hepatocellular Carcinoma | Completed | 2009-05-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT00889369 | Duloxetine for Major Depression in Peri-/Postmenopausal Women | Phase4 | Major Depressive Disorder | Unknown | 2009-05-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT00894322 | A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of E… | Phase1 | Type 2 Diabetes Mellitus | Completed | 2009-04-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00844857 | A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression | Phase4 | Bipolar Depression | Completed | 2009-04-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT00844857 | A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression | Phase4 | Bipolar Depression | Completed | 2009-04-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT01109472 | Improving Osteoporosis Care in a Home Health Setting | Na | Osteoporosis | Completed | 2009-04-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT00862784 | A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer | Phase2 | Colorectal Carcinoma | Completed | 2009-04-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00867009 | A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Sq… | Phase2 | Non-Small-Cell Lung Cancer | Completed | 2009-04-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT00882999 | A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) | Phase2 | Relapsing-Remitting Multiple Sclerosis | Completed | 2009-04-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT00887354 | A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone… | Phase4 | Osteoporosis | Completed | 2009-04-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT00887549 | A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2009-04-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00894322 | A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of E… | Phase1 | Type 2 Diabetes Mellitus | Completed | 2009-04-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT01067794 | Chemotherapy in Treating Patients With Lung Cancer | — | Non Small Cell Lung Cancer | Completed | 2009-04-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01067794 | Chemotherapy in Treating Patients With Lung Cancer | — | Non Small Cell Lung Cancer | Completed | 2009-04-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01869959 | A Study of LY2405319 in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2009-04-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT01109472 | Improving Osteoporosis Care in a Home Health Setting | Na | Osteoporosis | Completed | 2009-04-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT00887549 | A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2009-04-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00887354 | A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone… | Phase4 | Osteoporosis | Completed | 2009-04-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT00882999 | A Study of Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) | Phase2 | Relapsing-Remitting Multiple Sclerosis | Completed | 2009-04-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01869959 | A Study of LY2405319 in Participants With Type 2 Diabetes | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2009-04-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00867009 | A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Sq… | Phase2 | Non-Small-Cell Lung Cancer | Completed | 2009-04-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT00862784 | A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer | Phase2 | Colorectal Carcinoma | Completed | 2009-04-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00870870 | A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2009-03-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT01591317 | Study of Prasugrel in Korean Healthy Male Volunteers | Phase1 | Healthy Volunteers | Completed | 2009-03-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00882050 | Intravenous Exenatide (Byetta) During Surgery | Phase1 | Euglycemia | Completed | 2009-03-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT00870194 | A Comparison of Adding Exenatide With Switching to Exenatide in Patients With T… | Phase4 | Type 2 Diabetes Mellitus | Completed | 2009-03-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00848081 | A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are … | Phase3 | Benign Prostatic Hyperplasia | Completed | 2009-03-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00849693 | A Study in the Treatment of Children and Adolescents With Major Depressive Diso… | Phase3 | Major Depressive Disorder | Completed | 2009-03-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT00934908 | Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating … | Na | Bipolar Disorder | Withdrawn | 2009-03-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00861757 | Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms … | Phase3 | Benign Prostatic Hyperplasia | Completed | 2009-03-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00849901 | A Study in the Treatment of Children and Adolescents With Major Depressive Diso… | Phase3 | Major Depressive Disorder | Completed | 2009-03-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT00855582 | A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia | Phase3 | Erectile Dysfunction | Completed | 2009-03-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00861757 | Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms … | Phase3 | Benign Prostatic Hyperplasia | Completed | 2009-03-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00870194 | A Comparison of Adding Exenatide With Switching to Exenatide in Patients With T… | Phase4 | Type 2 Diabetes Mellitus | Completed | 2009-03-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00855582 | A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia | Phase3 | Erectile Dysfunction | Completed | 2009-03-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT01591317 | Study of Prasugrel in Korean Healthy Male Volunteers | Phase1 | Healthy Volunteers | Completed | 2009-03-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00870870 | A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2009-03-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT00882050 | Intravenous Exenatide (Byetta) During Surgery | Phase1 | Euglycemia | Completed | 2009-03-01 | 2016-04-01 | ClinicalTrials.gov |
| NCT00849901 | A Study in the Treatment of Children and Adolescents With Major Depressive Diso… | Phase3 | Major Depressive Disorder | Completed | 2009-03-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT00849693 | A Study in the Treatment of Children and Adolescents With Major Depressive Diso… | Phase3 | Major Depressive Disorder | Completed | 2009-03-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT00848081 | A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are … | Phase3 | Benign Prostatic Hyperplasia | Completed | 2009-03-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00871572 | A Study for Participants With Type 2 Diabetes Mellitus | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2009-03-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00934908 | Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating … | Na | Bipolar Disorder | Withdrawn | 2009-03-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00877890 | A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2009-03-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00877890 | A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2009-03-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00871572 | A Study for Participants With Type 2 Diabetes Mellitus | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2009-03-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00833638 | A Study in Erectile Dysfunction | Phase4 | Erectile Dysfunction | Completed | 2009-02-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00870818 | Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed … | Na | Type 1 Diabetes Mellitus | Terminated | 2009-02-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00698841 | Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Change… | Phase2 | Advanced Cancer | Completed | 2009-02-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00853151 | A Study to Test the Combination of Two Different Kinds of Medications for the T… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2009-02-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00843518 | Treatment for Aggression and Agitation in Patients With Alzheimer's Disease | Phase2 | Alzheimer's Disease | Completed | 2009-02-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00842660 | Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in Defined… | Phase3 | Cervical Cancer | Unknown | 2009-02-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT00840034 | A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major… | Phase2 | Depressive Disorder, Major | Completed | 2009-02-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00839332 | A Study for Participants With Pancreatic Cancer | Phase1 | Pancreatic Neoplasms | Completed | 2009-02-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00837811 | An Open Label Extension Study in Participants With Rheumatoid Arthritis | Phase2 | Rheumatoid Arthritis | Completed | 2009-02-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00830960 | A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Sy… | Phase3 | Acute Coronary Syndrome | Completed | 2009-02-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00853151 | A Study to Test the Combination of Two Different Kinds of Medications for the T… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2009-02-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00830960 | A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Sy… | Phase3 | Acute Coronary Syndrome | Completed | 2009-02-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00843518 | Treatment for Aggression and Agitation in Patients With Alzheimer's Disease | Phase2 | Alzheimer's Disease | Completed | 2009-02-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00842660 | Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in Defined… | Phase3 | Cervical Cancer | Unknown | 2009-02-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT00840034 | A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major… | Phase2 | Depressive Disorder, Major | Completed | 2009-02-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00781911 | A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer | Phase2 | Carcinoma | Completed | 2009-02-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT00839332 | A Study for Participants With Pancreatic Cancer | Phase1 | Pancreatic Neoplasms | Completed | 2009-02-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00870818 | Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed … | Na | Type 1 Diabetes Mellitus | Terminated | 2009-02-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00833638 | A Study in Erectile Dysfunction | Phase4 | Erectile Dysfunction | Completed | 2009-02-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00837811 | An Open Label Extension Study in Participants With Rheumatoid Arthritis | Phase2 | Rheumatoid Arthritis | Completed | 2009-02-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00781911 | A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer | Phase2 | Carcinoma | Completed | 2009-02-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT00698841 | Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Change… | Phase2 | Advanced Cancer | Completed | 2009-02-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00827242 | Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperpl… | Phase3 | Benign Prostatic Hyperplasia | Completed | 2009-01-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00836693 | Effect of Tadalafil Once a Day in Men With Erectile Dysfunction | Phase3 | Erectile Dysfunction | Completed | 2009-01-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00916630 | Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lympho… | Phase1 | Central Nervous System Lymphoma | Completed | 2009-01-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT00895648 | Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy fo… | Phase2 | Mesothelioma | Terminated | 2009-01-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01214668 | Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients … | Phase1 | Solid Tumors | Completed | 2009-01-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT00735696 | A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small… | Phase2 | Non Small Cell Lung Cancer | Completed | 2009-01-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00732303 | Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer | Phase2 | Non-Small Cell Lung Cancer | Terminated | 2009-01-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01214668 | Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients … | Phase1 | Solid Tumors | Completed | 2009-01-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT00735696 | A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small… | Phase2 | Non Small Cell Lung Cancer | Completed | 2009-01-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00732303 | Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer | Phase2 | Non-Small Cell Lung Cancer | Terminated | 2009-01-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00827242 | Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperpl… | Phase3 | Benign Prostatic Hyperplasia | Completed | 2009-01-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00836693 | Effect of Tadalafil Once a Day in Men With Erectile Dysfunction | Phase3 | Erectile Dysfunction | Completed | 2009-01-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00895648 | Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy fo… | Phase2 | Mesothelioma | Terminated | 2009-01-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT00916630 | Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lympho… | Phase1 | Central Nervous System Lymphoma | Completed | 2009-01-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT00762034 | A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsqua… | Phase3 | Non-small Cell Lung Cancer | Completed | 2008-12-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01754493 | Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms … | Phase4 | Major Depression | Completed | 2008-12-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT00804986 | A Study for Patients With Type 2 Diabetes Mellitus | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2008-12-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00803361 | Duloxetine for the Treatment of Generalized Anxiety Disorder | Phase3 | Generalized Anxiety Disorder | Completed | 2008-12-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00791479 | Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2008-12-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00805441 | A Study in the Treatment of Alcohol Dependence. | Phase2 | Alcohol Dependence | Completed | 2008-12-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00767299 | A Study of Arzoxifene to Treat Korean Women With Osteoporosis | Phase2 | Osteoporosis | Completed | 2008-12-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00804986 | A Study for Patients With Type 2 Diabetes Mellitus | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2008-12-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00767299 | A Study of Arzoxifene to Treat Korean Women With Osteoporosis | Phase2 | Osteoporosis | Completed | 2008-12-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00805441 | A Study in the Treatment of Alcohol Dependence. | Phase2 | Alcohol Dependence | Completed | 2008-12-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00795821 | A Study in Adult Patients With Major Depressive Disorder | Phase2 | Depressive Disorder, Major | Completed | 2008-12-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00795821 | A Study in Adult Patients With Major Depressive Disorder | Phase2 | Depressive Disorder, Major | Completed | 2008-12-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00845507 | Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese … | Phase4 | Weight Gain | Completed | 2008-12-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT00803361 | Duloxetine for the Treatment of Generalized Anxiety Disorder | Phase3 | Generalized Anxiety Disorder | Completed | 2008-12-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00838084 | A Safety Study of LY2811376 Single Doses in Healthy Subjects | Phase1 | Alzheimer's Disease | Completed | 2008-12-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00838084 | A Safety Study of LY2811376 Single Doses in Healthy Subjects | Phase1 | Alzheimer's Disease | Completed | 2008-12-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00791479 | Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2008-12-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00762034 | A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsqua… | Phase3 | Non-small Cell Lung Cancer | Completed | 2008-12-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT00845507 | Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese … | Phase4 | Weight Gain | Completed | 2008-12-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT01754493 | Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms … | Phase4 | Major Depression | Completed | 2008-12-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT00803231 | Follow-up Data of Patients Treated With XIGRIS® in France | — | Sepsis | Completed | 2008-11-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00790790 | A Study in the Treatment of Osteoarthritis Knee Pain | Phase2 | Osteoarthritis Knee Pain | Completed | 2008-11-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00803231 | Follow-up Data of Patients Treated With XIGRIS® in France | — | Sepsis | Completed | 2008-11-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00804570 | A Study for the Treatment of Alcohol Dependence | Phase2 | Alcohol Dependence | Completed | 2008-11-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00804973 | Study in Participants With Acute Migraines Headaches | Phase2 | Migraine Headache | Terminated | 2008-11-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00810069 | Early Versus Delayed Switch in Medication in Patients With Major Depressive Dis… | Phase4 | Major Depressive Disorder | Completed | 2008-11-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00712660 | Study With Information Technology (IT) - Aided Preventive Program in Schizophre… | Na | Schizophrenia | Completed | 2008-11-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT00676338 | Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipept… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2008-11-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00676338 | Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipept… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2008-11-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00712660 | Study With Information Technology (IT) - Aided Preventive Program in Schizophre… | Na | Schizophrenia | Completed | 2008-11-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT00783094 | Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostati… | Phase2 | Benign Prostatic Hyperplasia | Completed | 2008-11-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00785577 | A Study for Treatment of Pain in Patients With Diabetic Neuropathy. | Phase2 | Diabetic Neuropathy, Painful | Completed | 2008-11-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00789373 | A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Sma… | Phase3 | Non-Small Cell Lung Cancer | Completed | 2008-11-01 | 2017-11-01 | ClinicalTrials.gov |
| NCT00790790 | A Study in the Treatment of Osteoarthritis Knee Pain | Phase2 | Osteoarthritis Knee Pain | Completed | 2008-11-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00789373 | A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Sma… | Phase3 | Non-Small Cell Lung Cancer | Completed | 2008-11-01 | 2017-11-01 | ClinicalTrials.gov |
| NCT00804570 | A Study for the Treatment of Alcohol Dependence | Phase2 | Alcohol Dependence | Completed | 2008-11-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00804973 | Study in Participants With Acute Migraines Headaches | Phase2 | Migraine Headache | Terminated | 2008-11-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00810069 | Early Versus Delayed Switch in Medication in Patients With Major Depressive Dis… | Phase4 | Major Depressive Disorder | Completed | 2008-11-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT01394003 | A Study of LY2584702 in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Terminated | 2008-11-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01394003 | A Study of LY2584702 in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Terminated | 2008-11-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00783094 | Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostati… | Phase2 | Benign Prostatic Hyperplasia | Completed | 2008-11-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00785577 | A Study for Treatment of Pain in Patients With Diabetic Neuropathy. | Phase2 | Diabetic Neuropathy, Painful | Completed | 2008-11-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT01028352 | Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients… | Na | Breast Cancer | Completed | 2008-10-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT00793884 | Emory Latino Diabetes Education Program | — | Diabetes | Terminated | 2008-10-01 | 2019-11-01 | ClinicalTrials.gov |
| NCT01227187 | Safety and Dose Finding Study of Xigris in Hemodialysis Patients | Phase2 | End Stage Renal Disease | Completed | 2008-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00765817 | Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus | Phase3 | Type 2 Diabetes | Completed | 2008-10-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT01227187 | Safety and Dose Finding Study of Xigris in Hemodialysis Patients | Phase2 | End Stage Renal Disease | Completed | 2008-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00703976 | Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Adva… | Phase2 | Cancer | Completed | 2008-10-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT01613807 | Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes | Phase4 | Gestational Diabetes Mellitus | Completed | 2008-10-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT00784875 | An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chron… | Phase2 | Primary Insomnia | Completed | 2008-10-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00753896 | Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treat… | Phase3 | Type 2 Diabetes | Completed | 2008-10-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00768131 | A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Sma… | Phase2 | Lung Neoplasms | Withdrawn | 2008-10-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00785928 | A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrex… | Phase2 | Rheumatoid Arthritis | Completed | 2008-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01613807 | Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes | Phase4 | Gestational Diabetes Mellitus | Completed | 2008-10-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT00765817 | Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus | Phase3 | Type 2 Diabetes | Completed | 2008-10-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00857454 | A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulati… | Phase3 | Hypogonadism | Completed | 2008-10-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00755807 | Duloxetine for Multiple Sclerosis Pain | Phase3 | Multiple Sclerosis | Completed | 2008-10-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT02075697 | Spanish Registry of Systemic Treatments in Psoriasis | — | Psoriasis | Unknown | 2008-10-01 | 2025-10-01 | ClinicalTrials.gov |
| NCT00857454 | A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulati… | Phase3 | Hypogonadism | Completed | 2008-10-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT02075697 | Spanish Registry of Systemic Treatments in Psoriasis | — | Psoriasis | Unknown | 2008-10-01 | 2025-10-01 | ClinicalTrials.gov |
| NCT00785928 | A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrex… | Phase2 | Rheumatoid Arthritis | Completed | 2008-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00755807 | Duloxetine for Multiple Sclerosis Pain | Phase3 | Multiple Sclerosis | Completed | 2008-10-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT00753896 | Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treat… | Phase3 | Type 2 Diabetes | Completed | 2008-10-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00784875 | An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chron… | Phase2 | Primary Insomnia | Completed | 2008-10-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00768131 | A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Sma… | Phase2 | Lung Neoplasms | Withdrawn | 2008-10-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00793884 | Emory Latino Diabetes Education Program | — | Diabetes | Terminated | 2008-10-01 | 2019-11-01 | ClinicalTrials.gov |
| NCT01028352 | Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients… | Na | Breast Cancer | Completed | 2008-10-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT00703976 | Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Adva… | Phase2 | Cancer | Completed | 2008-10-01 | 2014-09-01 | ClinicalTrials.gov |
| NCT01393990 | A Study of LY2228820 in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2008-09-04 | 2013-12-14 | ClinicalTrials.gov |
| NCT01393990 | A Study of LY2228820 in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2008-09-04 | 2013-12-14 | ClinicalTrials.gov |
| NCT00687609 | Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (AD… | Phase4 | Attention Deficit Hyperactivity Disorder | Terminated | 2008-09-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT01648764 | A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Sp… | Phase1 | Malignant Solid Tumor | Completed | 2008-09-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT00687609 | Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (AD… | Phase4 | Attention Deficit Hyperactivity Disorder | Terminated | 2008-09-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00686959 | Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell… | Phase3 | Non Small Cell Lung Cancer | Completed | 2008-09-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT00767806 | A Study for Patient With Chronic Low Back Pain | Phase3 | Chronic Low Back Pain | Completed | 2008-09-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00762411 | Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With… | Phase3 | Alzheimer's Disease | Completed | 2008-09-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00760747 | Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Childr… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2008-09-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00759772 | The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa | Phase2 | Anorexia Nervosa | Completed | 2008-09-01 | 2016-02-22 | ClinicalTrials.gov |
| NCT00749216 | Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease | Phase2 | Alzheimer's Disease | Completed | 2008-09-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00744991 | A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma | Phase2 | Cutaneous T-Cell Lymphoma | Completed | 2008-09-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00762411 | Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With… | Phase3 | Alzheimer's Disease | Completed | 2008-09-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00760747 | Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Childr… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2008-09-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00716274 | Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in … | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2008-09-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT00759772 | The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa | Phase2 | Anorexia Nervosa | Completed | 2008-09-01 | 2016-02-22 | ClinicalTrials.gov |
| NCT00767806 | A Study for Patient With Chronic Low Back Pain | Phase3 | Chronic Low Back Pain | Completed | 2008-09-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00822354 | Tadalafil for the Treatment of Raynaud's | Na | Raynaud | Completed | 2008-09-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00686959 | Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell… | Phase3 | Non Small Cell Lung Cancer | Completed | 2008-09-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT00749216 | Solanezumab Safety Study in Japanese Patients With Alzheimer's Disease | Phase2 | Alzheimer's Disease | Completed | 2008-09-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00744991 | A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma | Phase2 | Cutaneous T-Cell Lymphoma | Completed | 2008-09-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00822354 | Tadalafil for the Treatment of Raynaud's | Na | Raynaud | Completed | 2008-09-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT01648764 | A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Sp… | Phase1 | Malignant Solid Tumor | Completed | 2008-09-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT00716274 | Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in … | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2008-09-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT00697463 | Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women | Phase2 | Menopause | Completed | 2008-08-20 | 2012-01-03 | ClinicalTrials.gov |
| NCT00697463 | Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women | Phase2 | Menopause | Completed | 2008-08-20 | 2012-01-03 | ClinicalTrials.gov |
| NCT00703326 | Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer | Phase3 | Breast Cancer | Completed | 2008-08-06 | 2020-11-19 | ClinicalTrials.gov |
| NCT00703326 | Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer | Phase3 | Breast Cancer | Completed | 2008-08-06 | 2020-11-19 | ClinicalTrials.gov |
| NCT00721162 | Study of Ramucirumab in Ovarian Cancer | Phase2 | Ovarian Cancer | Completed | 2008-08-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT00734604 | A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken … | Phase3 | Erectile Dysfunction | Completed | 2008-08-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00683475 | A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate … | Phase2 | Prostate Cancer | Completed | 2008-08-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT00415155 | A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma | Phase1 | Hepatocellular Carcinoma | Withdrawn | 2008-08-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00734474 | A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabet… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2008-08-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT00729326 | Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glu… | Phase4 | Type 2 Diabetes Mellitus | Completed | 2008-08-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00728949 | A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Anti… | Phase2 | Metastatic Breast Cancer | Completed | 2008-08-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT00721162 | Study of Ramucirumab in Ovarian Cancer | Phase2 | Ovarian Cancer | Completed | 2008-08-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT00718159 | Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia | Phase1 | Acute Myeloid Leukemia | Completed | 2008-08-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00481117 | Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subj… | Phase1 | Type 2 Diabetes | Completed | 2008-08-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00415155 | A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma | Phase1 | Hepatocellular Carcinoma | Withdrawn | 2008-08-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00728949 | A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Anti… | Phase2 | Metastatic Breast Cancer | Completed | 2008-08-01 | 2015-02-01 | ClinicalTrials.gov |
| NCT00729326 | Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glu… | Phase4 | Type 2 Diabetes Mellitus | Completed | 2008-08-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00701935 | Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabe… | Phase2 | Diabetes Mellitus | Terminated | 2008-08-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00683475 | A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate … | Phase2 | Prostate Cancer | Completed | 2008-08-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT00734474 | A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabet… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2008-08-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT00718159 | Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia | Phase1 | Acute Myeloid Leukemia | Completed | 2008-08-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00481117 | Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subj… | Phase1 | Type 2 Diabetes | Completed | 2008-08-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00734604 | A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken … | Phase3 | Erectile Dysfunction | Completed | 2008-08-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00701935 | Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabe… | Phase2 | Diabetes Mellitus | Terminated | 2008-08-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01258348 | A Phase 1b Trial in Patients With Renal Cell Cancer | Phase1 | Metastatic Renal Cell Cancer | Completed | 2008-07-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT01284335 | A Safety Study in Participants With Advanced Solid Tumors | Phase1 | Advanced Solid Tumors | Terminated | 2008-07-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT00718419 | A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Ma… | Phase2 | Waldenstrom's Macroglobulinemia | Completed | 2008-07-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01153425 | µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis | Phase4 | Osteoporosis, Osteopenia | Completed | 2008-07-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00668148 | A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma | Phase2 | Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET) | Completed | 2008-07-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT00668148 | A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma | Phase2 | Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET) | Completed | 2008-07-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT00718419 | A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Ma… | Phase2 | Waldenstrom's Macroglobulinemia | Completed | 2008-07-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01153425 | µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis | Phase4 | Osteoporosis, Osteopenia | Completed | 2008-07-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT01258348 | A Phase 1b Trial in Patients With Renal Cell Cancer | Phase1 | Metastatic Renal Cell Cancer | Completed | 2008-07-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT01284335 | A Safety Study in Participants With Advanced Solid Tumors | Phase1 | Advanced Solid Tumors | Terminated | 2008-07-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT00709995 | A Study for Participants With Metastatic Renal Cell Carcinoma | Phase2 | Metastatic Renal Cell Carcinoma | Completed | 2008-06-30 | 2018-09-05 | ClinicalTrials.gov |
| NCT00709995 | A Study for Participants With Metastatic Renal Cell Carcinoma | Phase2 | Metastatic Renal Cell Carcinoma | Completed | 2008-06-30 | 2018-09-05 | ClinicalTrials.gov |
| NCT00696644 | A Study for Teriparatide in Severe Osteoporosis | — | Osteoporosis, Postmenopausal | Completed | 2008-06-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00696644 | A Study for Teriparatide in Severe Osteoporosis | — | Osteoporosis, Postmenopausal | Completed | 2008-06-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00689728 | A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an In… | Phase2 | Arthritis, Rheumatoid | Completed | 2008-06-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00696774 | Switching to Duloxetine in Patients With Depression | Phase4 | Depressive Disorder, Major | Completed | 2008-06-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00699998 | A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects | Phase3 | Acute Coronary Syndrome | Completed | 2008-06-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT00700427 | A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivi… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2008-06-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT00702650 | A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cut… | Phase3 | Hypogonadism | Completed | 2008-06-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00855439 | Evaluation of Exenatide in Patients With Diabetic Neuropathy | Na | Type 2 Diabetes Mellitus | Completed | 2008-06-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT00725101 | Fibromyalgia Health Outcome Study on Cost of Treatments | — | Fibromyalgia | Completed | 2008-06-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00855439 | Evaluation of Exenatide in Patients With Diabetic Neuropathy | Na | Type 2 Diabetes Mellitus | Completed | 2008-06-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01155245 | Teriparatide (PTH) and Bone Strength in Postmenopausal Women | — | Osteoporosis | Active_Not_Recruiting | 2008-06-01 | 2028-01-01 | ClinicalTrials.gov |
| NCT01214655 | A Study for Patients With Acute Leukemia | Phase1 | Acute Leukemia | Terminated | 2008-06-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01742078 | A Study of LY2541546 in Healthy Postmenopausal Women | Phase1 | Healthy | Completed | 2008-06-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00673452 | A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia | Phase4 | Fibromyalgia | Completed | 2008-06-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00689728 | A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an In… | Phase2 | Arthritis, Rheumatoid | Completed | 2008-06-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT01214655 | A Study for Patients With Acute Leukemia | Phase1 | Acute Leukemia | Terminated | 2008-06-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT01155245 | Teriparatide (PTH) and Bone Strength in Postmenopausal Women | — | Osteoporosis | Active_Not_Recruiting | 2008-06-01 | 2028-01-01 | ClinicalTrials.gov |
| NCT00696774 | Switching to Duloxetine in Patients With Depression | Phase4 | Depressive Disorder, Major | Completed | 2008-06-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00699998 | A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects | Phase3 | Acute Coronary Syndrome | Completed | 2008-06-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT00700427 | A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivi… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2008-06-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT00702650 | A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cut… | Phase3 | Hypogonadism | Completed | 2008-06-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00725101 | Fibromyalgia Health Outcome Study on Cost of Treatments | — | Fibromyalgia | Completed | 2008-06-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00763724 | Antidepressant Drug Exposure and Risk of Suicide Attempt Resulting in Medical I… | — | Depression | Completed | 2008-06-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00763724 | Antidepressant Drug Exposure and Risk of Suicide Attempt Resulting in Medical I… | — | Depression | Completed | 2008-06-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00673452 | A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia | Phase4 | Fibromyalgia | Completed | 2008-06-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT01742078 | A Study of LY2541546 in Healthy Postmenopausal Women | Phase1 | Healthy | Completed | 2008-06-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00623974 | Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalce… | Phase2 | Hypocalcemia | Terminated | 2008-05-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT01214642 | A Dose-Escalation Study for Patients With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2008-05-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01779830 | A Study of LY2624803 in Participants With Transient Insomnia | Phase1 | Transient Insomnia | Completed | 2008-05-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT01214642 | A Dose-Escalation Study for Patients With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2008-05-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT01779830 | A Study of LY2624803 in Participants With Transient Insomnia | Phase1 | Transient Insomnia | Completed | 2008-05-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00623974 | Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalce… | Phase2 | Hypocalcemia | Terminated | 2008-05-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00661492 | Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) | Phase2 | Androgen-independent Prostate Cancer | Completed | 2008-05-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00661492 | Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) | Phase2 | Androgen-independent Prostate Cancer | Completed | 2008-05-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00666757 | A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Sever… | Phase4 | Depression | Completed | 2008-05-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00666757 | A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Sever… | Phase4 | Depression | Completed | 2008-05-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00535860 | Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal… | Phase2 | Osteoporosis | Completed | 2008-04-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00672399 | Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead… | Phase1 | Healthy Subjects | Completed | 2008-04-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00630825 | A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 D… | Phase2 | Diabetes Mellitus Type 2 | Completed | 2008-04-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT01836575 | Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung… | Phase3 | Non Small Cell Lung Carcinoma | Completed | 2008-04-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00641056 | Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients W… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2008-04-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00642174 | Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3) | Phase2 | Diabetes Mellitus | Completed | 2008-04-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00658931 | Cymbalta for Depression as a Complication of Bereavement | Phase4 | Depression | Unknown | 2008-04-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00664534 | Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Lig… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2008-04-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT00666718 | A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Typ… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2008-04-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00535860 | Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal… | Phase2 | Osteoporosis | Completed | 2008-04-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00664534 | Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Lig… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2008-04-01 | 2010-11-01 | ClinicalTrials.gov |
| NCT00672399 | Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead… | Phase1 | Healthy Subjects | Completed | 2008-04-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00658931 | Cymbalta for Depression as a Complication of Bereavement | Phase4 | Depression | Unknown | 2008-04-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00642174 | Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3) | Phase2 | Diabetes Mellitus | Completed | 2008-04-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00666718 | A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Typ… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2008-04-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT01836575 | Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung… | Phase3 | Non Small Cell Lung Carcinoma | Completed | 2008-04-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00641056 | Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients W… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2008-04-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00630825 | A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 D… | Phase2 | Diabetes Mellitus Type 2 | Completed | 2008-04-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00604214 | Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Sept… | Phase3 | Sepsis | Completed | 2008-03-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT00307268 | Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults… | — | Attention-Deficit/Hyperactivity Disorder (ADHD) | Completed | 2008-03-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00594568 | Effect of LY450139 on the Long Term Progression of Alzheimer's Disease | Phase3 | Alzheimer's Disease | Completed | 2008-03-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00604214 | Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Sept… | Phase3 | Sepsis | Completed | 2008-03-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT00607919 | Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorb… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2008-03-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00617734 | Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With … | Phase2 | Head and Neck Cancer | Completed | 2008-03-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT00620321 | A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myelo… | Phase2 | Acute Myeloid Leukemia | Completed | 2008-03-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00623233 | Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer | Phase2 | Metastatic Breast Cancer | Completed | 2008-03-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00636818 | Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity … | Phase2 | Attention Deficit Hyperactivity Disorder | Completed | 2008-03-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00640510 | A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated… | Phase3 | Schizophrenia | Completed | 2008-03-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00641719 | A Long-term Study for the Treatment of Painful Diabetic Neuropathy | Phase3 | Diabetic Neuropathies | Completed | 2008-03-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00642018 | A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory… | Phase2 | Prostate Cancer | Completed | 2008-03-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT00645593 | Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Canc… | Phase2 | Bladder Cancer | Completed | 2008-03-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT00689507 | A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib | Phase1 | Multiple Myeloma | Completed | 2008-03-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01606397 | A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 D… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2008-03-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00307268 | Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults… | — | Attention-Deficit/Hyperactivity Disorder (ADHD) | Completed | 2008-03-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00594568 | Effect of LY450139 on the Long Term Progression of Alzheimer's Disease | Phase3 | Alzheimer's Disease | Completed | 2008-03-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00607919 | Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorb… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2008-03-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00617734 | Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With … | Phase2 | Head and Neck Cancer | Completed | 2008-03-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT00620321 | A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myelo… | Phase2 | Acute Myeloid Leukemia | Completed | 2008-03-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00623233 | Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer | Phase2 | Metastatic Breast Cancer | Completed | 2008-03-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00636818 | Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity … | Phase2 | Attention Deficit Hyperactivity Disorder | Completed | 2008-03-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00640510 | A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated… | Phase3 | Schizophrenia | Completed | 2008-03-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00641719 | A Long-term Study for the Treatment of Painful Diabetic Neuropathy | Phase3 | Diabetic Neuropathies | Completed | 2008-03-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00642018 | A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory… | Phase2 | Prostate Cancer | Completed | 2008-03-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT00645593 | Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Canc… | Phase2 | Bladder Cancer | Completed | 2008-03-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT00689507 | A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib | Phase1 | Multiple Myeloma | Completed | 2008-03-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01606397 | A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 D… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2008-03-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00612586 | Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab … | Phase2 | Colorectal Cancer | Completed | 2008-02-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT01215916 | A Phase 1 Study in Patients With Solid Tumors | Phase1 | Solid Tumors | Completed | 2008-02-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00618748 | Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Diso… | Phase3 | Bipolar I Disorder | Completed | 2008-02-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00627042 | Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not… | Phase2 | Hepatocellular Carcinoma | Completed | 2008-02-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00622323 | Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Pa… | — | Type 2 Diabetes Mellitus | Completed | 2008-02-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00618748 | Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Diso… | Phase3 | Bipolar I Disorder | Completed | 2008-02-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00622323 | Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Pa… | — | Type 2 Diabetes Mellitus | Completed | 2008-02-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00627042 | Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not… | Phase2 | Hepatocellular Carcinoma | Completed | 2008-02-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00761332 | Back Pain in Patients With Severe Osteoporosis | — | Osteoporosis | Completed | 2008-02-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01215916 | A Phase 1 Study in Patients With Solid Tumors | Phase1 | Solid Tumors | Completed | 2008-02-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00609518 | A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer | Phase2 | Non Small Cell Lung Cancer | Completed | 2008-02-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00761332 | Back Pain in Patients With Severe Osteoporosis | — | Osteoporosis | Completed | 2008-02-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00609518 | A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer | Phase2 | Non Small Cell Lung Cancer | Completed | 2008-02-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00612586 | Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab … | Phase2 | Colorectal Cancer | Completed | 2008-02-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT00363376 | A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain | Phase3 | Weight Gain | Completed | 2008-01-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00637273 | A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide … | Phase3 | Type 2 Diabetes Mellitus | Completed | 2008-01-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT01524224 | A Dose-Escalation Study in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2008-01-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT00635492 | CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Init… | — | Type 2 Diabetes Mellitus | Completed | 2008-01-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00634439 | Safety Study of Atomoxetine and Cerebrovascular Outcomes | — | Cerebrovascular Accident | Completed | 2008-01-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00606021 | A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Adva… | Phase2 | Non Small Cell Lung Cancer | Completed | 2008-01-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00603239 | Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiaz… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2008-01-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00363376 | A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain | Phase3 | Weight Gain | Completed | 2008-01-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00577863 | Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to… | Phase3 | Osteoporosis | Completed | 2008-01-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00577824 | Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who … | Phase3 | Type 2 Diabetes | Completed | 2008-01-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00637273 | A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide … | Phase3 | Type 2 Diabetes Mellitus | Completed | 2008-01-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00635492 | CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Init… | — | Type 2 Diabetes Mellitus | Completed | 2008-01-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00634439 | Safety Study of Atomoxetine and Cerebrovascular Outcomes | — | Cerebrovascular Accident | Completed | 2008-01-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00606021 | A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Adva… | Phase2 | Non Small Cell Lung Cancer | Completed | 2008-01-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT01524224 | A Dose-Escalation Study in Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2008-01-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT00603239 | Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiaz… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2008-01-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00577863 | Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to… | Phase3 | Osteoporosis | Completed | 2008-01-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00577824 | Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who … | Phase3 | Type 2 Diabetes | Completed | 2008-01-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT01848028 | PsoBest - The German Psoriasis Registry | — | Psoriasis | Recruiting | 2008-01-01 | 2032-12-01 | ClinicalTrials.gov |
| NCT01848028 | PsoBest - The German Psoriasis Registry | — | Psoriasis | Recruiting | 2008-01-01 | 2032-12-01 | ClinicalTrials.gov |
| NCT00575666 | Intranasal Insulin Treatment in Patients With Schizophrenia | Phase4 | Schizophrenia | Completed | 2007-12-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00580073 | Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinom… | Phase2 | Rectal Cancer | Terminated | 2007-12-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00414960 | A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smok… | Phase2 | Lung Cancer | Completed | 2007-12-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00545948 | Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Ear… | Phase2 | Carcinoma, Non-Small-Cell Lung | Terminated | 2007-12-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00414960 | A Trial of Placebo Versus Enzastaurin for Lung Cancer Prevention in Former Smok… | Phase2 | Lung Cancer | Completed | 2007-12-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00575666 | Intranasal Insulin Treatment in Patients With Schizophrenia | Phase4 | Schizophrenia | Completed | 2007-12-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00580073 | Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinom… | Phase2 | Rectal Cancer | Terminated | 2007-12-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00545948 | Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Ear… | Phase2 | Carcinoma, Non-Small-Cell Lung | Terminated | 2007-12-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00515697 | A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma | Phase2 | Metastatic Renal Cell Carcinoma | Completed | 2007-11-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00548808 | A Study for Type 2 Diabetic Patients | Phase4 | Type 2 Diabetes Mellitus | Completed | 2007-11-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00542919 | A Study for Patients With Non-Hodgkin's Lymphomas | Phase2 | T-Cell Lymphoma | Completed | 2007-11-01 | 2018-02-27 | ClinicalTrials.gov |
| NCT00540826 | Treatment Compliance in Children and Adolescents on ADHD Medication | — | ADHD | Completed | 2007-11-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00536939 | Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizuma… | Phase2 | Breast Cancer | Terminated | 2007-11-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00568685 | Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyp… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2007-11-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00568685 | Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyp… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2007-11-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00561509 | Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunctio… | — | Major Depressive Disorder | Completed | 2007-11-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00560417 | Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2007-11-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00557310 | A Study Using Imaging Technology to Measure Changes in Bone Structure After Tre… | Phase4 | Osteoporosis, Postmenopausal | Completed | 2007-11-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00552175 | A Study for the Treatment of Diabetic Peripheral Neuropathic Pain | Phase3 | Diabetic Neuropathies | Completed | 2007-11-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00550173 | A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer | Phase2 | Non-Small-Cell Lung Cancer | Completed | 2007-11-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00661427 | Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastat… | Phase2 | Head and Neck | Completed | 2007-11-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT01287520 | A Study of LY2090314 in Patients With Advanced or Metastatic Cancer | Phase1 | Advanced Cancer | Completed | 2007-11-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00536939 | Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizuma… | Phase2 | Breast Cancer | Terminated | 2007-11-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00561509 | Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunctio… | — | Major Depressive Disorder | Completed | 2007-11-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00630149 | Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcino… | Phase2 | Nasopharyngeal Neoplasms | Completed | 2007-11-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01606423 | The Effect of LY2409021 on Blood Sugar Levels When Glucagon Levels Are Increase… | Phase1 | Healthy Volunteers | Completed | 2007-11-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00542919 | A Study for Patients With Non-Hodgkin's Lymphomas | Phase2 | T-Cell Lymphoma | Completed | 2007-11-01 | 2018-02-27 | ClinicalTrials.gov |
| NCT00614822 | Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer | Phase2 | Non Small Cell Lung Cancer | Completed | 2007-11-01 | 2016-08-22 | ClinicalTrials.gov |
| NCT00540826 | Treatment Compliance in Children and Adolescents on ADHD Medication | — | ADHD | Completed | 2007-11-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00533702 | A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Ma… | Phase2 | Metastatic Malignant Melanoma | Completed | 2007-11-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00548808 | A Study for Type 2 Diabetic Patients | Phase4 | Type 2 Diabetes Mellitus | Completed | 2007-11-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00560417 | Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral … | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2007-11-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00557310 | A Study Using Imaging Technology to Measure Changes in Bone Structure After Tre… | Phase4 | Osteoporosis, Postmenopausal | Completed | 2007-11-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00552175 | A Study for the Treatment of Diabetic Peripheral Neuropathic Pain | Phase3 | Diabetic Neuropathies | Completed | 2007-11-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00515697 | A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma | Phase2 | Metastatic Renal Cell Carcinoma | Completed | 2007-11-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT01606423 | The Effect of LY2409021 on Blood Sugar Levels When Glucagon Levels Are Increase… | Phase1 | Healthy Volunteers | Completed | 2007-11-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00586508 | Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant G… | Phase2 | Recurrent Glioblastoma | Completed | 2007-11-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT00533702 | A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Ma… | Phase2 | Metastatic Malignant Melanoma | Completed | 2007-11-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00630149 | Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcino… | Phase2 | Nasopharyngeal Neoplasms | Completed | 2007-11-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00614822 | Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer | Phase2 | Non Small Cell Lung Cancer | Completed | 2007-11-01 | 2016-08-22 | ClinicalTrials.gov |
| NCT00661427 | Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastat… | Phase2 | Head and Neck | Completed | 2007-11-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT00586508 | Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant G… | Phase2 | Recurrent Glioblastoma | Completed | 2007-11-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01287520 | A Study of LY2090314 in Patients With Advanced or Metastatic Cancer | Phase1 | Advanced Cancer | Completed | 2007-11-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00550173 | A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer | Phase2 | Non-Small-Cell Lung Cancer | Completed | 2007-11-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00540124 | Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Ben… | Phase2 | Benign Prostatic Hyperplasia | Completed | 2007-10-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00475657 | Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer | Phase2 | Small Cell Lung Cancer | Terminated | 2007-10-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00509821 | Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in P… | Phase2 | Glioblastoma Multiforme | Completed | 2007-10-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT00529204 | Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolis… | Phase2 | Diabetes Complications | Terminated | 2007-10-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00568672 | Optimal Duration of Olanzapine Add-on Therapy in Major Depression | Phase3 | Relapse Rate of a Major Depressive Episode | Withdrawn | 2007-10-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00864513 | Study of Pemetrexed for Second-Line Pancreas Cancer | Phase2 | Pancreas Cancer | Terminated | 2007-10-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00520507 | An Investigation of the Sleep Architecture and Consequent Cognitive Changes in … | Phase4 | Bipolar Disorder | Completed | 2007-10-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00857961 | A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formul… | Phase2 | Hypogonadism | Completed | 2007-10-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00546910 | Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyp… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2007-10-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00520676 | Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | Phase3 | Non-Small Cell Lung Cancer | Completed | 2007-10-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00546728 | The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes | Phase4 | Impaired Glucose Tolerance | Completed | 2007-10-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00475657 | Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer | Phase2 | Small Cell Lung Cancer | Terminated | 2007-10-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00520507 | An Investigation of the Sleep Architecture and Consequent Cognitive Changes in … | Phase4 | Bipolar Disorder | Completed | 2007-10-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00546728 | The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes | Phase4 | Impaired Glucose Tolerance | Completed | 2007-10-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00540124 | Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Ben… | Phase2 | Benign Prostatic Hyperplasia | Completed | 2007-10-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00857961 | A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formul… | Phase2 | Hypogonadism | Completed | 2007-10-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00509821 | Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in P… | Phase2 | Glioblastoma Multiforme | Completed | 2007-10-01 | 2016-03-01 | ClinicalTrials.gov |
| NCT00529204 | Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolis… | Phase2 | Diabetes Complications | Terminated | 2007-10-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00533429 | Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed… | Phase2 | Non-small Cell Lung Cancer | Completed | 2007-10-01 | 2009-02-01 | ClinicalTrials.gov |
| NCT00520676 | Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | Phase3 | Non-Small Cell Lung Cancer | Completed | 2007-10-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00533429 | Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed… | Phase2 | Non-small Cell Lung Cancer | Completed | 2007-10-01 | 2009-02-01 | ClinicalTrials.gov |
| NCT00568672 | Optimal Duration of Olanzapine Add-on Therapy in Major Depression | Phase3 | Relapse Rate of a Major Depressive Episode | Withdrawn | 2007-10-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00864513 | Study of Pemetrexed for Second-Line Pancreas Cancer | Phase2 | Pancreas Cancer | Terminated | 2007-10-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00546910 | Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyp… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2007-10-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00536471 | A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Ma… | Phase4 | Major Depressive Disorder | Completed | 2007-09-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00612794 | A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics … | Phase1 | Type 2 Diabetes | Completed | 2007-09-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00549887 | An Observational Study Evaluating Patient Satisfaction and Quality of Life Asso… | — | Diabetes Mellitus, Type 2 | Completed | 2007-09-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00540241 | Performance Status During Treatment With Pemetrexed in Patients With NSCLC | — | Non Small Cell Lung Cancer | Completed | 2007-09-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00538681 | Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lu… | Phase2 | Lung Cancer | Terminated | 2007-09-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00612794 | A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics … | Phase1 | Type 2 Diabetes | Completed | 2007-09-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00532480 | Study of Brain Response to Emotional Pictures Using a fMRI While on Duloxetine | Phase4 | Major Depression | Completed | 2007-09-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00530621 | Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advan… | Phase2 | Non-small Cell Lung Cancer | Completed | 2007-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00530335 | Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyp… | Phase2 | Attention Deficit Hyperactivity Disorder | Completed | 2007-09-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00523419 | Chemotherapy for Patients With Osteosarcoma | Phase2 | Osteosarcoma | Completed | 2007-09-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00520936 | A Study of Pemetrexed in Children With Recurrent Cancer | Phase2 | Osteosarcoma | Completed | 2007-09-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00520923 | A Study for Patients With Schizophrenia | Phase2 | Schizophrenia | Completed | 2007-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00549887 | An Observational Study Evaluating Patient Satisfaction and Quality of Life Asso… | — | Diabetes Mellitus, Type 2 | Completed | 2007-09-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00516074 | A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate … | Phase3 | Type 2 Diabetes Mellitus | Completed | 2007-09-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00540241 | Performance Status During Treatment With Pemetrexed in Patients With NSCLC | — | Non Small Cell Lung Cancer | Completed | 2007-09-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00538681 | Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lu… | Phase2 | Lung Cancer | Terminated | 2007-09-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00536471 | A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Ma… | Phase4 | Major Depressive Disorder | Completed | 2007-09-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00532480 | Study of Brain Response to Emotional Pictures Using a fMRI While on Duloxetine | Phase4 | Major Depression | Completed | 2007-09-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00494026 | Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cel… | Phase2 | Small Cell Lung Cancer | Terminated | 2007-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00530621 | Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advan… | Phase2 | Non-small Cell Lung Cancer | Completed | 2007-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00530335 | Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyp… | Phase2 | Attention Deficit Hyperactivity Disorder | Completed | 2007-09-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00523419 | Chemotherapy for Patients With Osteosarcoma | Phase2 | Osteosarcoma | Completed | 2007-09-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00520936 | A Study of Pemetrexed in Children With Recurrent Cancer | Phase2 | Osteosarcoma | Completed | 2007-09-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00520923 | A Study for Patients With Schizophrenia | Phase2 | Schizophrenia | Completed | 2007-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00516074 | A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate … | Phase3 | Type 2 Diabetes Mellitus | Completed | 2007-09-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00494026 | Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cel… | Phase2 | Small Cell Lung Cancer | Terminated | 2007-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00517595 | Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elder… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2007-08-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00529789 | Open-Label Study of Duloxetine in the Treatment of Children and Adolescents Wit… | Phase2 | Major Depressive Disorder | Completed | 2007-08-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00835185 | Study of IMC-11F8 in Participants With Colorectal Cancer | Phase2 | Metastatic Colorectal Cancer | Completed | 2007-08-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT00494013 | Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY) | Phase3 | Diabetes Mellitus Type 2 | Completed | 2007-08-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00494013 | Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY) | Phase3 | Diabetes Mellitus Type 2 | Completed | 2007-08-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00510952 | Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hype… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2007-08-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00510276 | Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine i… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2007-08-01 | 2009-02-01 | ClinicalTrials.gov |
| NCT00529789 | Open-Label Study of Duloxetine in the Treatment of Children and Adolescents Wit… | Phase2 | Major Depressive Disorder | Completed | 2007-08-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00490451 | A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Ti… | Phase2 | Sarcoma, Soft Tissue | Completed | 2007-08-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00682448 | Metformin for the Prevention of the Metabolic Side-effects of Zyprexa | Phase4 | Metabolic Complications | Completed | 2007-08-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00835185 | Study of IMC-11F8 in Participants With Colorectal Cancer | Phase2 | Metastatic Colorectal Cancer | Completed | 2007-08-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT00510146 | Olanzapine Treatment of Patients With Bipolar I Disorder | Phase3 | Depression, Bipolar | Completed | 2007-08-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00682448 | Metformin for the Prevention of the Metabolic Side-effects of Zyprexa | Phase4 | Metabolic Complications | Completed | 2007-08-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00520481 | Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treat… | Phase2 | Adenocarcinoma of the Prostate | Completed | 2007-08-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT00490451 | A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Ti… | Phase2 | Sarcoma, Soft Tissue | Completed | 2007-08-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00517595 | Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elder… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2007-08-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00516048 | An Exploratory Study of the Effect of Treatment Interruption on Safety of Exena… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2007-08-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00510952 | Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hype… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2007-08-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00510276 | Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine i… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2007-08-01 | 2009-02-01 | ClinicalTrials.gov |
| NCT00520481 | Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treat… | Phase2 | Adenocarcinoma of the Prostate | Completed | 2007-08-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT00516048 | An Exploratory Study of the Effect of Treatment Interruption on Safety of Exena… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2007-08-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00510146 | Olanzapine Treatment of Patients With Bipolar I Disorder | Phase3 | Depression, Bipolar | Completed | 2007-08-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00503399 | Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With… | Phase3 | Osteoporosis | Completed | 2007-07-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT00538122 | Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment | — | Schizophrenia | Completed | 2007-07-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00337012 | The Effect of Duloxetine on Interoceptive Awareness | — | Depressive Disorder | Unknown | 2007-07-01 | — | ClinicalTrials.gov |
| NCT01214629 | A Study for Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2007-07-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT00529893 | Efficacy of Atomoxetine in the Neuropsychological Tests Among Children With ADHD | — | Attention Deficit Disorder With Hyperactivity | Completed | 2007-07-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00533026 | Duloxetine - Warfarin Pharmacodynamic Study | Phase1 | Anticoagulant Effect of Warfarin When Taken With Duloxetine. | Completed | 2007-07-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00533026 | Duloxetine - Warfarin Pharmacodynamic Study | Phase1 | Anticoagulant Effect of Warfarin When Taken With Duloxetine. | Completed | 2007-07-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00503399 | Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With… | Phase3 | Osteoporosis | Completed | 2007-07-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT00617201 | Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial | Phase2 | Substance Abuse | Completed | 2007-07-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00496587 | Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sar… | Phase2 | Renal Cell Carcinoma | Completed | 2007-07-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT00512070 | Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffect… | Na | Schizophrenia | Completed | 2007-07-01 | 2024-12-01 | ClinicalTrials.gov |
| NCT00617201 | Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial | Phase2 | Substance Abuse | Completed | 2007-07-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00512070 | Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffect… | Na | Schizophrenia | Completed | 2007-07-01 | 2024-12-01 | ClinicalTrials.gov |
| NCT00496587 | Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sar… | Phase2 | Renal Cell Carcinoma | Completed | 2007-07-01 | 2016-05-01 | ClinicalTrials.gov |
| NCT00490854 | A Study for Patients With Type 2 Diabetes Mellitus | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2007-07-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT01214629 | A Study for Participants With Advanced Cancer | Phase1 | Advanced Cancer | Completed | 2007-07-01 | 2012-05-01 | ClinicalTrials.gov |
| NCT00529893 | Efficacy of Atomoxetine in the Neuropsychological Tests Among Children With ADHD | — | Attention Deficit Disorder With Hyperactivity | Completed | 2007-07-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00517829 | Docetaxel+Oxali+/-Cetux Met Gastric/GEJ | Phase2 | Gastric Cancer Adenocarcinoma Metastatic | Completed | 2007-07-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT00538122 | Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment | — | Schizophrenia | Completed | 2007-07-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00337012 | The Effect of Duloxetine on Interoceptive Awareness | — | Depressive Disorder | Unknown | 2007-07-01 | — | ClinicalTrials.gov |
| NCT00490854 | A Study for Patients With Type 2 Diabetes Mellitus | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2007-07-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00517829 | Docetaxel+Oxali+/-Cetux Met Gastric/GEJ | Phase2 | Gastric Cancer Adenocarcinoma Metastatic | Completed | 2007-07-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT00466440 | A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy… | Phase2 | Prostate Cancer | Completed | 2007-06-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00503685 | Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants Wit… | Phase2 | Colorectal Cancer | Completed | 2007-06-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00500370 | A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Pat… | Phase2 | Obesity | Completed | 2007-06-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00487240 | Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2007-06-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00466440 | A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy… | Phase2 | Prostate Cancer | Completed | 2007-06-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00487240 | Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2007-06-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00500370 | A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Pat… | Phase2 | Obesity | Completed | 2007-06-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00503685 | Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants Wit… | Phase2 | Colorectal Cancer | Completed | 2007-06-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00696293 | Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Ad… | Phase4 | Major Depressive Disorder | Completed | 2007-05-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00587639 | An Evaluation of Safety and Feasibility Using Repetitive Transcranial Magnetic … | Na | Depression | Completed | 2007-05-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00482014 | A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radia… | Phase1 | Non-Small-Cell Lung Cancer | Completed | 2007-05-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT00452257 | A Study of Enzastaurin in Patients With Leukemia | Phase1 | Leukemia, Lymphocytic | Completed | 2007-05-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00451178 | A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared … | Phase2 | Lymphoma | Completed | 2007-05-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT00477581 | A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glu… | Phase4 | Type 2 Diabetes Mellitus | Completed | 2007-05-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00475644 | A Study of Enzastaurin in Participants With Follicular Lymphoma | Phase2 | Lymphoma, Follicular | Completed | 2007-05-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT00451178 | A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared … | Phase2 | Lymphoma | Completed | 2007-05-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT00452257 | A Study of Enzastaurin in Patients With Leukemia | Phase1 | Leukemia, Lymphocytic | Completed | 2007-05-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00452413 | A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung… | Phase1 | Non-Small Cell Lung Cancer | Completed | 2007-05-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT00473486 | Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetre… | Phase1 | Carcinoma, Non-Small-Cell Lung | Terminated | 2007-05-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00509366 | Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stag… | Phase2 | Non Small Cell Lung Cancer | Terminated | 2007-05-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT01606371 | A First-in-Human Study of LY2409021 in Healthy Participants and Participants Wi… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2007-05-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00473486 | Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetre… | Phase1 | Carcinoma, Non-Small-Cell Lung | Terminated | 2007-05-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00475644 | A Study of Enzastaurin in Participants With Follicular Lymphoma | Phase2 | Lymphoma, Follicular | Completed | 2007-05-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT00477581 | A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glu… | Phase4 | Type 2 Diabetes Mellitus | Completed | 2007-05-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00452413 | A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung… | Phase1 | Non-Small Cell Lung Cancer | Completed | 2007-05-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT00696293 | Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Ad… | Phase4 | Major Depressive Disorder | Completed | 2007-05-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00587639 | An Evaluation of Safety and Feasibility Using Repetitive Transcranial Magnetic … | Na | Depression | Completed | 2007-05-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT01606371 | A First-in-Human Study of LY2409021 in Healthy Participants and Participants Wi… | Phase1 | Diabetes Mellitus, Type 2 | Completed | 2007-05-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00509366 | Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stag… | Phase2 | Non Small Cell Lung Cancer | Terminated | 2007-05-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00482014 | A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radia… | Phase1 | Non-Small-Cell Lung Cancer | Completed | 2007-05-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT00451555 | Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer | Phase2 | Breast Cancer | Completed | 2007-04-11 | 2018-10-18 | ClinicalTrials.gov |
| NCT00451555 | Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer | Phase2 | Breast Cancer | Completed | 2007-04-11 | 2018-10-18 | ClinicalTrials.gov |
| NCT00447213 | A Study for Patients With Type 1 Diabetes Mellitus | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2007-04-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00456885 | The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women | Phase4 | Obesity | Completed | 2007-04-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00510211 | An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiv… | — | Schizophrenia | Completed | 2007-04-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00456885 | The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women | Phase4 | Obesity | Completed | 2007-04-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00471354 | A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2007-04-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00470548 | Abraxane and Alimta in Advanced Solid Tumors | Phase1 | Breast Cancer | Terminated | 2007-04-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT00447213 | A Study for Patients With Type 1 Diabetes Mellitus | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2007-04-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00470548 | Abraxane and Alimta in Advanced Solid Tumors | Phase1 | Breast Cancer | Terminated | 2007-04-01 | 2014-10-01 | ClinicalTrials.gov |
| NCT00471354 | A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2007-04-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00510211 | An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiv… | — | Schizophrenia | Completed | 2007-04-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00447278 | A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy … | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2007-03-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00437125 | Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's … | Phase4 | Major Depressive Disorder | Completed | 2007-03-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00437268 | A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participant… | Phase2 | Colorectal Cancer | Completed | 2007-03-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00437294 | Enzastaurin in Combination of Capecitabine to Treat Breast Cancer | Phase2 | Breast Cancer | Terminated | 2007-03-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00447057 | Study of Pemetrexed Versus Pemetrexed Plus Erlotinib as Treatment of Nonsquamou… | Phase2 | Histological or Cytological Diagnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy. | Completed | 2007-03-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00447278 | A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy … | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2007-03-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00455442 | A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention o… | Phase2 | Weight-Gain Prevention | Completed | 2007-03-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00456261 | First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With A… | Phase2 | Lung Cancer | Completed | 2007-03-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT00456261 | First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With A… | Phase2 | Lung Cancer | Completed | 2007-03-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT00455442 | A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention o… | Phase2 | Weight-Gain Prevention | Completed | 2007-03-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00447057 | Study of Pemetrexed Versus Pemetrexed Plus Erlotinib as Treatment of Nonsquamou… | Phase2 | Histological or Cytological Diagnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy. | Completed | 2007-03-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00437294 | Enzastaurin in Combination of Capecitabine to Treat Breast Cancer | Phase2 | Breast Cancer | Terminated | 2007-03-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00437268 | A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participant… | Phase2 | Colorectal Cancer | Completed | 2007-03-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00437125 | Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's … | Phase4 | Major Depressive Disorder | Completed | 2007-03-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00400803 | Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV No… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2007-03-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00385944 | The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel i… | Phase2 | Acute Coronary Syndrome | Completed | 2007-03-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00400803 | Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV No… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2007-03-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00385944 | The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel i… | Phase2 | Acute Coronary Syndrome | Completed | 2007-03-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00667732 | How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood… | Phase4 | Type 2 Diabetes | Completed | 2007-03-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00667732 | How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood… | Phase4 | Type 2 Diabetes | Completed | 2007-03-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00497770 | An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd)… | — | Lung Neoplasms | Completed | 2007-02-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00440895 | A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary A… | Phase4 | Myocardial Infarction | Completed | 2007-02-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT00517985 | Duloxetine for Perimenopausal Depression | Phase4 | Major Depressive Disorder | Completed | 2007-02-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00512499 | Strategies to Treat Osteoporosis Following a Fragility Fracture | Na | Osteoporosis | Completed | 2007-02-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT00440843 | Zyprexa and Task Engagement in Schizophrenia | Phase3 | Schizophrenia | Withdrawn | 2007-02-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT00870155 | A Study for Patients With Multiple Sclerosis | Phase2 | Secondary Progressive Multiple Sclerosis | Terminated | 2007-02-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00440895 | A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary A… | Phase4 | Myocardial Infarction | Completed | 2007-02-01 | 2013-05-01 | ClinicalTrials.gov |
| NCT00440843 | Zyprexa and Task Engagement in Schizophrenia | Phase3 | Schizophrenia | Withdrawn | 2007-02-01 | 2012-06-01 | ClinicalTrials.gov |
| NCT00440778 | A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary A… | Phase4 | Myocardial Infarction | Completed | 2007-02-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00517985 | Duloxetine for Perimenopausal Depression | Phase4 | Major Depressive Disorder | Completed | 2007-02-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00436280 | Chemotherapy for Participants With Lymphoma | Phase2 | Lymphoma, Large Cell, Diffuse | Completed | 2007-02-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT00438776 | Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambli… | Phase3 | Pathological Gambling | Completed | 2007-02-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00437112 | Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients Wi… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2007-02-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00437112 | Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients Wi… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2007-02-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00436280 | Chemotherapy for Participants With Lymphoma | Phase2 | Lymphoma, Large Cell, Diffuse | Completed | 2007-02-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT00434954 | Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemi… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2007-02-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00433290 | Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain | Phase3 | Osteoarthritis Knee Pain | Completed | 2007-02-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00428610 | A Study of Chemotherapy Treatment for Patients With Ovarian Cancer | Phase2 | Ovarian Cancer | Completed | 2007-02-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00870155 | A Study for Patients With Multiple Sclerosis | Phase2 | Secondary Progressive Multiple Sclerosis | Terminated | 2007-02-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00422162 | A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression | Phase4 | Major Depressive Disorder | Completed | 2007-02-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00438776 | Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambli… | Phase3 | Pathological Gambling | Completed | 2007-02-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00497770 | An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd)… | — | Lung Neoplasms | Completed | 2007-02-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00527111 | Pre-op Rectal ChemoRad +/- Cetuximab | Phase2 | Rectal Cancer | Completed | 2007-02-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT00448097 | Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Pro… | Phase2 | Prostatic Neoplasms | Terminated | 2007-02-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00447421 | A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetr… | Phase1 | Small Cell Lung Cancer | Terminated | 2007-02-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00448097 | Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Pro… | Phase2 | Prostatic Neoplasms | Terminated | 2007-02-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00409006 | Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers | Phase2 | Non-small Cell Lung Cancer | Completed | 2007-02-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00383331 | Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non S… | Phase2 | Non-Small-Cell Lung Cancer | Terminated | 2007-02-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00428610 | A Study of Chemotherapy Treatment for Patients With Ovarian Cancer | Phase2 | Ovarian Cancer | Completed | 2007-02-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT00440778 | A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary A… | Phase4 | Myocardial Infarction | Completed | 2007-02-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00383331 | Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non S… | Phase2 | Non-Small-Cell Lung Cancer | Terminated | 2007-02-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00409006 | Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers | Phase2 | Non-small Cell Lung Cancer | Completed | 2007-02-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00512499 | Strategies to Treat Osteoporosis Following a Fragility Fracture | Na | Osteoporosis | Completed | 2007-02-01 | 2016-07-01 | ClinicalTrials.gov |
| NCT00447421 | A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetr… | Phase1 | Small Cell Lung Cancer | Terminated | 2007-02-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00527111 | Pre-op Rectal ChemoRad +/- Cetuximab | Phase2 | Rectal Cancer | Completed | 2007-02-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT00422162 | A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression | Phase4 | Major Depressive Disorder | Completed | 2007-02-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00434954 | Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemi… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2007-02-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00433290 | Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain | Phase3 | Osteoarthritis Knee Pain | Completed | 2007-02-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00429858 | Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic … | Phase2 | Pancreatic Cancer | Terminated | 2007-01-22 | 2010-01-20 | ClinicalTrials.gov |
| NCT00429858 | Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic … | Phase2 | Pancreatic Cancer | Terminated | 2007-01-22 | 2010-01-20 | ClinicalTrials.gov |
| NCT00918567 | Impact of Strattera and Behavior Therapy on the Home and School Functioning of … | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2007-01-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00415636 | Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/… | Phase1 | Cancer | Completed | 2007-01-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT01445119 | A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Ad… | Phase1 | Recurrent Gliomas | Completed | 2007-01-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT00433160 | Phase 3 Clinical Trial of Teriparatide in Japan | Phase3 | Osteoporosis | Completed | 2007-01-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00428714 | Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Ho… | Phase2 | Prostate Cancer | Completed | 2007-01-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00424593 | Duloxetine Versus Placebo in Chronic Low Back Pain | Phase3 | Back Pain Without Radiation | Completed | 2007-01-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00420095 | A Study for Patients With Diabetes Mellitus (IOPA) | Phase4 | Diabetes Mellitus, Type 1 | Completed | 2007-01-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00457730 | A Study to Test the Use of Duloxetine for Pain in MS | Phase2 | Multiple Sclerosis | Completed | 2007-01-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT00433160 | Phase 3 Clinical Trial of Teriparatide in Japan | Phase3 | Osteoporosis | Completed | 2007-01-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00424593 | Duloxetine Versus Placebo in Chronic Low Back Pain | Phase3 | Back Pain Without Radiation | Completed | 2007-01-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT03577197 | Southeast Netherlands Advanced Metastatic Breast Cancer Registry | — | Advanced Breast Cancer | Recruiting | 2007-01-01 | 2027-12-31 | ClinicalTrials.gov |
| NCT00420381 | Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian o… | Phase2 | Ovarian Cancer | Completed | 2007-01-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT00415636 | Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/… | Phase1 | Cancer | Completed | 2007-01-01 | 2010-07-01 | ClinicalTrials.gov |
| NCT00384332 | Medication, Weight Gain and GI Hormones | Phase4 | Bipolar Depression | Completed | 2007-01-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00384332 | Medication, Weight Gain and GI Hormones | Phase4 | Bipolar Depression | Completed | 2007-01-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00918567 | Impact of Strattera and Behavior Therapy on the Home and School Functioning of … | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2007-01-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00420381 | Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian o… | Phase2 | Ovarian Cancer | Completed | 2007-01-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT00420095 | A Study for Patients With Diabetes Mellitus (IOPA) | Phase4 | Diabetes Mellitus, Type 1 | Completed | 2007-01-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT01445119 | A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Ad… | Phase1 | Recurrent Gliomas | Completed | 2007-01-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT00569907 | Observational Study of Interstitial Glucose Monitoring With Continuous Glucose … | — | Diabetes Mellitus Type 2 | Completed | 2007-01-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00569907 | Observational Study of Interstitial Glucose Monitoring With Continuous Glucose … | — | Diabetes Mellitus Type 2 | Completed | 2007-01-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT03577197 | Southeast Netherlands Advanced Metastatic Breast Cancer Registry | — | Advanced Breast Cancer | Recruiting | 2007-01-01 | 2027-12-31 | ClinicalTrials.gov |
| NCT00457730 | A Study to Test the Use of Duloxetine for Pain in MS | Phase2 | Multiple Sclerosis | Completed | 2007-01-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT00428714 | Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Ho… | Phase2 | Prostate Cancer | Completed | 2007-01-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00402324 | A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabil… | Phase4 | Bipolar I Disorder | Completed | 2006-12-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00343291 | A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carbopl… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2006-12-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00316225 | Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around … | Phase2 | Non-small Cell Lung Cancer | Completed | 2006-12-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00415168 | Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of … | Phase2 | Gastric Cancer | Completed | 2006-12-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00768391 | Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Th… | Phase1 | Solid Tumors | Completed | 2006-12-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00420004 | A Study for Participants With Major Depression | Phase2 | Major Depressive Disorder | Completed | 2006-12-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00415363 | Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Met… | Phase2 | Non Small Cell Lung Cancer | Completed | 2006-12-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00415194 | A Study for Patients With Head and Neck Cancer | Phase3 | Head and Neck Neoplasms | Completed | 2006-12-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00415168 | Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of … | Phase2 | Gastric Cancer | Completed | 2006-12-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00414973 | A Study for Patients With Osteoporosis | Phase3 | Osteoporosis | Completed | 2006-12-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00402324 | A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabil… | Phase4 | Bipolar I Disorder | Completed | 2006-12-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00408993 | Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral… | Phase3 | Diabetic Neuropathies | Completed | 2006-12-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00408876 | Duloxetine Versus Placebo in Chronic Low Back Pain | Phase3 | Back Pain Without Radiation | Completed | 2006-12-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00394095 | Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated Wi… | Phase4 | Bipolar Disorder | Completed | 2006-12-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00408876 | Duloxetine Versus Placebo in Chronic Low Back Pain | Phase3 | Back Pain Without Radiation | Completed | 2006-12-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00400166 | Recovery Guide Intervention for Recurrent Psychiatric Hospitalization | Na | Schizophrenia | Completed | 2006-12-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00841919 | Insulin Therapy in the Hospital Comparing Two Protocols | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2006-12-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00394095 | Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated Wi… | Phase4 | Bipolar Disorder | Completed | 2006-12-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00415363 | Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Met… | Phase2 | Non Small Cell Lung Cancer | Completed | 2006-12-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00415194 | A Study for Patients With Head and Neck Cancer | Phase3 | Head and Neck Neoplasms | Completed | 2006-12-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00841919 | Insulin Therapy in the Hospital Comparing Two Protocols | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2006-12-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00768391 | Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Th… | Phase1 | Solid Tumors | Completed | 2006-12-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00414973 | A Study for Patients With Osteoporosis | Phase3 | Osteoporosis | Completed | 2006-12-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00343291 | A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carbopl… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2006-12-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00400166 | Recovery Guide Intervention for Recurrent Psychiatric Hospitalization | Na | Schizophrenia | Completed | 2006-12-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00420004 | A Study for Participants With Major Depression | Phase2 | Major Depressive Disorder | Completed | 2006-12-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00316225 | Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around … | Phase2 | Non-small Cell Lung Cancer | Completed | 2006-12-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00408993 | Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral… | Phase3 | Diabetic Neuropathies | Completed | 2006-12-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00402883 | Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage … | Phase2 | Lung Cancer | Terminated | 2006-11-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00384774 | A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144… | Phase2 | Migraine | Completed | 2006-11-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00406354 | Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD … | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2006-11-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00618826 | A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metas… | Phase2 | Metastatic Breast Cancer | Completed | 2006-11-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT00406848 | A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Tre… | Phase4 | Major Depressive Disorder | Completed | 2006-11-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00383292 | A Study of Tasisulam in Treating Participants With Malignant Melanoma | Phase2 | Metastatic Melanoma | Completed | 2006-11-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT00408421 | Duloxetine Versus Placebo for Osteoarthritis Knee Pain | Phase3 | Osteoarthritis Knee Pain | Completed | 2006-11-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00414323 | Evaluation of the Effects of Duloxetine on Norepinephrine | Phase1 | Major Depressive Disorder | Completed | 2006-11-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00538564 | Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia | Phase2 | Sickle Cell Anemia | Withdrawn | 2006-11-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00402883 | Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage … | Phase2 | Lung Cancer | Terminated | 2006-11-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00618826 | A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metas… | Phase2 | Metastatic Breast Cancer | Completed | 2006-11-01 | 2014-02-01 | ClinicalTrials.gov |
| NCT00401258 | An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome | Phase4 | Irritable Bowel Syndrome | Completed | 2006-11-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00380718 | Chemotherapy for Patients With Non-Small Cell Lung Cancer | Phase4 | Non-small Cell Lung Cancer | Completed | 2006-11-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00406354 | Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD … | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2006-11-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00406848 | A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Tre… | Phase4 | Major Depressive Disorder | Completed | 2006-11-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00408421 | Duloxetine Versus Placebo for Osteoarthritis Knee Pain | Phase3 | Osteoarthritis Knee Pain | Completed | 2006-11-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00869986 | A Study for Patients With Relapsing Remitting Multiple Sclerosis | Phase2 | Relapsing Remitting Multiple Sclerosis | Completed | 2006-11-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00391118 | Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzasta… | Phase2 | Ovarian Cancer | Completed | 2006-11-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT00422734 | Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintai… | Phase3 | Impotence | Completed | 2006-11-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00384774 | A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144… | Phase2 | Migraine | Completed | 2006-11-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00414323 | Evaluation of the Effects of Duloxetine on Norepinephrine | Phase1 | Major Depressive Disorder | Completed | 2006-11-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00383292 | A Study of Tasisulam in Treating Participants With Malignant Melanoma | Phase2 | Metastatic Melanoma | Completed | 2006-11-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT00550927 | Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metas… | Phase1 | Unspecified Adult Solid Tumor, Protocol Specific | Completed | 2006-11-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT00386087 | Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline… | Phase2 | Breast Neoplasms | Completed | 2006-11-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00386425 | Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activa… | Phase2 | Severe Sepsis | Completed | 2006-11-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00422734 | Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintai… | Phase3 | Impotence | Completed | 2006-11-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00380718 | Chemotherapy for Patients With Non-Small Cell Lung Cancer | Phase4 | Non-small Cell Lung Cancer | Completed | 2006-11-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00538564 | Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia | Phase2 | Sickle Cell Anemia | Withdrawn | 2006-11-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00398632 | Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction | Phase4 | Depression | Terminated | 2006-11-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00550927 | Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metas… | Phase1 | Unspecified Adult Solid Tumor, Protocol Specific | Completed | 2006-11-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT00402051 | Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Smal… | Phase2 | Non-Small-Cell Lung Cancer | Completed | 2006-11-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00391118 | Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzasta… | Phase2 | Ovarian Cancer | Completed | 2006-11-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT00869986 | A Study for Patients With Relapsing Remitting Multiple Sclerosis | Phase2 | Relapsing Remitting Multiple Sclerosis | Completed | 2006-11-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00386425 | Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activa… | Phase2 | Severe Sepsis | Completed | 2006-11-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00386087 | Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline… | Phase2 | Breast Neoplasms | Completed | 2006-11-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00398632 | Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction | Phase4 | Depression | Terminated | 2006-11-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00401258 | An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome | Phase4 | Irritable Bowel Syndrome | Completed | 2006-11-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00401973 | Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain … | Phase3 | Schizophrenia | Completed | 2006-11-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00401973 | Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain … | Phase3 | Schizophrenia | Completed | 2006-11-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00402051 | Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Smal… | Phase2 | Non-Small-Cell Lung Cancer | Completed | 2006-11-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00386009 | Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of … | Phase2 | Benign Prostatic Hyperplasia | Completed | 2006-10-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00394147 | Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer | Phase2 | Head and Neck Cancer | Terminated | 2006-10-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00393705 | Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titrati… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2006-10-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00391274 | Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) | Phase3 | Non-Small Cell Lung Cancer | Completed | 2006-10-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00391209 | Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Me… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2006-10-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00386815 | Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Maligna… | Phase2 | Malignant Pleural Mesothelioma | Completed | 2006-10-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00385697 | The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent… | Phase2 | Type 1 Diabetes Mellitus | Completed | 2006-10-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00383422 | Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteop… | Phase3 | Osteoporosis, Postmenopausal | Completed | 2006-10-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00383266 | A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal C… | Phase2 | Esophageal Neoplasms | Terminated | 2006-10-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00380692 | Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Diso… | Phase4 | Autistic Disorder | Completed | 2006-10-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00394147 | Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer | Phase2 | Head and Neck Cancer | Terminated | 2006-10-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00393705 | Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titrati… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2006-10-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00391274 | Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) | Phase3 | Non-Small Cell Lung Cancer | Completed | 2006-10-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00391209 | Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Me… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2006-10-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00386815 | Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Maligna… | Phase2 | Malignant Pleural Mesothelioma | Completed | 2006-10-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00386009 | Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of … | Phase2 | Benign Prostatic Hyperplasia | Completed | 2006-10-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00385697 | The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent… | Phase2 | Type 1 Diabetes Mellitus | Completed | 2006-10-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00576394 | Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients | Phase1 | Glycemic Control | Completed | 2006-10-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT00383422 | Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteop… | Phase3 | Osteoporosis, Postmenopausal | Completed | 2006-10-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00607789 | Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depre… | Phase4 | Binge Eating | Completed | 2006-10-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00383266 | A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal C… | Phase2 | Esophageal Neoplasms | Terminated | 2006-10-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00380692 | Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Diso… | Phase4 | Autistic Disorder | Completed | 2006-10-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00576394 | Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients | Phase1 | Glycemic Control | Completed | 2006-10-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT00607789 | Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depre… | Phase4 | Binge Eating | Completed | 2006-10-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00375492 | Effect on Weight Loss of Exenatide Versus Placebo | Phase3 | Type 2 Diabetes Mellitus | Completed | 2006-09-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00363766 | Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer | Phase2 | Non-Small-Cell Lung Cancer | Completed | 2006-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00402116 | Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM)… | Phase1 | Glioblastoma | Completed | 2006-09-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00402116 | Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM)… | Phase1 | Glioblastoma | Completed | 2006-09-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00290121 | Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics | Phase4 | Schizophrenia | Completed | 2006-09-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00356525 | Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After… | Phase2 | Lung Neoplasms | Terminated | 2006-09-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00661869 | Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Pati… | Na | Schizophrenia | Completed | 2006-09-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00359762 | Exenatide Versus Glimepiride in Patients With Type 2 Diabetes | Phase3 | Type 2 Diabetes Mellitus | Completed | 2006-09-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00418093 | Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carc… | Phase2 | Ovarian Cancer | Terminated | 2006-09-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT00359879 | Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and… | Phase3 | Type 2 Diabetes | Completed | 2006-09-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00420030 | Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiog… | Phase4 | Shock, Cardiogenic | Completed | 2006-09-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00382239 | A Study to Assess the Effect on Glucose Control and Safety and Tolerability of … | Phase2 | Type 2 Diabetes Mellitus | Completed | 2006-09-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00385671 | An Open-Label Comparison of Duloxetine to Other Alternatives for the Management… | Phase4 | Diabetic Neuropathy, Painful | Completed | 2006-09-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00382239 | A Study to Assess the Effect on Glucose Control and Safety and Tolerability of … | Phase2 | Type 2 Diabetes Mellitus | Completed | 2006-09-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00381342 | Safety and Efficacy of Exenatide as Monotherapy | Phase3 | Type 2 Diabetes Mellitus | Completed | 2006-09-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00420030 | Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiog… | Phase4 | Shock, Cardiogenic | Completed | 2006-09-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00363766 | Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer | Phase2 | Non-Small-Cell Lung Cancer | Completed | 2006-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00661869 | Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Pati… | Na | Schizophrenia | Completed | 2006-09-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00381342 | Safety and Efficacy of Exenatide as Monotherapy | Phase3 | Type 2 Diabetes Mellitus | Completed | 2006-09-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00370292 | Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Me… | Phase2 | Non Small Cell Lung Cancer | Completed | 2006-09-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00356525 | Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After… | Phase2 | Lung Neoplasms | Terminated | 2006-09-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00380588 | Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Pat… | Phase2 | Biliary Tract Cancer | Completed | 2006-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00418093 | Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carc… | Phase2 | Ovarian Cancer | Terminated | 2006-09-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT00380588 | Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Pat… | Phase2 | Biliary Tract Cancer | Completed | 2006-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00290121 | Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics | Phase4 | Schizophrenia | Completed | 2006-09-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00377520 | A Trial for Patients With Advanced/Recurrent Endometrial Cancer | Phase2 | Neoplasms | Completed | 2006-09-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00375973 | Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome | Phase2 | Fatigue Syndrome, Chronic | Completed | 2006-09-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT00375492 | Effect on Weight Loss of Exenatide Versus Placebo | Phase3 | Type 2 Diabetes Mellitus | Completed | 2006-09-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00377520 | A Trial for Patients With Advanced/Recurrent Endometrial Cancer | Phase2 | Neoplasms | Completed | 2006-09-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00371956 | Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chr… | Phase4 | Osteoporosis | Completed | 2006-09-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00359762 | Exenatide Versus Glimepiride in Patients With Type 2 Diabetes | Phase3 | Type 2 Diabetes Mellitus | Completed | 2006-09-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00374855 | A Study in People With Mild Hypertension | Phase2 | Mild Hypertension | Completed | 2006-09-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00374855 | A Study in People With Mild Hypertension | Phase2 | Mild Hypertension | Completed | 2006-09-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00359879 | Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and… | Phase3 | Type 2 Diabetes | Completed | 2006-09-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00371956 | Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chr… | Phase4 | Osteoporosis | Completed | 2006-09-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00370292 | Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Me… | Phase2 | Non Small Cell Lung Cancer | Completed | 2006-09-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00375973 | Double Blind Trial of Duloxetine in Chronic Fatigue Syndrome | Phase2 | Fatigue Syndrome, Chronic | Completed | 2006-09-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT00385671 | An Open-Label Comparison of Duloxetine to Other Alternatives for the Management… | Phase4 | Diabetic Neuropathy, Painful | Completed | 2006-09-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00369629 | Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis … | Phase1 | Lymphoma | Terminated | 2006-08-28 | 2013-06-04 | ClinicalTrials.gov |
| NCT00369629 | Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis … | Phase1 | Lymphoma | Terminated | 2006-08-28 | 2013-06-04 | ClinicalTrials.gov |
| NCT00363415 | Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Trea… | Phase3 | Small Cell Lung Cancer | Completed | 2006-08-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00360724 | Duloxetine for Chronic Depression: a Double-blind Study | Phase4 | Dysthymic Disorder | Completed | 2006-08-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00438971 | The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder | Phase4 | Panic Disorder | Completed | 2006-08-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00374868 | Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metast… | Phase1 | Urologic Neoplasms | Completed | 2006-08-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00355849 | Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2006-08-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00356109 | Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2006-08-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00355849 | Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2006-08-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00353834 | The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type… | Phase4 | Type 2 Diabetes Mellitus | Completed | 2006-08-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00350792 | Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients | Phase2 | Non Small Cell Lung Cancer | Completed | 2006-08-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00363415 | Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Trea… | Phase3 | Small Cell Lung Cancer | Completed | 2006-08-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00384930 | Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Be… | Phase2 | Benign Prostatic Hyperplasia | Completed | 2006-08-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00360724 | Duloxetine for Chronic Depression: a Double-blind Study | Phase4 | Dysthymic Disorder | Completed | 2006-08-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00357968 | Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous … | Phase2 | Coronary Artery Disease | Completed | 2006-08-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00438971 | The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder | Phase4 | Panic Disorder | Completed | 2006-08-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00350792 | Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients | Phase2 | Non Small Cell Lung Cancer | Completed | 2006-08-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00356109 | Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2006-08-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00384930 | Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Be… | Phase2 | Benign Prostatic Hyperplasia | Completed | 2006-08-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00353834 | The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type… | Phase4 | Type 2 Diabetes Mellitus | Completed | 2006-08-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00374868 | Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metast… | Phase1 | Urologic Neoplasms | Completed | 2006-08-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00377858 | Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabete… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2006-08-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00357968 | Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous … | Phase2 | Coronary Artery Disease | Completed | 2006-08-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00377858 | Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabete… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2006-08-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00782002 | Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Lon… | Phase1 | Advanced Solid Tumors | Completed | 2006-07-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00351039 | Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients W… | Phase1 | Non-Small Cell Lung Cancer | Terminated | 2006-07-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00885807 | A Prospective Chart Review to Validate the WFIRS (Weiss Functional Impairment R… | — | Attention-Deficit/Hyperactivity Disorder | Completed | 2006-07-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00765115 | A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Pe… | Phase1 | Alzheimer Disease | Completed | 2006-07-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00636896 | Effects of Modafinil on Olanzapine Weight Gain | Na | Weight Gain | Completed | 2006-07-01 | 2007-08-01 | ClinicalTrials.gov |
| NCT00351039 | Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients W… | Phase1 | Non-Small Cell Lung Cancer | Terminated | 2006-07-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00885807 | A Prospective Chart Review to Validate the WFIRS (Weiss Functional Impairment R… | — | Attention-Deficit/Hyperactivity Disorder | Completed | 2006-07-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00190918 | A Trial for Patients With Gestational Trophoblastic Disease | Phase2 | Trophoblastic Neoplasms | Completed | 2006-07-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00765115 | A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Pe… | Phase1 | Alzheimer Disease | Completed | 2006-07-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00782002 | Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Lon… | Phase1 | Advanced Solid Tumors | Completed | 2006-07-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00356135 | Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clop… | Phase2 | Coronary Arteriosclerosis | Completed | 2006-07-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00636896 | Effects of Modafinil on Olanzapine Weight Gain | Na | Weight Gain | Completed | 2006-07-01 | 2007-08-01 | ClinicalTrials.gov |
| NCT00356135 | Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clop… | Phase2 | Coronary Arteriosclerosis | Completed | 2006-07-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00190918 | A Trial for Patients With Gestational Trophoblastic Disease | Phase2 | Trophoblastic Neoplasms | Completed | 2006-07-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00330473 | A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabet… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2006-06-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00824603 | Impact of Continuing Medical Education (CME) Insulin Program | — | Diabetes | Completed | 2006-06-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00360334 | A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With… | Phase3 | Type 2 Diabetes | Completed | 2006-06-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00355030 | Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopath… | Phase3 | Idiopathic Short Stature (ISS) | Completed | 2006-06-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT00343252 | Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spi… | Phase3 | Osteoporosis, Postmenopausal | Completed | 2006-06-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00337259 | Gemcitabine for Marginal Zone Lymphoma | Phase2 | Non-Hodgkin's Lymphoma | Terminated | 2006-06-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00334802 | Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Ca… | Phase2 | Metastatic Breast Cancer | Completed | 2006-06-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00332202 | PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily … | Phase3 | Non Hodgkin Lymphoma | Completed | 2006-06-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT00330915 | A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatmen… | Phase2 | Rectal Neoplasms | Completed | 2006-06-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00330473 | A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabet… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2006-06-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00325234 | Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer | Phase2 | Breast Cancer | Completed | 2006-06-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00323869 | Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small … | Phase2 | Lung Cancer | Completed | 2006-06-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT00299234 | Atomoxetine for Children With Acquired Attentional Disorders Following Completi… | Phase4 | Attention Deficit Hyperactivity Disorder | Terminated | 2006-06-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00824603 | Impact of Continuing Medical Education (CME) Insulin Program | — | Diabetes | Completed | 2006-06-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00360334 | A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With… | Phase3 | Type 2 Diabetes | Completed | 2006-06-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00355030 | Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopath… | Phase3 | Idiopathic Short Stature (ISS) | Completed | 2006-06-01 | 2015-07-01 | ClinicalTrials.gov |
| NCT00343252 | Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spi… | Phase3 | Osteoporosis, Postmenopausal | Completed | 2006-06-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00337259 | Gemcitabine for Marginal Zone Lymphoma | Phase2 | Non-Hodgkin's Lymphoma | Terminated | 2006-06-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00334802 | Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Ca… | Phase2 | Metastatic Breast Cancer | Completed | 2006-06-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00332202 | PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily … | Phase3 | Non Hodgkin Lymphoma | Completed | 2006-06-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT00330915 | A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatmen… | Phase2 | Rectal Neoplasms | Completed | 2006-06-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00325234 | Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer | Phase2 | Breast Cancer | Completed | 2006-06-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00323869 | Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small … | Phase2 | Lung Cancer | Completed | 2006-06-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT00299234 | Atomoxetine for Children With Acquired Attentional Disorders Following Completi… | Phase4 | Attention Deficit Hyperactivity Disorder | Terminated | 2006-06-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00326911 | Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancr… | Phase2 | Metastatic Pancreatic Cancer | Terminated | 2006-05-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00329082 | Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and … | Phase2 | Alzheimer's Disease | Completed | 2006-05-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00337662 | Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia | Phase4 | Schizophrenia | Completed | 2006-05-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00329082 | Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and … | Phase2 | Alzheimer's Disease | Completed | 2006-05-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00377117 | Diabetes Screening, Risk Management and Disease Management in a High-Risk Menta… | — | Diabetes Mellitus | Completed | 2006-05-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00377117 | Diabetes Screening, Risk Management and Disease Management in a High-Risk Menta… | — | Diabetes Mellitus | Completed | 2006-05-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00324051 | Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine … | Phase4 | Schizophrenia | Completed | 2006-05-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00320541 | A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizu… | Phase2 | Breast Cancer | Completed | 2006-05-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT00324051 | Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine … | Phase4 | Schizophrenia | Completed | 2006-05-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00320541 | A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizu… | Phase2 | Breast Cancer | Completed | 2006-05-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT00337662 | Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia | Phase4 | Schizophrenia | Completed | 2006-05-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00326911 | Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancr… | Phase2 | Metastatic Pancreatic Cancer | Terminated | 2006-05-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00290706 | A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refra… | Phase1 | Lymphoma | Terminated | 2006-04-07 | 2012-09-05 | ClinicalTrials.gov |
| NCT00290706 | A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refra… | Phase1 | Lymphoma | Terminated | 2006-04-07 | 2012-09-05 | ClinicalTrials.gov |
| NCT00950365 | Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patient… | Phase2 | Bronchioloalveolar Carcinoma | Completed | 2006-04-01 | 2017-11-17 | ClinicalTrials.gov |
| NCT00785941 | A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond … | Phase1 | Advanced Solid Tumors | Completed | 2006-04-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00316199 | Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer | Phase2 | Metastatic Breast Cancer | Completed | 2006-04-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00325364 | Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2006-04-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00325364 | Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2006-04-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00330044 | Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer | Phase1 | Inoperable Non Small Cell Lung Cancer | Completed | 2006-04-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00531895 | An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache | Phase4 | Major Depression | Completed | 2006-04-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00322621 | Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neurop… | Phase4 | Diabetic Neuropathies | Completed | 2006-04-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00320528 | Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents Wi… | Phase3 | Attention Deficit Disorder With Hyperactivity | Completed | 2006-04-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00785941 | A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond … | Phase1 | Advanced Solid Tumors | Completed | 2006-04-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00320528 | Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents Wi… | Phase3 | Attention Deficit Disorder With Hyperactivity | Completed | 2006-04-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00354406 | Efficacy Study on Early Versus Late Abciximab Administration During Primary Cor… | Phase4 | Myocardial Infarction | Completed | 2006-04-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00531895 | An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache | Phase4 | Major Depression | Completed | 2006-04-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00322621 | Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neurop… | Phase4 | Diabetic Neuropathies | Completed | 2006-04-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00320489 | Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpat… | Phase3 | Schizophrenia | Completed | 2006-04-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00316238 | A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With S… | Phase2 | Schizophrenia | Completed | 2006-04-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00316199 | Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer | Phase2 | Metastatic Breast Cancer | Completed | 2006-04-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00354406 | Efficacy Study on Early Versus Late Abciximab Administration During Primary Cor… | Phase4 | Myocardial Infarction | Completed | 2006-04-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00316238 | A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With S… | Phase2 | Schizophrenia | Completed | 2006-04-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT01035073 | Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depress… | Phase4 | Major Depressive Disorder | Completed | 2006-04-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT01035073 | Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depress… | Phase4 | Major Depressive Disorder | Completed | 2006-04-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00330044 | Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer | Phase1 | Inoperable Non Small Cell Lung Cancer | Completed | 2006-04-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00950365 | Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patient… | Phase2 | Bronchioloalveolar Carcinoma | Completed | 2006-04-01 | 2017-11-17 | ClinicalTrials.gov |
| NCT00320489 | Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpat… | Phase3 | Schizophrenia | Completed | 2006-04-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00308282 | A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Participa… | Phase2 | Arthritis, Rheumatoid | Completed | 2006-03-28 | 2007-10-18 | ClinicalTrials.gov |
| NCT00308282 | A Multi-Site Study to Evaluate the Safety and Effect of Study Drug on Participa… | Phase2 | Arthritis, Rheumatoid | Completed | 2006-03-28 | 2007-10-18 | ClinicalTrials.gov |
| NCT00291707 | Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer | Phase1 | Head and Neck Cancer | Completed | 2006-03-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00227019 | Phase 2 Trial of Bevacizumab in Combination With Pemetrexed | Phase2 | Non-small Cell Lung Cancer (NSCLC) | Completed | 2006-03-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT00315861 | Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies | Phase1 | Ovarian Cancer | Completed | 2006-03-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00311532 | Observational Study of Pergolide Mesylate and Cardiac Valvulopathy | — | Parkinson Disease | Completed | 2006-03-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00310427 | Effect of LY686017 on Alcohol Craving | Phase2 | Alcohol Dependence | Completed | 2006-03-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00309140 | An Open Label Study of Oral Enzastaurin in Participants With Cancer | Phase2 | Neoplasms | Completed | 2006-03-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00308750 | First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) | Phase2 | Non-Small Cell Lung Cancer | Completed | 2006-03-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00303602 | Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine… | Phase4 | Schizophrenia | Completed | 2006-03-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00291707 | Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer | Phase1 | Head and Neck Cancer | Completed | 2006-03-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00308750 | First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) | Phase2 | Non-Small Cell Lung Cancer | Completed | 2006-03-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00309140 | An Open Label Study of Oral Enzastaurin in Participants With Cancer | Phase2 | Neoplasms | Completed | 2006-03-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00310427 | Effect of LY686017 on Alcohol Craving | Phase2 | Alcohol Dependence | Completed | 2006-03-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00311532 | Observational Study of Pergolide Mesylate and Cardiac Valvulopathy | — | Parkinson Disease | Completed | 2006-03-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00315861 | Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies | Phase1 | Ovarian Cancer | Completed | 2006-03-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00227019 | Phase 2 Trial of Bevacizumab in Combination With Pemetrexed | Phase2 | Non-small Cell Lung Cancer (NSCLC) | Completed | 2006-03-01 | 2016-12-01 | ClinicalTrials.gov |
| NCT00303602 | Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine… | Phase4 | Schizophrenia | Completed | 2006-03-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT01215071 | Eingeschränkte vs Ausgedehnte Lymphadenektomie LEA | Na | Bladder Cancer | Completed | 2006-02-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT00254254 | A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of… | Phase2 | Type 2 Diabetes Mellitus | Completed | 2006-02-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00497315 | Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresecta… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2006-02-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00497315 | Evaluation of Pemetrexed Combined With Cisplatin and Radiotherapy for Unresecta… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2006-02-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00403130 | Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for … | Phase2 | Breast Cancer | Completed | 2006-02-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT00254254 | A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of… | Phase2 | Type 2 Diabetes Mellitus | Completed | 2006-02-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00786383 | Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Sta… | Phase1 | Cancer | Completed | 2006-02-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00786383 | Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Sta… | Phase1 | Cancer | Completed | 2006-02-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT01215071 | Eingeschränkte vs Ausgedehnte Lymphadenektomie LEA | Na | Bladder Cancer | Completed | 2006-02-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT00403130 | Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for … | Phase2 | Breast Cancer | Completed | 2006-02-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT00292955 | Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical … | Phase2 | Cancer of the Cervix | Unknown | 2006-02-01 | — | ClinicalTrials.gov |
| NCT00292955 | Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical … | Phase2 | Cancer of the Cervix | Unknown | 2006-02-01 | — | ClinicalTrials.gov |
| NCT01668251 | Turner Syndrome Prenatal Diagnosis Study | — | Turner Syndrome | Unknown | 2006-01-01 | 2017-01-01 | ClinicalTrials.gov |
| NCT01852383 | Duloxetine Treatment in Elderly With Dysthymia | Phase4 | Depression | Completed | 2006-01-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT00295815 | Enzastaurin Versus Lomustine in Glioblastoma | Phase3 | Glioblastoma | Completed | 2006-01-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT01668251 | Turner Syndrome Prenatal Diagnosis Study | — | Turner Syndrome | Unknown | 2006-01-01 | 2017-01-01 | ClinicalTrials.gov |
| NCT00434928 | Dietary Intake and Nutrient Status of Children With ADHD | — | Attention Deficit Hyperactivity Disorder | Completed | 2006-01-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00280150 | Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stag… | Phase1 | Lung Cancer | Completed | 2006-01-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT00280150 | Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stag… | Phase1 | Lung Cancer | Completed | 2006-01-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT00434928 | Dietary Intake and Nutrient Status of Children With ADHD | — | Attention Deficit Hyperactivity Disorder | Completed | 2006-01-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00295815 | Enzastaurin Versus Lomustine in Glioblastoma | Phase3 | Glioblastoma | Completed | 2006-01-01 | 2014-05-01 | ClinicalTrials.gov |
| NCT00324363 | Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metform… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2006-01-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00324363 | Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metform… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2006-01-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00327002 | A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Chol… | Phase2 | Metabolic Syndrome X | Completed | 2006-01-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00327002 | A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Chol… | Phase2 | Metabolic Syndrome X | Completed | 2006-01-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT01852383 | Duloxetine Treatment in Elderly With Dysthymia | Phase4 | Depression | Completed | 2006-01-01 | 2013-03-01 | ClinicalTrials.gov |
| NCT01682187 | A Dose-Escalation Study in Participants With Recurrent Malignant Glioma | Phase1 | Glioma | Completed | 2005-12-15 | 2024-09-30 | ClinicalTrials.gov |
| NCT01682187 | A Dose-Escalation Study in Participants With Recurrent Malignant Glioma | Phase1 | Glioma | Completed | 2005-12-15 | 2024-09-30 | ClinicalTrials.gov |
| NCT00549302 | Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the B… | Phase3 | Hypertension, Pulmonary | Completed | 2005-12-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT00529100 | Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage I… | Phase1 | Non-Small Cell Lung Cancer | Completed | 2005-12-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT00491075 | Pemetrexed Plus Gemcitabine in Renal Cell Cancer | Phase2 | Renal Cell Carcinoma | Terminated | 2005-12-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT00464698 | Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD) | Phase4 | Obsessive Compulsive Disorder | Completed | 2005-12-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00464698 | Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD) | Phase4 | Obsessive Compulsive Disorder | Completed | 2005-12-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00279201 | The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Pat… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2005-12-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00275301 | PET Imaging and Olanzapine Treatment in Borderline Personality Disorder | Na | Borderline Personality Disorder | Completed | 2005-12-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00269152 | Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2005-12-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT00267020 | Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With … | Phase2 | Pancreatic Neoplasm | Completed | 2005-12-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00266656 | Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turn… | Phase4 | Turner Syndrome | Completed | 2005-12-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT00266643 | Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pa… | Phase4 | Diabetic Neuropathy, Painful | Completed | 2005-12-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00583193 | Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Diso… | Phase3 | Posttraumatic Stress Disorders | Unknown | 2005-12-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00491075 | Pemetrexed Plus Gemcitabine in Renal Cell Cancer | Phase2 | Renal Cell Carcinoma | Terminated | 2005-12-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT00176241 | Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Met… | Phase1 | Head and Neck Cancer | Terminated | 2005-12-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00529100 | Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage I… | Phase1 | Non-Small Cell Lung Cancer | Completed | 2005-12-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT00549302 | Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the B… | Phase3 | Hypertension, Pulmonary | Completed | 2005-12-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT00583193 | Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Diso… | Phase3 | Posttraumatic Stress Disorders | Unknown | 2005-12-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00176241 | Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Met… | Phase1 | Head and Neck Cancer | Terminated | 2005-12-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00351936 | A Placebo-Controlled, Cross-Over Trial of Aripiprazole | Phase4 | Schizophrenia | Completed | 2005-12-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00279201 | The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Pat… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2005-12-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00275301 | PET Imaging and Olanzapine Treatment in Borderline Personality Disorder | Na | Borderline Personality Disorder | Completed | 2005-12-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00269152 | Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2005-12-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT00267020 | Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With … | Phase2 | Pancreatic Neoplasm | Completed | 2005-12-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00266656 | Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turn… | Phase4 | Turner Syndrome | Completed | 2005-12-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT00266643 | Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pa… | Phase4 | Diabetic Neuropathy, Painful | Completed | 2005-12-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00351936 | A Placebo-Controlled, Cross-Over Trial of Aripiprazole | Phase4 | Schizophrenia | Completed | 2005-12-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00251524 | A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Adva… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2005-11-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00255138 | Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects | Phase3 | Cancer | Withdrawn | 2005-11-01 | — | ClinicalTrials.gov |
| NCT00254800 | The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Fema… | Phase1 | Type 2 Diabetes Mellitus | Completed | 2005-11-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00234494 | Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transition… | Phase2 | Bladder Cancer | Completed | 2005-11-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00380744 | A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis | Phase1 | Arthritis, Rheumatoid | Completed | 2005-11-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00259272 | Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in… | Phase3 | Bipolar Disorder I or II | Completed | 2005-11-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00259285 | Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer | Phase2 | Non-Small-Cell Lung Cancer | Terminated | 2005-11-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00259298 | Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal … | Phase4 | Osteoporosis | Completed | 2005-11-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00259311 | Efficacy Study of LY2422347 to Treat Insomnia | Phase2 | Sleep Initiation and Maintenance Disorders | Completed | 2005-11-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00368849 | Atomoxetine and Huntington's Disease | Phase2 | Huntington Disease | Completed | 2005-11-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00380744 | A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis | Phase1 | Arthritis, Rheumatoid | Completed | 2005-11-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00260533 | Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Gen… | Phase2 | Generalized Social Phobia | Completed | 2005-11-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00266630 | Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed … | Phase3 | Manic or Mixed Episode Associated With Bipolar I Disorder | Completed | 2005-11-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00267696 | Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube o… | Phase2 | Ovarian Cancer | Completed | 2005-11-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00279214 | Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients … | Phase4 | Sepsis | Completed | 2005-11-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00254800 | The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Fema… | Phase1 | Type 2 Diabetes Mellitus | Completed | 2005-11-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00222729 | Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer | Phase2 | Cancer | Completed | 2005-11-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT00234494 | Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transition… | Phase2 | Bladder Cancer | Completed | 2005-11-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00368849 | Atomoxetine and Huntington's Disease | Phase2 | Huntington Disease | Completed | 2005-11-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00252278 | Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents | Phase4 | Attention-Deficit/Hyperactivity Disorder (ADHD) | Unknown | 2005-11-01 | — | ClinicalTrials.gov |
| NCT00279214 | Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients … | Phase4 | Sepsis | Completed | 2005-11-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00252278 | Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents | Phase4 | Attention-Deficit/Hyperactivity Disorder (ADHD) | Unknown | 2005-11-01 | — | ClinicalTrials.gov |
| NCT00251524 | A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Adva… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2005-11-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00267696 | Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube o… | Phase2 | Ovarian Cancer | Completed | 2005-11-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00266630 | Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed … | Phase3 | Manic or Mixed Episode Associated With Bipolar I Disorder | Completed | 2005-11-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00260533 | Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Gen… | Phase2 | Generalized Social Phobia | Completed | 2005-11-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00259311 | Efficacy Study of LY2422347 to Treat Insomnia | Phase2 | Sleep Initiation and Maintenance Disorders | Completed | 2005-11-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00259298 | Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal … | Phase4 | Osteoporosis | Completed | 2005-11-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00259285 | Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer | Phase2 | Non-Small-Cell Lung Cancer | Terminated | 2005-11-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00259272 | Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in… | Phase3 | Bipolar Disorder I or II | Completed | 2005-11-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00255138 | Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects | Phase3 | Cancer | Withdrawn | 2005-11-01 | — | ClinicalTrials.gov |
| NCT00222729 | Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer | Phase2 | Cancer | Completed | 2005-11-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT00211562 | Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty … | Phase3 | Schizophrenia | Terminated | 2005-10-01 | — | ClinicalTrials.gov |
| NCT00362102 | A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable … | Phase2 | Colorectal Carcinoma | Completed | 2005-10-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00785538 | A Study of IMC-A12 in Participants With Tumors Who No Longer Respond to Treatme… | Phase1 | Advanced Solid Tumors | Completed | 2005-10-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00251550 | Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesotheli… | Phase1 | Malignant Pleural Mesotherioma | Completed | 2005-10-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00135330 | An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes M… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2005-10-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00241423 | Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in P… | Phase2 | Type 2 Diabetes Mellitus | Completed | 2005-10-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00785538 | A Study of IMC-A12 in Participants With Tumors Who No Longer Respond to Treatme… | Phase1 | Advanced Solid Tumors | Completed | 2005-10-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00251550 | Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesotheli… | Phase1 | Malignant Pleural Mesotherioma | Completed | 2005-10-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00244296 | To Determine How Effective Duloxetine is in Treating Women 65 Years and Older W… | Phase4 | Urinary Incontinence, Stress | Completed | 2005-10-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00362102 | A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable … | Phase2 | Colorectal Carcinoma | Completed | 2005-10-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00244322 | Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Dis… | Phase2 | Alzheimer's Disease | Completed | 2005-10-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00244296 | To Determine How Effective Duloxetine is in Treating Women 65 Years and Older W… | Phase4 | Urinary Incontinence, Stress | Completed | 2005-10-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00241423 | Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in P… | Phase2 | Type 2 Diabetes Mellitus | Completed | 2005-10-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00244322 | Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Dis… | Phase2 | Alzheimer's Disease | Completed | 2005-10-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00135330 | An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes M… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2005-10-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00211562 | Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty … | Phase3 | Schizophrenia | Terminated | 2005-10-01 | — | ClinicalTrials.gov |
| NCT00117962 | Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuxim… | Phase2 | Lung Cancer | Completed | 2005-09-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT00207116 | An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Me… | Phase1 | Carcinoma, Non-Small-Cell Lung | Completed | 2005-09-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00236899 | Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combinati… | Phase3 | Metastatic Breast Cancer (MBC) | Completed | 2005-09-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT00239629 | Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial | Phase4 | Postmenopausal Osteoporosis | Completed | 2005-09-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00239629 | Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial | Phase4 | Postmenopausal Osteoporosis | Completed | 2005-09-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00507858 | Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer | Phase1 | Head and Neck Cancer | Completed | 2005-09-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT02181101 | Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as … | Phase3 | Breast Neoplasms | Completed | 2005-09-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT00193206 | Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Infl… | Phase2 | Breast Cancer | Completed | 2005-09-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00157326 | Tadalafil in Subjects With Mild to Moderate Hypertension | Phase2 | Hypertension | Completed | 2005-09-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00507858 | Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer | Phase1 | Head and Neck Cancer | Completed | 2005-09-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT00157326 | Tadalafil in Subjects With Mild to Moderate Hypertension | Phase2 | Hypertension | Completed | 2005-09-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00149721 | Anterior Pituitary Function in Patients With Hydrocephalus | Na | Normal Pressure Hydrocephalus | Terminated | 2005-09-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00149721 | Anterior Pituitary Function in Patients With Hydrocephalus | Na | Normal Pressure Hydrocephalus | Terminated | 2005-09-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00149214 | Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment… | Phase2 | Breast Cancer | Completed | 2005-09-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00149214 | Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment… | Phase2 | Breast Cancer | Completed | 2005-09-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT00149110 | Chronos: the Use of Chronobiological Treatment in Depression | Na | Major Depression | Completed | 2005-09-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00149110 | Chronos: the Use of Chronobiological Treatment in Depression | Na | Major Depression | Completed | 2005-09-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00508144 | Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer | Phase2 | Lung Cancer | Completed | 2005-09-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT00117962 | Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuxim… | Phase2 | Lung Cancer | Completed | 2005-09-01 | 2012-09-01 | ClinicalTrials.gov |
| NCT00236899 | Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combinati… | Phase3 | Metastatic Breast Cancer (MBC) | Completed | 2005-09-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT02181101 | Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as … | Phase3 | Breast Neoplasms | Completed | 2005-09-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT00216918 | Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2005-09-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00391235 | White Matter in Pediatric Bipolar Disorder: A DTI Study | — | Bipolar Disorder | Completed | 2005-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00231725 | Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twi… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2005-09-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00207116 | An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Me… | Phase1 | Carcinoma, Non-Small-Cell Lung | Completed | 2005-09-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00193206 | Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Infl… | Phase2 | Breast Cancer | Completed | 2005-09-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00233025 | Duloxetine Versus Placebo in the Treatment of FMS | Phase3 | Fibromyalgia | Completed | 2005-09-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00216918 | Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2005-09-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00391235 | White Matter in Pediatric Bipolar Disorder: A DTI Study | — | Bipolar Disorder | Completed | 2005-09-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00508144 | Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer | Phase2 | Lung Cancer | Completed | 2005-09-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT00231725 | Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twi… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2005-09-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00233025 | Duloxetine Versus Placebo in the Treatment of FMS | Phase3 | Fibromyalgia | Completed | 2005-09-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00110357 | Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors | Phase1 | Cancer | Completed | 2005-08-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00110357 | Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors | Phase1 | Cancer | Completed | 2005-08-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00125918 | PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension | Phase3 | Pulmonary Hypertension | Completed | 2005-08-01 | 2007-08-01 | ClinicalTrials.gov |
| NCT00129974 | Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extens… | Phase2 | Carcinoma, Small Cell | Terminated | 2005-08-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT00157339 | Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or … | Phase3 | Diabetes Mellitus | Completed | 2005-08-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00157339 | Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or … | Phase3 | Diabetes Mellitus | Completed | 2005-08-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00129974 | Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extens… | Phase2 | Carcinoma, Small Cell | Terminated | 2005-08-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT00125918 | PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension | Phase3 | Pulmonary Hypertension | Completed | 2005-08-01 | 2007-08-01 | ClinicalTrials.gov |
| NCT00192114 | Enzastaurin for Patients With Metastatic Colorectal Cancer | Phase2 | Colonic Neoplasms | Completed | 2005-08-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00200902 | Evaluation of Depression Symptoms and Brain Activity Associated With Response t… | Phase4 | Depression | Completed | 2005-08-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00207077 | Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumors | Phase1 | Neoplasms | Completed | 2005-08-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00192114 | Enzastaurin for Patients With Metastatic Colorectal Cancer | Phase2 | Colonic Neoplasms | Completed | 2005-08-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT01080313 | Head and Neck Cancer Registry (LORHAN) | — | Head and Neck Cancer | Completed | 2005-08-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00200902 | Evaluation of Depression Symptoms and Brain Activity Associated With Response t… | Phase4 | Depression | Completed | 2005-08-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00207077 | Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumors | Phase1 | Neoplasms | Completed | 2005-08-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT01080313 | Head and Neck Cancer Registry (LORHAN) | — | Head and Neck Cancer | Completed | 2005-08-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00414115 | National Active Surveillance Network and Pharmacogenomics of Adverse Drug React… | — | Adverse Drug Reaction (ADR) | Recruiting | 2005-08-01 | 2029-03-01 | ClinicalTrials.gov |
| NCT00417794 | Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome… | Phase1 | Fetal Alcohol Syndrome | Completed | 2005-08-01 | 2015-04-22 | ClinicalTrials.gov |
| NCT00417794 | Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome… | Phase1 | Fetal Alcohol Syndrome | Completed | 2005-08-01 | 2015-04-22 | ClinicalTrials.gov |
| NCT00414115 | National Active Surveillance Network and Pharmacogenomics of Adverse Drug React… | — | Adverse Drug Reaction (ADR) | Recruiting | 2005-08-01 | 2029-03-01 | ClinicalTrials.gov |
| NCT00125892 | A Study of Duloxetine in the Treatment of Fibromyalgia | Phase3 | Fibromyalgia | Completed | 2005-07-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00127634 | Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2005-07-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00129220 | Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disord… | Phase3 | Bipolar Disorder | Completed | 2005-07-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00857246 | Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adj… | Phase2 | Gastric Cancer | Completed | 2005-07-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT00127634 | Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2005-07-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00133380 | A Study in People With High Cholesterol | Phase2 | Hypercholesterolemia | Completed | 2005-07-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00953862 | Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disord… | Na | Attention Deficit Hyperactivity Disorder | Completed | 2005-07-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00125892 | A Study of Duloxetine in the Treatment of Fibromyalgia | Phase3 | Fibromyalgia | Completed | 2005-07-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00186017 | Short Term Rescue Study of Olanzapine | Phase4 | Bipolar Disorder | Completed | 2005-07-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00116519 | A Study in People With Abnormal Fat Levels in the Blood | Phase2 | Dyslipidemia | Completed | 2005-07-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT00857246 | Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adj… | Phase2 | Gastric Cancer | Completed | 2005-07-01 | 2015-10-01 | ClinicalTrials.gov |
| NCT00489359 | Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Prima… | Phase1 | Ovarian Cancer | Completed | 2005-07-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00953862 | Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disord… | Na | Attention Deficit Hyperactivity Disorder | Completed | 2005-07-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00489359 | Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Prima… | Phase1 | Ovarian Cancer | Completed | 2005-07-01 | 2010-02-01 | ClinicalTrials.gov |
| NCT00186017 | Short Term Rescue Study of Olanzapine | Phase4 | Bipolar Disorder | Completed | 2005-07-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00116519 | A Study in People With Abnormal Fat Levels in the Blood | Phase2 | Dyslipidemia | Completed | 2005-07-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT00129220 | Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disord… | Phase3 | Bipolar Disorder | Completed | 2005-07-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00133380 | A Study in People With High Cholesterol | Phase2 | Hypercholesterolemia | Completed | 2005-07-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00113594 | Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder | Phase3 | Schizophrenia | Completed | 2005-06-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00131469 | Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta | Phase4 | Osteogenesis Imperfecta | Completed | 2005-06-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00191269 | Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Ta… | Phase2 | Metastatic Breast Cancer | Completed | 2005-06-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00131469 | Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta | Phase4 | Osteogenesis Imperfecta | Completed | 2005-06-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00148109 | Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tis… | Phase2 | Sarcoma | Completed | 2005-06-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00190879 | Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adult… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2005-06-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00190866 | Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome | Phase3 | Fibromyalgia | Completed | 2005-06-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00190671 | A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Brea… | Phase1 | Breast Cancer | Completed | 2005-06-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00109096 | Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have F… | Phase2 | Ovarian Neoplasms | Completed | 2005-06-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00190671 | A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Brea… | Phase1 | Breast Cancer | Completed | 2005-06-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00190866 | Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome | Phase3 | Fibromyalgia | Completed | 2005-06-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00190879 | Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adult… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2005-06-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00109096 | Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have F… | Phase2 | Ovarian Neoplasms | Completed | 2005-06-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00333281 | A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for S… | Phase4 | Erectile Dysfunction | Completed | 2005-06-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00191269 | Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Ta… | Phase2 | Metastatic Breast Cancer | Completed | 2005-06-01 | 2010-03-01 | ClinicalTrials.gov |
| NCT00113594 | Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder | Phase3 | Schizophrenia | Completed | 2005-06-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00333281 | A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for S… | Phase4 | Erectile Dysfunction | Completed | 2005-06-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00148109 | Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tis… | Phase2 | Sarcoma | Completed | 2005-06-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00216203 | Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer | Phase1 | Non-Small Cell Lung Cancer | Completed | 2005-05-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00193414 | Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer | Phase2 | Lung Cancer | Completed | 2005-05-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00262769 | Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Lo… | Phase3 | Extrahepatic Bile Duct Cancer | Completed | 2005-05-01 | — | ClinicalTrials.gov |
| NCT00287352 | Study of Amantadine for Weight Stabilization During Olanzapine Treatment | Phase1 | Psychotic Disorder | Completed | 2005-05-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00191945 | Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attenti… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2005-05-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00191919 | A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD a… | Phase3 | Depressive Disorder, Major | Completed | 2005-05-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00191386 | Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2005-05-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00191308 | Molecular Profiling in Lung Cancer Patients | Phase2 | Non-Small Cell Lung Cancer | Completed | 2005-05-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00563160 | Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin fo… | Phase2 | Lung Neoplasms | Unknown | 2005-05-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00193414 | Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer | Phase2 | Lung Cancer | Completed | 2005-05-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00262769 | Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Lo… | Phase3 | Extrahepatic Bile Duct Cancer | Completed | 2005-05-01 | — | ClinicalTrials.gov |
| NCT00191308 | Molecular Profiling in Lung Cancer Patients | Phase2 | Non-Small Cell Lung Cancer | Completed | 2005-05-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00563160 | Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin fo… | Phase2 | Lung Neoplasms | Unknown | 2005-05-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00191386 | Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2005-05-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00287352 | Study of Amantadine for Weight Stabilization During Olanzapine Treatment | Phase1 | Psychotic Disorder | Completed | 2005-05-01 | 2009-09-01 | ClinicalTrials.gov |
| NCT00191919 | A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD a… | Phase3 | Depressive Disorder, Major | Completed | 2005-05-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00216203 | Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer | Phase1 | Non-Small Cell Lung Cancer | Completed | 2005-05-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00191945 | Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attenti… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2005-05-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00216164 | Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Larg… | Phase2 | Lymphoma, B-Cell | Terminated | 2005-04-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00106002 | Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer | Phase2 | Breast Cancer | Completed | 2005-04-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00191633 | Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional… | Phase4 | Attention-Deficit/Hyperactivity Disorder | Completed | 2005-04-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00216164 | Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Larg… | Phase2 | Lymphoma, B-Cell | Terminated | 2005-04-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00191906 | Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hypera… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2005-04-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00191906 | Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hypera… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2005-04-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00191633 | Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional… | Phase4 | Attention-Deficit/Hyperactivity Disorder | Completed | 2005-04-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00122837 | A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in t… | Phase3 | Anxiety Disorder | Completed | 2005-04-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00122837 | A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in t… | Phase3 | Anxiety Disorder | Completed | 2005-04-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00106002 | Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer | Phase2 | Breast Cancer | Completed | 2005-04-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00115635 | Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer | Phase1 | Prostate Cancer | Completed | 2005-03-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00296699 | A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression | Phase4 | Atypical Depression | Completed | 2005-03-01 | — | ClinicalTrials.gov |
| NCT00191594 | Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous D… | Phase3 | Major Depressive Disorder | Completed | 2005-03-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00389805 | Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small… | Phase1 | Lung Cancer | Completed | 2005-03-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00105092 | Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer. | Phase2 | Non-Small-Cell Lung Carcinoma | Completed | 2005-03-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00162318 | A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Adv… | Phase1 | Non-Small-Cell Lung Carcinoma | Completed | 2005-03-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00191542 | Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolesc… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2005-03-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00296699 | A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression | Phase4 | Atypical Depression | Completed | 2005-03-01 | — | ClinicalTrials.gov |
| NCT00105989 | Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive D… | Phase3 | Depressive Disorder, Major | Completed | 2005-03-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00191854 | Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line | Phase2 | Breast Cancer | Completed | 2005-03-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00523640 | A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Re… | Phase2 | Carcinoma, Renal Cell | Terminated | 2005-03-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00191581 | Local Registration Trial in China Humalog Mix 50 | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2005-03-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00102804 | Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in … | Phase3 | Non-Small Cell Lung Cancer | Completed | 2005-03-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00191854 | Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line | Phase2 | Breast Cancer | Completed | 2005-03-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00523640 | A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Re… | Phase2 | Carcinoma, Renal Cell | Terminated | 2005-03-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00167765 | Abciximab in Wake-up Stroke | Phase3 | Stroke | Terminated | 2005-03-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00162318 | A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Adv… | Phase1 | Non-Small-Cell Lung Carcinoma | Completed | 2005-03-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00102804 | Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in … | Phase3 | Non-Small Cell Lung Cancer | Completed | 2005-03-01 | 2013-12-01 | ClinicalTrials.gov |
| NCT00167765 | Abciximab in Wake-up Stroke | Phase3 | Stroke | Terminated | 2005-03-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00389805 | Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small… | Phase1 | Lung Cancer | Completed | 2005-03-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00191594 | Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous D… | Phase3 | Major Depressive Disorder | Completed | 2005-03-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00191581 | Local Registration Trial in China Humalog Mix 50 | Phase3 | Diabetes Mellitus, Type 1 | Completed | 2005-03-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00115635 | Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer | Phase1 | Prostate Cancer | Completed | 2005-03-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00105092 | Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer. | Phase2 | Non-Small-Cell Lung Carcinoma | Completed | 2005-03-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00191542 | Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolesc… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2005-03-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00105989 | Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive D… | Phase3 | Depressive Disorder, Major | Completed | 2005-03-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00201760 | Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients Wi… | Phase2 | Breast Cancer | Completed | 2005-02-25 | 2009-10-31 | ClinicalTrials.gov |
| NCT00201760 | Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients Wi… | Phase2 | Breast Cancer | Completed | 2005-02-25 | 2009-10-31 | ClinicalTrials.gov |
| NCT00216099 | Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory … | Phase2 | Prostate Cancer | Completed | 2005-02-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00191867 | Clinical Trial of Teriparatide in Japan | Phase2 | Osteoporosis | Completed | 2005-02-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00191867 | Clinical Trial of Teriparatide in Japan | Phase2 | Osteoporosis | Completed | 2005-02-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00933439 | Assessment of Cognitive Functioning Before and After Treatment With Duloxetine | Na | Major Depressive Disorder | Completed | 2005-02-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00103935 | Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes | Phase2 | Type 2 Diabetes Mellitus | Completed | 2005-02-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00190983 | A Trial for Patients With Advanced/Recurrent Cervical Cancer | Phase2 | Cervical Intraepithelial Neoplasia | Completed | 2005-02-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00188942 | A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and… | Phase4 | Major Depressive Disorder | Completed | 2005-02-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00191295 | Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Dis… | Phase2 | Attention Deficit Hyperactivity Disorder | Completed | 2005-02-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00103935 | Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes | Phase2 | Type 2 Diabetes Mellitus | Completed | 2005-02-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00191295 | Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Dis… | Phase2 | Attention Deficit Hyperactivity Disorder | Completed | 2005-02-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00190983 | A Trial for Patients With Advanced/Recurrent Cervical Cancer | Phase2 | Cervical Intraepithelial Neoplasia | Completed | 2005-02-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00933439 | Assessment of Cognitive Functioning Before and After Treatment With Duloxetine | Na | Major Depressive Disorder | Completed | 2005-02-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00216099 | Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory … | Phase2 | Prostate Cancer | Completed | 2005-02-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00188942 | A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and… | Phase4 | Major Depressive Disorder | Completed | 2005-02-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00286949 | Treatment of Executive Dysfunction in Parkinson's Disease | Na | Parkinson's Disease | Completed | 2005-01-06 | 2008-06-30 | ClinicalTrials.gov |
| NCT00286949 | Treatment of Executive Dysfunction in Parkinson's Disease | Na | Parkinson's Disease | Completed | 2005-01-06 | 2008-06-30 | ClinicalTrials.gov |
| NCT00095199 | Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or… | Phase3 | Non Small Cell Lung Cancer | Completed | 2005-01-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00216216 | Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Ce… | Phase2 | Small Cell Lung Cancer | Terminated | 2005-01-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00517283 | A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying… | Phase1 | Type 2 Diabetes Mellitus | Completed | 2005-01-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00122863 | Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized An… | Phase3 | Anxiety Disorders | Completed | 2005-01-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00112346 | Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patient… | Phase2 | Non-Small-Cell Lung Carcinoma | Completed | 2005-01-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00191503 | Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma | Phase2 | Adenocarcinoma | Completed | 2005-01-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00191412 | A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Can… | Phase2 | Liver Cancer | Completed | 2005-01-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00793975 | Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy | Phase1 | Advanced Solid Tumors | Completed | 2005-01-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00122863 | Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized An… | Phase3 | Anxiety Disorders | Completed | 2005-01-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00095199 | Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or… | Phase3 | Non Small Cell Lung Cancer | Completed | 2005-01-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00638638 | Myocardial Infarction With ST-Elevation | Phase3 | Myocardial Infarction | Unknown | 2005-01-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00793975 | Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy | Phase1 | Advanced Solid Tumors | Completed | 2005-01-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00190853 | Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment o… | Phase3 | Urinary Stress Incontinence | Completed | 2005-01-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00216216 | Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Ce… | Phase2 | Small Cell Lung Cancer | Terminated | 2005-01-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00488163 | Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia | Phase4 | Schizophrenia | Completed | 2005-01-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00191503 | Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma | Phase2 | Adenocarcinoma | Completed | 2005-01-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00112346 | Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patient… | Phase2 | Non-Small-Cell Lung Carcinoma | Completed | 2005-01-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00191412 | A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Can… | Phase2 | Liver Cancer | Completed | 2005-01-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00517283 | A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying… | Phase1 | Type 2 Diabetes Mellitus | Completed | 2005-01-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00638638 | Myocardial Infarction With ST-Elevation | Phase3 | Myocardial Infarction | Unknown | 2005-01-01 | 2010-01-01 | ClinicalTrials.gov |
| NCT00190853 | Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment o… | Phase3 | Urinary Stress Incontinence | Completed | 2005-01-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00488163 | Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia | Phase4 | Schizophrenia | Completed | 2005-01-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00656084 | Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell | Phase2 | Relapsed or Refractory Mantle Cell Lymphoma (MCL) | Completed | 2004-12-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00191022 | Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety … | Phase2 | Social Phobia | Completed | 2004-12-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00656084 | Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell | Phase2 | Relapsed or Refractory Mantle Cell Lymphoma (MCL) | Completed | 2004-12-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00191334 | Gemcitabine in Ovarian Cancer | Phase2 | Ovarian Cancer | Completed | 2004-12-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00101842 | Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients Wit… | Phase1 | Carcinoma, Transitional Cell | Completed | 2004-12-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00190944 | Effects of Teriparatide on Distal Radius Fracture Healing | Phase2 | Colles' Fracture | Completed | 2004-12-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00112294 | Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients … | Phase3 | Non-Small-Cell Lung Carcinoma | Completed | 2004-12-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00191334 | Gemcitabine in Ovarian Cancer | Phase2 | Ovarian Cancer | Completed | 2004-12-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00191022 | Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety … | Phase2 | Social Phobia | Completed | 2004-12-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00869726 | A Study for Patients With Secondary Progressive Multiple Sclerosis | Phase2 | Secondary Progressive Multiple Sclerosis | Completed | 2004-12-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00112294 | Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients … | Phase3 | Non-Small-Cell Lung Carcinoma | Completed | 2004-12-01 | 2008-08-01 | ClinicalTrials.gov |
| NCT00101842 | Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients Wit… | Phase1 | Carcinoma, Transitional Cell | Completed | 2004-12-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00869726 | A Study for Patients With Secondary Progressive Multiple Sclerosis | Phase2 | Secondary Progressive Multiple Sclerosis | Completed | 2004-12-01 | 2009-05-01 | ClinicalTrials.gov |
| NCT00190944 | Effects of Teriparatide on Distal Radius Fracture Healing | Phase2 | Colles' Fracture | Completed | 2004-12-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00079924 | Effects of Teriparatide in Postmenopausal Women With Osteoporosis | Phase4 | Postmenopausal Osteoporosis | Completed | 2004-11-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00150657 | Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer | Phase2 | Non-Small Cell Lung Cancer | Unknown | 2004-11-01 | — | ClinicalTrials.gov |
| NCT00159952 | Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in … | Phase2 | Severe Sepsis | Completed | 2004-11-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00162110 | A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adeno… | Phase2 | Mucinous Gastrointestinal Adenocarcinoma | Completed | 2004-11-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00801177 | Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Th… | Phase1 | Solid Tumors | Completed | 2004-11-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00079924 | Effects of Teriparatide in Postmenopausal Women With Osteoporosis | Phase4 | Postmenopausal Osteoporosis | Completed | 2004-11-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00801177 | Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard Th… | Phase1 | Solid Tumors | Completed | 2004-11-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00162110 | A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adeno… | Phase2 | Mucinous Gastrointestinal Adenocarcinoma | Completed | 2004-11-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00082212 | A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary … | Phase2 | Ovarian Cancer | Terminated | 2004-11-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00159952 | Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in … | Phase2 | Severe Sepsis | Completed | 2004-11-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00150657 | Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer | Phase2 | Non-Small Cell Lung Cancer | Unknown | 2004-11-01 | — | ClinicalTrials.gov |
| NCT00099515 | Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2004-11-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00097591 | A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome S… | Phase3 | Coronary Arteriosclerosis | Completed | 2004-11-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00097227 | Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung … | Phase2 | Non-small Cell Lung Cancer | Completed | 2004-11-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00097214 | Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung C… | Phase2 | Non-small Cell Lung Cancer | Completed | 2004-11-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00082212 | A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary … | Phase2 | Ovarian Cancer | Terminated | 2004-11-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00099515 | Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2004-11-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00097591 | A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome S… | Phase3 | Coronary Arteriosclerosis | Completed | 2004-11-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00097227 | Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung … | Phase2 | Non-small Cell Lung Cancer | Completed | 2004-11-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00097214 | Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung C… | Phase2 | Non-small Cell Lung Cancer | Completed | 2004-11-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00191737 | An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hypera… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2004-10-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT00094549 | Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar… | Phase4 | Bipolar Disorder | Completed | 2004-10-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00083720 | Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon… | Phase2 | Colorectal Neoplasms | Completed | 2004-10-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00192023 | An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children an… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2004-10-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00191061 | A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for … | Phase4 | Depressive Disorder | Completed | 2004-10-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00191347 | A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Brea… | Phase2 | Breast Cancer | Completed | 2004-10-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00102219 | A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast C… | Phase2 | Breast Cancer | Completed | 2004-10-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00547625 | Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Se… | Phase2 | Prostatic Hyperplasia | Completed | 2004-10-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00094549 | Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar… | Phase4 | Bipolar Disorder | Completed | 2004-10-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00547183 | Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have P… | Phase3 | Impotence | Completed | 2004-10-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00192101 | Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Pa… | Phase2 | Metastatic Breast Cancer | Completed | 2004-10-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00191997 | Optimal Length of Treatment Continuation With Olanzapine After Remission of Man… | Phase4 | Bipolar Disorder | Completed | 2004-10-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00767715 | A Study in the Treatment of Acute Mania | Phase4 | Bipolar Disorder | Terminated | 2004-10-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00422578 | Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunct… | Phase4 | Impotence | Completed | 2004-10-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00191516 | An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperacti… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2004-10-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT00547183 | Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have P… | Phase3 | Impotence | Completed | 2004-10-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00547625 | Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Se… | Phase2 | Prostatic Hyperplasia | Completed | 2004-10-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00083720 | Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon… | Phase2 | Colorectal Neoplasms | Completed | 2004-10-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00102219 | A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast C… | Phase2 | Breast Cancer | Completed | 2004-10-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00192023 | An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children an… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2004-10-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00191737 | An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hypera… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2004-10-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT00767715 | A Study in the Treatment of Acute Mania | Phase4 | Bipolar Disorder | Terminated | 2004-10-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00191516 | An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperacti… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2004-10-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT00422578 | Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunct… | Phase4 | Impotence | Completed | 2004-10-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00191997 | Optimal Length of Treatment Continuation With Olanzapine After Remission of Man… | Phase4 | Bipolar Disorder | Completed | 2004-10-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00191061 | A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for … | Phase4 | Depressive Disorder | Completed | 2004-10-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00191191 | To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therap… | Phase2 | Non-small Cell Lung Cancer | Completed | 2004-10-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00122850 | A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in t… | Phase3 | Anxiety Disorders | Completed | 2004-10-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00191191 | To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therap… | Phase2 | Non-small Cell Lung Cancer | Completed | 2004-10-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00122850 | A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in t… | Phase3 | Anxiety Disorders | Completed | 2004-10-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00191347 | A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Brea… | Phase2 | Breast Cancer | Completed | 2004-10-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00192101 | Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Pa… | Phase2 | Metastatic Breast Cancer | Completed | 2004-10-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00181948 | Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant T… | Phase4 | ADHD | Completed | 2004-09-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00181948 | Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant T… | Phase4 | ADHD | Completed | 2004-09-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00185575 | Duloxetine for the Treatment of Dysthymia | Na | Depressive Disorder | Completed | 2004-09-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00190775 | A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride … | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2004-09-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT01077323 | A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenat… | — | Type 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies) | Completed | 2004-09-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00099619 | Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom I… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2004-09-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT00461786 | A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent… | Phase2 | Ovarian Cancer | Completed | 2004-09-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00097500 | Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes | Phase3 | Type 2 Diabetes Mellitus | Completed | 2004-09-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00461786 | A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent… | Phase2 | Ovarian Cancer | Completed | 2004-09-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00421083 | Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused b… | Phase3 | Erectile Dysfunction | Completed | 2004-09-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00190736 | Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD… | Phase4 | ADHD | Completed | 2004-09-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00191724 | Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Pha… | Phase2 | Submassive Pulmonary Embolism | Completed | 2004-09-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00190736 | Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD… | Phase4 | ADHD | Completed | 2004-09-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00097500 | Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes | Phase3 | Type 2 Diabetes Mellitus | Completed | 2004-09-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00191724 | Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Pha… | Phase2 | Submassive Pulmonary Embolism | Completed | 2004-09-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00190775 | A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride … | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2004-09-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00190892 | Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania | Phase4 | Bipolar Disorder | Completed | 2004-09-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00099619 | Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom I… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2004-09-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT00609557 | A Single-Blind Placebo Run-in Study of Duloxetine for Activity-Limiting Osteoar… | Phase4 | Osteoarthritis | Completed | 2004-09-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT01077323 | A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenat… | — | Type 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies) | Completed | 2004-09-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00185575 | Duloxetine for the Treatment of Dysthymia | Na | Depressive Disorder | Completed | 2004-09-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00609557 | A Single-Blind Placebo Run-in Study of Duloxetine for Activity-Limiting Osteoar… | Phase4 | Osteoarthritis | Completed | 2004-09-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00190892 | Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania | Phase4 | Bipolar Disorder | Completed | 2004-09-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00421083 | Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused b… | Phase3 | Erectile Dysfunction | Completed | 2004-09-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00088465 | Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophren… | Phase3 | Schizophrenic Disorders | Completed | 2004-08-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00475969 | Duloxetine vs Placebo in the Treatment of General Anxiety | Phase3 | Anxiety | Completed | 2004-08-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00192036 | Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Tho… | Phase2 | Non Small Cell Lung Cancer | Completed | 2004-08-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00479726 | Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS) | Phase4 | Major Depressive Disorder | Completed | 2004-08-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00475969 | Duloxetine vs Placebo in the Treatment of General Anxiety | Phase3 | Anxiety | Completed | 2004-08-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00479726 | Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS) | Phase4 | Major Depressive Disorder | Completed | 2004-08-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00190957 | Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse | Phase4 | ADHD | Completed | 2004-08-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00191932 | Switching to Duloxetine From Other Antidepressants | Phase4 | Major Depressive Disorder | Completed | 2004-08-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00192036 | Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Tho… | Phase2 | Non Small Cell Lung Cancer | Completed | 2004-08-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00088465 | Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophren… | Phase3 | Schizophrenic Disorders | Completed | 2004-08-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00191932 | Switching to Duloxetine From Other Antidepressants | Phase4 | Major Depressive Disorder | Completed | 2004-08-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00277706 | Impact of Parathyroid Hormone (PTH) on Osseous Cavity | Phase1 | Bone Loss | Completed | 2004-08-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00277706 | Impact of Parathyroid Hormone (PTH) on Osseous Cavity | Phase1 | Bone Loss | Completed | 2004-08-01 | 2009-07-01 | ClinicalTrials.gov |
| NCT00190957 | Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse | Phase4 | ADHD | Completed | 2004-08-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00192062 | A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for… | Phase2 | Breast Cancer | Completed | 2004-07-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00191750 | A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned | Phase2 | Carcinoma, Small Cell | Completed | 2004-07-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00191321 | Teriparatide Use in Hip Replaced Subjects | Phase3 | Osteoporosis | Completed | 2004-07-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00103571 | Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Sc… | Phase4 | Schizophrenia | Completed | 2004-07-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00090012 | Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or… | Phase4 | Schizophrenia | Completed | 2004-07-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00087711 | A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and C… | Phase3 | Non Small Cell Lung Carcinoma | Completed | 2004-07-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00087087 | Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Prim… | Phase2 | Ovarian Cancer | Completed | 2004-07-01 | — | ClinicalTrials.gov |
| NCT00386581 | Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Vers… | Phase3 | Attention Deficit Disorder With Hyperactivity | Completed | 2004-07-01 | 2005-02-01 | ClinicalTrials.gov |
| NCT00485901 | Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patient… | Phase3 | Schizophrenia | Completed | 2004-07-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00485901 | Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patient… | Phase3 | Schizophrenia | Completed | 2004-07-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00386581 | Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Vers… | Phase3 | Attention Deficit Disorder With Hyperactivity | Completed | 2004-07-01 | 2005-02-01 | ClinicalTrials.gov |
| NCT00192062 | A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for… | Phase2 | Breast Cancer | Completed | 2004-07-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00191750 | A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned | Phase2 | Carcinoma, Small Cell | Completed | 2004-07-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00191321 | Teriparatide Use in Hip Replaced Subjects | Phase3 | Osteoporosis | Completed | 2004-07-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00103571 | Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Sc… | Phase4 | Schizophrenia | Completed | 2004-07-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00090012 | Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or… | Phase4 | Schizophrenia | Completed | 2004-07-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00087711 | A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and C… | Phase3 | Non Small Cell Lung Carcinoma | Completed | 2004-07-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00087087 | Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Prim… | Phase2 | Ovarian Cancer | Completed | 2004-07-01 | — | ClinicalTrials.gov |
| NCT00485875 | Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in … | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2004-06-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00190788 | Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion | Phase3 | Sepsis | Completed | 2004-06-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00191659 | Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/A… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2004-06-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00088491 | Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose De… | Phase3 | Schizophrenic Disorders | Completed | 2004-06-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT00088010 | Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer | Phase3 | Osteoporosis, Postmenopausal | Completed | 2004-06-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00088478 | Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of P… | Phase3 | Schizophrenia | Completed | 2004-06-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00547352 | Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for P… | Phase4 | Impotence | Completed | 2004-06-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00088491 | Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose De… | Phase3 | Schizophrenic Disorders | Completed | 2004-06-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT00485875 | Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in … | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2004-06-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00485810 | Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schi… | Phase1 | Schizophrenia | Completed | 2004-06-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT00193362 | Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinore… | Phase3 | Lung Cancer | Completed | 2004-06-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00193362 | Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinore… | Phase3 | Lung Cancer | Completed | 2004-06-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00444678 | Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastat… | Phase2 | Colorectal Cancer | Completed | 2004-06-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT00547352 | Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for P… | Phase4 | Impotence | Completed | 2004-06-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00191659 | Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/A… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2004-06-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00191984 | A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Meta… | Phase2 | Metastatic Colorectal Cancer | Completed | 2004-06-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00191984 | A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Meta… | Phase2 | Metastatic Colorectal Cancer | Completed | 2004-06-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00122824 | Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder | Phase3 | Anxiety Disorders | Completed | 2004-06-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00122824 | Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder | Phase3 | Anxiety Disorders | Completed | 2004-06-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00088010 | Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer | Phase3 | Osteoporosis, Postmenopausal | Completed | 2004-06-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00444678 | Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastat… | Phase2 | Colorectal Cancer | Completed | 2004-06-01 | 2015-06-01 | ClinicalTrials.gov |
| NCT00485810 | Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schi… | Phase1 | Schizophrenia | Completed | 2004-06-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT00088478 | Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of P… | Phase3 | Schizophrenia | Completed | 2004-06-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00190788 | Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion | Phase3 | Sepsis | Completed | 2004-06-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00099320 | Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazol… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2004-05-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT00203307 | A Research Study Examining the Use of Olanzapine for the Prevention of Migraine | Na | Migraine | Terminated | 2004-05-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00192088 | A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastri… | Phase2 | Advanced Gastric Carcinoma | Completed | 2004-05-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00611533 | Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Co… | Na | Menopause | Completed | 2004-05-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00203307 | A Research Study Examining the Use of Olanzapine for the Prevention of Migraine | Na | Migraine | Terminated | 2004-05-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00192088 | A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastri… | Phase2 | Advanced Gastric Carcinoma | Completed | 2004-05-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00191685 | Duloxetine in the Treatment of Melancholic Depression | Phase3 | Depressive Disorder, Major | Completed | 2004-05-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00191399 | Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Resp… | Phase4 | Depression, Bipolar | Completed | 2004-05-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00611533 | Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Co… | Na | Menopause | Completed | 2004-05-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00191880 | Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2004-05-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00191399 | Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Resp… | Phase4 | Depression, Bipolar | Completed | 2004-05-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00191685 | Duloxetine in the Treatment of Melancholic Depression | Phase3 | Depressive Disorder, Major | Completed | 2004-05-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00191880 | Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2004-05-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00099320 | Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazol… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2004-05-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT00085956 | Effects of Arzoxifene on Bone Mass and the Uterus | Phase3 | Postmenopausal Bone Loss | Completed | 2004-04-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00785421 | Chemotherapy With or Without Enoxaparin in Pancreatic Cancer | Phase2 | Pancreatic Cancer | Completed | 2004-04-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00785421 | Chemotherapy With or Without Enoxaparin in Pancreatic Cancer | Phase2 | Pancreatic Cancer | Completed | 2004-04-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00126139 | Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptoma… | Phase3 | Stroke | Terminated | 2004-04-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00193427 | Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Pa… | Phase2 | Lung Cancer | Completed | 2004-04-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00110370 | Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting In… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2004-04-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00279175 | REPAIR-AMI: Intracoronary Progenitor Cells in Acute Myocardial Infarction (AMI) | Phase3 | Myocardial Infarction | Completed | 2004-04-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00110370 | Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting In… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2004-04-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00191451 | A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growt… | Phase2 | Breast Cancer | Completed | 2004-04-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00142467 | Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepat… | Phase2 | Hepatocellular Carcinoma | Completed | 2004-04-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00279175 | REPAIR-AMI: Intracoronary Progenitor Cells in Acute Myocardial Infarction (AMI) | Phase3 | Myocardial Infarction | Completed | 2004-04-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00191451 | A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growt… | Phase2 | Breast Cancer | Completed | 2004-04-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00085956 | Effects of Arzoxifene on Bone Mass and the Uterus | Phase3 | Postmenopausal Bone Loss | Completed | 2004-04-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00126139 | Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptoma… | Phase3 | Stroke | Terminated | 2004-04-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00193427 | Preoperative Therapy in Patients With Stages IB, II, IIIA, and Selected IIIB Pa… | Phase2 | Lung Cancer | Completed | 2004-04-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00142467 | Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepat… | Phase2 | Hepatocellular Carcinoma | Completed | 2004-04-01 | 2011-06-01 | ClinicalTrials.gov |
| NCT00190710 | A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients Wit… | Phase3 | Non-Small Cell Lung Cancer | Completed | 2004-03-01 | 2007-08-01 | ClinicalTrials.gov |
| NCT00088205 | Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma | Phase2 | Mantle-Cell Lymphoma | Completed | 2004-03-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00191035 | Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD | Phase4 | Attention-Deficit/Hyperactivity Disorder | Completed | 2004-03-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00159445 | Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer | Phase2 | Colorectal Cancer | Completed | 2004-03-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00147875 | Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patie… | Phase1 | Hodgkin's Disease | Completed | 2004-03-01 | — | ClinicalTrials.gov |
| NCT00191165 | Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin… | Phase3 | Growth Hormone Deficiency | Completed | 2004-03-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00191035 | Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD | Phase4 | Attention-Deficit/Hyperactivity Disorder | Completed | 2004-03-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00191165 | Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin… | Phase3 | Growth Hormone Deficiency | Completed | 2004-03-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00191620 | Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non… | Phase2 | Non-Small-Cell Lung Carcinoma | Completed | 2004-03-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00450762 | Gemcitabine + Carboplatin in Breast Cancer | Phase2 | Breast Cancer | Completed | 2004-03-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT00159445 | Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer | Phase2 | Colorectal Cancer | Completed | 2004-03-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00320515 | Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer | Phase1 | Neoplasm, Gastric | Completed | 2004-03-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00191620 | Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non… | Phase2 | Non-Small-Cell Lung Carcinoma | Completed | 2004-03-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00450762 | Gemcitabine + Carboplatin in Breast Cancer | Phase2 | Breast Cancer | Completed | 2004-03-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT00547495 | Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or… | Phase3 | Impotence | Completed | 2004-03-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT00147875 | Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patie… | Phase1 | Hodgkin's Disease | Completed | 2004-03-01 | — | ClinicalTrials.gov |
| NCT00320515 | Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer | Phase1 | Neoplasm, Gastric | Completed | 2004-03-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00091650 | Olanzapine in Patients With Borderline Personality Disorder | Phase3 | Borderline Personality Disorder | Completed | 2004-03-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00547495 | Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or… | Phase3 | Impotence | Completed | 2004-03-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT00088205 | Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma | Phase2 | Mantle-Cell Lymphoma | Completed | 2004-03-01 | 2008-05-01 | ClinicalTrials.gov |
| NCT00091650 | Olanzapine in Patients With Borderline Personality Disorder | Phase3 | Borderline Personality Disorder | Completed | 2004-03-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00190710 | A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients Wit… | Phase3 | Non-Small Cell Lung Cancer | Completed | 2004-03-01 | 2007-08-01 | ClinicalTrials.gov |
| NCT00099333 | Study of the Safety of Substituting Exenatide for Insulin in Patients Using Ins… | Phase2 | Type 2 Diabetes Mellitus | Completed | 2004-02-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT00287820 | Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glu… | Phase4 | Schizophrenia | Completed | 2004-02-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00079872 | Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Lin… | Phase2 | Colorectal Cancer | Completed | 2004-02-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00088036 | Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disor… | Phase3 | Borderline Personality Disorder | Completed | 2004-02-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00287820 | Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glu… | Phase4 | Schizophrenia | Completed | 2004-02-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00485849 | A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviou… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2004-02-01 | 2004-10-01 | ClinicalTrials.gov |
| NCT00191711 | Intravesical Gemcitabine Instillation Followed by Transurethral Resection for t… | Phase2 | Superficial Bladder Cancer | Completed | 2004-02-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00485459 | Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents … | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2004-02-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT00494377 | Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression | Phase4 | Depression | Completed | 2004-02-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00485459 | Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents … | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2004-02-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT00190905 | Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrou… | Phase4 | Stress Urinary Incontinence | Completed | 2004-02-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00176436 | Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients | Phase4 | Schizophrenia | Completed | 2004-02-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00485849 | A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviou… | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2004-02-01 | 2004-10-01 | ClinicalTrials.gov |
| NCT00190905 | Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrou… | Phase4 | Stress Urinary Incontinence | Completed | 2004-02-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00176436 | Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients | Phase4 | Schizophrenia | Completed | 2004-02-01 | 2008-03-01 | ClinicalTrials.gov |
| NCT00494377 | Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression | Phase4 | Depression | Completed | 2004-02-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00191711 | Intravesical Gemcitabine Instillation Followed by Transurethral Resection for t… | Phase2 | Superficial Bladder Cancer | Completed | 2004-02-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00226577 | Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cel… | Phase2 | Lung Cancer | Completed | 2004-02-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00099333 | Study of the Safety of Substituting Exenatide for Insulin in Patients Using Ins… | Phase2 | Type 2 Diabetes Mellitus | Completed | 2004-02-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT00215930 | The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therap… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2004-02-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00088036 | Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disor… | Phase3 | Borderline Personality Disorder | Completed | 2004-02-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00215930 | The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therap… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2004-02-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00226577 | Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cel… | Phase2 | Lung Cancer | Completed | 2004-02-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00079872 | Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Lin… | Phase2 | Colorectal Cancer | Completed | 2004-02-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00485550 | Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With AD… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2004-01-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT00485550 | Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With AD… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2004-01-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT00489775 | Duloxetine Versus Paroxetine for Major Depression | Phase3 | Major Depressive Disorder | Completed | 2004-01-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00191971 | 2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium … | Phase2 | Urologic Neoplasms | Completed | 2004-01-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00191971 | 2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium … | Phase2 | Urologic Neoplasms | Completed | 2004-01-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00191477 | Instillation of Gemcitabine in Patients With Superficial Bladder Cancer | Phase3 | Bladder Neoplasms | Terminated | 2004-01-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00191477 | Instillation of Gemcitabine in Patients With Superficial Bladder Cancer | Phase3 | Bladder Neoplasms | Terminated | 2004-01-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00489775 | Duloxetine Versus Paroxetine for Major Depression | Phase3 | Major Depressive Disorder | Completed | 2004-01-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00191464 | Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postpra… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2003-12-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00181766 | Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not… | Phase4 | ADHD NOS | Completed | 2003-12-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00229476 | Study of Medication and Placebo Response in Major Depression | Phase4 | Depressive Disorder, Major | Completed | 2003-12-01 | — | ClinicalTrials.gov |
| NCT00475397 | Duloxetine Stress Urinary Incontinence Efficacy and Safety Study | Phase3 | Urinary Incontinence, Stress | Completed | 2003-12-01 | 2004-10-01 | ClinicalTrials.gov |
| NCT00486083 | Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients Wi… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2003-12-01 | 2004-10-01 | ClinicalTrials.gov |
| NCT00192049 | A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Vers… | Phase2 | Superficial Bladder Cancer | Completed | 2003-12-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00191672 | A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metast… | Phase2 | Breast Neoplasms | Completed | 2003-12-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00181766 | Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not… | Phase4 | ADHD NOS | Completed | 2003-12-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00078260 | A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer | Phase3 | Non-Small Cell Lung Cancer | Completed | 2003-12-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00071136 | Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer… | Phase1 | Lung Neoplasms | Completed | 2003-12-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00191698 | Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2003-12-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00485680 | Olanzapine Versus Comparator in the Treatment of Bipolar Disorder | Phase3 | Bipolar Disorder | Completed | 2003-12-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00485680 | Olanzapine Versus Comparator in the Treatment of Bipolar Disorder | Phase3 | Bipolar Disorder | Completed | 2003-12-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00486083 | Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients Wi… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2003-12-01 | 2004-10-01 | ClinicalTrials.gov |
| NCT00192049 | A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Vers… | Phase2 | Superficial Bladder Cancer | Completed | 2003-12-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00229476 | Study of Medication and Placebo Response in Major Depression | Phase4 | Depressive Disorder, Major | Completed | 2003-12-01 | — | ClinicalTrials.gov |
| NCT00071136 | Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer… | Phase1 | Lung Neoplasms | Completed | 2003-12-01 | 2006-08-01 | ClinicalTrials.gov |
| NCT00078260 | A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer | Phase3 | Non-Small Cell Lung Cancer | Completed | 2003-12-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00077233 | FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenoca… | Phase3 | Colorectal Cancer | Terminated | 2003-12-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00191698 | Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2003-12-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00207155 | An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Me… | Phase1 | Metastatic Colorectal Cancer | Completed | 2003-12-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT00475397 | Duloxetine Stress Urinary Incontinence Efficacy and Safety Study | Phase3 | Urinary Incontinence, Stress | Completed | 2003-12-01 | 2004-10-01 | ClinicalTrials.gov |
| NCT01876849 | An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Dai… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2003-12-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00207155 | An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Me… | Phase1 | Metastatic Colorectal Cancer | Completed | 2003-12-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT00077233 | FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenoca… | Phase3 | Colorectal Cancer | Terminated | 2003-12-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00074828 | New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip … | Phase2 | Total Knee Replacement | Completed | 2003-12-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT01876849 | An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Dai… | Phase3 | Type 2 Diabetes Mellitus | Completed | 2003-12-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00191464 | Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postpra… | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2003-12-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00074828 | New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip … | Phase2 | Total Knee Replacement | Completed | 2003-12-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00191672 | A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metast… | Phase2 | Breast Neoplasms | Completed | 2003-12-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00382135 | A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg | Phase4 | Erectile Dysfunction | Completed | 2003-11-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00485771 | Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar… | Phase4 | Bipolar Disorder | Completed | 2003-11-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00190931 | A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adult… | Phase4 | Attention Deficit Disorder With Hyperactivity | Completed | 2003-11-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00532207 | Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis | Phase3 | Osteoporosis, Post-Menopausal | Completed | 2003-11-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT00382135 | A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg | Phase4 | Erectile Dysfunction | Completed | 2003-11-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00193076 | Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients Wi… | Phase2 | Breast Cancer | Completed | 2003-11-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00485771 | Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar… | Phase4 | Bipolar Disorder | Completed | 2003-11-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00082407 | Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Ty… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2003-11-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00532207 | Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis | Phase3 | Osteoporosis, Post-Menopausal | Completed | 2003-11-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT00193076 | Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients Wi… | Phase2 | Breast Cancer | Completed | 2003-11-01 | 2008-10-01 | ClinicalTrials.gov |
| NCT00490880 | Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiot… | Phase2 | Bladder Cancer | Completed | 2003-11-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT00211263 | Bipolar Disorder Research Study for Ages 12 and Older | Na | Bipolar Disorder | Completed | 2003-11-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00211263 | Bipolar Disorder Research Study for Ages 12 and Older | Na | Bipolar Disorder | Completed | 2003-11-01 | 2007-02-01 | ClinicalTrials.gov |
| NCT00073411 | Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients Wi… | Phase3 | Depression | Completed | 2003-11-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00082407 | Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Ty… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2003-11-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00073411 | Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients Wi… | Phase3 | Depression | Completed | 2003-11-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00190931 | A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adult… | Phase4 | Attention Deficit Disorder With Hyperactivity | Completed | 2003-11-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00490880 | Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiot… | Phase2 | Bladder Cancer | Completed | 2003-11-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT00191009 | Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer'… | Phase2 | Alzheimer Disease | Completed | 2003-10-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00490373 | Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated… | Phase2 | Pancreatic Cancer | Completed | 2003-10-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00547092 | Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems G… | Phase4 | Impotence | Completed | 2003-10-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT00490373 | Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated… | Phase2 | Pancreatic Cancer | Completed | 2003-10-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00547092 | Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems G… | Phase4 | Impotence | Completed | 2003-10-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT00390182 | Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients … | Phase1 | Gastrointestinal Neoplasms | Completed | 2003-10-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00381732 | A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given On… | Phase3 | Erectile Dysfunction | Completed | 2003-10-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00073372 | A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemi… | Phase3 | Cerebrovascular Accident | Terminated | 2003-10-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00088049 | Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia | Phase4 | Schizophrenia | Completed | 2003-10-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00169819 | EArly Discharge After Transradial Stenting of CoronarY Arteries: The EASY Study | Phase4 | Coronary Artery Disease | Completed | 2003-10-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00191048 | Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD | Phase4 | Attention-Deficit/Hyperactivity Disorder | Completed | 2003-10-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00191009 | Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer'… | Phase2 | Alzheimer Disease | Completed | 2003-10-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00190749 | Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and … | Phase4 | Schizophrenia | Completed | 2003-10-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00190749 | Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and … | Phase4 | Schizophrenia | Completed | 2003-10-01 | 2008-06-01 | ClinicalTrials.gov |
| NCT00169819 | EArly Discharge After Transradial Stenting of CoronarY Arteries: The EASY Study | Phase4 | Coronary Artery Disease | Completed | 2003-10-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00191048 | Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD | Phase4 | Attention-Deficit/Hyperactivity Disorder | Completed | 2003-10-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00088049 | Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia | Phase4 | Schizophrenia | Completed | 2003-10-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00073372 | A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemi… | Phase3 | Cerebrovascular Accident | Terminated | 2003-10-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00381732 | A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given On… | Phase3 | Erectile Dysfunction | Completed | 2003-10-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00390182 | Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients … | Phase1 | Gastrointestinal Neoplasms | Completed | 2003-10-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00191802 | Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Pa… | Phase3 | Osteoporosis | Completed | 2003-09-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00190840 | A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-… | Phase2 | Carcinoma, Non-Small Cell Lung | Completed | 2003-09-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00193596 | Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Car… | Phase3 | Neoplasms, Unknown Primary | Completed | 2003-09-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00100776 | Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoa… | Phase4 | Schizophrenia | Completed | 2003-09-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00742157 | Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients… | Phase4 | Short Bowel Syndrome | Terminated | 2003-09-01 | 2008-10-20 | ClinicalTrials.gov |
| NCT00191893 | Bone Effects of Teriparatide Following Alendronate | Phase3 | Osteoporosis | Completed | 2003-09-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00191802 | Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Pa… | Phase3 | Osteoporosis | Completed | 2003-09-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00069875 | A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2003-09-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00063401 | Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advan… | Phase2 | Ovarian Cancer | Completed | 2003-09-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00063401 | Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advan… | Phase2 | Ovarian Cancer | Completed | 2003-09-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00193596 | Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Car… | Phase3 | Neoplasms, Unknown Primary | Completed | 2003-09-01 | 2009-06-01 | ClinicalTrials.gov |
| NCT00490659 | Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Ch… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2003-09-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT00100776 | Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoa… | Phase4 | Schizophrenia | Completed | 2003-09-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00069875 | A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2003-09-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00742157 | Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients… | Phase4 | Short Bowel Syndrome | Terminated | 2003-09-01 | 2008-10-20 | ClinicalTrials.gov |
| NCT00486122 | Evaluation of Continuous Symptom Treatment of ADHD | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2003-09-01 | 2004-06-01 | ClinicalTrials.gov |
| NCT00190840 | A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-… | Phase2 | Carcinoma, Non-Small Cell Lung | Completed | 2003-09-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00190827 | Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Unc… | Phase3 | Urinary Incontinence, Stress | Completed | 2003-09-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00190814 | Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Du… | Phase3 | Urinary Incontinence, Stress | Completed | 2003-09-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00490659 | Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Ch… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2003-09-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT00087698 | Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery an… | Phase2 | Pleural Neoplasms | Completed | 2003-09-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00190801 | Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced G… | Phase2 | Gastrointestinal Neoplasms | Completed | 2003-09-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00191893 | Bone Effects of Teriparatide Following Alendronate | Phase3 | Osteoporosis | Completed | 2003-09-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00085969 | Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diab… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2003-09-01 | 2004-01-01 | ClinicalTrials.gov |
| NCT00190801 | Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced G… | Phase2 | Gastrointestinal Neoplasms | Completed | 2003-09-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00087698 | Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery an… | Phase2 | Pleural Neoplasms | Completed | 2003-09-01 | 2008-02-01 | ClinicalTrials.gov |
| NCT00190814 | Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Du… | Phase3 | Urinary Incontinence, Stress | Completed | 2003-09-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00085969 | Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diab… | Phase2 | Diabetes Mellitus, Type 2 | Completed | 2003-09-01 | 2004-01-01 | ClinicalTrials.gov |
| NCT00486122 | Evaluation of Continuous Symptom Treatment of ADHD | Phase4 | Attention Deficit Hyperactivity Disorder | Completed | 2003-09-01 | 2004-06-01 | ClinicalTrials.gov |
| NCT00190827 | Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Unc… | Phase3 | Urinary Incontinence, Stress | Completed | 2003-09-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00191178 | Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes | Phase4 | Type 2 Diabetes | Completed | 2003-08-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT01078805 | Study of FORTEO Use in Subjects in the Community Setting | — | Osteoporosis | Completed | 2003-08-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00542984 | Comparison Medications in the Treatment of Postmenopausal Women With Osteoporos… | Phase3 | Osteoporosis, Postmenopausal | Completed | 2003-08-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT00489242 | Prediction of CK-MB Release During Otherwise Successful Stenting Procedure | Na | Diabetes Mellitus | Completed | 2003-08-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00191555 | Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional… | Phase4 | Schizophrenia | Completed | 2003-08-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT01078805 | Study of FORTEO Use in Subjects in the Community Setting | — | Osteoporosis | Completed | 2003-08-01 | 2011-02-01 | ClinicalTrials.gov |
| NCT00489242 | Prediction of CK-MB Release During Otherwise Successful Stenting Procedure | Na | Diabetes Mellitus | Completed | 2003-08-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00191178 | Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes | Phase4 | Type 2 Diabetes | Completed | 2003-08-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00191555 | Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional… | Phase4 | Schizophrenia | Completed | 2003-08-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00542984 | Comparison Medications in the Treatment of Postmenopausal Women With Osteoporos… | Phase3 | Osteoporosis, Postmenopausal | Completed | 2003-08-01 | 2004-11-01 | ClinicalTrials.gov |
| NCT00547417 | To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and… | Phase3 | Impotence | Completed | 2003-07-01 | 2004-03-01 | ClinicalTrials.gov |
| NCT00490711 | Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplat… | Phase2 | Epithelial Ovarian Cancer | Completed | 2003-07-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00491114 | Intravesical Chemotherapy Treatment of Superficial Bladder Cancer | Phase2 | Bladder Neoplasms | Completed | 2003-07-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT00121446 | Which Therapy for Acute Heart Attacks? (The WEST Study) | Phase2 | Myocardial Infarction | Completed | 2003-07-01 | — | ClinicalTrials.gov |
| NCT00071695 | Duloxetine vs. Active Comparator in the Treatment of Patients With Depression | Phase4 | Depression | Completed | 2003-07-01 | 2004-05-01 | ClinicalTrials.gov |
| NCT00485407 | Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of At… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2003-07-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00121446 | Which Therapy for Acute Heart Attacks? (The WEST Study) | Phase2 | Myocardial Infarction | Completed | 2003-07-01 | — | ClinicalTrials.gov |
| NCT00071695 | Duloxetine vs. Active Comparator in the Treatment of Patients With Depression | Phase4 | Depression | Completed | 2003-07-01 | 2004-05-01 | ClinicalTrials.gov |
| NCT00491114 | Intravesical Chemotherapy Treatment of Superficial Bladder Cancer | Phase2 | Bladder Neoplasms | Completed | 2003-07-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT00490711 | Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplat… | Phase2 | Epithelial Ovarian Cancer | Completed | 2003-07-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00547417 | To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and… | Phase3 | Impotence | Completed | 2003-07-01 | 2004-03-01 | ClinicalTrials.gov |
| NCT00485407 | Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of At… | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2003-07-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00489983 | Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced L… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2003-07-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT00063570 | Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receivin… | Phase2 | Breast Cancer | Completed | 2003-07-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00489983 | Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced L… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2003-07-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT00063570 | Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receivin… | Phase2 | Breast Cancer | Completed | 2003-07-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00169702 | The Effect of a Weight Management Program During Treatment With Olanzapine | Na | Schizophrenia | Completed | 2003-06-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00192075 | A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid… | Phase2 | Colorectal Cancer | Completed | 2003-06-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00485862 | Combination Therapy in Patients With Depression | Phase4 | Depressive Symptoms | Completed | 2003-06-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00082381 | Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabete… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2003-06-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00169702 | The Effect of a Weight Management Program During Treatment With Olanzapine | Na | Schizophrenia | Completed | 2003-06-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00359047 | Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme | Na | Osteoporosis | Unknown | 2003-06-01 | 2025-12-01 | ClinicalTrials.gov |
| NCT00192075 | A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid… | Phase2 | Colorectal Cancer | Completed | 2003-06-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00543023 | A Study of the Treatment of Postmenopausal Women With Osteoporosis | Phase3 | Osteoporosis, Post-Menopausal | Completed | 2003-06-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT00485862 | Combination Therapy in Patients With Depression | Phase4 | Depressive Symptoms | Completed | 2003-06-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00359047 | Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme | Na | Osteoporosis | Unknown | 2003-06-01 | 2025-12-01 | ClinicalTrials.gov |
| NCT00082381 | Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabete… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2003-06-01 | 2008-07-01 | ClinicalTrials.gov |
| NCT00072865 | Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer | Phase2 | Breast Cancer | Completed | 2003-06-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00072865 | Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer | Phase2 | Breast Cancer | Completed | 2003-06-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00543023 | A Study of the Treatment of Postmenopausal Women With Osteoporosis | Phase3 | Osteoporosis, Post-Menopausal | Completed | 2003-06-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT00551538 | 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine | Phase4 | Type 2 Diabetes | Completed | 2003-05-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT00551538 | 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine | Phase4 | Type 2 Diabetes | Completed | 2003-05-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT00065533 | Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer | Phase2 | Breast Cancer | Completed | 2003-05-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00206375 | Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism | Phase4 | Hypothyroidism | Terminated | 2003-05-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT00063388 | Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer | Phase2 | Non-Small-Cell Lung Cancer | Completed | 2003-05-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00065533 | Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer | Phase2 | Breast Cancer | Completed | 2003-05-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00063388 | Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer | Phase2 | Non-Small-Cell Lung Cancer | Completed | 2003-05-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00220571 | CARESS in Acute Myocardial Infarction | Phase3 | Myocardial Infarction | Completed | 2003-05-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00220571 | CARESS in Acute Myocardial Infarction | Phase3 | Myocardial Infarction | Completed | 2003-05-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00206375 | Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism | Phase4 | Hypothyroidism | Terminated | 2003-05-01 | 2011-11-01 | ClinicalTrials.gov |
| NCT00059215 | A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing … | Phase2 | Cardiovascular Diseases | Completed | 2003-04-01 | 2004-01-01 | ClinicalTrials.gov |
| NCT00067912 | Duloxetine vs. Active Comparator for the Treatment of Depression | Phase4 | Depression | Completed | 2003-04-01 | 2004-03-01 | ClinicalTrials.gov |
| NCT00547573 | Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Need… | Phase3 | Impotence | Completed | 2003-04-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT00059215 | A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing … | Phase2 | Cardiovascular Diseases | Completed | 2003-04-01 | 2004-01-01 | ClinicalTrials.gov |
| NCT00485498 | Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics | Phase4 | Schizophrenia | Completed | 2003-04-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT00491127 | Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-H… | Phase2 | Non-Hodgkin's Lymphoma | Completed | 2003-04-01 | 2004-06-01 | ClinicalTrials.gov |
| NCT00532428 | Long Term Effects of Raloxifene Treatment on Bone Quality | Phase4 | Osteoporosis, Post-Menopausal | Completed | 2003-04-01 | 2003-09-01 | ClinicalTrials.gov |
| NCT00532545 | Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis | Phase4 | Osteoporosis, Post-Menopausal | Completed | 2003-04-01 | 2004-04-01 | ClinicalTrials.gov |
| NCT00491127 | Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-H… | Phase2 | Non-Hodgkin's Lymphoma | Completed | 2003-04-01 | 2004-06-01 | ClinicalTrials.gov |
| NCT00063141 | Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in… | Phase3 | Colorectal Cancer | Completed | 2003-04-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00063128 | Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 … | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2003-04-01 | 2004-04-01 | ClinicalTrials.gov |
| NCT00547599 | Determine If the Stress That Comes With Not Developing an Erection Affects Tada… | Phase4 | Impotence | Completed | 2003-04-01 | 2004-01-01 | ClinicalTrials.gov |
| NCT00485628 | Safety Study in Outpatient Japanese Children With ADHD | Phase2 | Attention Deficit Hyperactivity Disorder | Completed | 2003-04-01 | 2003-10-01 | ClinicalTrials.gov |
| NCT00547599 | Determine If the Stress That Comes With Not Developing an Erection Affects Tada… | Phase4 | Impotence | Completed | 2003-04-01 | 2004-01-01 | ClinicalTrials.gov |
| NCT00532428 | Long Term Effects of Raloxifene Treatment on Bone Quality | Phase4 | Osteoporosis, Post-Menopausal | Completed | 2003-04-01 | 2003-09-01 | ClinicalTrials.gov |
| NCT00169195 | Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell… | Phase2 | Diffuse Large Cell Lymphoma | Completed | 2003-04-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT00475358 | Efficacy and Safety Stress Urinary Incontinence Study | Phase3 | Urinary Incontinence, Stress | Completed | 2003-04-01 | 2005-02-01 | ClinicalTrials.gov |
| NCT00485628 | Safety Study in Outpatient Japanese Children With ADHD | Phase2 | Attention Deficit Hyperactivity Disorder | Completed | 2003-04-01 | 2003-10-01 | ClinicalTrials.gov |
| NCT00532545 | Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis | Phase4 | Osteoporosis, Post-Menopausal | Completed | 2003-04-01 | 2004-04-01 | ClinicalTrials.gov |
| NCT00547573 | Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Need… | Phase3 | Impotence | Completed | 2003-04-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT00063128 | Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 … | Phase2 | Diabetes Mellitus, Type 1 | Completed | 2003-04-01 | 2004-04-01 | ClinicalTrials.gov |
| NCT00063141 | Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in… | Phase3 | Colorectal Cancer | Completed | 2003-04-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00485498 | Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics | Phase4 | Schizophrenia | Completed | 2003-04-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT00067912 | Duloxetine vs. Active Comparator for the Treatment of Depression | Phase4 | Depression | Completed | 2003-04-01 | 2004-03-01 | ClinicalTrials.gov |
| NCT00169195 | Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell… | Phase2 | Diffuse Large Cell Lymphoma | Completed | 2003-04-01 | 2012-11-01 | ClinicalTrials.gov |
| NCT00475358 | Efficacy and Safety Stress Urinary Incontinence Study | Phase3 | Urinary Incontinence, Stress | Completed | 2003-04-01 | 2005-02-01 | ClinicalTrials.gov |
| NCT00062673 | Study of Duloxetine in Elderly Patients With Major Depressive Disorder | Phase3 | Depression | Completed | 2003-03-01 | 2004-07-01 | ClinicalTrials.gov |
| NCT00061815 | Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patient… | Phase3 | Colorectal Cancer | Completed | 2003-03-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00062673 | Study of Duloxetine in Elderly Patients With Major Depressive Disorder | Phase3 | Depression | Completed | 2003-03-01 | 2004-07-01 | ClinicalTrials.gov |
| NCT00067730 | A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Canc… | Phase4 | Sepsis | Completed | 2003-03-01 | 2003-10-01 | ClinicalTrials.gov |
| NCT00532246 | Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Place… | Phase4 | Osteoporosis, Post-Menopausal | Completed | 2003-03-01 | 2003-08-01 | ClinicalTrials.gov |
| NCT00128856 | Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breas… | Phase2 | Breast Cancer | Completed | 2003-03-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT00191828 | A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its … | Phase4 | Weight Gain | Completed | 2003-03-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT00490399 | Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Ca… | Phase2 | Biliary Tract Carcinoma | Completed | 2003-03-01 | 2004-09-01 | ClinicalTrials.gov |
| NCT00176813 | Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer | Phase2 | Pancreatic Cancer | Completed | 2003-03-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00191139 | Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiat… | Phase2 | Non-small Cell Lung Cancer | Completed | 2003-03-01 | 2009-02-01 | ClinicalTrials.gov |
| NCT00532246 | Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Place… | Phase4 | Osteoporosis, Post-Menopausal | Completed | 2003-03-01 | 2003-08-01 | ClinicalTrials.gov |
| NCT00176813 | Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer | Phase2 | Pancreatic Cancer | Completed | 2003-03-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00191139 | Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiat… | Phase2 | Non-small Cell Lung Cancer | Completed | 2003-03-01 | 2009-02-01 | ClinicalTrials.gov |
| NCT00128856 | Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breas… | Phase2 | Breast Cancer | Completed | 2003-03-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT00465387 | FORCE (Falls, Fracture, and Osteoporosis Risk Control Evaluation) Study | Na | Osteoporosis | Completed | 2003-03-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00465387 | FORCE (Falls, Fracture, and Osteoporosis Risk Control Evaluation) Study | Na | Osteoporosis | Completed | 2003-03-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00191828 | A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its … | Phase4 | Weight Gain | Completed | 2003-03-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT00490399 | Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Ca… | Phase2 | Biliary Tract Carcinoma | Completed | 2003-03-01 | 2004-09-01 | ClinicalTrials.gov |
| NCT00067730 | A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Canc… | Phase4 | Sepsis | Completed | 2003-03-01 | 2003-10-01 | ClinicalTrials.gov |
| NCT00061815 | Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patient… | Phase3 | Colorectal Cancer | Completed | 2003-03-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00050609 | Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upse… | Phase2 | Gastroparesis | Completed | 2003-02-01 | 2003-09-01 | ClinicalTrials.gov |
| NCT00191789 | Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operab… | Phase2 | Breast Cancer | Completed | 2003-02-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00050609 | Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upse… | Phase2 | Gastroparesis | Completed | 2003-02-01 | 2003-09-01 | ClinicalTrials.gov |
| NCT00055419 | A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer | Phase2 | Colorectal Neoplasms | Completed | 2003-02-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT00191789 | Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operab… | Phase2 | Breast Cancer | Completed | 2003-02-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00055419 | A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer | Phase2 | Colorectal Neoplasms | Completed | 2003-02-01 | 2004-08-01 | ClinicalTrials.gov |
| NCT00061464 | Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NS… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2003-02-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT00486005 | Weight Gain Management in Patients With Schizophrenia | Phase4 | Schizophrenia | Completed | 2003-02-01 | 2003-10-01 | ClinicalTrials.gov |
| NCT00061464 | Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NS… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2003-02-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT00486005 | Weight Gain Management in Patients With Schizophrenia | Phase4 | Schizophrenia | Completed | 2003-02-01 | 2003-10-01 | ClinicalTrials.gov |
| NCT00489996 | Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients W… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2003-01-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT01977300 | Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acu… | Phase3 | Bipolar I Disorder | Completed | 2003-01-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00568893 | An Open Label Study of Severe Sepsis in Adults | Phase4 | Severe Sepsis | Completed | 2003-01-01 | 2003-10-01 | ClinicalTrials.gov |
| NCT00879801 | Genetic Physiopathology and Evolution of Type 2 Diabetes | — | Pre-Diabetes | Completed | 2003-01-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00055250 | A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Canc… | Phase2 | Pancreatic Cancer | Completed | 2003-01-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00191360 | Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Pati… | Phase3 | Adult Growth Hormone Deficiency | Completed | 2003-01-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00463515 | Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiati… | Phase2 | Non-Small-Cell-Lung Cancer | Completed | 2003-01-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00879801 | Genetic Physiopathology and Evolution of Type 2 Diabetes | — | Pre-Diabetes | Completed | 2003-01-01 | 2008-12-01 | ClinicalTrials.gov |
| NCT00822471 | Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program … | Na | Diabetes | Completed | 2003-01-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00190996 | Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incont… | Phase3 | Urinary Incontinence, Stress | Completed | 2003-01-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00489996 | Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients W… | Phase2 | Non-Small Cell Lung Cancer | Completed | 2003-01-01 | 2005-06-01 | ClinicalTrials.gov |
| NCT00822471 | Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program … | Na | Diabetes | Completed | 2003-01-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00568893 | An Open Label Study of Severe Sepsis in Adults | Phase4 | Severe Sepsis | Completed | 2003-01-01 | 2003-10-01 | ClinicalTrials.gov |
| NCT01977300 | Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acu… | Phase3 | Bipolar I Disorder | Completed | 2003-01-01 | 2011-08-01 | ClinicalTrials.gov |
| NCT00055250 | A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Canc… | Phase2 | Pancreatic Cancer | Completed | 2003-01-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00190996 | Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incont… | Phase3 | Urinary Incontinence, Stress | Completed | 2003-01-01 | 2006-06-01 | ClinicalTrials.gov |
| NCT00463515 | Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiati… | Phase2 | Non-Small-Cell-Lung Cancer | Completed | 2003-01-01 | 2006-11-01 | ClinicalTrials.gov |
| NCT00191360 | Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Pati… | Phase3 | Adult Growth Hormone Deficiency | Completed | 2003-01-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00049777 | A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment … | Phase4 | Sepsis | Completed | 2002-12-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT00543218 | PTH Comparison in Post Menopausal Women | Phase3 | Osteoporosis, Post-Menopausal | Completed | 2002-12-01 | 2004-06-01 | ClinicalTrials.gov |
| NCT00042562 | Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evalua… | Phase3 | Major Depressive Disorder | Completed | 2002-12-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT00052273 | LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors | Phase1 | Adult | Completed | 2002-12-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00191841 | Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2002-12-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT00061451 | Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locall… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2002-12-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00061477 | Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malign… | Phase2 | Mesothelioma | Completed | 2002-12-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00191841 | Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2002-12-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT00543218 | PTH Comparison in Post Menopausal Women | Phase3 | Osteoporosis, Post-Menopausal | Completed | 2002-12-01 | 2004-06-01 | ClinicalTrials.gov |
| NCT00191529 | Growth Hormone Treatment in Short Children Born Small for Gestational Age | Phase3 | Infant, Small for Gestational Age | Completed | 2002-12-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00485823 | Assessment of a Weight Management Program for Weight Gain in Patients With Schi… | Phase4 | Schizophrenic Disorders | Completed | 2002-12-01 | 2003-09-01 | ClinicalTrials.gov |
| NCT00061477 | Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malign… | Phase2 | Mesothelioma | Completed | 2002-12-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00191529 | Growth Hormone Treatment in Short Children Born Small for Gestational Age | Phase3 | Infant, Small for Gestational Age | Completed | 2002-12-01 | 2007-06-01 | ClinicalTrials.gov |
| NCT00061451 | Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locall… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2002-12-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00042562 | Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evalua… | Phase3 | Major Depressive Disorder | Completed | 2002-12-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT00485823 | Assessment of a Weight Management Program for Weight Gain in Patients With Schi… | Phase4 | Schizophrenic Disorders | Completed | 2002-12-01 | 2003-09-01 | ClinicalTrials.gov |
| NCT00052273 | LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors | Phase1 | Adult | Completed | 2002-12-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00049777 | A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment … | Phase4 | Sepsis | Completed | 2002-12-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT00049764 | Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Ped… | Phase3 | Sepsis | Completed | 2002-11-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00051909 | Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease | Phase2 | Alzheimer's Disease | Completed | 2002-11-01 | 2003-06-01 | ClinicalTrials.gov |
| NCT00475696 | Urge Incontinence Bladder Overactivity Study | Phase2 | Urinary Incontinence | Completed | 2002-11-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT00183794 | Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resista… | Phase2 | Ovarian Carcinoma | Completed | 2002-11-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00049764 | Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Ped… | Phase3 | Sepsis | Completed | 2002-11-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00051558 | Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced… | Phase3 | Osteoporosis | Completed | 2002-11-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00183794 | Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resista… | Phase2 | Ovarian Carcinoma | Completed | 2002-11-01 | 2010-05-01 | ClinicalTrials.gov |
| NCT00547287 | Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting… | Phase3 | Impotence | Completed | 2002-11-01 | 2004-05-01 | ClinicalTrials.gov |
| NCT00489073 | Duloxetine Versus Placebo for Fibromyalgia | Phase3 | Fibromyalgia | Completed | 2002-11-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT00547287 | Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting… | Phase3 | Impotence | Completed | 2002-11-01 | 2004-05-01 | ClinicalTrials.gov |
| NCT00191763 | Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of… | Phase2 | Carcinoma, Non-Small-Cell-Lung Cancer | Completed | 2002-11-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00489073 | Duloxetine Versus Placebo for Fibromyalgia | Phase3 | Fibromyalgia | Completed | 2002-11-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT00191763 | Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of… | Phase2 | Carcinoma, Non-Small-Cell-Lung Cancer | Completed | 2002-11-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00051558 | Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced… | Phase3 | Osteoporosis | Completed | 2002-11-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00551356 | Lispro Mix 25 vs. Glargine in Type 2 Diabetics | Phase3 | Diabetes Mellitus Type 2 | Completed | 2002-11-01 | 2003-07-01 | ClinicalTrials.gov |
| NCT00568737 | The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis … | Phase3 | Sepsis | Completed | 2002-11-01 | 2005-02-01 | ClinicalTrials.gov |
| NCT00051298 | Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia | Phase3 | Schizophrenia | Completed | 2002-11-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00050206 | Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar… | Phase4 | Bipolar Disorder | Completed | 2002-11-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00051909 | Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease | Phase2 | Alzheimer's Disease | Completed | 2002-11-01 | 2003-06-01 | ClinicalTrials.gov |
| NCT00050206 | Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar… | Phase4 | Bipolar Disorder | Completed | 2002-11-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00475696 | Urge Incontinence Bladder Overactivity Study | Phase2 | Urinary Incontinence | Completed | 2002-11-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT00568737 | The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis … | Phase3 | Sepsis | Completed | 2002-11-01 | 2005-02-01 | ClinicalTrials.gov |
| NCT00051298 | Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia | Phase3 | Schizophrenia | Completed | 2002-11-01 | 2005-04-01 | ClinicalTrials.gov |
| NCT00551356 | Lispro Mix 25 vs. Glargine in Type 2 Diabetics | Phase3 | Diabetes Mellitus Type 2 | Completed | 2002-11-01 | 2003-07-01 | ClinicalTrials.gov |
| NCT00191646 | An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That… | Phase3 | Genital Neoplasms, Female | Completed | 2002-10-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00191646 | An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That… | Phase3 | Genital Neoplasms, Female | Completed | 2002-10-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00191438 | Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agen… | Phase3 | Breast Neoplasms | Completed | 2002-10-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00547508 | To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Er… | Phase3 | Impotence | Completed | 2002-10-01 | 2003-09-01 | ClinicalTrials.gov |
| NCT00058968 | A Study for the Treatment of Painful Diabetic Neuropathy | Phase3 | Diabetic Neuropathy, Painful | Completed | 2002-10-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT00191815 | Combination Chemotherapy for Metastatic Breast Cancer | Phase2 | Breast Cancer | Completed | 2002-10-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00191438 | Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agen… | Phase3 | Breast Neoplasms | Completed | 2002-10-01 | 2007-03-01 | ClinicalTrials.gov |
| NCT00547508 | To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Er… | Phase3 | Impotence | Completed | 2002-10-01 | 2003-09-01 | ClinicalTrials.gov |
| NCT00191282 | Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2002-10-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00191282 | Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes | Phase4 | Diabetes Mellitus, Type 2 | Completed | 2002-10-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00058968 | A Study for the Treatment of Painful Diabetic Neuropathy | Phase3 | Diabetic Neuropathy, Painful | Completed | 2002-10-01 | 2005-03-01 | ClinicalTrials.gov |
| NCT00190723 | A Study of LY317615 in Patients With Brain Tumors | Phase2 | Malignant Glioma | Completed | 2002-10-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00191815 | Combination Chemotherapy for Metastatic Breast Cancer | Phase2 | Breast Cancer | Completed | 2002-10-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00191568 | Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely … | Phase2 | Pancreatic Neoplasms | Completed | 2002-10-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00190723 | A Study of LY317615 in Patients With Brain Tumors | Phase2 | Malignant Glioma | Completed | 2002-10-01 | 2006-12-01 | ClinicalTrials.gov |
| NCT00191568 | Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely … | Phase2 | Pancreatic Neoplasms | Completed | 2002-10-01 | 2007-05-01 | ClinicalTrials.gov |
| NCT00046930 | Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly D… | Phase3 | Leukemia | Completed | 2002-09-17 | — | ClinicalTrials.gov |
| NCT00046930 | Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly D… | Phase3 | Leukemia | Completed | 2002-09-17 | — | ClinicalTrials.gov |
| NCT01088399 | A Prospective Observational Study of Effect of Somatropin on Growth Hormone Def… | — | Hypopituitarism | Completed | 2002-09-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00045760 | The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients … | Phase4 | Sepsis | Completed | 2002-09-01 | — | ClinicalTrials.gov |
| NCT00485420 | eCare for Moods: An Internet-based Management Program | Na | Major Depressive Disorder | Completed | 2002-09-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT00485420 | eCare for Moods: An Internet-based Management Program | Na | Major Depressive Disorder | Completed | 2002-09-01 | 2009-12-01 | ClinicalTrials.gov |
| NCT01088399 | A Prospective Observational Study of Effect of Somatropin on Growth Hormone Def… | — | Hypopituitarism | Completed | 2002-09-01 | 2012-12-01 | ClinicalTrials.gov |
| NCT00045760 | The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients … | Phase4 | Sepsis | Completed | 2002-09-01 | — | ClinicalTrials.gov |
| NCT00044668 | Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients Wi… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2002-08-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00046228 | A Study of Abciximab and Reteplase When Administered Prior to Catherization Aft… | Phase3 | Myocardial Infarction | Completed | 2002-08-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00044863 | Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma | Phase2 | Colorectal Neoplasms | Completed | 2002-08-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00191425 | 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxife… | Phase4 | Osteoporosis, Postmenopausal | Completed | 2002-08-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00044863 | Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma | Phase2 | Colorectal Neoplasms | Completed | 2002-08-01 | 2005-12-01 | ClinicalTrials.gov |
| NCT00191425 | 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxife… | Phase4 | Osteoporosis, Postmenopausal | Completed | 2002-08-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00044668 | Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients Wi… | Phase3 | Diabetes Mellitus, Type 2 | Completed | 2002-08-01 | 2005-09-01 | ClinicalTrials.gov |
| NCT00046228 | A Study of Abciximab and Reteplase When Administered Prior to Catherization Aft… | Phase3 | Myocardial Infarction | Completed | 2002-08-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00194064 | Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine | Phase3 | Bipolar Disorder | Terminated | 2002-07-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT00191490 | A Randomized Study Evaluating the Feasibility and Activity of Three Different C… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2002-07-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00044395 | Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes | Phase3 | Diabetic Neuropathies | Completed | 2002-07-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00044421 | Treatment of Peripheral Neuropathy in Patients With Diabetes | Phase3 | Diabetic Neuropathies | Completed | 2002-07-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT00123825 | Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer | Phase2 | Gallbladder Cancer | Completed | 2002-07-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00759226 | Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Es… | Phase2 | Esophageal Cancer | Completed | 2002-07-01 | 2007-08-01 | ClinicalTrials.gov |
| NCT00191607 | A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or P… | Phase3 | Genital Neoplasms, Female | Completed | 2002-07-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00191490 | A Randomized Study Evaluating the Feasibility and Activity of Three Different C… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2002-07-01 | 2005-05-01 | ClinicalTrials.gov |
| NCT00044395 | Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes | Phase3 | Diabetic Neuropathies | Completed | 2002-07-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00044421 | Treatment of Peripheral Neuropathy in Patients With Diabetes | Phase3 | Diabetic Neuropathies | Completed | 2002-07-01 | 2006-10-01 | ClinicalTrials.gov |
| NCT00123825 | Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer | Phase2 | Gallbladder Cancer | Completed | 2002-07-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00194064 | Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine | Phase3 | Bipolar Disorder | Terminated | 2002-07-01 | 2006-02-01 | ClinicalTrials.gov |
| NCT00191607 | A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or P… | Phase3 | Genital Neoplasms, Female | Completed | 2002-07-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00759226 | Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Es… | Phase2 | Esophageal Cancer | Completed | 2002-07-01 | 2007-08-01 | ClinicalTrials.gov |
| NCT00042679 | A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2002-06-01 | — | ClinicalTrials.gov |
| NCT00042575 | Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Dail… | Phase3 | Major Depressive Disorder | Completed | 2002-06-01 | 2002-08-01 | ClinicalTrials.gov |
| NCT00042666 | A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphom… | Phase2 | Non-Hodgkin's Lymphoma | Completed | 2002-06-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00042679 | A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2002-06-01 | — | ClinicalTrials.gov |
| NCT00042666 | A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphom… | Phase2 | Non-Hodgkin's Lymphoma | Completed | 2002-06-01 | 2008-09-01 | ClinicalTrials.gov |
| NCT00042575 | Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Dail… | Phase3 | Major Depressive Disorder | Completed | 2002-06-01 | 2002-08-01 | ClinicalTrials.gov |
| NCT00036309 | Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Diso… | Phase3 | Depressive Disorder | Completed | 2002-05-01 | 2003-07-01 | ClinicalTrials.gov |
| NCT00191100 | Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and R… | Phase3 | Cancer of Cervix | Completed | 2002-05-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00191100 | Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and R… | Phase3 | Cancer of Cervix | Completed | 2002-05-01 | 2008-04-01 | ClinicalTrials.gov |
| NCT00036309 | Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Diso… | Phase3 | Depressive Disorder | Completed | 2002-05-01 | 2003-07-01 | ClinicalTrials.gov |
| NCT00051493 | ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Ad… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2002-04-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT00051493 | ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Ad… | Phase2 | Carcinoma, Non-Small-Cell Lung | Completed | 2002-04-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT00035321 | The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatme… | Phase3 | Major Depressive Disorder | Completed | 2002-04-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00035321 | The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatme… | Phase3 | Major Depressive Disorder | Completed | 2002-04-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00036335 | Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing V… | Phase3 | Depression | Completed | 2002-03-01 | 2003-01-01 | ClinicalTrials.gov |
| NCT00191243 | Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer | Phase2 | Breast Cancer | Completed | 2002-03-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00191243 | Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer | Phase2 | Breast Cancer | Completed | 2002-03-01 | 2009-04-01 | ClinicalTrials.gov |
| NCT00202800 | Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Me… | Phase2 | Pancreatic Cancer | Completed | 2002-03-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00191373 | A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease | Phase2 | Breast Neoplasms | Completed | 2002-03-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00034554 | Study of gp75 Vaccine in Patients With Stage III and IV Melanoma | Phase1 | Malignant Melanoma | Completed | 2002-03-01 | 2004-09-01 | ClinicalTrials.gov |
| NCT00034268 | A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine a… | Phase3 | Carcinoma, Non-Small-Cell Lung | Completed | 2002-03-01 | — | ClinicalTrials.gov |
| NCT00034268 | A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine a… | Phase3 | Carcinoma, Non-Small-Cell Lung | Completed | 2002-03-01 | — | ClinicalTrials.gov |
| NCT00036335 | Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing V… | Phase3 | Depression | Completed | 2002-03-01 | 2003-01-01 | ClinicalTrials.gov |
| NCT00034554 | Study of gp75 Vaccine in Patients With Stage III and IV Melanoma | Phase1 | Malignant Melanoma | Completed | 2002-03-01 | 2004-09-01 | ClinicalTrials.gov |
| NCT00191373 | A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease | Phase2 | Breast Neoplasms | Completed | 2002-03-01 | 2007-07-01 | ClinicalTrials.gov |
| NCT00202800 | Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Me… | Phase2 | Pancreatic Cancer | Completed | 2002-03-01 | 2011-01-01 | ClinicalTrials.gov |
| NCT00191152 | A Phase III Trial For Patients With Metastatic Breast Cancer | Phase3 | Breast Cancer | Completed | 2002-02-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00332553 | Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combina… | Phase2 | Vasomotor Symptoms | Completed | 2002-02-01 | 2004-05-01 | ClinicalTrials.gov |
| NCT00332553 | Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combina… | Phase2 | Vasomotor Symptoms | Completed | 2002-02-01 | 2004-05-01 | ClinicalTrials.gov |
| NCT00191152 | A Phase III Trial For Patients With Metastatic Breast Cancer | Phase3 | Breast Cancer | Completed | 2002-02-01 | 2008-11-01 | ClinicalTrials.gov |
| NCT00190606 | Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in … | Phase2 | Urinary Stress Incontinence | Completed | 2002-01-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00190606 | Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in … | Phase2 | Urinary Stress Incontinence | Completed | 2002-01-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT02046304 | PP-Gemcitabine & External Beam Radiation-Sarcomas | Phase1 | Sarcoma | Completed | 2001-12-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02046304 | PP-Gemcitabine & External Beam Radiation-Sarcomas | Phase1 | Sarcoma | Completed | 2001-12-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT00193050 | Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammato… | Phase2 | Breast Cancer | Completed | 2001-11-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00193050 | Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammato… | Phase2 | Breast Cancer | Completed | 2001-11-01 | 2009-03-01 | ClinicalTrials.gov |
| NCT00035256 | Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenop… | Phase4 | Osteoporosis, Postmenopausal | Completed | 2001-10-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00190567 | Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in… | Phase2 | Urinary Stress Incontinence | Completed | 2001-10-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00035256 | Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenop… | Phase4 | Osteoporosis, Postmenopausal | Completed | 2001-10-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00034476 | A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Pat… | Phase1 | Sepsis | Completed | 2001-10-01 | 2002-10-01 | ClinicalTrials.gov |
| NCT00034476 | A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Pat… | Phase1 | Sepsis | Completed | 2001-10-01 | 2002-10-01 | ClinicalTrials.gov |
| NCT00190567 | Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in… | Phase2 | Urinary Stress Incontinence | Completed | 2001-10-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00190762 | A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive C… | Phase3 | Mesothelioma | Completed | 2001-10-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00190762 | A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive C… | Phase3 | Mesothelioma | Completed | 2001-10-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00191204 | Open Label Phase III Duloxetine Study for Stress Urinary Incontinence | Phase3 | Urinary Incontinence Stress | Completed | 2001-09-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00191230 | Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patie… | Phase2 | Carcinoma, Non Small Cell Lung | Completed | 2001-09-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00191204 | Open Label Phase III Duloxetine Study for Stress Urinary Incontinence | Phase3 | Urinary Incontinence Stress | Completed | 2001-09-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00034801 | Olanzapine Versus Active Comparator in the Treatment of Depression in Patients … | Phase4 | Depression | Completed | 2001-09-01 | 2003-03-01 | ClinicalTrials.gov |
| NCT00034801 | Olanzapine Versus Active Comparator in the Treatment of Depression in Patients … | Phase4 | Depression | Completed | 2001-09-01 | 2003-03-01 | ClinicalTrials.gov |
| NCT00191230 | Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patie… | Phase2 | Carcinoma, Non Small Cell Lung | Completed | 2001-09-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00036504 | Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Onc… | Phase4 | Type 2 Diabetes Mellitus | Completed | 2001-08-01 | 2002-08-01 | ClinicalTrials.gov |
| NCT00036062 | A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects… | Phase1 | Respiratory Distress Syndrome, Adult | Completed | 2001-08-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT00036062 | A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects… | Phase1 | Respiratory Distress Syndrome, Adult | Completed | 2001-08-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT00036088 | Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia | Phase4 | Schizophrenia | Completed | 2001-08-01 | 2002-07-01 | ClinicalTrials.gov |
| NCT00034580 | Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder | Phase4 | Bipolar Disorder | Completed | 2001-08-01 | 2002-08-01 | ClinicalTrials.gov |
| NCT00036088 | Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia | Phase4 | Schizophrenia | Completed | 2001-08-01 | 2002-07-01 | ClinicalTrials.gov |
| NCT00034580 | Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder | Phase4 | Bipolar Disorder | Completed | 2001-08-01 | 2002-08-01 | ClinicalTrials.gov |
| NCT00036504 | Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Onc… | Phase4 | Type 2 Diabetes Mellitus | Completed | 2001-08-01 | 2002-08-01 | ClinicalTrials.gov |
| NCT00193063 | Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epid… | Phase2 | Breast Cancer | Completed | 2001-07-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00193063 | Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epid… | Phase2 | Breast Cancer | Completed | 2001-07-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT00245648 | Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic… | Phase3 | Myocardial Infarction | Completed | 2001-06-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00449553 | Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of… | — | Diabetes Mellitus | Completed | 2001-06-01 | 2003-09-01 | ClinicalTrials.gov |
| NCT00191256 | Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy … | Phase2 | Carcinoma, Non Small Cell Lung | Completed | 2001-06-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00191256 | Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy … | Phase2 | Carcinoma, Non Small Cell Lung | Completed | 2001-06-01 | 2006-07-01 | ClinicalTrials.gov |
| NCT00449553 | Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of… | — | Diabetes Mellitus | Completed | 2001-06-01 | 2003-09-01 | ClinicalTrials.gov |
| NCT00245648 | Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic… | Phase3 | Myocardial Infarction | Completed | 2001-06-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT01004731 | Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in C… | Phase1 | Stage IV Non-Small Cell Lung Cancer | Completed | 2001-06-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT01004731 | Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in C… | Phase1 | Stage IV Non-Small Cell Lung Cancer | Completed | 2001-06-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00148135 | Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carc… | Phase2 | Carcinoma of Unknown Primary | Terminated | 2001-05-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00190619 | Efficacy and Safety of Duloxetine | Phase3 | Urinary Stress Incontinence | Completed | 2001-05-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00174993 | Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabe… | Phase3 | Diabetes Mellitus | Completed | 2001-05-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00174993 | Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabe… | Phase3 | Diabetes Mellitus | Completed | 2001-05-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00148135 | Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carc… | Phase2 | Carcinoma of Unknown Primary | Terminated | 2001-05-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00190619 | Efficacy and Safety of Duloxetine | Phase3 | Urinary Stress Incontinence | Completed | 2001-05-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00149591 | The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The V… | Na | Myocardial Infarction | Unknown | 2001-04-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT00149591 | The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The V… | Na | Myocardial Infarction | Unknown | 2001-04-01 | 2007-01-01 | ClinicalTrials.gov |
| NCT02416271 | The Forteo Alendronate Comparator Trial | Phase4 | Osteoporosis | Completed | 2001-04-01 | 2003-05-01 | ClinicalTrials.gov |
| NCT00191087 | Duloxetine in the Treatment of Stress Urinary Incontinence. | Phase3 | Urinary Incontinence, Stress | Completed | 2001-04-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00044187 | The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associate… | Phase4 | Schizophrenia | Completed | 2001-04-01 | 2003-09-01 | ClinicalTrials.gov |
| NCT00191087 | Duloxetine in the Treatment of Stress Urinary Incontinence. | Phase3 | Urinary Incontinence, Stress | Completed | 2001-04-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00044187 | The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associate… | Phase4 | Schizophrenia | Completed | 2001-04-01 | 2003-09-01 | ClinicalTrials.gov |
| NCT02416271 | The Forteo Alendronate Comparator Trial | Phase4 | Osteoporosis | Completed | 2001-04-01 | 2003-05-01 | ClinicalTrials.gov |
| NCT00190632 | To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Inconti… | Phase3 | Stress Urinary Incontinence | Completed | 2001-03-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00190632 | To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Inconti… | Phase3 | Stress Urinary Incontinence | Completed | 2001-03-01 | 2006-04-01 | ClinicalTrials.gov |
| NCT00190645 | To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinen… | Phase3 | Stress Urinary Incontinence | Completed | 2001-02-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00190645 | To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinen… | Phase3 | Stress Urinary Incontinence | Completed | 2001-02-01 | 2006-05-01 | ClinicalTrials.gov |
| NCT00191074 | Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopath… | Phase3 | Growth Disorder | Completed | 2001-02-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00191074 | Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopath… | Phase3 | Growth Disorder | Completed | 2001-02-01 | 2006-01-01 | ClinicalTrials.gov |
| NCT00128310 | Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Pat… | Phase3 | Breast Cancer | Completed | 2001-01-18 | 2008-01-24 | ClinicalTrials.gov |
| NCT00128310 | Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Pat… | Phase3 | Breast Cancer | Completed | 2001-01-18 | 2008-01-24 | ClinicalTrials.gov |
| NCT00140998 | Estrogen Treatment (Oral vs. Patches) in Turner Syndrome | Phase3 | Turner Syndrome | Completed | 2001-01-01 | 2004-06-01 | ClinicalTrials.gov |
| NCT00140998 | Estrogen Treatment (Oral vs. Patches) in Turner Syndrome | Phase3 | Turner Syndrome | Completed | 2001-01-01 | 2004-06-01 | ClinicalTrials.gov |
| NCT00190697 | A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in … | Phase4 | Breast Cancer | Completed | 2001-01-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00190697 | A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in … | Phase4 | Breast Cancer | Completed | 2001-01-01 | 2007-04-01 | ClinicalTrials.gov |
| NCT00014209 | Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Res… | Phase2 | Lymphoma | Completed | 2000-12-12 | 2009-02-10 | ClinicalTrials.gov |
| NCT00014209 | Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Res… | Phase2 | Lymphoma | Completed | 2000-12-12 | 2009-02-10 | ClinicalTrials.gov |
| NCT00157560 | Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed… | Phase2 | Ovarian Cancer | Completed | 2000-12-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00157560 | Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed… | Phase2 | Ovarian Cancer | Completed | 2000-12-01 | 2005-07-01 | ClinicalTrials.gov |
| NCT00034541 | Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell… | Phase1 | Carcinoma, Non-Small-Cell Lung | Completed | 2000-12-01 | 2003-05-01 | ClinicalTrials.gov |
| NCT00034541 | Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell… | Phase1 | Carcinoma, Non-Small-Cell Lung | Completed | 2000-12-01 | 2003-05-01 | ClinicalTrials.gov |
| NCT00193310 | Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-… | Phase2 | Lung Cancer | Completed | 2000-11-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00193310 | Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-… | Phase2 | Lung Cancer | Completed | 2000-11-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00191126 | Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcit… | Phase3 | Non-Small Cell Lung Cancer | Completed | 2000-09-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00260962 | Olanzapine in the Treatment of Patients With Anorexia Nervosa | Phase2 | Anorexia Nervosa | Completed | 2000-09-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00260962 | Olanzapine in the Treatment of Patients With Anorexia Nervosa | Phase2 | Anorexia Nervosa | Completed | 2000-09-01 | 2006-09-01 | ClinicalTrials.gov |
| NCT00331487 | Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabete… | Phase3 | Diabetes Mellitus | Completed | 2000-09-01 | 2004-03-01 | ClinicalTrials.gov |
| NCT00331487 | Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabete… | Phase3 | Diabetes Mellitus | Completed | 2000-09-01 | 2004-03-01 | ClinicalTrials.gov |
| NCT00191126 | Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcit… | Phase3 | Non-Small Cell Lung Cancer | Completed | 2000-09-01 | 2007-09-01 | ClinicalTrials.gov |
| NCT00190684 | Long-Term, Open Label Atomoxetine Study | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2000-08-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00190684 | Long-Term, Open Label Atomoxetine Study | Phase3 | Attention Deficit Hyperactivity Disorder | Completed | 2000-08-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00146276 | Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advan… | Phase3 | Bladder Cancer | Unknown | 2000-07-01 | — | ClinicalTrials.gov |
| NCT00006459 | Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast C… | Phase3 | Breast Cancer | Completed | 2000-07-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00146276 | Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advan… | Phase3 | Bladder Cancer | Unknown | 2000-07-01 | — | ClinicalTrials.gov |
| NCT00006459 | Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast C… | Phase3 | Breast Cancer | Completed | 2000-07-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00212043 | Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in C… | Phase2 | Non Small Cell Lung Cancer | Completed | 2000-07-01 | 2004-02-01 | ClinicalTrials.gov |
| NCT00212043 | Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in C… | Phase2 | Non Small Cell Lung Cancer | Completed | 2000-07-01 | 2004-02-01 | ClinicalTrials.gov |
| NCT00182507 | Olanzapine in the Treatment of Hair Pulling (Trichotillomania) | Phase4 | Trichotillomania | Completed | 2000-06-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00592930 | Olanzapine in the Treatment of Anorexia Nervosa | Phase4 | Anorexia Nervosa | Completed | 2000-06-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT00182507 | Olanzapine in the Treatment of Hair Pulling (Trichotillomania) | Phase4 | Trichotillomania | Completed | 2000-06-01 | 2006-03-01 | ClinicalTrials.gov |
| NCT00592930 | Olanzapine in the Treatment of Anorexia Nervosa | Phase4 | Anorexia Nervosa | Completed | 2000-06-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT00190658 | Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome | Phase3 | Failure to Thrive | Completed | 2000-02-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00190658 | Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome | Phase3 | Failure to Thrive | Completed | 2000-02-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT00004865 | Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Canc… | Phase2 | Head and Neck Cancer | Completed | 1999-11-01 | — | ClinicalTrials.gov |
| NCT00004865 | Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Canc… | Phase2 | Head and Neck Cancer | Completed | 1999-11-01 | — | ClinicalTrials.gov |
| NCT00406926 | The Effect of Growth Hormone in Very Young Girls With Turner Syndrome | Phase3 | Turner Syndrome | Completed | 1999-08-01 | 2003-08-01 | ClinicalTrials.gov |
| NCT00406926 | The Effect of Growth Hormone in Very Young Girls With Turner Syndrome | Phase3 | Turner Syndrome | Completed | 1999-08-01 | 2003-08-01 | ClinicalTrials.gov |
| NCT00761852 | Signaling Mechanisms and Vascular Function in Diabetes Mellitus | Phase2 | Type 1 Diabetes Mellitus | Completed | 1999-05-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00003906 | Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in… | Phase3 | Breast Cancer | Completed | 1999-05-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT00003906 | Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in… | Phase3 | Breast Cancer | Completed | 1999-05-01 | 2012-08-01 | ClinicalTrials.gov |
| NCT00761852 | Signaling Mechanisms and Vascular Function in Diabetes Mellitus | Phase2 | Type 1 Diabetes Mellitus | Completed | 1999-05-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00505245 | New Assessment System in Measuring Symptom Distress in Cancer Patients | — | Caregiver | Recruiting | 1999-04-13 | 2031-04-30 | ClinicalTrials.gov |
| NCT00505245 | New Assessment System in Measuring Symptom Distress in Cancer Patients | — | Caregiver | Recruiting | 1999-04-13 | 2031-04-30 | ClinicalTrials.gov |
| NCT01088412 | Observational Study of Somatropin Treatment in Children | — | Growth Hormone (GH) Deficiency | Completed | 1999-04-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT01088412 | Observational Study of Somatropin Treatment in Children | — | Growth Hormone (GH) Deficiency | Completed | 1999-04-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT00490191 | Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone D… | Phase4 | Hypopituitarism | Completed | 1999-01-01 | 2001-07-01 | ClinicalTrials.gov |
| NCT00490191 | Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone D… | Phase4 | Hypopituitarism | Completed | 1999-01-01 | 2001-07-01 | ClinicalTrials.gov |
| NCT00003669 | Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent,… | Phase2 | Endometrial Cancer | Completed | 1998-11-01 | 2001-04-01 | ClinicalTrials.gov |
| NCT00003669 | Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent,… | Phase2 | Endometrial Cancer | Completed | 1998-11-01 | 2001-04-01 | ClinicalTrials.gov |
| NCT00003670 | Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic… | Phase2 | Ovarian Cancer | Completed | 1998-10-01 | 2001-01-01 | ClinicalTrials.gov |
| NCT00003670 | Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic… | Phase2 | Ovarian Cancer | Completed | 1998-10-01 | 2001-01-01 | ClinicalTrials.gov |
| NCT00037713 | Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) … | Phase3 | Carcinoma, Small Cell Lung | Completed | 1998-09-01 | 2002-10-01 | ClinicalTrials.gov |
| NCT00037713 | Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) … | Phase3 | Carcinoma, Small Cell Lung | Completed | 1998-09-01 | 2002-10-01 | ClinicalTrials.gov |
| NCT00169065 | Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophre… | Phase4 | Schizophrenia | Completed | 1998-08-01 | 2002-06-01 | ClinicalTrials.gov |
| NCT00169065 | Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophre… | Phase4 | Schizophrenia | Completed | 1998-08-01 | 2002-06-01 | ClinicalTrials.gov |
| NCT00190593 | Raloxifene Use for The Heart | Phase3 | Cardiovascular Diseases | Completed | 1998-06-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00190593 | Raloxifene Use for The Heart | Phase3 | Cardiovascular Diseases | Completed | 1998-06-01 | 2005-11-01 | ClinicalTrials.gov |
| NCT00007774 | To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Trea… | Phase4 | Schizoaffective Disorder | Completed | 1998-03-01 | — | ClinicalTrials.gov |
| NCT00007774 | To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Trea… | Phase4 | Schizoaffective Disorder | Completed | 1998-03-01 | — | ClinicalTrials.gov |
| NCT00018174 | Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers | Phase3 | Depression | Completed | 1998-02-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00018174 | Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers | Phase3 | Depression | Completed | 1998-02-01 | 2005-01-01 | ClinicalTrials.gov |
| NCT00208897 | Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childh… | Na | Major Depressive Disorder | Completed | 1997-12-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00208897 | Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childh… | Na | Major Depressive Disorder | Completed | 1997-12-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00919282 | Gemcitabine (GFF) in Patients With Pancreatic Cancer | Phase2 | Metastatic Pancreatic Cancer | Completed | 1997-09-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT00919282 | Gemcitabine (GFF) in Patients With Pancreatic Cancer | Phase2 | Metastatic Pancreatic Cancer | Completed | 1997-09-01 | 2002-12-01 | ClinicalTrials.gov |
| NCT00570011 | Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patie… | Phase3 | Growth Hormone Deficiency | Completed | 1997-06-01 | 1998-12-01 | ClinicalTrials.gov |
| NCT00570011 | Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patie… | Phase3 | Growth Hormone Deficiency | Completed | 1997-06-01 | 1998-12-01 | ClinicalTrials.gov |
| NCT01223001 | Feasibility Study of Duloxetine in the Treatment of Depression in Patients With… | Phase2 | Traumatic Brain Injury | Terminated | 1996-09-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT01223001 | Feasibility Study of Duloxetine in the Treatment of Depression in Patients With… | Phase2 | Traumatic Brain Injury | Terminated | 1996-09-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00670501 | Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporo… | Phase3 | Osteoporosis, Postmenopausal | Completed | 1996-08-01 | 1999-04-01 | ClinicalTrials.gov |
| NCT00670501 | Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporo… | Phase3 | Osteoporosis, Postmenopausal | Completed | 1996-08-01 | 1999-04-01 | ClinicalTrials.gov |
| NCT00670319 | Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmeno… | Phase3 | Osteoporosis, Postmenopausal | Completed | 1994-11-01 | 1999-09-01 | ClinicalTrials.gov |
| NCT00670319 | Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmeno… | Phase3 | Osteoporosis, Postmenopausal | Completed | 1994-11-01 | 1999-09-01 | ClinicalTrials.gov |
| NCT00191113 | Somatropin Treatment to Final Height in Turner Syndrome | Phase3 | Turner Syndrome | Completed | 1989-02-01 | 2007-12-01 | ClinicalTrials.gov |
| NCT00191113 | Somatropin Treatment to Final Height in Turner Syndrome | Phase3 | Turner Syndrome | Completed | 1989-02-01 | 2007-12-01 | ClinicalTrials.gov |
Total clinical trials: 5684
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Durvalumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Olomorasib | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Tirzepatide | Other | Phase PHASE1 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT07299084 |
| Placebo | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| LY3981314 | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| Tirzepatide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07438444 |
| Pirtobrutinib | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | RECRUITING | NCT06588478 |
| Standard therapy for INCS | Drug | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY3650150 | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Fluconazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| Olomorasib | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| LY4052031 | Other | Phase PHASE1 | Metastatic Solid Tumor | RECRUITING | NCT06465069 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| LY4395089 | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Pemetrexed | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Carboplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Cisplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| LY3537982 | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Orforglipron | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| enfortumab vedotin | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pembrolizumab | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LOXO-435 | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Placebo | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Muvalaplin | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Placebo | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Lepodisiran Sodium | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Tirzepatide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Lepodisiran | Other | Phase PHASE1 | Liver Dysfunction | RECRUITING | NCT06916078 |
| LY4395089 | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Durvalumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Olomorasib | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Tirzepatide | Other | Phase PHASE1 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT07299084 |
| Placebo | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| LY3981314 | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| Tirzepatide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07438444 |
| Pirtobrutinib | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | RECRUITING | NCT06588478 |
| Standard therapy for INCS | Drug | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY3650150 | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Fluconazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| Olomorasib | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| LY4052031 | Other | Phase PHASE1 | Metastatic Solid Tumor | RECRUITING | NCT06465069 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| LY4395089 | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Pemetrexed | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Carboplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Cisplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| LY3537982 | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Orforglipron | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| enfortumab vedotin | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pembrolizumab | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LOXO-435 | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Placebo | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Muvalaplin | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Placebo | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Lepodisiran Sodium | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Tirzepatide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Lepodisiran | Other | Phase PHASE1 | Liver Dysfunction | RECRUITING | NCT06916078 |
| LY4395089 | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Durvalumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Olomorasib | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Tirzepatide | Other | Phase PHASE1 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT07299084 |
| Placebo | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| LY3981314 | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| Tirzepatide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07438444 |
| Pirtobrutinib | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | RECRUITING | NCT06588478 |
| Standard therapy for INCS | Drug | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY3650150 | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Fluconazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| Olomorasib | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| LY4052031 | Other | Phase PHASE1 | Metastatic Solid Tumor | RECRUITING | NCT06465069 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| LY4395089 | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Pemetrexed | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Carboplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Cisplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| LY3537982 | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Orforglipron | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| enfortumab vedotin | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pembrolizumab | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LOXO-435 | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Placebo | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Muvalaplin | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Placebo | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Lepodisiran Sodium | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Tirzepatide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Lepodisiran | Other | Phase PHASE1 | Liver Dysfunction | RECRUITING | NCT06916078 |
| LY4395089 | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Durvalumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Olomorasib | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Tirzepatide | Other | Phase PHASE1 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT07299084 |
| Placebo | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| LY3981314 | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| Tirzepatide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07438444 |
| Pirtobrutinib | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | RECRUITING | NCT06588478 |
| Standard therapy for INCS | Drug | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY3650150 | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Fluconazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| Olomorasib | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| LY4052031 | Other | Phase PHASE1 | Metastatic Solid Tumor | RECRUITING | NCT06465069 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| LY4395089 | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Pemetrexed | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Carboplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Cisplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| LY3537982 | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Orforglipron | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| enfortumab vedotin | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pembrolizumab | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LOXO-435 | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Placebo | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Muvalaplin | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Placebo | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Lepodisiran Sodium | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Tirzepatide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Lepodisiran | Other | Phase PHASE1 | Liver Dysfunction | RECRUITING | NCT06916078 |
| LY4395089 | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Durvalumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Olomorasib | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Tirzepatide | Other | Phase PHASE1 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT07299084 |
| Placebo | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| LY3981314 | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| Tirzepatide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07438444 |
| Pirtobrutinib | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | RECRUITING | NCT06588478 |
| Standard therapy for INCS | Drug | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY3650150 | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Fluconazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| Olomorasib | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| LY4052031 | Other | Phase PHASE1 | Metastatic Solid Tumor | RECRUITING | NCT06465069 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| LY4395089 | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Pemetrexed | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Carboplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Cisplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| LY3537982 | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Orforglipron | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| enfortumab vedotin | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pembrolizumab | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LOXO-435 | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Placebo | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Muvalaplin | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Placebo | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Lepodisiran Sodium | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Tirzepatide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Lepodisiran | Other | Phase PHASE1 | Liver Dysfunction | RECRUITING | NCT06916078 |
| LY4395089 | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Durvalumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Olomorasib | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Tirzepatide | Other | Phase PHASE1 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT07299084 |
| Placebo | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| LY3981314 | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| Tirzepatide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07438444 |
| Pirtobrutinib | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | RECRUITING | NCT06588478 |
| Standard therapy for INCS | Drug | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY3650150 | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Fluconazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| Olomorasib | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| LY4052031 | Other | Phase PHASE1 | Metastatic Solid Tumor | RECRUITING | NCT06465069 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| LY4395089 | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Pemetrexed | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Carboplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Cisplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| LY3537982 | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Orforglipron | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| enfortumab vedotin | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pembrolizumab | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LOXO-435 | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Itraconazole | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| LY4395089 | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| Placebo | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Muvalaplin | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Placebo | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Lepodisiran Sodium | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Tirzepatide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Lepodisiran | Other | Phase PHASE1 | Liver Dysfunction | RECRUITING | NCT06916078 |
| LY4395089 | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Durvalumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Olomorasib | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Tirzepatide | Other | Phase PHASE1 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT07299084 |
| Placebo | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| LY3981314 | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| Tirzepatide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07438444 |
| Pirtobrutinib | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | RECRUITING | NCT06588478 |
| Standard therapy for INCS | Drug | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY3650150 | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Fluconazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| Olomorasib | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| LY4052031 | Other | Phase PHASE1 | Metastatic Solid Tumor | RECRUITING | NCT06465069 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| LY4395089 | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Pemetrexed | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Carboplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Cisplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| LY3537982 | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Orforglipron | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| enfortumab vedotin | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pembrolizumab | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LOXO-435 | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Itraconazole | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| LY4395089 | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| Placebo | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Muvalaplin | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Placebo | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Lepodisiran Sodium | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Tirzepatide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Lepodisiran | Other | Phase PHASE1 | Liver Dysfunction | RECRUITING | NCT06916078 |
| LY4395089 | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Durvalumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Olomorasib | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Tirzepatide | Other | Phase PHASE1 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT07299084 |
| Placebo | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| LY3981314 | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| Tirzepatide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07438444 |
| Pirtobrutinib | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | RECRUITING | NCT06588478 |
| Standard therapy for INCS | Drug | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY3650150 | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Fluconazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| Olomorasib | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| LY4052031 | Other | Phase PHASE1 | Metastatic Solid Tumor | RECRUITING | NCT06465069 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| LY4395089 | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Pemetrexed | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Carboplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Cisplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| LY3537982 | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Orforglipron | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| enfortumab vedotin | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pembrolizumab | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LOXO-435 | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Itraconazole | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| LY4395089 | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| Placebo | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Muvalaplin | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Placebo | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Lepodisiran Sodium | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Tirzepatide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Lepodisiran | Other | Phase PHASE1 | Liver Dysfunction | RECRUITING | NCT06916078 |
| LY4395089 | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Durvalumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Olomorasib | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Tirzepatide | Other | Phase PHASE1 | Diabetes Mellitus, Type 2 | ACTIVE_NOT_RECRUITING | NCT07299084 |
| Placebo | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| LY3981314 | Other | Phase PHASE1 | Healthy | ACTIVE_NOT_RECRUITING | NCT07005284 |
| Tirzepatide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07438444 |
| Pirtobrutinib | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | RECRUITING | NCT06588478 |
| Standard therapy for INCS | Drug | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY3650150 | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Fluconazole | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| Olomorasib | Other | Phase PHASE1 | Healthy | COMPLETED | NCT07439250 |
| LY4052031 | Other | Phase PHASE1 | Metastatic Solid Tumor | RECRUITING | NCT06465069 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| LY4395089 | Other | Phase PHASE2 | Crohn Disease | RECRUITING | NCT07483099 |
| Pemetrexed | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Carboplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Cisplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| LY3537982 | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Orforglipron | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| enfortumab vedotin | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pembrolizumab | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LOXO-435 | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Itraconazole | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| LY4395089 | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| Placebo | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Muvalaplin | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Placebo | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Lepodisiran Sodium | Other | Phase PHASE3 | Atherosclerotic Cardiovascular Disease (ASCVD) | ACTIVE_NOT_RECRUITING | NCT06292013 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Tirzepatide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Lepodisiran | Other | Phase PHASE1 | Liver Dysfunction | RECRUITING | NCT06916078 |
| LY4395089 | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Subcutaneous (SC) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Mirikizumab - Intravenous (IV) | Other | Phase PHASE2 | Colitis, Ulcerative | RECRUITING | NCT07483073 |
| Itraconazole | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| LY4395089 | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| Itraconazole | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| LY4395089 | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| Itraconazole | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| LY4395089 | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| Itraconazole | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| LY4395089 | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| Itraconazole | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| LY4395089 | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| Itraconazole | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| LY4395089 | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| Itraconazole | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| LY4395089 | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| Itraconazole | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| LY4395089 | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| Itraconazole | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| LY4395089 | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| Itraconazole | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| LY4395089 | Other | Phase PHASE1 | Healthy | NOT_YET_RECRUITING | NCT07592572 |
| Buprenorphine | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Placebo | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Brenipatide | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Placebo | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Donanemab | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Placebo | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| Brenipatide | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| MORF-057 | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Placebo | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Zanubrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Acalabrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Ibrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Pirtobrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Peripheral blood | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| FACT H&N | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| EORTC QLQ-30 | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Pembrolizumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Ramucirumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Placebo | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Donanemab | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Placebo | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Eloralintide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Macupatide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Buprenorphine | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Placebo | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Brenipatide | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Placebo | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Donanemab | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Placebo | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| Brenipatide | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| MORF-057 | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Placebo | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Zanubrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Acalabrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Ibrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Pirtobrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Peripheral blood | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| FACT H&N | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| EORTC QLQ-30 | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Pembrolizumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Ramucirumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Placebo | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Donanemab | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Placebo | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Eloralintide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Macupatide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Buprenorphine | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Placebo | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Brenipatide | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Placebo | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Donanemab | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Placebo | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| Brenipatide | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| MORF-057 | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Placebo | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Zanubrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Acalabrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Ibrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Pirtobrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Peripheral blood | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| FACT H&N | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| EORTC QLQ-30 | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Pembrolizumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Ramucirumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Placebo | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Donanemab | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Placebo | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Eloralintide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Macupatide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Buprenorphine | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Placebo | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Brenipatide | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Placebo | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Donanemab | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Placebo | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| Brenipatide | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| MORF-057 | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Placebo | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Zanubrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Acalabrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Ibrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Pirtobrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Peripheral blood | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| FACT H&N | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| EORTC QLQ-30 | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Pembrolizumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Ramucirumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Placebo | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Donanemab | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Placebo | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Eloralintide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Macupatide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Buprenorphine | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Placebo | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Brenipatide | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Placebo | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Donanemab | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Placebo | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| Brenipatide | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| MORF-057 | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Placebo | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Zanubrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Acalabrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Ibrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Pirtobrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Peripheral blood | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| FACT H&N | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| EORTC QLQ-30 | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Pembrolizumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Ramucirumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Placebo | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Donanemab | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Placebo | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Eloralintide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Macupatide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| EV | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| Eloralintide | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| Tirzepatide | Other | Phase PHASE4 | Psoriasis | RECRUITING | NCT06857942 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Vepugratinib | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| P-tau217 Test | Other | Phase PHASE3 | Alzheimer Disease | RECRUITING | NCT07142954 |
| Buprenorphine | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Placebo | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Brenipatide | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Carboplatin | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Bevacizumab | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| MIRV | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Pegylated liposomal doxorubicin (PLD) | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Gemcitabine | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Topotecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Paclitaxel | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Sofetabart Mipitecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Placebo | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| LY4005130 | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| Placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Orforglipron | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Placebo | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Donanemab | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Placebo | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| Brenipatide | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| Mirikizumab | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT04844606 |
| Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3532226 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3549492 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Tirzepatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3841136 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3305677 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Placebo | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| Brenipatide | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| Placebo | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Brenipatide | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| MORF-057 | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Placebo | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Zanubrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Acalabrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Ibrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Pirtobrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Peripheral blood | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| FACT H&N | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| EORTC QLQ-30 | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Pembrolizumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Ramucirumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Fulvestrant | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Exemestane | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Letrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Anastrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Abemaciclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Palbociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Ribociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| LY4064809 | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Retatrutide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Tirzepatide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Mirikizumab | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07446101 |
| Placebo | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| Orforglipron | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| Placebo | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| LY4005130 | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| LY4337713 | Other | Phase PHASE1 | Ovarian Neoplasms | RECRUITING | NCT07213791 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Placebo | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Orforglipron | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Placebo | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Donanemab | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Placebo | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Eloralintide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Macupatide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Eloralintide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Orforglipron | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Eloralintide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Eloralintide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Retatrutide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07357415 |
| Placebo | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| Eloralintide | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| LY4257529 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Standard of Care Anticancer Therapies | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| LY4257496 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| EV | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| Eloralintide | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| Tirzepatide | Other | Phase PHASE4 | Psoriasis | RECRUITING | NCT06857942 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Vepugratinib | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| P-tau217 Test | Other | Phase PHASE3 | Alzheimer Disease | RECRUITING | NCT07142954 |
| Buprenorphine | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Placebo | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Brenipatide | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Carboplatin | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Bevacizumab | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| MIRV | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Pegylated liposomal doxorubicin (PLD) | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Gemcitabine | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Topotecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Paclitaxel | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Sofetabart Mipitecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Placebo | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| LY4005130 | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| Placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Orforglipron | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Placebo | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Donanemab | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Placebo | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| Brenipatide | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| Mirikizumab | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT04844606 |
| Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3532226 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3549492 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Tirzepatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3841136 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3305677 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Placebo | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| Brenipatide | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| Placebo | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Brenipatide | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| MORF-057 | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Placebo | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Zanubrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Acalabrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Ibrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Pirtobrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Peripheral blood | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| FACT H&N | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| EORTC QLQ-30 | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Pembrolizumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Ramucirumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Fulvestrant | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Exemestane | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Letrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Anastrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Abemaciclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Palbociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Ribociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| LY4064809 | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Retatrutide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Tirzepatide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Mirikizumab | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07446101 |
| Placebo | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| Orforglipron | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| Placebo | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| LY4005130 | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| LY4337713 | Other | Phase PHASE1 | Ovarian Neoplasms | RECRUITING | NCT07213791 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Placebo | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Orforglipron | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Placebo | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Donanemab | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Placebo | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Eloralintide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Macupatide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Eloralintide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Orforglipron | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Eloralintide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Eloralintide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Retatrutide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07357415 |
| Placebo | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| Eloralintide | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| LY4257529 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Standard of Care Anticancer Therapies | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| LY4257496 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| EV | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| Eloralintide | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| Tirzepatide | Other | Phase PHASE4 | Psoriasis | RECRUITING | NCT06857942 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Vepugratinib | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| P-tau217 Test | Other | Phase PHASE3 | Alzheimer Disease | RECRUITING | NCT07142954 |
| Buprenorphine | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Placebo | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Brenipatide | Other | Phase PHASE2 | Opioid Use Disorder | RECRUITING | NCT07420283 |
| Carboplatin | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Bevacizumab | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| MIRV | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Pegylated liposomal doxorubicin (PLD) | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Gemcitabine | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Topotecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Paclitaxel | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Sofetabart Mipitecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Placebo | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| LY4005130 | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| Placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Orforglipron | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Placebo | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Donanemab | Other | Phase PHASE4 | Down Syndrome (DS) | NOT_YET_RECRUITING | NCT06911944 |
| Placebo | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| Brenipatide | Other | Phase PHASE2 | Bipolar Disorder | RECRUITING | NCT07286175 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| Mirikizumab | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT04844606 |
| Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3532226 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3549492 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Tirzepatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3841136 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3305677 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Placebo | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| Brenipatide | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| Placebo | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Brenipatide | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| MORF-057 | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Placebo | Other | Phase PHASE2 | Inflammatory Bowel Diseases | RECRUITING | NCT06226883 |
| Zanubrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Acalabrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Ibrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Pirtobrutinib | Other | Phase PHASE3 | Lymphoma, Mantle-Cell | ACTIVE_NOT_RECRUITING | NCT04662255 |
| Peripheral blood | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| FACT H&N | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| EORTC QLQ-30 | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Pembrolizumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Ramucirumab | Other | Phase PHASE1 | Head and Neck Squamous Cell Carcinoma | COMPLETED | NCT03650764 |
| Fulvestrant | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Exemestane | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Letrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Anastrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Abemaciclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Palbociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Ribociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| LY4064809 | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Retatrutide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Tirzepatide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Mirikizumab | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07446101 |
| Placebo | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| Orforglipron | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| Placebo | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| LY4005130 | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| LY4337713 | Other | Phase PHASE1 | Ovarian Neoplasms | RECRUITING | NCT07213791 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Placebo | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Orforglipron | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Placebo | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Donanemab | Other | Phase PHASE2 | Cognitive Dysfunction | NOT_YET_RECRUITING | NCT07589595 |
| Placebo | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Eloralintide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Macupatide | Other | Phase PHASE2 | Overweight | NOT_YET_RECRUITING | NCT07589608 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Eloralintide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Orforglipron | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Eloralintide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Eloralintide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Retatrutide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07357415 |
| Placebo | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| Eloralintide | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| LY4257529 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Standard of Care Anticancer Therapies | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| LY4257496 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Eloralintide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Eloralintide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Retatrutide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07357415 |
| LY4257529 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Standard of Care Anticancer Therapies | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| LY4257496 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Placebo | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| Eloralintide | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| Eloralintide | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| Fulvestrant | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Exemestane | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Letrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Anastrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Abemaciclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Palbociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Ribociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| LY4064809 | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Brenipatide | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Carboplatin | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Bevacizumab | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| MIRV | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Pegylated liposomal doxorubicin (PLD) | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Gemcitabine | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Topotecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Paclitaxel | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Sofetabart Mipitecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Placebo | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| LY4005130 | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Placebo | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Retatrutide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Tirzepatide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Mirikizumab | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT04844606 |
| Placebo | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Orforglipron | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Eloralintide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Tirzepatide | Other | Phase PHASE4 | Psoriasis | RECRUITING | NCT06857942 |
| LY4337713 | Other | Phase PHASE1 | Ovarian Neoplasms | RECRUITING | NCT07213791 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| EV | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Orforglipron | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Vepugratinib | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Mirikizumab | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07446101 |
| Placebo | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| LY4005130 | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3532226 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3549492 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Tirzepatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3841136 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3305677 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| Placebo | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| Orforglipron | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Orforglipron | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Placebo | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| Brenipatide | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| P-tau217 Test | Other | Phase PHASE3 | Alzheimer Disease | RECRUITING | NCT07142954 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| Eloralintide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Eloralintide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Retatrutide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07357415 |
| LY4257529 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Standard of Care Anticancer Therapies | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| LY4257496 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Placebo | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| Eloralintide | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| Eloralintide | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| Fulvestrant | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Exemestane | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Letrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Anastrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Abemaciclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Palbociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Ribociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| LY4064809 | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Brenipatide | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Carboplatin | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Bevacizumab | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| MIRV | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Pegylated liposomal doxorubicin (PLD) | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Gemcitabine | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Topotecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Paclitaxel | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Sofetabart Mipitecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Placebo | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| LY4005130 | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Placebo | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Retatrutide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Tirzepatide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Mirikizumab | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT04844606 |
| Placebo | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Orforglipron | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Eloralintide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Tirzepatide | Other | Phase PHASE4 | Psoriasis | RECRUITING | NCT06857942 |
| LY4337713 | Other | Phase PHASE1 | Ovarian Neoplasms | RECRUITING | NCT07213791 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| EV | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Orforglipron | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Vepugratinib | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Mirikizumab | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07446101 |
| Placebo | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| LY4005130 | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3532226 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3549492 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Tirzepatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3841136 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3305677 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| Placebo | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| Orforglipron | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Orforglipron | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Placebo | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| Brenipatide | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| P-tau217 Test | Other | Phase PHASE3 | Alzheimer Disease | RECRUITING | NCT07142954 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| Eloralintide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Eloralintide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Retatrutide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07357415 |
| LY4257529 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Standard of Care Anticancer Therapies | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| LY4257496 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Placebo | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| Eloralintide | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| Eloralintide | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| Fulvestrant | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Exemestane | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Letrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Anastrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Abemaciclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Palbociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Ribociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| LY4064809 | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Brenipatide | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Carboplatin | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Bevacizumab | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| MIRV | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Pegylated liposomal doxorubicin (PLD) | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Gemcitabine | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Topotecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Paclitaxel | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Sofetabart Mipitecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Placebo | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| LY4005130 | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Placebo | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Retatrutide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Tirzepatide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Mirikizumab | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT04844606 |
| Placebo | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Orforglipron | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Eloralintide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Tirzepatide | Other | Phase PHASE4 | Psoriasis | RECRUITING | NCT06857942 |
| LY4337713 | Other | Phase PHASE1 | Ovarian Neoplasms | RECRUITING | NCT07213791 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| EV | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Orforglipron | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Vepugratinib | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Mirikizumab | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07446101 |
| Placebo | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| LY4005130 | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3532226 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3549492 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Tirzepatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3841136 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3305677 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| Placebo | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| Orforglipron | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Orforglipron | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Placebo | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| Brenipatide | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| P-tau217 Test | Other | Phase PHASE3 | Alzheimer Disease | RECRUITING | NCT07142954 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| Placebo | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545772 |
| LY3537031 | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545772 |
| Eloralintide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Eloralintide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Placebo SC | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Mirikizumab IV | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Mirikizumab SC | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Retatrutide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07357415 |
| LY4257529 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Standard of Care Anticancer Therapies | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| LY4257496 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Placebo | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545759 |
| LY3537031 | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545759 |
| Placebo | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| Eloralintide | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| Eloralintide | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| LY4152199 - IV | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin | NOT_YET_RECRUITING | NCT07101328 |
| Fulvestrant | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Exemestane | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Letrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Anastrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Abemaciclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Palbociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Ribociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| LY4064809 | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Brenipatide | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Carboplatin | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Bevacizumab | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| MIRV | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Pegylated liposomal doxorubicin (PLD) | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Gemcitabine | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Topotecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Paclitaxel | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Sofetabart Mipitecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Placebo | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| LY4005130 | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Placebo | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Retatrutide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Tirzepatide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Mirikizumab | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT04844606 |
| Placebo | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Orforglipron | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Eloralintide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Tirzepatide | Other | Phase PHASE4 | Psoriasis | RECRUITING | NCT06857942 |
| LY4337713 | Other | Phase PHASE1 | Ovarian Neoplasms | RECRUITING | NCT07213791 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| EV | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Orforglipron | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Vepugratinib | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Mirikizumab | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07446101 |
| Placebo | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| LY4005130 | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| LY4268989 Placebo | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| Mirikizumab | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| LY4268989 | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3532226 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3549492 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Tirzepatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3841136 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3305677 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Placebo | Other | Phase PHASE2 | Obesity | COMPLETED | NCT06683508 |
| LY3549492 | Other | Phase PHASE2 | Obesity | COMPLETED | NCT06683508 |
| Placebo | Other | Phase PHASE2 | Ulcerative Colitis (UC) | RECRUITING | NCT07415044 |
| LY4268989 | Other | Phase PHASE2 | Ulcerative Colitis (UC) | RECRUITING | NCT07415044 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| Placebo | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| Orforglipron | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| LY4256984 | Other | Phase PHASE1 | Amyotrophic Lateral Sclerosis | NOT_YET_RECRUITING | NCT07571174 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Orforglipron | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Placebo | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| Brenipatide | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| P-tau217 Test | Other | Phase PHASE3 | Alzheimer Disease | RECRUITING | NCT07142954 |
| Tirzepatide | Other | Phase PHASE3 | Psoriatic Arthritis | COMPLETED | NCT06588296 |
| Ixekizumab | Other | Phase PHASE3 | Psoriatic Arthritis | COMPLETED | NCT06588296 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| Placebo | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545772 |
| LY3537031 | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545772 |
| Eloralintide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Eloralintide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Macupatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT07215559 |
| Placebo SC | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Mirikizumab IV | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Mirikizumab SC | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Retatrutide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07357415 |
| LY4257529 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Standard of Care Anticancer Therapies | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| LY4257496 | Other | Phase PHASE1 | Breast Neoplasms | RECRUITING | NCT07114601 |
| Placebo | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545759 |
| LY3537031 | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545759 |
| Placebo | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| Eloralintide | Other | Phase PHASE3 | Sleep Apnea, Obstructive | RECRUITING | NCT07369011 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| Eloralintide | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07353931 |
| LY4152199 - IV | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin | NOT_YET_RECRUITING | NCT07101328 |
| Fulvestrant | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Exemestane | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Letrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Anastrozole | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Abemaciclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Palbociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Ribociclib | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| LY4064809 | Other | Phase PHASE3 | Breast Neoplasms | RECRUITING | NCT07174336 |
| Placebo | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Brenipatide | Other | Phase PHASE2 | Asthma | RECRUITING | NCT07219173 |
| Carboplatin | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Bevacizumab | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| MIRV | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Pegylated liposomal doxorubicin (PLD) | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Gemcitabine | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Topotecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Paclitaxel | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Sofetabart Mipitecan | Other | Phase PHASE3 | Ovarian Neoplasms | RECRUITING | NCT07213804 |
| Placebo | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| LY4005130 | Other | Phase PHASE2 | Alopecia Areata | RECRUITING | NCT07533006 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07282600 |
| Placebo | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Retatrutide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Tirzepatide | Other | Phase PHASE3 | Metabolic Dysfunction-Associated Steatotic Liver Disease | RECRUITING | NCT07165028 |
| Mirikizumab | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT04844606 |
| Placebo | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Orforglipron | Other | Phase PHASE3 | Atherosclerosis Cardiovascular Disease | RECRUITING | NCT07241390 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222137 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Eloralintide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT07321886 |
| Tirzepatide | Other | Phase PHASE4 | Psoriasis | RECRUITING | NCT06857942 |
| LY4337713 | Other | Phase PHASE1 | Ovarian Neoplasms | RECRUITING | NCT07213791 |
| Placebo | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| Eloralintide | Other | Phase PHASE3 | Overweight | RECRUITING | NCT07392190 |
| EV | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Orforglipron | Other | Phase PHASE3 | Peripheral Arterial Disease | RECRUITING | NCT07223593 |
| Placebo | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Baricitinib | Other | Phase PHASE3 | Diabetes Mellitus, Type 1 | RECRUITING | NCT07222332 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Vepugratinib | Other | Phase PHASE3 | Carcinoma, Transitional Cell | RECRUITING | NCT07218380 |
| Mirikizumab | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07446101 |
| Placebo | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| LY4005130 | Other | Phase PHASE2 | Vitiligo | RECRUITING | NCT07533019 |
| LY4268989 Placebo | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| Mirikizumab | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| LY4268989 | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| Placebo | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3532226 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3549492 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Tirzepatide | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3841136 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| LY3305677 | Other | Phase PHASE2 | Obesity | RECRUITING | NCT06143956 |
| Placebo | Other | Phase PHASE2 | Obesity | COMPLETED | NCT06683508 |
| LY3549492 | Other | Phase PHASE2 | Obesity | COMPLETED | NCT06683508 |
| Placebo | Other | Phase PHASE2 | Ulcerative Colitis (UC) | RECRUITING | NCT07415044 |
| LY4268989 | Other | Phase PHASE2 | Ulcerative Colitis (UC) | RECRUITING | NCT07415044 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219953 |
| Placebo | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| Orforglipron | Other | Phase PHASE3 | Urinary Incontinence,Stress | RECRUITING | NCT07202884 |
| LY4256984 | Other | Phase PHASE1 | Amyotrophic Lateral Sclerosis | NOT_YET_RECRUITING | NCT07571174 |
| Placebo | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Orforglipron | Other | Phase PHASE3 | Osteoarthritis | RECRUITING | NCT07153471 |
| Placebo | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| Brenipatide | Other | Phase PHASE2 | Schizophrenia | RECRUITING | NCT07410507 |
| P-tau217 Test | Other | Phase PHASE3 | Alzheimer Disease | RECRUITING | NCT07142954 |
| Tirzepatide | Other | Phase PHASE3 | Psoriatic Arthritis | COMPLETED | NCT06588296 |
| Ixekizumab | Other | Phase PHASE3 | Psoriatic Arthritis | COMPLETED | NCT06588296 |
| Placebo | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| LY3537031 | Other | Phase PHASE3 | Alcohol Use Disorder | RECRUITING | NCT07219966 |
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4268989 Placebo | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| Mirikizumab | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| LY4268989 | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| LY4152199 - IV | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin | NOT_YET_RECRUITING | NCT07101328 |
| Placebo SC | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Mirikizumab IV | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Mirikizumab SC | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Tirzepatide | Other | Phase PHASE3 | Psoriatic Arthritis | COMPLETED | NCT06588296 |
| Ixekizumab | Other | Phase PHASE3 | Psoriatic Arthritis | COMPLETED | NCT06588296 |
| Placebo | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545772 |
| LY3537031 | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545772 |
| LY4256984 | Other | Phase PHASE1 | Amyotrophic Lateral Sclerosis | NOT_YET_RECRUITING | NCT07571174 |
| Placebo | Other | Phase PHASE2 | Ulcerative Colitis (UC) | RECRUITING | NCT07415044 |
| LY4268989 | Other | Phase PHASE2 | Ulcerative Colitis (UC) | RECRUITING | NCT07415044 |
| Placebo | Other | Phase PHASE2 | Obesity | COMPLETED | NCT06683508 |
| LY3549492 | Other | Phase PHASE2 | Obesity | COMPLETED | NCT06683508 |
| Placebo | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545759 |
| LY3537031 | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545759 |
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4268989 Placebo | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| Mirikizumab | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| LY4268989 | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| LY4152199 - IV | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin | NOT_YET_RECRUITING | NCT07101328 |
| Placebo SC | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Mirikizumab IV | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Mirikizumab SC | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Tirzepatide | Other | Phase PHASE3 | Psoriatic Arthritis | COMPLETED | NCT06588296 |
| Ixekizumab | Other | Phase PHASE3 | Psoriatic Arthritis | COMPLETED | NCT06588296 |
| Placebo | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545772 |
| LY3537031 | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545772 |
| LY4256984 | Other | Phase PHASE1 | Amyotrophic Lateral Sclerosis | NOT_YET_RECRUITING | NCT07571174 |
| Placebo | Other | Phase PHASE2 | Ulcerative Colitis (UC) | RECRUITING | NCT07415044 |
| LY4268989 | Other | Phase PHASE2 | Ulcerative Colitis (UC) | RECRUITING | NCT07415044 |
| Placebo | Other | Phase PHASE2 | Obesity | COMPLETED | NCT06683508 |
| LY3549492 | Other | Phase PHASE2 | Obesity | COMPLETED | NCT06683508 |
| Placebo | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545759 |
| LY3537031 | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545759 |
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4268989 Placebo | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| Mirikizumab | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| LY4268989 | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| LY4152199 - IV | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin | NOT_YET_RECRUITING | NCT07101328 |
| Placebo SC | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Mirikizumab IV | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Mirikizumab SC | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Tirzepatide | Other | Phase PHASE3 | Psoriatic Arthritis | COMPLETED | NCT06588296 |
| Ixekizumab | Other | Phase PHASE3 | Psoriatic Arthritis | COMPLETED | NCT06588296 |
| Placebo | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545772 |
| LY3537031 | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545772 |
| LY4256984 | Other | Phase PHASE1 | Amyotrophic Lateral Sclerosis | NOT_YET_RECRUITING | NCT07571174 |
| Placebo | Other | Phase PHASE2 | Ulcerative Colitis (UC) | RECRUITING | NCT07415044 |
| LY4268989 | Other | Phase PHASE2 | Ulcerative Colitis (UC) | RECRUITING | NCT07415044 |
| Placebo | Other | Phase PHASE2 | Obesity | COMPLETED | NCT06683508 |
| LY3549492 | Other | Phase PHASE2 | Obesity | COMPLETED | NCT06683508 |
| Placebo | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545759 |
| LY3537031 | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545759 |
| Rituximab | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| LY4584180 | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin's | RECRUITING | NCT07226843 |
| Tirzepatide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07438444 |
| Placebo | Other | Phase PHASE1 | Healthy | RECRUITING | NCT06945419 |
| LY4086940 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT06945419 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Tirzepatide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Standard therapy for INCS | Drug | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY3650150 | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY4268989 Placebo | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| Mirikizumab | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| LY4268989 | Other | Phase PHASE2 | Ulcerative Colitis | RECRUITING | NCT07186101 |
| Placebo | Other | Phase PHASE1 | Immune Thrombocytopenia (ITP) | RECRUITING | NCT06721013 |
| Pirtobrutinib | Other | Phase PHASE1 | Immune Thrombocytopenia (ITP) | RECRUITING | NCT06721013 |
| Placebo | Other | Phase PHASE3 | Type 1 Diabetes | ACTIVE_NOT_RECRUITING | NCT06914895 |
| Tirzepatide | Other | Phase PHASE3 | Type 1 Diabetes | ACTIVE_NOT_RECRUITING | NCT06914895 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Orforglipron | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| [14C]-LY4064809 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07519525 |
| LY4064809 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07519525 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Durvalumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Olomorasib | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Placebo | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Tirzepatide | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Mirikizumab | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Placebo | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Muvalaplin | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| LY4152199 - IV | Other | Phase PHASE1 | Lymphoma, Non-Hodgkin | NOT_YET_RECRUITING | NCT07101328 |
| Placebo | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Tirzepatide | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Mirikizumab | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Baricitinib | Other | Phase PHASE3 | Juvenile Idiopathic Arthritis | RECRUITING | NCT03773965 |
| Placebo | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07090785 |
| LY4088044 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07090785 |
| Pemetrexed | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Carboplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Cisplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| LY3537982 | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo SC | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Mirikizumab IV | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Mirikizumab SC | Other | Phase PHASE3 | Ulcerative Colitis | COMPLETED | NCT03524092 |
| Tirzepatide | Other | Phase PHASE3 | Psoriatic Arthritis | COMPLETED | NCT06588296 |
| Ixekizumab | Other | Phase PHASE3 | Psoriatic Arthritis | COMPLETED | NCT06588296 |
| Placebo | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545772 |
| LY3537031 | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545772 |
| enfortumab vedotin | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pembrolizumab | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LOXO-435 | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LY4052031 | Other | Phase PHASE1 | Metastatic Solid Tumor | RECRUITING | NCT06465069 |
| LY4256984 | Other | Phase PHASE1 | Amyotrophic Lateral Sclerosis | NOT_YET_RECRUITING | NCT07571174 |
| Dulaglutide | Other | Phase PHASE3 | Type 2 Diabetes | RECRUITING | NCT06739122 |
| Placebo | Other | Phase PHASE3 | Hypertension | RECRUITING | NCT06948422 |
| Orforglipron | Other | Phase PHASE3 | Hypertension | RECRUITING | NCT06948422 |
| Pirtobrutinib | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | RECRUITING | NCT06588478 |
| Placebo | Other | Phase PHASE2 | Ulcerative Colitis (UC) | RECRUITING | NCT07415044 |
| LY4268989 | Other | Phase PHASE2 | Ulcerative Colitis (UC) | RECRUITING | NCT07415044 |
| Placebo | Other | Phase PHASE2 | Obesity | COMPLETED | NCT06683508 |
| LY3549492 | Other | Phase PHASE2 | Obesity | COMPLETED | NCT06683508 |
| Placebo | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545759 |
| LY3537031 | Other | Phase PHASE2 | Irritable Bowel Syndrome | RECRUITING | NCT07545759 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Orforglipron | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Placebo | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Muvalaplin | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Placebo | Other | Phase PHASE1 | Immune Thrombocytopenia (ITP) | RECRUITING | NCT06721013 |
| Pirtobrutinib | Other | Phase PHASE1 | Immune Thrombocytopenia (ITP) | RECRUITING | NCT06721013 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Tirzepatide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Placebo | Other | Phase PHASE3 | Hypertension | RECRUITING | NCT06948422 |
| Orforglipron | Other | Phase PHASE3 | Hypertension | RECRUITING | NCT06948422 |
| enfortumab vedotin | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pembrolizumab | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LOXO-435 | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pemetrexed | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Carboplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Cisplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| LY3537982 | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Tirzepatide | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Mirikizumab | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Placebo | Other | Phase PHASE1 | Healthy | RECRUITING | NCT06945419 |
| LY4086940 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT06945419 |
| Placebo | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07090785 |
| LY4088044 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07090785 |
| Baricitinib | Other | Phase PHASE3 | Juvenile Idiopathic Arthritis | RECRUITING | NCT03773965 |
| Pirtobrutinib | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | RECRUITING | NCT06588478 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Durvalumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Olomorasib | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| LY4052031 | Other | Phase PHASE1 | Metastatic Solid Tumor | RECRUITING | NCT06465069 |
| Placebo | Other | Phase PHASE3 | Type 1 Diabetes | ACTIVE_NOT_RECRUITING | NCT06914895 |
| Tirzepatide | Other | Phase PHASE3 | Type 1 Diabetes | ACTIVE_NOT_RECRUITING | NCT06914895 |
| Dulaglutide | Other | Phase PHASE3 | Type 2 Diabetes | RECRUITING | NCT06739122 |
| [14C]-LY4064809 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07519525 |
| LY4064809 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07519525 |
| Tirzepatide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07438444 |
| Placebo | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Tirzepatide | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Mirikizumab | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Standard therapy for INCS | Drug | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY3650150 | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Orforglipron | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Placebo | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Muvalaplin | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Placebo | Other | Phase PHASE1 | Immune Thrombocytopenia (ITP) | RECRUITING | NCT06721013 |
| Pirtobrutinib | Other | Phase PHASE1 | Immune Thrombocytopenia (ITP) | RECRUITING | NCT06721013 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Tirzepatide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Placebo | Other | Phase PHASE3 | Hypertension | RECRUITING | NCT06948422 |
| Orforglipron | Other | Phase PHASE3 | Hypertension | RECRUITING | NCT06948422 |
| enfortumab vedotin | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pembrolizumab | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LOXO-435 | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pemetrexed | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Carboplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Cisplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| LY3537982 | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Tirzepatide | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Mirikizumab | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Placebo | Other | Phase PHASE1 | Healthy | RECRUITING | NCT06945419 |
| LY4086940 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT06945419 |
| Placebo | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07090785 |
| LY4088044 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07090785 |
| Baricitinib | Other | Phase PHASE3 | Juvenile Idiopathic Arthritis | RECRUITING | NCT03773965 |
| Pirtobrutinib | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | RECRUITING | NCT06588478 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Durvalumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Olomorasib | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| LY4052031 | Other | Phase PHASE1 | Metastatic Solid Tumor | RECRUITING | NCT06465069 |
| Placebo | Other | Phase PHASE3 | Type 1 Diabetes | ACTIVE_NOT_RECRUITING | NCT06914895 |
| Tirzepatide | Other | Phase PHASE3 | Type 1 Diabetes | ACTIVE_NOT_RECRUITING | NCT06914895 |
| Dulaglutide | Other | Phase PHASE3 | Type 2 Diabetes | RECRUITING | NCT06739122 |
| [14C]-LY4064809 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07519525 |
| LY4064809 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07519525 |
| Tirzepatide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07438444 |
| Placebo | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Tirzepatide | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Mirikizumab | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Standard therapy for INCS | Drug | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY3650150 | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Omeprazole | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT05134350 |
| LOXO-305 | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT05134350 |
| Omeprazole | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT05134350 |
| LOXO-305 | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT05134350 |
| Omeprazole | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT05134350 |
| LOXO-305 | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT05134350 |
| Ibrutinib | Other | Phase PHASE3 | Chronic Lymphocytic Leukemia | RECRUITING | NCT05254743 |
| Pirtobrutinib | Other | Phase PHASE3 | Chronic Lymphocytic Leukemia | RECRUITING | NCT05254743 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Orforglipron | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Placebo | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Muvalaplin | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Placebo | Other | Phase PHASE1 | Immune Thrombocytopenia (ITP) | RECRUITING | NCT06721013 |
| Pirtobrutinib | Other | Phase PHASE1 | Immune Thrombocytopenia (ITP) | RECRUITING | NCT06721013 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Tirzepatide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Placebo | Other | Phase PHASE3 | Hypertension | RECRUITING | NCT06948422 |
| Orforglipron | Other | Phase PHASE3 | Hypertension | RECRUITING | NCT06948422 |
| enfortumab vedotin | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pembrolizumab | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LOXO-435 | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pemetrexed | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Carboplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Cisplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| LY3537982 | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Tirzepatide | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Mirikizumab | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Placebo | Other | Phase PHASE1 | Healthy | RECRUITING | NCT06945419 |
| LY4086940 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT06945419 |
| Placebo | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07090785 |
| LY4088044 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07090785 |
| Baricitinib | Other | Phase PHASE3 | Juvenile Idiopathic Arthritis | RECRUITING | NCT03773965 |
| Pirtobrutinib | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | RECRUITING | NCT06588478 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Durvalumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Olomorasib | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| LY4052031 | Other | Phase PHASE1 | Metastatic Solid Tumor | RECRUITING | NCT06465069 |
| Placebo | Other | Phase PHASE3 | Type 1 Diabetes | ACTIVE_NOT_RECRUITING | NCT06914895 |
| Tirzepatide | Other | Phase PHASE3 | Type 1 Diabetes | ACTIVE_NOT_RECRUITING | NCT06914895 |
| Dulaglutide | Other | Phase PHASE3 | Type 2 Diabetes | RECRUITING | NCT06739122 |
| [14C]-LY4064809 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07519525 |
| LY4064809 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07519525 |
| Tirzepatide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07438444 |
| Placebo | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Tirzepatide | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Mirikizumab | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Standard therapy for INCS | Drug | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY3650150 | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Pirtobrutinib | Other | Preclinical | Leukemia, Lymphocytic, Chronic, B-Cell | APPROVED_FOR_MARKETING | NCT05172700 |
| Pirtobrutinib | Other | Preclinical | Leukemia, Lymphocytic, Chronic, B-Cell | APPROVED_FOR_MARKETING | NCT05172700 |
| Rifampin | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT05134337 |
| Itraconazole | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT05134337 |
| LOXO-305 | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT05134337 |
| Rifampin | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT05134337 |
| Itraconazole | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT05134337 |
| LOXO-305 | Other | Phase PHASE1 | Healthy Volunteers | COMPLETED | NCT05134337 |
| Allopurinol | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Valacyclovir | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Venetoclax | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Obinutuzumab | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Pirtobrutinib | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Allopurinol | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Valacyclovir | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Venetoclax | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Obinutuzumab | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Pirtobrutinib | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Allopurinol | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Valacyclovir | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Venetoclax | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Obinutuzumab | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Pirtobrutinib | Other | Phase PHASE2 | Leukemia | RECRUITING | NCT05536349 |
| Venetoclax | Other | Phase PHASE2 | Mantle Cell Lymphoma | RECRUITING | NCT05529069 |
| Pirtobrutinib | Other | Phase PHASE2 | Mantle Cell Lymphoma | RECRUITING | NCT05529069 |
| Venetoclax | Other | Phase PHASE2 | Mantle Cell Lymphoma | RECRUITING | NCT05529069 |
| Pirtobrutinib | Other | Phase PHASE2 | Mantle Cell Lymphoma | RECRUITING | NCT05529069 |
| Ibrutinib | Other | Phase PHASE3 | Chronic Lymphocytic Leukemia | RECRUITING | NCT05254743 |
| Pirtobrutinib | Other | Phase PHASE3 | Chronic Lymphocytic Leukemia | RECRUITING | NCT05254743 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Orforglipron | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06672549 |
| Placebo | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Muvalaplin | Other | Phase PHASE3 | Elevated Lp(a) | RECRUITING | NCT07157774 |
| Placebo | Other | Phase PHASE1 | Immune Thrombocytopenia (ITP) | RECRUITING | NCT06721013 |
| Pirtobrutinib | Other | Phase PHASE1 | Immune Thrombocytopenia (ITP) | RECRUITING | NCT06721013 |
| Placebo | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Tirzepatide | Other | Phase PHASE3 | Obesity | RECRUITING | NCT06439277 |
| Placebo | Other | Phase PHASE3 | Hypertension | RECRUITING | NCT06948422 |
| Orforglipron | Other | Phase PHASE3 | Hypertension | RECRUITING | NCT06948422 |
| enfortumab vedotin | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pembrolizumab | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| LOXO-435 | Other | Phase PHASE1 | Urinary Bladder Neoplasms | RECRUITING | NCT05614739 |
| Pemetrexed | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Carboplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Cisplatin | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| LY3537982 | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06119581 |
| Placebo | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Tirzepatide | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Mirikizumab | Other | Phase PHASE3 | Crohn's Disease | RECRUITING | NCT06937099 |
| Placebo | Other | Phase PHASE1 | Healthy | RECRUITING | NCT06945419 |
| LY4086940 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT06945419 |
| Placebo | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07090785 |
| LY4088044 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07090785 |
| Baricitinib | Other | Phase PHASE3 | Juvenile Idiopathic Arthritis | RECRUITING | NCT03773965 |
| Pirtobrutinib | Other | Phase PHASE2 | Chronic Lymphocytic Leukemia | RECRUITING | NCT06588478 |
| Placebo | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Durvalumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Pembrolizumab | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| Olomorasib | Other | Phase PHASE3 | Carcinoma, Non-Small-Cell Lung | RECRUITING | NCT06890598 |
| LY4052031 | Other | Phase PHASE1 | Metastatic Solid Tumor | RECRUITING | NCT06465069 |
| Placebo | Other | Phase PHASE3 | Type 1 Diabetes | ACTIVE_NOT_RECRUITING | NCT06914895 |
| Tirzepatide | Other | Phase PHASE3 | Type 1 Diabetes | ACTIVE_NOT_RECRUITING | NCT06914895 |
| Dulaglutide | Other | Phase PHASE3 | Type 2 Diabetes | RECRUITING | NCT06739122 |
| [14C]-LY4064809 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07519525 |
| LY4064809 | Other | Phase PHASE1 | Healthy | RECRUITING | NCT07519525 |
| Tirzepatide | Other | Phase PHASE4 | Diabetes Mellitus, Type 2 | RECRUITING | NCT07438444 |
| Placebo | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Tirzepatide | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Mirikizumab | Other | Phase PHASE3 | Ulcerative Colitis | RECRUITING | NCT06937086 |
| Standard therapy for INCS | Drug | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| Placebo | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
| LY3650150 | Other | Phase PHASE3 | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | RECRUITING | NCT06338995 |
Total products: 1579